https://dev.clinicalresearch.eu/trials https://dev.clinicalresearch.eu/trial/18f-mc225-pet-imaging-to-quantify-p-glycoprotein-function-at-the-blood-brain-barrier-in-patients-with-suspected-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/2022-501606-35-00-randomized-multicenter-open-label-phase-3-study-of-mirvetuximab-soravtansine-in-combination-with-bevacizumab-versus-bevacizumab-alone-as-maintenance-therapy-for-patients-with-fra-hig2026-10-07 https://dev.clinicalresearch.eu/trial/20289-a-phase-2-basket-study-of-the-oral-trk-inhibitor-larotrectinib-in-subjects-with-ntrk-fusion-positive-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/20290-a-phase-1-2-study-of-the-oral-trk-inhibitor-larotrectinib-in-pediatric-patients-with-advanced-solid-or-primary-central-nervous-system-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/20321-an-open-label-single-arm-roll-over-study-to-provide-continued-treatment-with-darolutamide-in-participants-who-were-enrolled-in-previous-bayer-sponsored-studies2026-10-07 https://dev.clinicalresearch.eu/trial/21140-aranote-a-randomized-double-blind-placebo-controlled-phase-3-study-of-darolutamide-in-addition-to-androgen-deprivation-therapy-adt-versus-placebo-plus-adt-in-men-with-metastatic-hormone-sensitiv2026-10-07 https://dev.clinicalresearch.eu/trial/21181-a-multicenter-randomized-prospective-double-blind-cross-over-phase-3-study-to-evaluate-the-efficacy-and-safety-of-0-04-mmol-gd-kg-body-weight-of-gadoquatrane-for-mri-in-adults-with-known-or-susp2026-10-07 https://dev.clinicalresearch.eu/trial/21196-a-multicenter-prospective-open-label-study-to-evaluate-the-pharmacokinetics-and-safety-of-gadoquatrane-in-pediatric-participants-from-birth-to-18-years-undergoing-contrast-enhanced-magnetic-reso2026-10-07 https://dev.clinicalresearch.eu/trial/21197-a-multicenter-randomized-prospective-double-blind-cross-over-phase-3-study-to-evaluate-the-efficacy-and-safety-of-0-04-mmol-gd-kg-body-weight-of-gadoquatrane-for-mri-in-adults-with-known-or-susp2026-10-07 https://dev.clinicalresearch.eu/trial/21466-a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-to-investigate-the-efficacy-safety-and-pk-pd-of-finerenone-in-addition-to-standard-of-care-in-pediatric-patients-6-months-t2026-10-07 https://dev.clinicalresearch.eu/trial/21467-a-phase-3-single-arm-open-label-extension-study-to-evaluate-the-safety-of-finerenone-in-addition-to-standard-of-care-in-pediatric-heart-failure-patients-from-birth-to-18-years-of-age-with-left-v2026-10-07 https://dev.clinicalresearch.eu/trial/21492-arastep-a-randomized-double-blind-placebo-controlled-phase-3-study-of-darolutamide-plus-androgen-deprivation-therapy-adt-compared-with-placebo-plus-adt-in-patients-with-high-risk-biochemical-rec2026-10-07 https://dev.clinicalresearch.eu/trial/21751-first-in-human-single-dose-escalation-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bay-3018250-in-healthy-men-in-a-randomized-placebo-controlled-single-b2026-10-07 https://dev.clinicalresearch.eu/trial/22081-open-label-fixed-sequence-crossover-study-to-determine-the-effects-of-a-single-dose-of-elinzanetant-bay-3427080-on-the-pharmacokinetics-of-dabigatran-etexilate-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/22104-a-randomized-double-blind-placebo-controlled-multicenter-phase-2b-3-study-to-evaluate-the-efficacy-and-safety-of-izokibep-in-subjects-with-active-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/22153-randomized-double-masked-active-controlled-phase-3-study-of-the-efficacy-and-safety-of-aflibercept-8-mg-in-macular-edema-secondary-to-retinal-vein-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/22419-a-randomized-double-blind-placebo-controlled-parallel-group-phase-2a-study-with-an-extension-phase-to-evaluate-the-efficacy-and-safety-of-bay-3401016-in-participants-aged-18-to-45-with-alport-sy2026-10-07 https://dev.clinicalresearch.eu/trial/68ga-dotatate-pet-ct-and-177lu-oxodotreotide-in-patients-with-well-differentiated-grade-2-gastroenteropancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/68ga-fapi-pet-ct-imaging-to-assess-pulmonary-artery-and-right-ventricle-remodeling-sofapi-study2026-10-07 https://dev.clinicalresearch.eu/trial/68ga-ga-pentixafor-positron-emission-tomography-for-improved-risk-and-disease-assessment-in-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/89zr-trastuzumab-pet-imaging-in-her2-positive-breast-cancer-gastroesophageal-adenocarcinomas-and-erbbr2-gene-altered-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-104-week-multicenter-open-label-single-arm-phase-3-extension-trial-investigating-the-long-term-safety-and-efficacy-of-glepaglutide-in-adult-patients-with-short-bowel-syndrome-sbs-rolling-over-from-t2026-10-07 https://dev.clinicalresearch.eu/trial/a-12-month-randomized-multicenter-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-safety-and-efficacy-of-daily-subcutaneous-metreleptin-treatment-in-subjects-with-partial-lipodystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/a-2-part-multicenter-randomized-blinded-active-controlled-phase-2-study-to-sequentially-evaluate-the-safety-and-efficacy-of-biib091-monotherapy-and-biib091-combination-therapy-with-diroximel-fumarate-2026-10-07 https://dev.clinicalresearch.eu/trial/a-2-stage-adaptive-randomised-double-blind-placebo-controlled-multicentre-study-to-evaluate-dose-and-treatment-effect-of-pentosan-polysulfate-sodium-compared-with-placebo-in-participants-with-knee-ost2026-10-07 https://dev.clinicalresearch.eu/trial/a-2-year-open-label-extension-study-to-assess-the-long-term-safety-and-efficacy-of-lebrikizumab-in-adult-and-adolescent-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-24-month-multi-centre-open-label-phase-iv-post-authorisation-efficacy-study-to-evaluate-the-efficacy-safety-and-immunogenicity-of-daily-subcutaneous-metreleptin-treatment-in-patients-with-partial-li2026-10-07 https://dev.clinicalresearch.eu/trial/a-26-week-with-26-week-extension-randomized-multi-center-double-blind-phase-2-study-to-evaluate-the-efficacy-and-safety-of-xc001-gene-therapy-as-an-adjunct-to-coronary-artery-bypass-graft-surgery-for-2026-10-07 https://dev.clinicalresearch.eu/trial/a-3-month-phase-2-single-blind-randomised-no-treatment-controlled-study-assessing-efficacy-and-safety-of-renaparin-r-for-improvement-of-kidney-graft-function-in-deceased-donor-transplant-recipients-wi2026-10-07 https://dev.clinicalresearch.eu/trial/a-4-week-double-blind-randomized-placebo-controlled-phase-ii-study-evaluating-the-effects-of-oral-pamapimod-150-mg-with-pioglitazone-10-mg-daily-on-covid-19-evolution-and-recovery-in-non-hospitalized-2026-10-07 https://dev.clinicalresearch.eu/trial/a-40-week-randomized-study-evaluating-the-efficacy-and-safety-of-weekly-insulin-icodec-semaglutide-versus-daily-insulin-glargine-in-type-2-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-40-week-study-comparing-the-efficacy-safety-and-patient-reported-outcomes-of-once-weekly-icosema-and-once-or-twice-daily-insulin-degludec-insulin-aspart-100-units-ml-both-treatment-arms-with-or-with2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-phase-3-open-label-extension-study-of-acp-204-in-adults-with-lewy-body-dementia-psychosis-lbdp2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-randomised-double-blind-multicentre-2-arm-parallel-group-trial-assessing-the-efficacy-and-safety-of-chf6001-total-daily-dose-3200-mg-dry-powder-inhaler-dpi-add-on-to-maintenance-medium-or-hi2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-randomized-controlled-trial-of-intramuscular-testosterone-undecanoate-on-intrahepatic-fat-in-obese-hypogonadal-men-with-type-2-diabetes-or-prediabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-randomized-double-blind-placebo-controlled-multi-center-phase-2b-study-with-a-52-week-blinded-extension-and-an-optional-open-label-extension-assessing-the-safety-and-efficacy-of-frexalimab-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-randomized-double-blind-trial-comparing-chf5993-beclometasone-dipropionate-formoterol-fumarate-glycopyrronium-bromide-to-fluticasone-propionate-salmeterol-in-adolescents-with-uncontrolled-as2026-10-07 https://dev.clinicalresearch.eu/trial/a-52-week-study-of-dexpramipexole-with-standard-asthma-drug-combination-in-adolescents-and-adults-with-severe-eosinophilic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-and-bioavailability-study-of-indapamide-sr-1-5-mg-film-coated-mini-tablet-versus-indapamide-sr-1-5-mg-and-indapamide-ir-2-5-mg-film-coated-tablets-in-healthy-participants-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-and-safety-study-of-free-acid-tafamidis-61-mg-capsule-and-tablet-in-healthy-adults-under-fed-conditions-for-the-treatment-of-transthyretin-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-comparing-two-formulations-of-rosuvastatin-in-patients-with-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-a-68-mg-etonogestrel-implant-in-healthy-pre-menopausal-nonpregnant-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-a-test-product-compared-to-a-reference-product-in-adult-patients-with-schizophrenia-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-empagliflozin-25-mg-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-empagliflozin-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-lenvatinib-10-mg-capsules-versus-lenvatinib-10-mg-capsules-in-healthy-participants-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-mirabegron-50-mg-prolonged-release-tablets-in-healthy-participants-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-mirabegron-50-mg-prolonged-release-tablets-in-healthy-participants-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-netupitant-palonosetron-oral-suspension-versus-hard-capsules-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-testosterone-transdermal-gel-in-healthy-female-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-formulations-of-dapagliflozin-and-metformin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-formulations-of-ezetimibe-and-atorvastatin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-formulations-of-ezetimibe-and-atorvastatin-in-healthy-volunteers-22026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-formulations-of-linagliptin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-loperamide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-oral-formulations-of-linagliptin-and-metformin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-of-two-oral-formulations-of-loperamide-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-bioequivalence-study-to-compare-the-pharmacokinetics-of-parkinson-s-disease-medications-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-biomarker-directed-multi-centre-phase-ii-iii-study-of-ctdna-response-adaptive-immuno-chemotherapy-in-lung-cancer-br-362026-10-07 https://dev.clinicalresearch.eu/trial/a-biomarker-enrichment-trial-of-anti-egfr-agents-in-patients-with-advanced-colorectal-cancer-acrc-with-wild-type-ras-and-right-primary-tumour-location-right-ptl-ariel-engic-trial2026-10-07 https://dev.clinicalresearch.eu/trial/a-clinical-trial-of-pembrolizumab-mk-3475-evaluating-predictive-biomarkers-in-subjects-with-advanced-solid-tumors-keynote-1582026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-bioavailability-and-bioequivalence-study-of-two-dosage-formulations-of-an-investigational-medicinal-product-in-healthy-adults-for-migraine-management2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-bioavailability-study-of-indapamide-sr-1-5-mg-mini-tablets-versus-indapamide-ir-2-5-mg-tablets-under-fasting-and-fed-conditions-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-bioavailability-study-of-two-oral-formulations-of-dexketoprofen-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-pharmacokinetic-study-of-different-oral-formulations-of-petadeferitrin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-pharmacokinetic-study-of-two-survodutide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-abp-234-and-pembrolizumab-in-patients-with-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-pre-filled-syringe-and-pen-injector-formulations-of-survodutide-in-healthy-and-overweight-or-obese-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-pre-filled-syringe-versus-pen-injector-formulations-of-survodutide-in-healthy-volunteers-and-individuals-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-prefilled-syringe-and-autoinjector-delivery-formulations-of-fyb202-in-patients-with-chronic-inflammatory-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-rituximab-and-cyclophosphamide-versus-rituximab-monotherapy-in-patients-with-anca-associated-vasculitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-somapacitan-and-somatropin-in-pediatric-patients-with-short-stature-due-to-sga-turner-syndrome-noonan-syndrome-or-idiopathic-short-stature2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-the-pharmacokinetics-safety-and-tolerability-of-epoetin-alfa-following-multiple-intravenous-doses-in-healthy-male-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-the-pharmacokinetics-safety-and-tolerability-of-single-intravenous-doses-of-epoetin-alfa-and-erythropoietin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-comparative-study-of-triamcinolone-acetonide-and-triamcinolone-hexacetonide-injection-strategies-versus-surgical-intervention-in-carpal-tunnel-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-crossover-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-mucosal-versus-oral-tacrolimus-administration-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-danish-double-blind-randomized-placebo-controlled-clinical-trial-evaluating-allogeneic-adipose-tissue-derived-mesenchymal-stromal-cell-therapy-in-patients-with-recently-diagnosed-non-ischemic-heart-2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-blinded-extension-study-to-evaluate-the-long-term-efficacy-safety-and-tolerability-of-ucb0599-in-study-participants-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-determination-study-of-sugammadex-as-a-rocuronium-decurarization-agent-in-children-under-2-years-of-age2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-escalation-study-to-evaluate-the-efficacy-and-safety-of-andexanet-alfa-on-systemic-coagulation-profiles-in-healthy-volunteers-following-factor-xa-inhibitor-administration2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-finding-study-of-once-weekly-subcutaneous-ubt251-versus-semaglutide-in-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-ranging-randomized-open-label-study-evaluating-the-effect-of-bilateral-intravitreal-injection-of-gs010-at-two-dose-levels-on-visual-acuity-and-retinal-mitochondrial-activity-in-patients-affecte2026-10-07 https://dev.clinicalresearch.eu/trial/a-dose-ranging-study-to-evaluate-the-effects-of-oral-macitentan-10-mg-versus-75-mg-on-endothelin-1-clearance-endothelial-function-and-hemodynamics-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-multicentre-randomised-three-period-three-treatment-cross-over-study-to-evaluate-the-effect-of-bgf-mdi-bff-mdi-and-placebo-mdi-on-exercise-parameters-in-participants-with-chronic-obstru2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-placebo-controlled-crossover-study-to-evaluate-the-effect-of-steady-state-azd6793-on-the-pharmacokinetics-and-pharmacodynamics-of-metformin-in-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-placebo-controlled-phase-2-efficacy-and-safety-study-of-acp-204-in-adults-with-lewy-body-dementia-psychosis-lbdp2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-active-controlled-parallel-group-phase-1-3-study-to-compare-efficacy-pharmacokinetics-pharmacodynamics-and-safety-of-ct-p53-and-ocrevus-in-patients-with-relapsing-remitting-m2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-controlled-trial-of-clostridium-botulinum-neurotoxin-type-a-injection-in-preoperative-management-of-large-incisional-hernia2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-phase-iii-study-of-radiotherapy-combined-with-cetuximab-xevinapant-compared-to-radiotherapy-combined-with-cetuximab-standard-of-care-placebo-in-patients-with-locally-advanced2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-interventional-multicenter-phase-iii-clinical-trial-to-investigate-the-safety-and-efficacy-of-abcb5-positive-mesenchymal-stromal-cells-abcb5-mscs-on-epider2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-multi-center-study-evaluating-the-safety-tolerability-and-effect-of-olpasiran-on-coronary-artery-plaque-burden-assessed-by-coronary-computed-tomography-ang2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-study-of-wharton-s-jelly-derived-allogeneic-mesenchymal-stromal-cells-for-type-1-diabetes-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-tolerability-of-intravenous-ganaxolone-added-to-standard-of-care-in-refractory-status-epilepticus2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-trial-of-vericiguat-in-patients-with-heart-failure-with-reduced-ejection-fraction-hfref-using-cardiomems-tm-hf-system2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-trial-to-assess-safety-and-efficacy-of-sls-005-trehalose-injection-90-5-mg-ml-for-intravenous-infusion-for-the-treatment-of-adults-with-spinocerebellar-ata2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-blind-randomized-placebo-controlled-trial-to-evaluate-the-efficacy-pharmacokinetics-and-safety-of-remibrutinib-lou064-for-24-weeks-in-adolescents-from-12-to-less-than-18-years-of-age-with-chr2026-10-07 https://dev.clinicalresearch.eu/trial/a-double-masked-randomized-placebo-controlled-parallel-group-12-week-administration-with-two-week-gradual-dose-taper-phase-and-38-week-follow-up-phase-phase-3-study-to-investigate-the-safety-and-effic2026-10-07 https://dev.clinicalresearch.eu/trial/a-first-in-human-double-blind-placebo-controlled-multiple-ascending-dose-study-of-intrathecally-administered-ltx-002-in-adult-participants-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-first-in-human-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-klr-003-in-healthy-volunteers-and-patients-with-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-four-way-crossover-thorough-qt-qtc-study-to-evaluate-the-electrocardiographic-effects-of-therapeutic-and-supratherapeutic-doses-of-cytisinicline-in-healthy-smokers2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-multicenter-prospective-controlled-open-label-pivotal-study-of-iodofalan-131i-solution-for-injection-tlx101-tx-plus-lomustine-versus-lomustine-alone-in-patients-with-radiographically-confirme2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-multicenter-randomized-double-blind-double-dummy-parallel-group-phase-3b-study-to-assess-the-efficacy-safety-and-tolerability-of-remibrutinib-25-mg-b-i-d-in-comparison-to-placebo-with-omalizu2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-open-label-adaptive-design-study-to-investigate-the-efficacy-and-safety-of-serpinpc-in-subjects-with-severe-hemophilia-a-or-moderately-severe-to-severe-hemophilia-b-present-22026-10-07 https://dev.clinicalresearch.eu/trial/a-global-open-label-study-to-investigate-the-efficacy-and-safety-of-serpinpc-in-subjects-with-hemophilia-b-with-inhibitors-present-32026-10-07 https://dev.clinicalresearch.eu/trial/a-global-phase-1-2-open-label-dose-optimization-study-to-evaluate-the-safety-pharmacodynamics-and-pharmacokinetics-of-mrna-3927-in-participants-with-propionic-acidemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-phase-1-2-study-to-evaluate-the-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-mrna-3705-in-participants-with-isolated-methylmalonic-acidemia-due-to-methylmalonyl-coa-mutase-def2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-phase-3-multicenter-open-label-study-to-assess-the-long-term-safety-and-tolerability-of-nbi-1117568-in-adults-with-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-global-phase-3-randomized-multicenter-open-label-study-to-evaluate-the-efficacy-and-safety-of-firmonertinib-compared-with-investigator-s-choice-of-osimertinib-or-afatinib-as-first-line-treatment-in-2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-follow-up-study-to-evaluate-safety-and-tolerability-of-olipudase-alfa-in-patients-who-completed-the-dfi12712-or-the-lts13632-study-in-france-pta173972026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-follow-up-study-to-evaluate-the-safety-and-efficacy-of-adeno-associated-virus-aav-serotype-8-aav8-mediated-gene-transfer-of-human-ornithine-transcarbamylase-otc-in-adults-with-late-onset-o2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-safety-extension-study-of-mavacamten-myk-461-in-adults-with-hypertrophic-cardiomyopathy-who-have-completed-the-maverickhcm-myk-461-006-or-explorer-hcm-myk-461-005-trials-mava-lte2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-safety-study-of-kyv-101-in-patients-previously-treated-for-lupus-nephritis-systemic-sclerosis-myasthenia-gravis-rheumatoid-arthritis-or-stiff-person-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-study-of-apremilast-in-children-with-mouth-ulcers-from-behcet-s-disease-or-juvenile-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-study-to-evaluate-the-safety-and-effectiveness-of-bitopertin-in-patients-with-erythropoietic-protoporphyria-or-x-linked-protoporphyria2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-study-to-evaluate-the-safety-and-effectiveness-of-imeroprubart-in-adult-patients-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-long-term-study-to-evaluate-the-safety-and-effectiveness-of-navenibart-in-people-with-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/a-modular-phase-i-ii-open-label-multi-centre-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-of-azd3632-monotherapy-or-in-combination-with-anticanc2026-10-07 https://dev.clinicalresearch.eu/trial/a-modular-phase-i-iia-open-label-multi-center-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-azd0516-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-2026-10-07 https://dev.clinicalresearch.eu/trial/a-modular-phase-i-iia-open-label-multicentre-study-to-assess-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-of-ascending-doses-of-azd5305-as-monotherapy-and-in-comb2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-double-blind-placebo-controlled-phase-ii-study-evaluating-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-ro7268489-a-monoacylglycerol-lipase-inhibitor-as-add-on-therapy-to2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-double-blind-randomized-placebo-controlled-2-way-cross-over-post-approval-study-to-investigate-the-efficacy-of-daridorexant-in-subjects-with-insomnia-and-comorbid-nocturia2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-open-label-randomized-phase-3-trial-comparing-the-safety-and-efficacy-of-177lu-lu-psma-i-t-versus-hormone-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-open-label-single-arm-study-to-evaluate-the-efficacy-and-safety-of-oral-rilzabrutinib-in-adults-with-immune-thrombocytopenia-itp-who-failed-first-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-randomized-active-controlled-clinical-trial-to-evaluate-the-efficacy-and-safety-of-otl-203-in-subjects-with-mucopolysaccharidosis-type-i-hurler-syndrome-mps-ih-compared-to-standard-of-c2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-randomized-double-blind-placebo-controlled-parallel-group-dose-finding-study-to-evaluate-efficacy-safety-and-tolerability-of-dii235-in-adults-with-elevated-lipoprotein-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-randomized-double-blinded-phase-iib-trial-evaluating-oral-pooled-fecal-microbiotherapy-maat033-to-prevent-allogeneic-hematopoietic-cell-transplantation-complications2026-10-07 https://dev.clinicalresearch.eu/trial/a-multi-center-study-to-characterize-the-long-term-safety-and-efficacy-of-bms-986165-in-subjects-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-adaptive-randomized-controlled-trial-platform-to-evaluate-safety-and-efficacy-of-strategies-and-treatments-for-hospitalized-patients-with-respiratory-infections-strategies-and-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-double-blind-placebo-controlled-clinical-trial-to-evaluate-the-efficacy-and-safety-of-two-concentrations-of-a-mixture-of-depigmented-polymerized-allergenic-extracts-of-d-pteronyssinus-an2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-double-blind-randomized-placebo-controlled-parallel-group-twelve-week-treatment-proof-of-concept-trial-to-explore-the-efficacy-and-safety-of-idor-1117-2520-in-adults-with-moderate-to-sev2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-double-blind-randomized-study-comparing-the-safety-and-efficacy-of-vedolizumab-versus-infliximab-in-pediatric-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-double-blind-randomized-study-to-evaluate-the-effects-of-tasimelteon-vs-placebo-in-treating-pediatric-insomnia2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-double-blind-randomized-withdrawal-study-of-subcutaneous-secukinumab-for-long-term-efficacy-and-safety-in-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-evaluator-blinded-study-comparing-ritlecitinib-and-narrowband-uvb-combination-therapy-versus-ritlecitinib-monotherapy-in-vitiligo-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-extension-study-to-evaluate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-two-doses-of-linsitinib-in-subjects-with-active-moderate-to-severe-thyroid-eye-disease-ted2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-non-inferiority-trial-comparing-rituximab-and-ocrelizumab-in-patients-with-active-relapsing-remitting-multiple-sclerosis-aged-18-60-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-extension-study-to-evaluate-the-long-term-safety-and-tolerability-of-atogepant-in-pediatric-subjects-6-to-17-years-of-age-with-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-follow-up-study-to-assess-the-long-term-use-of-oral-lacosamide-in-study-participants-who-completed-ep0034-or-sp848-and-received-lacosamide-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-long-term-safety-tolerability-and-efficacy-study-of-xen1101-in-subjects-diagnosed-with-epilepsy-x-tole42026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-phase-2-basket-study-to-evaluate-the-efficacy-and-safety-of-skb264-in-combination-with-pembrolizumab-in-subjects-with-selected-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-phase-2-dose-escalation-and-confirmation-and-efficacy-expansion-study-of-zilovertamab-vedotin-mk-2140-in-combination-with-r-chp-in-participants-with-dlbcl-waveline2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-phase-3-study-to-evaluate-the-long-term-safety-and-efficacy-in-participants-who-are-currently-on-treatment-or-in-follow-up-in-studies-that-include-pembrolizumab2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-open-label-uncontrolled-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-safety-tolerability-and-activity-of-zilucoplan-in-pediatric-study-participants-from-2-to-less-than-18-year2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-placebo-controlled-randomized-double-blind-parallel-group-comparison-trial-to-investigate-the-efficacy-and-safety-of-brexpiprazole-once-weekly-qw-formulation-in-patients-with-acute-schiz2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-prospective-clinical-trrial-evaluating-patient-s-ability-to-make-an-independent-and-safe-decision-regarding-the-use-of-the-medicinal-product-sildenafil-polpharma100-mg-indicated-in-the-t2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-clinical-trial-comparing-the-efficacy-and-safety-of-certolizumab-pegol-and-belimumab-in-patients-with-moderate-or-severe-activity-of-systemic-lupus-erythematosus-cert-sle2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-controlled-single-blind-adaptive-phase-iv-clinical-trial-to-evaluate-the-efficiency-and-effectiveness-of-a-pre-emptive-pharmacogenetic-strategy-for-antidepressant-selection-in2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-controlled-trial-comparing-dapagliflozin-propanediol-and-metformin-in-early-stage-type-2-diabetes-for-mortality-and-vascular-complications2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-controlled-trial-comparing-oral-levofloxacin-monotherapy-to-intravenous-ertapenem-followed-by-oral-antibiotics-in-uncomplicated-acute-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-comparative-phase-3-study-to-evaluate-the-efficacy-and-safety-of-intravenous-imipenem-cilastatin-xnw4107-in-comparison-with-imipenem-cilastatin-relebactam-in-adul2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-parallel-group-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-iptacopan-lnp023-in-idiopathic-immune-complex-mediated-membranoproliferative-glomer2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-2-stage-trial-to-evaluate-efficacy-and-safety-of-telitacicept-compared-to-placebo-in-patients-with-moderately-to-severely-active-systemic-lupus2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-parallel-group-dose-ranging-study-to-evaluate-the-efficacy-and-safety-of-dc-806-in-participants-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-phase-2-study-to-evaluate-efficacy-safety-tolerability-pharmacokinetics-and-target-engagement-of-gsk3858279-in-adult-participants-with-chronic-2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-deucravacitinib-in-adolescent-subjects-12-years-to-less-than-18-years-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of-deucravacitinib-bms-986165-in-pediatric-subjects-with-moderate-to-severe-2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-phase-ii-platform-study-to-assess-the-efficacy-and-safety-of-investigational-compound-s-in-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-placebo-controlled-phase-ii-study-to-investigate-the-efficacy-and-safety-of-cyp-001-in-combination-with-corticosteroids-vs-corticosteroids-alone-for-the-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-double-blind-study-comparing-the-efficacy-safety-and-immunogenicity-of-fyb206-and-pembrolizumab-in-metastatic-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-open-label-phase-1b-2-trial-of-valemetostat-tosylate-plus-pembrolizumab-vs-pembrolizumab-alone-in-participants-with-advanced-or-metastatic-non-small-cell-lung-cancer-whose-tum2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-open-label-study-comparing-romiplostim-plus-dexamethasone-versus-dexamethasone-in-newly-diagnosed-primary-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-open-label-study-to-assess-the-efficacy-safety-and-pharmacokinetics-of-upadacitinib-with-a-tocilizumab-reference-arm-in-subjects-from-1-year-to-less-than-18-years-old-with-act2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-participant-and-investigator-blinded-placebo-controlled-phase-2a-study-to-assess-the-efficacy-safety-and-tolerability-of-gia632-in-adult-participants-with-moderate-to-severe-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-placebo-controlled-double-blind-adaptive-phase-3-study-to-evaluate-the-efficacy-and-safety-of-sinecatechins-defined-extract-of-green-tea-leaves-ointment-in-adult-patients-with2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-placebo-controlled-study-of-leflunomide-for-relapse-prevention-in-polymyalgia-rheumatica-during-corticosteroid-tapering2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-trial-comparing-flecainide-acetate-and-amiodarone-hydrochloride-for-cardioversion-of-paroxysmal-atrial-fibrillation-in-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-trial-comparing-fosfomycin-calcium-and-ciprofloxacin-hydrochloride-for-febrile-neutropenia-in-acute-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-randomized-trial-to-evaluate-the-efficacy-of-pioglitazone-to-promote-renal-tolerance-in-anca-associated-vasculitis-renato2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-single-arm-open-label-trial-to-evaluate-efficacy-and-safety-of-oral-twice-daily-iptacopan-in-adult-pnh-patients-who-have-hb-10-g-dl-in-response-to-anti-c5-antibody-and-switch-to-iptacopa2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicenter-uncontrolled-open-label-prospective-non-comparative-single-arm-phase-ii-study-with-bicalutamide-an-antiandrogen-in-combination-with-abemaciclib-an-oral-cdk-4-6-inhibitor-in-4-cohorts-of-2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-double-blind-randomized-controlled-trial-of-inhaled-amikacin-versus-placebo-in-critically-ill-patients-with-ventilator-associated-tracheobronchitis-amivat2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-parallel-group-phase-iib-randomised-double-blind-placebo-controlled-4-arm-24-week-study-to-evaluate-the-efficacy-and-safety-of-azd6793-tablets-in-adult-participants-with-moderate-to-very2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomised-double-blind-parallel-group-placebocontrolled-time-to-first-asthma-exacerbation-phase-iii-efficacy-and-safety-study-of-benralizumab-in-paediatric-patients-with-severe-eosinoph2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomised-double-blind-placebo-controlled-12-week-parallel-group-trial-to-evaluate-the-efficacy-and-safety-of-oral-bp1-7881-in-adult-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomised-double-blind-placebo-controlled-crossover-study-to-evaluate-the-efficacy-and-safety-of-dirocaftor-posenacaftor-nesolicaftor-in-subjects-with-cystic-fibrosis-aged-18years-or-ol2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomised-double-blind-placebo-controlled-parallel-group-phase-2a-trial-to-evaluate-the-efficacy-and-safety-of-bp1-4979-in-adult-participants-with-obsessive-compulsive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomised-study-on-percutaneous-stellate-ganglion-block-as-first-line-treatment-in-patients-with-electrical-storm-the-star-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-randomized-double-blind-placebo-controlled-dose-finding-phase-2-study-mars-17-of-gsk3858279-in-adult-participants-with-moderate-to-severe-pain-due-to-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-single-arm-trial-on-contraceptive-efficacy-safety-and-tolerability-of-lvds-levonorgestrel-vaginal-delivery-system-during-13-cycles2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-triple-blind-placebo-controlled-parallel-group-study-of-atorvastatin-in-chronic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicentre-triple-blind-placebo-controlled-parallel-group-study-of-atorvastatin-in-episodic-migraine-statinmigepisodic2026-10-07 https://dev.clinicalresearch.eu/trial/a-multicohort-open-label-phase-2-study-of-botensilimab-agen1181-for-treatment-of-advanced-melanoma-refractory-to-prior-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-multiple-ascending-dose-study-of-mk-1708-in-healthy-participants-for-amyotrophic-lateral-sclerosis-and-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-multiple-ascending-dose-study-of-mk-4318-for-the-management-of-pain-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-multiple-ascending-dose-study-of-mk-7480-in-healthy-participants-for-the-treatment-of-non-alcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-non-inferiority-randomised-and-controlled-trial-to-compare-the-safety-tolerability-and-preliminary-efficacy-between-standard-and-torque-teno-virus-guided-immunosuppression-in-stable-adult-kidney-tra2026-10-07 https://dev.clinicalresearch.eu/trial/a-parallel-group-2-arm-randomized-double-blind-12-week-trial-to-evaluate-the-efficacy-and-safety-of-mc2-25-cream-and-mc2-25-vehicle-in-subjects-with-chronic-kidney-disease-associated-pruritus-ckd-ap2026-10-07 https://dev.clinicalresearch.eu/trial/a-parallel-group-treatment-proof-of-concept-phase-2-multicenter-double-blind-randomized-2-arm-clinical-trial-to-investigate-the-efficacy-and-safety-of-subcutaneous-nt-201-injections-compared-with-plac2026-10-07 https://dev.clinicalresearch.eu/trial/a-pharmacokinetic-and-safety-study-of-bimekizumab-via-different-routes-of-administration-in-adults-with-chronic-cutaneous-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/a-pharmacokinetic-comparison-of-jpb898-and-nivolumab-in-patients-with-resected-stage-iib-iic-or-iii-melanoma-in-the-adjuvant-setting2026-10-07 https://dev.clinicalresearch.eu/trial/a-pharmacokinetic-study-of-ibuzatrelvir-following-oral-administration-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-pharmacokinetic-study-of-petrelintide-at-various-concentrations-in-participants-with-body-mass-index-27-0-kg-m2-for-weight-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-0-open-label-positron-emission-tomography-study-to-assess-the-biodistribution-and-binding-characteristics-of-11c-az14132516-following-administration-to-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-1b-first-in-human-study-to-evaluate-the-safety-and-pharmacokinetics-of-bms-986506-in-patients-with-advanced-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-1b-open-label-dose-escalation-and-dose-optimization-study-of-bgb-21447-in-patients-with-mature-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-1b-study-to-evaluate-the-safety-pharmacokinetics-and-anti-tumor-activity-of-vvd-159642-as-a-single-agent-and-in-combination-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-1b-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-immunogenicity-of-single-and-multiple-ascending-doses-of-bcx17725-in-healthy-participants-and-multiple-doses-of-bcx17725-in-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-ascending-dose-study-to-evaluate-the-safety-and-effects-on-progranulin-levels-of-ly3884963-in-patients-with-fronto-temporal-dementia-with-progranulin-mutations-ftd-grn-proclaim2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-clinical-evaluation-of-pyx-201-and-pembrolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-dose-escalation-study-of-crn09682-with-an-expansion-phase-in-participants-with-progressive-metastatic-somatostatin-receptor-type-2-sst2-expressing-neuroendocrine-neoplasms-nens-and-other-s2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-dose-escalation-trial-with-administration-schedule-exploration-evaluating-single-agent-td001-a-psma-targeted-antibody-drug-conjugate-in-patients-with-psma-expressing-metastatic-castration-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-first-in-human-study-of-dcc-3116-as-monotherapy-and-in-combination-with-ras-mapk-pathway-inhibitors-in-patients-with-advanced-or-metastatic-solid-tumors-with-ras-mapk-pathway-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-first-time-in-human-open-label-multicenter-dose-escalation-and-expansion-study-of-gsk5458514-psma-targeting-t-cell-engager-alone-or-in-combination-with-other-anti-cancer-agents-in-adult-pa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-first-time-in-human-open-label-multicenter-dose-escalation-and-expansion-study-of-the-oral-dna-polymerase-theta-inhibitor-polqi-gsk4524101-and-the-parp-inhibitor-parpi-niraparib-in-adult-p2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-global-open-label-extension-study-to-evaluate-the-long-term-safety-and-clinical-activity-of-mrna-3705-in-participants-previously-enrolled-in-other-clinical-studies-of-mrna-37052026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-multi-center-open-label-study-to-evaluate-the-safety-tolerability-and-preliminary-anti-tumor-activity-of-tng462-as-a-single-agent-and-in-combination-in-patients-with-mtap-deleted-advanced-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-multicenter-open-label-study-to-investigate-treatment-of-hydroxyurea-hu-in-combination-with-valproic-acid-vpa-or-6-mercaptopurine-6-mp-in-combination-with-vpa-in-patients-with-acute-myeloi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-multicentre-open-label-clinical-trial-of-dt-7012-as-monotherapy-and-in-combination-with-an-immune-checkpoint-inhibitor-in-participants-with-selected-advanced-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-dose-escalation-safety-pharmacokinetic-and-pharmacodynamic-study-of-oral-nuvisertib-tp-3654-in-patients-with-intermediate-or-high-risk-primary-or-secondary-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-multicenter-trial-to-characterize-the-safety-tolerability-and-preliminary-efficacy-of-cft1946-as-monotherapy-and-combination-therapy-in-subjects-with-braf-v600-mutant-solid-tumo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-platform-study-to-evaluate-safety-and-efficacy-of-etentamig-monotherapy-or-etentamig-combinations-in-subjects-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-platform-study-to-evaluate-safety-and-efficacy-of-the-bcl-2-inhibitor-abbv-453-given-as-monotherapy-or-in-combination-with-antimyeloma-regimens-in-subjects-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-randomized-dose-finding-and-dose-expansion-study-of-gedatolisib-in-combination-with-darolutamide-in-metastatic-castration-resistant-prostate-cancer-mcrpc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-rolling-arm-umbrella-platform-study-of-investigational-agents-in-combination-with-enfortumab-vedotin-plus-pembrolizumab-as-first-line-treatment-in-participants-with-locally-adva2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-study-of-debio-0123-in-combination-with-temozolomide-in-adult-participants-with-recurrent-or-progressive-glioblastoma-and-of-debio-0123-in-combination-with-temozolomide-and-radi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-open-label-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-preliminary-activity-of-tolinapant-in-combination-with-oral-decitabine-cedazuridine-and-oral-decitabine-cedazuridine-al2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-randomized-dose-finding-dose-confirmation-study-to-evaluate-the-reactogenicity-safety-and-immunogenicity-of-mrna-based-multivalent-seasonal-influenza-vaccine-candidates-administered-in-hea2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-randomized-double-blind-placebo-controlled-2-part-study-of-the-safety-tolerability-efficacy-pharmacokinetics-and-pharmacodynamics-of-single-dose-aln-6400-in-adult-healthy-volunteers-and-mu2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-arv-027-in-healthy-male-participants-and-patients-with-spinal-and-bulbar-muscular-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-bms-986408-alone-and-in-combination-with-nivolumab-or-with-nivolumab-and-ipilimumab-in-participants-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-cr-001-to-evaluate-safety-and-antitumor-activity-in-adults-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-cusp06-in-patients-with-platinum-resistant-ovarian-cancer-advanced-renal-cell-carcinoma-and-other-cdh6-positive-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-regn5668-muc16-x-cd28-a-costimulatory-bispecific-antibody-administered-in-combination-with-other-agents-in-muc16-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-regn7075-egfrxcd28-costimulatory-bispecific-antibody-in-combination-with-cemiplimab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-tas3351-in-patients-with-advanced-non-small-cell-lung-cancer-and-egfr-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-the-safety-pharmacokinetics-and-anti-tumor-activity-of-the-oral-kit-inhibitor-the-630-in-patients-with-advanced-gastrointestinal-stromal-tumors-gist2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-of-vs-7375-with-drug-combination-in-adults-with-advanced-kras-g12d-mutated-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-to-evaluate-stk-012-as-a-single-agent-and-in-combination-therapy-in-subjects-with-front-line-advanced-nsclc-and-other-selected-indications2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2-study-to-evaluate-the-safety-pharmacokinetics-and-efficacy-of-blu-222-as-a-single-agent-and-in-combination-therapy-for-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-2a-dose-escalating-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-aro-dm1-in-subjects-with-type-1-myotonic-dystrophy-who-are-18-to-65-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-adaptive-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-syx-5219-in-healthy-volunteers-and-participants-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-bioequivalence-study-of-cvc-001-cartridge-and-vial-formulations-compared-to-insulin-glargine-in-healthy-male-volunteers-using-a-glucose-clamp-technique2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-first-in-human-study-of-men2312-as-monotherapy-and-in-combination-therapy-in-participants-with-advanced-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-first-in-human-study-to-evaluate-the-safety-and-pharmacokinetics-of-ro7812653-in-patients-with-early-symptomatic-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-first-in-human-study-to-evaluate-the-safety-and-pharmacokinetics-of-sar447754-in-healthy-adults-and-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-regn20423-in-healthy-adults-and-adults-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-multicentre-open-label-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-a-single-iv-dose-of-rezafungin-acetate-in-paediatric-subjects-from-birth-to-18-years-of-age-receiving2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-multiple-ascending-dose-study-of-2-methoxyestradiol-in-healthy-non-pregnant-female-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-multicenter-study-of-incb160058-in-participants-with-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-non-comparative-multicenter-clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ceftolozane-tazobactam-mk-7625a-in-pediatric-participants-with-nosocomial-pn2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-randomized-crossover-study-to-evaluate-the-bioavailability-and-food-effect-of-various-oral-formulations-of-a-novel-investigational-compound-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-randomized-crossover-study-to-evaluate-the-pharmacokinetics-of-nurandociguat-in-patients-with-chronic-kidney-disease-under-fasted-and-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-randomized-study-to-evaluate-the-relative-bioavailability-and-safety-of-single-dose-subcutaneous-pasireotide-via-arm-thigh-or-abdominal-administration-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-single-center-study-to-determine-the-absorption-distribution-metabolism-and-excretion-of-a-single-oral-dose-of-sar443820-containing-microtracer-14c-sar443820-in-healthy-male-parti2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-single-dose-mass-balance-and-metabolite-profiling-study-of-14c-labeled-izicopan-inf904-in-healthy-male-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-study-to-assess-the-adme-and-mass-balance-of-a-single-oral-dose-of-14c-vafidemstat-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-study-to-evaluate-the-effect-of-food-on-the-relative-bioavailability-of-glpg3667-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-open-label-study-to-evaluate-the-safety-tolerability-and-efficacy-of-vididencel-in-chronic-phase-chronic-myeloid-leukemia-patients-with-measurable-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-phase-2-study-to-evaluate-the-safety-and-tolerability-of-mk-1088-as-monotherapy-and-in-combination-with-pembrolizumab-in-participants-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-crossover-study-to-evaluate-the-pharmacokinetics-of-multiple-oral-dosing-of-cs014-compared-to-valproic-acid-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-placebo-controlled-multiple-ascending-dose-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-deuruxolitinib-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-placebo-controlled-study-in-healthy-participants-followed-by-a-randomized-double-blind-placebo-controlled-phase-2-study-in-participants-with-moderate-to-severe-active2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-placebo-controlled-study-of-bbt001-in-healthy-volunteers-and-adults-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-placebo-controlled-study-of-single-and-multiple-ascending-doses-of-pf-07832837-in-healthy-adults-and-patients-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-aci-19764-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-double-blind-two-way-crossover-study-of-the-pharmacokinetics-and-pharmacodynamics-of-ql0911-in-patients-with-immune-thrombocytopenia-and-acute-radiation-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-observer-blind-placebo-controlled-age-de-escalation-study-of-the-safety-tolerability-and-immunogenicity-of-mrna-1345-and-mrna-1365-in-participants-aged-5-months-to-24-months2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-open-label-study-to-evaluate-the-effect-of-food-and-esomeprazole-on-the-single-dose-pharmacokinetics-of-arv-102-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-open-label-study-to-evaluate-the-pharmacokinetics-and-bioequivalence-of-a-levonorgestrel-vaginal-delivery-system-in-healthy-female-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-placebo-controlled-study-to-evaluate-the-safety-and-immunogenicity-of-the-nipah-measles-vector-mv-niv-vaccine-in-healthy-adults-aged-18-40-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-randomized-placebo-controlled-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intrathecal-aln-5288-in-adults-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-evaluating-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-zp7570-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-afimkibart-effects-on-cytochrome-p450-mediated-drug-metabolism-in-patients-with-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-air-001-in-adults-with-alpha-1-antitrypsin-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-autx-703-in-participants-with-relapsed-or-refractory-acute-myeloid-leukemia-or-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-im-1021-in-participants-with-advanced-solid-tumors-and-advanced-b-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-jnj-95437446-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-colorectal-cancer-or-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-of-zw251-in-participants-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-compare-the-pharmacokinetics-of-vonafexor-acid-and-its-lysine-salt-eyp651-and-evaluate-potential-drug-drug-interactions-in-healthy-volunteers-and-patients-with-impaired-renal-function-or-mash2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-effect-of-bv100-on-the-pharmacokinetics-of-polymyxin-b-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-effect-of-nirogacestat-on-cyp-induction-in-healthy-male-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-pharmacokinetics-and-drug-drug-interaction-potential-of-imu-838-and-oral-contraceptives-in-women-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-pharmacokinetics-and-safety-of-nnc0487-in-subjects-with-hepatic-impairment-and-normal-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-pharmacokinetics-of-nex-22a-in-subjects-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-a-fentanyl-vaccine-in-patients-with-opioid-induced-respiratory-depression2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-ag-181-in-adults-and-adolescents-with-phenylketonuria2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-azd5335-and-the-effect-of-itraconazole-co-administration-in-adults-with-ovarian-peritoneal-or-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-mk-4605-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-nurandociguat-on-the-pharmacokinetics-of-rosuvastatin-and-dabigatran-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-pf-08046876-in-participants-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-pharmacokinetics-of-pf-08052667-in-patients-with-non-muscle-invasive-bladder-cancer-nmibc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-arv-806-in-adults-with-kras-g12d-mutated-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-nnc1679-0001-in-healthy-volunteers-and-participants-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-single-ascending-intravenous-doses-of-im-250-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-dnl628-in-participants-with-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1a-1b-open-label-study-of-bbo-8520-safety-tolerability-pharmacokinetics-and-efficacy-in-patients-with-advanced-krasg12c-mutant-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1a-1b-study-of-the-safety-pharmacokinetics-and-antitumor-activity-of-bg-75202-as-monotherapy-and-in-combination-therapy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1a-b-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-antitumor-activity-of-bg-c0979-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-2-double-blind-placebo-controlled-randomized-parallel-arm-study-to-explore-safety-pharmacokinetics-and-early-clinical-signal-of-efficacy-of-ds-2325a-in-patients-with-netherton-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-2-multicenter-adaptive-double-blind-randomized-placebo-controlled-study-to-assess-the-safety-tolerability-immunogenicity-and-pharmacodynamic-effects-of-aci-24-060-in-subjects-with-prodromal2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-2-single-and-multiple-dose-study-to-assess-the-safety-tolerability-clinical-activity-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-star-0215-in-participants-with-hereditary-angioe2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-2-study-of-lrk-4189-with-drug-combination-to-assess-safety-and-efficacy-in-patients-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-2a-multicenter-open-label-study-to-determine-the-recommended-dose-and-schedule-and-evaluate-the-safety-and-preliminary-efficacy-of-mezigdomide-in-combination-with-elranatamab-in-participant2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-open-label-study-of-mirdametinib-in-infants-and-toddlers-with-neurofibromatosis-type-1-associated-plexiform-neurofibromas2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-open-label-study-of-the-safety-pharmacokinetics-and-preliminary-efficacy-of-cnd261-in-patients-with-seropositive-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-open-label-study-to-evaluate-the-safety-and-efficacy-of-cln-978-in-patients-with-moderate-to-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-prospective-randomized-double-blind-placebo-controlled-trial-evaluating-the-safety-and-tolerability-of-multiple-oral-doses-of-irl757-in-participants-with-parkinson-s-disease-and-apathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-1b-study-to-evaluate-the-safety-and-tolerability-of-sr-878-in-patients-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-2-part-open-label-single-arm-study-to-investigate-the-efficacy-and-safety-of-dupilumab-in-adult-and-adolescent-patients-with-eosinophilic-gastritis-with-or-without-eosinophilic-duodenitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-double-blind-placebo-controlled-study-of-bhv-8000-in-participants-with-early-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-open-label-randomized-active-control-study-of-zilovertamab-vedotin-mk-2140-in-combination-with-standard-of-care-in-participants-with-relapsed-or-refractory-diffuse-large-b-cell2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-randomized-active-controlled-open-label-study-to-evaluate-the-efficacy-and-safety-of-zanubrutinib-in-patients-with-primary-membranous-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-randomized-dose-optimization-part-i-double-blind-part-ii-study-to-compare-the-efficacy-and-safety-of-oral-azacitidine-oral-aza-onureg-r-plus-best-supportive-care-bsc-versus-pla2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-randomized-double-blind-placebo-controlled-adaptive-design-study-to-evaluate-the-efficacy-and-safety-of-mk-5475-in-adults-with-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-randomized-double-blind-placebo-controlled-trial-of-the-safety-and-efficacy-of-flexible-doses-of-sep-363856-as-adjunctive-therapy-in-the-treatment-of-adults-with-major-depressi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-multicenter-randomized-open-label-study-of-zanzalintinib-vs-everolimus-in-participants-with-previously-treated-unresectable-locally-advanced-or-metastatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-randomized-double-blind-parallel-group-placebo-controlled-flexible-dose-multicenter-study-to-evaluate-the-efficacy-and-safety-of-sep-363856-in-the-treatment-of-adults-with-generalized-anxi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-randomized-placebo-controlled-double-blind-clinical-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-vericiguat-in-pediatric-participants-with-heart-failure-due-to-systemic-le2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-study-of-navtemadlin-as-maintenance-therapy-in-subjects-with-tp53wt-advanced-or-recurrent-endometrial-cancer-who-responded-to-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-3-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-atumelnant-treatment-in-pediatric-participants-with-congenital-adrenal-hyperplasia-including-a-long-term-extension2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-clinical-trial-of-pembrolizumab-in-combination-with-carboplatin-and-cabazitaxel-in-aggressive-variant-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-dose-finding-study-evaluating-the-safety-and-efficacy-of-linaclotide-in-pediatric-subjects-6-months-to-less-than-2-years-of-age-with-functional-constipation-fc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blind-12-week-multicenter-study-to-assess-the-safety-and-effectiveness-of-daily-oral-administration-of-dexlansoprazole-delayed-release-capsules-in-pediatric-subjects-aged-2-to-11-year2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blind-36-week-multicenter-study-to-assess-the-safety-and-effectiveness-of-daily-oral-administration-of-dexlansoprazole-delayed-release-capsules-for-healing-of-erosive-esophagitis-ee-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blind-randomized-16-week-vehicle-controlled-efficacy-and-safety-study-of-ruxolitinib-cream-followed-by-an-open-label-extension-period-in-adults-with-chronic-hand-eczema2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blind-randomized-clinical-trial-to-explore-the-safety-tolerability-efficacy-and-pharmacokinetics-of-prax-562-in-pediatric-participants-with-developmental-and-epileptic-encephalopathie2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blind-randomized-placebo-controlled-dose-ranging-efficacy-and-safety-study-of-povorcitinib-in-participants-with-inadequately-controlled-moderate-to-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-double-blinded-randomized-placebo-controlled-dose-ranging-study-evaluating-the-efficacy-and-safety-of-gs-5290-in-participants-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-exploratory-multicenter-open-label-trial-to-determine-the-safety-and-preliminary-clinical-activity-of-gen1046-in-combination-with-anticancer-agents-in-subjects-with-advanced-endometrial-canc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multi-center-platform-study-to-evaluate-the-safety-efficacy-pharmacokinetics-and-pharmacodynamics-with-multiple-therapies-in-participants-with-active-crohn-s-disease-or-active-ulcerative-col2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multi-center-study-consisting-of-a-randomized-double-blind-placebo-controlled-period-followed-by-an-open-label-extension-period-to-assess-the-efficacy-safety-and-tolerability-of-tibulizumab-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multi-center-study-investigating-the-efficacy-safety-and-tolerability-of-pioglitazone-in-adult-participants-with-non-segmental-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multi-centre-prospective-randomized-standard-of-care-plus-placebo-controlled-patient-and-central-evaluator-blinded-parallel-arm-clinical-study-to-evaluate-safety-tolerability-and-efficacy-of2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multi-cohort-open-label-multi-center-clinical-study-evaluating-the-efficacy-and-safety-of-disitamab-vedotin-rc48-adc-alone-and-in-combination-with-pembrolizumab-in-subjects-with-locally-adva2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-multi-arm-study-to-evaluate-mk-1308a-coformulated-quavonlimab-mk-1308-pembrolizumab-versus-other-treatments-in-participants-with-microsatellite-instability-high-msi-h-or-mismatch2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-multinational-randomized-double-blind-placebo-controlled-study-to-assess-the-safety-efficacy-and-pharmacokinetics-of-multiple-dose-levels-of-esk-001-in-adult-patients-with-system2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-open-label-study-of-cc-97540-bms-986353-cd19-targeted-nex-t-car-t-cells-in-participants-with-active-sle-including-lupus-nephritis-with-inadequate-response-to-glucocorticoids-and-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-randomized-open-label-active-control-study-of-regn9933-a-factor-xi-monoclonal-antibody-for-prevention-of-venous-thromboembolism-after-elective-unilateral-total-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-randomized-placebo-controlled-double-blind-dose-ranging-trial-to-evaluate-the-efficacy-and-safety-of-zasocitinib-in-participants-with-nonsegmental-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-randomized-placebo-controlled-double-blind-study-to-investigate-the-safety-pharmacodynamics-and-preliminary-efficacy-of-s-606001-as-an-add-on-to-enzyme-replacement-therapy-in-pat2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-multicenter-randomized-study-to-compare-the-efficacy-and-safety-of-mk-7684a-or-mk-7684a-plus-docetaxel-versus-docetaxel-monotherapy-in-the-treatment-of-participants-with-metastatic-non-small2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-basket-study-investigating-the-safety-and-efficacy-of-gtx-102-in-adult-and-pediatric-subjects-with-deletion-or-nondeletion-type-angelman-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-clinical-study-to-evaluate-the-efficacy-and-safety-of-zilovertamab-vedotin-mk-2140-in-participants-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-waveline-0042026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multi-cohort-study-to-assess-the-efficacy-and-safety-of-asp5541-in-participants-with-advanced-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multicenter-basket-study-evaluating-the-efficacy-of-brexucabtagene-autoleucel-in-adults-with-rare-b-cell-malignancies-zuma-25-substudy-c-relapsed-refractory-burkitt-lymphoma-bl2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multicenter-basket-study-evaluating-the-safety-and-efficacy-of-brexucabtagene-autoleucel-in-adults-with-rare-b-cell-malignancies-zuma-25-substudy-a-relapsed-refractory-waldenstrom2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multicenter-basket-study-evaluating-the-safety-and-efficacy-of-brexucabtagene-autoleucel-in-adults-with-rare-b-cell-malignancies-zuma-25-substudy-b-relapsed-refractory-richter-tra2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multicenter-basket-study-evaluating-the-safety-and-efficacy-of-brexucabtagene-autoleucel-in-adults-with-rare-b-cell-malignancies-zuma-25-substudy-d-relapsed-refractory-hairy-cell-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-multicenter-tumor-agnostic-study-of-mk-1084-as-monotherapy-and-in-combination-with-cetuximab-in-participants-with-kras-g12c-mutant-advanced-solid-tumors-kandlelit-0142026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-randomized-master-protocol-dose-optimization-study-to-evaluate-safety-and-efficacy-of-multiple-treatment-combinations-with-mirvetuximab-soravtansine-in-subjects-with-ovarian-cance2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-open-label-study-of-loncastuximab-tesirine-in-combination-with-rituximab-lonca-r-in-previously-untreated-unfit-frail-patients-with-diffuse-large-b-cell-lymphoma-dlbcl-lotis-92026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-parallel-group-dose-range-finding-study-with-randomized-double-blind-treatment-and-open-label-periods-to-evaluate-the-safety-and-efficacy-of-alks-2680-in-subjects-with-narcolepsy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-peri-operative-trial-of-fianlimab-and-cemiplimab-compared-with-anti-pd1-alone-in-patients-with-resectable-stage-iii-and-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-precision-oncology-study-of-biomarker-directed-pembrolizumab-mk-3475-sch-900475-based-combination-therapy-for-advanced-non-small-cell-lung-cancer-keynote-495-keyimpact2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-prospective-interventional-open-label-multisite-extension-study-to-assess-the-long-term-safety-and-tolerability-of-soticlestat-tak-935-as-adjunctive-therapy-in-subjects-with-developmental-ep2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-crossover-study-evaluating-the-efficacy-and-safety-of-ltg-001-in-patients-with-osteoarthritis-of-the-knee2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-of-the-effect-of-edg-5506-on-biomarker-response-to-exercise-in-adults-with-becker-muscular-dystrophy-mcardle-disease-or-limb-girdle-muscular-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-of-the-safety-tolerability-and-efficacy-of-caveolin-1-scaffolding-protein-derived-peptide-lti-03-in-patients-with-idiopathic-pulmonary-fibros2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-the-effect-of-edg-5506-on-safety-biomarkers-pharmacokinetics-and-functional-measures-in-adults-and-adolescents-with-becker-muscul2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-bia-28-6156-in-subjects-with-parkinson-s-disease-with-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-inhaled-nintedanib-ap02-in-participants-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-topical-at-004-1-in-the-participants-with-acne-vulgaris2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-double-blind-study-of-mrna-4157-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-adjuvant-treatment-of-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-multicenter-open-label-neoadjuvant-study-evaluating-zanidatamab-in-combination-with-chemotherapy-in-participants-with-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-open-label-study-evaluating-the-safety-and-efficacy-of-magrolimab-in-combination-with-bevacizumab-and-folfiri-versus-bevacizumab-and-folfiri-in-previously-treated-advanced-inopera2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-open-label-study-of-axatilimab-versus-best-available-therapy-in-pediatric-chronic-graft-versus-host-disease-post-two-systemic-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-open-label-study-of-two-dose-levels-of-vobramitamab-duocarmazine-in-participants-with-metastatic-castration-resistant-prostate-cancer-tamarack2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-open-label-three-arm-clinical-study-to-evaluate-the-safety-and-efficacy-of-lenvatinib-e7080-mk-7902-in-combination-with-pembrolizumab-mk-3475-versus-standard-of-care-chemotherapy-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-placebo-controlled-double-blind-dose-ranging-study-to-evaluate-the-efficacy-safety-and-tolerability-of-amg-133-in-adult-subjects-with-overweight-or-obesity-with-or-without-type-2-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-placebo-controlled-double-blind-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-mk-2214-in-participants-with-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-study-of-carfilzomib-lenalidomide-and-dexamethasone-versus-lenalidomide-and-dexamethasone-in-high-risk-smoldering-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-randomized-study-to-evaluate-the-optimized-dose-safety-and-efficacy-of-livmoniplimab-in-combination-with-budigalimab-for-locally-advanced-or-metastatic-hepatocellular-carcinoma-patients-who-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-safety-tolerability-and-proof-of-concept-study-of-vgl101-in-patients-with-adult-onset-leukoencephalopathy-with-axonal-spheroids-and-pigmented-glia-alsp2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-single-arm-study-of-incb123667-in-participants-with-platinum-resistant-ovarian-cancer-with-cyclin-e1-overexpression-maestra-12026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-evaluating-efficacy-and-safety-of-bay-3670549-in-adult-patients-with-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-evaluating-incb099280-in-participants-with-advanced-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-evaluating-incb099280-in-participants-with-select-solid-tumors-who-are-immune-checkpoint-inhibitor-naive2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-evaluating-the-efficacy-and-safety-of-ltg-321-in-patients-with-osteoarthritis-of-the-knee2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-for-the-treatment-of-anemia-with-alpha-a-thalassemia-to-determine-the-efficacy-and-safety-of-luspatercept-bms-986346-ace-536-in-adults-and-evaluate-the-safety-and-pharmacokinetics-in-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-aganirsen-eye-drops-to-extend-aflibercept-injection-interval-in-patients-with-wet-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-intratumoral-injection-of-ltx-315-in-combination-with-pembrolizumab-in-patients-with-percutaneously-accessible-lesions-with-advanced-melanoma-refractory-to-pd-1-pd-l1-inhibitor-ther2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-ly4257496-in-participants-with-advanced-or-metastatic-solid-tumors-including-breast-colorectal-prostate-and-endometrial-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-methylenedioxymethamphetamine-assisted-therapy-in-young-adults-with-treatment-resistant-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-mtx-474-for-safety-and-efficacy-in-adults-with-diffuse-cutaneous-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-nemolizumab-in-adult-patients-with-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-neoadjuvant-cemiplimab-for-stage-ii-to-iv-m0-cutaneous-squamous-cell-carcinoma-cscc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-olaparib-monotherapy-in-participants-with-previously-treated-homologous-recombination-repair-mutation-hrrm-or-homologous-recombination-deficiency-hrd-positive-advanced-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-oral-pipe-791-to-assess-efficacy-safety-and-tolerability-in-patients-with-idiopathic-pulmonary-fibrosis-ipf2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-of-tml-6-versus-placebo-to-assess-safety-and-efficacy-in-patients-with-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-efficacy-safety-and-pharmacokinetics-of-pbf-999-in-the-treatment-of-patients-with-prader-willi-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-ap-2-in-patients-with-amyotrophic-lateral-sclerosis-and-related-neurodegenerative-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-cevostamab-in-patients-with-systemic-lupus-erythematosus-with-or-without-active-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-mk-7228-in-adults-with-atherosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-nnc0363-1063-in-participants-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-rpt193-in-adults-with-moderate-to-severe-t2-high-asthma-who-are-partially-controlled-on-inhaled-corticosteroid-and-long-acting-beta-2-agonist-the2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-theranostic-trial-evaluating-the-effects-of-thiethylperazine-in-patients-diagnosed-with-an-early-stage-of-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-three-arm-randomized-study-of-the-efficacy-of-intratumorally-administered-l19il2-or-l19tnf-or-l19il2-l19tnf-all-in-combination-with-systemic-anti-pd1-pembrolizumab-in-stage-iii-and-iv-unrese2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-trial-of-gremubamab-compared-to-placebo-in-participants-with-bronchiectasis-and-chronic-pseudomonas-aeruginosa-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2-trial-of-nivolumab-plus-ipilimumab-ipilimumab-alone-or-cabazitaxel-in-men-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-2b-open-label-proof-of-concept-phase-2a-and-open-label-phase-2b-multicenter-efficacy-and-safety-study-of-ag-946in-participants-with-anemia-due-to-lower-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-b-randomized-double-blind-placebo-controlled-parallel-group-multicenter-clinical-study-to-evaluate-the-efficacy-and-safety-of-og-6219-in-3-dose-levels-in-women-18-to-49-years-of-age-with-mo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-investigator-and-subject-blinded-sponsor-unblinded-placebo-controlled-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-crd-4730-in-participants-wi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-open-label-single-arm-multicenter-exploratory-study-to-evaluate-the-safety-tolerability-and-efficacy-of-oral-doses-of-roc-101-in-patients-with-pulmonary-arterial-hypertension-pah-and-pulmon2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-double-blind-parallel-group-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-tolerability-of-fexlamose-aer-01-inhalation-solution-in-the-treatment-of-adults-with-mode2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-double-blind-placebo-controlled-dose-comparison-and-exploratory-efficacy-study-of-orally-administered-sat-3247-in-ambulatory-dmd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-double-blind-placebo-controlled-parallel-group-multicenter-study-to-evaluate-the-efficacy-safety-tolerability-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-alxn1920-in-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-multicenter-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-multiple-subcutaneous-doses-of-triv-509-in-adults-with-moderate-to-sever2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-observer-blind-study-to-evaluate-the-immunogenicity-and-safety-of-mrna-based-multivalent-seasonal-influenza-vaccine-candidates-in-adults-18-years-of-age-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-placebo-controlled-clinical-study-to-evaluate-the-efficacy-and-safety-of-mk-5475-in-adults-with-pulmonary-hypertension-associated-with-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-randomized-placebo-controlled-double-blind-study-to-assess-the-safety-pharmacokinetics-and-pharmacodynamics-of-agmb-129-in-patients-with-fibrostenotic-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-study-of-empasiprubart-iv-and-efgartigimod-alfa-subcutaneous-injection-in-adults-with-achr-ab-seropositive-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-study-of-ly4005130-vs-placebo-in-adults-with-severe-alopecia-areata2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-study-of-sar445399-versus-placebo-in-adults-aged-18-80-with-non-cystic-fibrosis-bronchiectasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2a-study-to-evaluate-the-safety-and-pharmacokinetics-of-luspatercept-ace-536-in-pediatric-participants-with-beta-b-thalassemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-adaptive-randomized-active-controlled-study-evaluating-the-efficacy-safety-and-tolerability-of-povetacicept-versus-calcineurin-inhibitor-in-the-treatment-of-primary-membranous-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-adaptive-randomized-double-blind-placebo-controlled-multicenter-study-to-assess-the-efficacy-and-safety-of-danicamtiv-in-participants-with-symptomatic-genetic-and-familial-dilated-cardiom2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-double-blind-randomized-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-mk-1654-in-healthy-pre-term-and-full-term-infants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-multicenter-randomized-double-blind-placebo-controlled-combined-dose-finding-and-cardiovascular-outcome-study-to-investigate-the-efficacy-and-safety-of-csl300-clazakizumab-in-subjects-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-open-label-multicenter-trial-evaluating-the-efficacy-and-safety-of-switching-to-brelovitug-for-the-treatment-of-chronic-hepatitis-delta-infection-in-participants-receiving-bulevirtide-azu2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-3-randomized-double-blind-placebo-controlled-parallel-group-multicenter-protocol-to-evaluate-the-efficacy-and-safety-of-icotrokinra-in-participants-with-moderately-to-severely-active-crohn-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multi-center-randomized-double-blind-placebo-controlled-study-of-imvt-1402-treatment-in-adult-participants-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multicenter-randomized-double-blind-parallel-group-placebo-controlled-dose-range-finding-study-to-evaluate-the-efficacy-safety-and-tolerability-of-nebulized-csl787-in-adults-18-to-85-years-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multicenter-randomized-double-blind-placebo-controlled-dose-finding-efficacy-and-safety-study-of-hro350-in-subjects-with-mild-to-moderate-psoriasis-the-heropa-study2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multicenter-randomized-double-blind-placebo-controlled-parallel-group-study-to-assess-the-efficacy-safety-and-tolerability-of-imvt-1402-in-adult-participants-with-primary-sjogren-s-disease-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multicenter-randomized-double-blinded-placebo-controlled-parallel-group-dose-finding-study-to-evaluate-the-efficacy-and-safety-of-img-007-in-adult-participants-with-moderate-to-severe-atopi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-multinational-randomized-double-blind-study-to-investigate-the-efficacy-and-safety-of-redasemtide-s-005151-compared-with-placebo-in-adult-participants-with-acute-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-open-label-two-cohort-study-of-subcutaneous-amivantamab-in-combination-with-lazertinib-as-first-line-treatment-or-subcutaneous-amivantamab-in-combination-with-platinum-based-chemotherapy-as2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomised-double-blind-placebo-controlled-multi-site-parallel-group-dose-finding-trial-to-evaluate-the-efficacy-and-safety-of-different-doses-of-subcutaneously-administered-leo-138559-in-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomised-double-blind-placebo-controlled-parallel-arm-dose-finding-study-evaluating-the-efficacy-and-safety-of-sab-142-for-delaying-the-progression-of-type-1-diabetes-t1d-in-patients-with2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-blinded-trial-investigating-the-efficacy-and-safety-of-visugromab-in-combination-with-nivolumab-and-lenvatinib-compared-to-double-placebo-and-lenvatinib-in-participants-with-unre2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-controlled-double-blind-multicenter-study-comparing-the-efficacy-and-safety-of-zetomipzomib-kzr-616-30-mg-or-60-mg-with-placebo-in-patients-with-active-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-multicenter-study-of-the-efficacy-and-safety-of-brensocatib-in-participants-with-chronic-rhinosinusitis-without-nasal-polyps-the-birch-study2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-multicenter-study-to-evaluate-the-efficacy-and-safety-of-efinopegdutide-mk-6024-in-adults-with-precirrhotic-nonalcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-parallel-group-multicenter-dose-ranging-study-with-an-open-label-period-investigating-the-efficacy-and-safety-profile-of-kt-621-administered-orall2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-tulisokibart-in-participants-with-radiographic-axial-spondyloarthritis-ankylosing-spondylitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-tulisokibart-in-participants-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-3-active-dose-regimens-of-morf-057-in-adults-with-moderately-to-severely-active-ulcerative-colitis-em2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-double-masked-multicenter-dose-ranging-sham-controlled-clinical-trial-to-evaluate-intravitreal-jnj-81201887-aavcagscd59-compared-to-sham-procedure-for-the-treatment-of-geographic2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-randomized-open-label-active-controlled-study-evaluating-the-safety-and-efficacy-of-oral-vh4524184-coadministered-with-emtricitabine-and-tenofovir-alafenamide-in-treatment-naive-viremic-per2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-study-of-env-294-for-efficacy-and-safety-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-study-of-pf-08049820-vs-placebo-in-adults-with-moderate-to-severe-eczema2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-2b-trial-assessing-efficacy-and-safety-of-semaglutide-subcutaneous-depot-cam2056-in-adults-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-24-week-randomized-placebo-controlled-double-blind-study-to-assess-the-efficacy-safety-and-tolerability-of-rocatinlimab-amg-451-monotherapy-in-adult-subjects-with-moderate-to-severe-atopic-d2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-placebo-controlled-randomized-study-to-assess-the-efficacy-and-safety-of-epicutaneous-immunotherapy-with-dbv712-250-mg-in-4-7-year-old-children-with-peanut-allergy-vitesse2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-placebo-controlled-randomized-study-to-assess-the-safety-of-epicutaneous-immunotherapy-with-dbv712-250-ug-in-1-through-3-year-old-children-with-peanut-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-placebo-controlled-randomized-withdrawal-study-to-evaluate-the-efficacy-and-safety-of-synb1934-in-patients-with-pku-synpheny-32026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-randomized-parallel-group-placebo-controlled-multicenter-trial-to-confirm-the-efficacy-and-safety-of-glepaglutide-10-mg-twice-weekly-followed-by-a-long-term-open-label-safety-ev2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-randomized-placebo-controlled-efficacy-and-safety-study-of-povorcitinib-incb054707-in-participants-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blind-randomized-two-period-multicenter-placebo-controlled-efficacy-and-safety-study-of-jnt-517-for-the-treatment-of-participants-with-phenylketonuria2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-double-blinded-two-arm-study-to-evaluate-the-safety-and-efficacy-of-pembrolizumab-mk-3475-versus-placebo-as-adjuvant-therapy-in-participants-with-hepatocellular-carcinoma-and-complete-radiol2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-international-multi-center-randomized-double-blind-placebo-controlled-clinical-trial-to-study-the-efficacy-immunogenicity-and-safety-of-the-9vhpv-vaccine-a-multivalent-l1-virus-like-particle2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-international-multicenter-open-label-study-to-evaluate-the-safety-and-immunogenicity-of-9vhpv-vaccine-administered-as-2-dose-regimen-with-extended-dosing-intervals-in-9-to-14-year-old-boys-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multi-center-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of-risankizumab-with-open-label-induction-randomized-double-blind-maintenance-and-long-term-extension-periods-in-pedia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-12-week-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-atogepant-for-the-preventive-treatment-of-episodic-migraine-in-pediatric-subjects-6-to-17-yea2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-double-blind-active-controlled-study-to-evaluate-the-efficacy-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-oral-ozanimod-compared-to-oral-fingolimod-in-children-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-double-blind-maintenance-study-to-assess-long-term-safety-tolerability-and-efficacy-of-rocatinlimab-in-adult-and-adolescent-subjects-with-moderate-to-severe-atopic-dermatitis-ad-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-double-blind-randomized-placebo-controlled-clinical-study-to-evaluate-the-safety-and-efficacy-of-ertugliflozin-mk-8835-pf-04971729-in-pediatric-participants-ages-10-to-17-years-i2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-open-label-basket-long-term-extension-study-of-ustekinumab-in-pediatric-clinical-study-participants-2-to-18-years-of-age2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-parallel-group-safety-and-efficacy-study-of-linaclotide-versus-placebo-in-pediatric-subjects-ages-2-to-5-years-with-functional-constipation-fc-with-a-24-w2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-enlicitide-decanoate-coadministered-with-rosuvastatin-in-adults-with-hyperlipidemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-obexelimab-in-patients-with-igg4-related-disease-indigo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-placebo-controlled-study-with-a-safety-and-dose-confirmation-run-in-period-to-evaluate-the-efficacy-and-safety-of-obexelimab-in-patients-with-warm-autoimm2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-comparing-the-efficacy-and-safety-of-tafasitamab-plus-lenalidomide-in-addition-to-r-chop-versus-r-chop-in-previously-untreated-hi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-efficacy-and-safety-of-sibeprenlimab-administered-subcutaneously-in-subjects-with-immunoglobulin-a-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blind-study-to-evaluate-the-safety-and-efficacy-of-contezolid-acefosamil-and-contezolid-compared-to-linezolid-administered-intravenously-and-orally-to-adults-wi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-blinded-active-controlled-clinical-study-to-evaluate-the-safety-and-efficacy-of-lenvatinib-e7080-mk-7902-with-pembrolizumab-mk-3475-in-combination-with-transart2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-double-masked-vehicle-controlled-study-to-demonstrate-efficacy-and-safety-of-dfl24498-eye-drop-solution-in-adult-participants-with-atopic-keratoconjunctivitis-akc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-efficacy-assessor-blinded-study-of-risankizumab-compared-to-ustekinumab-for-the-treatment-of-adult-subjects-with-moderate-to-severe-crohn-s-disease-who-have-failed-ant2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-open-label-sponsor-blinded-study-to-evaluate-regn7508-a-factor-xi-monoclonal-antibody-versus-apixaban-and-enoxaparin-for-prophylaxis-of-venous-thromboembolism-after-el2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-open-label-trial-of-trastuzumab-deruxtecan-versus-standard-of-care-chemotherapy-with-or-without-radiotherapy-as-adjuvant-treatment-for-her2-expressing-ihc-3-2-endometr2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-open-label-trial-to-compare-the-efficacy-and-safety-of-pembrolizumab-mk-3475-in-combination-with-lenvatinib-e7080-mk-7902-versus-docetaxel-in-previously-treated-partic2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-partially-blinded-palivizumab-controlled-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-mk-1654-in-infants-and-children-at-increased-risk-for-severe-rsv2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-placebo-controlled-double-blind-study-to-assess-the-efficacy-and-safety-of-imvt-1402-in-patients-with-mild-to-severe-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-randomized-study-comparing-int230-6-vinblastine-sulfate-cisplatin-to-standard-care-in-adults-with-metastatic-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicenter-study-to-evaluate-efficacy-safety-and-pharmacokinetics-of-upadacitinib-with-open-label-induction-randomized-double-blind-maintenance-and-open-label-long-term-extension-in-pediatr2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicentre-randomised-1-1-parallel-group-active-controlled-central-reader-colonoscopist-blind-study-to-evaluate-the-bowel-cleansing-efficacy-safety-tolerability-palatability-and-acceptabili2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-multicentre-randomized-prospective-open-label-trial-of-ibrutinib-monotherapy-versus-fixed-duration-venetoclax-plus-obinutuzumab-versus-fixed-duration-venetoclax-plus-ibrutinib-in-patients-wi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-52-week-study-to-assess-the-safety-tolerability-and-efficacy-of-rocatinlimab-amg-451-in-adolescent-subjects-aged-12-to-18-years-with-moderate-to-severe-atopic-dermatitis-ad-rocket2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-clinical-study-of-doravirine-islatravir-dor-isl-100-mg-0-25-mg-once-daily-for-the-treatment-of-hiv-1-infection-in-participants-who-previously-received-dor-isl-100-mg-0-75-mg-qd-in2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-controlled-randomised-multi-centre-trial-comparing-imlifidase-and-standard-of-care-with-standard-of-care-alone-in-the-treatment-of-severe-anti-gbm-antibody-disease-goodpasture-dis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-long-term-extension-study-to-evaluate-the-safety-and-efficacy-of-vosoritide-in-children-with-hypochondroplasia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-multicenter-extension-study-of-acoramidis-in-patients-with-newly-diagnosed-variant-transthyretin-amyloid-cardiomyopathy-act-early-ole2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-multicenter-randomized-study-of-xaluritamig-plus-abiraterone-versus-investigator-s-choice-in-participants-with-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-multicenter-study-to-evaluate-anti-tumor-efficacy-of-dzd8586-versus-investigator-s-choice-in-patients-with-relapsed-refractory-chronic-lymphocytic-leukemia-small-lympho2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-prospective-study-of-apalutamide-with-continued-versus-intermittent-androgen-deprivation-therapy-adt-following-psa-response-in-participants-with-metastatic-castration-s2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-study-of-nivolumab-combined-with-ipilimumab-or-with-standard-of-care-chemotherapy-versus-standard-of-care-chemotherapy-in-participants-with-previously-untreated-unresec2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-study-to-compare-the-efficacy-and-safety-of-luspatercept-ace-536-versus-epoetin-alfa-for-the-treatment-of-anemia-due-to-ipss-r-very-low-low-or-intermediate-risk-myelody2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-study-to-compare-the-efficacy-and-safety-of-luspatercept-ace-536-vs-epoetin-alfa-for-the-treatment-of-anemia-due-to-revised-international-prognostic-scoring-system-ipss2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-study-to-compare-the-efficacy-and-safety-of-odronextamab-regn1979-an-anti-cd20-x-anti-cd3-bispecific-antibody-combined-with-chemotherapy-versus-rituximab-combined-with-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-randomized-study-to-compare-the-efficacy-and-safety-of-odronextamab-regn1979-an-anti-cd20-x-anti-cd3-bispecific-antibody-versus-investigator-s-choice-in-previously-untreated-parti2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-single-arm-multicenter-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-activity-and-safety-of-ravulizumab-administered-subcutaneously-in-pediatric-participants-2-to-18-yea2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-single-arm-multicenter-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-efficacy-safety-and-immunogenicity-of-ravulizumab-administered-intravenously-in-pediatric-participan2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-csl312-garadacimab-in-the-prophylactic-treatment-of-hereditary-angioedema-in-pediatric-subjects-2-to2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-open-label-uncontrolled-study-to-evaluate-the-activity-safety-pharmacokinetics-and-pharmacodynamics-of-roxadustat-for-the-treatment-of-anemia-in-pediatric-participants-with-chronic-kidney-di2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-prospective-open-label-multisite-extension-of-phase-3-studies-to-assess-the-long-term-safety-and-tolerability-of-soticlestat-as-adjunctive-therapy-in-subjects-with-dravet-syndrome-or-lennox-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomised-double-blind-parallel-group-76-week-efficacy-and-safety-study-of-bi-456906-administered-subcutaneously-compared-with-placebo-in-participants-with-overweight-or-obesity-and-type-2-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomised-double-blind-parallel-group-76-week-efficacy-and-safety-study-of-bi-456906-administered-subcutaneously-compared-with-placebo-in-participants-with-overweight-or-obesity-without-typ2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomised-double-blind-parallel-group-event-driven-cardiovascular-safety-study-with-bi-456906-administered-subcutaneously-compared-with-placebo-in-participants-with-overweight-or-obesity-wi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-24-week-placebo-controlled-double-blind-study-to-assess-the-efficacy-safety-and-tolerability-of-rocatinlimab-amg-451-in-combination-with-topical-corticosteroids-and-or-topical-cal2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-24-week-placebo-controlled-double-blind-study-to-assess-the-efficacy-safety-and-tolerability-of-rocatinlimab-amg-451-monotherapy-in-adult-subjects-with-moderate-to-severe-atopic-d2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-52-week-placebo-controlled-double-blind-study-with-rerandomization-to-assess-the-efficacy-safety-and-tolerability-of-rocatinlimab-amg-451-in-adolescent-subjects-with-moderate-to-s2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-active-controlled-double-blind-clinical-study-to-evaluate-a-switch-to-doravirine-islatravir-dor-isl-100-mg-0-25-mg-once-daily-in-participants-with-hiv-1-virologically-suppressed-o2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-active-controlled-double-blind-clinical-study-to-evaluate-the-antiretroviral-activity-safety-and-tolerability-of-doravirine-islatravir-dor-isl-100-mg-0-25-mg-once-daily-in-hiv-1-i2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-active-controlled-double-blind-clinical-study-to-evaluate-the-efficacy-and-safety-of-mk-8527-oral-once-monthly-as-hiv-1-preexposure-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-active-controlled-open-label-clinical-study-to-evaluate-a-switch-to-doravirine-islatravir-dor-isl-100-mg-0-25-mg-once-daily-in-participants-with-hiv-1-who-are-virologically-suppre2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-comparator-controlled-clinical-trial-to-study-the-efficacy-and-safety-of-pembrolizumab-mk-3475-in-combination-with-bacillus-calmette-guerin-bcg-in-participants-with-high-risk-non-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-crossover-study-of-sepiapterin-vs-sapropterin-in-phenylketonuria-patients-aged-2-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-active-comparator-controlled-clinical-study-of-adjuvant-mk-7684a-vibostolimab-with-pembrolizumab-versus-adjuvant-pembrolizumab-in-participants-with-high-risk-stage-ii2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-active-comparator-controlled-clinical-study-to-evaluate-the-safety-tolerability-and-immunogenicity-of-v116-in-pneumococcal-vaccine-naive-adults-18-to-64-years-of-age-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-double-dummy-parallel-group-active-controlled-study-to-evaluate-the-efficacy-and-safety-of-milvexian-an-oral-factor-xia-inhibitor-versus-apixaban-in-participants-with2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-multi-center-study-of-adjuvant-nivolumab-versus-placebo-in-subjects-with-high-risk-invasive-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-parallel-group-placebo-controlled-study-to-demonstrate-the-efficacy-and-safety-of-milvexian-an-oral-factor-xia-inhibitor-for-stroke-prevention-after-an-acute-ischemic2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-3-arm-3-period-study-to-assess-the-efficacy-and-safety-of-a-new-formulation-of-oral-cladribine-compared-with-placebo-in-participants-with-generaliz2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-clinical-trial-of-pembrolizumab-mk-3475-as-monotherapy-in-the-adjuvant-treatment-of-renal-cell-carcinoma-post-nephrectomy-keynote-5642026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-event-driven-study-to-demonstrate-the-efficacy-and-safety-of-milvexian-an-oral-factor-xia-inhibitor-after-a-recent-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-multicenter-parallelgroup-study-to-evaluate-the-efficacy-and-safety-of-treprostinil-palmitil-inhalation-powder-in-participants-with-pulmonary-hyper2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-multicenter-study-with-open-label-extension-to-evaluate-the-efficacy-and-safety-of-bimekizumab-in-study-participants-with-palmoplantar-pustulosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-3-arm-multinational-multicenter-study-to-evaluate-the-efficacy-and-safety-of-amlitelimab-monotherapy-by-subcutaneous-injection-in-pa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-multicenter-protocol-in-adults-with-an-open-label-study-in-adolescents-to-evaluate-the-efficacy-and-safety-of-induction-and-maintena2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-erenumab-in-children-6-to-12-years-and-adolescents-12-to-18-years-with-chronic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-erenumab-in-children-6-to-12-years-and-adolescents-12-to-18-years-with-episodic-migrain2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-karxt-karx-ec-for-the-treatment-of-cognitive-impairment-associated-with-mild-to-moderat2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-ribitol-bbp-418-in-limb-girdle-muscular-dystrophy-2i-r92026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-of-abemaciclib-and-fulvestrant-in-hr-her2-advanced-or-metastatic-breast-cancer-post-cdk4-6-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-of-felzartamab-in-adults-with-iga-nephropathy-299ig301-prevail2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-of-fulvestrant-with-or-without-abemaciclib-in-hr-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-of-jnj-78278343-a-t-cell-redirecting-agent-targeting-human-kallikrein-2-versus-placebo-for-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-assess-the-efficacy-safety-and-tolerability-of-valbenazine-for-the-treatment-of-dyskinesia-due-to-cerebral-palsy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-efficacy-and-safety-of-mezagitamab-subcutaneous-injection-in-participants-with-chronic-primary-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-pembrolizumab-versus-placebo-as-adjuvant-therapy-following-surgery-and-radiation-in-participants-with-high-risk-locally-advanced-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-adjunctive-karxt-for-the-treatment-of-mania-with-or-without-mixed-features-in-individuals-with-bipolar2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-deucravacitinib-in-participants-with-active-systemic-lupus-erythematosus-sle-poetyk-sle-12026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-deucravacitinib-in-participants-with-active-systemic-lupus-erythematosus-sle-poetyk-sle-22026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-mk-0616-in-adults-with-heterozygous-familial-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-mk-0616-in-adults-with-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-tolerability-of-maridebart-cafraglutide-in-adult-participants-with-obstructive-sleep-apnea-not-on-positiv2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-tolerability-of-valbenazine-as-adjunctive-treatment-in-subjects-with-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-the-impactof-maridebart-cafraglutide-on-cardiovascular-outcomes-in-participants-with-atherosclerotic-cardiovascular-disease-and-o2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-placebo-controlled-study-to-investigate-the-efficacy-and-safety-of-oral-brepocitinib-in-adults-with-dermatomyositis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-comparing-upadacitinib-abt-494-to-placebo-and-to-adalimumab-in-subjects-with-moderately-to-severely-active-rheumatoid-arthritis-who-are-on-a-stable-background-o2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-of-adjuvant-immunotherapy-with-nivolumab-versus-placebo-after-complete-resection-of-stage-iib-c-melanoma-checkmate-76k-checkpoint-pathway-and-nivolumab-clinical2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-of-neoadjuvant-chemotherapy-plus-nivolumab-versus-neoadjuvant-chemotherapy-plus-placebo-followed-by-surgical-resection-and-adjuvant-treatment-with-nivolumab-or-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-of-pembrolizumab-versus-placebo-in-combination-with-adjuvant-chemotherapy-with-or-without-radiotherapy-for-the-treatment-of-newly-diagnosed-high-risk-endometria2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-of-pembrolizumab-versus-placebo-in-combination-with-paclitaxel-and-bevacizumab-for-platinum-resistant-recurrent-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-of-risankizumab-versus-placebo-in-patients-with-active-psoriatic-arthritis-and-inadequate-response-to-dmard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-to-evaluate-perioperative-pembrolizumab-mk-3475-neoadjuvant-chemotherapy-versus-perioperative-placebo-neoadjuvant-chemotherapy-in-cisplatin-eligible-participant2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-study-to-evaluate-the-safety-and-efficacy-of-emtricitabine-and-tenofovir-alafenamide-f-taf-fixed-dose-combination-once-daily-for-pre-exposure-prophylaxis-in-men-and-t2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-trial-of-pembrolizumab-mk-3475-plus-enzalutamide-versus-placebo-plus-enzalutamide-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-keynote-62026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blind-trial-of-risankizumab-versus-placebo-in-patients-with-active-psoriatic-arthritis-and-prior-biologic-therapy-inadequacy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-double-blinded-double-dummy-study-evaluating-the-efficacy-and-safety-of-intravenous-empasiprubart-versus-intravenous-immunoglobulin-in-adults-with-chronic-inflammatory-demyelinati2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-subcutaneous-pembrolizumab-coformulated-with-hyaluronidase-mk-3475a-versus-intravenous-pembrolizumab-admin2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-induction-double-blind-maintenance-parallel-group-multicenter-protocol-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-guselkumab-in-pediatric-participants-with2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-multicenter-clinical-study-to-evaluate-the-safety-and-efficacy-of-mk-1084-cetuximab-and-mfolfox6-versus-mfolfox6-with-or-without-bevacizumab-as-first-line-treatment-of-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-multicenter-study-evaluating-the-efficacy-and-safety-of-tar-210-erdafitinib-intravesical-delivery-system-versus-investigator-s-choice-of-intravesical-chemotherapy-in-pa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-multicenter-study-of-amivantamab-in-addition-to-carboplatin-and-pembrolizumab-compared-to-standard-of-care-platinum-and-pembrolizumab-and-5-fu-in-participants-with-trea2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-multicenter-study-of-zanubrutinib-bgb-3111-plus-anti-cd20-antibodies-versus-lenalidomide-plus-rituximab-in-patients-with-relapsed-refractory-follicular-or-marginal-zone2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-multicenter-study-to-evaluate-the-efficacy-and-safety-of-sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-with-or-without-bevacizumab-compared-with-sta2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-non-inferiority-study-of-acalabrutinib-versus-ibrutinib-in-high-risk-relapsed-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-comparing-sigvotatug-vedotin-and-docetaxel-in-adults-with-previously-treated-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-odronextamab-regn1979-an-anti-cd20-x-anti-cd3-bispecific-antibody-versus-standard-of-care-therapy-in-participants-with-relap2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-of-imetelstat-versus-best-available-therapy-in-intermediate-2-or-high-risk-myelofibrosis-refractory-to-jak-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-of-opevesostat-tosylate-versus-abiraterone-acetate-or-enzalutamide-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-of-sacituzumab-govitecan-versus-physician-s-choice-in-recurrent-or-persistent-endometrial-cancer-post-chemotherapy-and-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-open-label-study-of-subcutaneous-nivolumab-relatlimab-fixed-dose-combination-versus-intravenous-nivolumab-relatlimab-fixed-dose-combination-in-participants-with-previously-untreat2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-clinical-study-to-evaluate-the-efficacy-and-safety-of-mk-0616-in-reducing-major-adverse-cardiovascular-events-in-participants-at-high-cardiovascular-risk2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-clinical-study-to-evaluate-the-safety-and-efficacy-of-stereotactic-body-radiotherapy-sbrt-with-or-without-pembrolizumab-mk-3475-in-participants-with-unresected-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-double-blind-multicenter-study-to-evaluate-the-efficacy-and-safety-of-nipocalimab-in-pregnancies-at-risk-for-severe-hemolytic-disease-of-the-fetus-and-newborn-h2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-double-blind-parallel-group-program-to-evaluate-efficacy-and-safety-of-filgotinib-in-adult-subjects-with-active-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-double-blind-program-to-evaluate-efficacy-and-safety-of-upadacitinib-in-adult-subjects-with-axial-spondyloarthritis-followed-by-a-remission-withdrawal-period2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-double-blind-study-to-evaluate-upadacitinib-in-adolescent-and-adult-subjects-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-double-blind-study-to-evaluate-upadacitinib-in-combination-with-topical-corticosteroids-in-adolescent-and-adult-subjects-with-moderate-to-severe-atopic-dermatit2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-placebo-controlled-triple-blind-parallel-group-study-of-candesartan-in-adults-with-episodic-cluster-headache-episodic-candclus22026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-comparing-odronextamab-and-lenalidomide-versus-rituximab-and-lenalidomide-in-relapsed-refractory-follicular-and-marginal-zone-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-comparing-talquetamab-in-combination-with-pomalidomide-tal-p-talquetamab-in-combination-with-teclistamab-tal-tec-and-investigator-s-choice-of-either-elotuzumab-pomalidomide-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-of-lazertinib-and-subcutaneous-amivantamab-versus-intravenous-amivantamab-in-egfr-mutated-advanced-nsclc-post-osimertinib-and-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-of-mirvetuximab-soravtansine-versus-chemotherapy-in-platinum-resistant-high-grade-epithelial-ovarian-peritoneal-or-fallopian-tube-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-of-sacituzumab-govitecan-and-pembrolizumab-versus-physician-s-choice-in-triple-negative-breast-cancer-with-residual-invasive-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-of-votoplam-in-adults-with-huntington-s-disease-to-assess-efficacy-safety-and-tolerability2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-to-compare-nemtabrutinib-versus-comparator-investigator-s-choice-of-ibrutinib-or-acalabrutinib-in-participants-with-untreated-chronic-lymphocytic-leukemia-small-lymphocytic-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-study-to-evaluate-the-efficacy-and-safety-of-pembrolizumab-mk-3475-lenvatinib-e7080-mk-7902-chemotherapy-compared-with-standard-of-care-as-first-line-intervention-in-participants-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-randomized-trial-of-endocrine-therapy-versus-radiation-therapy-in-women-aged-70-with-luminal-a-like-early-stage-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-single-arm-multicenter-multinational-open-label-one-way-crossover-study-to-investigate-the-efficacy-and-safety-of-fitusiran-prophylaxis-in-male-participants-aged-12-years-with-severe-hemophi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-single-arm-multicenter-open-label-extension-of-study-argx-113-2007-to-investigate-the-long-term-safety-tolerability-and-efficacy-of-efgartigimod-ph20-sc-in-participants-aged-18-years-and-old2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-adjunctive-ly3537031-to-delay-relapse-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-dupilumab-versus-placebo-for-pruritus-of-neurodermatitis-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-elritercept-compared-with-epoetin-alfa-for-anemia-in-esa-naive-adults-with-lower-risk-myelodysplastic-syndromes-requiring-red-blood-cell-transfusions2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-engasertib-in-adults-with-moderate-to-severe-hereditary-hemorrhagic-telangiectasia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-fenfluramine-hydrochloride-for-safety-and-efficacy-in-patients-with-rett-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-incb161734-with-chemotherapy-drug-combination-in-previously-untreated-kras-g12d-mutated-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-once-monthly-pf-08653944-injection-for-weight-loss-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-sonelokimab-versus-placebo-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-subcutaneous-nomlabofusp-in-adults-and-children-with-friedreich-s-ataxia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-of-upadacitinib-in-adolescents-and-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-study-to-evaluate-the-efficacy-and-safety-of-intravitreal-pozelimab-in-adult-patients-with-geographic-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-trial-of-fianlimab-anti-lag-3-and-cemiplimab-versus-pembrolizumab-in-the-adjuvant-setting-in-patients-with-completely-resected-high-risk-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-two-stage-randomized-multi-center-controlled-open-label-study-comparing-iberdomide-maintenance-to-lenalidomide-maintenance-therapy-after-autologous-stem-cell-transplantation-asct-in-particip2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3-two-stage-randomized-multicenter-open-label-study-comparing-mezigdomide-cc-92480-bms-986348-carfilzomib-and-dexamethasone-mezikd-versus-carfilzomib-and-dexamethasone-kd-in-participants-with-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3a-randomized-controlled-trial-comparing-metformin-and-tolvaptan-in-adults-with-autosomal-dominant-polycystic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-4-multi-center-randomized-open-label-long-term-safety-study-of-deucravacitinib-in-comparison-to-ustekinumab-in-participants-with-moderate-to-severe-plaque-psoriasis-pragmatyk2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-4-randomized-double-blind-double-dummy-active-comparator-controlled-study-comparing-the-efficacy-and-safety-of-upadacitinib-versus-adalimumab-in-subjects-with-moderate-to-severe-rheumatoid-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-4-randomized-open-label-efficacy-assessor-blinded-study-to-evaluate-the-efficacy-and-safety-of-upadacitinib-for-the-treatment-of-adult-subjects-with-moderate-to-severe-atopic-dermatitis-and2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-4-study-evaluating-the-efficacy-and-safety-of-daily-subcutaneous-elamipretide-in-patients-with-genetically-confirmed-barth-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-extension-study-to-evaluate-the-long-term-safety-of-vedolizumab-subcutaneous-in-pediatric-subjects-with-ulcerative-colitis-or-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-interventional-adaptive-clinical-trial-to-evaluate-the-efficacy-and-safety-of-tralokinumab-300-mg-every-second-week-monotherapy-compared-with-placebo-in-subjects-with-moderate-to-severe-ato2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-multicenter-open-label-daratumumab-long-term-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-open-label-multicenter-study-evaluating-physical-activity-and-joint-health-in-previously-treated-patients-12-years-of-age-with-severe-haemophilia-a-treated-with-intravenous-recombinant-coag2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-open-label-single-arm-rollover-study-to-evaluate-long-term-safety-in-subjects-who-have-participated-in-other-luspatercept-ace-536-also-known-as-bms-986346-clinical-trials2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-study-comparing-dolutegravir-lamivudine-to-bictegravir-emtricitabine-tenofovir-alafenamide-in-antiretroviral-naive-adults-with-hiv2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-study-comparing-efficacy-and-safety-of-guselkumab-vs-risankizumab-in-adults-with-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-3b-study-to-evaluate-the-duration-of-effect-of-bimatoprost-sr-in-participants-with-open-angle-glaucoma-or-ocular-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-4-multicenter-2-part-study-composed-of-a-randomized-double-blind-parallel-group-placebo-controlled-active-comparator-dose-optimization-evaluation-followed-by-a-open-label-evaluation-to-assess-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-4-randomized-open-label-active-controlled-study-to-investigate-the-efficacy-and-safety-of-switching-from-weekly-dulaglutide-to-weekly-tirzepatide-in-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-dose-escalation-and-safety-study-of-bi-3821001-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-dose-escalation-study-of-bispecific-antibodies-in-adult-patients-with-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-dose-escalation-study-to-evaluate-the-safety-and-efficacy-of-anti-hepatitis-b-antibodies-in-patients-with-chronic-hepatitis-b-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-dose-escalation-study-to-evaluate-the-safety-and-tolerability-of-bi-3814916-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-dose-escalation-study-to-evaluate-the-safety-and-tolerability-of-bi-3820768-in-patients-with-advanced-relapsed-or-refractory-ovarian-endometrial-or-germ-cell-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-dose-escalation-study-to-evaluate-the-safety-and-efficacy-of-ari-her2-her2bbz-car-t-cells-in-patients-with-her2-positive-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-study-to-evaluate-the-safety-and-pharmacokinetics-of-gen3018-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-or-higher-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-study-to-evaluate-the-safety-and-pharmacokinetics-of-kk2223-in-patients-with-t-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-study-to-evaluate-the-safety-and-tolerability-of-aln-snca-in-adult-participants-with-early-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-mr-l45-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pbgene-hbv-in-patients-with-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-multi-site-open-label-two-part-trial-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-bnt323-in-combination-with-bnt327-in-participants-with-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-multicenter-study-evaluating-the-feasibility-safety-and-efficacy-of-point-of-care-manufactured-glpg5101-19cp02-in-subjects-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-open-label-multi-center-study-to-assess-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-azd7789-an-anti-pd-1-and-anti-tim-3-bispecific-antibody-in-patients-with-relapsed-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-open-label-multicenter-study-evaluating-the-feasibility-safety-and-efficacy-of-point-of-care-manufactured-antibcma-car-t-cells-glpg5301-bcmacp03-in-subjects-with-relapsed-refractory-multi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-amg-410-monotherapy-and-combination-therapy-in-participants-with-kras-altered-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-anifrolumab-safety-pharmacokinetics-and-pharmacodynamics-in-adults-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-carcik-cd123-33-in-adults-and-children-with-relapsed-or-refractory-acute-myeloid-leukemia-and-blastic-plasmacytoid-dendritic-cell-neoplasm2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-gen1106-in-participants-with-metastatic-or-advanced-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-gs-2426-in-adults-with-mtap-deleted-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-ide892-monotherapy-and-combination-therapy-in-patients-with-mtap-deleted-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-kisima-02-vaccine-based-immunotherapy-in-kras-g12d-g12v-mutated-pancreatic-ductal-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-neoadjuvant-intra-arterial-administration-of-177lu-lu-psma-617-in-subjects-with-high-risk-localised-or-locally-advanced-prostate-cancer-who-are-candidates-for-radical-prostatecto2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-oral-flc-436-evaluating-safety-tolerability-and-antitumor-activity-in-patients-with-refractory-or-relapsed-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-of-pembrolizumab-mk-3475-in-children-with-advanced-melanoma-or-a-pd-l1-positive-advanced-relapsed-or-refractory-solid-tumor-or-lymphoma-keynote-0512026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-evaluate-the-feasibility-safety-and-preliminary-efficacy-of-point-of-care-manufactured-anti-cd19-car-t-in-subjects-with-relapsed-or-refractory-chronic-lymphocytic-leukemia-cll-or2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-evaluate-the-safety-and-efficacy-of-cat-01-in-patients-with-advanced-cervical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-evaluate-the-safety-pharmacokinetics-and-clinical-activity-of-bbt002-in-healthy-volunteers-and-patients-with-copd-crswnp-or-comorbid-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-evaluate-the-safety-tolerability-and-pharmacodynamics-of-lfd-200-in-healthy-volunteers-and-patients-with-moderate-to-severe-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-tnv108-in-healthy-adults-and-patients-with-diabetic-peripheral-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-ii-study-to-investigate-the-safety-and-feasibility-of-point-of-care-human-cd19-targeting-car-t-cells-in-paediatric-and-young-adult-patients-with-relapsed-or-refractory-b-cell-malignancies-pa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-iia-open-label-dose-escalation-and-expansion-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-azd7789-an-anti-pd-1-and-anti-tim-3-bispecific-antibody-in-partici2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-iia-open-label-single-ascending-dose-study-to-assess-safety-and-tolerability-of-regulatory-t-cells-to-promote-discontinuation-of-tacrolimus-monotherapy-in-liver-transplant-recipients-livetre2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-multi-center-study-of-autologous-cd19-car-t-cell-therapy-in-patients-with-refractory-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-multiple-ascending-dose-study-of-mk-3508-in-healthy-participants-for-the-treatment-of-respiratory-syncytial-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-comparative-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-immunogenicity-and-safety-of-ckd-706-in-healthy-adult-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-dose-escalation-study-evaluating-the-safety-and-tolerability-of-bi-4060107-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-dose-finding-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-egl-003-in-healthy-volunteers-and-adults-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-single-dose-mass-balance-trial-to-investigate-metabolism-and-pharmacokinetics-of-bi-1291583-c-14-administered-as-oral-solution-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-study-assessing-safety-tolerability-and-dose-escalation-of-yg-01-in-adults-with-newly-diagnosed-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-study-comparing-the-bioavailability-of-2-and-4-lidocaine-gel-following-urethral-administration-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-study-evaluating-the-pharmacokinetics-immunogenicity-and-drug-drug-interaction-potential-of-trontinemab-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-study-to-evaluate-the-absorption-distribution-metabolism-excretion-and-pharmacokinetics-of-14c-ltp001-in-healthy-male-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-open-label-study-to-evaluate-the-bioavailability-of-naloxone-hydrochloride-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-pharmacokinetic-and-safety-study-comparing-km04-to-recombinant-human-follicle-stimulating-hormone-in-healthy-adult-female-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-double-blind-placebo-controlled-four-way-cross-over-study-to-evaluate-the-analgesic-effects-of-trv045-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-double-blind-placebo-controlled-study-assessing-safety-tolerability-pk-and-pd-of-st-905-ag1-in-healthy-volunteers-for-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-topical-ocular-ds101-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-double-blind-placebo-controlled-two-way-cross-over-multiple-dose-study-to-evaluate-the-pharmacodynamic-effects-of-trv045-on-the-cortical-excitability-in-healthy-male-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-double-blind-study-assessing-the-safety-and-tolerability-of-nnc9836-0001-in-healthy-volunteers-and-subjects-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-open-label-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-wal0623-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-randomized-placebo-controlled-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ojr520-in-healthy-volunteers-and-patients-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-safety-and-tolerability-study-of-ax-5006-in-healthy-volunteers-and-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-safety-dose-finding-and-feasibility-trial-of-gd2il18cart-in-patients-with-relapsed-or-refractory-gd2-positive-solid-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-single-and-multiple-ascending-dose-study-of-topical-ladarixin-ophthalmic-solution-in-healthy-volunteers-for-the-treatment-of-ocular-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-single-and-multiple-ascending-dose-study-of-zp6590-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-adults-with-overweight-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-single-and-multiple-ascending-dose-study-to-evaluate-the-safety-and-pharmacokinetics-of-grt6019-in-healthy-male-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-single-ascending-dose-study-to-evaluate-the-safety-and-pharmacokinetics-of-ev25-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-assessing-safety-and-tolerability-of-bca101-monotherapy-and-bca101-based-combination-therapy-in-patients-with-egfr-driven-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-evaluating-safety-pharmacokinetics-and-preliminary-antitumor-activity-of-odm-216-in-patients-with-advanced-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-225ac-etn029-in-patients-with-advanced-small-cell-lung-cancer-neuroendocrine-prostate-cancer-gep-nec-and-large-cell-neuroendocrine-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-gs-5319-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-mk-2420-in-patients-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-mk-7480-in-single-ascending-doses-for-non-alcoholic-steatohepatitis-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-nnc0497-0040-in-healthy-adults-individuals-with-overweight-or-obesity-and-patients-with-type-1-diabetes-and-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-ptc844-in-single-and-multiple-ascending-doses-for-patients-with-autoimmune-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-sie-1-in-post-menopausal-women-with-hormone-receptor-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-tk-6302-in-patients-with-advanced-prame-positive-solid-tumors-harboring-the-hla-a-02-01-allele2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-of-ves001-in-patients-with-frontotemporal-dementia-ftd2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-absolute-bioavailability-of-cenerimod-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-cardiovascular-safety-of-vicadrostat-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-effect-of-different-liquid-vehicles-on-the-pharmacokinetics-of-mk-3214-in-healthy-volunteers-with-hypercholesterolaemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-pharmacokinetics-and-metabolism-of-bi-3000202-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-pharmacokinetics-and-safety-of-a-single-dose-of-duvakitug-in-healthy-adult-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-pharmacokinetics-and-safety-of-nolasiban-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-pharmacokinetics-and-safety-of-subcutaneous-rilvegostomig-in-adults-with-advanced-solid-tumors-previously-treated-with-standard-of-care2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-absorption-and-elimination-of-ro7795081-in-subjects-with-type-2-diabetes-and-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-efficacy-of-kup-101a-in-patients-with-advanced-solid-tumors-including-cutaneous-and-mucosal-melanoma-and-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-ctx-187-following-single-and-repeated-intravenous-administration-in-healthy-volunteers-and-patients-with-bacterial-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-mk-6050-in-participants-with-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-mk-6916-in-healthy-participants-for-the-management-of-acute-and-chronic-pain2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-ro7763505-in-healthy-volunteers-and-patients-with-stable-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-ro7795074-in-overweight-or-obese-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-preliminary-efficacy-of-gen1079-in-participants-with-advanced-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-and-tolerability-of-lu-ah70212-and-lu-ah69593-in-healthy-adults-for-the-treatment-of-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-pharmacokinetics-and-absorption-of-ro7795068-in-subjects-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-a-cd19-cd20-t-cell-engager-in-patients-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-and-efficacy-of-lad106-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-bal2420-in-healthy-adult-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-pf-08065010-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-single-ascending-doses-of-opt101-in-patients-with-chronic-kidney-disease-on-peritoneal-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-a-single-subcutaneous-dose-of-gsk4771261-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-i-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-surovatamig-in-adults-with-rheumatoid-arthritis-or-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-ii-multi-center-open-label-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-gfh925-in-combination-with-cetuximab-in-previously-untreated-advanced-nsclc-harboring-k2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-ii-multi-site-open-label-dose-finding-trial-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-bnt326-in-combination-with-bnt327-in-participants-with-advanced-non-small-cell-lung-cance2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-ii-open-label-multicenter-randomized-platform-study-evaluating-the-efficacy-and-safety-of-neoadjuvant-immunotherapy-combinations-in-patients-with-surgically-resectable-hepatoceullular-carci2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-ii-study-of-atezolizumab-and-dendritic-cell-vaccination-as-maintenance-therapy-in-extensive-stage-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-iia-randomized-double-blind-placebo-controlled-multiple-ascending-dose-parallel-group-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ro7126209-followi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ib-randomized-placebo-controlled-study-evaluating-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-crovalimab-for-the-management-of-acute-uncomplicated-vaso-occlusive-episodes-voe-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-clinical-trial-to-study-the-efficacy-and-safety-of-pembrolizumab-mk-3475-and-pembrolizumab-in-combination-with-other-investigational-agents-in-subjects-with-high-risk-non-muscle-invasive-bl2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-double-blind-multi-center-placebo-controlled-trial-to-assess-the-efficacy-and-safety-of-alpelisib-byl719-in-pediatric-and-adult-patients-with-megalencephaly-capillary-malformation-polymicro2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-iii-randomized-double-blind-placebo-controlled-multicenter-study-to-determine-the-efficacy-and-safety-of-abc008-in-the-treatment-of-subjects-with-inclusion-body-myositis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-iii-randomized-double-blind-placebo-controlled-study-of-tiragolumab-in-combination-with-atezolizumab-plus-pemetrexed-and-carboplatin-cisplatin-versus-pembrolizumab-plus-pemetrexed-and-carbo2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-iii-randomized-study-of-brigimadlin-bi-907828-versus-doxorubicin-in-first-line-treatment-of-advanced-dedifferentiated-liposarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-multicenter-randomized-double-blind-study-of-tobemstomig-ro7247669-combined-with-nab-paclitaxel-compared-with-pembrolizumab-combined-with-nab-paclitaxel-in-participants-with-previously-untr2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-multi-drug-multi-center-master-protocol-to-evaluate-the-efficacy-and-safety-of-novel-immunomodulators-as-monotherapy-and-in-combination-with-anticancer-agents-in-participants-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-multicenter-randomized-study-of-the-efficacy-and-safety-of-adjuvant-autogene-cevumeran-plus-atezolizumab-and-mfolfirinox-versus-mfolfirinox-alone-in-patients-with-resected-pancre2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-multicenter-trial-investigating-irinotecan-plus-cetuximab-rechallenge-compared-with-trifluridine-tipiracil-plus-bevacizumab-as-third-line-treatment-in-circulating-tumor-dna-molec2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-pilot-trial-assessing-the-safety-of-anifrolumab-in-adult-patients-with-primary-antiphospholipid-syndrome-aps-the-anifaps-trial2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-platform-study-to-evaluate-immunotherapy-based-combinations-in-participants-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-open-label-single-center-single-arm-pilot-study-to-evaluate-the-safety-tolerability-and-efficacy-of-blinatumomab-for-treatment-of-patients-with-autoimmune-b-cell-driven-diseases-including-s2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomised-placebo-controlled-double-blind-parallel-group-efficacy-and-safety-study-of-at-least-48-weeks-of-oral-bi-685509-treatment-in-adults-with-progressive-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-double-blind-study-comparing-fulvestrant-and-palbociclib-versus-fulvestrant-and-placebo-in-hr-positive-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-open-label-multi-center-study-of-jsb462-in-combination-with-lutetium-177lu-vipivotide-tetraxetan-in-adult-male-patients-with-psma-positive-metastatic-castration-resistant-prostat2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-open-label-national-multicenter-study-evaluating-the-efficacy-and-safety-of-the-combination-of-atezolizumab-and-bevacizumab-as-neoadjuvant-plus-adjuvant-treatment-in-hepatocellul2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-open-label-non-inferiority-study-of-niraparib-maintenance-after-3-vs-6-cycles-of-platinum-based-chemotherapy-in-completely-debulked-advanced-hrdpositive-high-grade-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-open-label-parallel-group-multicenter-study-to-assess-bioequivalence-of-two-subcutaneous-formulations-of-ocrelizumab-in-patients-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-open-label-study-evaluating-two-inavolisib-dose-levels-in-combination-with-fulvestrant-in-participants-with-pik3ca-mutated-hr-positive-her2-negative-locally-advanced-or-metastati2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-randomized-study-of-regn9933-regn7508-and-regn9533-monoclonal-antibody-combination-therapy-in-adults-with-end-stage-kidney-disease-on-hemodialysis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-single-blind-randomized-controlled-study-to-evaluate-the-immunogenicity-and-safety-of-a-measles-mumps-rubella-varicella-vaccine-compared-with-proquad-administered-in-healthy-children-4-to-62026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-evaluating-efficacy-of-kte-x19-car-t-cell-therapy-in-relapsed-or-refractory-mantle-cell-lymphoma-achieving-a-partial-response-during-ibrutinib-salvage-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-evaluating-the-efficacy-and-safety-of-imetelstat-in-patients-with-hr-myelodysplastic-syndromes-or-aml-failing-hma-based-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-abx-001-or-abx-001-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-tumors-previously-treated-with-standard-of-care-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-adcx-020-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-amg-436-monotherapy-and-combination-therapy-in-participants-with-microsatellite-instability-high-mismatch-repair-deficient-msi-h-dmmr-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-gilteritinib-in-adults-with-locally-advanced-or-metastatic-alk-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-ibi3009-monotherapy-or-in-combination-with-combination-therapy-in-patients-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-iev407-monotherapy-and-iev407-combined-with-endocrine-therapy-in-patients-with-advanced-hr-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-intravenous-abbv901-monotherapy-and-abbv901-in-combination-with-bevacizumab-in-adults-with-advanced-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-kisima-02-vaccine-based-immunotherapy-in-patients-with-kras-g12d-g12v-mutated-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-men2501-in-patients-with-platinum-resistant-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-mk-1045-in-patients-with-systemic-lupus-erythematosus-or-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-mx006-in-patients-with-advanced-solid-tumors-expressing-b7-h32026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-regn9220-combined-with-odronextamab-in-relapsed-refractory-aggressive-b-cell-non-hodgkin-lymphoma-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-study-of-tarlatamab-neoadjuvant-and-adjuvant-therapy-in-patients-with-surgically-resectable-recurrent-high-grade-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-ii-trial-evaluating-the-safety-and-efficacy-of-the-combination-of-zimberelimab-domvanalimab-and-sacituzumab-govitecan-as-first-line-therapy-for-pd-l1-positive-advanced-triple-negative-breast-c2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-open-label-proof-of-concept-study-to-evaluate-the-safety-of-aqueous-afamelanotide-solution-in-patients-with-acute-arterial-ischaemic-stroke-ais-who-are-ineligible-for-intravenous-thromboly2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-open-label-single-centre-study-to-assess-the-initial-antifibrotic-efficacy-safety-tolerability-pharmacokinetic-and-pharmacodynamic-profile-of-mbf-118-in-crohn-s-disease-patients-with-steno2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-open-label-study-to-evaluate-the-safety-of-afamelanotide-in-patients-with-early-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-randomised-double-blind-placebo-controlled-multicentre-study-to-assess-the-efficacy-safety-and-tolerability-of-azd4144-in-participants-with-sepsis-associated-acute-kidney-injury-serenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-randomized-double-blind-placebo-controlled-study-to-evaluate-safety-tolerability-and-pharmacodynamics-of-azd4831-in-participants-with-non-cirrhotic-non-alcoholic-steatohepatitis-nash-with-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-randomized-open-label-proof-of-concept-study-to-evaluate-safety-tolerability-and-efficacy-of-ir-cpi-in-patients-with-spontaneous-intracerebral-haemorrhage-the-birch-study2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-randomized-parallel-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-enpatoran-in-dermatomyositis-and-polymyositis-participants-receiving-standard-of-care2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iia-trial-evaluating-the-efficacy-of-anti-cd19-chimeric-antigen-receptor-engineered-t-cells-in-patients-with-systemic-sclerosis-ssc-resistant-to-immunosuppressive-drugs-sclerocar2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iib-multicenter-double-blind-placebo-controlled-induction-study-with-an-active-treatment-extension-to-assess-the-efficacy-safety-and-pharmacokinetics-of-ro7837195-in-patients-with-moderately-t2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iib-multicentre-randomised-double-blind-placebo-controlled-crossover-study-to-evaluate-the-efficacy-and-safety-of-dirocaftor-posenacaftor-nesolicaftor-in-subjects-with-cystic-fibrosis-aged-18-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iib-randomised-double-blind-placebo-controlled-multi-centre-dose-ranging-study-of-azd3427-in-participants-with-heart-failure-and-pulmonary-hypertension-due-to-left-heart-disease-who-group-22026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iib-randomized-study-of-adjuvant-durvalumab-and-regorafenib-versus-control-in-stage-iv-colorectal-cancer-patients-with-no-evidence-of-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iib-study-of-intra-articular-allocetra-ots-versus-placebo-in-adults-with-primary-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-comparative-study-of-xdivane-versus-nivolumab-for-the-treatment-of-patients-with-resected-melanoma-efficacy-safety-pharmacokinetics-and-immunogenicity2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-double-blind-multicenter-randomized-study-of-atezolizumab-anti-pd-l1-antibody-versus-placebo-as-adjuvant-therapy-in-patients-with-high-risk-muscle-invasive-bladder-cancer-who-are-ctdna-pos2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-double-blind-placebo-controlled-randomised-trial-of-aspirin-on-recurrence-and-survival-in-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-double-blind-placebo-controlled-study-of-adjuvant-durvalumab-in-resected-stage-ib-iiia-non-small-cell-lung-cancer-with-pd-l1-expression-252026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-double-blind-randomized-placebo-controlled-parallel-group-trial-of-the-efficacy-of-citicoline-eyedrops-2-on-visual-field-preservation-in-patients-with-open-angle-glaucoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-controlled-trial-comparing-opioid-free-versus-opioid-based-anesthesia-in-breast-free-flap-reconstruction-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-double-blind-double-dummy-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-fenebrutinib-compared-with-ocrelizumab-in-adult-patients-with-primary-progressi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-double-blind-double-dummy-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-fenebrutinib-compared-with-teriflunomide-in-adult-patients-with-relapsing-multi2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-ro7434656-an-antisense-inhibitor-of-complement-factor-b-in-patients-with-primary-iga-nep2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-double-masked-sham-controlled-study-to-investigate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-ro7200220-administered-intravitreally-in-patients-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-fulvestrant-versus-alpelisib-plus-fulvestrant-in-patients-with-hormone-receptor-positive-her2-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-open-label-study-of-atezolizumab-and-bevacizumab-as-adjuvant-therapy-in-high-risk-hepatocellular-carcinoma-post-resection-or-ablation2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-open-label-trial-to-evaluate-the-safety-and-efficacy-of-systemic-therapy-with-regorafenib-and-pembrolizumab-versus-locoregional-therapy-with-transarterial-chemoembol2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicenter-randomized-trial-comparing-anakinra-and-intravenous-immunoglobulin-in-kawasaki-disease-patients-unresponsive-to-initial-ivig-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicentre-open-label-chronic-dosing-extension-study-to-evaluate-the-long-term-safety-of-tozorakimab-in-participants-with-chronic-obstructive-pulmonary-disease-copd-with-a-history-of-copd2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicentre-open-label-randomised-study-evaluating-the-efficacy-and-safety-of-r-mini-chop-x2-followed-by-azd0486-versus-r-mini-chop-x6-in-elderly-or-unfit-participants-with-newly-diagnosed2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicentre-randomised-double-blind-chronic-dosing-parallel-group-placebo-controlled-extension-study-to-evaluate-the-long-term-efficacy-and-safety-of-tozorakimab-in-participants-with-chron2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multicentre-randomized-double-blind-chronic-dosing-parallel-group-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-two-dose-regimens-of-tozorakimab-in-participants-with-symp2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-multisite-double-blinded-randomized-trial-of-bnt327-in-combination-with-chemotherapy-etoposide-carboplatin-compared-to-atezolizumab-in-combination-with-chemotherapy-etoposide-carboplatin-i2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-open-label-randomized-controlled-multi-country-study-to-evaluate-the-immune-response-safety-and-reactogenicity-of-rsvpref3-oa-investigational-vaccine-when-co-administered-with-20-valent-pn2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-open-label-randomized-study-of-atezolizumab-and-tiragolumab-compared-with-durvalumab-in-patients-with-locally-advanced-unresectable-stage-iii-non-small-cell-lung-cancer-who-have-not-progre2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomised-double-blind-multicentre-study-comparing-the-efficacy-safety-and-immunogenicity-of-proposed-tocilizumab-biosimilar-drl-tocilizumab-with-tocilizumab-reference-product-roactemra-r2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomised-double-blind-placebo-controlled-multicentre-study-of-durvalumab-in-combination-with-chemotherapy-and-bevacizumab-followed-by-maintenance-durvalumab-bevacizumab-and-olaparib-in-n2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomised-double-blind-placebo-controlled-parallel-group-pivotal-trial-to-assess-the-efficacy-and-safety-of-sonlicromanol-in-adult-subjects-with-a-genetically-confirmed-mitochondrial-dna-2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomised-open-label-sponsor-blinded-multicenter-study-of-rilvegostomig-in-combination-with-bevacizumab-with-or-without-tremelimumab-as-first-line-treatment-in-patients-with-advanced-hepa2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-controlled-multi-center-3-arm-study-of-neoadjuvant-osimertinib-as-monotherapy-or-in-combination-with-chemotherapy-versus-standard-of-care-chemotherapy-alone-for-the-treatment-of2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-parallel-group-placebo-controlled-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-efficacy-and-safety-of-iv-anifrolumab-in-pediatric-participants-5-to-18-ye2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-international-study-of-osimertinib-as-maintenance-therapy-in-patients-with-locally-advanced-unresectable-egfr-mutation-positive-non-s2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-study-to-evaluate-the-efficacy-and-safety-of-astegolimab-in-patients-with-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-study-to-evaluate-the-efficacy-and-safety-of-intravenous-prasinezumab-in-participants-with-early-stage-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-palbociclib-and-fulvestrant-versus-placebo-plus-palbociclib-and-fulvestrant-in-patien2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-study-of-atezolizumab-with-or-without-tiragolumab-anti-tigit-antibody-in-patients-with-unresectable-esophageal-squamous-cell-carcinoma-whose-canc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-placebo-controlled-study-of-toripalimab-and-lenvatinib-versus-placebo-and-lenvatinib-in-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-study-of-pembrolizumab-trastuzumab-and-chemotherapy-in-her2-positive-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blind-study-to-evaluate-pembrolizumab-plus-chemotherapy-vs-placebo-plus-chemotherapy-as-neoadjuvant-therapy-and-pembrolizumab-vs-placebo-as-adjuvant-therapy-for-triple-ne2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-double-blinded-placebo-controlled-study-of-tiragolumab-an-anti-tigit-antibody-in-combination-with-atezolizumab-compared-with-placebo-in-combination-with-atezolizumab-in-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-multi-site-open-label-trial-of-bnt323-db-1303-versus-investigator-s-choice-of-chemotherapy-in-previously-treated-patients-with-her2-expressing-recurrent-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-clinical-trial-to-compare-pembrolizumab-with-brentuximab-vedotin-in-subjects-with-relapsed-or-refractory-classical-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-multicenter-global-study-of-puxitatug-samrotecan-azd8205-monotherapy-versus-physician-s-choice-of-chemotherapy-in-participants-with-b7-h4-selected-advanced-metastatic2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-non-inferiority-study-comparing-the-efficacy-and-safety-of-furazidin-vaginal-tablets-and-clindamycin-vaginal-cream-in-the-local-treatment-of-bacterial-vaginosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-giredestrant-in-combination-with-phesgo-versus-phesgo-after-induction-therapy-with-phesgo-taxane-in-patients-with-previous2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-study-of-acalabrutinib-and-venetoclax-versus-venetoclax-and-obinutuzumab-in-treatment-naive-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-randomized-open-label-study-to-evaluate-pembrolizumab-as-neoadjuvant-therapy-and-in-combination-with-standard-of-care-as-adjuvant-therapy-for-stage-iii-iva-resectable-locoregionally-advanc2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-study-evaluating-efficacy-and-safety-of-elecoglipron-combined-with-dapagliflozin-in-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-study-of-atezolizumab-combined-with-folfox-versus-folfox-alone-in-stage-iii-colon-adenocarcinoma-with-deficient-mismatch-repair2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-study-of-azd0486-plus-rituximab-drug-combination-versus-standard-chemoimmunotherapy-in-previously-untreated-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-study-of-elecoglipron-for-weight-loss-in-adults-with-obesity-or-overweight-with-or-without-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iii-study-of-ro7795068-vs-placebo-for-weight-loss-in-adults-with-obesity-without-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iiib-single-arm-open-label-multicentre-study-of-durvalumab-and-tremelimumab-as-first-line-treatment-in-participants-with-advanced-hepatocellular-carcinoma-sierra2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iiib-single-arm-open-label-multicentre-study-of-durvalumab-in-combination-with-chemotherapy-for-the-first-line-treatment-for-patients-with-advanced-biliary-tract-cancers-tourmaline2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iv-multicenter-open-label-randomized-study-of-acalabrutinib-monotherapy-versus-investigator-s-choice-in-chronic-lymphocytic-leukemia-with-cardiac-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iv-randomised-double-blind-parallel-design-controlled-multi-center-trial-of-a-novel-moisturiser-for-atopic-dermatitis-effect-on-relapse-prevention-in-children-nova-ii2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iv-study-to-investigate-the-immunogenicity-of-the-seqirus-licensed-mf59-adjuvanted-zoonotic-influenza-vaccine-h5n8-in-adults-previously-vaccinated-in-2009-with-the-matrix-m-adjuvanted-virosoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-iv-trial-to-confirm-the-efficacy-of-olaparib-in-combination-with-bevacizumab-as-maintenance-frontline-treatment-of-hrd-positive-ovarian-tumours-iolanthe2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-study-of-mk-4716-in-patients-with-kras-altered-advanced-or-metastatic-non-small-cell-lung-cancer-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-phase-study-of-phn-012-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-pilot-bioavailability-study-comparing-sublingual-500-g-and-intramuscular-100-g-administration-of-carbetocin-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-pilot-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-intra-articular-cntx-0066-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-pilot-study-on-the-use-of-gadopiclenol-for-enhanced-cardiac-mri-in-children-with-congenital-heart-conditions-a-self-controlled-non-randomised-open-label-study-to-compare-the-image-quality-and-diagno2026-10-07 https://dev.clinicalresearch.eu/trial/a-pivotal-multicentre-randomised-open-label-parallel-group-trial-on-contraceptive-efficacy-safety-and-tolerability-of-lvds-levonorgestrel-vaginal-delivery-system-during-9-cycles-in-comparison-with-des2026-10-07 https://dev.clinicalresearch.eu/trial/a-pivotal-phase-3-clinical-trial-to-assess-the-diagnostic-performance-and-safety-of-68ga-ga-pentixafor-68ga-ga-ptf-a-positron-emission-tomography-pet-imaging-agent-versus-18f-fdg-pet-ct-imaging-for-st2026-10-07 https://dev.clinicalresearch.eu/trial/a-pivotal-phase-3-randomized-placebo-controlled-clinical-study-to-evaluate-the-efficacy-and-safety-of-the-sgc-stimulator-vericiguat-mk-1242-in-adults-with-chronic-heart-failure-with-reduced-ejection-f2026-10-07 https://dev.clinicalresearch.eu/trial/a-pragmatic-randomized-trial-to-evaluate-the-effectiveness-of-high-dose-quadrivalent-influenza-vaccine-vs-standard-dose-quadrivalent-influenza-vaccine-in-older-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-pragmatic-study-evaluating-the-efficacy-of-once-weekly-insulin-icodec-versus-daily-basal-insulin-analogues-in-insulin-naive-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-proof-of-concept-phase-iia-open-label-study-to-evaluate-the-safety-and-efficacy-of-afamelanotide-in-patients-with-early-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-multi-centre-randomised-double-blind-placebo-controlled-phase-iii-trial-to-investigate-the-efficacy-and-safety-of-lozenges-with-benzydamine-hydrochloride-and-dichlorobenzyl-alcohol-in-th2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-multi-centric-randomised-double-dummy-double-blind-placebo-controlled-3-way-phase-iii-study-to-investigate-the-efficacy-and-safety-of-two-dexamfetamine-sulfate-formulations-in-adults-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-multicenter-open-label-phase-3-clinical-study-to-evaluate-the-efficacy-and-safety-of-prophylactic-vga039-in-adolescent-and-adult-patients-with-von-willebrand-disease-vivid-62026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-open-label-multicenter-phase-ii-trial-to-evaluate-the-efficacy-and-safety-of-a-sequential-regimen-of-bendamustine-followed-by-obinutuzumab-ga101-zanubrutinib-bgb-3111-and-venetoclax-abt-2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-open-label-multicenter-randomized-study-to-evaluate-the-benefits-and-risks-of-conversion-of-existing-adolescent-renal-allograft-recipients-aged-12-to-less-than-18-years-of-age-to-a-belat2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-open-label-randomized-interventional-study-to-evaluate-the-efficacy-and-tolerability-of-sucrosomial-r-iron-vs-ferric-maltol-in-iron-deficient-women2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-post-authorisation-long-term-follow-up-trial-of-patients-previously-treated-with-imlifidase-prior-to-kidney-transplantation-including-a-non-comparative-concurrent-reference-cohort2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-randomised-multi-centre-double-blind-placebo-controlled-phase-iii-trial-to-investigate-the-efficacy-and-safety-of-lozenges-with-benzydamine-hydrochloride-and-dichlorobenzyl-alcohol-in-th2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-randomized-controlled-clinical-pilot-trial-investigating-the-partial-down-titration-of-guideline-directed-medical-therapy-in-patients-with-heart-failure-in-remission2026-10-07 https://dev.clinicalresearch.eu/trial/a-prospective-study-comparing-18f-mfbg-pet-ct-to-123i-mibg-scanning-in-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-controlled-assessor-blind-parallel-groups-multicentre-multinational-trial-comparing-the-ovarian-response-after-controlled-ovarian-stimulation-with-mixed-protocols-of-follitropin-delta-rek2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-controlled-trial-to-investigate-the-effect-of-a-four-six-week-intensified-pharmacological-treatment-for-schizophrenia-major-depressive-disorder-and-bipolar-depression-compared-to-treatmen2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-double-blind-placebo-controlled-parallel-group-trial-evaluating-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-bi-1291583-one-tablet-once-daily-over-12-weeks-versus-placebo-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-double-masked-placebo-controlled-trial-to-evaluate-the-efficacy-safety-and-tolerability-of-oral-bi-1815368-in-participants-with-centre-involved-diabetic-macular-edema-for-48-weeks-of-trea2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-multicentre-double-blind-placebo-controlled-phase-iii-study-of-first-line-carboplatin-and-paclitaxel-in-combination-with-durvalumab-followed-by-maintenance-durvalumab-with-or-without-olap2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-open-label-phase-iii-multicenter-2-arm-study-comparing-177lu-psma-i-t-versus-apalutamide-enzalutamide-abiraterone-in-metastatic-hormon-sensitive-prostate-cancer-patients-receiving-castrat2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-phase-3-trial-comparing-3-weekly-docetaxel-75-mg-m2-in-a-3-week-cycle-versus-2-weekly-docetaxel-50-mg-m2-in-a-4-week-cycle-in-combination-with-darolutamide-adt-in-patients-with-metastatic2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomised-placebo-controlled-double-blind-single-ascending-dose-and-multiple-ascending-dose-first-in-human-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-oral2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-assessor-blinded-trial-comparing-lenalidomide-and-methotrexate-in-patients-with-refractory-cutaneous-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-blinded-placebo-controlled-phase-2a-proof-of-concept-study-to-evaluate-efficacy-safety-and-tolerability-of-gs-5718-in-participants-with-cutaneous-lupus-erythematosus-cle2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-blinded-study-of-clostridium-botulinum-neurotoxin-type-a-and-capsaicin-in-treating-postmastectomy-syndrome-in-unilateral-breast-neoplasia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-first-in-human-study-of-ap31969-on-single-and-multiple-ascending-doses-and-food-effect-in-healthy-subjects-with-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-non-inferiority-trial-of-low-dose-amitriptyline-versus-cognitive-behavioral-therapy-for-chronic-insomnia-with-medical-comorbidity2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-partially-masked-phase-3b-study-to-assess-the-injection-burden-efficacy-safety-and-long-term-preservation-of-visual-acuity-of-surabgene-lomparvovec-abbv-rgx-314-in-a-real-world2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-azathioprine-and-methotrexate-in-combination-with-adalimumab-for-endoscopic-response-in-crohn-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-azithromycin-and-clarithromycin-in-mycobacterium-avium-complex-pulmonary-disease-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-lithium-carbonate-and-lamotrigine-for-mood-stabilization-in-patients-with-bipolar-disorder-type-ii2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-methotrexate-and-prednisone-as-first-line-therapy-in-patients-with-pulmonary-sarcoidosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-proactive-therapeutic-drug-monitoring-with-routine-care-using-secukinumab-ixekizumab-or-guselkumab-in-moderate-to-severe-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-remimazolam-and-midazolam-for-sedation-in-diagnostic-upper-gastrointestinal-endoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-sodium-chloride-and-sodium-lactate-in-the-management-of-severe-diabetic-ketoacidosis-in-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-tapering-strategies-for-discontinuation-of-paroxetine-hydrochloride-and-venlafaxine-in-remitted-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-comparing-the-efficacy-of-umeclidinium-bromide-fluticasone-furoate-and-vilanterol-versus-laba-lama-combination-in-high-risk-copd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-evaluating-metformin-and-metformin-hydrochloride-dosing-in-overweight-adults-with-polycystic-ovary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-of-angiotensin-ii-versus-noradrenaline-for-prevention-of-cardiac-surgery-associated-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-of-autologous-immune-cell-therapy-in-patients-with-newly-diagnosed-highly-active-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-of-dalteparin-sodium-and-enoxaparin-sodium-for-thromboprophylaxis-in-patients-undergoing-liver-resection2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-of-intra-articular-prp-mfat-and-prp-mfat-for-symptomatic-knee-osteoarthritis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-on-fecal-microbiota-transplantation-versus-sodium-chloride-for-recurrent-pouchitis-in-ulcerative-colitis-with-ipaa2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-controlled-trial-on-the-efficacy-of-allogenic-ex-vivo-expanded-bone-marrow-derived-mesenchymal-stem-cells-in-treating-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-crossover-bioequivalence-study-of-memantine-20-mg-capsules-versus-memantine-20-mg-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-crossover-comparative-bioavailability-study-of-oral-suspension-versus-film-coated-tablet-formulations-of-tadalafil-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-crossover-pilot-study-of-quinidine-versus-verapamil-in-patients-with-short-coupled-idiopathic-ventricular-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-crossover-study-evaluating-bioavailability-biopotency-and-food-effect-of-scd0503-versus-subcutaneous-regular-human-insulin-in-adults-with-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-controlled-trial-evaluating-10-lidocaine-spray-for-pain-reduction-in-peripheral-intravenous-catheter-insertion-in-adult-females2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-controlled-trial-of-glucocorticoids-and-rituximab-versus-glucocorticoids-and-placebo-in-adult-iga-vasculitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-cross-over-trial-assessing-rosuvastatin-calcium-and-placebo-in-statin-intolerant-patients-with-high-cardiovascular-risk2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-dose-escalation-study-evaluating-the-safety-and-tolerability-of-bi-3034701-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-multicenter-phase-3-study-in-patients-with-moderately-to-severely-active-ulcerative-colitis-uc-to-compare-the-efficacy-safety-and-immunogenicity-of-pb016-and-entyvio-r-for-th2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-multicenter-phase-iii-study-to-evaluate-the-long-term-efficacy-and-safety-of-abx464-25-mg-or-50-mg-once-daily-as-a-maintenance-therapy-in-subjects-with-moderately-to-severely2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-multicenter-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-atumelnant-in-adult-participants-with-classic-congenital-adrenal-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-parallel-group-active-controlled-trial-with-open-label-safety-extension-to-evaluate-the-tolerability-safety-and-efficacy-of-atogepant-versus-topiramate-in-subjects-requiring-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-parallel-group-study-comparing-remibrutinib-and-teriflunomide-in-relapsing-multiple-sclerosis-patients-with-open-label-remibrutinib-extension2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-phase-2-3-study-of-fianlimab-anti-lag-3-antibody-in-combination-with-cemiplimab-anti-pd-1-antibody-versus-cemiplimab-monotherapy-in-first-line-treatment-of-patients-with-adva2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-phase-2-3-trial-of-relatlimab-and-nivolumab-versus-nivolumab-monotherapy-in-untreated-metastatic-or-unresectable-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-phase-3-study-of-platinum-based-chemotherapy-with-or-without-incmga00012-in-first-line-metastatic-squamous-and-nonsquamous-non-small-cell-lung-cancer-pod1um-3042026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-phase-iia-study-evaluating-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-crovalimab-as-adjunct-treatment-in-prevention-of-vaso-occlusive-episodes-voe-in-sickle2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-2-way-crossover-study-to-assess-the-analgesic-effects-of-thc-in-patients-with-chronic-neuropathic-pain-and-to-phenotype-the-responders-to-thc-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-cross-over-trial-of-the-safety-tolerability-and-efficacy-of-pn6047-hcl-in-peripheral-neuropathic-pain-characterized-by-mechanical-allodynia2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-crossover-study-of-clebopride-hydrogen-maleate-in-patients-with-rumination-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-dose-finding-study-to-assess-the-efficacy-and-safety-of-sar443122-in-adult-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-dose-finding-study-to-evaluate-the-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-abbv-552-in-participants-with-mild-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-dose-ranging-phase-2-study-of-brivekimig-followed-by-a-maintenance-period-in-participants-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multi-center-study-to-evaluate-the-efficacy-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-orally-administered-glpg3667-once-daily-for-24-wee2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-phase-3-study-to-evaluate-the-safety-tolerability-and-efficacy-of-xen1101-as-adjunctive-therapy-in-focal-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-phase-3-study-to-evaluate-the-safety-tolerability-and-efficacy-of-xen1101-as-adjunctive-therapy-in-primary-generalized-tonic-clonic-seizures-x-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-abx464-once-daily-for-induction-treatment-in-subjects-with-moderately-to-severely-active2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-study-to-assess-the-efficacy-and-safety-of-rifaximin-soluble-solid-dispersion-ssd-tablets-for-the-delay-of-encephalopathy-decompensation-in-cir2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-study-to-evaluate-the-efficacy-and-safety-of-cal02-administered-intravenously-in-addition-to-standard-of-care-in-subjects-with-severe-community2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicenter-trial-assessing-the-impact-of-lipoprotein-a-lowering-with-pelacarsen-tqj230-on-the-progression-of-calcific-aortic-valve-stenosis-lp-a-frontiers2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-multicentre-trial-assessing-the-impact-of-ferric-carboxymaltose-on-exercise-capacity-and-functional-status-in-pulmonary-hypertension-iron-ph2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-national-multicenter-phase-3-trial-to-evaluate-the-efficacy-of-azathioprine-for-the-prevention-of-relapse-in-patients-with-myelin-oligodendrocyte-glycoprot2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-parallel-group-multicenter-study-of-the-efficacy-and-safety-of-depemokimab-in-adult-participants-with-copd-with-type-2-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-parallel-group-multicenter-study-with-a-long-term-extension-treatment-period-to-assess-the-efficacy-and-safety-of-jnj-63733657-an-anti-tau-monoclonal-antib2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-parallel-group-study-to-assess-the-efficacy-safety-and-tolerability-of-biib080-in-subjects-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-or-mil2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-parallel-group-study-to-assess-the-efficacy-safety-and-tolerability-of-sar444336-in-participants-with-microscopic-colitis-in-clinical-remission-with-budeso2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-of-methotrexate-as-remission-maintenance-therapy-after-remission-induction-therapy-with-tocilizumab-and-gluco2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-phase-1-2-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-exploratory-efficacy-of-aoc-1020-administered-intravenously-to-ad2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-efficacy-and-safety-of-fazirsiran-in-the-treatment-of-alpha-1-antitrypsin-deficiency-associated-liver-disease-with-metavir-st2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-efficacy-and-safety-of-intravenous-aoc-1020-for-the-treatment-of-facioscapulohumeral-muscular-dystrophy-fshd2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-phase-3-trial-of-pembrolizumab-mk-3475-versus-placebo-in-participants-with-esophageal-carcinoma-receiving-concurrent-definitive-chemoradiotherapy-keynote-92026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-pilot-study-of-riluzole-in-patients-with-spinocerebellar-ataxia-type-72026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-proof-of-concept-study-assessing-the-efficacy-and-safety-of-an-anti-tnf-ox40l-nanobody-r-molecule-sar442970-in-participants-with-moderate-to-severe-hidrade2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-250-mg-lebrikizumab-in-adults-with-moderate-to-severe-localized-scleroderma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-eloralintide-ly3841136-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-ijamp-in-adults-with-prick-test-induced-itch2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-impd-q-in-adults-with-prick-test-induced-itch2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-intravenously-administered-ale-f02-to-evaluate-the-safety-tolerability-pharmacokinetics-and-renal-sparing-in-antineutrophil-cytoplasmic-antibody-a2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-ly4213663-in-healthy-volunteers-and-adults-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-resomelagon-in-patients-with-idiopathic-membranous-nephropathy-and-severe-proteinuria2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-subcutaneous-mannan-conjugated-betula-pendula-pollen-allergoid-in-birch-pollen-induced-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-tak-360-in-patients-with-narcolepsy-with-cataplexy2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-of-trilaciclib-vs-placebo-in-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-receiving-topotecan-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-on-analgesic-and-cns-effects-of-morphine-and-fluvoxamine-in-chronic-pain-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-to-assess-the-effects-of-high-concentration-capsaicin-patch-qutenza-on-neuropathic-symptoms-nerve-fibers-and-microcirculation-in-painful-diabetic-per2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-abbv-916-in-subjects-with-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-tolerability-and-efficacy-of-an-inhaled-phage-cocktail-in-healthy-subjects-and-patients-with-chronic-pseudomonas-aeruginosa-lung-colonization2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-study-to-investigate-the-efficacy-of-fenebrutinib-in-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-assessing-triv-509-on-skin-barrier-function-in-adults-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-comparing-nicotine-containing-electronic-cigarettes-varenicline-and-nicotine-free-electronic-cigarettes-in-smokers2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-evaluating-the-efficacy-and-safety-of-e2086-in-adults-with-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-of-cannabidiol-as-an-adjunct-to-antipsychotic-therapy-in-remitted-early-phase-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-of-orforglipron-ly3502970-for-bmi-reduction-in-adolescents-with-obesity-or-overweight-related-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-placebo-controlled-trial-of-semaglutide-in-young-adults-with-early-onset-obesity-resistant-to-lifestyle-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-split-face-comparative-trial-evaluating-the-efficacy-and-safety-of-topical-4-hydroquinone-and-0-025-tretinoin-versus-4-hydroquinone-in-facial-melasma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-study-comparing-bevacizumab-and-aflibercept-in-neovascular-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-study-comparing-remibrutinib-and-teriflunomide-in-relapsing-multiple-sclerosis-patients-with-open-label-remibrutinib-extension2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-study-of-ataciguat-to-slow-progression-of-moderate-calcific-aortic-valve-stenosis-in-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-study-on-intravenous-propofol-injection-pain-versus-placebo-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blind-trial-assessing-efficacy-and-safety-of-oral-bi-1015550-in-patients-with-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blinded-placebo-controlled-dose-finding-adaptive-trial-to-evaluate-the-safety-tolerability-and-efficacy-of-tak-360-in-participants-with-narcolepsy-without-cataplexy-nt22026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-double-blinded-placebo-controlled-multicenter-phase-ii-iii-efficacy-and-safety-study-of-oral-thero2-01s22-as-add-on-therapy-on-top-of-first-line-anti-her2-targeted-treatment-of-patients-w2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-first-in-human-phase-1-single-center-observer-blind-active-controlled-3-arm-study-to-evaluate-the-safety-tolerability-and-immunogenicity-of-one-single-administration-of-tetralite-a-novel-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-intrapatient-crossover-study-evaluating-the-efficacy-of-oxybutynin-and-venlafaxine-in-reducing-hot-flashes-in-post-breast-cancer-endocrine-therapy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-multi-center-parallel-double-blinded-placebo-controlled-clinical-trial-to-evaluate-efficacy-safety-and-pharmacokinetics-of-xembify-r-plus-standard-medical-treatment-compared-to-placebo-pl2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-multi-center-study-comparing-fentanyl-citrate-nasal-spray-and-placebo-for-postoperative-pain-management-in-orthopedic-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-multi-regional-double-blind-double-dummy-parallel-group-placebo-and-allopurinol-controlled-phase-3-study-to-assess-the-efficacy-and-safety-of-tigulixostat-in-gout-patients-with-hyperurice2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-multicenter-double-blind-placebo-controlled-parallel-group-study-with-open-label-extension-period-to-assess-the-efficacy-and-safety-of-selexipag-as-add-on-treatment-to-standard-of-care-in2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-non-inferiority-trial-of-doxycycline-monohydrate-versus-benzathine-benzylpenicillin-for-the-treatment-of-early-syphilis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-observer-blind-trial-comparing-chloroprocaine-hydrochloride-gel-and-oxybuprocaine-eye-drops-for-pediatric-ocular-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-crossover-comparative-bioavailability-study-of-finerenone-20-mg-film-coated-tablets-in-healthy-participants-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-crossover-study-to-assess-the-relative-bioavailability-of-naproxen-sodium-660-mg-modified-release-tablets-in-healthy-adult-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-crossover-study-to-evaluate-the-effect-of-food-and-applesauce-on-the-bioavailability-of-bupropion-hydrochloride-extended-release-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-multicenter-phase-3-trial-evaluating-brelovitug-vs-delayed-treatment-for-the-treatment-of-chronic-hepatitis-delta-infection-azure-42026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-multicenter-phase-3-trial-of-ivonescimab-alone-or-ivonescimab-with-ligufalimab-versus-pembrolizumab-for-the-first-line-treatment-of-recurrent-and-or-metastatic-head-and-neck-sq2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-non-inferiority-trial-comparing-lacosamide-and-duloxetine-for-chemotherapy-induced-neuropathic-pain2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-2-3-study-of-datopotamab-deruxtecan-dato-dxd-plus-carboplatin-or-cisplatin-versus-gemcitabine-plus-carboplatin-or-cisplatin-in-participants-with-locally-advanced-or-metas2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-2-study-of-botensilimab-agen1181-as-monotherapy-and-in-combination-with-balstilimab-agen2034-or-investigator-s-choice-standard-of-care-regorafenib-or-trifluridine-and-tip2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-3-study-of-acalabrutinib-in-combination-with-rituximab-and-reduced-dose-chop-r-minichop-in-older-adults-with-untreated-diffuse-large-b-cell-lymphoma-arched-gla-2022-12026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-3-study-of-sacituzumab-govitecan-versus-treatment-of-physician-s-choice-in-patients-with-hormone-receptor-positive-hr-human-epidermal-growth-factor-receptor-2-negative-he2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-3-study-of-tarlatamab-compared-with-standard-of-care-in-subjects-with-relapsed-small-cell-lung-cancer-after-platinum-based-first-line-chemotherapy-dellphi-3042026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-3-study-of-xl092-nivolumab-vs-sunitinib-in-subjects-with-advanced-or-metastatic-non-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-3-trial-to-compare-the-efficacy-and-safety-of-idecabtagene-vicleucel-with-lenalidomide-maintenance-versus-lenalidomide-maintenance-therapy-alone-in-adult-participants-wit2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-phase-ii-trial-comparing-neoadjuvant-endocrine-therapy-in-combination-with-trastuzumab-pertuzumab-the-pi3k-inhibitor-inavolisib-in-patients-with-her2-positive-hr-positive-pik3c2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-placebo-controlled-trial-evaluating-aciclovir-gel-versus-aciclovir-cream-in-recurrent-herpes-labialis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-single-center-crossover-bioequivalence-study-of-two-temazepam-20-mg-tablet-formulations-in-healthy-subjects-following-fasted-administration2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-single-center-study-to-evaluate-the-bioequivalence-of-lanifibranor-in-patients-with-non-alcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-study-on-palivizumab-prophylaxis-for-prevention-of-respiratory-morbidity-in-preterm-infants-with-rsv-bronchiolitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-superiority-trial-comparing-subcutaneous-abatacept-and-tocilizumab-in-rheumatoid-arthritis-patients-with-inadequate-response-to-targeted-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-trial-comparing-dolutegravir-lamivudine-to-bictegravir-emtricitabine-tenofovir-alafenamide-for-maintenance-of-virological-suppression-in-hiv2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-trial-comparing-ethacizine-and-propafenone-hydrochloride-for-sinus-rhythm-maintenance-in-atrial-fibrillation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-crossover-bioequivalence-study-comparing-naproxen-sodium-660-mg-modified-release-tablets-to-a-reference-modified-release-product-in-healthy-adults-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-crossover-bioequivalence-study-of-deucravacitinib-6-mg-tablets-in-healthy-adult-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-crossover-bioequivalence-study-of-two-oral-formulations-of-canagliflozin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-crossover-study-to-compare-the-bioavailability-of-bupropion-hydrochloride-extended-release-capsules-and-tablets-in-healthy-adult-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-crossover-study-to-compare-the-relative-bioavailability-of-naproxen-sodium-660-mg-modified-release-tablets-to-a-reference-product-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-comparing-imatinib-mesylate-400-mg-tablets-to-reference-imatinib-mesylate-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-of-amoxicillin-clavulanate-film-coated-tablets-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-of-deucravacitinib-6-mg-tablets-in-healthy-adult-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-of-maribavir-200-mg-in-healthy-adult-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-of-ponatinib-15-mg-in-healthy-adult-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-sequence-crossover-bioequivalence-study-of-trametinib-2-mg-tablets-in-healthy-adult-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-treatment-cross-over-bioequivalence-study-of-pyridostigmine-bromide-180-mg-tablets-versus-prolonged-release-pyridostigmine-bromide-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-open-label-two-period-two-treatment-crossover-bioequivalence-study-of-pyridostigmine-bromide-180-mg-tablets-versus-a-prolonged-release-reference-product-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-parallel-group-24-week-double-blind-placebo-controlled-multicenter-phase-3-study-to-assess-the-efficacy-and-safety-of-secukinumab-compared-to-placebo-in-adult-patients-with-active-rotator2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-parallel-group-double-blind-placebo-controlled-multicenter-phase-iii-trial-to-evaluate-efficacy-and-safety-of-secukinumab-administered-subcutaneously-versus-placebo-in-combination-with-a-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-2-3-open-label-study-to-investigate-the-efficacy-and-safety-of-rp2-in-combination-with-nivolumab-versus-ipilimumab-in-combination-with-nivolumab-in-immune-checkpoint-inhibitor-naive2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-2-3-study-of-bms-986504-in-combination-with-pembrolizumab-and-chemotherapy-versus-placebo-plus-pembrolizumab-and-chemotherapy-in-first-line-metastatic-non-small-cell-lung-cancer-par2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-2-double-blind-placebo-controlled-study-to-investigate-the-safety-and-efficacy-of-ker-012-in-combination-with-background-therapy-in-adult-participants-with-pulmonary-arterial-hypert2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-2-study-of-adjunctive-equ-001-for-uncontrolled-focal-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-3-double-blind-study-of-chemoradiotherapy-with-or-without-pembrolizumab-for-the-treatment-of-high-risk-locally-advanced-cervical-cancer-keynote-a18-engot-cx11-gog-30472026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-3-double-blind-study-of-chemotherapy-with-or-without-pembrolizumab-followed-by-maintenance-with-olaparib-or-placebo-for-the-first-line-treatment-of-brca-non-mutated-advanced-epithel2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-3-open-label-study-of-neoadjuvant-darovasertib-in-subjects-with-primary-non-metastatic-uveal-melanoma-optimum-102026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-3-study-of-datopotamab-deruxtecan-dato-dxd-and-pembrolizumab-with-or-without-platinum-chemotherapy-in-subjects-with-no-prior-therapy-for-advanced-or-metastatic-pd-l1-tps-50-non-squa2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-ii-open-label-multicenter-study-investigating-efficacy-and-safety-of-anti-pd-1-pd-l1-treatment-uv1-vaccination-as-first-line-treatment-in-patients-with-inoperable-advanced-or-metast2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-ii-trial-on-the-addition-of-dutasteride-to-combined-androgen-blockade-therapy-versus-combined-androgen-blockade-therapy-alone-in-patients-with-recurrent-and-or-metastatic-salivary-d2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-iii-global-multicentre-open-label-clinical-trial-comparing-venetoclax-azacitidine-and-quizartinib-vs-venetoclax-and-azacitidine-in-newly-diagnosed-acute-myeloid-leukemia-patient-s-i2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-phase-iii-study-of-adjuvant-imatinib-for-recurrence-free-survival-in-high-risk-operable-gastrointestinal-stromal-tumor-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-double-blind-multi-center-phase-3-study-of-zipalertinib-plus-adjuvant-chemotherapy-versus-placebo-plus-adjuvant-chemotherapy-in-stage-ib-iiia-nsclc-patients-with-uncomm2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-double-blind-multi-center-phase-iii-trial-to-assess-the-efficacy-and-safety-of-trimodulin-bt588-in-adult-hospitalized-subjects-with-severe-community-acquired-pneumonia-2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-double-blind-parallel-group-6-month-study-to-evaluate-the-safety-tolerability-and-potential-efficacy-of-monthly-trappsol-r-cyclo-tm-hydroxypropyl-beta-cyclodextrin-hpbc2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-investigator-and-participant-blinded-study-investigating-safety-tolerability-and-efficacy-of-rhh646-in-participants-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-observer-blind-multicenter-trial-assessing-safety-and-immunogenicity-of-the-gbs-nn-nn2-vaccine-in-pregnant-women-and-their-infants-for-prevention-of-group-b-streptococcal-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-parallel-phase-2a-dose-ranging-study-to-investigate-the-efficacy-safety-and-tolerability-of-topical-ht-001-for-the-treatment-of-skin-toxicities-associated-with-epiderma2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-study-of-aficamten-myqorzo-on-post-valsalva-lvot-gradient-in-asymptomatic-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-study-on-prophylactic-azithromycin-and-cefuroxime-versus-cefuroxime-alone-for-post-hysterectomy-infection-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-trial-of-oral-vancomycin-in-adults-and-adolescents-with-primary-sclerosing-cholangitis-with-or-without-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-placebo-controlled-trial-of-rimonabant-for-cognitive-impairment-in-patients-with-post-covid-19-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-single-blind-non-inferiority-trial-comparing-efficacy-and-safety-of-adalimumab-and-etanercept-biosimilars-versus-originators-in-pediatric-juvenile-idiopathic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-study-of-acalabrutinib-and-venetoclax-in-newly-diagnosed-chronic-lymphocytic-leukemia-patients-at-high-risk-of-infection-or-early-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-study-of-andexanet-alfa-compared-to-usual-care-in-patients-receiving-a-factor-xa-inhibitor-who-require-urgent-surgery-or-procedure-annexa-rs2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-study-of-dosimetry-based-versus-standard-dose-peptide-receptor-radionuclide-therapy-with-lutetium-177lu-edotreotide-in-neuroendocrine-tumor-patients2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-study-of-obicetrapib-and-bempedoic-acid-in-patients-with-dyslipidemia-at-high-to-very-high-cardiovascular-risk2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-trial-of-dual-agent-fluorescence-guided-surgery-for-resection-of-colorectal-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-trial-of-prednisolone-versus-placebo-in-adult-patients-with-fibrotic-hypersensitivity-pneumonitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-trial-of-trastuzumab-deruxtecan-and-biology-driven-selection-of-neoadjuvant-treatment-for-her2-positive-breast-cancer-ariadne2026-10-07 https://dev.clinicalresearch.eu/trial/a-randomized-two-period-two-sequence-crossover-bioequivalence-study-of-bupropion-hydrochloride-sustained-release-tablets-in-healthy-adult-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/a-reactogenicity-safety-and-immunogenicity-study-of-gsk-s-paediatric-herpes-zoster-subunit-candidate-vaccine-ped-hz-su-gsk143713a-in-immunocompromised-paediatric-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/a-registry-based-extension-of-protocol-v503-001-in-countries-with-centralized-cervical-cancer-screening-infrastructures-to-evaluate-the-long-term-effectiveness-immunogenicity-and-safety-of-multivalent2026-10-07 https://dev.clinicalresearch.eu/trial/a-registry-study-of-treatment-with-bulevirtide-in-participants-with-chronic-hepatitis-d-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-safety-and-tolerability-study-of-qrl-101-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/a-safety-study-of-romosozumab-in-children-and-adolescents-with-osteogenesis-imperfecta2026-10-07 https://dev.clinicalresearch.eu/trial/a-seamless-phase-1b-2-multiple-ascending-dose-proof-of-concept-study-of-xtmab-16-in-patients-with-pulmonary-sarcoidosis-with-or-without-extrapulmonary-manifestations2026-10-07 https://dev.clinicalresearch.eu/trial/a-seamless-phase-2a-2b-randomized-double-blind-placebo-and-active-controlled-multiple-arm-multiple-stage-adaptive-study-evaluating-the-efficacy-and-safety-of-lad191-in-adults-with-moderate-to-severe-h2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-multi-centre-trial-to-evaluate-efficacy-and-safety-of-imlifidase-in-highly-sensitised-children-1-17-years-receiving-a-kidney-transplant-with-positive-crossmatch-against-a-living-or-deceas2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-multicenter-open-label-phase-i-ii-trial-of-allo-quadcar01-t-an-allogeneic-car-t-cell-therapy-targeting-cd19-and-cd20-for-the-treatment-of-relapsed-or-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-multicenter-phase-1-2-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-bcl-2-inhibitor-bgb-11417-in-patients-with-relapsed-or-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-multicenter-single-dose-phase-2b-clinical-study-evaluating-efficacy-and-safety-of-gene-therapy-using-autologous-cd34-hematopoietic-stem-cells-transduced-with-the-globe-lentivir2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-phase-1-2-study-evaluating-the-safety-efficacy-and-cellular-kinetics-pharmacodynamics-of-allo-501a-an-anti-cd19-allogeneic-car-t-cell-therapy-and-allo-647-an-anti-cd52-monoclon2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-phase-3b-study-to-describe-the-safety-and-tolerability-of-ivosidenib-in-combination-with-azacitidine-in-adult-patients-newly-diagnosed-with-idh1m-acute-myeloid-leukemia-aml-ine2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-phase-i-ii-clinical-trial-of-autologous-hematopoietic-stem-and-progenitor-cells-hspcs-genetically-modified-with-a-lentiviral-vector-lvv-encoding-for-the-human-programmed-death-2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-phase-ii-study-to-determine-the-safety-and-efficacy-of-obecabtagene-autoleucel-obe-cel-in-participants-with-severe-refractory-systemic-lupus-erythematosus-with-active-lupus-nep2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-open-label-study-to-evaluate-the-efficacy-and-safety-of-abbv-668-in-subjects-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-phase-ii-study-to-confirm-efficacy-and-feasibility-of-tarlatamab-treatment-in-patients-with-extensive-stage-small-cell-lung-cancer-with-poor-performance-status-space-t-without-impd-q2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-linperlisib-yy-20394-monotherapy-in-patients-with-relapsed-or-refractory-peripheral-t-nk-cell-or-cutaneous-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-study-investigating-the-glycaemic-control-and-safety-of-adding-semaglutide-to-insulin-icodec-in-participants-with-type-2-diabetes-qualifying-for-treatment-intensification2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-arm-study-to-evaluate-the-efficacy-and-safety-of-pozelimab-and-cemdisiran-combination-therapy-in-patients-with-paroxysmal-nocturnal-hemoglobinuria-with-inadequate-control-of-intravascular-hem2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-center-randomized-double-blind-placebo-controlled-parallel-group-proof-of-concept-trial-to-assess-the-efficacy-and-safety-of-act-1004-1239-in-adults-with-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-centre-open-label-randomised-phase-ii-study-on-the-maintenance-of-ovulation-inhibition-after-intentional-application-errors-during-84-days-of-treatment-with-mr-130a-01-contraceptive-transderm2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-centre-parallel-group-randomized-control-trial-of-magnetic-resonance-assessment-of-variations-in-effects-of-anaesthesia-on-renal-perfusion-in-children2026-10-07 https://dev.clinicalresearch.eu/trial/a-single-dose-pharmacokinetic-study-of-eloralintide-in-subjects-with-normal-hepatic-function-and-varying-degrees-of-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-7-day-and-4-week-esomeprazole-treatment-for-patients-with-unexplained-dyspepsia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-baricitinib-adalimumab-and-etanercept-in-patients-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-bgb-11417-and-zanubrutinib-with-venetoclax-and-acalabrutinib-in-patients-with-previously-untreated-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-cemiplimab-alone-or-with-a-drug-combination-to-prevent-rapid-disease-progression-in-patients-with-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-continuous-infusion-and-intermittent-injections-of-furosemide-and-amiloride-hydrochloride-in-patients-hospitalized-with-acute-heart-failure-and-volume-overload2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-different-doses-of-zinc-to-evaluate-copper-absorption-in-healthy-volunteers-for-the-treatment-of-wilson-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-different-schedules-of-venetoclax-and-azacitidine-in-patients-with-acute-myeloid-leukemia-who-cannot-receive-intensive-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-elacestrant-and-ribociclib-with-standard-hormone-therapy-for-patients-with-high-risk-estrogen-receptor-positive-and-her2-negative-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-esketamine-hydrochloride-mouthwash-and-esketamine-intravenous-infusion-to-treat-mouth-inflammation-in-patients-undergoing-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-exposure-of-semaglutide-and-dapagliflozin-dosed-orally-as-mono-components-versus-in-a-fixed-dose-combination2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-mifamurtide-and-sorafenib-for-children-and-young-adults-with-high-risk-osteosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-one-month-versus-one-year-of-aspirin-and-clopidogrel-for-patients-with-chronic-limb-threatening-ischemia-after-below-the-knee-vascular-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-rectal-progesterone-and-vaginal-progesterone-for-supporting-pregnancy-in-women-with-infertility-undergoing-frozen-embryo-transfer-using-estradiol2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-rilvegostomig-cisplatin-and-gemcitabine-versus-durvalumab-and-a-drug-combination-for-adults-with-advanced-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-rinatabart-sesutecan-to-doxorubicin-or-paclitaxel-in-patients-with-endometrial-cancer-who-have-previously-received-platinum-based-chemotherapy-and-pd-l-1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-standard-doses-of-abiraterone-acetate-with-dosing-guided-by-blood-levels-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-effectiveness-of-a-simeticone-drug-combination-and-sodium-picosulfate-magnesium-oxide-and-citric-acid-for-patients-undergoing-colorectal-cancer-screening2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-effectiveness-of-brimonidine-tartrate-and-timolol-eye-drops-against-a-standard-treatment-for-patients-with-glaucoma-or-ocular-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-effectiveness-of-datopotamab-deruxtecan-and-docetaxel-in-adults-with-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-effectiveness-of-vorolanib-and-aflibercept-in-patients-with-diabetic-macular-edema2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-effectiveness-of-vorolanib-and-aflibercept-in-patients-with-diabetic-macular-edema-22026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-the-subcutaneous-and-intravenous-administration-of-frexalimab-in-adults-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-comparing-xaluritamig-to-cabazitaxel-abiraterone-acetate-or-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer-previously-treated-with-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-effectiveness-of-inavolisib-and-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-effectiveness-of-secukinumab-compared-to-a-drug-combination-in-patients-with-severe-takayasu-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-safety-and-effectiveness-of-rilvegostomig-and-ramucirumab-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-safety-and-effectiveness-of-tub-040-and-standard-chemotherapy-drugs-in-women-with-high-grade-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-safety-and-efficacy-of-once-weekly-dosing-of-somapacitan-in-a-basket-study-design-in-paediatric-participants-with-short-stature-either-born-small-of-gestational-age-or-with-turn2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-safety-and-use-of-the-extroducer-infusion-catheter-system-for-delivering-gemcitabine-in-patients-with-locally-advanced-pancreatic-cancer-that-cannot-be-removed-by-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-evaluating-the-use-of-leflutrozole-to-improve-semen-quality-in-men-with-non-obstructive-azoospermia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-in-healthy-volunteers-to-improve-methods-for-detection-of-ghb-in-drug-rape-victims2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-abbv-142-to-evaluate-safety-and-disease-activity-in-adults-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-abbv-706-and-atezolizumab-for-patients-with-newly-diagnosed-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-acetylsalicylic-acid-and-diclofenac-to-treat-blood-clots-in-superficial-venous-malformations-in-children-aged-6-to-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-acoramidis-in-adults-with-transthyretin-amyloidosis-with-cardiomyopathy-who-are-switching-from-tafamidis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-alks-2680-for-reducing-excessive-daytime-sleepiness-in-adults-with-narcolepsy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-atrasentan-in-children-2-to-18-years-with-primary-iga-nephropathy-to-evaluate-reduction-of-proteinuria2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-azd0120-for-people-with-relapsed-or-refractory-multiple-myeloma-compared-to-standard-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-barzolvolimab-in-patients-with-chronic-spontaneous-urticaria-who-still-have-symptoms-despite-taking-antihistamines2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-belantamab-mafodotin-and-mezigdomide-in-patients-with-relapsed-multiple-myeloma-who-previously-received-car-t-cell-therapy-or-bispecific-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-belzutifan-and-lenvatinib-for-people-with-von-hippel-lindau-disease-related-tumors-or-specific-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-belzutifan-and-xl092-in-patients-with-advanced-kidney-cancer-who-have-received-previous-immunotherapy-and-targeted-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-bi-764532-atezolizumab-carboplatin-and-etoposide-in-patients-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-bifikafusp-alfa-and-onfekafusp-alfa-for-the-treatment-of-patients-with-locally-advanced-basal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-blinatumomab-for-adults-and-adolescents-with-relapsed-refractory-or-minimal-residual-disease-positive-b-cell-precursor-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-cc-122-in-patients-with-multiple-myeloma-follicular-lymphoma-and-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-cemiplimab-in-patients-with-locally-advanced-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-daraxonrasib-rmc-6236-compared-to-observation-in-patients-with-pancreatic-cancer-that-has-been-surgically-removed2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-decitabine-cedazuridine-and-ivosidenib-in-adult-patients-with-newly-diagnosed-acute-myeloid-leukemia-who-are-older-than-60-or-cannot-receive-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-donidalorsen-in-children-aged-2-to-12-years-with-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ds-3790a-rituximab-and-epcoritamab-in-patients-with-blood-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-el219-compared-to-liposomal-amphotericin-b-and-voriconazole-for-the-treatment-of-suspected-invasive-mould-infections2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-elafibranor-to-evaluate-efficacy-and-safety-in-adults-with-primary-sclerosing-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-eloralintide-for-adults-with-overweight-or-obesity-who-are-already-using-a-weekly-incretin-medication2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-emavusertib-and-zanubrutinib-in-patients-with-chronic-lymphocytic-leukemia-and-other-b-cell-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-enzomenib-in-adult-patients-with-acute-leukemia-including-those-with-mll-rearrangement-or-npm1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-epcoritamab-for-patients-with-waldenstrom-s-macroglobulinemia-that-has-returned-or-did-not-respond-to-previous-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-etentamig-and-daratumumab-for-adults-with-newly-diagnosed-multiple-myeloma-who-are-not-eligible-for-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-felzartamab-in-kidney-transplant-recipients-with-late-isolated-microvascular-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ficerafusp-alfa-and-nivolumab-in-patients-with-head-and-neck-cancer-who-did-not-respond-to-platinum-based-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-frevecitinib-kn-002-in-patients-with-severe-asthma-not-controlled-by-medium-to-high-dose-ics-laba-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-glucagon-and-dasiglucagon-with-automated-insulin-delivery-to-prevent-low-blood-sugar-during-exercise-in-people-with-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-grass-and-olive-pollen-extract-drug-combination-for-patients-with-hay-fever-and-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-inr731-monotherapy-and-inr731-combined-with-an-androgen-receptor-pathway-inhibitor-in-men-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-irinotecan-and-a-drug-combination-for-patients-with-gastric-cancer-or-cancer-of-the-gastroesophageal-junction-undergoing-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-irinotecan-fluorouracil-calcium-folinate-zimberelimab-and-domvanalimab-for-patients-with-metastatic-gastro-enteropancreatic-neuroendocrine-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-islatravir-and-ulonivirine-for-adults-with-hiv-who-have-not-previously-received-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-jnj-78278343-and-docetaxel-compared-to-docetaxel-and-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ketamine-hydrochloride-prolonged-release-tablets-as-an-additional-treatment-for-patients-with-major-depression-who-are-starting-antidepressant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-kra-533-in-advanced-krasg12c-mutated-non-small-cell-lung-cancer-patients-with-prior-therapy-progression-or-immuno-chemotherapy-contraindications2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-kt-621-in-adults-with-moderate-to-severe-eosinophilic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-linvoseltamab-and-linvoseltamab-plus-carfilzomib-for-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-lutetium-177lu-vipivotide-tetraxetan-for-patients-with-metastatic-hormone-sensitive-prostate-cancer-receiving-androgen-deprivation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ly4175408-in-adults-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ly4268989-and-mirikizumab-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-maridebart-cafraglutide-for-adults-with-obstructive-sleep-apnea-who-are-overweight-or-obese-and-use-positive-airway-pressure-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-mesenchymal-stromal-cells-expressing-cxcr4-and-il-10-for-patients-with-acute-graft-versus-host-disease-who-have-not-responded-to-steroids-or-ruxolitinib2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-mezigdomide-carfilzomib-and-dexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-mk-1084-and-a-drug-combination-for-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutations-who-have-received-previous-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-mk-4646-single-ascending-dose-and-drug-drug-interaction-in-healthy-participants-with-hiv-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-mrna-4157-and-a-drug-combination-for-people-with-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-om336-and-a-drug-combination-to-help-patients-with-end-stage-renal-failure-become-eligible-for-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-onfekafusp-alfa-and-bifikafusp-alfa-in-patients-with-locally-advanced-basal-cell-carcinoma-who-have-progressed-or-are-intolerant-to-systemic-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-osimertinib-and-febuxostat-to-improve-drug-levels-in-the-brain-for-patients-with-egfr-mutated-non-small-cell-lung-cancer-without-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-palazestrant-and-ribociclib-compared-to-letrozole-and-ribociclib-for-patients-with-advanced-hormone-receptor-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pembrolizumab-and-radiotherapy-for-patients-with-early-stage-favorable-classic-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pembrolizumab-belzutifan-and-lenvatinib-to-evaluate-response-before-main-treatment-in-patients-with-localized-kidney-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pembrolizumab-cetuximab-and-mk-1084-for-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-petosemtamab-and-pembrolizumab-in-adults-with-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pf-08634404-and-a-drug-combination-for-adult-patients-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pf-08634404-and-a-drug-combination-versus-bevacizumab-and-a-drug-combination-for-patients-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pf-08634404-and-sigvotatug-vedotin-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pf-08634404-ipilimumab-and-axitinib-in-adults-with-advanced-or-metastatic-kidney-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pivekimab-sunirine-with-venetoclax-and-azacitidine-in-adults-with-newly-diagnosed-acute-myeloid-leukemia-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pm54-and-pembrolizumab-in-adults-with-advanced-cancer-who-have-received-previous-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-psilocybin-and-psychological-support-for-patients-with-cocaine-addiction-compared-to-diphenhydramine-hydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-pumitamig-and-ipilimumab-for-patients-with-advanced-or-unresectable-liver-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-q702-in-patients-with-relapsed-or-refractory-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-regn7041-for-adults-with-active-noninfectious-uveitis-affecting-the-back-of-the-eye2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-romiplostim-for-treating-low-platelet-counts-caused-by-chemotherapy-in-adults-with-lung-ovarian-or-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-rptr-1-201-and-pembrolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-sacituzumab-tirumotecan-and-bevacizumab-for-people-with-newly-diagnosed-advanced-ovarian-cancer-after-first-line-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-sacituzumab-tirumotecan-versus-docetaxel-paclitaxel-or-vinflunine-for-patients-with-previously-treated-advanced-or-metastatic-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-semaglutide-to-treat-obstructive-sleep-apnea-in-older-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-subcutaneous-blinatumomab-in-children-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia-and-minimal-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-the-effects-of-tirzepatide-and-levonorgestrel-in-women-with-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-the-safety-and-effectiveness-of-sir9900-compared-with-placebo-in-adults-with-vexas-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-the-safety-tolerability-pharmacokinetics-and-efficacy-of-nnc0638-0355-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-tofacitinib-abatacept-and-tocilizumab-compared-to-adalimumab-or-etanercept-for-children-with-juvenile-idiopathic-arthritis-who-did-not-respond-to-previous-tnfi-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-trontinemab-in-patients-with-early-symptomatic-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-ulixertinib-tovorafenib-and-vinblastine-sulfate-for-children-with-progressive-relapsed-or-refractory-low-grade-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-vepugratinib-enfortumab-vedotin-and-pembrolizumab-in-adults-with-advanced-or-metastatic-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-vitamin-d3-treated-and-myelin-derived-peptide-loaded-toldc-therapy-for-patients-with-progressive-forms-of-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-yl201-and-atezolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-zenagamtide-for-people-with-obesity-and-obstructive-sleep-apnoea-treated-with-positive-airway-pressure2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-of-zenagamtide-to-reduce-major-adverse-cardiovascular-events-in-patients-with-established-atherosclerotic-cardiovascular-disease-who-are-overweight-or-obese2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-on-how-enzalutamide-and-apalutamide-affect-the-levels-of-dexamethasone-in-patients-with-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-on-the-effectiveness-of-cagrilintide-and-semaglutide-for-weight-management-in-children-and-adolescents-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-on-the-pharmacokinetic-interactions-of-cannabidiol-amitriptyline-and-tramadol-in-neurological-assessments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-on-using-dapagliflozin-in-elderly-patients-hospitalized-with-worsening-chronic-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-assess-the-effects-of-zigakibart-in-adults-with-iga-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-assess-the-safety-of-anumigilimab-in-adults-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-glofitamab-with-a-drug-combination-for-patients-with-relapsed-or-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-how-asundexian-is-absorbed-in-healthy-adults-using-different-formulations-and-the-effect-of-food-to-prevent-blood-clots2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-how-intravenous-lidocaine-hydrochloride-works-in-young-and-elderly-patients-undergoing-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-absorption-of-ezetimibe-and-atorvastatin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-and-safety-of-avt29-and-aflibercept-in-patients-with-diabetic-macular-edema2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-and-safety-of-bmn-333-and-vosoritide-in-children-with-achondroplasia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-of-bupivacaine-hydrochloride-monohydrate-and-lidocaine-hydrochloride-for-pain-caused-by-mouth-sores-in-patients-with-head-and-neck-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-of-cineole-and-mupirocin-in-treating-chronic-nasal-infections-caused-by-methicillin-resistant-staphylococcus-aureus2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-of-frexalimab-and-tacrolimus-in-preventing-kidney-transplant-rejection-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-effectiveness-of-topical-clobetasol-propionate-and-a-placebo-for-treating-pain-in-adults-with-inflammatory-hand-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-timing-of-etoposide-and-dexamethasone-treatment-for-patients-with-severe-sporadic-hemophagocytic-lymphohistiocytosis-in-intensive-care2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-the-use-of-amoxicillin-and-clavulanic-acid-for-a-shorter-duration-versus-a-standard-10-day-treatment-in-children-with-urinary-tract-infections-and-fever2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-treatment-without-antibiotics-versus-a-drug-combination-of-cefditoren-pivoxil-ciprofloxacin-cefuroxime-metronidazole-and-amoxicillin-and-clavulanic-acid-in-patients-with-acute-uncomplicated-diverticulitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-compare-using-a-half-dose-of-iomeprol-versus-a-standard-dose-for-imaging-lung-tumors-with-spectral-ct-scans2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-if-atorvastatin-prevents-gallstones-in-patients-undergoing-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-if-hydrocortisone-helps-reduce-symptoms-of-post-traumatic-stress-disorder-in-patients-following-exposure-to-trauma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-if-methylphenidate-helps-patients-in-a-coma-due-to-acute-brain-injury-wake-up-earlier2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-if-silymarin-prevents-liver-damage-caused-by-ribociclib-in-patients-with-hormone-receptor-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-ly3537021-and-a-drug-combination-for-treating-nausea-and-vomiting-caused-by-chemotherapy-in-adults-with-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-dose-of-polymerized-grass-pollen-extract-for-patients-with-seasonal-allergies-and-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-allogeneic-faecal-microbiota-on-the-core-symptoms-of-autism-spectrum-disorder-in-children2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-anifrolumab-in-patients-with-cutaneous-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-ciracigene-golparvovec-in-children-with-canavan-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-dexpramipexole-in-adolescents-and-adults-with-severe-eosinophilic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-diroximel-fumarate-on-brain-swelling-in-patients-with-a-stroke-caused-by-bleeding-in-the-brain2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-ea-230-on-the-hospital-stay-for-patients-with-coronary-artery-disease-undergoing-heart-bypass-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-isotretinoin-on-sperm-production-in-men-with-low-sperm-count2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-lebrikizumab-on-eczema-in-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-levothyroxine-sodium-in-patients-with-acute-unilateral-vestibulopathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-methylprednisolone-and-sodium-chloride-in-patients-with-a-heart-attack2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-muvalaplin-on-reducing-major-cardiovascular-events-in-adults-with-high-levels-of-lipoprotein-a-and-atherosclerotic-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-obinutuzumab-on-reducing-harmful-b-cells-in-the-tissues-of-patients-with-sjogren-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-olpasiran-on-major-cardiovascular-events-in-patients-with-atherosclerotic-cardiovascular-disease-and-high-lipoprotein-a-levels2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-omaveloxolone-on-mitochondrial-function-in-patients-with-friedreich-s-ataxia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-oral-prednisolone-compared-to-a-placebo-in-patients-with-vestibular-neuritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-orforglipron-on-heart-and-kidney-health-in-adults-with-atherosclerotic-cardiovascular-disease-or-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-pacritinib-on-bone-marrow-fibrosis-in-patients-with-myelofibrosis-and-low-platelet-counts2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-rimegepant-on-migraine-in-patients-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-semaglutide-on-cannabis-use-in-adults-with-cannabis-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-survodutide-on-protein-levels-in-the-urine-for-patients-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-tocilizumab-compared-to-sodium-chloride-in-adults-with-acute-ischemic-stroke-undergoing-endovascular-thrombectomy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effect-of-upadacitinib-on-the-frequency-of-recurrent-eye-inflammation-in-patients-with-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-adezunap-in-patients-with-borderline-personality-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-admilparant-in-patients-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-adx-038-in-adults-with-geographic-atrophy-caused-by-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-azd1163-in-adults-with-moderately-to-severely-active-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-azetukalner-in-patients-with-depressive-episodes-associated-with-bipolar-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-bfb759-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-bi-3000202-in-patients-with-moderate-to-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-cagrilintide-and-semaglutide-in-people-with-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-cagrilintide-and-semaglutide-in-people-with-type-2-diabetes-whose-blood-sugar-is-not-well-controlled-by-diet-and-exercise2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-clemizole-hydrochloride-as-an-additional-treatment-for-patients-with-lennox-gastaut-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-corline-heparin-conjugate-for-improving-kidney-function-in-patients-who-have-received-a-kidney-transplant-from-a-deceased-donor2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-dt-101-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-duvakitug-in-patients-with-moderate-to-severe-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-duvakitug-in-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-duvakitug-in-patients-with-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-dyne-101-in-patients-with-myotonic-dystrophy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-efcubitrog-rafutrombopag-ethanolamine-in-patients-with-low-blood-platelet-counts-caused-by-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-eloralintide-in-adults-with-knee-osteoarthritis-and-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-faricimab-compared-to-ranibizumab-in-patients-with-choroidal-neovascularization-caused-by-pathologic-myopia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-iadademstat-in-adult-patients-with-essential-thrombocythemia-who-do-not-respond-well-to-or-cannot-tolerate-hydroxyurea2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-jnj-88545223-in-people-with-active-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-kai-9531-in-people-living-with-obesity-or-being-overweight-and-having-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-kpl-387-in-patients-with-well-controlled-recurrent-pericarditis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-lad328-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-lad603-in-adults-with-severe-to-very-severe-alopecia-areata2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-lesigercept-in-adults-with-chronic-spontaneous-urticaria-who-do-not-have-enough-relief-from-antihistamines2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-mk-0616-in-reducing-major-cardiovascular-events-in-patients-with-atherosclerotic-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-nbi-1065845-as-an-additional-treatment-for-adults-with-major-depression2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-nbi-1117570-in-adults-with-schizophrenia-who-require-hospital-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-pf-07328948-in-adults-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-povorcitinib-in-patients-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-pridopidine-hydrochloride-in-patients-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-regn13335-in-adults-with-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-regn7508-in-preventing-blood-clots-in-adults-with-solid-tumors-undergoing-cancer-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-tak-861-in-patients-with-narcolepsy-with-cataplexy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-trospium-chloride-and-xanomeline-tartrate-for-treating-schizophrenia-in-adolescents-aged-13-to-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-tulisokibart-in-people-with-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-usnoflast-in-adults-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-visugromab-in-patients-with-cancer-associated-cachexia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-vormatrigine-in-adults-with-focal-epilepsy-who-are-currently-taking-one-to-three-anti-seizure-medications2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-zasocitinib-in-patients-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-zenagamtide-in-people-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-and-safety-of-zenagamtide-in-people-with-obesity-22026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-aav9-ap4m1-gene-therapy-in-patients-with-hereditary-spastic-paraplegia-type-50-spg502026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-acr-368-and-gemcitabine-in-patients-with-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-angiotensin-ii-and-sodium-chloride-solution-0-9-in-children-and-adolescents-aged-0-to-17-years-with-low-blood-pressure-in-distributive-shock2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-azd5148-in-preventing-the-recurrence-of-clostridioides-difficile-infection-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-azetukalner-in-patients-with-focal-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-azetukalner-in-patients-with-moderate-to-severe-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-barzolvolimab-in-patients-with-cold-urticaria-and-symptomatic-dermographism2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-benfotiamine-and-thioctic-acid-for-the-treatment-of-symptoms-in-patients-with-diabetic-sensorimotor-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-bleomycin-sulfate-for-treating-patients-with-low-flow-vascular-malformations-using-electrosclerotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-botulinum-toxin-type-a-haemagglutinin-complex-for-closing-the-abdomen-in-patients-with-an-open-abdomen2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-brenipatide-compared-to-a-placebo-in-adults-with-moderate-to-severe-alcohol-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-budesonide-suppositories-for-treating-acute-radiation-proctitis-in-men-with-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-colesevelam-hydrochloride-in-patients-with-moderate-to-severe-bile-acid-diarrhoea2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-dexamethasone-injections-for-adults-with-chronic-nerve-pain-in-the-neck-and-arm-that-has-not-responded-to-standard-medical-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-eloralintide-in-adults-with-obesity-or-overweight-without-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-ibutamoren-mesylate-in-prepubertal-children-with-growth-hormone-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-iloprost-compared-to-a-placebo-in-adult-patients-experiencing-pain-crises-from-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-k1-70-in-patients-with-graves-disease-and-active-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-lenalidomide-pyrimethamine-and-topiramate-in-reducing-hiv-in-people-living-with-hiv2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-levosimendan-in-patients-with-pulmonary-hypertension-and-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-methotrexate-in-preventing-the-recurrence-of-dermatological-vulvar-intraepithelial-neoplasia-in-women-with-resistant-lichen-sclerosus2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-nav-240-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-nicotinamide-in-patients-with-leber-s-hereditary-optic-neuropathy-who-experienced-vision-loss-within-the-last-18-months2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-nnc0662-0419-and-semaglutide-in-people-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-obinutuzumab-compared-to-prednisolone-in-adults-with-newly-diagnosed-minimal-change-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-pf-08634404-and-a-drug-combination-in-adults-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-pirtobrutinib-in-elderly-and-frail-patients-with-mantle-cell-lymphoma-who-have-not-received-previous-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-pmbl-drug-combination-in-reducing-respiratory-tract-infections-in-children-aged-3-to-12-years2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-r2r01-in-preventing-acute-kidney-injury-in-patients-at-high-risk-following-heart-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-remdesivir-in-adults-hospitalized-with-tick-borne-encephalitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-ritlecitinib-tosilate-and-loratadine-in-adults-with-chronic-spontaneous-urticaria-hives2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-rituximab-in-patients-with-interstitial-lung-disease-associated-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-tarlatamab-in-patients-with-extensive-stage-small-cell-lung-cancer-who-have-received-previous-treatment-and-have-a-limited-health-status2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-tenecteplase-in-patients-with-acute-ischemic-stroke-when-treated-more-than-4-5-hours-after-the-onset-of-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-upadacitinib-in-adults-with-erosive-mucosal-lichen-planus-and-lichen-planopilaris2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-zenagamtide-for-weight-loss-and-pain-relief-in-people-with-overweight-or-obesity-and-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effectiveness-of-zenagamtide-in-people-with-overweight-or-obesity-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-bi-1015550-in-people-with-lung-abnormalities-and-a-family-history-of-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-bi-764198-in-adults-and-adolescents-with-focal-segmental-glomerulosclerosis-fsgs2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-csx-1004-on-breathing-difficulties-caused-by-fentanyl-in-healthy-adults-and-people-with-opioid-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-cx11-trometamol-monohydrate-in-patients-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-estetrol-drospirenone-and-ethinylestradiol-on-blood-clotting-in-women-with-polycystic-ovary-syndrome-pcos2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-ezabenlimab-in-patients-with-locally-advanced-head-and-neck-cancer-who-have-signs-of-remaining-disease-after-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-n-acetyl-l-leucine-in-patients-with-cacna1a-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-nolasiban-on-uterine-contractions-in-women-undergoing-ivf-or-icsi-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-obicetrapib-and-ezetimibe-on-high-cholesterol-in-adults-with-type-2-diabetes-or-metabolic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-palopegteriparatide-and-alfacalcidol-on-the-quality-of-life-and-brain-health-in-patients-with-hypoparathyroidism2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-propranolol-hydrochloride-in-patients-with-head-injuries-admitted-to-the-intensive-care-unit2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-psilocybin-and-pimavanserin-in-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-rifaximin-in-patients-with-opioid-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-sul-238-in-patients-with-early-untreated-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-effects-of-xanomeline-tartrate-and-trospium-chloride-on-cognitive-impairment-in-adults-with-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-depemokimab-and-salbutamol-sulfate-in-patients-with-chronic-obstructive-pulmonary-disease-and-type-2-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-eloralintide-in-adults-with-obesity-or-overweight-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-empasiprubart-in-adults-with-chronic-inflammatory-demyelinating-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-enlicitide-chloride-in-adults-with-high-cholesterol2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-esk-001-and-apremilast-in-patients-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-etrasimod-arginine-in-children-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-gsk3862995b-in-adults-with-bronchiectasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-jnj-77242113-and-deucravacitinib-in-patients-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-nio752-in-patients-with-progressive-supranuclear-palsy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-nucresiran-and-vutrisiran-in-patients-with-hereditary-transthyretin-amyloidosis-with-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-plozasiran-in-adults-with-severe-hypertriglyceridemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-rilzabrutinib-in-adults-with-active-igg4-related-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-ursodeoxycholic-acid-in-patients-with-hepatorenal-polycystic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-vamifeport-in-adults-with-hereditary-hemochromatosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-vixarelimab-in-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-zampilimab-in-patients-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-and-safety-of-zenagamtide-in-people-with-overweight-or-obesity-and-obstructive-sleep-apnoea-not-treated-with-positive-airway-pressure2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-efficacy-of-mc0518-cell-therapy-in-adult-patients-with-acute-graft-versus-host-disease-that-has-not-responded-to-steroids-and-ruxolitinib2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-balinatunfib-in-adults-with-crohn-s-disease-or-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-barzolvolimab-in-patients-with-chronic-spontaneous-urticaria2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-bmn-351-in-patients-with-duchenne-muscular-dystrophy-amenable-to-exon-51-skipping2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-lunsekimig-in-adults-with-moderate-to-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-mrna-3927-in-patients-with-propionic-acidemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-orx750-in-patients-with-narcolepsy-and-idiopathic-hypersomnia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-sonelokimab-in-patients-with-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-of-rp2-rp3-and-vusolimogene-oderparepvec-in-patients-with-melanoma-or-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-long-term-safety-of-zigakibart-in-adults-with-iga-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-pain-relieving-effect-of-benzydamine-hydrochloride-lozenges-in-children-aged-6-to-11-years-with-non-streptococcal-pharyngotonsillitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-absorption-of-ublituximab-injections-in-patients-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-activity-of-tax2-in-patients-with-advanced-ovarian-colorectal-pancreatic-or-melanoma-cancers-who-have-completed-other-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-a-drug-combination-consisting-of-kayvirus-dsm-33474-kayvirus-dsm-33473-and-pbunavirus-dsm-33593-for-treating-bacterial-infections-in-complicated-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-aavb-039-in-people-with-stargardt-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-admilparant-in-patients-with-progressive-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-anxv-in-patients-with-diabetic-retinopathy-or-retinal-vein-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-asp2957-in-men-with-x-linked-myotubular-myopathy-who-require-a-ventilator2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-azd0292-in-people-aged-12-years-and-older-with-bronchiectasis-and-chronic-pseudomonas-aeruginosa-infection2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-azd9750-and-saruparib-in-patients-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-azd9793-in-adults-with-advanced-or-metastatic-liver-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-azetukalner-in-patients-with-bipolar-depression2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-bnt324-and-bnt327-in-patients-with-advanced-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-caba-201-in-patients-with-active-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-cenegermin-eye-drops-in-patients-with-a-persistent-corneal-epithelial-defect2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-dalbavancin-in-patients-with-erysipelas-and-limited-cellulitis-receiving-outpatient-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-darizmetinib-hydrochloride-in-patients-after-liver-surgery-due-to-colon-cancer-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-dextromethorphan-deramciclane-fumarate-and-deramciclane-for-treating-agitation-in-people-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-empasiprubart-and-efgartigimod-alfa-in-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-emrusolmin-in-adults-with-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-ep0031-and-a-drug-combination-in-patients-with-advanced-cancers-having-an-abnormal-ret-gene2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-filgotinib-in-children-and-adolescents-aged-8-to-17-years-with-polyarticular-juvenile-idiopathic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-filgotinib-in-children-and-adolescents-with-juvenile-idiopathic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-fwy003-tosilate-in-patients-with-geographic-atrophy-caused-by-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-galvokimig-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-gs-4321-in-healthy-volunteers-and-people-living-with-chronic-hepatitis-delta2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-gxv813-in-hospitalized-adults-with-schizophrenia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-hlx43-in-patients-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-ikt-001-compared-to-a-placebo-in-adults-with-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-im-101-in-adults-with-generalized-or-ocular-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-inhaled-treprostinil-in-patients-with-pulmonary-hypertension-associated-with-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-ion582-in-children-and-adults-with-angelman-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-kai-9531-in-people-with-obesity-or-overweight-and-related-health-conditions-who-do-not-have-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-liposomal-amphotericin-b-in-patients-with-simple-pulmonary-aspergilloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-mb-001-in-adults-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-met097-in-people-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-mrna3771-and-grna1599-in-adults-with-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-nivolumab-and-imiquimod-in-adults-with-vulvar-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-omalizumab-in-adults-with-episodic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-orforglipron-in-people-with-peripheral-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-oxaliplatin-delivered-directly-to-the-liver-for-patients-with-colorectal-cancer-and-liver-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-palopegteriparatide-in-adolescents-with-chronic-hypoparathyroidism2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-pegtibatinase-in-patients-aged-12-to-65-years-with-classical-homocystinuria2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-pf-08634404-and-ipilimumab-in-adults-with-advanced-or-metastatic-liver-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-ptt-4256-and-nivolumab-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-qel-005-in-patients-with-diffuse-cutaneous-systemic-sclerosis-or-difficult-to-treat-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-regn17372-and-linvoseltamab-in-adults-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-remibrutinib-in-patients-with-secondary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-resomelagon-in-patients-with-polymyalgia-rheumatica-who-are-in-remission-while-taking-glucocorticoids2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-rilvegostomig-ramucirumab-and-a-drug-combination-in-adults-with-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-ritlecitinib-tosilate-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-surlorian-in-adults-with-ryr1-related-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-tafasitamab-in-adults-with-immune-thrombocytopenia-or-autoimmune-hemolytic-anemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-tulisokibart-in-patients-with-systemic-sclerosis-and-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-vtx2735-sodium-in-patients-with-recurrent-pericarditis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-allogeneic-adipose-derived-mesenchymal-stem-cells-for-patients-with-chronic-active-antibody-mediated-rejection-after-kidney-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-aln-4324-in-overweight-or-obese-healthy-volunteers-and-in-overweight-or-obese-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-ceralasertib-tremelimumab-and-durvalumab-in-adults-with-various-types-of-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-gepotidacin-and-standard-antibiotics-in-children-aged-2-to-12-years-with-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-inebilizumab-in-children-and-adolescents-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-inebilizumab-in-children-and-adolescents-with-immunoglobulin-g4-related-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-effects-of-urokinase-catalytic-domain-fused-with-a-single-chain-antibody-against-von-willebrand-factor-in-patients-with-immune-mediated-thrombotic-thrombocytopenic-purpura-and-other-thrombotic-microangiopathies2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-how-the-body-processes-etavopivat-in-children-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-how-the-body-processes-ibuprofen-and-paracetamol-in-children-and-adolescents-with-acute-pain2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-how-the-body-processes-pivekimab-sunirine-in-children-with-relapsed-or-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-tolerability-of-oral-azathioprine-in-patients-with-autosomal-dominant-polycystic-kidney-and-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-tolerability-of-tinlarebant-in-patients-with-stargardt-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-and-tolerability-of-vtx-002-in-patients-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-adx-038-in-patients-with-kidney-disease-caused-by-the-complement-system2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-brimonidine-tartrate-gel-in-preventing-hand-and-foot-syndrome-in-patients-with-colorectal-or-breast-cancer-treated-with-capecitabine2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-mk-1403-in-healthy-men-for-the-treatment-of-atherosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-mrm-3379-in-men-with-fragile-x-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-omn6-in-patients-with-bacterial-pneumonia-caused-by-acinetobacter-baumannii-complex2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-safety-of-rjva-001-in-adults-with-type-2-diabetes-whose-blood-sugar-is-not-well-controlled-by-current-medications2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-68ga-bed003-imaging-for-detecting-colorectal-gastric-pancreatic-breast-and-ovarian-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-adenosine-and-tirofiban-to-treat-microvascular-injury-in-patients-with-st-elevation-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-colchicine-to-reduce-inflammation-and-the-risk-of-post-thrombotic-syndrome-in-patients-with-deep-vein-thrombosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-insulin-human-to-prevent-delirium-in-patients-aged-65-years-or-older-after-elective-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-meropenem-in-patients-at-risk-of-sepsis-and-infection-in-the-emergency-department2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-morphine-sulfate-to-reduce-shortness-of-breath-in-patients-with-chronic-respiratory-insufficiency-due-to-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-the-use-of-rituximab-for-patients-with-fibromyalgia2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-total-neoadjuvant-treatment-with-or-without-tislelizumab-for-patients-with-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-evaluate-two-initial-doses-of-aflibercept-in-patients-with-neovascular-age-related-macular-degeneration-who-have-not-received-prior-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-investigate-the-use-of-modafinil-for-the-treatment-of-severe-fatigue-in-patients-with-inactive-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-monitor-the-long-term-safety-and-effectiveness-of-giroctocogene-fitelparvovec-or-fidanacogene-elaparvovec-in-patients-with-hemophilia-a-or-hemophilia-b2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-test-how-well-alanyl-glutamine-cream-works-and-how-safe-it-is-for-adults-with-itching-caused-by-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-to-test-how-well-obefazimod-works-and-how-safe-it-is-for-patients-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-using-18f-cpfpx-to-examine-the-adenosine-pathway-in-the-brainstem-of-patients-with-drug-resistant-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/a-study-using-18f-mppf-imaging-to-examine-brain-pathways-in-patients-with-dravet-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/a-superiority-study-comparing-two-pharmaceutical-skin-care-creams-containing-different-humectants-with-a-non-humectant-containing-skin-care-cream-for-the-treatment-of-xerotic-foot-of-persons-with-diab2026-10-07 https://dev.clinicalresearch.eu/trial/a-three-year-multi-center-double-blind-extension-study-to-evaluate-the-long-term-safety-and-efficacy-of-ligelizumab-in-patients-who-completed-ligelizumab-s-phase-iii-studies-in-food-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/a-translational-randomized-phase-iii-study-exploring-the-effect-of-the-addition-of-capecitabine-to-carboplatinum-based-chemotherapy-in-early-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/a-two-cohort-phase-ii-multicenter-randomized-double-blind-parallel-group-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-vixarelimab-compared-with-placebo-in-patients-with-idiopathic-pu2026-10-07 https://dev.clinicalresearch.eu/trial/a-two-part-randomized-participant-and-investigator-blinded-2-arm-parallel-design-placebo-controlled-study-to-evaluate-the-safety-tolerability-and-preliminary-efficacy-of-ngi226-microparticles-on-tendo2026-10-07 https://dev.clinicalresearch.eu/trial/a-window-of-opportunity-trial-with-high-dose-vitamin-c-to-enhance-neoadjuvant-immune-checkpoint-therapy-in-mismatch-repair-proficient-colorectal-cancer-the-alfeo-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/aall2131-esphall2022-an-international-pilot-study-of-chemotherapy-and-tyrosine-kinase-inhibitor-with-blinatumomab-in-patients-with-newly-diagnosed-philadelphia-chromosome-positive-or-abl-class-philade2026-10-07 https://dev.clinicalresearch.eu/trial/abdominal-aortic-aneurysm-stabilization-with-truncal-cells-controlled-clinical-trial-with-historical-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/acetazolamide-added-to-standard-therapy-in-ambulatory-heart-failure-patients-to-improve-decongestion-and-reduce-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/acetylcysteine-for-adults-with-acute-infection-or-sepsis-and-liver-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/adalimumab-doxycycline-and-resorcinol-for-adults-with-non-severe-hidradenitis-suppurativa-at-high-risk-of-progression-to-severe-disease-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/adjunctive-aticaprant-and-antidepressant-therapy-for-relapse-prevention-in-major-depressive-disorder-with-moderate-to-severe-anhedonia-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/adjunctive-igm-enriched-immunoglobulin-therapy-versus-standard-dose-in-septic-shock-a-randomized-single-blinded-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/adjunctive-prucalopride-augments-sertraline-efficacy-and-verbal-memory-in-women-with-major-depressive-disorder-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-capecitabine-and-temozolomide-versus-surveillance-in-patients-with-resected-stage-i-iii-pancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-dynamic-marker-adjusted-personalized-therapy-ribociclib-plus-endocrine-therapy-versus-chemotherapy-in-hr-her2-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-mitotane-vs-mitotane-with-cisplatin-etoposide-after-primary-surgical-resection-of-localised-adrenocortical-carcinoma-with-high-risk-of-recurrence-adiuvo-2-trial-a-pragmatic-randomised-low-int2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-mk-7684a-pembrolizumab-vibostolimab-versus-pembrolizumab-for-recurrence-free-survival-in-adults-and-children-with-high-risk-stage-ii-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-nivolumab-in-stage-ii-high-risk-melanoma-a-randomized-phase-iii-trial-with-biomarker-based-risk-stratification2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-pembrolizumab-and-paclitaxel-versus-surveillance-in-early-triple-negative-breast-cancer-with-high-stromal-tumor-infiltrating-lymphocytes2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-pembrolizumab-versus-placebo-in-high-risk-stage-iii-melanoma-post-resection-a-randomized-double-blind-phase-3-eortc-trial2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-tebentafusp-versus-observation-in-hla-a-02-01-positive-patients-post-definitive-treatment-of-high-risk-uveal-melanoma-a-phase-iii-eortc-study2026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-therapy-with-pembrolizumab-versus-placebo-in-resected-highrisk-stage-ii-melanoma-a-randomized-double-blind-phase-3-study-keynote-7162026-10-07 https://dev.clinicalresearch.eu/trial/adjuvant-therapy-with-vincristine-sulfate-thiotepa-cyclophosphamide-etoposide-and-carboplatin-in-unilateral-retinoblastoma-post-enucleation2026-10-07 https://dev.clinicalresearch.eu/trial/advance-a-phase-iii-multi-centre-randomised-double-blind-double-dummy-clinical-trial-comparing-essentiale-r-liquid-vs-capsules-for-masld-mash-alcoholic-liver-disease-and-chronic-viral-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/alb-trial-personalized-long-term-human-albumin-treatment-in-patients-with-decompensated-cirrhosis-and-ascites2026-10-07 https://dev.clinicalresearch.eu/trial/alltogether1-a-treatment-study-protocol-of-the-alltogether-consortium-for-children-and-young-adults-0-45-years-of-age-with-newly-diagnosed-acute-lymphoblastic-leukaemia-all2026-10-07 https://dev.clinicalresearch.eu/trial/amg-732-in-patients-with-thyroid-eye-disease-who-did-not-respond-or-relapsed-after-previous-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/amum-trial-adjuvant-melatonin-for-uveal-melanoma-a-randomized-open-phase-iii-study2026-10-07 https://dev.clinicalresearch.eu/trial/an-18-month-low-interventional-prospective-multicentre-study-to-assess-joint-outcomes-in-patients-with-haemophilia-a-or-b-on-prophylaxis-with-efmoroctocog-alfa-or-eftrenonacog-alfa2026-10-07 https://dev.clinicalresearch.eu/trial/an-adaptive-phase-2-double-blind-randomized-placebo-controlled-multicenter-study-to-evaluate-the-safety-tolerability-immunogenicity-and-pharmacodynamic-effects-of-aci-7104-056-in-patients-with-early-s2026-10-07 https://dev.clinicalresearch.eu/trial/an-adaptive-phase-3-randomized-open-label-multicenter-study-to-compare-the-efficacy-and-safety-of-axicabtagene-ciloleucel-versus-standard-of-care-therapy-as-first-line-therapy-in-subjects-with-high-ri2026-10-07 https://dev.clinicalresearch.eu/trial/an-adaptive-platform-trial-evaluating-targeted-antimicrobial-therapies-for-the-treatment-of-staphylococcus-aureus-bacteraemia2026-10-07 https://dev.clinicalresearch.eu/trial/an-alfa-2101-multicenter-randomized-phase-ii-study-cpx-351-versus-intensive-chemotherapy-in-patients-with-de-novo-intermediate-or-adverse-risk-aml-stratified-by-genomics2026-10-07 https://dev.clinicalresearch.eu/trial/an-efficacy-and-safety-study-of-trontinemab-in-patients-with-early-symptomatic-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/an-evaluation-of-the-accuracy-of-gallium-68-pentixafor-pet-ct-imaging-in-patients-with-cardiac-sarcoidosis2026-10-07 https://dev.clinicalresearch.eu/trial/an-exploratory-first-in-human-study-to-investigate-the-safety-and-preliminary-efficacy-of-invivolprint-u-therapy-a-combination-of-an-advanced-therapy-medicinal-product-atmp-of-expanded-autologous-urot2026-10-07 https://dev.clinicalresearch.eu/trial/an-exploratory-prospective-multicenter-randomized-double-blind-placebo-sham-device-controlled-study-to-assess-the-safety-usability-and-initial-efficacy-of-the-vixe-combination-for-intravesical-adminis2026-10-07 https://dev.clinicalresearch.eu/trial/an-exploratory-study-to-evaluate-the-effect-of-rimonabant-on-hand-function-in-patients-with-spinal-cord-injury2026-10-07 https://dev.clinicalresearch.eu/trial/an-extension-study-of-venetoclax-for-subjects-who-have-completed-a-prior-venetoclax-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/an-induction-study-to-evaluate-the-efficacy-and-safety-of-duvakitug-in-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/an-international-prospective-umbrella-trial-for-children-with-atypical-teratoid-rhabdoid-tumours-atrt-including-a-randomized-phase-iii-study-evaluating-the-non-inferiority-of-three-courses-of-high-dos2026-10-07 https://dev.clinicalresearch.eu/trial/an-interventional-efficacy-and-safety-phase-3-double-blind-2-arm-study-to-investigate-iv-followed-by-oral-fosmanogepix-compared-with-iv-caspofungin-followed-by-oral-fluconazole-in-adult-participants-w2026-10-07 https://dev.clinicalresearch.eu/trial/an-interventional-prospective-open-label-study-of-immunosuppressive-therapies-to-mitigate-immune-mediated-loss-of-therapeutic-response-to-asfotase-alfa-strensiq-r-for-hypophosphatasia-restore2026-10-07 https://dev.clinicalresearch.eu/trial/an-investigator-initiated-descriptive-proof-of-concept-open-label-pilot-study-targeting-the-tumor-microenvironment-and-skin-barrier-deficiency-through-jak1-3-inhibition2026-10-07 https://dev.clinicalresearch.eu/trial/an-investigator-initiated-prospective-randomized-open-label-blinded-endpoint-crossover-trial-comparing-the-effect-and-safety-of-flecainide-and-metoprolol-versus-metoprolol-alone-to-suppress-ventricula2026-10-07 https://dev.clinicalresearch.eu/trial/an-observational-study-of-methotrexate-in-children-and-adolescents-with-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-dose-finding-phase-1-2-study-to-evaluate-the-safety-and-tolerability-of-a-single-intravenous-dose-of-ly3884961-in-subjects-with-peripheral-manifestations-of-gaucher-disease2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-early-access-phase-3b-study-of-ivosidenib-in-patients-with-a-pretreated-locally-advanced-or-metastatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-of-olezarsen-isis-678354-administered-subcutaneously-to-patients-with-severe-hypertriglyceridemia-shtg2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-to-assess-the-long-term-safety-of-eplontersen-ion-682884-in-patients-with-transthyretin-mediated-amyloid-cardiomyopathy-attr-cm2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-to-evaluate-long-term-efficacy-and-safety-of-odevixibat-a4250-in-children-with-biliary-atresia-bold-ext2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-to-evaluate-long-term-safety-and-efficacy-of-tildrakizumab-in-patients-with-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-to-evaluate-rozanolixizumab-in-pediatric-study-participants-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-extension-study-to-evaluate-the-long-term-safety-tolerability-pharmacokinetics-pharmacodynamics-and-activity-of-zilucoplan-in-pediatric-study-participants-with-acetylcholine-receptor-ant2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-long-term-follow-up-study-to-evaluate-the-effects-of-sotatercept-when-added-to-background-pulmonary-arterial-hypertension-pah-therapy-for-the-treatment-of-pah-mk-7962-0382026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multi-center-extension-study-to-characterize-the-long-term-safety-and-efficacy-of-bms-986165-in-subjects-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multi-center-non-randomized-pivotal-phase-3-study-to-evaluate-the-efficacy-and-safety-of-18f-florbetaben-positron-emission-tomography-pet-imaging-to-diagnose-cardiac-al-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multi-center-phase-i-ii-study-of-eci830-as-a-single-agent-and-in-combination-with-ribociclib-and-endocrine-therapy-in-patients-with-advanced-hormone-receptor-positive-her2-negative-breas2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-extension-study-in-patients-previously-enrolled-in-a-genentch-and-or-f-hoffmann-la-roche-ltd-sponsored-atezolizumab-study-imbrella-b2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-extension-study-to-provide-continued-treatment-for-patients-with-hematologic-malignancies-previously-enrolled-in-studies-with-tafasitamab2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-global-phase-ii-basket-study-of-entrectinib-for-the-treatment-of-patients-with-locally-advanced-or-metastatic-solid-tumors-that-harbor-ntrk1-2-3-ros1-or-alk-gene-rearrangemen2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-phase-1-2a-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-anti-tumour-activity-of-wef-001-in-participants-with-advanced-kras-mutant-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-phase-1-trial-to-evaluate-the-safety-pharmacokinetics-and-anti-tumor-activity-of-tln-372-as-a-single-agent-and-in-combination-with-other-anti-tumor-agents-in-patients-with-ad2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-phase-1b-2a-study-to-evaluate-efficacy-safety-tolerability-and-pharmacokinetics-of-the-atr-inhibitor-tuvusertib-m1774-in-combination-with-cemiplimab-in-participants-with-non-2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multicenter-randomized-non-inferiority-pharmacokinetic-and-safety-tolerability-study-of-two-different-weekly-doses-of-alpha1-proteinase-inhibitor-subcutaneous-human-15-in-patients-with-a2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multinational-multicenter-study-to-evaluate-the-long-term-safety-tolerability-and-efficacy-of-subcutaneous-amlitelimab-in-participants-aged-12-years-and-older-with-moderate-to-severe-ato2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-multinational-study-assessing-the-efficacy-and-safety-of-dato-dxd-treatment-in-patients-with-hr-positive-her2-ihc-0-locally-advanced-inoperable-or-metastatic-breast-cancer-refractory-to-2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-non-randomized-extension-study-to-further-investigate-the-long-term-efficacy-safety-and-tolerability-of-guanabenz-in-patients-with-early-childhood-onset-vanishing-white-matter-vwm2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-palatability-study-of-a-novel-orodispersible-paracetamol-and-ibuprofen-formulation-following-single-oral-administration-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-parallel-phase-3-two-arm-study-to-investigate-the-efficacy-and-safety-of-fitusiran-prophylaxis-in-male-participants-aged-1-to-less-than-12-years-with-hemophilia-a-or-b-with-or-without-in2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-2-study-evaluating-the-efficacy-of-treatment-with-gilteritinib-in-measurable-residual-disease-eradication-in-patients-with-flt3-itd-mutated-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-2-study-to-evaluate-the-effect-of-a3907-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-adults-with-primary-sclerosing-cholangitis-psc2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-2-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-ptx-100-monotherapy-in-patients-with-relapsed-or-refractory-cutaneous-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-i-ii-first-in-human-dose-escalation-dose-optimisation-and-dose-expansion-study-to-evaluate-the-safety-tolerability-pharmacokinetic-pharmacodynamic-immunogenicity-and-antitumour-act2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-i-ii-first-in-human-dose-escalation-optimisation-and-expansion-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodynamics-immunogenicity-and-anti-tumour-activity-o2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-i-ii-study-investigating-the-safety-and-efficacy-of-a-cd3-cd20-bispecific-t-cell-engager-therapy-in-patients-with-active-treatment-refractory-anca-igg-positive-associated-vasculiti2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-i-ii-study-to-evaluate-the-safety-pharmacokinetics-and-preliminary-anti-tumor-activity-of-englumafusp-alfa-ro7227166-a-cd19-targeted-4-1bb-ligand-in-combination-with-obinutuzumab-a2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-ii-iii-randomized-trial-of-bnt113-in-combination-with-pembrolizumab-versus-pembrolizumab-monotherapy-as-a-first-line-therapy-in-patients-with-unresectable-recurrent-or-metastatic-h2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-phase-ii-platform-modular-study-exploring-the-efficacy-and-safety-of-the-valemetostat-ezh1-2-inhibitor-in-patients-with-selected-solid-tumors-ezhiswitch2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-phase-2-3-study-of-olaparib-plus-pembrolizumab-versus-chemotherapy-plus-pembrolizumab-after-induction-of-clinical-benefit-with-first-line-chemotherapy-plus-pembrolizumab-in-pa2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-phase-3-study-of-linvoseltamab-regn5458-anti-bcma-x-anti-cd3-bispecific-antibody-versus-the-combination-of-elotuzumab-pomalidomide-and-dexamethasone-epd-in-patients-with-relap2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-phase-3-study-to-evaluate-efficacy-and-safety-of-pembrolizumab-mk-3475-in-combination-with-belzutifan-mk-6482-and-lenvatinib-mk-7902-or-mk-1308a-in-combination-with-lenvatinib2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-phase-iii-trial-comparing-local-radiotherapy-alone-or-combined-with-obinutuzumab-in-early-stage-follicular-lymphoma-the-gazebo-trial-from-the-fondazione-italiana-linfomi2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-three-period-crossover-study-to-compare-the-pharmacokinetics-of-gb1211-upon-dosing-a-capsule-under-fasting-condition-and-a-tablet-under-fasting-and-fed-conditions-in-healthy-v2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-randomized-trial-comparing-anakinra-and-prednisone-in-pediatric-colchicine-resistant-recurrent-pericarditis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-safety-and-efficacy-study-of-allogenic-adipose-tissue-derived-mesenchymal-stromal-cells-on-autism-and-gastrointestinal-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-single-arm-extension-study-to-evaluate-the-long-term-safety-tolerability-and-efficacy-of-leniolisib-for-immune-dysregulation-in-patients-with-primary-immunodeficiency2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-single-arm-pilot-study-of-venetoclax-in-combination-with-5-days-azacitidine-in-treatment-naive-subjects-with-acute-myelogenous-leukemia-who-are-18-years-of-age-and-not-eligible-for-stand2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-single-arm-study-evaluating-the-activity-safety-and-pharmacokinetics-of-rozanolixizumab-in-pediatric-study-participants-with-moderate-to-severe-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-single-arm-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-leniolisib-in-pediatric-patients-aged-1-to-6-years-with-apds-activated-phosphoinositide-3-kinase-delta-sy2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-study-of-the-safety-pharmacokinetics-efficacy-pharmacodynamics-and-immunogenicity-of-cipaglucosidase-alfa-miglustat-in-pediatric-subjects-aged-0-to-18-years-with-late-onset-pompe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-12-month-treatment-with-migalastat-in-pediatric-subjects-aged-2-to-12-years-with-fabry-disease-and-amenable-gla-vari2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-study-to-evaluate-the-safety-and-pharmacokinetics-of-migalastat-hcl-in-subjects-with-fabry-disease-and-amenable-gla-variants-and-severe-renal-impairment-or-end-stage-renal-disease-treate2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-study-to-evaluate-the-safety-efficacy-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-cipaglucosidase-alfa-miglustat-in-both-ert-experienced-and-ert-naive-pediatric-subjects-with2026-10-07 https://dev.clinicalresearch.eu/trial/an-open-label-uncontrolled-multicenter-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-safety-and-activity-of-nipocalimab-in-children-aged-2-to-less-than-18-years-with-generalized-myasthenia-g2026-10-07 https://dev.clinicalresearch.eu/trial/an-operationally-seamless-phase-1-2-3-study-consisting-of-a-safety-and-dose-finding-phase-1-2-and-randomized-open-label-active-controlled-phase-3-to-evaluate-ux701-aav-gene-therapy-in-adults-with-wils2026-10-07 https://dev.clinicalresearch.eu/trial/an-operationally-seamless-phase-2-3-randomized-open-label-multicenter-active-controlled-study-to-evaluate-the-safety-and-efficacy-of-bictegravir-lenacapavir-versus-stable-baseline-regimen-in-virologic2026-10-07 https://dev.clinicalresearch.eu/trial/an-operationally-seamless-phase-2-3-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-enlicitide-decanoate-in-pediatric-participants-with-heterozygous-familial-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/anakinra-for-patients-with-myeloproliferative-neoplasms-resistant-to-cytoreductive-therapy-a-study-to-improve-treatment-response2026-10-07 https://dev.clinicalresearch.eu/trial/anakinra-for-sepsis-and-hyperinflammation-in-pediatric-cancer-patients-in-intensive-care2026-10-07 https://dev.clinicalresearch.eu/trial/analgesic-effectiveness-of-capsaicin-8-cutaneous-patch-for-the-treatment-of-chronic-postsurgical-or-post-traumatic-neuropathic-pain-a-randomized-placebo-controlled-study-in-children-aged-12-to-17-y2026-10-07 https://dev.clinicalresearch.eu/trial/analytical-treatment-interruption-study-in-adults-with-hiv-using-emtricitabine-tenofovir-alafenamide-and-bictegravir2026-10-07 https://dev.clinicalresearch.eu/trial/andrometa-crc-064-an-open-label-randomized-controlled-global-phase-3-study-comparing-telisotuzumab-adizutecan-abbv-400-monotherapy-to-lonsurf-trifluridine-and-tipiracil-plus-bevacizumab-in-subjects-wi2026-10-07 https://dev.clinicalresearch.eu/trial/anti-pd-1-re-challenge-after-immune-priming-by-ipilimumab-and-immune-boosting-by-radiotherapy-in-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/antibiotics-microbiology-and-immunology-in-children-with-chronic-wet-cough-the-amic-study2026-10-07 https://dev.clinicalresearch.eu/trial/antisense-oligonucleotide-eye-drops-against-irs-1-to-optimize-pretransplant-lymphangio-regression-prior-to-high-risk-keratoplasty-olisens-precon2026-10-07 https://dev.clinicalresearch.eu/trial/antisense-oligonucleotide-eye-drops-against-irs-1-to-treat-pathological-corneal-neovascularisation-in-aniridia-associated-keratopathy-olisens-aniridia2026-10-07 https://dev.clinicalresearch.eu/trial/apalutamide-and-stereotactic-body-radiation-therapy-for-low-burden-metastatic-hormone-sensitive-prostate-cancer-a-randomized-trial-persian2026-10-07 https://dev.clinicalresearch.eu/trial/apixaban-for-preventing-blood-clots-in-adults-undergoing-neoadjuvant-therapy-before-surgery-or-chemoradiotherapy-for-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/apollo-a-randomized-double-blind-placebo-controlled-study-of-bitopertin-to-evaluate-the-efficacy-safety-and-tolerability-in-participants-with-erythropoietic-protoporphyria-epp-or-x-linked-protoporphyr2026-10-07 https://dev.clinicalresearch.eu/trial/apremilast-induces-headache-and-migraine-in-women-with-migraine-without-aura2026-10-07 https://dev.clinicalresearch.eu/trial/argx-113-2409-a-multicenter-randomized-double-blinded-parallel-arm-placebo-controlled-pharmacokinetic-and-pharmacodynamic-study-followed-by-an-open-label-arm-to-evaluate-efgartigimod-iv-in-pediatric-p2026-10-07 https://dev.clinicalresearch.eu/trial/artemis-effects-of-ziltivekimab-versus-placebo-on-cardiovascular-outcomes-in-patients-with-acute-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/artemis-ravulizumab-to-protect-patients-with-chronic-kidney-disease-ckd-from-cardiac-surgery-associated-acute-kidney-injury-csa-aki-and-subsequent-major-adverse-kidney-events-make-a-phase-3-randomized2026-10-07 https://dev.clinicalresearch.eu/trial/arthritis-interception-with-guselkumab-in-subclinical-psoriatic-arthritis-patients-in-clinical-transition-from-skin-to-joint-disease-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/asciminib-in-pediatric-patients-with-philadelphia-positive-chronic-myeloid-leukemia-in-chronic-phase-with-or-without-t315i-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/ask-pd0-cs002-long-term-safety-and-efficacy-follow-up-of-ab-1005-gene-transfer-study-participants-with-parkinson-s-disease-or-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/aspire-1-individual-and-combined-endothelin-receptor-and-sglt2-antagonism-in-adults-with-type-1-diabetes-mellitus-and-chronic-kidney-disease-a-phase-2-multicenter-open-label-randomized-cross-over-tria2026-10-07 https://dev.clinicalresearch.eu/trial/aspirin-for-the-prevention-of-preeclampsia-and-pregnancy-outcomes-in-nulliparous-women-after-assisted-reproductive-technology-appart-trial2026-10-07 https://dev.clinicalresearch.eu/trial/assessing-diagnostic-accuracy-of-68ga-fapi-46-pet-ct-in-patients-with-suspected-giant-cell-arteritis-and-polymyalgia-rheumatica2026-10-07 https://dev.clinicalresearch.eu/trial/assessing-inhaled-beclometasone-dipropionate-in-adults-and-children-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/assessing-inhaled-glycopyrronium-bromide-added-to-budesonide-and-formoterol-fumarate-in-children-aged-4-to-12-years-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/assessing-radium-ra-223-dichloride-as-sequential-therapy-after-triplet-induction-in-high-volume-metastatic-hormone-sensitive-prostate-cancer-phase-ii-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessing-residual-inflammation-and-macrophage-presence-in-lupus-nephritis-after-3-months-of-intensified-treatment-with-prednisolone-mycofenolate-mofetil-and-voclosporin-as-compared-to-mycofenolate-mo2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-18f-befiradol-in-pet-mri-for-pathophysiological-analysis-of-episodic-cluster-headache-in-active-vs-inactive-disease-phases2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-18f-f-arag-uptake-changes-post-radiotherapy-in-non-small-cell-lung-cancer-melanoma-breast-and-esophageal-cancers-using-nelarabine2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-18f-fluoromisonidazole-pet-hypoxia-imaging-in-idiopathic-pulmonary-fibrosis-a-non-randomized-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-64cu-atsm-pet-ct-as-a-predictor-of-neoadjuvant-therapy-response-in-locally-advanced-rectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-68ga-nota-anti-her2-vhh1-uptake-in-brain-metastases-of-her2-positive-and-her2-negative-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-bimekizumab-concentration-in-mature-breast-milk-of-lactating-women-with-psoriatic-arthritis-axial-spondyloarthritis-hidradenitis-suppurativa-or-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-blomia-tropicalis-allergen-extract-concentration-in-skin-prick-test-for-patients-with-blomia-tropicalis-allergy-using-histamine-dihydrochloride-control2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-cardiac-function-evolution-in-cancer-patients-undergoing-pd-1-inhibition-with-nivolumab-and-pembrolizumab2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-chf6795-s-impact-on-midazolam-repaglinide-and-rosuvastatin-pharmacokinetics-in-healthy-volunteers-with-chronic-cough2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-clobetasol-propionate-s-impact-on-bone-mineral-density-in-patients-with-bullous-pemphigoid-a-6-month-topical-corticosteroid-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-cn-stage-accuracy-of-ferumoxtran-10-enhanced-mri-versus-unenhanced-mri-in-newly-diagnosed-rectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-dexmedetomidine-s-hemodynamic-impact-in-general-anesthesia-for-outpatient-surgical-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-efficacy-and-safety-of-budesonide-and-formoterol-fumarate-inhalation-in-patients-with-inadequately-controlled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-efficacy-and-safety-of-switching-from-boosted-protease-inhibitor-to-fostemsavir-trometamol-in-hiv-1-patients-with-limited-therapeutic-options2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-feasibility-and-safety-of-a-polymeric-medical-device-with-autologous-bone-marrow-derived-mesenchymal-stem-cells-for-knee-femoral-cartilage-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-ficolin-2-levels-and-carotid-and-brain-inflammation-in-symptomatic-carotid-stenosis-using-18f-dpa-714-pet-mri-in-stroke-or-transient-ischemic-attack2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-filgrastim-efficacy-in-patients-with-severe-bullous-drug-eruptions-lyell-syndrome-and-stevens-johnson-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-hemodynamic-tolerance-of-potassium-canrenoate-in-brain-dead-organ-donors-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-high-intensity-focused-ultrasound-hemi-ablation-and-leuprorelin-acetate-in-intermediate-risk-localized-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-human-papillomavirus-infectivity-reduction-in-hpv16-18-positive-women-post-vaccination-with-9-valent-hpv-vaccine-recombinant-adsorbed2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-immunogenicity-of-recombinant-zoster-vaccine-in-immunosuppressed-rheumatic-disease-patients-treated-with-jak-inhibitors-and-methotrexate2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-intravenous-lidocaine-hydrochloride-on-systemic-inflammatory-response-in-elective-cardiac-surgery-with-cardiopulmonary-bypass2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-ischemia-and-viability-in-coronary-artery-chronic-total-occlusion-using-theophylline-anhydrous-gadoteric-acid-and-regadenoson-imaging-modalities2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-liver-fibrosis-staging-using-68ga-fapi-46-pet-ct-imaging-in-patients-undergoing-biopsy-for-suspected-or-confirmed-nonalcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-long-term-dupilumab-effects-on-acetylsalicylic-acid-intolerance-in-non-steroidal-anti-inflammatory-drug-exacerbated-respiratory-disease2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-lung-exposure-bioequivalence-of-budesonide-glycopyrronium-and-formoterol-in-bgf-mdi-hfo-vs-bgf-mdi-hfa-with-and-without-spacer-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-lung-function-equivalence-of-budesonide-glycopyrronium-bromide-and-formoterol-fumarate-mdi-hfo-vs-mdi-hfa-in-copd-patients-aged-40-802026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-metabolic-alterations-in-chronic-kidney-disease-and-autosomal-dominant-polycystic-kidney-disease-using-hyperpolarized-1-13c-pyruvate-mri2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-microvascular-alterations-in-basal-cell-carcinoma-undergoing-bleomycin-electrochemotherapy-or-photodynamic-therapy-via-optical-coherence-tomography2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-molecular-status-and-clinical-efficacy-of-fludeoxyglucose-18f-in-pet-ct-imaging-for-juvenile-histiocytic-cell-proliferation2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-multidrug-resistance-associated-protein-1-activity-in-healthy-volunteers-and-alzheimer-s-disease-patients-using-positron-emission-tomography2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-p-glycoprotein-activity-in-treatment-resistant-depression-using-18f-mc225-pet-ct-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-pd-l-506-in-stereotactic-interstitial-photodynamic-therapy-for-newly-diagnosed-supratentorial-idh-wild-type-glioblastoma-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-persistent-pulmonary-hypertension-incidence-in-neonates-with-respiratory-failure-treated-with-salbutamol-sulfate-and-sodium-chloride2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-pharmacodynamic-effects-of-an-authorized-compound-and-a-novel-agent-on-nerve-excitability-in-neuropathic-pain-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-prednisolone-transfer-into-breast-milk-and-infant-plasma-in-lactating-women-with-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-psilocybin-s-impact-on-neural-correlates-of-cognitive-control-in-psychogenic-non-epileptic-seizures-a-single-arm-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-pulmonary-fibroblast-activity-using-68ga-fapi-46-pet-ct-in-patients-with-post-acute-sequelae-of-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-rad51-foci-score-in-predicting-olaparib-efficacy-in-advanced-her2-negative-breast-cancer-with-brca1-2-palb2-or-rad51c-d-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-regional-lung-function-post-pulmonary-embolism-using-ventilation-perfusion-pet-ct-with-galligas-and-68ga-maa2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-safety-and-clinical-parameters-of-human-alpha1-proteinase-inhibitor-self-infusion-in-severe-alpha-1-antitrypsin-deficiency-patients2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-safety-tolerability-and-pharmacodynamics-of-topical-sudo-286-in-patients-with-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-somatostatin-receptor-2-expression-in-nasopharyngeal-carcinoma-using-68ga-ga-dota-toc-pet-ct-imaging-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-somatostatin-receptor-expression-via-68ga-dotatoc-pet-in-patients-with-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-t-cell-activation-in-breast-esophageal-melanoma-and-nsclc-using-18f-f-arag-and-89zr-zr-df-crefmirlimab-pet-tracers2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-tacrolimus-impact-on-glycemic-control-in-hemodialysis-patients-pre-renal-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-the-regenerative-efficacy-of-fibrin-matrix-endoret-prgf-on-the-ocular-surface-in-glaucoma-patients-undergoing-chronic-ocular-hypotensive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-the-relative-bioavailability-of-rotigotine-4-5-mg-transdermal-patch-compared-to-neupro-2-mg-24-h-in-healthy-adult-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-the-relative-bioavailability-of-rotigotine-4-5-mg-transdermal-patch-versus-neupro-2-mg-24-h-patch-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-ticagrelor-based-de-escalation-antiplatelet-strategies-versus-standard-dual-antiplatelet-therapy-in-acute-coronary-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-verapamil-s-impact-on-ep395-pharmacokinetics-and-ep395-s-influence-on-midazolam-and-digoxin-pharmacokinetics-in-copd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/assessment-of-vonafexor-on-renal-function-in-patients-with-impaired-renal-function-and-suspected-metabolic-associated-steatohepatitis-mash2026-10-07 https://dev.clinicalresearch.eu/trial/asthma-in-adults-beclometasone-dipropionate-formoterol-fumarate-dihydrate-and-glycopyrronium-bromide-compared-with-beclometasone-dipropionate-and-formoterol-fumarate-dihydrate2026-10-07 https://dev.clinicalresearch.eu/trial/atezolizumab-plus-lenvatinib-or-sorafenib-vs-lenvatinib-or-sorafenib-alone-in-patients-with-unresectable-hepatocellular-carcinoma-after-prior-atezolizumab-and-bevacizumab2026-10-07 https://dev.clinicalresearch.eu/trial/atezolizumab-with-drug-combination-for-patients-with-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/atorvastatin-placebo-and-no-treatment-in-adults-with-familial-hypercholesterolaemia-and-statin-associated-muscle-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/attach-a-phase-2-multicenter-long-term-open-label-extension-trial-evaluating-safety-tolerability-and-efficacy-of-subcutaneous-doses-of-transcon-cnp-administered-once-weekly-in-children-and-adolescents2026-10-07 https://dev.clinicalresearch.eu/trial/auc-guided-tacrolimus-dosing-to-achieve-target-drug-levels-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/aur200-for-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/autologous-cd4-t-cell-gene-edited-therapy-for-patients-with-x-linked-hyper-igm-syndrome-type-1-higm12026-10-07 https://dev.clinicalresearch.eu/trial/autologous-transplantation-of-adult-salivary-gland-stem-cells-for-submandibular-gland-function-restoration-post-radiotherapy-in-head-and-neck-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/avacopan-added-to-standard-of-care-therapy-in-anca-associated-vasculitis-with-severe-kidney-involvement-a-randomized-placebo-controlled-double-blinded-multicenter-superiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/avelumab-maintenance-after-second-line-platinum-based-chemotherapy-in-patients-with-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/azenosertib-versus-drug-combination-chemotherapy-in-platinum-resistant-high-grade-serous-ovarian-fallopian-tube-or-primary-peritoneal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/b-cell-depletion-for-the-treatment-of-patients-with-amyotrophic-lateral-sclerosis-als-a-randomized-double-blind-placebo-controlled-pilot-study-in-patients-with-amyotrophic-lateral-sclerosis-for-the-ev2026-10-07 https://dev.clinicalresearch.eu/trial/b7841007-an-open-label-extension-study-to-evaluate-the-long-term-safety-tolerability-and-efficacy-of-marstacimab-prophylaxis-in-severe-coagulation-factor-activity-1-hemophilia-a-participants-with-or-w2026-10-07 https://dev.clinicalresearch.eu/trial/b7841008-an-open-label-study-in-pediatric-18-years-of-age-severe-hemophilia-a-participants-coagulation-factor-activity-1-with-or-without-inhibitors-or-moderately-severe-to-severe-hemophilia-b-particip2026-10-07 https://dev.clinicalresearch.eu/trial/b7981028-a-long-term-double-blind-extension-study-to-investigate-the-safety-and-efficacy-of-ritlecitinib-in-participants-with-severe-alopecia-areata-who-previously-completed-studies-b7981027-or-b798102026-10-07 https://dev.clinicalresearch.eu/trial/b7981080-a-phase-3-randomized-double-blind-52-week-placebocontrolled-multi-center-study-with-a-double-blind-52-week-extension-period-with-randomized-dose-up-dose-down-titration-investigating-the-effic2026-10-07 https://dev.clinicalresearch.eu/trial/baclofen-for-improving-benzodiazepine-titration-in-benzodiazepine-dependence-babet2026-10-07 https://dev.clinicalresearch.eu/trial/balloon-oxytocin-versus-oral-misoprostol-to-induce-labor-in-case-of-premature-rupture-of-membranes-prom-at-term-in-nulliparous2026-10-07 https://dev.clinicalresearch.eu/trial/basecovid-bevacizumab-in-post-acute-sequelae-of-covid-19-efficacy-and-safety-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/be-mobilyzed-belimumab-to-mobilise-memory-b-cells-from-secondary-lymhoid-organs-to-improve-memory-b-cell-hla-specificity-profiling-to-support-delisting-for-transplant-access-in-highly-sensitized2026-10-07 https://dev.clinicalresearch.eu/trial/beamion-lung-3-a-randomized-controlled-multi-center-trial-evaluating-zongertinib-as-an-adjuvant-monotherapy-compared-with-standard-of-care-in-patients-with-early-stage-resectable-non-small-cell-lung-c2026-10-07 https://dev.clinicalresearch.eu/trial/behandling-af-gastroesofageal-refluks-sygdom-hos-spaedborn-et-randomiseret-studie-treatment-of-gastroesophageal-reflux-disease-in-infants-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/belasbridge-belatacept-as-a-replacement-for-cnis-3-to-12-months-post-transplantation-in-patients-with-early-graft-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/belatacept-half-dose-versus-standard-dose-immunosuppression-in-kidney-transplant-recipients-with-a-well-matched-donor2026-10-07 https://dev.clinicalresearch.eu/trial/beneficial-effects-of-amiloride-on-progression-of-chronic-kidney-disease-a-ckd2026-10-07 https://dev.clinicalresearch.eu/trial/berotralstat-prevents-attacks-in-patients-with-acquired-angioedema-due-to-c1-inhibitor-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/best-antithrombotic-therapy-in-patients-with-acute-venous-thromboembolism-while-taking-antiplatelets-the-bat-vte2026-10-07 https://dev.clinicalresearch.eu/trial/bi-764198-in-adults-and-adolescents-with-proteinuric-kidney-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/bicarbonate-for-in-hospital-cardiac-arrest-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-and-bioequivalence-assessment-of-niraparib-and-abiraterone-acetate-in-metastatic-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-and-pharmacokinetic-assessment-of-valacyclovir-oral-suspension-versus-valtrex-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-and-pharmacokinetic-study-of-valacyclovir-oral-suspension-versus-valtrex-extemporaneous-suspension-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-and-safety-assessment-of-valacyclovir-oral-suspension-versus-valtrex-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-cabozantinib-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-dapagliflozin-in-a-bioequivalence-study2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-deucrictibant-formulations-in-hereditary-angioedema-a-phase-i-open-label-randomized-cross-over-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-empagliflozin-25-mg-film-coated-tablets-single-dose-open-label-randomized-crossover-study-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-esomeprazole-syrup-40-mg-vs-nexium-40-mg-under-fasting-and-fed-conditions-in-a-monocentric-open-randomized-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-ruxolitinib-20-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-stiripentol-following-single-oral-administration-of-two-formulations-in-healthy-subjects-a-study-in-dravet-syndrome-context2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-three-gliclazide-mr-tablet-formulations-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-assessment-of-transdermal-estradiol-gel-0-1-w-w-estradiol-intermed-vs-estreva-in-healthy-postmenopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-comparison-of-finerenone-20-mg-tablet-versus-reference-product-under-fasting-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-comparison-of-midazolam-oromucosal-solution-versus-solution-for-injection-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-comparison-of-teriflunomide-14-mg-film-coated-tablets-single-dose-open-label-randomized-crossover-study-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-comparison-of-trazodone-hydrochloride-tablets-in-major-depressive-disorder-with-and-without-anxiety-a-randomized-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-of-paracetamol-and-naproxen-from-fixed-dose-tablet-vs-separate-tablets-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-amylmetacresol-dichlorobenzyl-alcohol-lidocaine-and-vitamin-c-lozenges-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-diclofenac-2-32-gel-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-epinephrine-via-auto-injector-versus-intramuscular-injection-in-healthy-adults-with-type-1-allergic-reactions-including-anaphylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-oral-minoxidil-1-mg-in-androgenetic-alopecia-randomized-crossover-trial-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-rosuvastatin-ezetimibe-and-nilemdo-versus-nustendi-and-crestor-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-telmisartan-indapamide-and-amlodipine-interaction-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-of-two-gliclazide-mr-tablet-formulations-in-type-2-diabetes-mellitus-under-fed-and-fasting-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioavailability-study-on-drug-drug-interaction-between-ramipril-and-indapamide-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/biodistribution-assessment-to-optimize-dosage-in-cancer-patients-using-long-axial-field-of-view-scanners-for-targeted-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-and-adhesion-study-of-lts-nicotine-tts-versus-nicotinell-r-in-healthy-smokers-following-single-patch-application2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-and-pharmacokinetic-comparison-of-parkinson-s-disease-agents-in-healthy-volunteers-study-32026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-and-relative-bioavailability-of-two-20-000-iu-cholecalciferol-oral-drop-formulations-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-a-68-mg-etonogestrel-subdermal-implant-compared-with-reference-product-in-healthy-premenopausal-non-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-a-generic-fexofenadine-180-mg-pseudoephedrine-240-mg-extended-release-tablet-versus-allegra-d-24-hr-in-healthy-adults-for-seasonal-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-estradiol-intermed-0-1-gel-versus-estreva-0-1-gel-in-healthy-postmenopausal-women-open-label-randomized-single-dose-four-period-study2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-generic-fexofenadine-hcl-pseudoephedrine-hcl-extended-release-180-mg-240-mg-tablet-versus-reference-formulation-in-healthy-adults-under-fed-conditions-seasonal-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-tramadol-200-mg-prolonged-release-tablets-under-fed-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-of-two-100-g-h-transdermal-fentanyl-patches-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-10-g-estradiol-vaginal-tablet-versus-reference-in-healthy-premenopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-600-mg-ibuprofen-comparison-of-ibuprofen-sopharma-and-brufen-in-a-monocentric-open-randomized-crossover-trial-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-a-fixed-dose-combination-of-bempedoic-acid-ezetimibe-and-atorvastatin-versus-individual-tablet-formulations2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-almotriptan-12-5-mg-orodispersible-vs-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-and-clavulanic-acid-250-mg-62-5-mg-5-ml-oral-suspension-compared-to-augmentin-r-forte-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-and-clavulanic-acid-500-mg-125-mg-film-coated-tablets-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-and-clavulanic-acid-875-mg-125-mg-film-coated-tablets-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-and-clavulanic-acid-oral-suspension-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-clavulanic-acid-formulations-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-amoxicillin-clavulanic-acid-powder-for-oral-suspension-in-healthy-adults-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-antipsychotic-test-product-versus-reference-in-schizophrenia-treatment-for-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-apixaban-5-mg-capsules-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-apixaban-5-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-apixaban-5-mg-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-apixaban-5-mg-film-coated-tablets-in-thromboembolism-single-dose-randomized-crossover-design-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-apixaban-5-mg-hard-capsules-vs-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-aqueous-humour-concentrations-of-active-ingredients-following-topical-application-of-leviosa-r-versus-f2904-in-cataract-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-atorvastatin-80-mg-capsules-vs-film-coated-tablets-in-hypercholesterolaemia-and-cardiovascular-disease-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-betis-10-mg-film-coated-tablets-versus-clozan-10-mg-tablets-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-bosutinib-100-mg-tablets-in-myeloid-leukemia-a-randomized-open-label-crossover-trial-in-healthy-adults-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-brivaracetam-100-mg-tablets-in-healthy-adults-under-fasting-conditions-for-epilepsy-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-bupropion-hydrochloride-sustained-release-tablets-in-major-depressive-illness-under-fasting-conditions-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-calcifediol-monohydrate-0-266-mg-soft-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-canagliflozin-300-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-cefixime-400-mg-hard-capsules-versus-cefixime-400-mg-film-coated-tablets-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-cinnarizine-and-dimenhydrinate-tablets-in-healthy-participants-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ciprofloxacin-in-patients-with-impaired-renal-function-and-bacterial-infection2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-circadin-and-melatonin-pileje-lp-2-mg-in-patients-with-primary-insomnia-characterized-by-poor-quality-of-sleep2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-cladribine-10-mg-in-healthy-volunteers-for-potential-use-in-highly-active-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-cladribine-10-mg-tablets-versus-mavenclad-10-mg-tablets-in-healthy-adults-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-clarithromycin-500-mg-tablets-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-clobetasol-propionate-0-05-cream-versus-reference-in-corticosteroid-sensitive-dermatosis-using-skin-blanching-bioassay-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-clobetasol-propionate-0-5-mg-g-ointments-in-localized-therapy-resistant-inflammatory-skin-diseases-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dapagliflozin-10-mg-tablet-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dapagliflozin-10-mg-tablets-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dapagliflozin-10-mg-tablets-in-healthy-volunteers-for-type-2-diabetes-chronic-heart-failure-and-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dapagliflozin-10-mg-tablets-in-healthy-volunteers-under-fasting-conditions-for-diabetes-management2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dapagliflozin-metformin-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dextroamphetamine-saccharate-amphetamine-aspartate-dextroamphetamine-sulfate-and-amphetamine-sulfate-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-dimenhydrinate-50-mg-test-product-vs-comparator-in-a-monocentric-open-randomized-crossover-trial-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-donepezil-5-mg-capsules-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-edoxaban-60-mg-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-edoxaban-60-mg-tablets-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-eltrombopag-25-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-eltrombopag-75-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions-for-thrombocytopenia-and-aplastic-anemia2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-eltrombopag-75-mg-film-coated-tablets-in-healthy-subjects-under-fed-conditions-for-aplastic-anemia-and-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-empagliflozin-25-mg-tablets-versus-jardiance-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-enzalutamide-160-mg-vs-xtandi-80-mg-in-healthy-adult-males-under-fasting-conditions-for-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-enzalutamide-80-mg-film-coated-tablets-in-healthy-adult-males-under-fasting-conditions-for-prostate-cancer-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-escitalopram-10-mg-capsules-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-escitalopram-20-mg-capsules-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-esomeprazole-syrup-40-mg-vs-nexium-40-mg-under-fasting-conditions-in-a-randomized-single-dose-four-period-replicate-crossover-design2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-esomeprazole-syrup-40-mg-vs-nexium-40-mg-under-fed-conditions-in-healthy-volunteers-an-open-randomized-single-dose-four-period-replicate-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-etonogestrel-68-mg-implant-in-healthy-pre-menopausal-non-pregnant-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-etonogestrel-68-mg-implant-in-healthy-pre-menopausal-nonpregnant-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ezetimibe-atorvastatin-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-fixed-dose-combination-of-bempedoic-acid-ezetimibe-and-atorvastatin-versus-individual-tablets-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-fixed-dose-combination-of-bempedoic-acid-ezetimibe-and-rosuvastatin-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-fixed-dose-combination-of-bempedoic-acid-ezetimibe-and-rosuvastatin-versus-individual-tablets-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-fluticasone-propionate-500mg-salmeterol-50mg-inhalation-powders-in-healthy-volunteers-for-asthma-and-copd-management2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-fluticasone-propionate-salmeterol-inhalation-powders-in-healthy-volunteers-and-patients-with-asthma-or-copd2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-furosemide-500-mg-tablets-versus-lasix-500-mg-tablets-in-healthy-male-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gliclazide-mr-120-mg-and-gliclazide-mr-60-mg-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gliclazide-mr-120-mg-and-gliclazide-mr-60-mg-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gliclazide-mr-120-mg-vs-gliclazide-mr-60-mg-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gliclazide-mr-90-mg-and-gliclazide-mr-60-mg-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gp-imp-001-in-comparison-to-reference-product-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-gp-imp-001-in-healthy-male-volunteers-for-rheumatoid-arthritis-juvenile-idiopathic-arthritis-psoriasis-psoriatic-arthritis-and-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-guanfacine-7-mg-prolonged-release-tablets-versus-intuniv-r-in-healthy-male-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ibuprofen-200-mg-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ibuprofen-400-mg-and-caffeine-100-mg-in-healthy-volunteers-a-monocentric-open-randomized-single-dose-two-period-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-indacaterol-glycopyrronium-inhalation-powder-in-adult-copd-patients-pg341-vs-ultibro-breezhaler2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-inosine-pranobex-100-mg-ml-syrup-versus-500-mg-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ivacaftor-150-mg-film-coated-tablets-in-healthy-adults-under-fed-conditions-for-cystic-fibrosis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lacosamide-200-mg-tablets-in-healthy-adults-under-fasting-conditions-for-epileptic-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lamotrigine-dispersible-tablets-in-healthy-adults-under-fasting-conditions-for-bipolar-disorder-and-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lenvatinib-10-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lenvatinib-10-mg-capsules-versus-lenvima-r-10-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lenvatinib-10-mg-capsules-versus-lenvima-r-10-mg-capsules-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-linagliptin-5-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-linagliptin-5-mg-film-coated-tablets-versus-trajenta-r-5-mg-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-linagliptin-5-mg-tablets-in-healthy-volunteers-under-fasting-conditions-for-diabetes-management2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-linagliptin-metformin-2-5-mg-1000-mg-tablets-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-linagliptin-metformin-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-10-mg-capsules-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-10-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-10-mg-ml-oral-solution-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-20-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-70-mg-capsules-in-healthy-adults-under-fasting-conditions-for-adhd-and-bed2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-70-mg-capsules-in-healthy-adults-under-fasting-conditions-for-adhd-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-lisdexamfetamine-dimesylate-70-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-mesalamine-delayed-release-capsules-400-mg-in-healthy-adults-under-fasting-conditions-for-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-mesalamine-delayed-release-capsules-in-ulcerative-colitis-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-mesalamine-delayed-release-tablets-in-ulcerative-colitis-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-mesalamine-delayed-release-tablets-in-ulcerative-colitis-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-metamizole-sodium-500-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-mirabegron-50-mg-prolonged-release-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-montelukast-10-mg-capsules-versus-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-naltrexone-hydrochloride-50-mg-tablets-in-healthy-adults-under-fasting-conditions-for-alcohol-dependence2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-naproxen-500-mg-esomeprazole-20-mg-modified-release-tablets-versus-vimovo-r-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-netupitant-palonosetron-oral-suspension-versus-capsules-in-healthy-volunteers-an-open-label-randomized-replicative-design2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-nilotinib-200-mg-capsules-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-nitrofuranoin-100-mg-prolonged-release-capsules-in-healthy-subjects-a-crossover-replicate-design2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-nitrofuranoin-100-mg-prolonged-release-capsules-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-paracetamol-orodispersible-tablet-500-mg-versus-alvedon-and-panadol-500-mg-film-coated-tablets-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-paracetamol-orodispersible-tablets-500-mg-versus-apiretal-100-mg-ml-oral-solution-in-fasting-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-parkinson-disease-drugs-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-perampanel-12-mg-film-coated-tablets-versus-reference-product-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-perampanel-2-mg-film-coated-tablets-versus-reference-product-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-polypill-aar-100-80-10-mg-versus-aspirin-100-mg-cardyl-80-mg-and-acovil-10-mg-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-progesterone-vaginal-insert-100-mg-in-healthy-pre-menopausal-nonpregnant-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-proposed-biosimilar-insulin-glargine-u300-compared-to-toujeo-r-in-patients-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-pyridostigmine-bromide-p-r-tab-180-mg-vs-mestinon-retard-180-mg-in-myasthenia-gravis-treatment-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rasagiline-1-mg-capsules-versus-tablets-in-healthy-volunteers-under-fasting-conditions-in-a-crossover-design2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rifaximin-200-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rivaroxaban-acetylsalicylic-acid-vs-xarelto-and-aspirin-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rivaroxaban-and-acetylsalicylic-acid-formulations-in-healthy-volunteers-under-fasting-conditions-for-increased-blood-clotting2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rosuvastatin-10-mg-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-rosuvastatin-amlodipine-ramipril-capsule-versus-reference-products-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ruxolitinib-20-mg-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ruxolitinib-25-mg-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ruxolitinib-tablets-in-myelofibrosis-polycythemia-vera-and-graft-versus-host-disease-under-fasting-conditions-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-sacubitril-and-valsartan-tablets-in-healthy-volunteers-after-a-single-oral-dose2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-sacubitril-valsartan-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-sacubitril-valsartan-versus-entresto-r-in-healthy-subjects-under-fasted-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-subcutaneous-tafoxiparin-administration-via-syringe-needle-and-auto-injector-in-healthy-female-volunteers-for-labor-priming2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-sulodexide-intexo-250-lru-and-vessel-due-f-250-lru-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tacrolimus-and-mycophenolate-mofetil-in-kidney-transplant-recipients-at-steady-state2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tafamidis-free-acid-61-mg-capsule-and-tablet-and-safety-evaluation-of-61-mg-tablet-in-healthy-adults-with-transthyretin-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tamsulosin-hydrochloride-capsules-in-benign-prostatic-hyperplasia-in-healthy-adult-male-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tamsulosin-hydrochloride-capsules-in-benign-prostatic-hyperplasia-in-healthy-adult-males-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-test-product-versus-reference-product-in-healthy-subjects-for-type-2-diabetes-mellitus-heart-failure-and-chronic-kidney-disease-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-test-product-versus-reference-product-in-healthy-subjects-for-type-2-diabetes-mellitus-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-test-product-versus-reference-product-in-healthy-subjects-for-uncomplicated-lower-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-test-product-versus-reference-product-in-the-treatment-and-prevention-of-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-testosterone-transdermal-gel-in-healthy-female-subjects-for-male-hypogonadism2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ticagrelor-90-mg-hard-capsules-versus-film-coated-tablets-in-healthy-volunteers-for-atherothrombotic-event-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tofacitinib-10-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tofacitinib-10-mg-film-coated-tablets-versus-xeljanz-r-10-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tofacitinib-10-mg-film-coated-tablets-versus-xeljanz-r-10-mg-film-coated-tablets-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-tramadol-200-mg-prolonged-release-tablets-under-fasting-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-triamcinolone-acetonide-40-mg-ml-injectable-suspension-in-systemic-corticosteroid-therapy-for-allergic-syndrome-and-connective-tissue-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-90-mg-intravaginal-progesterone-gel-formulations-in-healthy-women2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-apixaban-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-bilastine-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-dapagliflozin-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-dapagliflozin-metformin-fixed-dose-combination-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-edoxaban-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-empagliflozin-metformin-fixed-dose-combination-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-hydrochlorothiazide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-linagliptin-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-loperamide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-loperamide-formulations-in-healthy-volunteers-22026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-quetiapine-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-silexan-80-mg-formulations-in-healthy-volunteers-a-randomized-open-label-reference-replicated-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-tiotropium-inhalers-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-transdermal-therapeutic-systems-delivering-100-mcg-h-fentanyl-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-two-vortioxetine-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ulipristal-acetate-30-mg-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-ulipristal-acetate-30-mg-tablets-in-healthy-volunteers-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-upadacitinib-prolonged-release-tablets-15-mg-in-healthy-adults-under-fasting-conditions-for-rheumatoid-arthritis-and-related-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-upadacitinib-prolonged-release-tablets-in-healthy-adults-under-fed-conditions-for-axial-spondyloarthritis-crohn-s-disease-and-other-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-upadacitinib-prolonged-release-tablets-in-rheumatoid-arthritis-ulcerative-colitis-atopic-dermatitis-crohn-s-disease-psoriatic-arthritis-and-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-vortioxetine-20-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-vortioxetine-20-mg-film-coated-tablets-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/bioequivalence-study-of-vortioxetine-5-mg-film-coated-tablets-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/biological-standardization-of-blomia-tropicalis-allergen-extract-for-allergic-patients-using-skin-prick-test-with-histamine-dihydrochloride-and-sodium-chloride-controls2026-10-07 https://dev.clinicalresearch.eu/trial/biological-standardization-of-dermatophagoides-allergen-extracts-in-allergic-patients-using-dermatophagoides-pteronyssinus-and-dermatophagoides-farinae-solutions2026-10-07 https://dev.clinicalresearch.eu/trial/biological-standardization-of-dermatophagoides-allergen-extracts-in-allergic-patients-using-histamine-dihydrochloride-and-sodium-chloride-controls2026-10-07 https://dev.clinicalresearch.eu/trial/biological-standardization-of-lepidoglyphus-destructor-allergen-extract-for-allergic-patients-using-skin-prick-test-with-histamine-dihydrochloride-and-sodium-chloride-controls2026-10-07 https://dev.clinicalresearch.eu/trial/biomarker-driven-targeted-therapy-in-advanced-cancer-a-swedish-nationwide-clinical-trial-focu-se2026-10-07 https://dev.clinicalresearch.eu/trial/biomarker-guided-anakinra-tapering-strategy-in-pediatric-systemic-juvenile-idiopathic-arthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/biomarker-guided-dosing-interval-extension-of-mepolizumab-and-dupilumab-in-severe-asthma-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/biomarker-guided-early-clarithromycin-administration-to-prevent-sepsis-progression-in-community-acquired-pneumonia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/bisoprolol-for-pericarditis-phase-iii-randomized-controlled-clinical-trial-in-patients-with-acute-or-recurrent-pericarditis2026-10-07 https://dev.clinicalresearch.eu/trial/bisoprolol-in-patients-after-myocardial-infarction-with-preserved-ejection-fraction-undergoing-cardiac-rehabilitation2026-10-07 https://dev.clinicalresearch.eu/trial/bladder-preservation-with-sacituzumab-govitecan-zimberelimab-for-muscleinvasive-bladder-cancer-in-cisplatin-unfit-and-unwilling-for-cystectomy-patients-phase-ii-trial-presave-trial2026-10-07 https://dev.clinicalresearch.eu/trial/blinatumomab-plus-drug-combination-therapy-in-children-and-adolescents-with-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/bms-986365-in-metastatic-castration-sensitive-prostate-cancer-for-patients-with-suboptimal-psa-response-after-adt-plus-arpi2026-10-07 https://dev.clinicalresearch.eu/trial/bms-986525-alone-and-with-nivolumab-in-patients-with-relapsed-or-refractory-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/body-weight-adjusted-clopidogrel-and-prasugrel-dosing-in-chronic-coronary-syndrome-a-study-on-platelet-reactivity-in-patients-with-variable-bmi2026-10-07 https://dev.clinicalresearch.eu/trial/botox-r-botulinum-toxin-type-a-for-the-reduction-of-masseter-muscle-prominence-a-phase-3-multicenter-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/botulinum-toxin-type-a-for-refractory-upper-limb-rest-tremor-in-parkinson-s-disease-patients-placebo-controlled-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/botulinum-toxin-type-a-to-prevent-radiation-induced-salivary-gland-damage-in-patients-with-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/breche-efficacy-of-sphenopalatine-block-compared-to-blood-patch-in-the-management-of-post-dural-puncture-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/bright-a-phase-ii-double-blind-randomized-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-multiple-doses-of-lt3001-drug-product-in-subjects-with-acute-ischemic-stroke-ais2026-10-07 https://dev.clinicalresearch.eu/trial/budapesticivasc-cardiovascular-side-effects-of-immune-checkpoint-inhibitor-oncological-therapies-and-their-monitoring-in-the-context-of-onco-cardiology2026-10-07 https://dev.clinicalresearch.eu/trial/c0251006-a-phase-3-multicenter-double-blind-randomized-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-pf-06823859-in-participants-with-active-idiopathic-inflammatory-myopathies-includ2026-10-07 https://dev.clinicalresearch.eu/trial/c0371002-phase-3-open-label-single-arm-study-to-evaluate-efficacy-and-safety-of-fix-gene-transfer-with-pf-06838435-raav-spark100-hfix-r338l-in-adult-male-participants-with-moderately-severe-to-severe-2026-10-07 https://dev.clinicalresearch.eu/trial/c1091009-a-phase-3-randomized-placebo-controlled-double-blinded-trial-to-evaluate-the-safety-tolerability-and-immunogenicity-of-a-multivalent-group-b-streptococcus-vaccine-in-healthy-pregnant-women-an2026-10-07 https://dev.clinicalresearch.eu/trial/c2321008-a-phase-3-randomized-double-blind-placebo-controlled-study-of-mevrometostat-pf-06821497-with-enzalutamide-in-metastatic-castration-sensitive-prostate-cancer-mevpro-32026-10-07 https://dev.clinicalresearch.eu/trial/c3601008-a-phase-2a-multicenter-observer-blinded-randomized-2-arm-study-to-investigate-pharmacokinetics-safety-tolerability-and-efficacy-of-intravenous-aztreonam-avibactam-metronidazole-compared-to-be2026-10-07 https://dev.clinicalresearch.eu/trial/c3651021-a-phase-2b-3-randomized-double-blind-study-to-investigate-the-efficacy-safety-and-tolerability-of-ponsegromab-pf-06946860-compared-with-placebo-both-with-background-first-line-chemotherapy-in2026-10-07 https://dev.clinicalresearch.eu/trial/c4551002-an-interventional-open-label-randomized-multicenter-phase-3-study-of-pf-07248144-plus-fulvestrant-compared-to-investigator-s-choice-of-therapy-in-adult-participants-with-hormone-receptor-posi2026-10-07 https://dev.clinicalresearch.eu/trial/c4891001-a-phase-3-randomized-open-label-multicenter-trial-of-arv-471-pf-07850327-vs-fulvestrant-in-participants-with-estrogen-receptor-positive-her2-negative-advanced-breast-cancer-whose-disease-prog2026-10-07 https://dev.clinicalresearch.eu/trial/c4891002-a-phase-3-randomized-open-label-multicenter-study-of-arv-471-pf-07850327-plus-palbociclib-versus-letrozole-plus-palbociclib-for-the-treatment-of-participants-with-estrogen-receptor-positive-h2026-10-07 https://dev.clinicalresearch.eu/trial/c4891006-tactive-u-an-interventional-safety-and-efficacy-phase-1b-2-open-label-umbrella-study-to-investigate-tolerability-pk-and-antitumor-activity-of-vepdegestrant-arv-471-pf-07850327-an-oral-proteol2026-10-07 https://dev.clinicalresearch.eu/trial/c4891023-tactive-u-an-interventional-safety-and-efficacy-phase-1b-2-open-label-umbrella-study-to-investigate-tolerability-pk-and-antitumor-activity-of-vepdegestrant-arv-471-pf-07850327-an-oral-proteol2026-10-07 https://dev.clinicalresearch.eu/trial/c4971006-a-phase-1b-2-open-label-study-of-pf-07901801-in-combination-with-glofitamab-after-a-fixed-single-dose-of-obinutuzumab-in-participants-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-no2026-10-07 https://dev.clinicalresearch.eu/trial/c5001004-a-phase-2-open-label-extension-study-to-investigate-the-safety-and-efficacy-of-pf-07868489-administered-to-adult-participants-with-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/c5041010-apd334-207-an-open-label-single-arm-study-to-evaluate-the-efficacy-pharmacokinetics-and-safety-of-etrasimod-in-adolescent-participants-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/c5731001-an-open-label-randomized-controlled-phase-3-study-of-disitamab-vedotin-in-combination-with-pembrolizumab-versus-chemotherapy-in-subjects-with-previously-untreated-locally-advanced-or-metastat2026-10-07 https://dev.clinicalresearch.eu/trial/c5731002-a-phase-2-multi-cohort-open-label-multi-center-clinical-study-evaluating-the-efficacy-and-safety-of-disitamab-vedotin-rc48-adc-alone-or-in-combination-with-pembrolizumab-in-subjects-with-loca2026-10-07 https://dev.clinicalresearch.eu/trial/cabozantinib-maintenance-therapy-vs-best-supportive-care-in-osteosarcoma-patients-in-complete-remission-or-stable-disease-after-first-line-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/calcium-electroporation-for-non-muscle-invasive-bladder-cancer-first-in-human-feasibility-safety-and-early-efficacy-trial-calcifer2026-10-07 https://dev.clinicalresearch.eu/trial/calcium-electroporation-in-combination-with-irreversible-electroporation-and-immunotherapy-in-patients-with-pmmr-metastatic-colorectal-cancer-a-prospective-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/calibrate-a-phase-3-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-encaleret-compared-to-standard-of-care-in-participants-with-autosomal-dominant-hypocalcemia-type-1-adh12026-10-07 https://dev.clinicalresearch.eu/trial/cambria-1-a-phase-iii-open-label-randomised-study-to-assess-the-efficacy-and-safety-of-extended-therapy-with-camizestrant-azd9833-a-next-generation-oral-selective-estrogen-receptor-degrader-versus-sta2026-10-07 https://dev.clinicalresearch.eu/trial/cambria-2-a-phase-iii-open-label-randomised-study-to-assess-the-efficacy-and-safety-of-camizestrant-azd9833-a-next-generation-oral-selective-estrogen-receptor-degrader-vs-standard-endocrine-therapy-ar2026-10-07 https://dev.clinicalresearch.eu/trial/capillary-refill-time-targeted-resuscitation-in-early-septic-shock-using-sodium-chloride-and-lactated-ringer-s-solution-a-hemodynamic-phenotype-based-study2026-10-07 https://dev.clinicalresearch.eu/trial/captor-bc-comprehensive-analysis-of-spatial-temporal-and-molecular-patterns-of-ribociclib-efficacy-and-resistance-in-advanced-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/carboplatin-based-drug-combination-in-advanced-non-small-cell-lung-cancer-patients-with-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/carboplatin-plus-drug-combination-in-neoadjuvant-treatment-for-stage-ii-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/cardiotoxicity-detection-via-serial-cmr-and-biomarker-analysis-in-oncology-patients-undergoing-anthracycline-based-therapy-a-phase-iv-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/cardiovascular-safety-evaluation-of-chf6001-tanimilast-administered-via-nexthaler-r-in-healthy-adult-volunteers-a-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/caress-study-cabergoline-for-the-reduction-of-endometriosis-symptoms-and-lesion-size2026-10-07 https://dev.clinicalresearch.eu/trial/cat-trial-cgrp-monoclonal-antibody-for-treatment-of-painful-diabetic-neuropathy-a-double-blind-multicenter-placebo-controlled-international-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/cat-vhl-exploring-the-role-of-carbonic-anhydrase-ix-as-diagnostic-and-theranostic-target-in-von-hippel-lindau-disease2026-10-07 https://dev.clinicalresearch.eu/trial/cemsidomide-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/cerebroprotective-effect-of-ast-004-in-patients-with-complicated-mild-traumatic-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/cevostamab-pomalidomide-and-dexamethasone-in-patients-with-multiple-myeloma-after-prior-bcma-targeted-car-t-cell-therapy-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/changes-in-coronary-plaque-composition-by-semaglutide-use-in-diabetic-patients-with-acute-coronary-syndrome-a-randomized-optical-coherence-tomography-trial-armyda-10-study2026-10-07 https://dev.clinicalresearch.eu/trial/changes-in-plaque-characteristics-after-short-term-statin-therapy-assessed-with-coronary-ct2026-10-07 https://dev.clinicalresearch.eu/trial/characterization-of-dopaminergic-network-abnormalities-in-comatose-traumatic-brain-injury-patients-using-18f-lbt-999-radiotracer2026-10-07 https://dev.clinicalresearch.eu/trial/chemoablation-or-bladder-resection-with-adjuvant-chemotherapy-in-recurrent-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/chemoimmunotherapy-with-blood-brain-barrier-disruption-in-primary-central-nervous-system-lymphoma-using-etoposide-phosphate-carboplatin-methotrexate-rituximab-and-cyclophosphamide2026-10-07 https://dev.clinicalresearch.eu/trial/chloramphenicol-versus-ciprofloxacin-ear-drops-for-treating-otorrhea-in-adults-with-chronic-suppurative-otitis-media2026-10-07 https://dev.clinicalresearch.eu/trial/cholangiocarcinoma-treatment-with-radiofrequency-ablation-or-photodynamic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/chronobiological-intervention-with-melatonin-and-light-therapy-in-idiopathic-hypersomnia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/chronotherapy-in-rheumatoid-and-psoriatic-arthritis-a-randomized-controlled-trial-of-tofacitinib-extended-release-morning-vs-evening-dosing2026-10-07 https://dev.clinicalresearch.eu/trial/ciraano-multimodal-exploration-including-radiopharmaceuticals-amyvid-r-and-tauvid-r-of-theater-actors-memory-athletes-and-patients-with-various-memory-pathologies-evaluation-of-mnesic-strategies-and-t2026-10-07 https://dev.clinicalresearch.eu/trial/circulating-micrornas-to-choose-the-io-strategy-in-pd-l1-50-nsclc-patients-the-ark-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/cisplatin-based-drug-combination-with-hyperthermic-intraperitoneal-chemotherapy-for-patients-with-stage-ii-iii-adrenocortical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/citar-comparison-of-the-efficacy-and-safety-of-early-use-of-il-6r-blockade-with-tocilizumab-in-combination-with-short-term-glucocorticoids-versus-glucocorticoids-alone-for-the-treatment-of-arthritis-i2026-10-07 https://dev.clinicalresearch.eu/trial/cityview-pet-based-imaging-to-evaluate-the-distribution-of-radiolabeled-cit-013-in-patients-with-inflammatory-mediated-immune-disease2026-10-07 https://dev.clinicalresearch.eu/trial/clarithromycin-to-prevent-secondary-infections-in-patients-with-community-acquired-pneumonia-related-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/cleopattra-effects-of-nnc6019-0001-versus-placebo-on-cardiovascular-outcomes-in-participants-with-transthyretin-amyloid-cardiomyopathy-attr-cm2026-10-07 https://dev.clinicalresearch.eu/trial/clindamycin-as-an-alternative-to-vancomycin-in-patients-undergoing-aortic-cardiac-surgery-with-extracorporeal-circulation-ecc-a-prospective-single-center-pharmacokinetic-study-clindapass2026-10-07 https://dev.clinicalresearch.eu/trial/clinical-and-endocrinological-effects-of-letrozole-during-the-luteal-phase-after-controlled-ovarian-stimulation-in-oocyte-donors-a-low-interventional-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/clinical-application-of-the-androgen-receptor-inhibitor-darolutamide-to-upregulate-the-prostate-specific-membrane-antigen-psma-protein-expression-in-patients-with-hormone-sensitive-prostate-cancer-the2026-10-07 https://dev.clinicalresearch.eu/trial/clinical-randomised-phase-2-trial-of-ap31969-versus-placebo-for-rhythm-control-of-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/clinical-trial-evaluating-doxorubicin-hydrochloride-fluorouracil-and-oxaliplatin-in-pediatric-hepatoblastoma-and-hepatocarcinoma-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/cloxacillin-and-drug-combination-for-prevention-of-postoperative-infections-in-head-and-neck-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/cluster-and-registry-trials-of-the-working-group-of-heart-failure-in-denmark-are-spironolactone-and-eplerenone-comparable-treatments-crowd-aspect2026-10-07 https://dev.clinicalresearch.eu/trial/cluster-randomised-trial-of-low-molecular-weight-heparins-directly-through-epic2026-10-07 https://dev.clinicalresearch.eu/trial/cmv-preemptive-therapy-in-high-risk-immunocompetent-major-heart-surgery-patients-a-multicenter-double-blind-randomized-clinical-trial-gan-car2026-10-07 https://dev.clinicalresearch.eu/trial/cognitive-effects-of-methylphenidate-in-parkinson-s-disease-patients-with-mild-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/cohort-study-of-human-mpox-virus-disease2026-10-07 https://dev.clinicalresearch.eu/trial/colchicine-after-electrocardioversion-to-reduce-atrial-fibrillation-recurrence-in-patients-undergoing-ecv2026-10-07 https://dev.clinicalresearch.eu/trial/combination-therapy-of-monobenzone-and-imiquimod-with-standard-care-for-advanced-or-metastatic-malignant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/combined-treatment-of-intraperitoneal-chemotherapy-after-optimal-interval-surgery-in-advanced-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-analysis-of-oral-versus-transdermal-estradiol-replacement-therapy-on-endocrine-and-cardiovascular-outcomes-in-turner-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-analysis-of-phenylephrine-and-noradrenaline-on-hemodynamics-and-cerebral-perfusion-in-anesthetized-patients-with-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-analysis-of-preincisional-versus-postincisional-ultrasound-guided-transversus-abdominis-plane-block-with-levobupivacaine-on-chronic-postsurgical-pain-in-open-inguinal-hernia-repair2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-and-bioequivalence-of-oxazepam-10-mg-orodispersible-tablets-test-versus-seresta-r-10-mg-tablets-reference-a-single-dose-open-label-randomized-two-sequence-two-treatment-two2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-and-bioequivalence-of-oxazepam-50-mg-orodispersible-tablets-test-versus-seresta-r-50-mg-tablets-reference-a-single-dose-open-label-randomized-two-sequence-two-treatment-two2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-and-food-effect-of-four-norucholic-acid-formulations-tablet-granule-capsule-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-and-food-effect-study-of-celecoxib-oral-suspension-vs-celecoxib-capsules-in-healthy-adults-under-fasting-and-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-of-a-52-mg-levonorgestrel-intrauterine-system-versus-reference-levonorgestrel-ius-in-healthy-pre-menopausal-non-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-of-colistin-administered-at-three-dose-levels-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-of-intravenous-intranasal-and-sublingual-midazolam-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-of-lenvatinib-10-mg-capsules-a-two-part-single-dose-open-label-randomized-six-sequence-three-treatment-three-period-crossover-pilot-study-in-healthy-subjects-under-fasting-2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-of-nilotinib-200-mg-hard-capsules-a-single-dose-open-label-randomized-four-sequence-four-treatment-four-period-crossover-pilot-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-alendronate-70-mg-effervescent-versus-fosamax-70-mg-tablets-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-amlodipine-valsartan-hydrochlorothiazide-versus-reference-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-dapagliflozin-metformin-hydrochloride-5-mg-1000-mg-versus-reference-product-in-healthy-adults-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-ibuprofen-arginine-granules-versus-espidifen-r-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-intravenous-vs-oral-dofetilide-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-levodopa-via-cyclops-tm-versus-inbrija-r-in-healthy-adults-for-parkinson-s-disease-off-episodes2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-lisdexamfetamine-dimesylate-70-mg-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-new-pitolisant-hydrochloride-tablet-formulation-versus-marketed-pitolisant-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-paracetamol-ibuprofen-oral-suspension-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-ramipril-amlodipine-and-indapamide-in-hypertension-single-dose-randomized-crossover-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-reformulated-ibuprofen-2-and-4-oral-suspensions-versus-reference-ibuprofen-200-mg-5-ml-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-tv-44749-versus-oral-olanzapine-in-schizophrenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-two-ibuprofen-arginate-formulations-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-two-ibuprofen-formulations-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-two-pramipexole-tablet-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-two-tiotropium-inhalation-devices-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-bioavailability-study-of-udca-pmcs-500-mg-formulations-in-healthy-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-diagnostic-efficacy-of-18f-alf-fapi-74-versus-18f-fdg-pet-ct-in-fever-of-unknown-origin-igg4-related-disease-and-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-diagnostic-efficacy-of-copper-64cu-chloride-pet-ct-versus-fluorocholine-18f-pet-ct-in-detecting-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-effectiveness-of-levetiracetam-and-valproate-semisodium-in-benzodiazepine-resistant-status-epilepticus-in-patients-aged-65-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-acetylsalicylic-acid-and-clopidogrel-in-atrial-fibrillation-patients-post-left-atrial-appendage-closure2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-adalimumab-versus-mycophenolate-mofetil-in-steroid-dependent-non-infectious-uveitis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-autologous-hematopoietic-stem-cell-transplantation-versus-alemtuzumab-cladribine-or-ocrelizumab-in-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-botulinum-neurotoxin-type-a-products-in-treating-glabellar-rhytides-a-multicenter-triple-blind-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-dual-vs-single-antiplatelet-therapy-post-left-atrial-appendage-closure-in-end-stage-renal-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-infliximab-versus-tocilizumab-in-refractory-or-relapsing-takayasu-arteritis-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-ivermectin-10-mg-g-cream-versus-vehicle-in-patients-with-papulopustular-rosacea-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-obinutuzumab-versus-rituximab-in-pediatric-steroid-dependent-and-frequent-relapsing-idiopathic-nephrotic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-obinutuzumab-versus-rituximab-with-chemotherapy-in-newly-diagnosed-cd20-positive-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-risankizumab-versus-vedolizumab-in-adult-patients-with-moderate-to-severe-ulcerative-colitis-naive-to-targeted-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-sirolimus-versus-methylprednisolone-in-patients-with-active-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-sodium-chloride-versus-lactated-ringer-s-solution-in-acute-pancreatitis-resuscitation-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-of-tocilizumab-versus-adalimumab-in-severe-uveitis-associated-with-behcet-s-disease-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-safety-study-of-cyb704-and-ocrelizumab-in-relapsing-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-tolerability-of-intramuscular-diclofenac-and-thiocolchicoside-versus-diclofenac-in-acute-moderate-to-severe-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-and-tolerability-of-oral-versus-subcutaneous-methotrexate-in-early-rheumatoid-arthritis-a-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-18f-fluorocholine-and-18f-fluorodeoxyglucose-pet-ct-in-lesion-detection-for-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-2-lidocaine-gel-versus-tetracaine-oxybuprocaine-eye-drops-in-ophthalmic-needling-for-glaucoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-amoxicillin-clavulanic-acid-versus-amoxicillin-clavulanic-acid-plus-ciprofloxacin-in-chemotherapy-induced-fever-in-adult-hematology-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-apixaban-versus-carbasalate-calcium-in-antithrombotic-management-for-patients-with-aortic-bioprosthetic-valve-replacement2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-apixaban-versus-warfarin-in-thrombus-resolution-for-patients-with-left-ventricular-thrombosis-post-acute-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-autologous-hematopoietic-stem-cell-transplantation-versus-immunosuppressive-therapy-in-early-diffuse-cutaneous-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-bimekizumab-versus-clobetasol-propionate-in-early-plaque-psoriasis-a-multicenter-interventional-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-botulinum-toxin-type-a-triamcinolone-acetonide-and-bupivacaine-hydrochloride-monohydrate-in-persistent-post-surgical-scar-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-buprenorphine-naloxone-versus-methadone-in-opioid-use-disorder-and-chronic-non-cancer-pain-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-carvedilol-and-flecainide-in-the-management-of-idiopathic-ventricular-arrhythmias-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-carvedilol-and-metoprolol-succinate-in-heart-failure-patients-with-reduced-ejection-fraction-a-cluster-and-registry-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-cefoxitin-sodium-administration-regimens-in-preventing-surgical-site-infections-post-colorectal-surgery-a-multicenter-rct2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-cyclophosphamide-azathioprine-and-tacrolimus-in-antisynthetase-syndrome-related-interstitial-lung-disease-a-phase-iii-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-dexmedetomidine-versus-midazolam-on-extubation-time-in-mechanically-ventilated-very-preterm-neonates-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-dual-therapy-with-dabigatran-and-ticagrelor-versus-dabigatran-and-clopidogrel-in-acute-coronary-syndrome-patients-undergoing-pci2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-inclisiran-sodium-versus-bempedoic-acid-in-ldl-c-reduction-in-atherosclerotic-cardiovascular-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-infliximab-versus-nsaid-combination-in-axial-spondyloarthritis-patients-unresponsive-to-nsaid-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-insulin-aspart-insulin-lispro-glucose-and-salbutamol-in-acute-hyperkalemia-management-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-intrapleural-alteplase-and-dornase-alfa-versus-video-assisted-thoracoscopic-surgery-in-patients-with-pleural-empyema-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-itraconazole-and-nebulised-amphotericin-b-in-non-immunocompromised-chronic-pulmonary-aspergillosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-lithium-and-cariprazine-in-acute-bipolar-depression-a-randomized-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-meropenem-trihydrate-versus-piperacillin-tazobactam-in-critically-ill-adults-with-sepsis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-methotrexate-and-methotrexate-metformin-in-methotrexate-naive-rheumatoid-arthritis-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-methotrexate-versus-tocilizumab-in-giant-cell-arteritis-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-mirikizumab-versus-azathioprine-and-glucocorticoids-in-newly-diagnosed-moderate-to-severe-ulcerative-colitis-a-52-week-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-normal-saline-and-lactated-ringer-s-solution-in-fluid-resuscitation-for-acute-pancreatitis-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-oral-esketamine-versus-electroconvulsive-therapy-in-non-psychotic-treatment-resistant-unipolar-depression2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-pectoral-nerve-block-with-liposomal-bupivacaine-versus-levobupivacaine-in-post-mastectomy-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-psilocybin-and-personalized-repetitive-transcranial-magnetic-stimulation-in-treatment-resistant-depression2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-remimazolam-and-midazolam-with-fentanyl-for-sedation-in-screening-colonoscopy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-remimazolam-and-propofol-for-deep-sedation-in-endoscopic-ultrasound-procedures-in-patients-with-gastric-and-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-risankizumab-versus-deucravacitinib-in-adult-patients-with-moderate-plaque-psoriasis-eligible-for-systemic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-selective-laser-trabeculoplasty-versus-tafluprost-in-primary-treatment-of-exfoliation-ocular-hypertension-or-glaucoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-sequential-gembrax-and-folfirinox-versus-folfirinox-monotherapy-in-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-temocillin-sodium-versus-meropenem-and-ertapenem-sodium-in-treating-enterobacteriaceae-bacteremia-resistant-to-third-generation-cephalosporins2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-teriparatide-and-alendronate-in-preventing-vertebral-fractures-in-women-with-bone-fragility-a-52-week-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-topical-lidocaine-prilocaine-cream-versus-lidocaine-hydrochloride-infiltration-in-first-degree-perineal-laceration-repair2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-topical-permethrin-oral-ivermectin-and-their-combination-in-the-treatment-of-microscopy-confirmed-scabies2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-of-two-cell-therapies-in-treating-crohn-s-disease-associated-anal-fistulas2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-efficacy-safety-and-immunogenicity-of-intravenous-avt16-versus-vedolizumab-in-adults-with-moderate-to-severe-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-18f-ro6958948-18f-pi-2620-and-18f-mk-6240-pet-tracers-in-cognitive-impairment-a-longitudinal-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-68ga-fapi-46-and-18f-fdg-as-pet-tracers-in-estrogen-receptor-positive-breast-cancer-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-68ga-gozetotide-and-89zr-dfo-girentuximab-pet-imaging-in-primary-recurrent-or-metastatic-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-99mtc-mip-1404-spect-ct-versus-ce-wbct-in-detecting-local-lymph-node-metastases-in-primary-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-cardiac-18f-mfbg-pet-and-123i-mibg-spect-in-differentiating-parkinson-s-disease-multiple-system-atrophy-dementia-with-lewy-bodies-and-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-eplerenone-versus-irbesartan-in-blood-pressure-management-for-obese-hypertensive-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-evaluation-of-giredestrant-and-triptorelin-versus-anastrozole-and-triptorelin-in-premenopausal-er-positive-her2-negative-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-pharmacokinetic-study-of-multiple-dose-formulations-of-cagrilintide-in-adults-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-pharmacokinetics-of-subcutaneous-versus-intravenous-administration-of-cdr132l-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-pharmacokinetics-of-two-alendronic-acid-formulations-in-healthy-volunteers-a-randomized-open-label-single-dose-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-phase-3-study-of-gsk5764227-a-b7-h3-antibody-drug-conjugate-versus-topotecan-in-relapsed-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-phase-iii-trial-of-ferric-derisomaltose-versus-no-intravenous-iron-in-iron-deficient-patients-with-symptomatic-chronic-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-potency-evaluation-of-salbutamol-via-hfa-152a-and-hfa-134a-propellant-metered-dose-inhalers-in-adults-with-mild-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-safety-and-efficacy-of-apixaban-versus-warfarin-in-patients-with-end-stage-renal-disease-on-peritoneal-dialysis-and-non-valvular-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-adjuvant-gemcitabine-versus-mitomycin-in-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-anesthetic-efficacy-of-2-lidocaine-gel-versus-tetracaine-oxybuprocaine-eye-drops-in-glaucoma-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-antiatherosclerotic-efficacy-of-semaglutide-dapagliflozin-and-metformin-in-coronary-artery-disease-with-prediabetes2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-antithrombotic-strategies-apixaban-edoxaban-rivaroxaban-and-acetylsalicylic-acid-in-post-transcatheter-aortic-valve-implantation-for-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-atezolizumab-carboplatin-and-nab-paclitaxel-versus-pembrolizumab-platinum-and-pemetrexed-in-metastatic-ttf-1-negative-lung-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-betamethasone-dipropionate-and-salicylic-acid-ointments-versus-placebo-in-chronic-stable-plaque-psoriasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-bilastine-ebastine-and-desloratadine-on-histamine-induced-wheal-and-flare-suppression-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-cerebral-neuroinflammation-in-major-depressive-disorder-using-18f-dpa-714-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-corifollitropin-alfa-and-progestin-primed-ovarian-stimulation-versus-recombinant-fsh-and-gnrh-antagonist-in-subfertility-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-doravirine-lamivudine-versus-dolutegravir-lamivudine-for-maintenance-therapy-in-hiv-patients-with-suppressed-viral-load2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-early-ablation-versus-amiodarone-bisoprolol-and-sotalol-in-preventing-atrial-fibrillation-recurrence-in-hypertrophic-cardiomyopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-early-time-restricted-eating-mediterranean-diet-versus-bupropion-hydrochloride-and-naltrexone-hydrochloride-in-type-2-diabetes-with-liver-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-efficacy-pharmacokinetics-and-safety-of-denosumab-mab-22-versus-eu-sourced-denosumab-in-postmenopausal-osteoporosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-efficacy-safety-pharmacokinetics-and-immunogenicity-of-mb04-and-eu-sourced-etanercept-in-moderate-to-severe-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-esmolol-hydrochloride-and-sufentanil-citrate-on-recovery-quality-post-laparoscopic-cholecystectomy-with-orotracheal-intubation2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-integrase-inhibitor-regimen-versus-boosted-protease-inhibitor-regimen-in-late-presenting-advanced-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-isoflurane-inhalation-versus-propofol-intravenous-sedation-in-critically-ill-patients-requiring-prolonged-mechanical-ventilation2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-jpb898-and-nivolumab-in-combination-with-ipilimumab-for-advanced-unresectable-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-onivyde-from-two-production-sites-in-adults-with-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-pharmacokinetics-efficacy-safety-and-immunogenicity-of-mb11-and-nivolumab-in-untreated-advanced-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-pharmacokinetics-efficacy-safety-and-immunogenicity-of-mb12-and-pembrolizumab-in-advanced-metastatic-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-pharmacokinetics-pharmacodynamics-and-safety-of-abp-692-and-ocrelizumab-in-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-pharmacokinetics-safety-tolerability-and-immunogenicity-of-ckd-704-and-risankizumab-in-moderate-to-severe-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-preservative-free-vs-preserved-dexamethasone-and-diclofenac-eye-drops-post-cataract-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-propofol-versus-bupivacaine-and-fentanyl-for-sedation-in-external-cephalic-version-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-remifentanil-dexmedetomidine-propofol-and-ketamine-hydrochloride-for-sedation-in-aortic-stenosis-patients-undergoing-tavr2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-sacituzumab-govitecan-versus-sacituzumab-govitecan-plus-pembrolizumab-in-low-risk-triple-negative-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-short-term-dabigatran-etexilate-versus-antiplatelet-therapy-in-preventing-device-thrombosis-post-left-atrial-appendage-closure-in-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-short-vs-long-adjuvant-pembrolizumab-and-nivolumab-therapy-post-radical-surgery-in-stage-iib-iv-cutaneous-malignant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-somapacitan-and-somatropin-on-growth-outcomes-in-pediatric-growth-hormone-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-tacrolimus-bioavailability-envarsus-vs-advagraf-in-de-novo-liver-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-two-aramchol-formulations-in-healthy-volunteers-for-nonalcoholic-fatty-liver-disease-nonalcoholic-steatohepatitis-and-primary-sclerosing-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-ulipristal-acetate-versus-surgical-intervention-in-patients-with-symptomatic-uterine-fibroids2026-10-07 https://dev.clinicalresearch.eu/trial/comparative-study-of-ultrasound-guided-radiofrequency-ablation-and-sodium-iodide-131i-in-treating-hyperthyroidism-from-solitary-autonomous-thyroid-nodules2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-amoxicillin-and-amoxicillin-clavulanate-to-a-placebo-for-the-treatment-of-acute-middle-ear-infection-in-children2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-autologous-minced-cartilage-implantation-and-matrix-associated-autologous-chondrocyte-implantation-in-adults-with-large-full-thickness-knee-cartilage-defects2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-azd5335-with-mirvetuximab-soravtansine-or-drug-combinations-in-patients-with-platinum-resistant-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-ceftriaxone-and-azithromycin-with-amoxicillin-and-azithromycin-for-pregnant-women-with-preterm-premature-rupture-of-membranes-between-22-and-33-weeks-of-pregnancy2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-cognitive-behavioral-therapy-alone-with-cognitive-behavioral-therapy-combined-with-degarelix-to-prevent-sexual-misconduct-in-people-with-paraphilic-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-human-normal-immunoglobulin-iv-and-a-drug-combination-to-prevent-infections-in-adults-with-b-cell-acute-lymphoblastic-leukemia-or-b-cell-lymphoma-treated-with-car-t-cells2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-irinotecan-oxaliplatin-fluorouracil-and-calcium-folinate-with-other-drug-combinations-for-patients-with-high-risk-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-ivonescimab-and-a-drug-combination-with-bevacizumab-and-a-drug-combination-for-the-first-line-treatment-of-patients-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-local-gentamicin-or-vancomycin-hydrochloride-to-a-drug-combination-for-patients-with-diabetic-foot-osteomyelitis2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-low-dose-and-standard-dose-argatroban-or-enoxaparin-for-blood-thinning-in-patients-with-heart-or-lung-failure-receiving-extracorporeal-membrane-oxygenation2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-mesalazine-to-thiopurines-for-older-patients-with-ulcerative-colitis-in-long-term-remission2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-pivmecillinam-and-gentamicin-to-standard-treatments-for-adults-hospitalized-with-complicated-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-regn7508-and-acetylsalicylic-acid-to-prevent-blood-clots-in-adults-undergoing-elective-total-knee-replacement2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-remifentanil-propofol-bupivacaine-sufentanil-and-fentanyl-for-same-day-discharge-in-patients-undergoing-hip-or-knee-replacement-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-ro7771950-with-a-drug-combination-of-tucatinib-trastuzumab-and-capecitabine-for-patients-with-her2-positive-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-romosozumab-and-denosumab-on-coronary-artery-damage-in-women-with-postmenopausal-osteoporosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-tenecteplase-and-thrombectomy-versus-thrombectomy-alone-in-adults-with-a-large-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-the-effectiveness-of-bimekizumab-and-adalimumab-for-treating-chest-pain-in-patients-with-active-axial-spondyloarthritis-who-do-not-respond-well-to-non-steroidal-anti-inflammatory-drugs2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-the-effectiveness-of-chf5993-glycopyrronium-bromide-formoterol-fumarate-dihydrate-and-beclometasone-dipropionate-to-a-drug-combination-in-adults-with-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-the-effects-of-nepafenac-and-dexamethasone-sodium-phosphate-on-eye-inflammation-in-patients-after-cataract-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-the-efficacy-and-safety-of-linaprazan-glurate-and-lansoprazole-to-maintain-healing-in-patients-with-erosive-esophagitis-caused-by-acid-reflux-disease2026-10-07 https://dev.clinicalresearch.eu/trial/comparing-weekly-or-event-based-doxycycline-use-to-prevent-sexually-transmitted-infections-in-men-who-have-sex-with-men-and-transgender-women-taking-hiv-prevention-medication2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-18f-fluciclovine-and-18f-fluoroethyltyrosine-pet-in-newly-diagnosed-and-recurrent-cerebral-gliomas-and-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-adjustable-versus-standard-brodalumab-dosage-regimens-in-patients-with-moderate-to-severe-plaque-psoriasis-and-body-weight-120-kg2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-allogeneic-stem-cell-transplantation-and-conventional-therapy-in-relapsed-progressive-multiple-myeloma-post-first-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-analgesic-efficacy-of-levobupivacaine-hydrochloride-wound-infiltration-versus-ultrasound-guided-transversus-abdominis-plane-block-in-laparoscopic-colorectal-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-apixaban-rivaroxaban-and-acetylsalicylic-acid-for-thromboembolic-prevention-in-jak2v617f-positive-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-asciminib-hydrochloride-versus-investigator-selected-tyrosine-kinase-inhibitors-in-newly-diagnosed-philadelphia-chromosome-positive-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-atg-thymoglobulin-versus-atlg-grafalon-for-gvhd-prophylaxis-in-elderly-aml-or-mds-patients-undergoing-allogeneic-hsct-with-reduced-intensity-conditioning2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-autologous-bone-marrow-derived-mononuclear-cells-and-percutaneous-transluminal-angioplasty-in-diabetic-patients-with-chronic-limb-threatening-ischemia2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-b-cell-depletion-by-rituximab-and-anti-cd19-car-t-therapy-in-acpa-positive-treatment-refractory-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-body-surface-area-based-versus-concentration-based-dosing-of-cisplatin-in-hyperthermic-intraperitoneal-chemotherapy-for-advanced-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-cagrilintide-drug-combination-with-placebo-for-weight-loss-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-coagulation-outcomes-using-fresh-frozen-plasma-versus-solvent-detergent-plasma-in-pediatric-congenital-heart-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-controlled-ovarian-stimulation-with-corifollitropin-alfa-versus-modified-natural-cycles-in-subfertility-patients-with-poor-ovarian-response2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-conventional-salvage-radiotherapy-and-individualized-psma-pet-ct-targeted-treatment-in-biochemical-recurrence-post-prostatectomy-using-18f-psma-1007-and-gozetotide2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-cook-s-balloon-and-dinoprostone-for-labor-induction-in-term-pregnancies-with-fetal-growth-restriction-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-custodiol-n-and-custodiol-solutions-for-organ-perfusion-in-pediatric-heart-transplantation-a-phase-ii-randomized-single-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-darovasertib-and-crizotinib-combination-versus-standard-treatment-in-hla-a2-negative-metastatic-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-drug-coated-balloon-and-drug-eluting-stents-in-high-bleeding-risk-patients-with-coronary-artery-disease-a-study-of-prasugrel-acetylsalicylic-acid-and-ticagrelor2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-early-versus-delayed-etoposide-initiation-in-severe-sporadic-hemophagocytic-lymphohistiocytosis-in-intensive-care-a-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-efficacy-and-safety-of-bp11-and-eu-approved-omalizumab-in-chronic-spontaneous-urticaria-resistant-to-h1-antihistamines2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-efficacy-of-subcutaneous-abatacept-versus-adalimumab-on-methotrexate-in-early-seropositive-rheumatoid-arthritis-with-hla-class-ii-risk-alleles2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-electrochemotherapy-with-bleomycin-and-standard-radiotherapy-in-the-management-of-basal-cell-carcinoma-less-than-3-cm2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-ertapenem-metronidazole-and-levofloxacin-versus-placebo-in-the-management-of-uncomplicated-acute-appendicitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-fdg-pet-ct-and-conventional-ct-for-response-monitoring-in-metastatic-breast-cancer-a-multicenter-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-general-anesthesia-and-high-flow-nasal-cannula-sedation-in-endovascular-treatment-of-acute-ischemic-stroke-using-lidocaine-fentanyl-propofol-and-rocuronium2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-genicular-nerve-blocks-versus-a-combination-of-adductor-canal-and-ipack-nerve-blocks-using-ropivacaine-and-epinephrine-for-pain-relief-in-patients-undergoing-total-knee-replacement-due-to-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-hemodynamic-effects-of-dobutamine-hydrochloride-and-levosimendan-in-heart-failure-patients-with-depressed-left-ventricular-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-hemodynamic-effects-of-isobaric-levobupivacaine-and-isobaric-bupivacaine-with-fentanyl-in-subarachnoid-anesthesia-for-hip-fracture-in-patients-aged-652026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-hemodynamic-parameters-in-healthy-volunteers-intravenous-versus-oral-fluid-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-hemorrhagic-risk-in-acute-venous-thromboembolism-treatment-with-rivaroxaban-versus-apixaban2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-immunogenicity-and-skin-resident-memory-t-cell-induction-by-intradermal-versus-intramuscular-rabies-virus-inactivated-strain-flury-lep-vaccination-in-rabies-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-initial-dual-oral-therapy-with-riociguat-and-macitentan-versus-standard-monotherapy-in-inoperable-chronic-thromboembolic-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-initial-dual-oral-therapy-with-tadalafil-and-ambrisentan-versus-tadalafil-monotherapy-in-pulmonary-arterial-hypertension-with-cardiovascular-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-intra-arterial-vs-intravenous-oxaliplatin-with-lv5fu2-irinotecan-in-first-line-treatment-of-liver-restricted-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-intra-articular-methylprednisolone-acetate-and-lidocaine-hydrochloride-injection-versus-arthrocentesis-in-temporomandibular-joint-arthritis-management2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-intranasal-nafarelin-and-subcutaneous-triptorelin-for-final-oocyte-maturation-triggering-in-progesterone-primed-ovarian-stimulation-in-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-intrathecal-morphine-and-transversus-abdominis-plane-block-with-ropivacaine-and-clonidine-for-postoperative-analgesia-in-elective-cesarean-section2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-intravenous-iohexol-enhanced-ct-versus-non-contrast-ct-in-acute-abdomen-patients-with-impaired-renal-function-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-iodixanol-and-ethyl-esters-of-iodised-fatty-acids-for-hysterosalpingography-in-women-with-unexplained-infertility-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-isoprenaline-hydrochloride-and-epinephrine-in-out-of-hospital-cardiac-arrest-with-non-shockable-rhythm2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-letrozole-and-gonadotropins-for-ovulation-induction-in-polycystic-ovary-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-low-dose-esketamine-hydrochloride-and-ketamine-hydrochloride-for-severe-acute-pain-in-emergency-departments-a-randomized-controlled-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-low-versus-intermediate-intravenous-dexamethasone-doses-on-rebound-pain-after-ambulatory-open-foot-surgery-under-popliteal-sciatic-nerve-block-a-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-mfolfirinox-versus-platinum-etoposide-in-first-line-chemotherapy-for-metastatic-grade-3-gastroenteropancreatic-neuroendocrine-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-micronized-progesterone-and-gnrh-antagonists-in-preventing-lh-surge-during-controlled-ovarian-stimulation-in-oocyte-donation2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-morphine-and-alfentanil-in-the-emergency-treatment-of-severe-acute-pain-in-the-pre-hospital-setting2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-neoadjuvant-radiochemotherapy-versus-chemotherapy-in-locally-advanced-resectable-gastroesophageal-junction-adenocarcinoma-using-fluorouracil-docetaxel-oxaliplatin-and-calcium-folinate2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-neurodevelopmental-outcomes-in-children-undergoing-anesthesia-with-low-dose-sevoflurane-dexmedetomidine-and-remifentanil-versus-standard-dose-sevoflurane2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-non-invasive-ventilation-and-high-flow-oxygen-therapy-in-reducing-extubation-failure-in-patients-undergoing-mechanical-ventilation-weaning2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-octaplaslg-and-plasma-lyte-148-in-fluid-management-for-pediatric-instrumented-spinal-fusion-in-neuromuscular-and-adolescent-idiopathic-scoliosis2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-opioid-free-versus-opioid-based-anesthesia-on-postoperative-nausea-and-vomiting-in-robotic-bariatric-surgery-using-magnesium-sulfate2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-oral-amoxicillin-versus-outpatient-parenteral-antibiotic-therapy-in-patients-with-infective-endocarditis-a-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-oxytocin-and-prostaglandins-for-labor-induction-in-women-with-unfavorable-cervix-post-cervical-ripening-a-multicenter-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-peng-block-and-lumbar-plexus-block-for-postoperative-analgesia-and-mobilization-in-total-hip-arthroplasty-using-levobupivacaine-and-sodium-chloride2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-perioperative-and-adjuvant-mfolfirinox-regimens-in-patients-with-resectable-non-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-piperacillin-tazobactam-and-meropenem-in-treating-cephalosporin-resistant-enterobacteriaceae-bacteremia-a-non-inferiority-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-progestin-primed-ovarian-stimulation-versus-gnrh-antagonists-in-female-infertility-undergoing-duostim-for-embryo-accumulation-and-pgt-a2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-ramucirumab-with-irinotecan-leucovorin-and-5-fu-versus-ramucirumab-with-paclitaxel-in-advanced-or-metastatic-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-random-start-ovarian-stimulation-versus-conventional-early-follicular-phase-stimulation-in-elective-oocyte-cryopreservation-using-dydrogesterone-follitropin-alfa-and-triptorelin-acetate2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-reduced-dual-antiplatelet-therapy-with-prasugrel-monotherapy-versus-standard-regimen-in-stemi-patients-undergoing-oct-guided-versus-angiography-guided-revascularization2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-reduced-intensity-conditioning-regimens-fludarabine-melphalan-cyclophosphamide-vs-fludarabine-melphalan-anti-thymocyte-globulin-in-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-remifentanil-hydrochloride-and-rocuronium-bromide-for-video-laryngoscopy-assisted-tracheal-intubation-in-adults-undergoing-general-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-rifabutin-and-rifampicin-in-the-management-of-staphylococcal-prosthetic-joint-infection-using-dair-strategy-a-multicenter-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-rocuronium-bromide-dosing-based-on-ideal-versus-actual-body-weight-for-intubation-in-morbidly-obese-patients-with-propofol-and-sodium-chloride2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-ropivacaine-hydrochloride-and-lidocaine-hydrochloride-on-quality-of-recovery-in-subpectoral-cardiac-device-implantation2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-salvage-radiotherapy-with-androgen-deprivation-therapy-versus-anti-androgen-therapy-with-apalutamide-in-biochemical-progression-post-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-secretin-stimulated-duodenopancreatic-juice-aspiration-versus-eus-guided-fna-for-molecular-analysis-in-intraductal-papillary-mucinous-neoplasia2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-sentinel-node-policy-versus-standard-staging-in-intermediate-and-high-risk-endometrial-carcinoma-using-patent-blue-technetium-99mtc-rheniumsulfide-and-indocyanine-green2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-sevoflurane-and-propofol-for-general-anesthesia-in-patients-with-acute-ischemic-stroke-undergoing-mechanical-thrombectomy2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-short-and-long-term-androgen-deprivation-therapy-with-salvage-radiotherapy-in-prostate-cancer-recurrence-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-short-term-versus-12-month-dual-antiplatelet-therapy-with-prasugrel-and-acetylsalicylic-acid-in-acute-coronary-syndrome-patients-with-everolimus-eluting-stents2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-single-versus-dual-antiplatelet-therapy-with-acetylsalicylic-acid-and-clopidogrel-in-atrial-fibrillation-patients-undergoing-percutaneous-left-atrial-appendage-closure2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-sirolimus-and-mycophenolate-mofetil-in-simultaneous-pancreas-kidney-transplantation-for-incisional-hernia-risk-in-type-1-diabetic-end-stage-renal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-spinal-anesthesia-with-bupivacaine-hydrochloride-and-sedation-with-midazolam-for-external-cephalic-version-success-in-breech-presentation2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-subcutaneous-and-intravenous-pembrolizumab-with-platinum-based-chemotherapy-in-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-suprascapular-nerve-block-with-triamcinolone-acetonide-versus-pulsed-radiofrequency-in-chronic-shoulder-pain-a-double-blind-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-tezepelumab-and-dupilumab-for-the-treatment-of-patients-with-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-the-effects-of-bi-690517-and-spironolactone-on-kidney-function-in-patients-with-heart-failure-or-cardiovascular-disease-and-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-transversus-abdominis-plane-and-quadratus-lumborum-blocks-for-postoperative-analgesia-in-laparoscopic-colorectal-resection-for-colorectal-cancer-or-diverticulosis-using-ropivacaine-hydro2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-transversus-abdominis-plane-block-and-laparoscopic-port-site-wound-infiltration-with-levobupivacaine-in-colorectal-cancer-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-treatment-efficacy-in-the-patients-with-systemic-sclerosis-dapagliflozin-vs-tocilizumab-a-randomized-head-to-head-study2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-two-doses-of-cagrilintide-semaglutide-with-semaglutide-for-weight-loss-in-adults-with-obesity-with-or-without-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-two-intravenous-racemic-ketamine-administration-regimens-versus-target-controlled-infusion-for-perioperative-analgesia-in-spinal-fusion-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-vedolizumab-filgotinib-ustekinumab-and-infliximab-as-first-line-treatments-for-patients-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-weekly-low-dose-versus-three-weekly-high-dose-cisplatin-in-chemoradiation-for-sarcopenic-patients-with-locally-advanced-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/comparison-of-ziconotide-and-a-drug-combination-versus-standard-medical-management-for-patients-with-severe-refractory-cancer-pain2026-10-07 https://dev.clinicalresearch.eu/trial/concentration-guided-tocilizumab-dose-reduction-versus-standard-dosing-in-rheumatoid-arthritis-a-randomized-international-multicenter-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/concomitant-radiotherapy-with-olaparib-and-temozolomide-in-unresectable-high-grade-gliomas-a-phase-i-iia-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/congenital-cmv-treated-with-valaciclovir-during-pregnancy-a-prospective-cohort-study2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-for-myelofibrosis-patients-on-ruxolitinib-monotherapy-or-ruxolitinib-with-background-cancer-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-avapritinib-in-adult-patients-with-systemic-mastocytosis-previously-enrolled-in-avapritinib-clinical-trials2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-durvalumab-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-and-post-chemotherapy-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-elotuzumab-lenalidomide-and-dexamethasone-in-patients-with-multiple-myeloma-from-previous-elotuzumab-protocols2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-encorafenib-binimetinib-and-ribociclib-in-patients-with-solid-tumors-safety-and-tolerability-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-latozinemab-in-patients-with-neurodegenerative-diseases-following-prior-participation-in-alector-sponsored-trials2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-lorlatinib-in-alk-positive-or-ros1-positive-non-small-cell-lung-cancer-patients-from-previous-pfizer-trials2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-ocrelizumab-and-drug-combination-for-neurological-disease-in-patients-lacking-post-trial-access2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-olaparib-in-patients-with-brca-mutated-ovarian-metastatic-breast-pancreatic-prostate-and-endometrial-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-ribociclib-and-nazartinib-in-patients-with-advanced-cancer-following-novartis-sponsored-trials2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-of-sabatolimab-in-patients-with-intermediate-to-very-high-risk-mds-cmml-2-or-aml-unfit-for-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-on-efanesoctocog-alfa-for-safety-and-efficacy-in-severe-haemophilia-a-patients-post-previous-trial-completion2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-on-the-safety-and-tolerability-of-avelumab-talazoparib-axitinib-and-lorlatinib-in-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-study-to-assess-the-safety-of-crizotinib-in-participants-benefiting-from-previous-pfizer-sponsored-crizotinib-trials2026-10-07 https://dev.clinicalresearch.eu/trial/continuation-vs-discontinuation-of-dapagliflozin-or-empagliflozin-in-patients-with-heart-failure-undergoing-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/continued-access-and-safety-evaluation-of-rvu120-based-treatment-in-patients-with-relapsed-refractory-solid-tumors-myelodysplastic-syndrome-or-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/continued-treatment-with-avutometinib-alone-or-with-defactinib-in-patients-with-recurrent-low-grade-serous-ovarian-cancer-lgsoc-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/continuing-somatostatin-analogues-upon-progression-in-neuroendocrine-tumour-patients-sauna-trial2026-10-07 https://dev.clinicalresearch.eu/trial/continuous-wound-infiltration-with-bupivacaine-hydrochloride-versus-sodium-chloride-in-postoperative-recovery-following-elective-minimally-invasive-colorectal-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/contrast-strategy-in-fenestrated-endovascular-aneurysm-repair-randomized-control-trial2026-10-07 https://dev.clinicalresearch.eu/trial/contribution-of-an-antiviral-drug-valaciclovir-in-the-treatment-of-generalized-periodontitis-stage-iii-or-iv-and-grade-a-b-or-c-prospective-randomized-and-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/controlled-study-of-immunogenicity-and-safety-of-the-investigational-vyf-candidate-vaccine-in-comparison-to-stamaril-r-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/copanlisib-and-rituximab-in-marginal-zone-lymphoma-patients-a-multicenter-open-label-single-arm-phase-ii-study-coup-12026-10-07 https://dev.clinicalresearch.eu/trial/copd-2vax-enhancing-protection-against-respiratory-infections-through-as01-mediated-innate-immune-activation-in-high-risk-patients2026-10-07 https://dev.clinicalresearch.eu/trial/copd-eosinophil-guided-reduction-of-inhaled-corticosteroids-copernicos2026-10-07 https://dev.clinicalresearch.eu/trial/crossover-study-on-coronary-risk-factor-control-and-platelet-aggregation-using-ramipril-acetylsalicylic-acid-and-atorvastatin-calcium-trihydrate-in-patients2026-10-07 https://dev.clinicalresearch.eu/trial/cumulative-irritation-assessment-of-topical-formulations-in-healthy-volunteers-a-patch-test-study2026-10-07 https://dev.clinicalresearch.eu/trial/cupcake-early-detection-of-triple-negative-breast-cancer-relapse-a-clinical-utility-trial2026-10-07 https://dev.clinicalresearch.eu/trial/cyp2c19-genotype-guided-p2y12-inhibitor-monotherapy-versus-standard-dual-antiplatelet-therapy-in-stable-coronary-artery-disease-undergoing-stenting2026-10-07 https://dev.clinicalresearch.eu/trial/dalbavancin-versus-standard-drug-combination-for-treating-infective-endocarditis-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/dan-war-d-danish-warfarin-dialysis-study-safety-and-efficacy-of-warfarin-in-patients-with-atrial-fibrillation-on-dialysis-a-nationwide-parallel-group-open-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/dannoac-the-danish-non-vitamin-k-antagonist-oral-anticoagulation-study2026-10-07 https://dev.clinicalresearch.eu/trial/dapagliflozin-for-cardioprotection-in-newly-diagnosed-multiple-myeloma-patients-undergoing-autologous-stem-cell-transplant-randomized-double-blind-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/dapagliflozin-reduces-cardiovascular-events-in-patients-on-chronic-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/dapiglutide-for-the-treatment-of-obesity-dream-a-randomised-double-blind-placebo-controlled-investigator-initiated-trial2026-10-07 https://dev.clinicalresearch.eu/trial/db-1311-in-combination-with-bnt327-or-db-1305-for-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/defining-antibiotic-levels-in-intensive-care-patients-dali-2-protocol-a-multi-national-pharmacokinetic-pharmacodynamic-cohort-study-to-determine-whether-contemporary-antibiotic-dosing-for-critically-i2026-10-07 https://dev.clinicalresearch.eu/trial/delpacibart-zotadirsen-for-duchenne-muscular-dystrophy-in-patients-with-gene-mutations-amenable-to-exon-44-skipping2026-10-07 https://dev.clinicalresearch.eu/trial/demeter-milademetan-and-fulvestrant-in-gata3-mutant-er-positive-her2-negative-advanced-or-metastatic-breast-cancer-patients-a-multicenter-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/denosumab-versus-zoledronic-acid-in-patients-with-erosive-hand-osteoarthritis-and-osteoporosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/depeca-1-defeating-penile-cancer-1-a-phase-ii-study-to-evaluate-a-first-line-systemic-therapy-with-enfortumab-vedotin-plus-avelumab-for-advanced-and-metastatic-penile-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/dermal-bioequivalence-study-of-two-topical-doxepin-hydrochloride-creams-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/dermatophagoides-farinae-dermatophagoides-pteronyssinus-and-lepidoglyphus-destructor-immunotherapy-for-allergic-rhinitis-rhinoconjunctivitis-and-mild-asthma-in-patients-aged-12-to-65-years2026-10-07 https://dev.clinicalresearch.eu/trial/dermatophagoides-pteronyssinus-and-dermatophagoides-farinae-allergy-in-patients-skin-prick-test-with-allergen-extracts2026-10-07 https://dev.clinicalresearch.eu/trial/detection-of-metastatic-lesions-with-68ga-fapi-46-pet-ct-in-patients-with-lobular-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/determination-of-minimum-effective-dose-of-dobutamine-for-treating-low-superior-vena-cava-flow-in-neonates-with-hemodynamic-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/determining-the-optimal-strategy-for-stopping-chronic-proton-pump-inhibitor-therapy-in-primary-care-patients-impact-of-on-demand-use-adjustment-of-therapy-or-discontinuation2026-10-07 https://dev.clinicalresearch.eu/trial/dexamethasone-premedication-to-prevent-interstitial-lung-disease-in-breast-cancer-patients-receiving-trastuzumab-deruxtecan2026-10-07 https://dev.clinicalresearch.eu/trial/diagnostic-accuracy-of-18f-fapi-74-pet-ct-in-patients-with-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/diagnostic-accuracy-of-68ga-fapi-46-pet-ct-versus-18f-fludeoxyglucose-pet-ct-in-primary-staging-and-restaging-of-ovarian-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/diagnostic-accuracy-of-68ga-fapi-46-pet-ct-versus-18f-fludeoxyglucose-pet-ct-in-staging-and-restaging-of-gastric-and-gastroesophageal-junction-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/diagnostic-accuracy-of-spt-rx-dpt-drug-combination-skin-prick-test-in-adults-with-allergic-rhinitis-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/diagnostic-evaluation-of-68ga-nota-abscint-her2-pet-ct-in-metastatic-breast-cancer-a-comparative-study-with-standard-her2-status-testing2026-10-07 https://dev.clinicalresearch.eu/trial/digoxin-for-the-reinduction-or-radioiodine-uptake-in-metastatic-or-locally-advanced-non-medullary-thyroid-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/discontinuation-of-beta-blockers-in-heart-failure-patients-with-recovered-left-ventricular-ejection-fraction-a-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/discontinuation-of-esomeprazole-magnesium-trihydrate-in-patients-with-liver-cirrhosis-a-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/discontinuation-of-methotrexate-in-rheumatoid-arthritis-patients-receiving-tnf-inhibitor-therapy-a-randomized-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/discontinuation-vs-continuation-of-riociguat-in-chronic-thromboembolic-pulmonary-hypertension-patients-after-successful-balloon-pulmonary-angioplasty2026-10-07 https://dev.clinicalresearch.eu/trial/dnajb1-prkaca-fusion-peptide-vaccine-with-immune-checkpoint-inhibition-in-fibrolamellar-hcc-and-fusion-positive-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/docetaxel-and-apalutamide-for-metastatic-hormone-sensitive-prostate-cancer-in-patients-without-a-deep-psa-response-after-initial-apalutamide-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/does-adding-patient-controlled-sedation-with-propofol-during-repair-of-obstetric-perineal-lacerations-grade-i-and-ii-improve-patient-experiences-a-randomized-control-trial2026-10-07 https://dev.clinicalresearch.eu/trial/dosabema-pharmacokinetic-model-of-abemaciclib-correlation-with-severe-diarrhea-as-the-primary-toxicity-endpoint-in-patients-with-hormone-receptor-positive-localized-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/dosage-regimen-individualization-of-acyclovir-in-obese-patients-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/dose-adjustment-of-enoxaparin-sodium-via-bayesian-pharmacological-approach-in-pediatric-renal-transplant-recipients-with-allograft-vascular-thrombosis2026-10-07 https://dev.clinicalresearch.eu/trial/dose-and-safety-evaluation-of-asciminib-in-pediatric-patients-with-philadelphia-chromosome-positive-chronic-myeloid-leukemia-in-chronic-phase2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-cohort-expansion-study-of-kb-0742-in-relapsed-or-refractory-solid-tumors-and-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-comparative-study-of-eteplirsen-in-duchenne-muscular-dystrophy-patients-with-exon-51-skipping-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-dose-finding-study-of-s-4-5-dihydro-2-2-hydroxy-4-3-6-dioxaheptyloxy-phenyl-4-methyl-4-thiazolecarboxylic-acid-in-transfusion-dependent-a-or-b-thalassemia2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-expansion-study-evaluating-safety-and-tolerability-of-cap-100-in-patients-with-relapsed-refractory-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-expansion-study-of-bgb-16673-a-bruton-tyrosine-kinase-targeted-protein-degrader-in-patients-with-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-expansion-study-of-sodium-trans-tetrachlorobis-1h-indazole-ruthenate-iii-dihydrate-with-folfox-in-advanced-solid-gastrointestinal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-expansion-study-of-tl-895-and-navtemadlin-in-relapsed-refractory-b-cell-malignancies-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-and-expansion-study-of-xb002-monotherapy-and-combination-therapy-in-patients-with-inoperable-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-of-cladribine-in-conditioning-regimen-for-allogeneic-hematopoietic-stem-cell-transplantation-in-refractory-acute-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-177lu-lu-dota-tate-with-standard-care-in-newly-diagnosed-glioblastoma-and-as-monotherapy-in-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-allogeneic-adipose-derived-stromal-stem-cells-in-patients-with-crohn-s-fistula2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-apomorphine-hydrochloride-hemihydrate-and-psilocybin-in-comatose-patients-with-acute-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bi-1831169-monotherapy-and-in-combination-with-anti-pd-1-antibody-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bi-3810944-in-patients-with-advanced-melanoma-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bi-764532-in-patients-with-dll3-positive-small-cell-lung-carcinoma-and-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bi-765049-in-patients-with-advanced-colorectal-gastric-or-pancreatic-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bi-907828-with-bi-754091-and-bi-754111-or-bi-907828-with-bi-754091-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-bnt152-and-bnt153-in-patients-with-metastatic-or-unresectable-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-cc-91633-in-relapsed-refractory-acute-myeloid-leukemia-and-higher-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-cevostamab-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-emp16-acarbose-orlistat-and-ispaghula-husk-in-obesity-comparison-with-orlistat-and-placebo-fiber-supplementation2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-intracranial-temozolomide-based-si-053-in-combination-with-standard-care-in-newly-diagnosed-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-jnj-79635322-in-relapsed-refractory-multiple-myeloma-and-previously-treated-al-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-nnc0519-0130-in-patients-with-type-2-diabetes-mellitus-and-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-obrixtamig-bi-764532-and-ezabenlimab-in-dll3-expressing-neuroendocrine-neoplasms-and-small-cell-lung-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-omtx705-with-regorafenib-and-tislelizumab-in-advanced-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-sacituzumab-govitecan-in-patients-with-advanced-or-metastatic-solid-tumors-and-moderate-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-xmab24306-alone-and-with-atezolizumab-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-of-zongertinib-in-patients-with-advanced-non-small-cell-lung-cancer-and-solid-tumors-with-her2-aberrations2026-10-07 https://dev.clinicalresearch.eu/trial/dose-escalation-study-on-the-safety-and-efficacy-of-anti-hepatitis-b-antibodies-in-patients-with-chronic-hepatitis-b-infection2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-and-efficacy-evaluation-of-bi-1821736-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-and-efficacy-of-immuno-adjuvant-ip-001-post-microwave-ablation-or-irreversible-electroporation-in-colorectal-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-and-efficacy-study-of-bi-765883-alone-or-in-combination-with-chemotherapy-in-patients-with-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-exploratory-study-of-azithromycin-on-cellular-senescence-and-inflammatory-status-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-atropine-sulfate-eye-drops-for-inhibition-of-myopia-progression-in-european-pediatric-population2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-bi-907828-brigimadlin-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-intravenous-propofol-and-thiopental-sodium-for-anesthesia-induction-in-neonates-under-47-weeks-postmenstrual-age2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-propranolol-hydrochloride-to-reduce-reactive-aggression-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-recombinant-fsh-following-corifollitropin-alfa-in-subfertility-patients-undergoing-ivf-icsi-with-gnrh-antagonist-protocol2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-of-sarilumab-in-pediatric-patients-with-systemic-juvenile-idiopathic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/dose-finding-study-to-evaluate-intestinal-lactase-activity-via-oral-gaxilose-administration-in-healthy-adult-volunteers-with-hypolactasia2026-10-07 https://dev.clinicalresearch.eu/trial/dose-optimization-and-safety-evaluation-of-abbv-383-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-optimization-of-ibrutinib-drug-combination-in-adult-patients-with-blood-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/dose-optimization-of-nivolumab-in-patients-with-melanoma-or-renal-cell-carcinoma-exhibiting-complete-partial-or-stable-response2026-10-07 https://dev.clinicalresearch.eu/trial/dose-optimization-study-of-bmf-219-in-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-acute-myeloid-leukemia-and-lymphatic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/dose-optimization-study-of-onfekafusp-alfa-and-lomustine-in-patients-with-recurrent-or-progressive-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/dose-ranging-efficacy-evaluation-of-topical-sirolimus-in-patients-with-port-wine-stains-a-phase-ii-double-blind-placebo-controlled-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/dose-ranging-study-of-azd5462-in-stable-chronic-heart-failure-a-phase-iib-randomized-double-blind-placebo-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/dose-response-effects-of-tirzepatide-on-gastric-emptying-in-adults-with-type-1-diabetes-a-multicentre-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/dose-response-evaluation-of-daridorexant-in-pediatric-insomnia-a-randomized-double-blind-placebo-controlled-polysomnography-study2026-10-07 https://dev.clinicalresearch.eu/trial/dose-response-evaluation-of-dronabinol-ver-01-in-chronic-non-specific-low-back-pain-unresponsive-to-non-opioid-analgesics2026-10-07 https://dev.clinicalresearch.eu/trial/dose-response-study-of-nnc0487-0111-in-type-2-diabetes-patients-inadequately-controlled-with-metformin-and-or-sglt2-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/dose-study-of-tranexamic-acid-in-total-hip-replacement-to-reduce-postoperative-hemoglobin-loss-a-phase-2-randomized-double-blind-monocentric-study-the-prado-study2026-10-07 https://dev.clinicalresearch.eu/trial/dosimetry-based-administration-of-sodium-iodide-131i-in-metastatic-differentiated-thyroid-cancer-efficacy-and-toxicity-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/dosimetry-biodistribution-safety-and-tolerability-of-lutetium-177lu-vipivotide-tetraxetan-in-psma-positive-mcrpc-with-varying-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/dosimetry-study-of-the-novel-amino-acid-pet-tracer-18f-felp-in-patients-with-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/dosimetry-study-of-upar-targeted-radioligand-therapy-in-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/double-blind-placebo-controlled-phase-3-study-to-evaluate-the-efficacy-and-safety-of-plozasiran-in-adults-with-severe-hypertriglyceridemia-at-high-risk-of-acute-pancreatitis-shasta-5-study2026-10-07 https://dev.clinicalresearch.eu/trial/double-blind-randomised-clinical-study-comparing-efficacy-and-safety-of-mecloderm-r-ointment-test-vs-lotricomb-r-ointment-reference-vs-vehicle-in-patients-with-moderate-to-severely-inflamed-candidiasi2026-10-07 https://dev.clinicalresearch.eu/trial/double-blind-randomized-active-controlled-two-way-cross-over-study-with-12-week-treatment-duration-per-period-to-evaluate-the-efficacy-and-safety-of-qmf149-indacaterol-acetate-mometasone-furoate-compa2026-10-07 https://dev.clinicalresearch.eu/trial/double-blind-randomized-placebo-controlled-study-of-topical-asacaine-for-uvb-induced-topical-pain-in-healthy-volunteers-safety-tolerability-pk-pd2026-10-07 https://dev.clinicalresearch.eu/trial/doxycycline-for-asymptomatic-anal-lymphogranuloma-venereum-in-patients-with-lgv-infection2026-10-07 https://dev.clinicalresearch.eu/trial/doxycycline-prophylaxis-for-sexually-transmitted-infections-in-men-who-have-sex-with-men-and-transgender-women-drug-combination-comparator2026-10-07 https://dev.clinicalresearch.eu/trial/drepamir-a-phase-1-2-open-label-cohort-comparative-study-evaluating-the-efficacy-and-the-safety-of-gene-therapy-of-the-sickle-cell-disease-by-transplantation-of-an-autologous-cd34-enriched-cell-fracti2026-10-07 https://dev.clinicalresearch.eu/trial/drug-drug-interaction-study-of-rosuvastatin-amlodipine-and-ramipril-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/dual-wavelength-fluorescence-imaging-using-fluorescently-labelled-adalimumab-and-risankizumab-for-visualizing-drug-targeting-in-inflammatory-bowel-diseases-voyager2026-10-07 https://dev.clinicalresearch.eu/trial/dupilumab-step-down-strategy-to-maintain-remission-in-adult-and-adolescents-patients-with-atopic-dermatitis-a-non-inferiority-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/durable-hiv-1-remission-with-10-1074-ls-3bnc117-ls-and-low-dose-nivolumab-in-adults-on-antiretroviral-therapy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/duration-of-surfactant-administration-and-impact-on-stabilisation-of-vital-parameters-in-very-preterm-neonates-1-minute-versus-5-minutes-a-prospective-randomised-controlled-phase-iv-trial2026-10-07 https://dev.clinicalresearch.eu/trial/durvalumab-based-immunotherapy-with-chemoradiation-for-organ-preservation-in-early-stage-ct1-ct2n0-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/durvalumab-consolidation-immunotherapy-after-chemoradiotherapy-in-patients-with-stage-iii-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/durvalumab-versus-chemotherapy-drug-combination-in-elderly-patients-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/durvalumab-with-cisplatin-based-chemotherapy-in-adults-with-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/durvalumab-with-higher-versus-standard-thoracic-radiotherapy-after-chemotherapy-in-patients-with-limited-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/dutch-weight-control-in-atrial-fibrillation-study2026-10-07 https://dev.clinicalresearch.eu/trial/dynamic-82-rubidium-pet-imaging-for-grading-renal-cell-carcinoma-using-rubidium-chloride-in-patients-with-kidney-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/dynamic-pet-ct-imaging-to-predict-6-month-morphologic-response-in-hepatocellular-carcinoma-patients-undergoing-selective-internal-radiotherapy-y-90-radioembolization2026-10-07 https://dev.clinicalresearch.eu/trial/early-detection-of-relapse-in-high-risk-triple-negative-breast-cancer-patients-using-68ga-fapi-46-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/early-dexamethasone-versus-sodium-chloride-in-patients-with-severe-influenza-induced-acute-hypoxemic-respiratory-failure2026-10-07 https://dev.clinicalresearch.eu/trial/early-lyophilised-plasma-in-patients-with-haemorrhagic-shock-elips-trial2026-10-07 https://dev.clinicalresearch.eu/trial/early-saline-pleural-irrigation-for-patients-with-complicated-pleural-infections2026-10-07 https://dev.clinicalresearch.eu/trial/early-sedation-with-dexmedetomidine-vs-placebo-in-older-ventilated-critically-ill-patients2026-10-07 https://dev.clinicalresearch.eu/trial/early-switch-to-oral-amoxicillin-drug-combination-versus-standard-timing-in-patients-with-vertebral-osteomyelitis2026-10-07 https://dev.clinicalresearch.eu/trial/early-treatment-intensification-in-patients-with-high-risk-mantle-cell-lymphoma-using-car-t-cell-treatment-after-an-abbreviated-induction-therapy-with-rituximab-and-ibrutinib-and-6-months-ibrutinib-ma2026-10-07 https://dev.clinicalresearch.eu/trial/edoxaban-versus-drug-combination-for-incidental-subsegmental-pulmonary-embolism-in-cancer-patients-comparing-anticoagulant-treatment-with-no-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-a-coordinated-care-pathway-on-safety-of-abemaciclib-based-oral-anticancer-drug-combination-in-elderly-cancer-patients-70-years2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-a-high-fat-meal-on-the-pharmacokinetics-of-elinzanetant-in-healthy-women2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-acetylsalicylic-acid-on-recurrence-and-survival-in-patients-with-resected-stage-ii-iii-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-antimicrobial-therapy-on-tacrolimus-and-mycophenolate-mofetil-pharmacokinetics-and-gut-microbiome-in-kidney-transplant-recipients-axis2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-baclofen-gabapentin-and-oxazepam-on-brain-plasticity-and-motor-learning-in-subacute-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-bi-764198-on-metformin-pharmacokinetics-in-healthy-volunteers-a-single-dose-drug-interaction-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-bosentan-on-the-pharmacokinetics-of-zongertinib-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-cagrilintide-and-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2-diabetes-and-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-cagrilintide-on-food-intake-and-appetite-in-adults-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-cagrisema-combination-therapy-on-muscle-health-in-patients-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-calcifediol-monohydrate-on-myocardial-fibrosis-in-patients-with-acute-myocarditis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-cannabidiol-added-to-antipsychotic-treatment-on-symptoms-in-adults-with-first-episode-psychosis-a-double-blind-randomised-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-capivasertib-on-the-pharmacokinetics-of-oral-dextromethorphan-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-carbamazepine-on-plasma-pharmacokinetics-of-verducatib-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-carboxylesterase-2-and-cyp3a4-inhibition-on-the-pharmacokinetics-of-buloxibutid-in-healthy-volunteers-a-randomized-open-label-drug-drug-interaction-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-cefazolin-versus-placebo-on-surgical-site-infection-in-patients-undergoing-lumpectomy-for-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-celecoxib-with-pantoprazole-on-pain-quality-of-life-and-inflammation-in-adults-with-chronic-pancreatitis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-continuing-vs-discontinuing-acetylsalicylic-acid-in-elderly-patients-with-chronic-coronary-syndrome-a-randomised-registry-based-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-curcumin-on-the-pharmacokinetics-of-imu-838-and-rosuvastatin-in-subjects-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-dak539-on-the-pharmacokinetics-of-repaglinide-midazolam-drospirenone-and-ethinyl-estradiol-in-patients-with-advanced-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-dexmedetomidine-on-emergence-delirium-in-children-undergoing-adenotonsillectomy-a-double-blind-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-dry-extract-from-psilocybe-cubensis-on-treatment-resistant-anorexia-nervosa-in-adults-a-randomized-active-placebo-triple-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-elecoglipron-plus-dapagliflozin-on-cardiovascular-outcomes-in-adults-with-hfpef-or-hfmref-a-randomized-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-enzalutamide-apalutamide-and-bicalutamide-on-the-pharmacokinetics-of-fezolinetant-in-men-with-prostate-cancer-and-associated-hot-flashes2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-estradiol-progesterone-and-norethisterone-acetate-menopausal-hormone-therapy-on-qtc-in-peri-and-postmenopausal-women-with-long-qt-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-evening-metyrapone-hydrocortisone-and-placebo-on-cardio-metabolic-health-and-circadian-rhythm-in-patients-with-mild-autonomous-cortisol-secretion2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-everolimus-and-mycophenolate-mofetil-dose-adjustment-on-cytomegalovirus-infection-in-solid-organ-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-extra-fine-inhaled-corticosteroids-on-small-airway-disease-in-patients-with-chronic-obstructive-pulmonary-disease-a-randomized-prospective-cross-over-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-ferric-carboxymaltose-versus-ferrous-sulfate-on-physical-performance-and-quality-of-life-in-frail-older-adults-with-iron-deficiency-and-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-follitropin-delta-on-embryo-quality-in-older-women-with-infertility-a-randomized-trial-of-follitropin-delta-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-heparin-dose-on-silent-brain-lesions-in-patients-with-intracranial-aneurysms-undergoing-embolization-drug-combination-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-hepatic-impairment-on-the-pharmacokinetics-of-dak539-in-patients-with-advanced-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-high-dose-subcutaneous-semaglutide-on-gastric-emptying-in-adults-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-intravenous-immunoglobulins-on-painful-sensory-neuropathy-evaluated-by-aggregated-n-of-one-trials2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-intravenous-lidocaine-on-chronic-post-surgical-pain-in-patients-undergoing-emergency-abdominal-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-intravenous-metamizole-sodium-on-postoperative-pain-in-patients-undergoing-elective-laparoscopic-cholecystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-intravenous-sodium-thiosulfate-on-vascular-calcification-in-hemodialysis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-itraconazole-co-administration-on-the-pharmacokinetics-of-bi-764198-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-laroprovstat-rosuvastatin-fixed-dose-combination-versus-rosuvastatin-on-ldl-cholesterol-in-patients-with-high-cholesterol2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-lifestyle-changes-mushroom-supplementation-and-bupropion-hydrochloride-on-weight-loss-in-overweight-adults-a-52-week-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-liraglutide-on-pneumococcal-polysaccharide-vaccine-response-in-adults-with-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-losartan-on-the-pharmacokinetics-of-cephalexin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-metformin-hydrochloride-on-inflammation-and-aging-biomarkers-in-pre-diabetic-patients2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-methohexital-propofol-and-etomidate-on-electroconvulsive-therapy-outcomes-in-patients-with-severe-depression2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-methylphenidate-compared-with-placebo-on-attachment-learning-in-children-with-adhd2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-msp-2020-on-brain-activity-in-adults-with-incomplete-response-to-treatment-for-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-nbi-921355-on-corticospinal-excitability-in-healthy-participants-a-phase-i-study-relevant-to-epilepsy-pathophysiology2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-neoadjuvant-degarelix-on-mri-guided-transurethral-ultrasound-ablation-in-patients-with-intermediate-risk-prostate-cancer-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-nnc0487-0111-on-food-intake-appetite-and-postprandial-metabolism-in-adults-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-nnc0487-0111-on-insulin-regulation-in-adults-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-nnc0487-0111-on-resting-energy-expenditure-following-weight-loss-in-adults-with-obesity-randomized-placebo-controlled-trial-with-low-calorie-diet-comparator2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-oral-sodium-hydrogen-carbonate-versus-placebo-on-assisted-delivery-in-nulliparous-women-with-prolonged-labour2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-orlistat-on-liver-fat-content-in-obese-subjects-with-nafld-and-high-concentration-of-plasma-proneurotensin-through-inhibition-of-neurotensin-secretion-and-action2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-perioperative-intravenous-infusion-of-lidocaine-on-the-postoperative-course-and-the-immune-response-in-patients-undergoing-surgery-for-colon-cancer-the-pildi-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-perioperative-ketoprofen-calcium-and-sodium-chloride-on-chronic-pain-after-video-assisted-thoracic-surgery-vats-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-pregabalin-and-combination-therapy-on-driving-under-the-influence-in-healthy-adults-a-randomised-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-pressurized-intrathoracic-aerosol-chemotherapy-with-cisplatin-and-doxorubicin-in-patients-with-malignant-pleural-effusion2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-probenecid-on-the-pharmacokinetics-of-mirdametinib-in-healthy-adults-planned-neurofibromatosis-type-i-population2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-propranolol-on-traumatic-memory-reactivation-for-women-victims-of-violence-with-post-traumatic-stress-disorder-ptsd2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-psilocybin-on-the-positive-valence-system-in-treatment-resistant-depression-a-pilot-clinical-neuroimaging-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-ramipril-acetylsalicylic-acid-and-atorvastatin-combined-with-nurse-education-on-treatment-adherence-in-patients-with-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-recombinant-varicella-zoster-virus-glycoprotein-e-vaccine-timing-in-ms-and-nmosd-patients-on-rituximab-or-ocrelizumab2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-resistance-training-on-thigh-muscle-volume-in-adults-with-obesity-treated-with-tirzepatide-a-randomized-controlled-phase-iv-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-sedative-and-anxiolytic-sedation-on-children-experience-after-general-anesthesia-pedia-prem-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-semaglutide-2-4-mg-weekly-versus-placebo-on-sperm-concentration-in-overweight-infertile-men2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-semaglutide-and-dapagliflozin-on-heart-insulin-resistance-in-patients-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-semaglutide-vs-placebo-on-body-weight-in-adults-with-type-1-diabetes-and-obesity-bmi-30-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-sodium-hydrogen-carbonate-on-critically-ill-patients-with-metabolic-acidosis-and-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-stopping-ethinylestradiol-levonorgestrel-on-antidepressant-response-and-memory-in-adults-with-major-depressive-disorder-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-stopping-long-term-azithromycin-on-stable-non-cystic-fibrosis-bronchiectasis-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-tranexamic-acid-vs-sodium-chloride-on-post-surgical-infection-in-adults-undergoing-hind-and-midfoot-arthrodesis-for-foot-deformity-and-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-transporter-inhibition-on-the-pharmacokinetics-of-bi-3000202-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-various-injection-devices-on-the-pharmacokinetics-of-somatropin-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-verapamil-hydrochloride-on-beta-cell-function-in-children-and-adults-aged-7-45-with-stage-1-or-stage-2-type-1-diabetes-48-week-study2026-10-07 https://dev.clinicalresearch.eu/trial/effect-of-xenon-on-brain-injury-neurological-outcome-and-survival-in-patients-after-aneurysmal-subarachnoid-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/effectiveness-and-safety-of-intestifix-for-vancomycin-resistant-enterococci-vre-intestinal-colonization-in-immunocompromised-patients2026-10-07 https://dev.clinicalresearch.eu/trial/effectiveness-of-mcombriax-influenza-covid-19-vaccine-versus-high-dose-influenza-vaccine-and-mrna-1273-covid-19-vaccine-in-adults-65-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/effectiveness-of-rsv-glycoprotein-f-recombinant-vaccine-adjuvanted-with-as01e-in-preventing-rsv-related-respiratory-disease-hospitalizations-in-adults-60-years2026-10-07 https://dev.clinicalresearch.eu/trial/effectiveness-of-trazodone-hydrochloride-on-emotional-blunting-in-adults-with-major-depressive-disorder-not-fully-responding-to-ssris-snris2026-10-07 https://dev.clinicalresearch.eu/trial/effects-of-butyrate-enemas-on-postoperative-intestinal-motility-disorders-in-hirschsprung-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/effects-of-cladribine-tablets-on-the-immune-system-in-relapsing-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/effects-of-nnc0194-0499-alone-and-in-combination-with-semaglutide-of-semaglutide-alone-and-of-cagrilintide-alone-and-in-combination-with-semaglutide-on-liver-damage-and-alcohol-use-in-people-with-alco2026-10-07 https://dev.clinicalresearch.eu/trial/effects-of-plasma-exchange-with-human-serum-albumin-5-pe-a-5-on-short-term-survival-in-subjects-with-acute-on-chronic-liver-failure-aclf-at-high-risk-of-hospital-mortality2026-10-07 https://dev.clinicalresearch.eu/trial/effects-of-ziltivekimab-versus-placebo-on-coronary-atherosclerosis-in-patients-with-acute-myocardial-infarction-a-serial-multivessel-intravascular-ultrasound-near-infrared-spectroscopy-and-optical-coh2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-cost-effectiveness-of-collagenase-clostridium-histolyticum-percutaneous-needle-fasciotomy-and-limited-fasciectomy-in-dupuytren-s-contracture2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-durability-of-ampreloxetine-in-treating-symptomatic-neurogenic-orthostatic-hypotension-in-multiple-system-atrophy-a-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-androgen-deprivation-therapy-with-apalutamide-and-stereotactic-radiotherapy-in-high-risk-localized-or-locally-advanced-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-budesonide-glycopyrronium-and-formoterol-fumarate-mdi-in-adults-and-adolescents-with-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-budesonide-glycopyrronium-and-formoterol-fumarate-mdi-in-severe-asthma-uncontrolled-by-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-bw-20805-in-adult-patients-with-hereditary-angioedema-a-phase-2-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-capivasertib-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-a-phase-ii-open-label-multicentre-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-finerenone-and-empagliflozin-combination-versus-monotherapy-in-chronic-kidney-disease-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-folfirinox3-and-bevacizumab-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-stiripentol-in-patients-aged-6-and-older-with-primary-hyperoxaluria-types-1-2-or-32026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-t1695-ophthalmic-suspension-versus-ciclosporin-ophthalmic-emulsion-in-participants-with-moderate-to-severe-vernal-keratoconjunctivitis-vkc2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-assessment-of-vx-993-in-patients-with-painful-diabetic-peripheral-neuropathy-a-phase-2-randomized-double-blind-active-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-buckberg-and-del-nido-cardioplegia-in-isolated-myocardial-revascularization-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-etanercept-and-methotrexate-in-inducing-steroid-free-remission-in-giant-cell-arteritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-extended-vs-intermittent-infusion-of-beta-lactams-in-critically-ill-pediatric-patients-with-suspected-or-proven-infection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-herbal-medicinal-products-in-acute-bronchitis-liquid-extract-from-thyme-herb-primrose-root-tincture-and-ivy-leaf-extract2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-mexiletine-pr-vs-mexiletine-ir-in-adult-patients-with-non-dystrophic-myotonias-a-randomized-open-label-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-obinutuzumab-venetoclax-vs-obinutuzumab-chlorambucil-in-untreated-cll-with-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-once-weekly-insulin-icodec-versus-once-daily-insulin-glargine-u100-with-insulin-aspart-in-adults-with-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-srsd107-and-enoxaparin-in-preventing-venous-thromboembolism-in-elective-unilateral-total-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-ustekinumab-infliximab-and-dual-biological-therapy-in-moderate-to-severe-ulcerative-colitis-the-combo-uc-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-comparison-of-venetoclax-and-obinutuzumab-versus-fcr-br-in-fit-patients-with-untreated-chronic-lymphocytic-leukemia-without-del-17p-or-tp53-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-0-1-mometasone-furoate-cutaneous-emulsion-versus-ecural-fat-cream-and-vehicle-in-adult-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-177lu-lu-dota-tate-and-octreotide-lar-in-grade-1-and-2-advanced-gastroenteropancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-4-hydroxy-n-desmethyltamoxifen-in-adult-patients-with-bipolar-i-disorder-experiencing-acute-mania-or-manic-episodes2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-9-4-cyclohexyloxyphenyl-7-methyl-3-4-dihydropyrazino-2-1-c-1-2-4-thiadiazine-2-2-dioxide-as-adjunctive-therapy-in-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-abbv-400-in-patients-with-locally-advanced-or-metastatic-solid-tumors-a-phase-1-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-abrocitinib-in-moderate-to-severe-chronic-hand-eczema-refractory-to-corticosteroid-therapy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-acp-204-tartrate-in-adults-with-alzheimer-s-disease-psychosis-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-aficamten-in-pediatric-patients-with-symptomatic-obstructive-hypertrophic-cardiomyopathy-a-phase-2-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-alectinib-and-entrectinib-versus-durvalumab-in-biomarker-selected-stage-iii-nsclc-post-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-allogeneic-skin-derived-abcb5-positive-dermal-mesenchymal-stromal-cells-in-therapy-resistant-chronic-venous-ulcers2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-alxn1850-in-pediatric-patients-with-hypophosphatasia-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-alxn2030-in-antibody-mediated-rejection-post-kidney-transplantation-a-phase-2-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-alxn2220-in-adult-patients-with-transthyretin-amyloid-cardiomyopathy-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-alxn2420-with-somatostatin-analogs-in-adult-acromegaly-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-amikacin-liposome-inhalation-suspension-with-azithromycin-and-ethambutol-in-adult-patients-with-mac-induced-ntm-lung-infection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-amlitelimab-monotherapy-in-adults-with-severe-alopecia-areata-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-amy109-and-desogestrel-in-women-with-endometriosis-a-phase-ii-randomized-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-anifrolumab-in-refractory-chronic-and-subacute-cutaneous-lupus-erythematosus-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-anti-insulin-receptor-human-monoclonal-antibody-rz358-in-congenital-hyperinsulinism-associated-hypoglycemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-apremilast-in-pediatric-patients-aged-6-years-with-generalized-epidermolysis-bullosa-simplex-a-20-week-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-apremilast-in-pediatric-patients-with-active-oral-ulcers-associated-with-behcet-s-disease-a-phase-3-multicenter-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-aripiprazole-vs-paliperidone-risperidone-in-first-episode-psychosis-using-multi-omics-data2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-astegolimab-in-chronic-obstructive-pulmonary-disease-a-randomized-double-blind-placebo-controlled-multicenter-phase-iib-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-atacicept-in-adult-patients-with-iga-nephropathy-a-phase-2b-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-atogepant-in-acute-migraine-treatment-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-atropine-sulfate-and-dims-technology-lenses-in-myopia-control-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-atuliflapon-in-adults-with-moderate-to-severe-uncontrolled-asthma-a-phase-2a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-autogene-cevumeran-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-treatment-naive-advanced-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-recurrent-metastatic-or-persistent-cervical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-avalglucosidase-alfa-in-treatment-naive-pediatric-patients-with-infantile-onset-pompe-disease-iopd2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azd0486-monotherapy-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azd4604-in-adults-with-moderate-to-severe-asthma-uncontrolled-on-medium-high-dose-ics-laba2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azd7798-in-moderate-to-severe-crohn-s-disease-a-double-blind-placebo-controlled-phase-iia-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azd9550-and-azd6234-co-administration-in-obesity-or-overweight-patients-with-comorbidities-a-phase-iib-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azenosertib-zn-c3-in-high-grade-serous-ovarian-fallopian-tube-or-primary-peritoneal-cancer-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-azenosertib-zn-c3-in-recurrent-or-persistent-uterine-serous-carcinoma-a-phase-2-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-baricitinib-for-remission-induction-and-glucocorticoid-sparing-in-new-onset-polymyalgia-rheumatica2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-barzolvolimab-in-adults-with-active-eosinophilic-esophagitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-barzolvolimab-in-chronic-spontaneous-urticaria-patients-unresponsive-to-h1-antihistamines-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-barzolvolimab-in-prurigo-nodularis-a-phase-2-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-basimglurant-as-adjunctive-therapy-in-tuberous-sclerosis-complex-associated-seizures-in-pediatric-and-young-adult-populations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-baxdrostat-in-adults-with-primary-aldosteronism-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-baxdrostat-in-patients-with-uncontrolled-and-resistant-hypertension-on-multidrug-regimens-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bay-3018250-in-symptomatic-proximal-deep-vein-thrombosis-a-randomized-double-blind-placebo-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-belantamab-mafodotin-versus-pomalidomide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-belantamab-mafodotin-with-pomalidomide-and-dexamethasone-versus-pomalidomide-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-belinostat-chop-and-pralatrexate-cop-versus-chop-in-newly-diagnosed-peripheral-t-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-belzupacap-sarotalocan-in-primary-indeterminate-lesions-or-small-choroidal-melanoma-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-benralizumab-in-patients-with-hypereosinophilic-syndrome-a-randomized-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-benralizumab-in-patients-with-moderate-to-very-severe-chronic-obstructive-pulmonary-disease-with-frequent-exacerbations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-benralizumab-versus-mepolizumab-in-eosinophilic-granulomatosis-with-polyangiitis-patients-on-standard-care-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bepirovirsen-in-hbeag-negative-nucleos-t-ide-analogue-treated-patients-with-chronic-hepatitis-b-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bexotegrast-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bfb759-in-adult-patients-with-atopic-dermatitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bhv-7000-as-adjunctive-therapy-in-adults-with-refractory-focal-onset-epilepsy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bhv-7000-in-adults-with-refractory-focal-onset-epilepsy-a-phase-2-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bi-1015550-in-progressive-fibrosing-interstitial-lung-diseases-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bi-1839100-in-reducing-cough-frequency-in-idiopathic-and-progressive-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bi-3032950-in-moderate-to-severe-ulcerative-colitis-a-phase-iia-single-arm-open-label-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bi-764198-in-patients-with-focal-segmental-glomerulosclerosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-biib122-in-a-randomized-double-blind-placebo-controlled-phase-2b-study-in-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bimekizumab-versus-risankizumab-in-adults-with-active-psoriatic-arthritis-a-multicenter-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bimekizumab-versus-ustekinumab-in-pediatric-patients-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-botulinum-toxin-type-a-in-chronic-migraine-prevention-in-adults-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-botulinum-toxin-type-a-in-preventing-episodic-migraine-in-adults-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bovine-vs-marine-chondroitin-sulfate-800-mg-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-bp1-4979-in-adult-patients-with-primary-premature-ejaculation-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-brensocatib-in-adults-with-moderate-to-severe-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-budoprutug-tnt119-in-patients-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-buloxibutid-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-cabozantinib-at-60-mg-vs-140-mg-daily-in-patients-with-progressive-metastatic-medullary-thyroid-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-cariprazine-in-adolescents-with-schizophrenia-a-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-casimersen-and-golodirsen-in-duchenne-muscular-dystrophy-patients-amenable-to-exon-45-or-53-skipping-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-cdr132l-in-patients-with-post-myocardial-infarction-reduced-left-ventricular-ejection-fraction-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-cevostamab-and-tocilizumab-in-relapsed-refractory-multiple-myeloma-patients-with-prior-b-cell-maturation-antigen-exposure2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-clenbuterol-hydrochloride-in-spinal-and-bulbar-muscular-atrophy-a-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-clostridium-botulinum-neurotoxin-type-a-in-chronic-migraine-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-clostridium-botulinum-neurotoxin-type-a-in-episodic-migraine-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-crovalimab-in-complement-inhibitor-treatment-naive-adults-and-adolescents-with-atypical-hemolytic-uremic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-crovalimab-in-pediatric-patients-with-atypical-hemolytic-uremic-syndrome-ahus2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-crovalimab-versus-eculizumab-in-complement-inhibitor-naive-patients-with-paroxysmal-nocturnal-hemoglobinuria2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-cyclosporine-and-methotrexate-in-pediatric-and-adolescent-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-danicopan-in-adults-with-chronic-spontaneous-urticaria-resistant-to-h1-antihistamines2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-darvadstrocel-for-complex-perianal-fistulas-in-pediatric-crohn-s-disease-a-phase-3-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dazodalibep-in-patients-with-moderate-to-severe-systemic-sjogren-s-syndrome-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-debio-4126-a-12-week-octreotide-formulation-in-acromegaly-patients-previously-treated-with-somatostatin-analogs2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-delgocitinib-cream-versus-vehicle-in-adult-patients-with-mild-to-severe-palmoplantar-pustulosis-a-phase-2a-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-depemokimab-in-adults-with-chronic-obstructive-pulmonary-disease-and-type-2-inflammation-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-depemokimab-in-adults-with-hypereosinophilic-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-deucravacitinib-in-active-discoid-and-subacute-cutaneous-lupus-erythematosus-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-deucravacitinib-in-adult-patients-with-chronic-hand-eczema-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-deucravacitinib-in-adults-with-active-sjogren-s-syndrome-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-deucravacitinib-in-biologic-naive-patients-with-active-psoriatic-arthritis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dexamethasone-ocs-01-eye-drops-in-diabetic-macular-edema-a-phase-3-randomized-double-masked-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dexpramipexole-dihydrochloride-monohydrate-in-eosinophilic-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dextromethadone-hydrochloride-as-adjunctive-therapy-in-major-depressive-disorder-with-inadequate-response-to-antidepressants2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-diacerein-1-ointment-in-generalized-epidermolysis-bullosa-simplex-a-randomized-double-blind-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-diclofenac-gel-amz001-in-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dimethyl-fumarate-in-pediatric-patients-with-relapsing-remitting-multiple-sclerosis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dmx-200-in-adult-patients-with-focal-segmental-glomerulosclerosis-receiving-angiotensin-ii-receptor-blocker-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dnth103-in-adults-with-chronic-inflammatory-demyelinating-polyneuropathy-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-doxecitine-and-doxribtimine-in-adults-with-thymidine-kinase-2-deficiency-an-off-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-dupilumab-in-adult-bullous-pemphigoid-a-multicenter-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-durvalumab-paclitaxel-and-novel-oncology-agents-in-first-line-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-eblasakimab-in-moderate-to-severe-atopic-dermatitis-patients-previously-treated-with-dupilumab-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-alfa-in-acetylcholine-receptor-binding-antibody-seronegative-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-alfa-in-adults-with-ocular-myasthenia-gravis-a-randomized-double-blind-placebo-controlled-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-alfa-in-adults-with-primary-immune-thrombocytopenia-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-alfa-subcutaneous-injection-in-adult-patients-with-primary-sjogren-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-ph20-sc-in-adults-with-active-idiopathic-inflammatory-myopathy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-ph20-sc-in-adults-with-bullous-pemphigoid-a-phase-2-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efgartigimod-ph20-sc-in-adults-with-thyroid-eye-disease-a-phase-3-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-efinopegdutide-in-adults-with-compensated-cirrhosis-due-to-metabolic-dysfunction-associated-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-elafibranor-in-adult-patients-with-primary-biliary-cholangitis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-elafibranor-in-primary-biliary-cholangitis-patients-with-inadequate-ursodeoxycholic-acid-response-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-elsunersen-in-pediatric-patients-with-early-onset-scn2a-developmental-and-epileptic-encephalopathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-enfortumab-vedotin-and-pembrolizumab-in-advanced-melanoma-a-phase-ii-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-enlicitide-chloride-versus-ezetimibe-bempedoic-acid-and-their-combination-in-hypercholesterolemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-enzalutamide-and-leuprorelin-acetate-in-high-risk-nonmetastatic-prostate-cancer-post-definitive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-epcoritamab-venetoclax-and-lenalidomide-in-relapsed-refractory-chronic-lymphocytic-leukemia-and-richter-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-eplontersen-in-transthyretin-mediated-amyloid-cardiomyopathy-a-phase-3-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-eptinezumab-for-preventive-treatment-in-adults-with-chronic-migraine-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-erdafitinib-with-metformin-and-midazolam-in-metastatic-or-unresectable-urothelial-cancer-with-fgfr-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ersodetug-in-tumor-associated-hyperinsulinism-with-inadequately-controlled-hypoglycemia-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-esflurbiprofen-topical-system-in-acute-ankle-sprains-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-esomeprazole-magnesium-in-maintaining-healing-of-erosive-esophagitis-in-pediatric-patients-aged-1-to-11-years2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-etanercept-versus-placebo-in-sapho-syndrome-patients-undergoing-standard-nsaid-and-dmard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-evo756-potassium-in-adults-with-moderate-to-severe-chronic-spontaneous-urticaria-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-felzartamab-in-kidney-transplant-recipients-with-late-antibody-mediated-rejection-a-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-fidrisertib-ipn60130-in-fibrodysplasia-ossificans-progressiva-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-fipaxalparant-in-diffuse-cutaneous-systemic-sclerosis-a-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-fluticasone-propionate-salbutamol-sulfate-combination-in-asthma-patients-aged-12-and-older-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-folfirinox3-in-first-line-chemotherapy-for-unresectable-locally-advanced-or-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-frexalimab-sar442970-and-rilzabrutinib-in-primary-focal-segmental-glomerulosclerosis-and-minimal-change-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gal-101-ophthalmic-solution-in-non-foveal-geographic-atrophy-secondary-to-non-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-galactoarabino-rhamnogalacturonate-in-preventing-esophageal-varices-in-nash-cirrhosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gemlapodect-in-adult-and-adolescent-tourette-syndrome-a-double-blind-placebo-controlled-phase-iib-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-givinostat-in-non-ambulant-duchenne-muscular-dystrophy-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-glofitamab-with-gemcitabine-and-oxaliplatin-versus-rituximab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-golcadomide-and-rituximab-versus-investigator-s-choice-in-relapsed-refractory-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-golcadomide-with-rituximab-in-newly-diagnosed-advanced-stage-follicular-lymphoma-a-phase-2-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gs-1427-in-adults-with-moderately-to-severely-active-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gsk1070806-in-adults-with-moderate-to-severe-atopic-dermatitis-a-randomized-double-blind-placebo-controlled-phase-2b-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gsk3915393-in-idiopathic-pulmonary-fibrosis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gsk4527226-in-early-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-multicenter-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gsk4532990-in-adults-with-alcohol-related-liver-disease-a-phase-2-double-blind-placebo-controlled-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-gsk5764227-monotherapy-and-combination-therapy-in-advanced-unresectable-or-metastatic-gastrointestinal-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-guselkumab-and-golimumab-combination-therapy-in-moderate-to-severe-crohn-s-disease-a-phase-2b-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-guselkumab-in-moderate-to-severe-crohn-s-disease-a-phase-2-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-guselkumab-in-patients-with-moderately-to-severely-active-ulcerative-colitis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-human-normal-immunoglobulin-igpro20-in-adults-with-post-covid-19-postural-orthostatic-tachycardia-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-humanised-igg1-kappa-monoclonal-antibody-against-thymic-stromal-lymphopoietin-in-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-hzn-1116-in-moderate-to-severe-sjogren-s-syndrome-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ianalumab-in-adult-lupus-nephritis-patients-post-cvay736k12301-study-completion2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ianalumab-in-moderate-to-severe-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iduronate-2-sulfatase-fc-polypeptide-vs-idursulfase-in-pediatric-mucopolysaccharidosis-type-ii2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ifinatamab-deruxtecan-in-recurrent-or-metastatic-solid-tumors-a-phase-1b-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-imvt-1402-in-adult-patients-with-graves-disease-a-randomized-double-blind-placebo-controlled-phase-2b-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-inaxaplin-vx-147-in-apol1-mediated-proteinuric-kidney-disease-a-phase-2-3-adaptive-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-incb000928-in-fibrodysplasia-ossificans-progressiva-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-inebilizumab-in-adults-with-acetylcholine-receptor-or-muscle-specific-kinase-antibody-positive-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-infigratinib-in-pediatric-patients-with-hypochondroplasia-a-phase-2-3-multicenter-open-label-and-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-inhaled-azd8630-in-adults-with-uncontrolled-asthma-at-risk-of-exacerbations-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-inhaled-molgramostim-in-pediatric-patients-with-autoimmune-pulmonary-alveolar-proteinosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intra-articular-liraglutide-4p-004-in-patients-with-knee-synovitis-and-osteoarthritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intranasal-bpl-003-in-treatment-resistant-depression-a-quadruple-masked-dose-finding-study-with-open-label-extension2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intravenous-eptinezumab-for-preventive-treatment-of-chronic-migraine-in-adolescents-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intravenous-glm101-in-pmm2-cdg-a-phase-2b-multicenter-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intravenous-lasn01-in-thyroid-eye-disease-a-phase-2-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-intravitreal-eye103-versus-ranibizumab-in-diabetic-macular-edema-a-randomized-double-masked-phase-2-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-inupadenant-hydrochloride-with-carboplatin-and-pemetrexed-in-metastatic-nonsquamous-non-small-cell-lung-cancer-post-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ipn10200-in-adult-cervical-dystonia-a-phase-ii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iptacopan-in-patients-with-complement-3-glomerulopathy-a-multicenter-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-itepekimab-in-moderate-to-severe-chronic-obstructive-pulmonary-disease-in-former-smokers-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iti-1284-as-adjunctive-therapy-in-generalized-anxiety-disorder-patients-with-inadequate-response-to-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iti-1284-in-psychosis-associated-with-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iti-1284-in-treating-agitation-in-alzheimer-s-dementia-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-iti-1284-monotherapy-in-generalized-anxiety-disorder-patients-with-inadequate-response-to-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-izokibep-in-patients-with-non-infectious-intermediate-posterior-or-pan-uveitis-a-phase-2b-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-73763989-with-nucleos-t-ide-analog-in-hepatitis-b-and-d-co-infected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-in-biologic-experienced-patients-with-active-psoriatic-arthritis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-in-biologic-naive-patients-with-active-psoriatic-arthritis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-in-moderate-to-severe-plaque-psoriasis-affecting-special-areas-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-in-moderate-to-severe-ulcerative-colitis-a-phase-2b-randomized-placebo-controlled-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-versus-placebo-and-deucravacitinib-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-77242113-versus-placebo-and-ustekinumab-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-81241459-in-moderate-to-severe-plaque-psoriasis-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jnj-95475939-in-moderate-to-severe-atopic-dermatitis-a-phase-2b-randomized-double-blind-placebo-and-active-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-jx10-in-acute-ischemic-stroke-patients-with-delayed-presentation-a-multicenter-double-blind-placebo-controlled-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-kbp-336-in-combination-with-paracetamol-for-obesity-and-knee-osteoarthritis-in-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-kpl-404-in-a-phase-2-randomized-double-blind-placebo-controlled-study-for-sjogren-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-latozinemab-in-patients-with-frontotemporal-dementia-due-to-progranulin-gene-mutations-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lebrikizumab-and-mometasone-furoate-in-adult-patients-with-perennial-allergic-rhinitis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lebrikizumab-in-chronic-rhinosinusitis-with-nasal-polyps-on-intranasal-corticosteroids-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lecanemab-in-early-alzheimer-s-disease-a-placebo-controlled-double-blind-parallel-group-study-with-open-label-extension2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-leriglitazone-in-adult-males-with-cerebral-adrenoleukodystrophy-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-letibotulinumtoxina-in-treating-moderate-to-severe-horizontal-forehead-lines-a-randomized-blinded-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lisocabtagene-maraleucel-in-adults-with-relapsed-refractory-indolent-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-litifilimab-in-active-subacute-and-chronic-cutaneous-lupus-erythematosus-refractory-to-antimalarial-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-litifilimab-in-adults-with-active-systemic-lupus-erythematosus-on-nonbiologic-standard-of-care-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-litifilimab-in-adults-with-active-systemic-lupus-erythematosus-on-standard-nonbiologic-lupus-care-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-losmapimod-in-patients-with-facioscapulohumeral-muscular-dystrophy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-low-dose-acetylsalicylic-acid-as-adjunctive-therapy-in-bipolar-affective-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ltp001-in-idiopathic-pulmonary-fibrosis-a-randomized-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lumateperone-as-adjunctive-therapy-in-major-depressive-disorder-patients-with-inadequate-antidepressant-response2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lumateperone-in-acute-manic-episodes-of-bipolar-i-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lumateperone-in-acute-treatment-of-manic-episodes-in-bipolar-i-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-luspatercept-in-lower-risk-myelodysplastic-syndrome-requiring-red-blood-cell-transfusions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lutetium-177lu-oxodotreotide-in-advanced-gep-nets-with-high-proliferation-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-lutikizumab-and-risankizumab-in-adult-patients-with-active-psoriatic-arthritis-a-phase-2-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-luveltamab-tazevibulin-versus-investigator-s-choice-chemotherapy-in-relapsed-platinum-resistant-epithelial-ovarian-cancer-expressing-folr12026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ly3437943-in-patients-with-severe-obesity-and-established-cardiovascular-disease-a-randomized-double-blind-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-metformin-hydrochloride-in-myotonic-dystrophy-type-1-a-phase-iii-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-methyl-1-6-1s-1-cyclopropylethyl-amino-2-pyrazolo-5-1-b-1-3-thiazol-7-yl-pyrimidin-4-yl-carbonyl-piperidin-4-yl-carbamate-mono-4-methylbenzenesulfonate-monohydrate-in2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mf59-adjuvanted-influenza-vaccine-versus-non-adjuvanted-vaccine-in-adults-aged-65-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-milsaperidone-as-adjunctive-therapy-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mirodenafil-dihydrochloride-in-early-alzheimer-s-disease-a-phase-3-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mitapivat-in-non-transfusion-dependent-alpha-or-beta-thalassemia-a-phase-3-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mitapivat-in-patients-with-sickle-cell-disease-a-phase-2-3-double-blind-randomized-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mitapivat-in-pediatric-patients-with-pyruvate-kinase-deficiency-not-receiving-regular-transfusions-a-phase-3-multicenter-randomized-double-blind-placebo-controlled-st2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mitapivat-in-transfusion-dependent-alpha-or-beta-thalassemia-a-phase-3-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mk-1167-as-adjunctive-therapy-in-mild-to-moderate-alzheimer-s-disease-dementia-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mk-6194-in-adults-with-non-segmental-vitiligo-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mk-6194-in-adults-with-systemic-lupus-erythematosus-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ml-007c-ma-in-treating-hallucinations-and-delusions-in-alzheimer-s-disease-psychosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-molnupiravir-in-non-hospitalized-adults-with-sars-cov-2-infection-at-high-risk-for-disease-progression2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-montelukast-versus-placebo-in-patients-with-erosive-hand-osteoarthritis-a-randomized-double-blind-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mosliciguat-in-pulmonary-hypertension-associated-with-interstitial-lung-disease-a-phase-2-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-mosunetuzumab-plus-lenalidomide-versus-rituximab-plus-lenalidomide-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-myrrh-coffee-charcoal-and-chamomile-extract-in-diarrhea-predominant-and-mixed-type-irritable-bowel-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-myrrh-coffee-charcoal-and-chamomile-extract-in-diarrhea-predominant-irritable-bowel-syndrome-a-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-n-4-2-4-3-cyanophenyl-piperazin-1-yl-ethyl-cyclohexyl-3-methoxypropanamide-in-adults-with-essential-tremor2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-n-acetyl-ged-0507-34-levo-gel-5-in-patients-with-acne-vulgaris-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-namilumab-in-patients-with-chronic-pulmonary-sarcoidosis-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-namodenoson-in-patients-with-non-alcoholic-steatohepatitis-nash-with-f1-3-fibrosis-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-naporafenib-combinations-in-previously-treated-unresectable-or-metastatic-brafv600-nras-mutant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-naronapride-dihydrochloride-trihydrate-in-moderate-idiopathic-or-diabetic-gastroparesis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-navenibart-in-hereditary-angioedema-a-phase-3-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-navepegritide-and-lonapegsomatropin-in-pediatric-achondroplasia-a-156-week-phase-2-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-naxitamab-combined-with-standard-chemotherapy-in-patients-with-refractory-ewing-s-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-nbi-1065845-as-adjunctive-therapy-in-adults-with-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-nerandomilast-in-systemic-autoimmune-rheumatic-diseases-associated-interstitial-lung-diseases-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ninerafaxstat-in-symptomatic-non-obstructive-hypertrophic-cardiomyopathy-a-randomized-double-blind-placebo-controlled-phase-2b-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-nipocalimab-in-adults-with-active-idiopathic-inflammatory-myopathies-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-nmd670-in-ambulatory-adults-with-charcot-marie-tooth-disease-types-1-and-2-a-randomized-double-blind-placebo-controlled-phase-2a-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-nofazinlimab-and-lenvatinib-versus-placebo-and-lenvatinib-in-first-line-treatment-of-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-oatd-01-a-chitinase-1-inhibitor-in-active-pulmonary-sarcoidosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obexelimab-in-relapsing-multiple-sclerosis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obexelimab-in-systemic-lupus-erythematosus-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obinutuzumab-in-isn-rps-2003-class-iii-iv-lupus-nephritis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obinutuzumab-in-systemic-lupus-erythematosus-a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obinutuzumab-versus-mycophenolate-mofetil-in-pediatric-idiopathic-nephrotic-syndrome-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-obinutuzumab-versus-tacrolimus-in-primary-membranous-nephropathy-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ocrelizumab-in-adults-with-primary-progressive-multiple-sclerosis-a-phase-iiib-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ocs-01-dexamethasone-eye-drops-in-diabetic-macular-edema-a-phase-2-3-double-masked-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-odevixibat-in-pediatric-biliary-atresia-post-kasai-hepatoportoenterostomy-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-olaparib-monotherapy-and-olaparib-durvalumab-combination-in-neoadjuvant-treatment-of-her2-negative-brca-mutated-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-omecamtiv-mecarbil-in-patients-with-heart-failure-and-severely-reduced-ejection-fraction-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-oral-decitabine-tetrahydrouridine-in-hydroxyurea-non-eligible-sickle-cell-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-oral-etrasimod-arginine-as-induction-and-maintenance-therapy-in-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-oral-resomelagon-with-methotrexate-in-dmard-naive-patients-with-early-rheumatoid-arthritis-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-oral-zasocitinib-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pacritinib-in-patients-with-vexas-syndrome-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-paltusotine-in-adults-with-carcinoid-syndrome-secondary-to-well-differentiated-neuroendocrine-tumors-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-patisiran-in-transthyretin-amyloidosis-with-cardiomyopathy-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pazopanib-and-temozolomide-as-maintenance-therapy-in-glioblastoma-patients-post-surgery-and-induction-radiotherapy-temozolomide2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pelacarsen-tqj230-with-inclisiran-in-atherosclerotic-cardiovascular-disease-patients-with-elevated-lipoprotein-a2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pemafibrate-and-tofogliflozin-combination-in-noncirrhotic-nash-with-liver-fibrosis-a-phase-2-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pembrolizumab-and-lenvatinib-in-pre-treated-metastatic-thymic-carcinoma-and-b3-thymoma-patients-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pembrolizumab-in-advanced-progressive-adrenocortical-carcinoma-a-multicenter-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pf-07275315-and-pf-07264660-in-adults-with-moderate-to-severe-atopic-dermatitis-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pf-07275315-in-adults-with-moderate-to-severe-asthma-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-phleum-pratense-pollen-extract-sublingual-immunotherapy-in-moderate-to-severe-grass-pollen-induced-allergic-rhinitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-phleum-pratense-pollen-extract-sublingual-immunotherapy-in-patients-with-moderate-to-severe-grass-pollen-induced-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pioglitazone-with-metformin-and-empagliflozin-in-type-2-diabetes-mellitus-patients-with-inadequate-glycemic-control2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-piromelatine-in-patients-with-idiopathic-rapid-eye-movement-behavior-disorder-an-open-label-sleep-laboratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-plasma-rich-in-growth-factors-eye-drops-for-dry-eye-disease-in-glaucoma-patients-a-randomized-double-blind-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-plitidepsin-in-adults-with-post-covid-19-condition-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-post-coital-intravaginal-pentoxifylline-gel-pkb171-in-couples-with-mild-male-factor-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-povorcitinib-in-adult-patients-with-chronic-spontaneous-urticaria-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-povorcitinib-in-adult-patients-with-nonsegmental-vitiligo-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-povorcitinib-in-prurigo-nodularis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pq-birch-in-patients-with-birch-pollen-induced-seasonal-allergic-rhinitis-and-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pq-grass-27600-su-in-pediatric-patients-with-grass-pollen-induced-seasonal-allergic-rhinitis-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-prax-628-in-adults-with-focal-epilepsy-a-double-blind-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-pritelivir-in-immunocompromised-patients-with-acyclovir-resistant-mucocutaneous-herpes-simplex-virus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rapcabtagene-autoleucel-versus-rituximab-in-severe-refractory-diffuse-cutaneous-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ravulizumab-in-adults-with-proliferative-lupus-nephritis-or-immunoglobulin-a-nephropathy-a-phase-2-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rbd5044-sodium-in-patients-with-mixed-dyslipidemia-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-regorafenib-in-patients-with-refractory-primary-bone-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rezpegaldesleukin-in-biologic-naive-adults-with-moderate-to-severe-atopic-dermatitis-a-phase-2b-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rezpegaldesleukin-in-severe-to-very-severe-alopecia-areata-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ribociclib-plus-endocrine-therapy-in-hr-positive-her2-negative-early-breast-cancer-a-phase-iiib-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rigosertib-sodium-in-recessive-dystrophic-epidermolysis-bullosa-associated-advanced-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-riliprubart-in-refractory-chronic-inflammatory-demyelinating-polyneuropathy-a-phase-3-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rilzabrutinib-in-adults-and-adolescents-with-persistent-or-chronic-immune-thrombocytopenia-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rintatolimod-versus-control-post-folfirinox-in-locally-advanced-pancreatic-adenocarcinoma-a-phase-2-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ro7790121-in-moderate-to-severe-atopic-dermatitis-a-phase-ii-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ro7790121-in-moderate-to-severe-rheumatoid-arthritis-patients-unresponsive-or-intolerant-to-tnf-and-jak-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ro7790121-induction-therapy-in-moderately-to-severely-active-ulcerative-colitis-a-phase-iii-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rocatinlimab-in-adults-with-moderate-to-severe-asthma-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rosnilimab-in-moderate-to-severe-rheumatoid-arthritis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rozanolixizumab-in-adults-with-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mog-ad2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ruxolitinib-cream-in-hidradenitis-suppurativa-a-phase-3-double-blind-randomized-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ruxolitinib-cream-in-pediatric-patients-aged-6-to-12-years-with-nonsegmental-vitiligo-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-rvwf-prophylaxis-in-pediatric-patients-with-severe-von-willebrand-disease-using-vonicog-alfa-and-octocog-alfa2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-saccharomyces-boulardii-cncm-i-745-in-non-constipated-irritable-bowel-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sapablursen-in-phlebotomy-dependent-polycythemia-vera-a-phase-2a-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar441344-a-cd40l-antagonist-monoclonal-antibody-in-patients-with-relapsing-multiple-sclerosis-a-phase-2-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar441566-in-adults-with-moderate-to-severe-crohn-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar441566-in-adults-with-moderate-to-severe-plaque-psoriasis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar441566-in-adults-with-moderate-to-severe-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar442970-in-adults-with-moderate-to-severe-crohn-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar442970-in-adults-with-moderate-to-severe-ulcerative-colitis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sar444656-in-adults-with-moderate-to-severe-atopic-dermatitis-a-multinational-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-saroglitazar-magnesium-in-primary-biliary-cholangitis-a-multicenter-randomized-double-blind-placebo-controlled-phase-2b-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-satralizumab-in-patients-with-type-1-facioscapulohumeral-muscular-dystrophy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-selinexor-and-ruxolitinib-in-treatment-naive-myelofibrosis-patients-a-phase-1-3-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-selinexor-monotherapy-in-jak-inhibitor-naive-myelofibrosis-patients-with-moderate-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-selumetinib-in-adults-with-neurofibromatosis-type-1-and-symptomatic-inoperable-plexiform-neurofibromas2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-setrusumab-in-osteogenesis-imperfecta-a-randomized-phase-2-3-study-with-dose-evaluation-and-placebo-controlled-phases2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-solrikitug-in-adult-patients-with-eosinophilic-esophagitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sotagliflozin-in-patients-with-symptomatic-obstructive-and-non-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-soticlestat-in-dravet-syndrome-and-lennox-gastaut-syndrome-patients-previously-exposed-to-fenfluramine2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sparsentan-in-patients-with-immunoglobulin-a-nephropathy-a-randomized-double-blind-active-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-amlitelimab-in-adults-with-moderate-to-severe-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-amlitelimab-in-moderate-to-severe-atopic-dermatitis-with-background-topical-corticosteroids-in-adolescents-and-adults2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-belimumab-in-systemic-sclerosis-associated-interstitial-lung-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-cluster-immunotherapy-with-allergen-extract-from-phleum-pratense-pollen-in-moderate-to-severe-grass-pollen-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-cluster-immunotherapy-with-allergenic-extract-of-olea-europaea-pollen-in-moderate-to-severe-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-cluster-immunotherapy-with-birch-pollen-allergoid-glutaraldehyde-modified-in-moderate-to-severe-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-cluster-immunotherapy-with-dermatophagoides-pteronyssinus-allergoid-in-moderate-to-severe-house-dust-mite-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-golimumab-in-pediatric-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-lunsekimig-sar443765-in-adults-with-moderate-to-severe-atopic-dermatitis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-mepolizumab-in-pediatric-patients-with-hypereosinophilic-syndrome-a-52-week-phase-3-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-selatogrel-in-preventing-recurrent-acute-myocardial-infarction-in-post-ami-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-sibeprenlimab-in-sjogren-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-subcutaneous-sonelokimab-in-adults-with-moderate-to-severe-hidradenitis-suppurativa-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sublingual-immunotherapy-with-betula-pendula-pollen-extract-in-patients-with-birch-pollen-induced-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-sublingual-immunotherapy-with-betula-pollen-extract-in-patients-with-moderate-to-severe-birch-pollen-induced-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-suvecaltamide-in-treating-moderate-to-severe-residual-tremor-in-parkinson-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-taldefgrobep-alfa-in-ambulatory-and-non-ambulatory-spinal-muscular-atrophy-patients-on-stable-nusinersen-risdiplam-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tanimilast-chf6001-as-an-add-on-to-triple-therapy-in-patients-with-chronic-obstructive-pulmonary-disease-and-chronic-bronchitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tar-200-and-cetrelimab-in-high-risk-non-muscle-invasive-bladder-cancer-unresponsive-to-bacillus-calmette-guerin2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tebapivat-in-sickle-cell-disease-a-phase-2-double-blind-randomized-placebo-controlled-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-telitacicept-in-generalized-myasthenia-gravis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tev-53408-in-adults-with-celiac-disease-undergoing-oral-gluten-challenge-a-phase-2a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tezepelumab-in-adults-with-moderate-to-very-severe-chronic-obstructive-pulmonary-disease-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tezepelumab-in-adults-with-moderate-to-very-severe-chronic-obstructive-pulmonary-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tildacerfont-and-hydrocortisone-in-adults-with-classic-congenital-adrenal-hyperplasia-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tirbanibulin-1-ointment-in-the-treatment-of-superficial-basal-cell-carcinoma-an-open-label-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tirbanibulin-ointment-in-adult-patients-with-actinic-keratosis-on-the-face-or-scalp-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tisagenlecleucel-in-adult-patients-with-refractory-or-relapsed-follicular-lymphoma-a-phase-ii-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tobevibart-and-elebsiran-combination-therapy-versus-bulevirtide-in-chronic-hepatitis-d-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tobevibart-and-elebsiran-in-patients-with-chronic-hepatitis-d-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-topical-alanyl-glutamine-mc2-25-in-women-with-vulvar-lichen-sclerosus-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tozorakimab-in-adults-with-uncontrolled-asthma-on-medium-to-high-dose-inhaled-corticosteroids-a-phase-iib-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-trastuzumab-deruxtecan-in-patients-with-unresectable-or-metastatic-solid-tumors-harboring-her2-activating-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ttx-030-and-chemotherapy-with-or-without-budigalimab-in-untreated-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tulisokibart-in-moderate-to-severe-crohn-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tulisokibart-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-2b-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-tx000045-in-pulmonary-hypertension-secondary-to-heart-failure-with-preserved-ejection-fraction-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ugn-104-in-low-grade-upper-tract-urothelial-carcinoma-a-phase-3-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-ulotaront-sep-363856-in-acutely-psychotic-schizophrenia-patients-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-utreloxastat-in-adult-patients-with-amyotrophic-lateral-sclerosis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vemircopan-in-adults-with-proliferative-lupus-nephritis-or-immunoglobulin-a-nephropathy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-venetoclax-and-obinutuzumab-retreatment-in-patients-with-recurrent-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-venglustat-versus-imiglucerase-in-adult-and-pediatric-patients-with-gaucher-disease-type-3-achieving-therapeutic-goals-with-ert2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-verekitug-upb-101-in-adults-with-severe-asthma-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-verekitug-upb-101-in-chronic-rhinosinusitis-with-nasal-polyps-on-nasal-corticosteroids-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-verekitug-upb-101-in-moderate-to-severe-chronic-obstructive-pulmonary-disease-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vhb937-in-early-alzheimer-s-disease-a-randomized-placebo-controlled-parallel-group-72-week-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vibozilimod-in-moderate-to-severe-atopic-dermatitis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vibozilimod-in-moderate-to-severe-plaque-psoriasis-a-randomized-double-blind-placebo-controlled-phase-iib-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vilobelimab-in-ulcerative-pyoderma-gangrenosum-a-randomized-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vipoglanstat-in-moderate-to-severe-endometriosis-related-pain-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-volixibat-in-treating-cholestatic-pruritus-in-primary-biliary-cholangitis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-volixibat-in-treating-cholestatic-pruritus-in-primary-sclerosing-cholangitis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-vosoritide-in-pediatric-hypochondroplasia-a-phase-3-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-weekly-insulin-icodec-versus-daily-insulin-glargine-in-adults-with-type-2-diabetes-transitioning-from-basal-insulin2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-xelafaslatide-onl1204-in-geographic-atrophy-secondary-to-age-related-macular-degeneration-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-xxb750-in-heart-failure-patients-with-lvef-50-on-standard-care-including-acei-arb-or-sacubitril-valsartan2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-zagociguat-in-mitochondrial-encephalomyopathy-lactic-acidosis-and-stroke-like-episodes-melas-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-zasocitinib-tak-279-versus-apremilast-and-placebo-in-biologic-naive-adults-with-active-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-zibotentan-and-dapagliflozin-in-patients-with-liver-cirrhosis-and-portal-hypertension-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-evaluation-of-zyn002-transdermal-gel-in-pediatric-and-young-adult-patients-with-fragile-x-syndrome-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-2-hydroxyoleic-acid-with-radiotherapy-and-temozolomide-in-newly-diagnosed-primary-glioblastoma-multiforme-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-7-vs-14-days-of-antibiotic-therapy-with-meropenem-aztreonam-and-levofloxacin-in-pseudomonas-aeruginosa-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-abtl0812-with-folfirinox-in-first-line-treatment-of-metastatic-pancreatic-ductal-adenocarcinoma-a-phase-i-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-acalabrutinib-with-venetoclax-and-obinutuzumab-versus-chemoimmunotherapy-in-untreated-chronic-lymphocytic-leukemia-without-del-17p-or-tp53-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-acetylsalicylic-acid-versus-acetylsalicylic-acid-and-fondaparinux-sodium-in-non-st-elevation-myocardial-infarction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ad04-aluminium-hydroxide-in-early-alzheimer-s-disease-a-phase-2b-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-adjuvant-alectinib-vs-platinum-based-chemotherapy-in-resected-stage-ib-iiia-alk-positive-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-aef0217-in-treating-behavioral-and-cognitive-impairments-in-adults-and-adolescents-with-down-syndrome-a-phase-2b-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alirocumab-in-preventing-early-cardiac-allograft-vasculopathy-in-recent-heart-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alks-2680-compared-with-placebo-in-adults-with-narcolepsy-type-22026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-allogeneic-skin-derived-abcb5-positive-dermal-mesenchymal-stromal-cells-in-therapy-resistant-chronic-venous-ulcers2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alogliptin-and-empagliflozin-combination-compared-with-each-drug-alone-in-adults-with-type-2-diabetes-on-metformin2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alpelisib-and-olaparib-versus-cytotoxic-chemotherapy-in-platinum-resistant-refractory-high-grade-serous-ovarian-cancer-without-germline-brca-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alpelisib-in-pediatric-and-adult-patients-with-pik3ca-mutated-lymphatic-malformations-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alpelisib-in-pediatric-and-adult-patients-with-pik3ca-related-overgrowth-spectrum-a-phase-ii-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-alpha-1-proteinase-inhibitor-in-pulmonary-emphysema-due-to-alpha-1-antitrypsin-deficiency-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-amlitelimab-in-adults-with-moderate-to-severe-hidradenitis-suppurativa-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ampicillin-gentamicin-and-piperacillin-tazobactam-for-hospitalized-patients-with-community-acquired-infection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-anakinra-in-inflammatory-dilated-cardiomyopathy-a-phase-iia-randomized-double-blind-monocentric-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-anakinra-in-patients-with-post-acute-covid-19-syndrome-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-anifrolumab-in-patients-with-primary-sjogren-s-syndrome-a-randomized-double-blind-placebo-controlled-phase-iia-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-anti-t-lymphocyte-immunoglobulin-in-recent-onset-type-1-diabetes-in-pediatric-and-young-adult-populations-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-apremilast-versus-placebo-in-severe-recurrent-aphthous-stomatitis-resistant-or-intolerant-to-colchicine-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-artemisia-absinthium-herbal-drug-combination-in-patients-with-irritable-bowel-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-asciminib-hydrochloride-plus-imatinib-versus-imatinib-or-nilotinib-in-cml-cp-patients-lacking-deep-molecular-response2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-atezolizumab-plus-cabozantinib-versus-cabozantinib-in-advanced-renal-cell-carcinoma-post-checkpoint-inhibitor-progression2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-atezolizumab-versus-best-supportive-care-post-adjuvant-cisplatin-based-chemotherapy-in-resected-stage-ib-iiia-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-atezolizumab-with-flot-versus-flot-alone-in-locally-advanced-resectable-esophagogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-aticaprant-as-adjunctive-therapy-in-adults-with-major-depressive-disorder-and-anhedonia-unresponsive-to-antidepressants2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-atl1102-in-nonambulatory-duchenne-muscular-dystrophy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-atrasentan-in-patients-with-iga-nephropathy-receiving-sodium-glucose-cotransporter-2-inhibitors-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-autologous-adipose-derived-stem-cells-nvd003-versus-iliac-crest-bone-graft-in-pediatric-congenital-pseudarthrosis-of-the-tibia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-autologous-tumor-infiltrating-lymphocytes-ln-144-ln-145-with-checkpoint-inhibitors-in-metastatic-melanoma-hnscc-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-axl-inhibitor-bemcentinib-for-the-treatment-of-moderate-covid-19-axl-solidact2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-balcinrenone-and-dapagliflozin-versus-dapagliflozin-in-adults-with-chronic-kidney-disease-and-albuminuria-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-barzolvolimab-in-chronic-inducible-urticaria-a-phase-2-randomized-double-blind-placebo-controlled-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-baxdrostat-and-dapagliflozin-on-renal-and-cardiovascular-outcomes-in-chronic-kidney-disease-with-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-belimumab-versus-placebo-in-non-infectious-active-cryoglobulinemia-vasculitis-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-benralizumab-in-severe-eosinophilic-chronic-rhinosinusitis-with-nasal-polyps-and-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bepirovirsen-in-hiv-and-chronic-hepatitis-b-coinfected-patients-on-antiretroviral-therapy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bepirovirsen-in-nucleos-t-ide-analogue-treated-patients-with-chronic-hepatitis-b-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bexicaserin-hydrochloride-in-developmental-and-epileptic-encephalopathies-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bexicaserin-in-seizure-management-for-pediatric-and-adult-dravet-syndrome-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bgb-43395-drug-combination-versus-cdk4-6-inhibitor-drug-combination-in-patients-with-untreated-advanced-hr-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bi-1291583-in-patients-with-bronchiectasis-a-phase-iii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-birtamimab-with-standard-care-versus-placebo-in-mayo-stage-iv-light-chain-amyloidosis-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-botulinum-toxin-a-in-persistent-post-traumatic-headache-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-brenipatide-ly3537031-in-adults-with-moderate-to-severe-chronic-obstructive-pulmonary-disease-copd2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-buccalin-tablets-in-preventing-recurrent-lower-respiratory-tract-infections-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-bupivacaine-triamcinolone-and-sodium-chloride-in-treating-trapezius-myofascial-syndrome-in-fibromyalgia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cagrilintide-for-weight-management-in-participants-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cagrilintide-s-c-in-combination-with-semaglutide-s-c-cagrisema-s-c-1-0-mg-1-0-mg-and-1-7-mg-1-7-mg-once-weekly-in-participants-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-camoteskimab-compared-with-placebo-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-canakinumab-in-treating-anemia-in-patients-with-ipss-r-low-risk-myelodysplastic-syndromes-or-mds-mpn-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cannabidiol-oral-solution-as-adjunctive-therapy-in-pediatric-and-young-adult-patients-with-rare-disease-associated-severe-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cannabidiol-oral-solution-for-aromatase-inhibitor-induced-musculoskeletal-pain-in-early-hormone-receptor-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cannabidiol-oral-solution-for-aromatase-inhibitor-related-joint-pain-in-early-hormone-receptor-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cannabis-sativa-flower-aerosol-via-syqe-inhaler-in-diabetic-peripheral-neuropathic-pain-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-capivasertib-plus-abiraterone-in-pten-deficient-metastatic-hormone-sensitive-prostate-cancer-a-phase-iii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-capivasertib-plus-docetaxel-in-metastatic-castration-resistant-prostate-cancer-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-capivasertib-plus-paclitaxel-versus-placebo-plus-paclitaxel-in-first-line-treatment-of-locally-advanced-or-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cardiodoron-r-dilution-in-functional-cardiovascular-disorders-a-randomized-double-blind-placebo-controlled-phase-iv-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-carfilzomib-plus-ibrutinib-versus-ibrutinib-monotherapy-in-treatment-naive-or-relapsed-waldenstrom-s-macroglobulinemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-carisbamate-ykp509-as-adjunctive-therapy-for-lennox-gastaut-syndrome-associated-seizures-in-pediatric-and-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cd5-targeted-car-nk-cell-therapy-in-patients-with-refractory-invasive-mold-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cdr132l-in-cardiac-remodeling-for-heart-failure-with-reduced-ejection-fraction-and-left-ventricular-hypertrophy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cdr132l-in-heart-failure-with-preserved-ejection-fraction-and-left-ventricular-hypertrophy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cefepime-nacubactam-and-aztreonam-nacubactam-in-adults-with-cre-related-complicated-infections2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cell-based-immunotherapy-in-patients-with-stage-ii-and-iii-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cetuximab-based-regimen-in-ras-braf-wild-type-metastatic-colorectal-cancer-with-trifluridine-tipiracil-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-clostridium-botulinum-neurotoxin-type-a-in-pediatric-lower-limb-spasticity-due-to-cerebral-palsy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-co-administered-cagrilintide-and-semaglutide-cagrisema-1-0-mg-1-0-mg-s-c-once-weekly-versus-tirzepatide-5-mg-s-c-once-weekly-in-participants-with-type-2-diabetes-inadequately-co2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-colchicine-and-carbaspirin-calcium-in-cardiovascular-outcomes-for-type-2-diabetes-patients-without-prior-cardiovascular-events2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-colesevelam-hydrochloride-modified-release-tablets-in-idiopathic-bile-acid-diarrhoea-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-colistimethate-sodium-and-ciprofloxacin-for-eradicating-pseudomonas-aeruginosa-infection-in-adults-with-bronchiectasis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-combined-eplontersen-sodium-and-alxn2220-in-adults-with-transthyretin-mediated-amyloid-cardiomyopathy-attr-cm2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-concizumab-prophylaxis-in-adult-and-adolescent-patients-with-hemophilia-a-or-b-without-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-concizumab-prophylaxis-in-reducing-bleeding-episodes-in-adult-and-adolescent-patients-with-hemophilia-a-or-b-with-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-corabotase-versus-placebo-in-adults-with-moderate-to-severe-glabellar-lines2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-coramitug-nnc6019-0001-at-two-dose-levels-in-patients-with-transthyretin-amyloid-cardiomyopathy-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-corticosteroid-injections-for-the-treatment-of-achilles-tendinopathy-a-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-crizanlizumab-in-adolescent-and-adult-patients-with-sickle-cell-disease-experiencing-vaso-occlusive-crises-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-cvn424-in-reducing-motor-complications-in-parkinson-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dapansutrile-paracetamol-and-placebo-in-acute-gout-flare-a-randomized-double-blind-placebo-controlled-phase-2-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-darbepoetin-alfa-in-reducing-intraoperative-rbc-transfusion-in-liver-transplant-candidates-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-daxdilimab-in-adults-with-moderate-to-severe-primary-discoid-lupus-erythematosus-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-defosbarasertib-and-durvalumab-as-maintenance-therapy-in-first-line-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-delgocitinib-cream-in-adult-patients-with-lichen-sclerosus-a-52-week-randomized-double-blind-vehicle-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-depemokimab-in-adults-and-adolescents-with-type-2-asthma-at-risk-of-exacerbations-a-phase-3b-4-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-depemokimab-vs-mepolizumab-in-adults-with-relapsing-refractory-eosinophilic-granulomatosis-with-polyangiitis-egpa2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-deudextromethorphan-hydrobromide-and-quinidine-sulfate-for-treating-agitation-in-patients-with-alzheimer-s-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dexpramipexole-in-severe-eosinophilic-asthma-a-randomized-double-blind-placebo-controlled-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dfv890-and-mas825-in-reducing-inflammatory-markers-in-adults-with-coronary-heart-disease-and-clonal-hematopoiesis-of-indeterminate-potential2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dimethyl-fumarate-in-reducing-brain-atrophy-and-improving-cognitive-function-in-alzheimer-s-disease-related-mild-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-direclidine-nbi-1117568-in-hospitalized-adults-with-schizophrenia-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-divarasib-and-pembrolizumab-vs-pembrolizumab-with-pemetrexed-and-carboplatin-or-cisplatin-in-kras-g12c-mutated-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-donepezil-hydrochloride-in-mild-cognitive-impairment-associated-with-parkinson-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-doxycycline-hyclate-d-plex-with-standard-care-in-preventing-post-abdominal-surgery-incisional-infections-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dupilumab-in-pediatric-patients-aged-2-to-6-years-with-uncontrolled-asthma-and-or-recurrent-severe-asthmatic-wheeze2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-dupilumab-in-treating-pruritus-of-lichen-simplex-chronicus-in-adults-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-and-bacillus-calmette-guerin-in-high-risk-bcg-naive-non-muscle-invasive-bladder-cancer-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-and-novel-anti-cancer-agents-with-without-chemotherapy-in-treatment-naive-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-plus-olaparib-versus-durvalumab-monotherapy-in-stage-iv-non-small-cell-lung-cancer-post-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-tremelimumab-and-enfortumab-vedotin-in-perioperative-treatment-of-cisplatin-ineligible-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-with-cisplatin-carboplatin-and-etoposide-plus-radiotherapy-in-limited-disease-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-durvalumab-with-gemcitabine-and-cisplatin-in-neoadjuvant-and-adjuvant-treatment-of-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-efepoetin-alfa-versus-darbepoetin-alfa-in-anemia-management-for-chronic-kidney-disease-patients-on-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-efepoetin-alfa-versus-darbepoetin-alfa-in-anemia-management-for-chronic-kidney-disease-patients-on-dialysis-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-efgartigimod-alfa-in-adults-with-graves-disease-inadequately-controlled-by-antithyroid-drugs2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-efgartigimod-alfa-in-adults-with-sjogren-s-disease-associated-sensorimotor-or-sensory-polyneuropathy-phase-2-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elecoglipron-compared-with-placebo-in-adults-with-type-2-diabetes-mellitus-receiving-insulin2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elecoglipron-plus-dapagliflozin-in-adults-with-type-2-diabetes-and-impaired-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elezanumab-in-acute-traumatic-cervical-spinal-cord-injury-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elgn-2112-in-treating-intestinal-malabsorption-in-preterm-infants-a-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elinzanetant-in-treating-vasomotor-symptoms-induced-by-adjuvant-endocrine-therapy-in-hormone-receptor-positive-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-elixirium-thymi-compositum-in-pediatric-acute-bronchitis-a-double-blind-randomized-placebo-controlled-phase-4-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-eneboparatide-azp-3601-in-chronic-hypoparathyroidism-a-phase-3-randomized-placebo-controlled-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-enpatoran-in-adults-with-active-cutaneous-lupus-with-or-without-systemic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-escherichia-coli-dsm-17252-in-diarrhea-predominant-irritable-bowel-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-estriol-prasterone-and-estriol-lactobacillus-acidophilus-combination-in-breast-cancer-patients-with-vulvovaginal-atrophy-on-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-etranacogene-dezaparvovec-gene-therapy-in-adults-with-severe-or-moderately-severe-hemophilia-b-and-pre-existing-aav5-neutralizing-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-evenamide-as-an-adjunctive-treatment-in-patients-with-treatment-resistant-schizophrenia-on-stable-antipsychotic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-fenebrutinib-compared-with-teriflunomide-in-adult-patients-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-fenfluramine-hydrochloride-in-pediatric-and-adult-patients-with-cdkl5-deficiency-disorder-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-fezolinetant-in-treating-vasomotor-symptoms-in-hormone-receptor-positive-breast-cancer-patients-on-adjuvant-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-finerenone-in-non-diabetic-chronic-kidney-disease-a-randomized-double-blind-placebo-controlled-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-finerenone-in-reducing-morbidity-and-mortality-in-heart-failure-patients-with-lvef-40-hospitalized-for-acute-decompensated-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-finerenone-versus-placebo-in-chronic-kidney-disease-with-type-1-diabetes-a-phase-3-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-fixed-dose-ivermectin-versus-weight-adjusted-ivermectin-in-treating-uncomplicated-strongyloidiasis-in-immunocompetent-adults2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-fluasterone-buccal-tablet-in-managing-hyperglycemia-in-adults-with-endogenous-cushing-s-syndrome-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-follitropin-delta-in-men-with-idiopathic-infertility-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-gadopiclenol-versus-gadoterate-meglumine-enhanced-mra-in-adult-patients-with-suspected-vascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-galinpepimut-s-versus-best-available-therapy-in-acute-myeloid-leukemia-patients-in-second-or-later-complete-remission2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-gb-0895-adjunctive-therapy-in-adults-and-adolescents-with-severe-uncontrolled-asthma-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-gdc-6036-versus-sotorasib-or-adagrasib-in-kras-g12c-positive-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-giredestrant-plus-everolimus-versus-endocrine-therapy-plus-everolimus-in-er-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-giredestrant-plus-palbociclib-versus-letrozole-plus-palbociclib-in-er-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-giredestrant-vs-fulvestrant-with-cdk4-6-inhibitor-in-er-her2-advanced-breast-cancer-resistant-to-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-glenzocimab-as-an-adjunct-to-mechanical-thrombectomy-in-acute-ischemic-stroke-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-gliclazide-mr-and-dapagliflozin-with-or-without-metformin-in-type-2-diabetes-patients-inadequately-controlled-on-dapagliflozin2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-glofitamab-with-polatuzumab-vedotin-rituximab-cyclophosphamide-doxorubicin-and-prednisone-in-untreated-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-golcadomide-with-r-chop-versus-placebo-with-r-chop-in-high-risk-large-b-cell-lymphoma-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-guselkumab-versus-etanercept-in-pediatric-chronic-plaque-psoriasis-a-randomized-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-high-dose-insulin-lispro-potassium-chloride-and-glucose-infusion-in-patients-with-non-toxic-acute-cardiogenic-shock2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-hu14-18k322a-combined-with-temozolomide-and-irinotecan-in-children-and-adolescents-with-relapsed-or-refractory-high-risk-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-human-alpha1-proteinase-inhibitor-inhalation-in-adults-with-congenital-alpha-1-antitrypsin-deficiency-and-moderate-to-severe-airflow-limitation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-human-fibrinogen-concentrate-in-managing-bleeding-in-complex-cardiac-surgery-with-cardiopulmonary-bypass-a-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-human-plasma-derived-antithrombin-in-heparin-resistant-patients-undergoing-cardiopulmonary-bypass-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-hydrocortisone-sodium-phosphate-in-dry-eye-disease-with-moderate-meibomian-gland-dysfunction-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-hydroxychloroquine-in-early-systemic-sclerosis-a-double-blind-randomized-placebo-controlled-add-on-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ianalumab-versus-placebo-in-warm-autoimmune-hemolytic-anemia-patients-post-treatment-failure-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ibrutinib-with-rituximab-chop-and-maintenance-ibrutinib-in-untreated-intermediate-high-high-risk-abc-dlbcl-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ibuprofen-acetylcysteine-combination-vs-monotherapies-in-uncomplicated-upper-respiratory-tract-infections-with-wet-cough2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-iloprost-trometamol-infusion-in-mechanically-ventilated-patients-with-infectious-pulmonary-endotheliopathy-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-imlifidase-in-desensitizing-highly-sensitized-end-stage-ckd-patients-for-kidney-transplantation-with-positive-crossmatch2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-immune-guided-prophylaxis-with-ganciclovir-and-valganciclovir-hydrochloride-in-low-risk-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-inavolisib-cdk4-6-inhibitor-and-letrozole-in-endocrine-sensitive-pik3ca-mutated-hr-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-incobotulinumtoxina-in-individualized-dosing-for-severe-spasticity-in-brain-damage-related-upper-and-lower-limb-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-incobotulinumtoxina-in-pediatric-upper-and-lower-limb-spasticity-due-to-cerebral-palsy-a-dose-titration-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-infliximab-and-corticosteroids-in-treating-severe-immune-checkpoint-inhibitor-induced-colitis-a-multinational-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-infliximab-tofacitinib-and-vedolizumab-in-induction-resistant-ulcerative-colitis-a-comparative-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-infliximab-ustekinumab-and-vedolizumab-combination-therapy-in-refractory-crohn-s-disease-resistant-to-vedolizumab-induction2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-initial-triple-therapy-with-parenteral-treprostinil-vs-double-oral-therapy-in-pulmonary-arterial-hypertension-group-i-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intramuscular-methylprednisolone-acetate-in-hand-osteoarthritis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intraperitoneal-vs-01-with-standard-care-in-acute-on-chronic-liver-failure-with-ascites-a-phase-2a-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravenous-brincidofovir-versus-cidofovir-in-adenovirus-viremia-post-allogeneic-hematopoietic-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravenous-human-normal-immunoglobulin-ivig-10-in-adults-with-chronic-immune-thrombocytopenia-a-phase-iii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravenous-lidocaine-hydrochloride-and-magnesium-sulfate-heptahydrate-in-video-assisted-thoracic-surgery-for-lung-resection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravenous-ravulizumab-in-reducing-delayed-graft-function-in-high-risk-adult-kidney-transplant-recipients-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravitreal-anx007-in-geographic-atrophy-secondary-to-age-related-macular-degeneration-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-intravitreal-il6-mab-in-patients-with-uveitic-macular-edema2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-itacitinib-in-adults-with-diffuse-systemic-sclerosis-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-jnj-78934804-guselkumab-and-golimumab-versus-guselkumab-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lasofoxifene-and-abemaciclib-vs-fulvestrant-and-abemaciclib-in-er-her2-advanced-breast-cancer-with-esr1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lazertinib-versus-gefitinib-in-first-line-treatment-of-egfr-mutant-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-letrozole-injection-vs-oral-letrozole-with-ribociclib-in-postmenopausal-women-with-hr-positive-her2-negative-advanced-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-levetiracetam-in-preventing-seizures-in-adults-with-down-syndrome-and-alzheimer-s-disease-a-phase-iii-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lorlatinib-monotherapy-in-advanced-ros1-positive-non-small-cell-lung-cancer-post-first-line-tki-failure2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-low-dose-colchicine-in-reducing-cardiovascular-events-in-patients-with-peripheral-arterial-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lumbar-erector-spinae-plane-block-with-levobupivacaine-in-hip-fracture-surgery-a-comparative-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lunsekimig-in-adults-with-inadequately-controlled-eosinophilic-copd2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lunsekimig-in-adults-with-inadequately-controlled-eosinophilic-copd-phase-2b-3-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-luspatercept-versus-placebo-in-myeloproliferative-neoplasm-associated-myelofibrosis-with-jak2-inhibitor-therapy-requiring-rbc-transfusions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lutetium-177-vipivotide-tetraxetan-with-gozetotide-in-patients-with-progressive-adenoid-cystic-carcinoma-of-the-salivary-glands2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-lutetium-177lu-oxodotreotide-as-adjuvant-therapy-in-stage-iii-small-intestinal-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ly4005130-compared-with-placebo-in-adults-with-non-segmental-vitiligo-phase-2a2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-maintenance-cabozantinib-plus-best-supportive-care-in-pediatric-and-aya-patients-with-unresectable-residual-osteosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-maribavir-in-hsct-recipients-with-cytomegalovirus-infection-contraindicated-for-ganciclovir-valganciclovir-or-foscarnet2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-masitinib-dose-titration-in-primary-and-secondary-progressive-multiple-sclerosis-a-96-week-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-masitinib-plus-riluzole-versus-placebo-plus-riluzole-in-amyotrophic-lateral-sclerosis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mecloderm-cream-vs-lotricomb-cream-vs-vehicle-in-moderate-to-severely-inflamed-cutaneous-candidiasis-a-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-memantine-hydrochloride-in-adolescents-with-bipolar-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-met097-once-weekly-in-adults-with-overweight-or-obesity-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-methotrexate-methotrexate-disodium-and-adalimumab-in-non-infectious-non-anterior-uveitis-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mexiletine-hydrochloride-in-myotonic-dystrophy-type-1-and-2-a-randomized-double-blind-placebo-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mg01-and-t517-drug-combination-in-patients-with-allergic-rhinitis-or-rhinoconjunctivitis-with-or-without-mild-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mh002-in-adults-with-mild-to-moderate-ulcerative-colitis-not-adequately-controlled-by-5-asa2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mitapivat-in-pediatric-patients-with-pyruvate-kinase-deficiency-undergoing-regular-transfusions-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-mk-2060-in-preventing-arteriovenous-graft-thrombosis-in-end-stage-renal-disease-patients-undergoing-hemodialysis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ngm120-in-colorectal-cancer-patients-with-cancer-cachexia-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nicotinamide-in-type-2-diabetes-mellitus-and-hepatic-fibrosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nicotine-freshmint-mouthspray-for-vaping-cessation-in-e-cigarette-users-a-double-blind-placebo-controlled-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nipocalimab-in-adults-with-chronic-inflammatory-demyelinating-polyneuropathy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nipocalimab-vs-efgartigimod-in-a-randomized-open-label-phase-3b-interventional-trial-including-within-class-switching-from-efgartigimod-to-nipocalimab2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nnc0194-0499-and-semaglutide-in-non-alcoholic-steatohepatitis-with-fibrosis-stages-f2-f4-a-dose-ranging-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-normal-immunoglobulin-to-prevent-infections-in-patients-with-hypogammaglobulinemia-receiving-b-cell-depletion-therapy-for-autoimmune-rheumatic2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nt-201-in-treating-lower-limb-spasticity-post-stroke-or-traumatic-brain-injury-in-adults-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-nxt007-compared-with-emicizumab-prophylaxis-in-people-with-hemophilia-a2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oatd-01-in-adults-with-active-pulmonary-sarcoidosis-a-randomized-double-blind-placebo-controlled-12-week-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-obefazimod-abx464-in-adults-with-moderately-to-severely-active-ulcerative-colitis-a-randomized-placebo-controlled-phase-iii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-obefazimod-for-induction-in-adults-with-moderately-to-severely-active-ulcerative-colitis-randomized-double-blind-placebo-controlled-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-obeticholic-acid-in-pediatric-patients-with-biliary-atresia-post-hepatoportoenterostomy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-obinutuzumab-in-non-infectious-active-cryoglobulinemia-vasculitis-refractory-or-intolerant-to-rituximab-a-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-octreotide-subcutaneous-depot-cam2029-in-symptomatic-polycystic-liver-disease-a-randomized-placebo-controlled-double-blind-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-olaparib-as-adjuvant-therapy-in-germline-brca1-2-mutated-high-risk-her2-negative-primary-breast-cancer-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-om-85-in-pediatric-patients-with-recurrent-wheezing-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-atorvastatin-40-mg-as-prophylaxis-in-adults-with-chronic-migraine-a-multicentre-triple-blind-placebo-controlled-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-dronabinol-cannabidiol-solution-in-chronic-neuropathic-pain-due-to-multiple-sclerosis-a-phase-ii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-lucerastat-in-treatment-naive-adult-male-patients-with-fabry-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-lyophilized-allogeneic-faecal-microbiota-pooled-capsules-vs-placebo-in-patients-with-non-alcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-masitinib-in-severe-mast-cell-activation-syndrome-a-24-week-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-masitinib-versus-placebo-in-patients-with-smouldering-or-indolent-severe-systemic-mastocytosis-unresponsive-to-symptomatic-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-piclidenoson-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-roflumilast-in-adult-patients-with-chronic-hand-eczema-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-semaglutide-versus-placebo-in-combination-with-metformin-and-or-basal-insulin-in-pediatric-type-2-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-sirolimus-in-adult-patients-with-moderate-to-severe-facial-cutaneous-sarcoidosis-an-open-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-tti-0102-in-mitochondrial-encephalomyopathy-lactic-acidosis-and-stroke-like-episodes-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-oral-zasocitinib-in-moderate-to-severe-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-orforglipron-in-adults-with-type-2-diabetes-and-inadequate-glycemic-control-on-insulin-glargine-metformin-and-or-sglt-2-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-orforglipron-in-obesity-or-overweight-patients-with-and-without-type-2-diabetes-a-master-protocol-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-orforglipron-in-obstructive-sleep-apnea-with-obesity-or-overweight-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-osimertinib-in-egfr-mutant-stage-ia2-ia3-non-small-cell-lung-cancer-post-resection-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-osimertinib-versus-placebo-in-egfr-mutation-positive-stage-ib-iiia-non-small-cell-lung-carcinoma-post-tumor-resection2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-palbociclib-and-fulvestrant-in-hr-her2-advanced-breast-cancer-post-cdk4-6-inhibitor-therapy-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pasireotide-diaspartate-in-post-bariatric-hypoglycaemia-a-double-blind-randomized-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pembrolizumab-and-enfortumab-vedotin-with-without-investigational-agents-in-first-line-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pembrolizumab-and-lenvatinib-in-metastatic-uveal-melanoma-a-phase-ii-monocentric-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pembrolizumab-with-chemoradiotherapy-versus-chemoradiotherapy-alone-in-muscle-invasive-bladder-cancer-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pf-07275315-compared-with-placebo-in-adults-with-moderate-to-severe-copd-phase-2-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-photodynamic-therapy-with-5-aminolevulinic-acid-in-immunosuppressed-patients-with-actinic-keratosis-and-superficial-basal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-pitolisant-hydrochloride-in-prader-willi-syndrome-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-platelet-rich-plasma-vs-betamethasone-and-ropivacaine-injections-with-exercise-in-chronic-omalgia-due-to-rotator-cuff-tendinopathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-povorcitinib-in-a-52-week-randomized-double-blind-placebo-controlled-phase-3-trial-for-adult-nonsegmental-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-povorcitinib-in-prurigo-nodularis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-prednisone-and-azathioprine-in-biopsy-proven-virus-negative-myocarditis-or-inflammatory-cardiomyopathy-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-prednisone-plus-rivaroxaban-versus-prednisone-alone-in-deep-venous-thrombosis-of-behcet-s-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-prolonged-release-budesonide-versus-prednisone-in-pediatric-primary-iga-nephropathy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-prophylactic-nimodipine-for-hearing-preservation-post-vestibular-schwannoma-surgery-a-randomized-multicenter-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-propofol-pethidine-versus-midazolam-pethidine-for-analgosedation-in-bronchoscopic-procedures-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-psilocybin-comp360-in-adults-with-treatment-resistant-depression-a-phase-iii-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-qvm149-drug-combination-vs-salmeterol-fluticasone-drug-combination-in-adolescents-12-17-years-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-radioembolization-with-cisplatin-gemcitabine-and-durvalumab-in-unresectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-radium-223-dichloride-versus-novel-anti-hormonal-therapy-in-bone-dominant-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ramucirumab-combined-with-erlotinib-in-egfr-mutation-positive-metastatic-non-small-cell-lung-cancer-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ravulizumab-in-corticosteroid-resistant-idiopathic-iga-nephropathy-a-pilot-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-regn7508-compared-with-apixaban-for-treatment-and-prevention-of-cancer-associated-venous-thromboembolism-in-adults-with-solid-or-hematologic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-regn7544-in-sepsis-induced-hypotension-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-remibrutinib-in-adult-patients-with-papulopustular-rosacea-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-remibrutinib-in-adults-with-chronic-inducible-and-spontaneous-urticaria-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-remimazolam-compared-to-ketamine-and-propofol-in-rapid-sequence-induction-a-monocentric-pilot-randomised-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-reparixin-as-adjunctive-therapy-in-adult-patients-with-acute-respiratory-distress-syndrome-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rilzabrutinib-in-adults-with-warm-autoimmune-hemolytic-anemia-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-riociguat-in-early-pulmonary-vascular-disease-a-double-blind-randomized-placebo-controlled-phase-iia-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-risankizumab-as-maintenance-therapy-in-moderately-to-severely-active-ulcerative-colitis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-risankizumab-in-maintenance-and-long-term-extension-for-moderately-to-severely-active-crohn-s-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rituximab-for-the-management-of-grade-2-4-immune-related-adverse-events-induced-by-immune-checkpoint-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rituximab-versus-cyclophosphamide-in-severe-mucous-membrane-pemphigoid-a-randomized-double-blind-double-dummy-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rivaroxaban-versus-standard-care-in-patients-with-excessive-supraventricular-ectopy-or-short-atrial-runs-and-high-embolism-risk2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rly-2608-plus-fulvestrant-versus-capivasertib-plus-fulvestrant-in-pik3ca-mutant-hr-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ro7204239-and-tirzepatide-combination-in-obesity-patients-with-weight-related-comorbidities-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ro7288817-in-preventing-cardiac-surgery-associated-acute-kidney-injury-and-major-adverse-kidney-events-in-high-risk-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ro7790121-in-induction-and-maintenance-therapy-for-moderately-to-severely-active-crohn-s-disease-a-phase-iii-multicenter-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ro7790121-in-induction-and-maintenance-therapy-for-moderately-to-severely-active-ulcerative-colitis-a-phase-iii-multicenter-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ro7790121-induction-therapy-in-moderately-to-severely-active-crohn-s-disease-a-phase-iii-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rocatinlimab-in-adults-with-prurigo-nodularis-unresponsive-to-topical-therapies-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ropeginterferon-alfa-2b-with-bosutinib-in-chronic-myeloid-leukemia-a-randomized-prospective-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ropivacaine-hydrochloride-in-post-operative-analgesia-plane-block-vs-wound-infiltration-in-lumbar-arthrodesis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-rosuvastatin-and-rosuvastatin-ezetimibe-combination-in-high-risk-hyperlipidemia-patients-a-12-week-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ruxolitinib-cream-in-adults-with-moderate-atopic-dermatitis-a-phase-3b-double-blind-randomized-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ruxolitinib-cream-in-pediatric-patients-with-moderate-atopic-dermatitis-a-phase-3b-randomized-double-blind-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sar441566-and-methotrexate-in-adults-with-moderate-to-severe-rheumatoid-arthritis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sar443765-and-mometasone-furoate-in-adults-with-chronic-rhinosinusitis-with-nasal-polyps-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sar443765-in-adults-with-high-risk-asthma-ineligible-for-biologic-therapy-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sar445399-in-adults-with-moderate-to-severe-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-phase-2-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sarilumab-and-prednisone-in-adults-with-early-polymyalgia-rheumatica2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-satralizumab-in-adults-with-moderate-to-severe-thyroid-eye-disease-a-phase-iii-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-secukinumab-in-adult-patients-with-moderate-to-severe-rotator-cuff-tendinopathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-secukinumab-in-delaying-relapse-in-new-onset-giant-cell-arteritis-patients-in-clinical-remission2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-seltorexant-as-adjunctive-therapy-in-major-depressive-disorder-with-insomnia-symptoms-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-setanaxib-and-pembrolizumab-in-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-silexan-lavender-oil-in-mild-to-moderate-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sirolimus-in-drug-resistant-epilepsy-associated-with-tuberous-sclerosis-complex-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sirolimus-ophthalmic-suspension-in-fuchs-endothelial-corneal-dystrophy-a-phase-iia-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sirolimus-versus-vigabatrin-in-preventing-tuberous-sclerosis-complex-symptoms-in-infants-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sp16-in-preventing-acute-kidney-injury-in-at-risk-subjects-with-chronic-kidney-disease-undergoing-elective-cardiac-surgery-using-the-heart-lung-machine-a-prospective-randomized-2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-staccato-alprazolam-in-adolescents-and-adults-with-stereotypical-prolonged-seizures-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-statin-continuation-vs-discontinuation-in-patients-with-spontaneous-lobar-intracerebral-hemorrhage-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-amlitelimab-in-adults-with-non-responsive-celiac-disease-a-randomized-double-blind-placebo-controlled-phase-2a-b-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-anifrolumab-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-anifrolumab-versus-placebo-in-adult-idiopathic-inflammatory-myopathies-a-phase-iii-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-belimumab-in-adults-with-connective-tissue-disease-associated-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-belimumab-in-adults-with-early-systemic-lupus-erythematosus-a-phase-4-multicenter-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-dermatophagoides-allergoid-immunotherapy-in-allergic-rhinitis-rhinoconjunctivitis-with-or-without-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-guselkumab-in-active-psoriatic-arthritis-a-phase-3b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-guselkumab-in-active-psoriatic-arthritis-with-prior-anti-tnfa-agent-inadequate-response-a-phase-3b-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-guselkumab-in-bio-naive-patients-with-active-psoriatic-arthritis-axial-disease-a-phase-4-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-ixekizumab-versus-adalimumab-in-pediatric-enthesitis-related-arthritis-and-juvenile-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-risankizumab-induction-in-moderate-to-severe-crohn-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-subcutaneous-sonelokimab-versus-placebo-and-risankizumab-in-adults-with-active-psoriatic-arthritis-and-inadequate-response-to-tnf-a-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-sustained-release-dexamphetamine-and-piracetam-in-cocaine-use-disorder-with-comorbid-opioid-use-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tanimilast-dpi-as-add-on-to-triple-therapy-in-chronic-obstructive-pulmonary-disease-with-chronic-bronchitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-taplucainium-chloride-inhalation-powder-in-adults-with-refractory-or-unexplained-chronic-cough-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tar-200-vs-intravesical-chemotherapy-in-high-risk-non-muscle-invasive-bladder-cancer-post-bcg-recurrence2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-targeted-therapeutic-strategies-in-adults-with-rheumatoid-arthritis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-teplizumab-versus-placebo-in-stage-3-type-1-diabetes-patients-aged-1-25-a-randomized-double-blind-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tezepelumab-in-eosinophilic-esophagitis-a-randomized-double-blind-placebo-controlled-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tezepelumab-in-reducing-oral-corticosteroid-use-in-adults-with-oral-corticosteroid-dependent-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tianeptine-sodium-in-treating-cognitive-dysfunction-post-covid-19-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tildrakizumab-in-anti-tnf-experienced-patients-with-active-psoriatic-arthritis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tildrakizumab-in-anti-tnf-naive-patients-with-active-psoriatic-arthritis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tiotropium-bromide-monohydrate-in-preventing-severe-asthma-exacerbations-in-preschool-children-with-partial-and-uncontrolled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tirofiban-versus-intravenous-acetylsalicylic-acid-in-endovascular-treatment-of-acute-ischemic-stroke-with-tandem-lesion2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tirzepatide-versus-placebo-in-adolescents-with-obesity-and-weight-related-comorbidities-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tofacitinib-in-early-active-axial-spondyloarthritis-a-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tolebrutinib-in-primary-progressive-multiple-sclerosis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-topical-tiotropium-bromide-monohydrate-gel-in-severe-primary-hand-hyperhidrosis-a-randomized-double-blind-vehicle-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-tranexamic-acid-oral-solution-5-in-preventing-postoperative-bleeding-in-patients-on-anticoagulants-undergoing-dental-extractions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-trimodulin-bt588-in-hospitalized-adults-with-non-severe-cap-or-moderate-severe-covid-19-a-randomized-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-upacicalcet-sodium-hydrate-in-patients-with-secondary-hyperparathyroidism-on-maintenance-hemodialysis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-upacicalcet-sodium-hydrate-in-secondary-hyperparathyroidism-in-end-stage-kidney-disease-patients-on-hemodialysis-a-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-upadacitinib-in-idiopathic-inflammatory-myopathies-post-ivig-withdrawal-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-upadacitinib-in-maintenance-and-long-term-extension-for-crohn-s-disease-post-induction-responders2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-valaciclovir-in-dose-dependent-prevention-and-treatment-of-primary-cytomegalovirus-infection-in-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-vidofludimus-calcium-compared-with-placebo-in-adults-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-ycj-01-dronabinol-cannabidiol-in-refractory-epilepsy-associated-with-tuberous-sclerosis-complex-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-zanidatamab-with-cisplatin-and-gemcitabine-in-advanced-her2-positive-biliary-tract-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-zolbetuximab-with-nab-paclitaxel-and-gemcitabine-in-claudin-18-2-positive-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-of-zoledronic-acid-versus-sodium-chloride-in-patients-with-chronic-low-back-pain-and-modic-changes-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-safety-study-of-acasunlimab-as-monotherapy-and-in-combination-with-pembrolizumab-in-subjects-with-relapsed-refractory-unresectable-locally-advanced-or-metastatic-cutaneous-melanoma-that-p2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ap707-in-patients-with-chronic-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ap707-in-patients-with-chronic-pain-due-to-central-neuropathy-of-any-genesis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ap707-in-patients-with-chronic-pain-due-to-diabetic-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ap707-in-patients-with-chronic-pain-due-to-traumatic-or-post-operative-peripheral-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-bh-200-nelivaptan-in-v1b-high-outpatients-with-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-budesonide-orodispersible-tablets-in-preventing-esophageal-strictures-post-endoscopic-submucosal-dissection-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-diclofenac-potassium-and-thiocolchicoside-fixed-dose-combination-vs-diclofenac-potassium-in-adults-with-acute-severe-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-fixed-duration-teclistamab-and-talquetamab-for-frail-patients-with-newly-diagnosed-multiple-myeloma-2-cohort-study-the-emn-37-fitfix-for-frail-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-horse-chestnut-seed-extract-on-swelling-in-patients-undergoing-meniscus-surgery-a-placebo-controlled-randomized-double-blind-single-center-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ketotifen-nasal-spray-0-025-and-0-050-compared-with-sodium-cromoglicate-nasal-spray-in-patients-with-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-ofatumumab-versus-first-line-disease-modifying-therapies-in-newly-diagnosed-relapsing-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-rimegepant-in-acute-migraine-treatment-for-adults-contraindicated-for-triptans-a-phase-4-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-siltuximab-plus-corticosteroids-in-first-line-treatment-of-grade-iii-iv-acute-graft-versus-host-disease-of-the-liver-and-gastrointestinal-tract2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-tasipimidine-after-3-repeated-bed-time-doses-in-patients-with-insomnia-disorder-with-a-4-week-extension-part2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-transmucosal-midazolam-for-proportional-palliative-sedation-in-children-with-refractory-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerability-of-zed1227-in-patients-with-celiac-disease-experiencing-symptoms-despite-a-gluten-free-diet-a-randomized-double-blind-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerance-of-fludrocortisone-acetate-in-neurogenic-orthostatic-hypotension-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-and-tolerance-of-solriamfetol-in-idiopathic-hypersomnia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-assessment-of-induction-carboplatin-paclitaxel-and-pembrolizumab-in-locoregionally-advanced-penile-cancer-a-phase-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-assessment-of-ublituximab-in-combination-with-cetirizine-dexamethasone-paracetamol-methylprednisolone-and-diphenhydramine-in-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-brigatinib-versus-second-generation-tkis-in-first-line-treatment-of-locally-advanced-or-metastatic-alk-positive-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-monthly-bolus-versus-daily-colecalciferol-supplementation-in-correcting-vitamin-d-deficiency-in-obese-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-nivolumab-and-ipilimumab-versus-pazopanib-in-metastatic-or-unresectable-advanced-rare-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-nivolumab-ipilimumab-versus-immune-checkpoint-inhibitor-vegfr-tki-combinations-in-untreated-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-oral-alitretinoin-and-ciclosporin-in-moderate-to-very-severe-hand-eczema-a-randomized-prospective-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-comparison-of-zanzalintinib-xl092-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-pd-l1-positive-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-2lebv-and-2lxfs-on-asthenia-in-epstein-barr-virus-infected-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-2lherp-r-in-reducing-recurrent-orofacial-herpes-episodes-a-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-acalabrutinib-and-tafasitamab-in-relapsed-or-refractory-marginal-zone-lymphoma-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-acalabrutinib-venetoclax-and-rituximab-in-treatment-naive-mantle-cell-lymphoma-a-phase-ii-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-amlenetug-lu-af82422-in-clinical-progression-of-multiple-system-atrophy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-atezolizumab-bevacizumab-and-exl01-in-hepatocellular-carcinoma-patients-resistant-to-first-line-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-brexucabtagene-autoleucel-in-relapsed-refractory-mantle-cell-lymphoma-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-ceritinib-and-nivolumab-in-alk-positive-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-crizotinib-in-pediatric-patients-with-severe-neurofibromatosis-type-2-excluded-from-surgical-and-radiotherapeutic-interventions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-descartes-08-in-generalized-myasthenia-gravis-a-randomized-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-diclofenac-potassium-and-rimegepant-in-acute-migraine-treatment-a-randomized-parallel-group-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-equine-immunoglobulin-f-ab-2-fragments-targeting-shiga-toxin-in-pediatric-hemolytic-uremic-syndrome-induced-by-shiga-toxin-producing-e-coli2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-erdafitinib-in-advanced-solid-tumors-with-fgfr-gene-alterations-a-phase-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-interferon-alfa-interleukin-1-interleukin-2-and-nucleic-acid-combination-in-non-genital-warts-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-intravenous-prasinezumab-ro7046015-in-early-idiopathic-parkinson-s-disease-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-evaluation-of-oral-pyridoxal-phosphate-in-patients-with-seizures-due-to-pyridox-am-ine-5-phosphate-oxidase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-immunogenicity-and-safety-of-ovx836-influenza-vaccine-in-preventing-rt-pcr-confirmed-influenza-type-a-in-healthy-adults-aged-18-59-a-phase-2b-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-2lpapi-on-clearance-of-genital-high-risk-human-papillomavirus-infections-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-a-polymerized-mannan-conjugated-phleum-pratense-and-dactylis-glomerata-allergoid-vaccine-in-patients-with-grass-pollen-allergic-rhinitis-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-a-sequential-treatment-strategy-in-rheumatoid-arthritis-a-randomized-controlled-trial-with-an-independent-efficacy-assessor2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-a-single-intravenous-dose-of-sgt-003-in-ambulatory-male-patients-with-duchenne-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-abatacept-in-reducing-recurrence-risk-in-patients-with-igg4-related-disease-a-48-week-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-acetylsalicylic-acid-in-preventing-maternal-fetal-morbidity-in-pregnant-women-with-chronic-hypertension-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-add-on-cannabidiol-and-dronabinol-in-pediatric-refractory-epilepsy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-adjuvant-hepatic-arterial-infusion-of-floxuridine-post-resection-in-low-risk-resectable-colorectal-liver-metastases-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-allogeneic-bone-marrow-derived-mesenchymal-stromal-cells-and-biomaterial-in-delayed-union-and-non-union-long-bone-fractures2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-allogeneic-faecal-microbiota-transplantation-in-axial-spondyloarthritis-resistant-to-conventional-treatment-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-amiloride-hydrochloride-dihydrate-in-prophylaxis-of-migraine-with-aura-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-amiloride-in-treating-nephrogenic-diabetes-insipidus-in-bipolar-disorder-patients-on-long-term-lithium-therapy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-amoxicillin-trihydrate-and-potassium-clavulanate-post-surgical-drainage-in-preventing-anal-fistula-in-initial-perianal-abscess-cases2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-anakinra-versus-placebo-in-pediatric-acute-myocarditis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-annual-vs-semi-annual-ocrelizumab-infusions-on-radiological-disease-activity-in-active-multiple-sclerosis-a-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-anti-calcitonin-gene-related-peptide-antibody-therapy-for-the-prevention-of-chronic-headache-in-patients-with-idiopathic-intracranial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-apixaban-in-pain-management-for-patients-with-venous-malformations-and-localized-intravascular-coagulation-a-blinded-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-apixaban-versus-standard-care-in-patients-with-intracerebral-hemorrhage-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-asciminib-in-chronic-phase-chronic-myeloid-leukemia-patients-with-t315i-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-atorvastatin-in-mitigating-progression-of-arrhythmogenic-cardiomyopathy-in-patients-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-atropine-sulfate-monohydrate-eye-drops-in-slowing-myopia-progression-in-pediatric-patients-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-autologous-adipose-derived-stromal-vascular-fraction-injection-versus-placebo-in-patients-with-scarred-vocal-folds2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-autologous-platelet-rich-plasma-and-hyaluronic-acid-versus-estriol-in-genitourinary-syndrome-of-menopause-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-baricitinib-in-relapsing-or-naive-dermatomyositis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-baricitinib-in-treating-new-onset-juvenile-dermatomyositis-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-belatacept-versus-tacrolimus-in-subclinical-antibody-mediated-rejection-in-kidney-transplant-recipients-with-de-novo-donor-specific-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-belumosudil-mesilate-and-anhydrous-azithromycin-in-chronic-lung-allograft-dysfunction-post-bilateral-lung-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bemarituzumab-with-irinotecan-paclitaxel-ramucirumab-or-trifluridine-tipiracil-in-fgfr2b-positive-advanced-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-beta-blockers-and-antiplatelet-agents-in-spontaneous-coronary-artery-dissection-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-betamethasone-sodium-phosphate-in-pediatric-acute-facial-nerve-palsy-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-betamethasone-sodium-phosphate-in-pediatric-symptomatic-adenovirus-infection-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-betamethasone-sodium-phosphate-in-preventing-recurrent-wheezing-and-asthma-in-pediatric-patients-with-rhinovirus-induced-acute-wheezing2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bezafibrate-in-primary-sclerosing-cholangitis-with-persistent-cholestasis-despite-ursodeoxycholic-acid-therapy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bilateral-greater-occipital-nerve-block-with-lidocaine-hydrochloride-in-headache-management-post-spontaneous-subarachnoid-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bilateral-superficial-parasternal-intercostal-plane-block-with-ropivacaine-hydrochloride-in-postoperative-recovery-of-cardiac-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-botulinum-toxin-type-a-in-sphenopalatine-ganglion-blockade-for-refractory-chronic-cluster-headache-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-botulinum-toxin-type-a-in-sphenopalatine-ganglion-blockade-for-treatment-refractory-chronic-migraine-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bumetanide-in-enhancing-cognitive-function-in-pediatric-and-adolescent-down-syndrome-a-phase-2-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-bupropion-hydrochloride-for-treating-fatigue-in-patients-with-long-covid-post-covid-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cabergoline-in-reducing-migraine-frequency-in-patients-with-episodic-migraine-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-calcium-folinate-in-kearns-sayre-syndrome-with-cerebral-folate-deficiency-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cannabidiol-and-risperidone-in-treating-non-affective-psychosis-and-cannabis-use-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cerebrolysin-and-sodium-chloride-in-post-acute-ischemic-stroke-recovery-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-certolizumab-pegol-in-adult-women-with-unexplained-recurrent-implantation-failure-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cholecalciferol-in-managing-vitamin-d-deficiency-and-insufficiency-in-postmenopausal-women-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-choline-alfoscerate-in-subthreshold-depression-among-elderly-patients-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-citalopram-in-patients-with-reflux-hypersensitivity-or-functional-heartburn-unresponsive-to-proton-pump-inhibitors-a-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-clostridium-botulinum-neurotoxin-type-a-injections-for-postoperative-atrial-fibrillation-prevention-in-cardiac-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-clostridium-botulinum-neurotoxin-type-a-versus-placebo-in-reducing-sciatic-pain-in-piriformis-muscle-syndrome-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cobolimab-dostarlimab-and-docetaxel-in-advanced-non-small-cell-lung-cancer-post-anti-pd-l-1-therapy-and-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-colchicine-in-treating-inflammatory-cardiomyopathy-a-single-blinded-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-colchicine-versus-placebo-in-reducing-late-gadolinium-enhancement-in-acute-myocarditis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-colecalciferol-supplementation-in-patients-with-chronic-periodontitis-and-vitamin-d-deficiency-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-composite-personalized-care-with-calcium-folinate-omega-3-acid-ethyl-esters-90-cyanocobalamin-and-acetylcysteine-in-early-psychosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-cyclosporine-a-versus-placebo-in-reducing-myocardial-damage-in-takotsubo-syndrome-a-phase-ii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dalbavancin-and-rifampicin-in-treating-staphylococcal-prosthetic-joint-infections-in-hip-knee-and-shoulder-prostheses2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dapagliflozin-in-reducing-postoperative-atrial-fibrillation-and-acute-kidney-injury-in-patients-undergoing-coronary-artery-bypass-grafting2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dapagliflozin-on-cardiac-systolic-function-and-remodeling-in-acute-myocardial-infarction-patients-with-left-ventricular-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-daridorexant-in-adolescents-with-nocturnal-enuresis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-daridorexant-in-treating-insomnia-in-patients-with-mild-cognitive-impairment-and-mild-to-moderate-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-daridorexant-on-cognitive-performance-in-patients-with-chronic-insomnia-disorder-a-real-world-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-darolutamide-and-bipolar-androgen-therapy-in-metastatic-castration-resistant-prostate-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-denosumab-in-treating-acute-charcot-neuroarthropathy-in-diabetic-patients-a-multicenter-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-deucravacitinib-in-patients-with-lichen-planus-a-multicenter-phase-ii-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dexamethasone-and-olanzapine-in-patients-resuscitated-from-out-of-hospital-cardiac-arrest-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dexamethasone-olanzapine-hemodynamic-management-and-ventilation-strategies-in-elective-cardiac-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dexamethasone-phosphate-and-sodium-chloride-in-severe-hospital-acquired-pneumonia-with-proinflammatory-phenotype-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dimethyl-fumarate-in-reducing-geographic-atrophy-progression-in-patients-with-dry-age-related-macular-degeneration-a-12-month-comparative-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dostarlimab-as-neoadjuvant-therapy-in-mmrd-msi-h-stage-ii-iii-endometrial-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dostarlimab-in-fertility-sparing-treatment-of-young-women-with-newly-diagnosed-dmmr-endometrial-carcinoma-choose-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-doxycycline-monohydrate-in-reducing-bacterial-stis-in-msm-and-tgw-with-hiv-a-randomized-double-blind-placebo-controlled-cross-over-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dupilumab-added-to-standard-care-versus-standard-care-alone-in-adults-hospitalized-for-copd-exacerbation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dupilumab-in-a-randomized-double-blind-placebo-controlled-trial-for-nummular-eczema2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-dupilumab-with-medium-dose-ics-laba-vs-high-dose-ics-laba-in-adolescents-and-adults-with-uncontrolled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-durvalumab-and-tremelimumab-as-consolidation-therapy-in-limited-stage-small-cell-lung-cancer-post-concurrent-chemoradiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-durvalumab-with-folfox-and-imrt-in-localized-unresectable-esophageal-adenocarcinoma-or-squamous-cell-carcinoma-a-phase-ii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-durvalumab-with-platinum-based-chemoradiation-in-locally-advanced-unresectable-non-small-cell-lung-cancer-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-early-intravenous-high-dose-vitamin-c-in-post-cardiac-arrest-shock-a-multicenter-randomized-controled-to-standard-treatment-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-eculizumab-in-hypertensive-emergency-associated-hemolytic-uremic-syndrome-with-severe-renal-impairment-a-randomized-multicenter-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-efanesoctocog-alfa-in-patients-with-congenital-hemophilia-a-and-synovitis-a-phase-3-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-efgartigimod-alfa-as-first-line-add-on-to-intravenous-methylprednisolone-in-patients-with-moderate-to-severe-attacks-of-multiple-sclerosis-nmosd-or-mogad2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-efgartigimod-alfa-in-cognitive-impairment-of-autoimmune-dementia-a-double-blind-randomized-placebo-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-eptinezumab-as-adjunctive-therapy-in-preventing-migraine-and-treating-medication-overuse-headache-in-patients-with-dual-diagnosis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-erector-spinae-plane-block-with-ropivacaine-hydrochloride-in-acute-renal-colic-pain-management-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-esmolol-hydrochloride-in-diagnosing-cardiovascular-disorders-induced-by-cirrhosis-diabetes-mellitus-and-cardiotoxic-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-etifoxine-in-adults-with-adjustment-disorder-with-anxiety-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-etoricoxib-and-celecoxib-in-postoperative-pain-management-following-mandibular-third-molar-extraction-a-randomized-double-masked-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-evolocumab-versus-standard-care-in-ldl-c-reduction-for-acute-myocardial-infarction-patients-undergoing-percutaneous-coronary-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-fampridine-in-spinocerebellar-ataxia-sca27b-with-fgf14-gene-gaa-expansion-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-faricimab-in-patients-with-subretinal-hyperreflective-material-associated-with-type-2-or-mixed-neovascular-membranes-assessed-by-multimodal-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-first-line-bortezomib-rituximab-ibrutinib-b-ri-for-patients-with-treatment-naive-waldenstrom-s-macroglobulinemia-a-multicenter-open-label-single-arm-european-phase-ii-study-ecwm-22026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-flecainide-monotherapy-versus-flecainide-with-beta-blockers-or-calcium-channel-blockers-in-andersen-tawil-syndrome-and-meppc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-fluoxetine-added-to-usual-anti-seizure-treatment-in-children-8-years-with-drug-resistant-complex-and-rare-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-fluoxetine-and-internet-based-cognitive-behavioral-therapy-in-reducing-problematic-sexual-behaviors-in-men-with-pedophilic-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-gemcitabine-hydrochloride-and-cisplatin-versus-standard-care-in-post-resection-cholangiocarcinoma-and-muscle-invasive-gallbladder-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-glofitamab-and-pirtobrutinib-in-relapsed-refractory-and-treatment-naive-mantle-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-glyceryl-trinitrate-in-esophageal-food-impaction-a-multicenter-double-blind-randomized-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-golcadomide-post-cd19-car-t-cell-therapy-in-relapsed-refractory-aggressive-large-b-cell-lymphoma-at-high-relapse-risk2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-human-albumin-solution-and-ringer-lactate-versus-ringer-lactate-in-fluid-management-during-cytoreductive-surgery-with-hipec2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-hydroxychloroquine-sulfate-in-reducing-gfr-decline-in-biopsy-proven-iga-nephropathy-with-albuminuria-despite-raas-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ibrutinib-in-treating-autoimmune-hemolytic-anemia-in-patients-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-or-cll-like-mbl2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-imatinib-in-acute-ischemic-stroke-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-imatinib-resumption-with-atezolizumab-vs-imatinib-alone-in-unresectable-advanced-gastrointestinal-stromal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-imlifidase-combined-with-standard-of-care-in-severe-anca-associated-vasculitis-with-pulmonary-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-inclisiran-alirocumab-and-rosuvastatin-in-pediatric-heterozygous-familial-hypercholesterolemia-a-comparative-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-infiltrated-mepivacaine-as-a-local-anesthetic-prior-to-arterial-puncture-a-randomized-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-inhaled-aprotinin-in-moderate-to-severe-acute-respiratory-distress-syndrome-a-multicenter-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-inhaled-tranexamic-acid-and-terlipressin-in-the-immediate-management-of-mild-to-severe-hemoptysis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-injectable-gentamicin-sulfate-in-moderate-to-severe-congenital-ichthyosis-with-nonsense-mutation-a-phase-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intra-articular-onabotulinumtoxina-and-sodium-chloride-injections-in-base-of-thumb-osteoarthritis-a-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intra-articular-triamcinolone-acetonide-sodium-chloride-and-occupational-therapy-in-carpometacarpal-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intranasal-oxytocin-in-preventing-relapse-in-patients-with-substance-use-disorder-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intraoperative-methadone-hydrochloride-versus-fentanyl-citrate-and-oxycodone-hydrochloride-in-postoperative-pain-management-for-coronary-artery-bypass-grafting-and-valve-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intrapapillary-clostridium-botulinum-neurotoxin-type-a-injection-in-preventing-postoperative-pancreatic-fistula-following-distal-pancreatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intratumoral-bifikafusp-alfa-and-onfekafusp-alfa-in-stage-iiib-c-melanoma-patients-undergoing-surgery-and-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intravenous-flecainide-acetate-with-oral-ranolazine-vs-intravenous-flecainide-acetate-in-cardioversion-of-recent-onset-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intravenous-glenzocimab-in-patients-with-anterior-ischemic-stroke-and-large-core-eligible-for-endovascular-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intravesical-extract-of-fresh-ash-mistletoe-herb-versus-mitomycin-c-in-intermediate-risk-superficial-bladder-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intravesical-oxybutynin-in-children-with-neurogenic-bladder-dysfunction-a-randomized-prospective-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-intravitreal-bevacizumab-as-initial-and-adjuvant-therapy-in-coats-disease-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-iv-prasinezumab-in-parkinson-s-disease-patients-with-gba-mutation-to-prevent-cognitive-decline-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ivabradine-hydrochloride-in-heart-rate-control-and-28-day-survival-in-adult-patients-with-septic-shock-a-randomized-multi-stage-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ixekizumab-versus-methotrexate-in-psoriatic-arthritis-dactylitis-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ketamine-and-midazolam-hydrochloride-in-adults-with-comorbid-depression-and-alcohol-use-disorder-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ketamine-propofol-and-ketamine-propofol-combination-for-rapid-sequence-induction-in-patients-at-risk-of-aspiration-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-lenvatinib-in-locally-advanced-or-metastatic-gastrointestinal-stromal-tumors-post-imatinib-and-sunitinib-failure-a-phase-ii-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-letermovir-for-cytomegalovirus-prophylaxis-in-heart-transplant-recipients-a-non-randomized-cohort-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-leuprorelin-acetate-in-reducing-liver-growth-in-premenopausal-women-with-severe-polycystic-liver-disease-a-randomized-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-levobupivacaine-hydrochloride-for-post-endoscopic-submucosal-dissection-pain-in-esophageal-lesions-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-lidocaine-hydrochloride-betamethasone-and-sodium-chloride-injections-in-patients-with-adhesive-capsulitis-frozen-shoulder2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-lidocaine-hydrochloride-monohydrate-and-sodium-chloride-in-chronic-idiopathic-ano-perineal-pain-a-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-lithium-sulphate-in-preventing-cognitive-processing-speed-impairment-post-cns-radiotherapy-in-pediatric-brain-tumor-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-loncastuximab-tesirine-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-and-high-grade-b-cell-lymphoma-post-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-luspatercept-in-erythropoiesis-stimulating-agent-naive-lower-risk-myelodysplastic-syndromes-with-anemia-and-transfusion-independence2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ly4395089-plus-mirikizumab-versus-mirikizumab-alone-in-adults-with-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-melatonin-and-low-dose-quetiapine-in-adolescents-with-psychiatric-disorders-and-comorbid-insomnia-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-melatonin-and-low-dose-quetiapine-versus-placebo-in-patients-with-psychiatric-disorders-and-comorbid-insomnia-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-methylprednisolone-acetate-and-n-acetylcysteine-in-severe-acute-alcoholic-hepatitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-methylprednisolone-and-prednisone-versus-placebo-in-acute-exacerbation-of-idiopathic-pulmonary-fibrosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-mirikizumab-to-achieve-healing-of-the-intestinal-wall-in-patients-with-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-naloxegol-oxalate-in-preventing-opioid-induced-gastrointestinal-motility-disorders-in-patients-with-brain-injury-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-nintedanib-in-reducing-epistaxis-duration-in-hereditary-hemorrhagic-telangiectasia-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-nintedanib-in-reducing-total-lesion-glycolysis-in-adult-unicentric-hyalino-vascular-castleman-s-disease-over-6-month-treatment-period2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-niraparib-tosilate-monohydrate-rechallenge-post-surgery-in-ovarian-cancer-with-oligometastatic-progression-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-nivolumab-in-patients-with-nasopharyngeal-carcinoma-post-progression-on-platinum-based-chemotherapy-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-non-operative-treatment-with-amoxicillin-clavulanic-acid-versus-surgical-treatment-in-acute-uncomplicated-appendicitis-in-children-a-prospective-multicenter-randomized-controlled-non-infer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-om-85-in-preventing-recurrent-respiratory-tract-infections-with-wheezing-in-children-aged-6-months-to-5-years-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-om-89-versus-placebo-in-reducing-antibiotic-use-for-recurrent-urinary-tract-infections-in-patients-with-neurogenic-bladder-a-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-on-demand-anakinra-in-colchicine-resistant-familial-mediterranean-fever-patients-refusing-continuous-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-onc201-and-everolimus-with-radiotherapy-in-newly-diagnosed-diffuse-midline-gliomas-h3k28m-mutant-or-ezhip-positive-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-oral-dapagliflozin-10-mg-as-vasculoprotective-therapy-in-septic-shock-patients-with-microcirculatory-dysfunction-glifloshock2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-oral-gentamicin-and-metronidazole-in-reducing-intestinal-necrosis-or-mortality-in-acute-mesenteric-ischemia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-oral-lidocaine-hydrochloride-monohydrate-ore-001-in-reducing-postoperative-ileus-in-patients-undergoing-longitudinal-laparotomy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-oral-prednisolone-versus-placebo-in-the-management-of-acute-laryngitis-in-vocal-professionals-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-oral-sodium-hydrogen-carbonate-and-intravenous-hyoscine-butylbromide-in-facilitating-spontaneous-delivery-in-labor-induction-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-osimertinib-and-savolitinib-in-egfrm-and-met-advanced-or-metastatic-nsclc-post-osimertinib-progression2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-osimertinib-and-savolitinib-in-egfrm-met-advanced-or-metastatic-non-small-cell-lung-cancer-post-osimertinib-progression2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-osimertinib-in-treatment-naive-patients-with-egfr-mutant-nsclc-stratified-by-tp53-mutational-status2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pd-l1-and-tigit-targeting-in-tls-positive-advanced-or-metastatic-nsclc-in-systemically-naive-or-chemotherapy-and-pd1-pdl1-antagonist-treated-adults2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pegipanermin-xpro1595-in-early-alzheimer-s-disease-with-inflammatory-biomarkers-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pembrolizumab-and-cabozantinib-in-advanced-undifferentiated-pleomorphic-sarcoma-osteosarcoma-and-ewing-sarcoma-a-clinical-trial-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pembrolizumab-and-lenvatinib-maintenance-therapy-post-chemoradiation-in-locally-advanced-pd-l1-positive-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pembrolizumab-in-locally-advanced-unresectable-non-metastatic-dmmr-colorectal-cancer-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pembrolizumab-in-perioperative-management-of-localized-non-metastatic-msi-dmmr-carcinomas-and-ebv-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-pembrolizumab-in-progressive-multifocal-leukoencephalopathy-in-immunocompromised-patients-excluding-hiv-and-biologic-induced-immunosuppression2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-perioperative-duloxetine-in-reducing-chronic-postsurgical-pain-incidence-in-high-risk-patients-post-inguinal-hernia-repair-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-phage-therapy-combined-with-standard-treatment-versus-standard-treatment-plus-placebo-in-staphylococcus-aureus-infected-diabetic-foot-ulcers2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-plasma-rich-in-growth-factors-in-treating-diabetic-foot-ulcers-with-peripheral-arterial-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ponatinib-and-blinatumomab-versus-chemotherapy-and-imatinib-in-adult-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ponatinib-vs-imatinib-with-low-intensity-chemotherapy-in-adults-with-de-novo-ph-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-post-resection-chemotherapy-with-irinotecan-fluorouracil-and-oxaliplatin-in-metastatic-colorectal-cancer-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-prednisolone-and-losartan-potassium-in-post-acute-covid-19-inflammatory-cardiovascular-involvement-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-prophylactic-polyethylene-glycol-3350-with-electrolytes-in-preventing-constipation-in-critically-ill-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-prophylactic-rituximab-in-preventing-ebv-infection-and-ptld-in-ebv-negative-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-propranolol-in-treating-central-nervous-system-hemangioblastomas-in-von-hippel-lindau-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-prucalopride-in-patients-with-gastro-esophageal-reflux-disease-and-incomplete-proton-pump-inhibitor-response-a-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-psma-pet-imaging-with-gozetotide-in-intermediate-or-high-risk-prostate-cancer-prior-to-curative-intent-radiotherapy-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-purethal-mites-mixture-subcutaneous-immunotherapy-in-adults-with-moderate-to-severe-house-dust-mite-induced-allergic-rhinitis-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-retifanlimab-tuparstobart-and-anti-tim-3-in-pd-l1-positive-recurrent-metastatic-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-rituximab-in-reducing-glucocorticoid-exposure-in-patients-with-newly-diagnosed-polymyalgia-rheumatica-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-rituximab-in-reducing-glucocorticoid-exposure-in-patients-with-relapsing-polymyalgia-rheumatica-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-rituximab-in-restoring-ovarian-function-in-autoimmune-premature-ovarian-insufficiency-a-double-blind-placebo-controlled-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-rituximab-versus-placebo-in-anti-mag-neuropathy-patients-with-predicted-good-response-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-roluperidone-versus-drug-combination-in-adults-with-schizophrenia-and-negative-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ropivacaine-hydrochloride-and-epinephrine-in-periarticular-infiltration-vs-erector-spinae-plane-block-for-lumbar-arthrodesis-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ropivacaine-hydrochloride-in-medial-transversus-abdominis-plane-and-rectus-sheath-blocks-for-inguinal-hernia-surgery-recovery2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-s-ibuprofen-dexibuprofen-gel-with-paracetamol-for-pain-in-patients-with-acute-soft-tissue-contusions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-sacituzumab-govitecan-versus-standard-of-care-in-metastatic-refractory-colorectal-cancer-a-phase-ii-iii-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-sivelestat-in-patients-with-septic-coagulopathy-a-phase-iib-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-sodium-valproate-in-preserving-auditory-function-in-patients-with-wolfram-syndrome-due-to-monogenic-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-subcutaneous-infliximab-monotherapy-versus-infliximab-with-immunosuppression-in-moderate-to-severe-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-sublingual-dexmedetomidine-and-buccal-midazolam-versus-oral-lorazepam-for-acute-agitation-management-in-emergency-psychiatry2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-teclistamab-plus-pomalidomide-in-patients-with-relapsed-refractory-multiple-myeloma-who-received-1-3-prior-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tezepelumab-in-patients-with-bronchiolitis-obliterans-syndrome-after-allogeneic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tezepelumab-in-progressive-pulmonary-fibrosis-with-eosinophilia-a-phase-ii-randomized-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tirzepatide-monotherapy-on-endogenous-insulin-production-in-patients-with-wolfram-syndrome-type-12026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tislelizumab-and-spartalizumab-in-patients-with-pd1-high-mrna-expressing-metastatic-tumors-a-multicancer-type-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tislelizumab-versus-placebo-in-patients-with-molecular-residual-disease-post-curative-therapy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tocilizumab-in-chronic-active-antibody-mediated-rejection-in-kidney-transplant-recipients-a-randomized-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tocilizumab-with-steroids-in-giant-cell-arteritis-with-cerebrovascular-involvement-a-randomized-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-topical-acetic-acid-in-enhancing-healing-of-biofilm-associated-cutaneous-ulcers-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-topical-hydrocortisone-sodium-phosphate-and-dexamethasone-phosphate-versus-povidone-in-treating-inflammatory-conjunctival-secretions-in-ocular-prosthesis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-topical-sinecatechins-as-adjuvant-to-trichloroacetic-acid-in-treating-anal-high-grade-squamous-intraepithelial-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-topical-somatostatin-coliriobcn070660-in-moderately-severe-to-severe-non-proliferative-diabetic-retinopathy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tranexamic-acid-in-reducing-perioperative-blood-loss-in-patients-with-hip-fracture-a-randomized-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-transdermal-capsaicin-8-versus-low-dose-capsaicin-0-04-in-neuropathic-pain-associated-digital-osteoarthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-tuvusertib-in-recurrent-idh-mutant-astrocytoma-with-atrx-mutation-a-phase-ii-prospective-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-urea-in-treating-hyponatremia-associated-with-subarachnoid-hemorrhage-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ursodeoxycholic-acid-versus-corticosteroids-for-the-treatment-of-cholestatic-hepatitis-secondary-to-immunotherapy-a-multicenter-controlled-randomized-open-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-ustekinumab-in-patients-with-moderate-to-severe-crohn-s-disease-and-active-perianal-fistulas-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-valsartan-in-reducing-aortic-root-dilatation-in-pediatric-and-young-adult-patients-with-marfan-type-heritable-thoracic-aortic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-vedolizumab-versus-adalimumab-dose-intensification-in-crohn-s-disease-patients-with-secondary-loss-of-response-to-adalimumab2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-venetoclax-and-azacitidine-versus-standard-chemotherapy-in-newly-diagnosed-acute-myeloid-leukemia-with-npm1-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-venetoclax-and-decitabine-in-acute-myeloid-leukemia-secondary-to-myeloproliferative-neoplasms-unfit-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-venetoclax-and-dexamethasone-in-translocation-11-14-positive-relapsed-and-refractory-multiple-myeloma-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-venetoclax-in-combination-with-rituximab-in-waldenstrom-s-macroglobulinemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-venetoclax-plus-cytarabine-versus-idarubicin-plus-cytarabine-in-post-remission-therapy-for-elderly-patients-with-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-vitex-agnus-castus-bno-1095-in-the-management-of-primary-dysmenorrhea-in-women-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-volrustomig-medi5752-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-in-metastatic-non-small-cell-lung-cancer-with-pd-l1-12026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-zelpultide-alfa-in-preventing-bronchopulmonary-dysplasia-in-high-risk-preterm-neonates-a-phase-3-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-zolbetuximab-plus-capox-versus-placebo-plus-capox-in-claudin-18-2-positive-her2-negative-advanced-gastric-or-gej-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-zolbetuximab-plus-mfolfox6-versus-placebo-plus-mfolfox6-in-claudin-18-2-positive-her2-negative-metastatic-gastric-or-gej-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-zoledronic-acid-in-the-management-of-hip-osteoarthritis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-of-zoledronic-acid-or-denosumab-with-stereotactic-radiotherapy-in-inoperable-vertebral-bone-metastases-a-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-durability-of-faricimab-in-caucasian-patients-with-polypoidal-choroidal-vasculopathy-a-phase-iv-multicentre-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-immunogenicity-comparison-of-gme751-versus-eu-authorized-pembrolizumab-in-treatment-naive-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-immunogenicity-of-jnj-64042056-in-preclinical-alzheimer-s-disease-a-randomized-placebo-controlled-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-immunogenicity-of-mrna-1647-vaccine-in-preventing-primary-cytomegalovirus-infection-in-cmv-seronegative-females-aged-16-402026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-patient-reported-outcomes-of-peptide-receptor-radionuclide-therapy-with-177lu-edotreotide-compared-to-everolimus-in-somatostatin-receptor-positive-neuroendocrine-tumors-of-the-lung2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-apremilast-in-pediatric-patients-with-active-juvenile-psoriatic-arthritis-a-phase-3-multicenter-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-concizumab-prophylaxis-in-pediatric-patients-with-hemophilia-a-or-b-with-or-without-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-deucravacitinib-in-pediatric-patients-with-active-juvenile-psoriatic-arthritis-a-phase-3-randomized-withdrawal-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-pf-07054894-in-mild-to-severe-ulcerative-colitis-a-phase-1b-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-rbd1016-and-tenofovir-alafenamide-in-chronic-hepatitis-d-virus-infection-a-phase-2a-multicentre-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-single-dose-albaconazole-versus-fluconazole-and-placebo-in-acute-vulvovaginal-candidiasis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-subcutaneous-risankizumab-versus-adalimumab-in-pediatric-patients-with-active-juvenile-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-tildrakizumab-and-etanercept-in-pediatric-patients-with-moderate-to-severe-chronic-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-ustekinumab-in-pediatric-patients-with-moderate-to-severe-crohn-s-disease-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-pharmacokinetics-of-ustekinumab-in-pediatric-patients-with-moderate-to-severe-ulcerative-colitis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-atogepant-in-the-preventive-treatment-of-menstrual-migraine-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-avp-786-deudextromethorphan-hydrobromide-quinidine-sulfate-in-treating-agitation-in-alzheimer-s-dementia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-azd0780-in-dyslipidemia-a-phase-iib-randomized-double-blind-placebo-controlled-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-azd5004-in-obesity-or-overweight-patients-with-comorbidities-a-phase-iib-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-beclometasone-dipropionate-formoterol-fumarate-and-glycopyrronium-bromide-in-copd-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-bepranemab-in-prodromal-to-mild-alzheimer-s-disease-a-placebo-controlled-study-with-open-label-extension2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-bms-986368-a-faah-magl-inhibitor-in-treating-spasticity-in-multiple-sclerosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-brexanolone-caprilcerbate-in-adults-with-major-depressive-disorder-with-or-without-anxious-distress-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-ck-0045-in-overweight-obese-patients-with-type-2-diabetes-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-continuous-subcutaneous-nd0612-infusion-versus-oral-immediate-release-carbidopa-levodopa-in-parkinson-s-disease-with-motor-fluctuations2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-dfv890-in-patients-with-symptomatic-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-dimethyl-fumarate-in-patients-with-friedreich-s-ataxia-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-fipaxalparant-in-idiopathic-pulmonary-fibrosis-a-phase-2b-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-imvt-1402-in-acpa-positive-rheumatoid-arthritis-a-phase-2b-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-intra-articular-lna043-in-patients-with-symptomatic-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-itepekimab-in-chronic-rhinosinusitis-without-nasal-polyps-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-itepekimab-in-non-cystic-fibrosis-bronchiectasis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-jtt-861-in-heart-failure-with-reduced-ejection-fraction-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-kan-101-in-celiac-disease-a-phase-2a-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-nmd670-in-ambulatory-adults-with-type-3-spinal-muscular-atrophy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-pioglitazone-with-nb-uvb-in-adult-patients-with-active-non-segmental-vitiligo-a-phase-2-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-quc398-in-patients-with-symptomatic-knee-osteoarthritis-a-randomized-placebo-controlled-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-remibrutinib-in-adults-with-chronic-inducible-urticaria-unresponsive-to-h1-antihistamines-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-subcutaneous-folate-based-liposomes-encapsulating-methotrexate-in-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-subcutaneous-teprotumumab-in-moderate-to-severe-active-thyroid-eye-disease-a-phase-3-randomized-double-masked-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-sultiame-combined-with-oral-appliance-therapy-in-obstructive-sleep-apnea-with-incomplete-response2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-tibulizumab-in-adults-with-hidradenitis-suppurativa-a-phase-2-randomized-placebo-controlled-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-topical-tcp-25-gel-in-epidermolysis-bullosa-a-randomized-double-blind-vehicle-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-vidofludimus-calcium-in-progressive-multiple-sclerosis-a-multicenter-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-vrdn-003-in-active-thyroid-eye-disease-a-phase-3-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-vrdn-003-in-chronic-thyroid-eye-disease-a-phase-3-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-safety-and-tolerability-of-zasocitinib-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/efficacy-study-of-cemiplimab-with-platinum-and-gemcitabine-in-treatment-naive-patients-with-advanced-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/effisayil-r-rep-an-open-label-multicenter-single-arm-post-marketing-trial-in-select-countries-to-evaluate-efficacy-and-safety-and-the-impact-of-immunogenicity-on-efficacy-safety-and-pharmacokinetics-o2026-10-07 https://dev.clinicalresearch.eu/trial/eik1001-pembrolizumab-and-chemotherapy-for-stage-iv-non-small-cell-lung-cancer-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/eik1005-alone-and-with-pembrolizumab-for-advanced-solid-tumors-in-patients-with-msi-h-or-dmmr-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/elv001-as-add-on-treatment-for-active-rheumatoid-arthritis-in-patients-with-inadequate-response-to-methotrexate-and-tumor-necrosis-factor-inhibition2026-10-07 https://dev.clinicalresearch.eu/trial/endo-67-project-investigating-endocrine-therapy-related-questions-using-ki67-changes-in-the-window-of-opportunity-before-breast-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/enhanced-dual-antiplatelet-therapy-with-clopidogrel-and-aspirin-for-secondary-prevention-after-mild-acute-ischemic-stroke-treated-with-ivt-evt-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/enhancement-of-infant-mucosal-immunity-in-breastfeeding-mothers-receiving-measles-mumps-and-rubella-vaccine-live2026-10-07 https://dev.clinicalresearch.eu/trial/enhancing-lung-health-in-kids-with-structural-lung-damage-and-malformations-a-randomized-controlled-trial-on-azithromycin-azi-for-airway-infection-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/eortc-1820-cltf-open-label-phase-ii-multi-center-study-of-anti-ccr4-monoclonal-antibody-mogamulizumab-plus-total-skin-electron-beam-therapy-tseb-in-patients-with-stage-ib-iib-cutaneous-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/eortc-2120-hncg-radiotherapy-plus-xevinapant-or-placebo-in-older-patients-with-locally-advanced-head-and-neck-squamous-cell-carcinoma-a-randomized-phase-ii-study-ravina2026-10-07 https://dev.clinicalresearch.eu/trial/eortc-2129-bcg-elacestrant-for-treating-er-her2-breast-cancer-patients-with-ctdna-relapse-treat-ctdna2026-10-07 https://dev.clinicalresearch.eu/trial/epcoritamab-for-relapsed-or-refractory-marginal-zone-lymphoma-in-adult-patients-phase-ii2026-10-07 https://dev.clinicalresearch.eu/trial/epcoritamab-plus-rituximab-r-mini-chop-versus-rituximab-r-mini-chop-in-elderly-frail-or-unfit-patients-with-newly-diagnosed-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/eplerenone-impact-on-echocardiographic-abnormalities-in-kidney-transplant-recipients-under-calcineurin-inhibitors-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/eplerenone-versus-placebo-in-end-stage-renal-disease-patients-undergoing-kidney-transplantation-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/erdafitinib-versus-intravesical-chemotherapy-in-high-risk-non-muscle-invasive-bladder-cancer-with-fgfr-mutations-or-fusions-post-bcg-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/erdosteine-in-patients-with-copd2026-10-07 https://dev.clinicalresearch.eu/trial/esketamine-interaction-study-in-healthy-volunteers-a-clinical-trial-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/etic-lm-multicentric-single-arm-phase-ii-study-evaluating-the-efficacy-of-association-of-tucatinib-capecitabine-and-intra-csf-trastuzumab-in-her2-amplified-breast-cancer-patients-with-leptomeningeal-m2026-10-07 https://dev.clinicalresearch.eu/trial/etop-21-21-bounce-a-multicentre-randomised-phase-ii-trial-of-brigatinib-consolidation-versus-observation-or-durvalumab-in-patients-with-unresectable-stage-iii-nsclc-and-alk-rearrangement-after-definit2026-10-07 https://dev.clinicalresearch.eu/trial/etop-23-22-raise-a-single-arm-phase-ii-study-of-the-addition-of-niraparib-to-anti-pd-l1-antibody-maintenance-in-patients-with-slfn11-positive-extensive-disease-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/etude-de-phase-ii-evaluant-la-capacite-d-un-agoniste-des-recepteurs-5-ht4-le-prucalopride-resolor-c-a-accelerer-l-efficacite-therapeutique-d-un-antidepresseur-de-type-isrs-preuve-de-concept-clinique2026-10-07 https://dev.clinicalresearch.eu/trial/etude-evaluant-l-imagerie-proche-infrarouge-couplee-au-vert-d-indocyanine-pour-le-controle-peroperatoire-des-marges-de-resection-en-chirurgie-orl-magnolia2026-10-07 https://dev.clinicalresearch.eu/trial/european-clinical-research-alliance-on-infectious-diseases-primary-care-adaptive-platform-trial-for-pandemics-and-epidemics-ecraid-prime2026-10-07 https://dev.clinicalresearch.eu/trial/european-discovery-for-solidarity-an-adaptive-pandemic-and-emerging-infection-platform-trial-solidact2026-10-07 https://dev.clinicalresearch.eu/trial/european-larynx-organ-preservation-study-elos-induction-chemotherapy-with-docetaxel-and-cisplatin-tp-followed-by-radiation-compared-to-additional-pd-1-inhibition-in-cps-1-advanced-laryngeal-and-hypoph2026-10-07 https://dev.clinicalresearch.eu/trial/european-randomised-clinical-trial-on-mpox-infection-epoxi2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-a-drug-combination-for-treating-patients-with-infective-endocarditis-using-oral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-efficacy-and-safety-of-mk-7262-and-enlicitide-decanoate-in-adults-with-high-lipoprotein-a2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-ly4268989-adipic-acid-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-telisotuzumab-adizutecan-with-drug-combination-in-adults-with-first-line-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-effect-of-lyophilized-bacterial-lysates-on-the-frequency-of-flare-ups-in-patients-with-chronic-obstructive-pulmonary-disease-copd2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-effectiveness-of-guselkumab-and-dietary-changes-for-patients-with-recurring-or-difficult-to-treat-pouchitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-effectiveness-of-prednisone-and-antibiotics-in-adults-with-septic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-efficacy-and-safety-of-kai-9531-and-semaglutide-in-adults-with-obesity-who-do-not-have-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-efficacy-and-safety-of-lebrikizumab-in-adults-with-nummular-eczema-who-do-not-respond-well-to-topical-corticosteroids-or-cannot-use-them2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-efficacy-and-safety-of-personalized-tissue-engineered-veins-in-patients-with-severe-chronic-venous-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluating-the-efficacy-and-safety-of-tirzepatide-for-the-treatment-of-obesity-in-patients-waiting-for-a-liver-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-11c-az14132516-uptake-alterations-post-multiple-azd7798-doses-in-crohn-s-disease-patients-via-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-11c-savolitinib-brain-penetration-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-14c-pf-06821497-metabolism-in-healthy-adult-males-for-small-cell-lung-cancer-castration-resistant-prostate-cancer-and-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-dotatate-and-90y-dotatate-tandem-therapy-in-the-management-of-gastrointestinal-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-lu-fap-2286-safety-and-efficacy-in-advanced-solid-tumors-with-mfolfirinox-or-nab-paclitaxel-combinations-in-nsclc-bc-and-pdac2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-pnt2002-versus-abiraterone-or-enzalutamide-in-delaying-radiographic-progression-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-psma-as-systemic-adjuvant-therapy-in-high-risk-prostate-cancer-post-radical-locoregional-radiotherapy-and-hormone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-psma-i-t-radiometabolic-therapy-in-psma-pet-ct-positive-advanced-metastatic-tumors-a-phase-ii-basket-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-177lu-psma-theranostics-in-recurrent-grade-3-and-grade-4-glioma-safety-tolerability-and-efficacy-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-aci-15916-as-a-pet-radioligand-for-imaging-a-synuclein-pathology-in-parkinson-s-disease-dementia-with-lewy-bodies-and-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-fapi-74-pet-ct-and-laparoscopy-for-staging-in-advanced-gastric-cancer-a-multicenter-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-fapi-74-pet-ct-for-detection-of-primary-tumor-in-patients-with-carcinoma-of-unknown-primary-origin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-fapi-74-pet-ct-imaging-for-differentiating-fibrotic-and-inflammatory-phenotypes-in-progressive-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-fapi-74-pet-ct-in-diagnostic-management-of-resectable-cholangiocarcinoma-a-multicenter-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-fapi-74-pet-ct-with-hyoscine-butylbromide-for-diagnosis-of-suspected-endometriosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-nota-octreotide-pet-mri-for-characterization-of-carotid-artery-atherosclerosis-in-patients-with-recent-stroke-or-transient-ischemic-attack2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-alf-psma-11-pet-imaging-in-advanced-head-and-neck-squamous-cell-carcinoma-and-thyroid-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-ceto-for-subtyping-primary-aldosteronism-in-patients-with-confirmed-diagnosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-dpa-714-pet-mri-for-preoperative-localization-in-drug-resistant-partial-epilepsy-candidates-for-surgical-resection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fapi-74-pet-ct-for-detecting-local-lymph-node-metastasis-in-primary-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fapi-74-pet-ct-for-detecting-lymph-node-metastasis-in-primary-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fapi-74-pet-ct-imaging-for-early-detection-of-progressive-lung-fibrosis-in-connective-tissue-disease-associated-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fes-pet-mri-versus-axillary-ultrasound-in-detecting-macrometastatic-lymph-nodes-in-luminal-a-and-er-lobular-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-florastamin-pet-ct-for-localization-of-clinically-significant-prostate-cancer-in-patients-with-elevated-psa-and-pi-rads-32026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-flortaucipir-as-a-biomarker-for-locus-coeruleus-function-in-alzheimer-s-disease-risk-assessment-and-early-diagnosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fludarabine-and-gadoteric-acid-pet-mr-imaging-in-newly-diagnosed-primary-cns-lymphoma-patients-prior-to-therapeutic-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fludarabine-pet-in-initial-and-relapsed-assessment-of-symptomatic-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoro-peg-folate-pet-ct-for-assessing-anti-tnf-therapy-response-in-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoro-peg-folate-pet-ct-imaging-in-active-giant-cell-arteritis-patients-pre-and-post-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoro-peg-folate-pet-imaging-for-predicting-clinical-arthritis-in-acpa-positive-arthralgia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluorobenzylguanidine-pet-ct-for-detection-of-pheochromocytoma-lesions-compared-to-conventional-ct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluorodeoxyglucose-pet-ct-for-detecting-occult-malignancy-in-patients-aged-50-with-unprovoked-venous-thromboembolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoroestradiol-pet-ct-for-detection-and-characterization-of-endometriosis-lesions-associated-with-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoroestradiol-pet-ct-impact-on-management-of-er-her2-metastatic-breast-cancer-relapsing-post-hormone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-fluoroethyltyrosine-pet-mri-for-differentiating-cushing-s-disease-from-ectopic-cushing-s-syndrome-in-acth-dependent-hypercortisolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-flutemetamol-pet-tracer-for-diagnostic-imaging-in-cardiac-amyloidosis-a-phase-ii-monocentric-exploratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-mc225-for-assessing-p-glycoprotein-function-in-alzheimer-s-disease-mild-cognitive-impairment-and-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-mni-659-as-a-biomarker-for-monitoring-disease-progression-in-symptomatic-and-pre-symptomatic-huntington-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-olaparib-pet-imaging-for-dna-damage-response-in-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-pi-2620-pet-imaging-for-tau-quantification-in-progressive-supranuclear-palsy-and-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-psma-1007-pet-ct-imaging-for-detecting-pelvic-nodal-metastases-in-high-risk-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-psma-1007-piflufolastat-18f-and-gozetotide-for-pelvic-lymph-node-detection-in-newly-diagnosed-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-ro6958948-pet-imaging-for-early-detection-and-tau-pathology-mapping-in-neurodegenerative-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-sodium-fluoride-pet-ct-for-detecting-bone-formation-in-psoriasis-patients-at-risk-of-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-18f-tetrafluoroborate-pet-ct-for-metastatic-lymph-node-detection-and-radioiodine-therapy-response-in-differentiated-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-20-valent-pneumococcal-conjugate-vaccine-efficacy-against-radiologically-confirmed-community-acquired-pneumonia-in-adults-aged-65-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-5-aminolevulinic-acid-hydrochloride-for-intraoperative-imaging-in-ovarian-cancer-detection-a-single-center-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-5-fluorouracil-and-calcipotriol-combination-therapy-versus-5-fluorouracil-monotherapy-in-actinic-keratosis-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-64cu-dota-ae105-pet-imaging-for-isup-grade-classification-in-localized-untreated-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-64cucl2-pet-ct-imaging-for-detecting-local-recurrence-in-prostate-cancer-patients-post-prostatectomy-for-salvage-radiotherapy-suitability2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ath001-pet-tracer-binding-in-healthy-participants-and-patients-with-systemic-sclerosis-associated-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-citrate-pet-ct-for-diagnosing-chronic-prosthetic-joint-infection-in-hip-and-knee-arthroplasty-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-exendin-4-pet-ct-imaging-for-detection-of-paragangliomas-in-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-and-fdg-pet-ct-for-detecting-active-fibroblasts-and-inflammation-in-acute-phase-peyronie-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-and-fluor-18-fdg-pet-mri-for-diagnosis-and-monitoring-in-pediatric-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-and-gallium-68ga-chloride-pet-ct-imaging-in-chronic-inflammatory-and-fibrotic-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-for-assessing-fibroblast-activity-in-patients-with-non-resolving-acute-respiratory-distress-syndrome-ards-in-the-icu2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-for-assessing-peritoneal-metastases-response-to-intraperitoneal-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-for-molecular-assessment-of-fibroblast-activation-in-patients-with-solid-tumors-and-inconclusive-18f-fdg-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-for-predicting-histological-response-to-neoadjuvant-chemo-immunotherapy-in-early-stage-high-risk-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-imaging-biomarkers-in-non-metastatic-pancreatic-ductal-adenocarcinoma-for-prognostic-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-ct-in-initial-staging-of-pancreatic-adenocarcinoma-and-cholangiocarcinoma-for-curative-treatment-eligibility2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-imaging-for-non-invasive-diagnosis-of-desmoplastic-tumors-in-pancreatic-biliary-gastric-and-ovarian-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-46-pet-imaging-in-gastrointestinal-cancers-a-prospective-interventional-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-fapi-pet-ct-imaging-in-assessing-prognostic-value-in-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-aby-025-pet-imaging-for-her2-expression-and-predictive-value-of-trastuzumab-deruxtecan-in-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-dfo-b-pet-ct-imaging-for-pulmonary-aspergillosis-using-deferoxamine-mesilate-and-gallium-68-chloride-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-dota-siglec-9-pet-ct-for-safety-tolerability-and-biodistribution-in-active-rheumatoid-arthritis-vasculitis-and-pulmonary-sarcoidosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-dpi-4452-and-177lu-lu-dpi-4452-in-unresectable-locally-advanced-or-metastatic-solid-tumors-a-phase-1-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-and-gadobutrol-in-multimodal-pet-mri-imaging-for-detection-of-occult-invasive-cancer-in-ductal-carcinoma-in-situ2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-pet-ct-for-enhanced-diagnostic-sensitivity-and-preoperative-staging-in-gastroesophageal-and-pancreatic-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-pet-ct-for-lymph-node-metastasis-detection-in-early-rectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-pet-ct-for-response-assessment-in-immune-checkpoint-inhibitor-therapy-in-advanced-malignant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-pet-ct-for-visualizing-fibroblast-activation-in-early-healing-of-perianal-crohn-s-fistulas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-pet-imaging-for-staging-and-detecting-disease-progression-in-adult-patients-with-transthyretin-cardiac-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-46-total-body-pet-ct-for-enhanced-diagnostic-sensitivity-and-preoperative-staging-in-gastroesophageal-and-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-pet-ct-in-oncological-patients-with-indeterminate-or-inconclusive-18f-f-fdg-pet-ct-findings2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-fapi-pet-mri-for-disease-activity-assessment-in-patients-with-graves-orbitopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-nota-ae105-pet-mri-for-differentiating-glioma-grades-and-assessing-tumor-progression-in-glioma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-pentixafor-pet-ct-in-metastatic-small-cell-lung-carcinoma-at-diagnosis-and-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-pentixafor-pet-ct-versus-adrenal-venous-sampling-in-diagnosing-primary-aldosteronism-in-hypertensive-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-pentixafor-pet-for-initial-staging-and-therapeutic-assessment-in-symptomatic-multiple-myeloma-patients-at-diagnosis-or-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-ga-pentixafor-pet-imaging-for-detecting-unilateral-adrenal-aldosterone-secretion-in-primary-aldosteronism-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-nodaga-exendin-pet-ct-imaging-in-assessing-beta-cell-mass-in-type-1-diabetes-patients-treated-with-exenatide-and-verapamil2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-nodaga-rgd-pet-imaging-for-monitoring-therapeutic-response-in-unilateral-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-psma-hbed-cc-and-99mtc-psma-i-s-in-imaging-guided-detection-of-lymph-node-metastases-in-prostate-cancer-undergoing-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-psma-pet-ct-imaging-for-preoperative-lymph-node-assessment-in-intermediate-and-high-risk-nonmetastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-satoreotide-trizoxetan-gallium-ga68-versus-iodine-123i-iobenguane-in-pediatric-neuroblastoma-a-non-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-68ga-satoreotide-trizoxetan-pet-ct-imaging-in-high-grade-neuroendocrine-lung-cancer-a-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-7-day-versus-14-day-antibiotic-regimen-in-acute-pyelonephritis-among-kidney-transplant-recipients-a-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-7-hypertonic-saline-inhalation-and-eltgol-physiotherapy-on-mucus-clearance-in-bronchiectasis-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zirconium-labeled-ipilimumab-uptake-and-biodistribution-in-metastatic-melanoma-patients-treated-with-ipilimumab-nivolumab-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zirconium-labelled-girentuximab-pet-ct-imaging-in-hepatocellular-carcinoma-intrahepatic-cholangiocarcinoma-and-gastroenteropancreatic-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zr-bevacizumab-pet-ct-imaging-as-a-biomarker-for-predicting-bevacizumab-efficacy-in-nf2-related-vestibular-schwannomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zr-df-crefmirlimab-pet-ct-imaging-in-newly-diagnosed-giant-cell-arteritis-and-active-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zr-dfo-regn5054-immunopet-imaging-in-adults-with-advanced-solid-tumors-undergoing-cemiplimab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zr-trastuzumab-pet-ct-imaging-as-a-predictive-biomarker-for-antibody-drug-conjugate-sequencing-in-advanced-her2-positive-breast-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-89zr-zr-dfo-apac-safety-tolerability-and-biodistribution-in-peripheral-arterial-occlusive-disease-and-critical-limb-ischemia-an-open-label-pet-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-99mtc-euk-so3-cy5-mas3-for-psma-targeted-imaging-in-prostate-cancer-a-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-68ga-ga-her2-single-domain-antibody-pet-ct-for-predicting-pathological-complete-response-pcr-after-neoadjuvant-chemotherapy-nact-in-her2-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-chemotherapy-free-pathological-complete-response-guided-strategy-using-subcutaneous-trastuzumab-pertuzumab-and-trastuzumab-emtansine-in-her2-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-dihydrotetrabenazine-efficacy-in-moderate-to-severe-tardive-dyskinesia-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-for-treatment-of-bacterial-urinary-infection-in-patients-with-e-coli-urinary-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-in-patients-with-cutaneous-t-cell-lymphomas-ctcl2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-in-patients-with-metastatic-stomach-cancer-with-peritoneal-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-in-patients-with-non-small-cell-lung-cancer-spring-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-in-the-treatment-of-acute-lymphoblastic-leukemia-in-younger-adults-18-59-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-drug-combination-including-imipenem-for-the-treatment-of-mycobacterium-abscessus-pulmonary-disease-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-live-attenuated-vaccine-for-single-dose-administration-in-patients-with-rift-valley-fever-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-new-dispensing-device-and-application-for-patients-with-parkinson-s-disease-using-carbidopa-and-levodopa2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-new-moisturiser-containing-glycerol-and-urea-on-skin-barrier-function-in-adults-with-atopic-dermatitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-new-pain-management-regime-for-oocyte-pick-up-during-fertility-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-novel-hypoglycemic-clamp-procedure-to-determine-spontaneous-recovery-time-from-hypoglycemia-in-type-2-diabetes-using-insulin-aspart2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-novel-oral-anti-tumor-agent-in-patients-with-metastatic-or-locally-advanced-solid-tumors-lacking-standard-therapeutic-options2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-novel-therapeutic-agent-in-healthy-volunteers-and-parkinson-s-disease-patients-with-and-without-gba1-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-personalized-treatment-strategy-versus-standard-care-in-rheumatoid-arthritis-using-methotrexate-golimumab-and-hydroxychloroquine-sulfate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-single-measurement-and-adjustment-strategy-for-direct-oral-anticoagulants-in-frail-elderly-patients-with-atrial-fibrillation-or-venous-thromboembolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-sterile-self-limiting-acute-inflammatory-response-induced-by-lipopolysaccharides-in-healthy-volunteers-a-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-sublingual-vaccine-s-induction-of-trained-immunity-in-peripheral-blood-cells-of-healthy-adult-males-and-non-pregnant-females2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-weaning-protocol-for-high-flow-nasal-oxygen-therapy-in-patients-with-de-novo-acute-respiratory-failure-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-weekly-oral-islatravir-lenacapavir-regimen-versus-bictegravir-emtricitabine-tenofovir-alafenamide-in-virologically-suppressed-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-a-weekly-oral-islatravir-lenacapavir-regimen-versus-standard-antiretroviral-therapy-in-virologically-suppressed-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ab308-and-ab122-combination-therapy-in-patients-with-advanced-malignancies-including-multiple-myeloma-dlbcl-and-various-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abatacept-and-daratumumab-combination-therapy-in-acpa-positive-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abatacept-and-placebo-in-hospitalized-adults-with-covid-19-a-randomized-controlled-trial-on-immune-modulation-strategies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abbv-155-monotherapy-and-in-combination-with-taxane-therapy-in-adults-with-relapsed-refractory-solid-tumors-sclc-nsclc-and-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abbv-319-pharmacokinetics-safety-and-efficacy-in-adults-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-follicular-lymphoma-or-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abbv-383-for-safety-and-efficacy-in-patients-with-light-chain-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abbv-400-fluorouracil-leucovorin-and-budigalimab-in-advanced-gastric-gastroesophageal-junction-or-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abbv-cls-484-monotherapy-and-combination-therapy-in-patients-with-metastatic-or-locally-advanced-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abd-3001-safety-in-patients-with-relapsed-refractory-acute-myeloid-leukemia-or-high-very-high-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abemaciclib-and-darolutamide-in-metastatic-prostatic-neoplasms-post-initial-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abemaciclib-and-letrozole-efficacy-in-estrogen-receptor-positive-low-grade-serous-ovarian-cancer-and-adult-type-granulosa-cell-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abemaciclib-and-pembrolizumab-in-stage-iv-lung-and-breast-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abp-206-versus-nivolumab-in-treatment-naive-patients-with-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abrupt-versus-phased-withdrawal-of-solifenacin-succinate-and-mirabegron-on-recurrence-risk-in-pediatric-daytime-urinary-incontinence2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-absolute-bioavailability-and-metabolic-profile-of-aticaprant-via-oral-tablet-and-microdose-intravenous-infusion-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-absorbed-tumor-dose-in-peptide-receptor-radionuclide-therapy-with-octreotide-lanreotide-and-lutetium-177lu-oxodotreotide-in-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-absorption-and-food-effect-on-tablet-formulations-of-jnj-77242113-in-the-management-of-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-absorption-systemic-pharmacokinetics-and-hpa-axis-suppression-of-topical-halobetasol-propionate-in-pediatric-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-absorption-systemic-pharmacokinetics-and-hpa-axis-suppression-of-topical-idp-118-lotion-in-pediatric-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-abx-001-monotherapy-and-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-tumors-beyond-standard-of-care2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acalabrutinib-and-rituximab-in-elderly-patients-with-untreated-mantle-cell-lymphoma-a-clinical-trial-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acalabrutinib-monotherapy-and-combination-with-rituximab-in-relapsed-refractory-marginal-zone-lymphoma-a-phase-1b-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acalabrutinib-monotherapy-in-treatment-naive-or-relapsed-refractory-chronic-lymphocytic-leukemia-a-phase-3b-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acalabrutinib-on-skin-prick-test-wheal-size-in-adults-with-grass-pollen-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acalabrutinib-r-chop-therapy-in-disseminated-large-b-cell-lymphoma-with-myd88-l265p-and-or-cd79a-b-mutations-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-accelerated-intermittent-theta-burst-stimulation-with-d-cycloserine-augmentation-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-accelerator-based-boron-neutron-capture-therapy-in-patients-with-head-and-neck-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetazolamide-and-metolazone-in-diuretic-strategies-for-acute-heart-failure-with-volume-overload2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetazolamide-and-sglt2-inhibitors-in-managing-volume-overload-in-acute-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetazolamide-sodium-on-gait-in-patients-with-normal-pressure-hydrocephalus-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylcysteine-amide-in-hereditary-cystatin-c-amyloid-angiopathy-safety-tolerability-and-efficacy-in-patients-aged-12-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-and-clopidogrel-monotherapy-for-secondary-prevention-in-intracerebral-hemorrhage-survivors-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-and-cytisine-in-multi-factorial-primary-prevention-for-high-risk-individuals-in-lung-cancer-early-detection-programs2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-and-pantoprazole-in-reducing-cardiovascular-events-in-hospitalized-patients-with-community-acquired-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-in-reducing-mortality-in-elderly-patients-with-acute-pneumonia-a-multicenter-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-in-reducing-sars-cov-2-susceptibility-in-patients-with-aspirin-exacerbated-respiratory-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-s-effect-on-cox-1-and-cox-2-acetylation-in-obese-and-non-obese-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acetylsalicylic-acid-versus-placebo-for-preeclampsia-prevention-in-twin-pregnancies-a-multicenter-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aciclovir-and-valaciclovir-hydrochloride-in-the-treatment-of-hsv-2-meningitis-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acupuncture-and-metformin-hydrochloride-on-insulin-sensitivity-in-women-with-polycystic-ovary-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acyclovir-for-preemptive-treatment-in-mechanically-ventilated-icu-patients-with-herpes-simplex-virus-oropharyngeal-reactivation-and-limited-organ-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-acyclovir-infusion-on-mortality-in-ventilated-icu-patients-with-pneumonia-and-herpes-simplex-virus-type-1-in-bronchoalveolar-lavage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adagrasib-dosing-regimens-in-previously-treated-kras-g12c-mutant-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adalimumab-in-a-selective-top-down-treatment-strategy-for-patients-with-severe-ulcerative-colitis-the-duct-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adalimumab-monotherapy-versus-corticosteroid-based-step-up-therapy-in-newly-diagnosed-crohn-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adalimumab-tapering-strategy-for-sustained-remission-in-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adalimumab-vedolizumab-and-tofacitinib-on-aortic-stiffness-and-cardiovascular-risk-in-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adaptive-immunity-modulation-against-bk-polyomavirus-in-kidney-transplant-recipients-using-sirolimus-and-mycophenolic-acid2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adct-901-monotherapy-in-patients-with-advanced-solid-tumors-a-phase-1-open-label-dose-escalation-and-dose-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ademetionine-efficacy-and-safety-as-adjunctive-therapy-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ademetionine-intramuscular-injection-as-an-adjunctive-therapy-to-antidepressants-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adhesion-properties-of-rotigotine-transdermal-patch-in-parkinson-s-disease-a-randomized-open-label-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adipose-derived-regenerative-cells-and-autologous-stromal-vascular-fraction-in-hypertrophic-scar-remodeling-post-burn-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjunctive-hyperbaric-oxygen-therapy-on-30-day-mortality-in-necrotizing-soft-tissue-infection-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-chemotherapy-with-cyclophosphamide-doxorubicin-and-docetaxel-in-er-positive-her2-negative-breast-carcinoma-in-women-over-702026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-chemotherapy-with-fluorouracil-levoleucovorin-and-oxaliplatin-in-resected-stage-i-iv-small-bowel-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-chemotherapy-with-oxaliplatin-capecitabine-fluorouracil-and-calcium-folinate-in-high-risk-rectal-cancer-patients-with-detectable-ctdna-post-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-chemotherapy-with-paclitaxel-cisplatin-and-carboplatin-in-high-risk-stage-i-iia-non-squamous-nsclc-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-doxorubicin-and-trabectedin-chemotherapy-in-high-risk-localized-resected-uterine-leiomyosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-hepatic-arterial-infusion-pump-chemotherapy-with-floxuridine-for-preventing-liver-recurrence-in-resectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-imatinib-mesilate-efficacy-in-intermediate-risk-gastrointestinal-stromal-tumor-with-high-genomic-grade-index2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-nonavalent-human-papillomavirus-vaccination-in-preventing-recurrence-of-vulvar-high-grade-squamous-intraepithelial-lesion-in-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-pembrolizumab-versus-observation-in-early-triple-negative-breast-cancer-with-pathologic-complete-response-post-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-pressurized-intraperitoneal-aerosol-chemotherapy-with-oxaliplatin-in-resected-high-risk-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-therapy-with-capecitabine-in-stage-ii-colon-and-rectal-cancer-patients-with-ctdna-positivity-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-therapy-with-carboplatin-and-cisplatin-in-early-stage-intermediate-risk-cervical-cancer-post-radical-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adjuvant-wt1-lamp-mrna-dc-immunotherapy-and-temozolomide-in-post-surgical-chemoradiation-for-newly-diagnosed-glioblastoma-grade-iv2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-administration-route-preference-for-nivolumab-and-relatlimab-in-melanoma-patients-subcutaneous-versus-intravenous-delivery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-admsc-fib-safety-and-efficacy-in-the-treatment-of-chronic-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adoptive-til-therapy-combined-with-low-dose-peginterferon-alfa-2a-and-nivolumab-in-patients-with-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adoptive-tumor-infiltrating-lymphocyte-therapy-combined-with-chemoimmunotherapy-in-patients-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adp-a2m4cd8-in-patients-with-advanced-urothelial-esophageal-gastric-nsclc-head-and-neck-ovarian-melanoma-and-endometrial-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adp-tilil7-in-patients-with-locally-advanced-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adrenalized-lidocaine-with-or-without-sodium-bicarbonate-on-postoperative-recovery-in-ambulatory-hand-and-foot-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adv7103-on-gastric-ph-in-fed-and-fasting-conditions-in-healthy-adults-with-distal-renal-tubular-acidosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adverse-events-and-disease-activity-in-hepatocellular-carcinoma-and-squamous-cell-non-small-cell-lung-cancer-with-iv-abbv-324-vs-oral-lenvatinib2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adverse-events-and-disease-activity-in-relapsed-refractory-multiple-myeloma-with-intravenous-etentamig-abbv-383-and-anti-cancer-regimens2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adverse-events-pharmacokinetics-and-disease-activity-of-intravenous-abbv-291-in-adults-with-non-hodgkin-s-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-adverse-events-pharmacokinetics-and-disease-activity-of-oral-abbv-101-in-adult-patients-with-select-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-afamelanotide-s-effect-on-uv-induced-dna-damage-and-repair-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-afamitresgene-autoleucel-in-hla-a-02-positive-patients-with-advanced-synovial-sarcoma-or-myxoid-round-cell-liposarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-afatinib-followed-by-osimertinib-versus-osimertinib-monotherapy-in-egfr-mutated-t790m-negative-non-squamous-nsclc-a-phase-iv-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-affective-states-post-administration-of-morphine-oxycodone-and-fentanyl-in-asa1-and-asa2-patients-undergoing-day-surgery-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-afimetoran-efficacy-and-safety-in-active-systemic-lupus-erythematosus-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aflibercept-8mg-efficacy-in-extending-treatment-intervals-for-neovascular-age-related-macular-degeneration-post-faricimab-and-aflibercept-2mg-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aflibercept-for-neovascular-glaucoma-prevention-in-patients-with-large-choroid-melanoma-undergoing-proton-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aflibercept-ranibizumab-and-brolucizumab-in-active-neovascular-age-related-macular-degeneration-a-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-afm24-and-atezolizumab-in-combination-with-ramucirumab-and-docetaxel-for-advanced-metastatic-egfr-expressing-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aga2118-efficacy-and-safety-in-postmenopausal-osteoporosis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-agtc-501-efficacy-and-safety-in-male-patients-with-x-linked-retinitis-pigmentosa-due-to-rpgr-mutations-a-randomized-controlled-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ai-driven-personalized-rituximab-protocol-versus-standard-care-in-nephrotic-membranous-nephropathy-for-clinical-remission-induction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ai-enhanced-low-dose-gadoteric-acid-in-contrast-enhanced-mri-for-diagnostic-imaging-in-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-airway-cross-sectional-area-changes-during-residual-neuromuscular-blockade-and-reversal-with-sugammadex-and-rocuronium-bromide2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-al-18f-f-nota-folate-pet-imaging-in-patients-with-suspected-cardiac-sarcoidosis-or-infective-endocarditis-and-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alectinib-and-chemotherapy-efficacy-and-safety-in-resectable-stage-i-iii-alk-positive-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alectinib-as-neoadjuvant-therapy-in-alk-stage-iii-nsclc-a-phase-ii-open-label-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alendronate-sodium-monohydrate-on-bone-and-glycemic-markers-in-type-1-and-type-2-diabetes-mellitus-with-osteopenia-osteoporosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alfacalcidol-in-the-management-of-secondary-hyperparathyroidism-post-roux-en-y-gastric-bypass-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alglucosidase-alfa-administration-frequency-reduction-in-elderly-patients-with-late-onset-pompe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aliskiren-versus-enalapril-in-the-management-of-c3-glomerulopathy-in-pediatric-and-adult-populations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alks-2680-efficacy-and-safety-in-idiopathic-hypersomnia-a-phase-2-randomized-double-blind-dose-range-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alks-2680-for-safety-and-efficacy-in-treating-excessive-daytime-sleepiness-in-narcolepsy-type-2-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allergenic-potency-of-lepidoglyphus-destructor-extract-in-patients-with-allergy-using-histamine-equivalent-prick-testing-units2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-derived-mesenchymal-stem-cells-in-treating-draining-fistulas-in-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-derived-mesenchymal-stromal-cells-in-adults-with-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-derived-mesenchymal-stromal-stem-cell-transplantation-tolerance-in-patients-with-critical-limb-ischemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-tissue-derived-mesenchymal-stem-cells-for-localized-treatment-of-ulcerative-colitis-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-tissue-derived-mesenchymal-stem-cells-for-refractory-ischemic-digital-ulcers-in-systemic-sclerosis-a-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-adipose-tissue-derived-stem-cells-in-the-treatment-of-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-faecal-microbiota-transplantation-for-decolonization-of-multidrug-resistant-gram-negative-bacteria-in-colonized-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-fecal-microbiota-transfer-on-glycemic-control-in-post-bariatric-surgery-patients-with-non-remission-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-fecal-microbiota-transplantation-for-complication-prevention-post-allogeneic-hematopoietic-stem-cell-transplantation-in-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-fecal-microbiota-transplantation-versus-placebo-in-achieving-steroid-free-remission-in-adult-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-hematopoietic-stem-cell-transplantation-with-azacitidine-versus-conventional-chemotherapy-in-high-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-nanostructured-artificial-cornea-in-advanced-corneal-trophic-ulcers-refractory-to-conventional-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-umbilical-cord-tissue-derived-mesenchymal-stromal-cells-in-chronic-antibody-mediated-renal-graft-rejection-resistant-to-conventional-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogeneic-wharton-s-jelly-derived-mesenchymal-stem-cells-pirfenidone-and-nintedanib-in-fibrotic-interstitial-lung-disease-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogenic-adipose-derived-mesenchymal-stem-cells-on-fibrin-hyaluronic-matrix-for-venous-ulcer-treatment-in-lower-limbs2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogenic-adipose-derived-mesenchymal-stromal-cell-injections-on-orofacial-fibrosis-in-systemic-scleroderma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogenic-adipose-tissue-derived-mesenchymal-stem-cells-for-safety-and-efficacy-in-diabetic-foot-ulcer-treatment-a-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allogenic-adipose-tissue-derived-mesenchymal-stromal-cells-in-primary-progressive-multiple-sclerosis-an-open-label-phase-i-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allopurinol-and-febuxostat-in-the-maintenance-or-withdrawal-of-urate-lowering-therapy-in-gout-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allopurinol-benzbromarone-and-febuxostat-hemihydrate-in-gout-remission-a-randomized-superiority-trial-on-urate-lowering-therapy-strategies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allopurinol-on-cardiovascular-event-risk-in-patients-with-high-cardiovascular-risk-and-long-covid-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allopurinol-sodium-and-hypothermia-in-neonatal-hypoxic-ischemic-encephalopathy-impact-on-neurodevelopmental-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-allopurinol-sodium-for-cerebral-and-cardiac-protection-in-neonates-with-critical-congenital-heart-disease-undergoing-cardiopulmonary-bypass2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aln-app-safety-and-tolerability-in-early-onset-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aln-bcat-in-patients-with-advanced-or-metastatic-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aln-htt02-in-adult-patients-with-huntington-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alnuctamab-and-mezigdomide-combination-therapy-in-relapsed-refractory-multiple-myeloma-a-phase-1b-2a-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alocelyvir-combined-with-chemotherapy-and-radiotherapy-in-pediatric-relapsed-refractory-extracranial-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alpelisib-administration-timing-fasting-and-low-carbohydrate-diet-on-toxicity-and-efficacy-in-hr-her2-pik3ca-mutated-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alpelisib-and-trametinib-combination-therapy-in-patients-with-progressive-refractory-meningiomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alpha1h-safety-and-efficacy-in-non-muscle-invasive-bladder-cancer-patients-awaiting-transurethral-resection-a-randomized-placebo-controlled-phase-i-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alteplase-as-an-adjunct-to-mechanical-thrombectomy-in-acute-ischemic-stroke-with-proximal-vessel-recanalization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alternative-dosing-regimens-of-belantamab-mafodotin-in-relapsed-or-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alutard-sq-dog-in-dog-allergic-patients-with-allergic-rhinitis-a-study-on-efficacy-and-symptom-improvement-in-swedish-clinical-practice2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-alxn2350-gene-therapy-in-adults-with-bag3-mutation-associated-dilated-cardiomyopathy-a-phase-1-2-open-label-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amantadine-hemisulfate-for-neuroenhancement-in-patients-with-unresponsive-wakefulness-syndrome-in-intensive-and-intermediate-care-settings2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amantadine-hydrochloride-and-transcranial-magnetic-stimulation-for-fatigue-management-in-multiple-sclerosis-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amantadine-hydrochloride-as-adjunctive-therapy-for-motor-fluctuations-in-advanced-parkinson-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ambroxol-hydrochloride-and-clenbuterol-hydrochloride-in-gaucher-disease-type-3-a-randomized-placebo-controlled-n-of-1-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ambroxol-hydrochloride-and-clenbuterol-hydrochloride-in-parkinson-s-disease-patients-with-gba1-mutation-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-193-and-ide397-combination-therapy-in-advanced-mtap-null-solid-tumors-and-non-small-cell-lung-cancer-a-phase-1-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-193-combined-with-additional-therapies-in-advanced-gastrointestinal-biliary-tract-or-pancreatic-cancers-with-homozygous-mtap-deletion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-193-monotherapy-and-combination-regimens-in-advanced-thoracic-tumors-with-homozygous-mtap-deletion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-193-monotherapy-and-combination-with-docetaxel-in-advanced-mtap-null-solid-tumors-a-phase-1-1b-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-691-in-a-phase-1-randomized-double-blind-placebo-controlled-trial-in-healthy-subjects-and-those-with-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amg-732-efficacy-and-safety-in-moderate-to-severe-thyroid-eye-disease-a-phase-1-2-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amikacin-liposome-inhalation-suspension-in-combination-therapy-for-mycobacterium-xenopi-pulmonary-infection-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amikacin-sulfate-based-antibiotic-regimen-and-protective-isolation-in-critically-ill-neutropenic-adults-with-sepsis-a-2x2-factorial-rct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amiloride-and-sodium-chloride-on-arterial-stiffness-in-autosomal-dominant-polycystic-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amiodarone-hydrochloride-efficacy-in-pre-electrical-cardioversion-for-persistent-atrial-fibrillation-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amitriptyline-flunarizine-topiramate-and-propranolol-for-first-line-migraine-prophylaxis-in-primary-care-a-pragmatic-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amivantamab-monotherapy-and-combination-therapies-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amivantamab-monotherapy-and-combination-with-standard-chemotherapy-in-advanced-or-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amlitelimab-and-bi-1015550-in-interstitial-lung-disease-secondary-to-systemic-sclerosis-a-randomized-double-blind-placebo-controlled-phase-2b-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amlitelimab-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-with-topical-corticosteroids-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amlitelimab-monotherapy-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-in-patients-aged-12-and-older-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amlitelimab-monotherapy-in-maintaining-treatment-response-in-adolescents-and-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amlodipine-in-reversible-cerebral-vasoconstriction-syndrome-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-and-clavulanic-acid-in-reducing-hospital-stay-for-pediatric-complicated-acute-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-clavulanic-acid-and-fluticasone-propionate-versus-placebo-in-pediatric-patients-with-protracted-cough-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-clavulanic-acid-followed-by-allogeneic-fecal-microbiota-transplantation-in-moderate-to-severe-hidradenitis-suppurativa-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-on-post-surgical-complications-in-edentulous-patients-undergoing-implant-surgery-with-guided-bone-regeneration-and-sinus-floor-elevation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-on-post-surgical-outcomes-in-patients-undergoing-implant-surgery-with-guided-bone-regeneration-and-sinus-floor-elevation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-trihydrate-regimen-duration-in-pediatric-community-acquired-alveolar-pneumonia-a-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amoxicillin-trihydrate-versus-placebo-in-preschool-children-with-lower-respiratory-tract-infection-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-amyloid-pet-imaging-with-florbetaben-18f-and-flutemetamol-18f-in-dementia-related-morbidity-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-an-idh1m-inhibitor-in-patients-with-idh1-mutated-malignancies-and-hepatic-or-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-an-immuno-guided-preventive-strategy-versus-universal-prophylaxis-with-valganciclovir-for-cytomegalovirus-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anakinra-combined-with-azathioprine-and-prednisone-in-virus-negative-myocarditis-a-double-blind-phase-iia-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anakinra-efficacy-and-safety-in-cystic-fibrosis-a-phase-iia-randomized-placebo-controlled-double-blind-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anakinra-for-efficacy-and-safety-in-non-covid-19-acute-respiratory-distress-syndrome-ards-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-analgesic-efficacy-and-safety-of-low-dose-intrathecal-morphine-hydrochloride-in-elective-caesarean-section-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-analgesic-efficacy-of-lidocaine-prilocaine-versus-lidocaine-in-dental-anesthesia-for-patients-with-mc1r-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-analgesic-efficacy-of-transversus-abdominis-plane-block-versus-local-infiltration-with-ropivacaine-hydrochloride-in-laparoscopic-inguinal-hernia-repair2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anb032-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-androgen-deprivation-therapy-on-prostate-specific-membrane-antigen-expression-in-treatment-naive-metastatic-prostate-cancer-using-degarelix2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-angiotensin-converting-enzyme-inhibitor-perindopril-and-valsartan-on-cardiac-remodeling-in-women-with-asymptomatic-subclinical-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-angiotensin-ii-enhanced-radioembolization-with-90y-glass-microspheres-in-primary-and-secondary-liver-cancer-the-radiant-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anhydrous-benzoyl-peroxide-and-ethanol-povidone-iodine-solution-for-reducing-cutibacterium-acnes-in-male-shoulder-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anifrolumab-and-phototherapy-efficacy-in-adults-with-progressive-non-segmental-vitiligo-a-randomized-double-blind-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anifrolumab-efficacy-and-safety-in-systemic-sclerosis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anthracycline-taxane-chemotherapy-combined-with-fasting-mimicking-diet-and-metformin-in-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-cd19-car-t-cell-therapy-in-patients-with-systemic-lupus-erythematosus-systemic-sclerosis-and-dermatomyositis-polymyositis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-cd19-car-t-cell-therapy-in-refractory-systemic-autoimmune-diseases-a-study-of-autologous-t-cells-with-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-cd19-car-t-cell-therapy-with-kyv-101-fludarabine-phosphate-and-cyclophosphamide-monohydrate-in-refractory-anca-igg-positive-vasculitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-cd38-daratumumab-and-ctla4-ig-belatacept-in-highly-hla-sensitized-patients-awaiting-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-ceacam5-antibody-drug-conjugate-m9140-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-circumsporozoite-antibody-interference-and-synergy-on-ga2-induced-immunity-in-plasmodium-falciparum-malaria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-gd2-antibody-drug-conjugate-m3554-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-pd-1-and-anti-ctla-4-antibodies-in-advanced-melanoma-with-brain-metastases-requiring-steroid-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-sars-cov-2-polyclonal-hyperimmune-globulin-efficacy-and-safety-in-early-stage-covid-19-adult-outpatients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-seizure-treatment-with-esketamine-lorazepam-and-midazolam-in-comatose-cardiac-arrest-patients-with-status-epilepticus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-t-lymphocyte-immunoglobulin-rabbit-in-preventing-chronic-histological-lesions-in-low-immunological-risk-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-tnf-therapy-de-escalation-using-adalimumab-and-infliximab-in-adolescents-and-young-adults-with-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anti-tumor-activity-of-bms-986340-plus-nivolumab-in-adults-with-metastatic-solid-tumors-nsclc-gastric-colorectal-mss-pancreatic2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibacterial-efficacy-of-arbutin-metabolites-in-urine-for-patients-with-urinary-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-absorption-in-patients-with-short-bowel-syndrome-undergoing-treatment-for-bacterial-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-discontinuation-in-adult-patients-with-viral-respiratory-tract-infections-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-duration-optimization-in-acute-lower-respiratory-tract-infection-and-acute-rhinosinusitis-using-beta-lactam-antibacterials-penicillins2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-impact-on-microbiota-and-resistance-genes-in-esbl-and-vre-carriers-using-ciprofloxacin-and-vancomycin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-prophylaxis-with-fosfomycin-calcium-bromhexine-hydrochloride-sulfamethoxazole-and-trimethoprim-in-pre-surgical-benign-prostate-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibiotic-regimens-in-uncomplicated-staphylococcus-aureus-bacteremia-a-randomized-study-of-clarithromycin-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibody-response-following-sars-cov-2-booster-immunization-with-a-novel-covid-19-vaccine-formulation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibody-responses-in-healthy-individuals-following-intranasal-vs-intramuscular-administration-of-influenza-vaccine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antibody-titers-against-influenza-virus-strains-in-healthcare-personnel-post-vaccination-with-inactivated-split-virus-vaccine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anticoagulant-therapy-discontinuation-in-atrial-fibrillation-patients-post-surgical-left-atrial-appendage-closure-a-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-anticoagulation-strategies-with-unfractionated-heparin-argatroban-and-enoxaparin-in-extracorporeal-membrane-oxygenation-for-acute-respiratory-distress-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antifibrotic-effects-of-spironolactone-and-dihydralazine-on-myocardial-fibrosis-post-tavi-in-aortic-stenosis-with-high-fibrotic-burden2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antimicrobial-agents-moxifloxacin-levofloxacin-ertapenem-and-metronidazole-in-uncomplicated-and-complicated-acute-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antimicrobial-duration-in-treating-infections-associated-with-osteosynthesis-material-post-long-bone-fracture-a-phase-3-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antimicrobial-stewardship-using-amoxicillin-and-clavulanic-acid-for-ventilator-associated-pneumonia-in-intensive-care-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiplatelet-therapy-discontinuation-versus-continuation-in-young-patients-post-cryptogenic-stroke-a-comparative-analysis-of-carbasalate-calcium-clopidogrel-and-dipyridamole2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antipsychotic-maintenance-versus-discontinuation-dose-reduction-in-remitted-first-episode-psychosis-a-study-of-haloperidol-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiretroviral-therapy-combined-with-10-1074-ls-and-teropavimab-in-primary-or-early-hiv-infection-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiretroviral-treatment-interruption-in-perinatally-hiv-infected-patients-using-lamivudine-and-drug-combinations-guided-by-hiv-1-reservoir-profiling2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antithrombotic-regimens-on-subclinical-leaflet-thickening-in-patients-with-transcatheter-bioprosthetic-aortic-valves-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antithrombotic-strategies-with-aspirin-and-clopidogrel-post-left-atrial-appendage-closure-in-atrial-fibrillation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antitumor-efficacy-of-durvalumab-and-tazemetostat-in-metastatic-or-unresectable-locally-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiviral-efficacy-and-safety-of-gsk4004280-and-gsk4011499-in-treatment-naive-adults-with-hiv-1-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiviral-efficacy-safety-and-pharmacokinetics-of-vh4524184-in-treatment-naive-adults-with-hiv-1-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-antiviral-prophylaxis-with-cytolytic-t-lymphocytes-for-cytomegalovirus-infection-in-hla-identical-familial-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aon-d21-efficacy-and-safety-in-severe-community-acquired-pneumonia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apac-unfractionated-heparin-porcine-conjugated-with-human-serum-albumin-in-peripheral-arterial-occlusive-disease-and-chronic-limb-threatening-ischemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apalutamide-addition-to-radiotherapy-and-lhrh-agonist-in-high-risk-hormone-sensitive-prostate-cancer-assessed-by-psma-pet2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apalutamide-in-non-metastatic-castration-resistant-prostate-cancer-a-randomized-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apalutamide-with-androgen-deprivation-therapy-versus-androgen-deprivation-therapy-alone-in-high-risk-oligometastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apg777-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apixaban-for-the-prevention-of-symptomatic-leg-vein-thrombosis-in-long-haul-flight-passengers-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apixaban-on-thrombin-generation-in-de-novo-multiple-myeloma-and-post-total-knee-replacement-patients-for-thromboembolism-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apixaban-versus-no-anticoagulation-for-thromboprophylaxis-in-patients-undergoing-abdominal-gynecologic-and-urologic-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apixaban-versus-placebo-on-portal-venous-system-thrombosis-in-patients-with-intrahepatic-non-cirrhotic-portal-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apl-101-in-advanced-solid-tumors-and-non-small-cell-lung-cancer-with-met-aberrations-a-phase-1-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apneic-oxygenation-with-high-flow-nasal-oxygenation-post-noninvasive-ventilation-preoxygenation-in-hypoxemic-acute-respiratory-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apomorphine-hydrochloride-hemihydrate-in-subcutaneous-infusion-for-severe-disorder-of-consciousness-in-brain-injured-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apomorphine-rifaximin-and-levodopa-in-managing-peripheral-levodopa-resistance-in-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-apraglutide-efficacy-and-safety-in-steroid-refractory-gastrointestinal-acute-graft-versus-host-disease-a-randomized-single-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aprepitant-for-the-prevention-of-postoperative-nausea-and-vomiting-in-patients-undergoing-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aprepitant-on-aldosterone-secretion-in-patients-with-obstructive-sleep-apnea-and-arterial-hypertension-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-arbaclofen-for-biomarker-based-treatment-of-social-function-in-pediatric-autism-spectrum-disorder-a-follow-up-shiftability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-arfolitixorin-5-fluorouracil-oxaliplatin-and-bevacizumab-in-first-line-treatment-of-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argipressin-adjunctive-therapy-in-hyperkinetic-septic-shock-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argipressin-efficacy-in-adult-intensive-care-patients-with-norepinephrine-refractory-vasoplegic-shock-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argipressin-infusion-on-intraoperative-blood-loss-in-hepatic-resection-for-malignant-and-benign-tumors-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argipressin-versus-noradrenaline-in-reducing-intraoperative-fluid-administration-during-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-in-disseminated-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argon-oxygen-ventilation-in-reducing-neurological-injury-post-out-of-hospital-cardiac-arrest-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-argx-119-safety-tolerability-and-efficacy-in-amyotrophic-lateral-sclerosis-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aro-atxn2-injection-in-adult-patients-with-spinocerebellar-ataxia-type-22026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aro-mmp7-inhalation-solution-in-idiopathic-pulmonary-fibrosis-a-phase-1-2a-clinical-trial-in-healthy-subjects-and-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aro-muc5ac-inhalation-solution-in-asthma-and-chronic-obstructive-pulmonary-disease-a-phase-1-2a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aro-rage-ads-015-inhalation-solution-in-healthy-volunteers-and-patients-with-inflammatory-lung-disease-a-phase-1-2a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-art0380-mesilate-monotherapy-and-combination-therapy-with-gemcitabine-hydrochloride-or-irinotecan-hydrochloride-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-art6043-monotherapy-and-combination-therapy-with-olaparib-and-niraparib-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-artesunate-sulfasalazine-polyunsaturated-fatty-acids-and-iron-in-patients-with-solid-tumors-a-clinical-trial-on-cancer-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-arthroscopic-debridement-versus-platelet-concentrate-injection-in-chronic-lateral-epicondylitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-arv-102-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-healthy-participants-for-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-arv-393-in-adult-patients-with-advanced-non-hodgkin-s-lymphoma-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asciminib-in-combination-with-atp-competing-bcr-abl1-inhibitors-for-achieving-deep-molecular-response-in-newly-diagnosed-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ascorbic-acid-efficacy-in-reducing-systemic-inflammatory-response-in-patients-undergoing-cardiac-surgery-a-pilot-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asp1570-monotherapy-and-combination-with-pembrolizumab-or-standard-therapies-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asp2138-monotherapy-and-combination-therapy-in-adults-with-gastric-gastroesophageal-junction-and-pancreatic-adenocarcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asp3082-in-adult-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aspirin-omission-on-bleeding-and-ischemic-outcomes-in-non-st-segment-elevation-acute-coronary-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-assisted-reproductive-technology-outcomes-in-adenomyosis-a-randomized-study-of-leuprorelin-acetate-and-progestogen-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-astx727-and-donor-lymphocyte-infusions-post-allogeneic-stem-cell-transplantation-in-high-risk-myelodysplastic-syndromes-or-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-astx727-low-dose-extended-schedule-in-patients-with-lower-risk-myelodysplastic-syndromes-a-phase-1-2-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asundexian-and-metformin-pharmacokinetics-in-healthy-subjects-for-ischemic-stroke-prevention-post-acute-non-cardioembolic-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-asundexian-for-the-prevention-of-ischemic-stroke-in-patients-post-acute-non-cardioembolic-ischemic-stroke-or-high-risk-transient-ischemic-attack2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atacicept-administration-on-gd-iga1-levels-in-patients-with-iga-nephropathy-a-monthly-dosing-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atacicept-for-safety-and-efficacy-in-patients-with-multiple-autoimmune-glomerular-diseases-a-phase-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ataluren-in-a-single-patient-with-severe-common-variable-immunodeficiency-and-autoimmunity-due-to-homozygous-lrba-stop-codon-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-and-bevacizumab-safety-in-liver-transplant-recipients-with-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-and-bevacizumab-with-or-without-tiragolumab-in-untreated-locally-advanced-or-metastatic-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-and-digital-health-solutions-on-health-outcomes-in-metastatic-and-early-stage-lung-and-hepatocellular-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-and-wt1-lamp-mrna-dc-vaccine-in-combination-with-platinum-pemetrexed-for-epithelioid-malignant-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-carboplatin-etoposide-and-tiragolumab-in-untreated-extensive-stage-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-combined-with-radiotherapy-in-muscle-invasive-bladder-cancer-patients-for-pathological-complete-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-in-patients-with-metastatic-urothelial-cancer-experiencing-biochemical-relapse-post-radical-cystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-resiquimod-sulfate-and-immunogenic-radiotherapy-in-advanced-solid-tumors-a-multicohort-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-tiragolumab-and-ipilimumab-in-advanced-triple-negative-breast-cancer-tonic-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atezolizumab-with-rechallenge-chemotherapy-in-patients-with-sensitive-relapse-small-cell-lung-cancer-post-first-line-platinum-etoposide-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atogepant-for-preventive-treatment-of-chronic-migraine-in-pediatric-patients-aged-12-17-a-phase-3-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atomoxetine-on-freezing-of-gait-in-parkinson-s-disease-a-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atomoxetine-on-noradrenergic-system-s-role-in-learning-dynamics-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-and-supervised-exercise-on-anticancer-therapy-efficacy-in-metastatic-breast-ovarian-prostate-and-kidney-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-as-an-adjuvant-therapy-in-philadelphia-negative-myeloproliferative-neoplasms-impact-on-inflammatory-markers-and-cell-counts2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-in-modulating-bile-acid-synthesis-in-patients-with-moderate-to-severe-bile-acid-diarrhoea-a-dose-response-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-in-preventing-immune-checkpoint-inhibitor-induced-atherosclerosis-progression-in-patients-undergoing-ici-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-on-copd-exacerbation-reduction-in-smokers-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-on-post-operative-atrial-fibrillation-incidence-in-statin-naive-patients-undergoing-elective-surgical-aortic-valve-replacement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atorvastatin-on-progression-of-metastatic-or-high-risk-recurrent-prostate-cancer-during-androgen-deprivation-therapy-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atropine-sulfate-monohydrate-eye-drops-in-myopia-progression-in-pediatric-patients-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atropine-sulfate-monohydrate-syd-101-ophthalmic-solution-for-myopia-progression-in-pediatric-patients-a-randomized-double-masked-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-atx101-at-three-dose-levels-for-treating-vascular-hyperpermeability-in-sepsis-and-septic-shock-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aumolertinib-in-european-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-aup1602-c-in-combination-with-foam-dressing-for-non-healing-neuroischemic-diabetic-foot-ulcers-a-phase-2a-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-derived-mesenchymal-stem-cells-for-intradiscal-injection-in-degenerative-disc-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-derived-mesenchymal-stem-cells-for-urinary-incontinence-post-radical-prostatectomy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-and-microfat-for-refractory-perianal-crohn-s-fistulas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-cells-as-an-adjunct-to-endoscopic-urethrotomy-in-recurrent-bulbar-urethral-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-cells-in-refractory-diabetic-foot-ulcers-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-in-temporomandibular-joint-osteoarthritis-wilkes-classification-4-52026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-bone-marrow-derived-mononuclear-cell-therapy-versus-standard-care-in-diabetic-patients-with-chronic-limb-threatening-ischemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-bone-marrow-derived-mononuclear-cells-and-saline-in-advanced-chronic-limb-ischemia-with-high-amputation-risk2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-car-t-cells-tarcidomgen-kimleucel-in-refractory-and-relapsed-cd19-b-cell-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-dendritic-cells-loaded-with-coagulation-factor-viii-in-patients-with-hemophilia-a-and-inhibitory-antibodies-to-factor-viii2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-hematopoietic-stem-cell-transplantation-and-drug-combination-in-aggressive-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-platelet-rich-plasma-and-focal-shockwave-therapy-in-moderate-erectile-dysfunction-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-thymic-treg-cell-infusion-for-acute-rejection-prevention-in-pediatric-heart-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-tissue-engineered-fibrin-agarose-oral-mucosa-substitute-in-cleft-palate-treatment-a-phase-i-iia-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-tolerogenic-dendritic-cells-combined-with-first-line-immunotherapy-in-relapsing-remitting-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autologous-tolerogenic-dendritic-cells-in-highly-sensitized-patients-undergoing-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-automated-carbon-dioxide-injection-for-contrast-medium-reduction-in-peripheral-arterial-disease-patients-to-prevent-major-adverse-kidney-events2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-autovaccines-versus-antibiotic-regimen-in-managing-hip-or-knee-prosthesis-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-av-101-imatinib-efficacy-and-safety-in-pulmonary-arterial-hypertension-a-randomized-double-blind-placebo-controlled-phase-2b-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-av-ec2023-efficacy-and-safety-in-insomnia-a-randomized-placebo-controlled-double-blind-biphasic-clinical-trial-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avacopan-efficacy-pharmacokinetics-and-safety-in-combination-with-rituximab-or-cyclophosphamide-regimen-in-pediatric-anca-associated-vasculitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avalglucosidase-alfa-efficacy-and-safety-in-non-classic-pompe-disease-patients-aged-5-years-with-deterioration-on-alglucosidase-alfa-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avapritinib-blu-285-efficacy-and-safety-in-indolent-systemic-mastocytosis-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avapritinib-in-pediatric-patients-with-solid-tumors-dependent-on-kit-or-pdgfra-signaling-a-phase-1-2-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avelumab-as-maintenance-therapy-in-patients-with-unresectable-locally-advanced-or-metastatic-urothelial-carcinoma-post-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avelumab-combined-with-neoadjuvant-chemotherapy-in-resectable-gastric-and-gastroesophageal-junction-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-avelumab-maintenance-immunotherapy-post-first-line-platinum-based-chemotherapy-in-locally-advanced-or-metastatic-squamous-cell-penile-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-axatilimab-efficacy-safety-and-tolerability-in-idiopathic-pulmonary-fibrosis-a-26-week-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-axatilimab-inca034176-and-corticosteroids-in-initial-treatment-of-moderate-to-severe-chronic-graft-versus-host-disease-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-axicabtagene-ciloleucel-car-t-cell-therapy-in-relapsed-or-refractory-primary-mediastinal-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-axicabtagene-ciloleucel-efficacy-in-late-relapse-diffuse-large-b-cell-lymphoma-a-phase-ii-single-arm-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd0022-monotherapy-and-combination-therapy-with-cetuximab-in-krasg12d-mutated-advanced-tumors-a-phase-i-iia-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd0305-monotherapy-and-combination-therapy-in-relapsed-or-refractory-multiple-myeloma-a-phase-i-ii-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd0486-and-tocilizumab-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia-in-adolescents-and-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd0486-monotherapy-and-combination-therapy-in-mature-b-cell-malignancies-a-phase-i-ii-study-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-mantle-cell-lymphoma-and-large-b-c2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd0901-monotherapy-and-combination-therapy-in-advanced-solid-tumors-expressing-claudin-18-2-a-phase-ii-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd2014-and-anastrozole-in-metastatic-hormone-receptor-positive-endometrial-adenocarcinoma-a-phase-i-ii-multicentric-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd2693-sodium-efficacy-safety-and-tolerability-in-non-cirrhotic-nash-with-fibrosis-and-pnpla3-rs738409-148m-allele-carriers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd2962-an-irak4-inhibitor-as-monotherapy-and-in-combination-therapy-in-patients-with-dysplastic-chronic-myelomonocytic-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd3152-and-cilgavimab-for-pre-exposure-prophylaxis-of-covid-19-in-immunocompromised-patients-a-randomized-double-blind-phase-i-iii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd3427-on-renal-perfusion-in-heart-failure-with-reduced-ejection-fraction-and-renal-impairment-using-positron-emission-tomography2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd4360-safety-pharmacokinetics-and-efficacy-in-adults-with-advanced-solid-tumors-expressing-cldn18-22026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd4512-monotherapy-and-combination-therapy-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-a-phase-i-ii-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd4604-on-airway-inflammation-and-biomarkers-in-adult-asthma-a-randomized-double-blind-placebo-controlled-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd5004-efficacy-safety-and-tolerability-in-adults-with-type-2-diabetes-mellitus-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd5335-monotherapy-and-combination-therapy-in-patients-with-platinum-resistant-recurrent-ovarian-cancer-and-lung-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd5462-combined-with-dapagliflozin-in-heart-failure-patients-with-moderate-renal-impairment-a-phase-ib-randomized-placebo-controlled-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd5863-and-tocilizumab-in-advanced-or-metastatic-solid-tumors-a-phase-i-ii-dose-escalation-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd9550-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-overweight-and-obese-patients-with-non-alcoholic-steatohepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd9574-monotherapy-and-combination-therapy-in-advanced-solid-malignancies-a-phase-i-iia-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azd9829-monotherapy-and-combination-therapy-in-cd123-positive-hematological-malignancies-focus-on-relapsed-refractory-acute-myeloid-leukemia-and-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azithromycin-and-doxycycline-in-reducing-inflammatory-activity-in-biopsy-confirmed-sarcoidosis-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azithromycin-efficacy-in-idiopathic-purulent-oedematous-sinusitis-in-adults-a-multicentre-randomised-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-azithromycin-versus-placebo-in-hospitalized-pediatric-patients-with-asthma-like-symptoms-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bacillus-calmette-guerin-vaccine-in-patients-with-radiologically-isolated-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baclofen-as-an-adjunctive-therapy-for-reducing-pharmaceutical-ghb-requirements-in-inpatient-detoxification-for-ghb-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baclofen-as-an-adjunctive-therapy-in-sodium-oxybate-detoxification-for-patients-with-gamma-hydroxybutyrate-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-balcinrenone-and-dapagliflozin-on-cardiovascular-outcomes-in-heart-failure-patients-with-renal-impairment-a-phase-iii-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baloxavir-marboxil-susceptibility-in-pediatric-patients-with-influenza-a-phase-iiib-multicenter-single-arm-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-balstilimab-monotherapy-in-advanced-metastatic-non-melanoma-skin-cancers-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-and-tocilizumab-in-pediatric-patients-with-systemic-juvenile-idiopathic-arthritis-a-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-combined-with-anti-tnf-agents-adalimumab-or-etanercept-versus-baricitinib-monotherapy-in-refractory-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-efficacy-in-refractory-non-infectious-non-anterior-uveitis-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-in-combination-with-standard-care-for-treatment-of-large-inflammatory-hepatocellular-adenomas-in-histologically-confirmed-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-in-the-preclinical-phase-of-rheumatoid-arthritis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-in-the-treatment-of-hospital-acquired-pneumonia-in-critically-ill-patients-with-a-proinflammatory-phenotype-a-phase-ii-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-on-hiv-1-reservoir-and-safety-in-virologically-suppressed-patients-with-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-on-synovial-inflammation-in-calcium-pyrophosphate-deposition-disease-a-phase-ii-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-pharmacokinetics-efficacy-and-safety-in-pediatric-patients-with-moderate-to-severe-atopic-dermatitis-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baricitinib-tralokinumab-abrocitinib-upadacitinib-and-dupilumab-in-second-line-systemic-therapy-for-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-basimglurant-efficacy-and-safety-in-trigeminal-neuralgia-patients-with-suboptimal-response-to-current-analgesic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-batoclimab-efficacy-and-safety-in-an-open-label-extension-study-for-thyroid-eye-disease-treatment-in-participants-completing-imvt-1401-3201-32022026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-batoclimab-efficacy-and-safety-in-patients-with-graves-disease-an-open-label-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baxdrostat-and-dapagliflozin-on-chronic-kidney-disease-progression-in-hypertensive-patients-a-randomized-double-blind-active-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baxdrostat-and-dapagliflozin-on-heart-failure-incidence-and-cardiovascular-mortality-in-high-risk-patients-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-baxdrostat-on-cardiac-electrophysiology-in-healthy-subjects-with-treatment-resistant-hypertension-primary-aldosteronism-and-uncontrolled-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bay-3283142-efficacy-and-safety-in-reducing-albuminuria-in-chronic-kidney-disease-patients-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bay-3498264-monotherapy-and-combination-with-sotorasib-in-advanced-solid-tumors-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bay63-2521-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-interstitial-lung-disease-associated-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bdc-1001-monotherapy-and-bdc-1001-with-nivolumab-in-advanced-her2-expressing-solid-tumors-a-phase-1-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beam-302-safety-and-efficacy-in-adult-patients-with-alpha-1-antitrypsin-deficiency-associated-lung-and-or-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-behavioral-and-co-occurring-outcomes-with-cannabidiol-as-adjunctive-therapy-in-tuberous-sclerosis-complex-associated-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belantamab-mafodotin-in-adults-with-primary-immune-thrombocytopenia-post-thrombopoietin-receptor-agonist-and-or-rituximab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belantamab-mafodotin-monotherapy-and-combinatorial-regimens-in-relapsed-refractory-multiple-myeloma-a-phase-i-ii-platform-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belantamab-mafodotin-with-daratumumab-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-transplant-ineligible-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belantamab-mafodotin-with-lenalidomide-dexamethasone-and-nirogacestat-in-transplant-ineligible-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belantamab-monotherapy-and-combination-regimens-in-patients-with-multiple-myeloma-safety-and-clinical-activity-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belatacept-as-a-non-nephrotoxic-immunosuppressive-agent-in-cardiac-transplant-recipients-at-risk-of-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belatacept-versus-calcineurin-inhibitors-on-endothelial-function-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belimumab-and-rituximab-combination-therapy-in-patients-with-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belimumab-on-synovial-inflammation-and-lymph-node-composition-in-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belimumab-plus-standard-therapy-in-pediatric-patients-with-systemic-lupus-erythematosus-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belumosudil-and-prednisone-versus-placebo-and-prednisone-in-patients-aged-12-and-older-with-newly-diagnosed-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belvarafenib-monotherapy-and-combination-therapy-with-cobimetinib-and-nivolumab-in-nras-mutant-advanced-cutaneous-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-belzutifan-in-von-hippel-lindau-disease-associated-renal-cell-carcinoma-an-open-label-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bemarituzumab-monotherapy-in-patients-with-fgfr2b-overexpressing-solid-tumors-a-phase-1b-2-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bemnifosbuvir-hemisulfate-efficacy-and-safety-in-high-risk-covid-19-outpatients-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bempedoic-acid-in-achieving-ldl-c-targets-in-post-myocardial-infarction-patients-insufficiently-managed-with-atorvastatin-and-ezetimibe2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bempikibart-adx-914-safety-and-efficacy-in-moderate-to-severe-atopic-dermatitis-a-randomized-double-blind-placebo-controlled-phase-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-benralizumab-efficacy-and-safety-in-eosinophilic-asthma-patients-uncontrolled-on-medium-dose-ics-laba-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-benralizumab-on-structural-and-lung-function-alterations-in-severe-eosinophilic-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-benralizumab-s-predictive-gene-expression-signature-in-reducing-exacerbations-in-severe-asthma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-benralizumab-safety-and-pharmacokinetics-in-children-with-eosinophilic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-berubicin-hydrochloride-safety-and-efficacy-in-central-nervous-system-lymphomas-a-phase-1-study-on-dose-determination-and-tolerability2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-berubicin-hydrochloride-versus-lomustine-in-adult-patients-with-recurrent-glioblastoma-multiforme-post-standard-therapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-berzosertib-and-gemcitabine-hydrochloride-in-advanced-metastatic-soft-tissue-leiomyosarcomas-a-randomized-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beta-adrenergic-blockers-on-outcomes-in-patients-undergoing-transcatheter-aortic-valve-replacement-for-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beta-blocker-therapy-in-idiopathic-ventricular-fibrillation-a-study-of-bisoprolol-fumarate-hydrochlorothiazide-and-metoprolol-in-post-cardiac-arrest-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beta-blockers-with-alpha-activity-and-nitric-oxide-liberation-in-takotsubo-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beta-lactam-intermittent-vs-continuous-infusion-and-combination-antibiotic-therapy-in-icu-patients-with-hospital-acquired-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-beta-receptor-modulation-with-esmolol-hydrochloride-dobutamine-and-milrinone-in-cardiogenic-shock-patients-on-v-a-ecmo2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-betaine-citrate-efficacy-and-safety-in-functional-dyspepsia-treatment-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-800cw-and-cetuximab-800cw-for-early-detection-of-neoplastic-lesions-in-barrett-s-esophagus-via-fluorescence-molecular-endoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-800cw-immuno-oct-imaging-for-safety-and-feasibility-in-barrett-s-esophagus-colon-carcinoma-and-gastrointestinal-dysplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-and-trifluridine-tipiracil-biweekly-regimen-to-mitigate-grade-3-4-neutropenia-in-metastatic-colorectal-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-dose-equivalence-in-first-line-treatment-of-ovarian-fallopian-tube-and-peritoneal-carcinomas-with-olaparib-carboplatin-and-paclitaxel2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-efficacy-and-safety-in-patients-with-symptomatic-cerebral-arteriovenous-malformations-ineligible-for-interventional-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-encorafenib-and-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer-a-phase-ii-study-with-safety-lead-in2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-temozolomide-and-irinotecan-in-pediatric-refractory-relapsed-neuroblastoma-a-randomized-phase-iib-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bevacizumab-versus-dexamethasone-for-symptomatic-cerebral-radiation-necrosis-in-high-grade-glioma-and-brain-metastases-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bexmarilimab-combined-with-standard-of-care-in-myelodysplastic-syndrome-chronic-myelomonocytic-leukemia-and-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bezafibrate-400-mg-and-200-mg-as-adjunctive-therapy-in-primary-biliary-cholangitis-with-suboptimal-ursodeoxycholic-acid-response-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bezafibrate-and-obeticholic-acid-combination-therapy-on-alkaline-phosphatase-levels-in-primary-biliary-cholangitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgb-11417-and-azacitidine-with-posaconazole-interaction-in-myeloid-malignancies-a-phase-1b-2-dose-finding-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgb-11417-in-the-treatment-of-mature-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgb-11417-monotherapy-and-combinations-with-dexamethasone-carfilzomib-daratumumab-and-pomalidomide-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgb-16673-in-combination-with-glofitamab-obinutuzumab-and-other-agents-in-relapsed-or-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgb-16673-versus-pirtobrutinib-in-relapsed-refractory-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgc101-in-peripheral-arterial-disease-with-critical-limb-ischemia-a-phase-1-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bgy-1601-vt-vaginal-tablet-in-treating-acute-vaginal-infections-in-women-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bhv-7000-as-adjunctive-therapy-in-idiopathic-generalized-epilepsy-with-generalized-tonic-clonic-seizures-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1291583-on-dabigatran-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1569912-as-adjunctive-therapy-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-dose-finding-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1569912-on-pharmacokinetics-of-repaglinide-midazolam-and-bupropion-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1584862-tolerability-across-varying-doses-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1703880-and-ezabenlimab-combination-therapy-in-patients-with-advanced-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1815368-on-metformin-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1815368-tolerability-across-multiple-doses-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1819479-efficacy-safety-and-dose-response-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-1820237-bi-456906-and-their-combination-on-neural-activity-in-individuals-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3000202-on-pharmacokinetics-and-tolerability-of-midazolam-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3000202-on-pharmacokinetics-of-rosuvastatin-and-digoxin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3000202-pharmacokinetics-and-tolerability-in-healthy-male-volunteers-under-fed-and-fasted-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3000202-tolerability-in-patients-with-type-1-interferonopathies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3009947-pharmacokinetics-and-tolerability-in-healthy-male-subjects-impact-of-dose-formulation-and-food-intake2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3031185-pharmacokinetics-and-tolerability-in-healthy-male-volunteers-under-fed-and-fasted-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3031185-tolerability-across-multiple-doses-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3031185-tolerability-in-patients-with-borderline-personality-disorder-and-attention-deficit-hyperactivity-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3034701-dose-tolerability-in-healthy-male-and-overweight-or-obese-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3731579-tolerability-across-multiple-dosages-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-3804379-tolerability-across-multiple-doses-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-425809-on-pharmacokinetics-of-contraceptive-agents-in-healthy-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-456906-in-adults-with-nash-mash-and-stage-2-3-liver-fibrosis-a-randomized-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-456906-versus-semaglutide-on-hepatic-glucagon-receptor-activity-in-obese-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-685509-and-empagliflozin-on-portal-hypertension-in-compensated-cirrhosis-patients-with-csph-a-randomized-open-label-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-685509-on-portal-hypertension-in-patients-with-decompensated-cirrhosis-post-first-decompensation-event2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-706321-and-ustekinumab-combination-therapy-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-randomized-double-blind-placebo-controlled-phase-iia-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-764532-in-combination-with-chemotherapy-for-tolerability-in-advanced-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-764532-in-combination-with-single-agent-chemotherapy-for-tolerability-in-patients-with-relapsed-refractory-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-764532-in-combination-with-standard-of-care-for-tolerability-in-patients-with-extensive-stage-small-cell-lung-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-764532-uptake-in-tumors-of-patients-with-large-cell-neuroendocrine-lung-carcinoma-neuroendocrine-carcinoma-or-small-cell-lung-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-765063-and-bi-770371-uptake-in-tumors-of-patients-with-advanced-head-and-neck-squamous-cell-carcinoma-non-small-cell-lung-cancer-or-melanoma-receiving-ezabenlimab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-765063-ezabenlimab-chemotherapy-cetuximab-and-bi-836880-combinations-in-head-and-neck-squamous-cell-carcinoma-and-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-765179-monotherapy-and-combination-therapy-with-ezabenlimab-or-pembrolizumab-in-advanced-solid-tumors-and-head-and-neck-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-765423-on-lung-function-in-idiopathic-pulmonary-fibrosis-a-phase-iia-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-770371-and-pembrolizumab-with-or-without-cetuximab-versus-pembrolizumab-monotherapy-in-head-and-neck-squamous-cell-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-907828-monotherapy-in-patients-with-mdm2-amplified-tp53-wild-type-biliary-tract-pancreatic-lung-and-urothelial-bladder-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bi-907828-pharmacokinetics-in-advanced-solid-tumors-with-oatp-and-cyp3-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bictegravir-lenacapavir-versus-bictegravir-emtricitabine-tenofovir-alafenamide-in-virologically-suppressed-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bilateral-sentinel-lymph-node-detection-using-indocyanine-green-versus-99mtc-and-blue-dye-in-stage-i-iia-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bimatoprost-sr-and-timolol-maleate-in-reducing-intraocular-pressure-in-open-angle-glaucoma-and-ocular-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bimekizumab-on-gene-expression-biomarkers-in-moderate-to-severe-plaque-psoriasis-and-psoriatic-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bintrafusp-alfa-and-doxorubicin-hydrochloride-in-advanced-soft-tissue-sarcoma-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bintrafusp-alfa-combined-with-chemoradiation-in-esophageal-squamous-cell-carcinoma-a-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biologic-tapering-with-mepolizumab-and-dupilumab-in-patients-with-severe-chronic-rhinosinusitis-with-nasal-polyps-a-danish-rct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biological-activity-of-allergenic-mite-extracts-dermatophagoides-pteronyssinus-dermatophagoides-farinae-blomia-tropicalis-lepidoglyphus-destructor-in-sensitized-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biomarker-driven-intensification-of-cardiovascular-risk-management-in-patients-with-high-risk-for-recurrent-events-using-icosapent-ethyl-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biomarker-driven-therapies-in-persistent-or-recurrent-rare-epithelial-ovarian-tumors-using-palbociclib-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biomarkers-for-identifying-risk-of-glucocorticoid-induced-secondary-osteoporosis-in-patients-administered-prednisolone-and-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biomarkers-predicting-mepolizumab-response-in-chronic-rhinosinusitis-with-nasal-polyps-crswnp-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biotin-and-biotin-sodium-formulations-on-treatment-adherence-in-pediatric-patients-with-methylcrotonylglycinuria-and-biotinidase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bisacodyl-and-a-drug-combination-for-constipation-prevention-in-postoperative-hip-fracture-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bisoprolol-fumarate-and-verapamil-on-symptomatic-non-obstructive-hypertrophic-cardiomyopathy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-biweekly-vs-triweekly-folfiri-regimens-on-progression-free-survival-in-first-line-treatment-of-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bjt-778-versus-delayed-treatment-in-chronic-hepatitis-delta-infection-a-global-randomized-open-label-multicenter-phase-2b-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-blinatumomab-isatuximab-and-ponatinib-in-frontline-therapy-for-adults-with-acute-lymphoblastic-leukemia-and-t-lymphoblastic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-blood-pressure-changes-in-narcolepsy-patients-transitioning-from-high-sodium-oxybate-to-jzp258-sodium-calcium-magnesium-potassium-oxybate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-blu-263-monotherapy-and-blu-263-combined-with-azacitidine-in-patients-with-kit-altered-advanced-systemic-mastocytosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986012-with-platinum-and-etoposide-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986326-in-multiple-ascending-doses-for-discoid-subacute-cutaneous-and-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986435-myk-224-safety-and-tolerability-in-heart-failure-with-preserved-ejection-fraction-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986442-with-nivolumab-and-chemotherapy-in-advanced-solid-tumors-and-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986446-an-anti-mtbr-tau-monoclonal-antibody-in-early-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986449-monotherapy-and-combination-with-nivolumab-in-advanced-metastatic-solid-malignancies-a-phase-1-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986470-pharmacokinetics-pharmacodynamics-safety-and-tolerability-in-healthy-volunteers-and-sickle-cell-disease-patients-a-phase-1-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bms-986482-monotherapy-and-combination-regimens-in-advanced-solid-tumors-a-phase-1-2-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bnt116-monotherapy-and-combination-regimens-in-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bnt314-monotherapy-and-bnt314-with-pembrolizumab-in-advanced-malignant-solid-tumors-safety-and-preliminary-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bnt326-monotherapy-and-combination-with-bnt327-in-advanced-solid-tumors-a-phase-i-ii-open-label-adaptive-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bnt327-combined-with-chemotherapy-and-investigational-agents-in-first-line-treatment-of-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bomedemstat-safety-and-efficacy-in-myeloproliferative-neoplasms-an-open-label-extension-study-for-participants-from-previous-trials2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bomedemstat-versus-best-available-therapy-in-essential-thrombocythemia-patients-with-hydroxyurea-intolerance-or-inadequate-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bortezomib-and-daratumumab-based-regimens-in-primary-plasma-cell-leukemia-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bortezomib-blinatumomab-and-methotrexate-in-pediatric-acute-lymphoblastic-leukemia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bortezomib-efficacy-and-safety-in-severe-autoimmune-encephalitis-a-multicenter-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bosentan-in-the-management-of-coronary-vasospasm-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bosentan-in-the-treatment-of-early-non-arteritic-anterior-ischemic-optic-neuropathy-in-acute-phase-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bosentan-prednisone-and-prednisolone-in-the-management-of-newly-diagnosed-or-relapsing-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bosentan-s-effect-on-nerandomilast-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-a-on-gene-expression-and-cellular-plasticity-in-myogenous-temporomandibular-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-on-hamstring-contracture-and-cyclops-syndrome-incidence-post-anterior-cruciate-ligament-reconstruction-in-cyclops-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-and-dry-needling-in-treating-lower-limb-spasticity-post-stroke-a-controlled-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-efficacy-and-safety-in-cervical-dystonia-patients-with-abnormal-back-muscle-activity-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-efficacy-and-safety-in-trigeminal-neuralgia-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-for-preventing-shoulder-deformity-in-infants-with-obstetrical-brachial-plexus-palsy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-for-the-prevention-of-postoperative-pancreatic-fistula-in-patients-undergoing-distal-pancreatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-in-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-within-subject-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-in-the-management-of-buerger-s-disease-a-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-in-the-management-of-piriformis-hypertonia-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-in-tinnitus-patients-with-concurrent-bruxism-and-or-jaw-muscle-myalgia-a-triple-blind-randomized-placebo-controlled-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-injection-in-split-doses-for-wrinkle-and-fine-line-treatment-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-injection-versus-hyoscine-transdermal-system-for-drooling-in-pediatric-cerebral-palsy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-injections-for-dystrophic-scar-prevention-post-sternotomy-a-placebo-controlled-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-on-muscle-tendon-and-neural-properties-in-spastic-equinovarus-post-first-ever-stroke-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-botulinum-toxin-type-a-on-spastic-co-contractions-in-chronic-post-stroke-hemiplegic-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bovine-alkaline-phosphatase-in-mitigating-ischemia-reperfusion-injury-in-deceased-donor-kidney-transplantation-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bovine-alkaline-phosphatase-in-reducing-systemic-inflammation-and-acute-kidney-injury-post-cardiac-surgery-with-cardiopulmonary-bypass2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bp1-15205-on-safety-tolerability-and-pharmacokinetics-in-narcolepsy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bp1-4979-in-female-patients-with-moderate-to-severe-binge-eating-disorder-a-double-blind-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bpalm-regimen-efficacy-in-multidrug-resistant-tuberculosis-patients-in-france-a-comparative-study-with-historical-cohort-data2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brain-metabolism-with-fludeoxyglucose-18f-pet-in-patients-with-persistent-post-covid-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brecadd-versus-escalated-beacopp-in-first-line-treatment-of-advanced-hodgkin-lymphoma-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brentuximab-vedotin-combined-with-adriamycin-vinblastine-and-dacarbazine-in-pediatric-advanced-stage-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brentuximab-vedotin-doxorubicin-hydrochloride-dacarbazine-and-nivolumab-in-untreated-classical-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brentuximab-vedotin-eshap-versus-eshap-in-relapsed-refractory-classical-hodgkin-lymphoma-a-phase-iib-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brentuximab-vedotin-for-maintenance-therapy-in-cutaneous-t-cell-lymphomas-post-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brexanolone-caprilcerbate-monotherapy-in-adults-with-major-depressive-disorder-with-or-without-anxious-distress-a-6-week-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brexucabtagene-autoleucel-in-pediatric-and-adolescent-patients-with-relapsed-refractory-b-precursor-acute-lymphoblastic-leukemia-or-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brigatinib-efficacy-in-alk-positive-non-small-cell-lung-cancer-via-liquid-biopsy-an-exploratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brimonidine-tartrate-ophthalmic-solution-in-mitigating-myopia-progression-in-pediatric-patients-aged-6-14-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-briquilimab-and-adrenaline-tartrate-in-chronic-inducible-urticaria-unresponsive-to-h1-antihistamines-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-briquilimab-s-safety-and-efficacy-in-a-double-blind-placebo-controlled-study-for-patients-with-allergic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-briquilimab-safety-and-pharmacokinetics-in-adults-with-chronic-spontaneous-urticaria-unresponsive-to-h1-antihistamines-or-omalizumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-brivaracetam-monotherapy-efficacy-and-safety-in-pediatric-and-young-adult-patients-with-childhood-or-juvenile-absence-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bt8009-monotherapy-and-bt8009-with-pembrolizumab-versus-chemotherapy-in-locally-advanced-or-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budesonide-efficacy-in-pediatric-crohn-s-disease-of-the-esophagus-stomach-and-duodenum-a-comparative-study-with-omeprazole2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budesonide-for-duodenal-eosinophilia-in-functional-dyspepsia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budesonide-glycopyrronium-bromide-and-formoterol-fumarate-on-cardiac-and-pulmonary-function-in-copd-with-hyperinflation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budesonide-glycopyrronium-bromide-and-formoterol-fumarate-on-cardiopulmonary-outcomes-in-chronic-obstructive-pulmonary-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budigalimab-and-abbv-382-efficacy-safety-and-pharmacokinetics-in-hiv-patients-on-stable-antiretroviral-therapy-undergoing-analytical-treatment-interruption2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budoprutug-tnt119-efficacy-and-safety-in-patients-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-budoprutug-tnt119-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-immune-thrombocytopenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-buparlisib-and-paclitaxel-versus-paclitaxel-monotherapy-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bupivacaine-hydrochloride-10-ml-vs-20-ml-for-popliteal-plexus-block-on-opioid-consumption-and-pain-in-postoperative-total-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-buprenorphine-as-an-adjunctive-treatment-for-severe-suicidal-ideation-in-major-depressive-episode-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-bupropion-hydrochloride-and-naltrexone-hydrochloride-in-patients-with-post-bariatric-surgery-weight-regain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-burfiralimab-hzvsf-v13-efficacy-and-safety-in-combination-with-dmards-in-moderate-to-severe-rheumatoid-arthritis-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-buspirone-hydrochloride-on-esophageal-motility-and-dysphagia-symptoms-in-patients-with-ineffective-motility-or-absent-peristalsis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-byon4413-in-relapsed-refractory-acute-myeloid-leukemia-and-myelodysplastic-neoplasms-safety-pharmacokinetics-and-preliminary-efficacy-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-c1-esterase-inhibitor-human-and-sodium-chloride-in-the-management-of-traumatic-brain-injury-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabergoline-in-the-management-of-non-functioning-pituitary-adenomas-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabotegravir-sodium-and-oral-emtricitabine-tenofovir-disoproxil-for-hiv-pre-exposure-prophylaxis-in-men-who-have-sex-with-men-in-france2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-and-avelumab-combination-therapy-in-advanced-neuroendocrine-neoplasias-g3-refractory-to-standard-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-and-durvalumab-in-advanced-chemotherapy-treated-bladder-carcinoma-a-phase-2-single-arm-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-and-lanreotide-combination-in-gastroenteropancreatic-and-thoracic-neuroendocrine-tumors-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-and-nivolumab-in-elderly-patients-with-metastatic-clear-cell-renal-cell-carcinoma-a-prospective-cohort-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-efficacy-in-non-small-cell-lung-cancer-patients-with-met-deregulation-a-phase-ii-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cabozantinib-in-radioiodine-refractory-differentiated-thyroid-cancer-post-vegfr-targeted-therapy-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cael-101-and-plasma-cell-dyscrasia-treatment-efficacy-and-safety-in-treatment-naive-mayo-stage-iiia-al-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cael-101-and-plasma-cell-dyscrasia-treatment-efficacy-and-safety-in-treatment-naive-mayo-stage-iiib-al-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrilintide-and-semaglutide-co-administration-on-glycemic-control-in-type-2-diabetes-patients-on-basal-insulin-therapy-with-or-without-metformin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrilintide-and-semaglutide-combination-for-weight-reduction-in-patients-with-overweight-obesity-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrilintide-for-weight-management-in-patients-with-overweight-or-obesity-and-type-2-diabetes-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrilintide-on-bone-metabolism-in-post-menopausal-women-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrisema-on-appetite-regulation-in-patients-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrisema-on-gastric-emptying-appetite-and-food-intake-in-patients-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cagrisema-semaglutide-and-cagrilintide-on-insulin-regulation-in-patients-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cal101-efficacy-and-safety-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-calcifediol-supplementation-on-vitamin-d-deficiency-in-patients-with-pulmonary-arterial-hypertension-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-calcium-chloride-dihydrate-electroporation-bleomycin-electrochemotherapy-and-irreversible-electroporation-in-unresectable-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-camizestrant-pharmacokinetics-safety-and-tolerability-in-post-menopausal-females-with-moderate-or-severe-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-camostat-mesilate-on-renal-function-and-blood-pressure-in-patients-with-chronic-kidney-disease-and-proteinuria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-candesartan-cilexetil-versus-placebo-in-asymptomatic-genetic-carriers-of-dilated-cardiomyopathy-causing-variants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cangrelor-and-bivalirudin-in-myocardial-infarction-related-cardiogenic-shock-cardiac-arrest-with-va-ecmo-impella-support2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cangrelor-tetrasodium-with-mechanical-thrombectomy-in-perfusion-imaging-selected-acute-ischemic-stroke-patients-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-administration-for-alleviating-anxiety-and-ptsd-symptoms-in-dutch-uniformed-personnel-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-and-naltrexone-on-cue-induced-alcohol-craving-in-alcohol-dependence-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-as-an-adjunctive-therapy-in-juvenile-substance-induced-psychosis-with-cannabis-use-disorder-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-cardiolrx-in-the-management-of-recurrent-pericarditis-an-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-efficacy-and-safety-in-end-stage-metastatic-castration-resistant-prostate-cancer-a-randomized-double-blind-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-efficacy-in-maintaining-remission-post-il-1-blocker-withdrawal-in-recurrent-pericarditis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-efficacy-in-reducing-self-injurious-behavior-in-pediatric-patients-with-severe-neurodevelopmental-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-in-reducing-alcohol-consumption-in-patients-with-alcohol-use-disorder-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-on-behavioral-symptoms-in-tuberous-sclerosis-complex-sanfilippo-syndrome-and-fragile-x-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-on-central-nervous-system-function-and-cortical-excitability-in-healthy-males-a-randomized-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-on-muscle-recovery-post-resistance-exercise-in-healthy-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-on-myocardial-recovery-in-patients-with-acute-myocarditis-a-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cannabidiol-on-sleep-quality-in-multiple-sclerosis-patients-with-insomnia-a-randomized-placebo-controlled-n-of-1-trial-series2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capecitabine-and-chemo-radiotherapy-versus-total-mesorectal-excision-in-organ-preservation-for-early-stage-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capecitabine-and-oxaliplatin-in-neoadjuvant-and-adjuvant-therapy-for-high-risk-rectal-cancer-to-mitigate-metastatic-recurrence2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capecitabine-and-oxaliplatin-in-neoadjuvant-chemotherapy-and-pre-operative-chemoradiation-for-high-risk-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capecitabine-and-pembrolizumab-as-adjuvant-therapy-in-triple-negative-breast-cancer-with-residual-disease-post-neoadjuvant-chemoimmunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capivasertib-and-fulvestrant-in-hr-her2-advanced-breast-cancer-patients-post-endocrine-and-cdk4-6-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capivasertib-and-fulvestrant-in-hr-her2-advanced-breast-cancer-with-endocrine-therapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-caplacizumab-and-immunosuppressive-therapy-without-initial-plasma-exchange-in-adult-immune-mediated-thrombotic-thrombocytopenic-purpura2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-capsaicin-patch-versus-amitriptyline-for-neuropathic-pain-in-remission-of-head-and-neck-cancer-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-car123-t-cell-therapy-in-patients-with-relapsed-refractory-cd123-hematologic-malignancies-including-acute-myeloid-leukemia-and-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carbachol-and-acetylcholine-chloride-in-assessing-forearm-blood-flow-in-patients-with-vascular-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carbamazepine-s-effect-on-nerandomilast-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carbamazepine-s-effect-on-the-pharmacokinetics-of-bi-1810631-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carbamazepine-s-impact-on-the-pharmacokinetics-of-vepdegestrant-in-healthy-adults-with-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carboplatin-and-chemotherapeutic-regimen-in-pediatric-patients-with-standard-risk-and-high-risk-medulloblastoma-a-multinational-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carboplatin-paclitaxel-and-cetuximab-in-second-line-treatment-of-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cardiac-metabolism-in-heart-failure-patients-using-hyperpolarized-1-13c-pyruvate-and-cardiac-magnetic-resonance-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cardiac-safety-of-treosulfan-based-chemotherapy-in-patients-with-acute-myeloid-leukemia-or-myelodysplastic-syndrome-undergoing-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cardiometabolic-risk-and-chronobiology-in-patients-with-mild-autonomous-cortisol-secretion-using-metyrapone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cardiovascular-risk-determinants-following-temporary-cessation-and-resumption-of-estradiol-therapy-in-older-transgender-women-on-long-term-hormone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cariprazine-on-cognitive-function-in-schizophrenia-patients-requiring-oral-antipsychotic-adjustment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cart19-cell-therapy-in-relapsed-refractory-cd19-acute-lymphoblastic-leukemia-and-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carvedilol-for-prevention-of-decompensation-or-mortality-in-asymptomatic-child-pugh-a5-b8-cirrhosis-with-clinically-significant-portal-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carvedilol-metoprolol-tartrate-and-bisoprolol-fumarate-in-post-myocardial-infarction-patients-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-carvedilol-on-portosystemic-gradient-in-cirrhotic-portal-hypertension-via-endoscopic-ultrasound2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-casirivimab-cilgavimab-sotrovimab-and-nirmatrelvir-in-sars-cov-2-infection-a-dutch-cohort-study-on-antiviral-efficacy-and-viral-kinetics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-catequentinib-dihydrochloride-combined-with-platinum-based-chemotherapy-in-recurrent-or-metastatic-gynecologic-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-catheter-directed-thrombolysis-with-alteplase-in-intermediate-high-risk-acute-pulmonary-embolism-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cc-11050-and-metformin-hydrochloride-as-adjunctive-therapies-in-rifampin-resistant-multidrug-resistant-pulmonary-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cc-486-in-patients-with-myeloid-malignancies-and-varying-degrees-of-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cc-90010-in-combination-with-standard-therapy-in-patients-with-newly-diagnosed-who-grade-iv-glioblastoma-post-tumor-resection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cc-90011-combined-with-cisplatin-and-etoposide-in-treatment-naive-patients-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cc-95251-monotherapy-and-in-combination-with-antineoplastic-agents-in-patients-with-acute-myeloid-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cd8-lymphocyte-infiltration-in-metastatic-melanoma-patients-using-89zr-zr-df-iab22m2c-pet-for-early-detection-of-immune-checkpoint-inhibitor-side-effects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cd8-t-lymphocyte-recruitment-via-pet-imaging-induced-by-local-and-remote-radiotherapy-in-patients-with-polymetastatic-solid-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cdk4-6-inhibitor-discontinuation-in-metastatic-hr-her2-breast-cancer-with-exemestane-fulvestrant-anastrozole-letrozole-and-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cdk4-6-inhibitors-abemaciclib-palbociclib-and-ribociclib-in-hr-her2-metastatic-breast-cancer-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cefazolin-prophylaxis-in-preventing-surgical-site-infections-in-inguinal-and-femoral-hernia-repair2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cefazolin-sodium-flucloxacillin-sodium-monohydrate-and-clindamycin-in-reducing-antibiotic-duration-for-complicated-staphylococcus-aureus-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cefepime-piperacillin-tazobactam-and-ceftobiprole-on-gut-microbiota-in-patients-with-osteoarticular-infections-on-prosthetic-devices2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceftobiprole-and-oatp1b-interaction-in-patients-with-community-acquired-bacterial-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceftriaxone-and-amoxicillin-trihydrate-in-reducing-major-adverse-cardiovascular-events-in-patients-with-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceftriaxone-cough-simulator-and-subglottic-secretion-aspiration-for-early-respiratory-infection-prevention-in-intubated-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceftriaxone-sodium-clarithromycin-and-metronidazole-in-reducing-neonatal-mortality-in-threatened-late-miscarriage-with-intact-membranes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cefuroxime-and-metronidazole-in-reducing-infectious-complications-post-pancreatoduodenectomy-in-high-risk-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-celecoxib-as-an-adjunctive-treatment-in-major-depressive-disorder-with-immuno-metabolic-characteristics-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cell-based-immunotherapy-in-patients-with-stage-ii-and-iii-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cell-therapy-in-amyotrophic-lateral-sclerosis-treatment-for-patients-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cellthrpe1-in-patients-with-geographic-atrophy-secondary-to-dry-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-celtil-score-changes-in-hr-her2-advanced-or-metastatic-breast-cancer-patients-treated-with-sacituzumab-govitecan2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cemiplimab-as-maintenance-immunotherapy-in-patients-with-advanced-adrenocortical-carcinoma-post-edp-m-cycles2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cemiplimab-consolidation-therapy-on-progression-free-survival-in-stage-iv-synchronous-oligometastatic-non-small-cell-lung-cancer-post-radical-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cemiplimab-monotherapy-and-chemotherapy-combination-based-on-ctdna-levels-in-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cemiplimab-plus-chemotherapy-with-or-without-additional-cancer-therapies-in-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cenegermin-eye-drop-solution-at-two-concentrations-for-safety-and-efficacy-in-patients-with-dry-eye-disease-a-randomized-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cenerimod-efficacy-and-safety-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cenobamate-as-adjunctive-therapy-in-patients-aged-12-and-older-with-primary-generalized-tonic-clonic-seizures-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-central-nervous-system-pharmacodynamic-activity-of-brexanolone-via-transcranial-magnetic-stimulation-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceralasertib-in-patients-with-molecularly-altered-advanced-cancer-a-phase-2a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceralasertib-oleclumab-and-monalizumab-in-combination-with-durvalumab-versus-docetaxel-in-advanced-non-small-cell-lung-cancer-with-pd-1-pd-l1-resistance2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceralasertib-pharmacokinetics-and-safety-in-combination-with-other-agents-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceralasertib-priming-followed-by-durvalumab-and-nab-paclitaxel-in-advanced-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ceralasertib-safety-and-tolerability-in-combination-with-anti-cancer-therapies-in-patients-with-advanced-solid-malignancies-and-atm-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cerebral-amyloid-and-glucose-metabolism-in-alzheimer-s-disease-using-18f-flutemetamol-and-18f-fludeoxyglucose-pet-in-alfa-project-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cerebral-tau-aggregates-using-18f-ro6958948-pet-imaging-in-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cerebrolysin-and-sodium-chloride-for-neurorecovery-in-moderate-severe-traumatic-brain-injury-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cerebrolysin-concentrate-in-genetically-confirmed-cadasil-a-randomized-double-blind-placebo-controlled-cross-over-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cetuximab-800cw-conjugate-in-targeted-fluorescence-endoscopy-for-identifying-primary-tumors-in-head-and-neck-cancer-of-unknown-primary-origin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cetuximab-irinotecan-and-fluorouracil-in-first-line-treatment-of-immunologically-selected-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cetuximab-with-or-without-paclitaxel-following-pembrolizumab-and-platinum-5fu-in-recurrent-metastatic-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cevostamab-monotherapy-and-cevostamab-with-pomalidomide-dexamethasone-or-daratumumab-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cevostamab-with-lenalidomide-or-iberdomide-in-high-risk-and-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cgrp-monoclonal-antibodies-and-onabotulinumtoxina-in-reducing-monthly-migraine-days-in-adults-with-chronic-migraine-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chemotherapy-addition-in-egfr-mutant-advanced-nsclc-with-persistent-plasma-ctdna-egfr-mutation-post-osimertinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chemotherapy-regimen-in-standard-risk-adult-medulloblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chemotherapy-regimens-including-cisplatin-cyclophosphamide-and-etoposide-in-pediatric-and-young-adult-ependymoma-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chemotherapy-versus-endocrine-therapy-as-second-line-treatment-in-er-positive-her2-negative-metastatic-breast-cancer-using-fluoroestradiol-f-182026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chemotherapy-with-nivolumab-in-early-stage-classical-hodgkin-lymphoma-with-low-metabolic-tumor-volume-and-negative-interim-pet2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chf-1535-with-different-propellants-on-pharmacokinetics-and-safety-in-asthma-patients-using-aerochamber-plus-r-spacer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chf-1535-with-two-propellants-on-pharmacokinetics-and-safety-in-asthma-and-copd-using-aerochamber-plus-r-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chiropractic-spinal-manipulative-therapy-and-ibuprofen-in-the-management-of-acute-neck-pain-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chlorhexidine-and-ethanol-for-pre-cannulation-antisepsis-in-hemodialysis-a-randomized-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chloroprocaine-hydrochloride-1-and-2-for-peripheral-nerve-block-in-pediatric-patients-undergoing-calcaneo-stop-or-inguinal-hernia-repair2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chloroprocaine-hydrochloride-3-gel-versus-oxybuprocaine-0-4-eye-drops-for-ocular-surface-anesthesia-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cholecalciferol-and-glycerol-supplementation-on-inflammatory-markers-in-obese-elderly-patients-with-vitamin-d-deficiency-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cholecalciferol-supplementation-in-patients-with-depressive-disorder-or-bipolar-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-choline-alfoscerate-on-hippocampal-atrophy-and-cortical-stability-in-patients-with-mild-cognitive-dysfunction-and-vascular-damage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-choline-chloride-injection-versus-placebo-in-adolescents-and-adults-with-intestinal-failure-on-long-term-parenteral-support2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cholinergic-and-dopaminergic-pathway-integrity-in-post-stroke-apathy-using-fluoroethoxybenzovesamicol-f-18-and-fluorodopa-18f2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-chronotherapeutics-active-light-therapy-and-prolonged-release-melatonin-in-major-depressive-episode-with-insomnia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ciclopirox-in-the-clinical-progression-of-onychomycosis-a-phase-iv-multicenter-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cilostazol-addition-to-nimodipine-on-neurological-outcomes-in-aneurysmal-subarachnoid-hemorrhage-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ciltacabtagene-autoleucel-and-dara-vrd-in-high-risk-smoldering-multiple-myeloma-a-phase-ii-open-label-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ciprofloxacin-colistimethate-sodium-and-ceftazidime-pentahydrate-regimens-for-early-pseudomonas-aeruginosa-infection-in-bronchiectasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ciprofloxacin-s-impact-on-antimicrobial-resistance-in-escherichia-coli-a-randomized-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-circulating-tumor-dna-guided-adjuvant-therapy-with-fluorouracil-folinic-acid-and-oxaliplatin-in-stage-ii-colon-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-circumcision-and-antibiotic-prophylaxis-on-febrile-urinary-tract-infections-in-boys-with-posterior-urethral-valves-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cisplatin-based-regimens-and-drug-combinations-in-pediatric-hepatoblastoma-and-hepatocellular-carcinoma-a-multicenter-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cisplatin-gemcitabine-and-oxaliplatin-on-speech-perception-cognition-and-quality-of-life-in-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cisplatin-nab-paclitaxel-and-nivolumab-with-radiotherapy-post-maximal-tumor-resection-in-non-metastatic-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cit-013-efficacy-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-2a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-citalopram-on-spontaneous-chest-pain-in-achalasia-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-citicoline-in-mitigating-cognitive-decline-post-delirium-in-elderly-patients-with-proximal-hip-fracture-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cladribine-based-regimen-in-pediatric-and-adolescent-langerhans-cell-histiocytosis-a-randomized-multicenter-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cladribine-on-microglial-activation-in-multiple-sclerosis-using-11c-pk11195-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clascoterone-solution-efficacy-and-safety-in-androgenetic-alopecia-treatment-in-adult-males-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cle-905-ag-an-m1-m4-muscarinic-agonist-with-peripheral-muscarinic-antagonist-in-schizophrenia-a-phase-1-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clemastine-and-aerobic-exercise-on-cognitive-dysfunction-in-schizophrenia-targeting-myelin-plasticity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clemastine-fumarate-and-fampridine-in-remyelination-for-internuclear-ophthalmoparesis-and-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clemizole-hydrochloride-epx-100-as-adjunctive-therapy-in-pediatric-and-adult-dravet-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clic-1901-car-t-cell-therapy-in-relapsed-refractory-cd19-positive-hematological-malignancies-with-tocilizumab-support2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-click-cleavable-imaging-agents-in-her2-positive-tumors-the-cleavher-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clindamycin-hydrochloride-and-drug-combination-on-90-day-mortality-in-patients-with-staphylococcus-aureus-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clinical-and-biological-response-to-repeated-low-dose-aldesleukin-in-type-1-diabetes-patients-with-residual-insulin-secretion-post-ciclosporin-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clinical-and-economic-outcomes-of-conservative-management-in-pediatric-acute-non-complicated-appendicitis-using-amoxicillin-clavulanic-acid-and-metronidazole2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clinical-behavior-resectability-and-survival-in-metastatic-colorectal-cancer-with-fluorouracil-and-capecitabine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clinical-outcomes-of-nusinersen-in-patients-with-spinal-muscular-atrophy-post-onasemnogene-abeparvovec-administration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clinical-surveillance-versus-rivaroxaban-in-low-risk-patients-with-isolated-subsegmental-pulmonary-embolism-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clioquinol-as-an-adjunctive-therapy-in-patients-with-drug-resistant-epilepsy-an-exploratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clofutriben-spi-62-in-the-management-of-acth-dependent-cushing-s-syndrome-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clonidine-and-doxazosin-for-nightmare-reduction-in-posttraumatic-stress-disorder-a-randomized-placebo-controlled-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clonidine-hydrochloride-as-an-analgesic-in-retinopathy-of-prematurity-eye-examinations-in-premature-infants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clonidine-hydrochloride-for-prevention-of-emergence-agitation-post-anesthesia-in-pediatric-patients-aged-1-year2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clopidogrel-and-dalteparin-sodium-in-thromboprophylaxis-for-pancreatic-ductal-adenocarcinoma-patients-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clopidogrel-atorvastatin-rosuvastatin-and-acetylsalicylic-acid-in-covert-brain-infarction-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clopidogrel-monotherapy-versus-clopidogrel-and-acetylsalicylic-acid-dual-therapy-on-atherothrombotic-events-in-peripheral-arterial-disease-post-angioplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-closed-loop-automatic-control-of-inspiratory-fraction-of-oxygen-on-outcomes-in-extremely-preterm-infants-a-randomized-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clostridium-botulinum-neurotoxin-type-a-for-myalgia-and-myofascial-pain-in-temporomandibular-disorders-a-dose-dependent-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clostridium-botulinum-neurotoxin-type-a-in-degenerative-rotator-cuff-tendinopathy-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-clozapine-induced-immunodeficiency-in-patients-with-parkinson-s-disease-a-study-on-serum-igg-level-variation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cnty-101-a-cd19-targeted-car-ink-cell-therapy-in-refractory-systemic-lupus-erythematosus-idiopathic-inflammatory-myopathy-and-diffuse-cutaneous-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cocaine-lidocaine-hydrochloride-xylometazoline-hydrochloride-and-sodium-chloride-for-intranasal-analgesia-in-nasotracheal-intubation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cognitive-function-post-liver-transplantation-a-comparative-study-of-once-daily-versus-twice-daily-tacrolimus-formulations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-and-thiamine-hydrochloride-in-patients-with-heart-failure-secondary-to-ischemic-heart-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-and-ticagrelor-in-preventing-recurrent-ischemic-stroke-in-patients-with-atherosclerosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-and-tiemonium-methylsulphate-in-secondary-prevention-of-cardiovascular-events-in-moderate-chronic-renal-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-efficacy-in-reducing-cardiovascular-events-in-post-pci-patients-with-coronary-artery-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-efficacy-in-reducing-nt-probnp-levels-in-patients-with-acute-decompensated-heart-failure-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-for-reducing-microvascular-complications-in-patients-with-type-1-diabetes-and-high-glycemic-variability2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-in-patients-with-ischemia-and-coronary-microvascular-dysfunction-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-on-aortic-valve-stenosis-progression-in-patients-with-moderate-aortic-valve-stenosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-on-endothelial-function-in-patients-with-clonal-hematopoiesis-and-chronic-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-on-health-status-in-patients-with-heart-failure-with-preserved-ejection-fraction-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-on-inflammatory-biomarkers-in-patients-with-stroke-and-atherosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-on-the-incidence-of-knee-or-hip-replacements-in-patients-with-symptomatic-osteoarthritis-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colchicine-opium-and-tiemonium-methylsulphate-on-atherosclerosis-in-cancer-patients-undergoing-immune-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colecalciferol-in-graft-versus-host-disease-prophylaxis-for-patients-undergoing-allogeneic-stem-cell-transplantation-a-phase-ii-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colecalciferol-supplementation-on-free-testosterone-levels-in-men-with-type-2-diabetes-mellitus-a-placebo-controlled-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-colestyramine-on-serum-persistent-organic-pollutants-in-obese-women-indicated-for-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-com701-monotherapy-and-combination-therapy-in-maintenance-treatment-for-relapsed-platinum-sensitive-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-combined-diuretic-therapy-with-acetazolamide-and-metolazone-on-exercise-capacity-and-euvolemia-in-chronic-congestive-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-combined-sorafenib-and-trametinib-therapy-in-advanced-malignancies-with-braf-mutations-a-multicenter-dose-determination-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-concomitant-human-papillomavirus-vaccination-and-screening-for-accelerated-elimination-of-hpv-infection-and-cervical-cancer-in-swedish-women-aged-23-252026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-conservative-treatment-in-retinoblastoma-using-etoposide-carboplatin-and-melphalan-for-ocular-preservation-without-external-beam-radiation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-conservative-versus-conventional-oxygen-administration-on-icu-mortality-in-mechanically-ventilated-critically-ill-adults-using-nitrous-oxide-and-oxygen2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-continuous-intravenous-infusion-of-cloxacillin-sodium-for-achieving-therapeutic-unbound-concentrations-in-staphylococcus-aureus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-continuous-intravenous-lidocaine-hydrochloride-monohydrate-on-postoperative-discomfort-in-critical-care-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-continuous-versus-intermittent-infusion-of-ampicillin-sodium-and-ceftriaxone-sodium-in-enterococcus-faecalis-infective-endocarditis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-contrast-enhanced-mammography-using-iomeprol-for-diagnostic-efficacy-in-patients-with-birads-4-or-5-breast-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-contrast-enhanced-spectral-mammography-with-iopromide-in-enhancing-diagnostic-specificity-for-breast-lesions-in-patients-undergoing-further-examination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-contrast-enhanced-ultrasound-with-sulfur-hexafluoride-for-diagnosing-adnexal-torsion-in-suspected-cases-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-controlled-ileal-release-nicotinic-acid-for-remission-induction-in-prediabetes-a-phase-ii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-copper-cu-64-psma-i-t-pet-ct-for-detecting-pelvic-lymph-node-metastasis-in-high-risk-prostate-cancer-pre-prostatectomy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-copper-cu-64-psma-i-t-pet-ct-for-detection-of-pelvic-lymph-node-metastasis-in-high-risk-prostate-cancer-pre-prostatectomy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cor-1167-sodium-in-patients-with-worsening-heart-failure-a-randomized-placebo-controlled-dose-response-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-coramitug-distribution-and-effects-on-cardiac-amyloid-deposits-in-patients-with-transthyretin-amyloid-cardiomyopathy-using-pet-ct-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-corifollitropin-alfa-versus-follitropin-beta-in-oocyte-donors-undergoing-medroxyprogesterone-acetate-induced-pituitary-suppression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-corpus-luteum-presence-on-endothelial-and-placental-function-in-infertility-using-choriogonadotropin-alfa-nomegestrol-acetate-estradiol-hemihydrate-and-progesterone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-corticosteroids-and-rituximab-in-preventing-generalization-in-ocular-myasthenia-gravis-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-corticosteroids-dapagliflozin-and-rasbs-on-proteinuria-in-iga-nephropathy-patients-with-active-and-chronic-renal-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cpft-trifluoroacetate-in-enhancing-live-birth-rates-post-icsi-in-women-under-37-with-infertility-a-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cpv-104-pharmacokinetics-safety-and-tolerability-in-healthy-subjects-and-patients-with-c3-glomerulopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cpx-351-versus-conventional-care-regimens-prior-to-allogeneic-hematopoietic-cell-transplantation-in-high-risk-mds-and-oligoblastic-aml-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crd-4730-safety-and-tolerability-in-catecholaminergic-polymorphic-ventricular-tachycardia-a-phase-2-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crgd-zw800-1-for-enhanced-surgical-resection-margins-in-oral-cancer-via-real-time-fluorescence-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crinecerfont-nbi-74788-efficacy-and-safety-in-adults-with-classic-congenital-adrenal-hyperplasia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crinecerfont-nbi-74788-efficacy-and-safety-in-pediatric-patients-with-classic-congenital-adrenal-hyperplasia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crispr-edited-tumor-infiltrating-lymphocytes-in-patients-with-advanced-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crn04894-safety-efficacy-and-pharmacokinetics-in-congenital-adrenal-hyperplasia-a-12-week-phase-2-open-label-sequential-dose-cohort-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crofelemer-for-adult-short-bowel-syndrome-with-intestinal-failure-without-colon-in-continuity-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-crofelemer-powder-for-oral-solution-in-pediatric-microvillus-inclusion-disease-safety-tolerability-and-efficacy-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cryopreserved-autologous-cd34-cells-transduced-with-lentiviral-vector-arsa-cdna-for-early-onset-metachromatic-leukodystrophy-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cryopreserved-autologous-cd34-cells-transduced-with-lentiviral-vector-encoding-was-cdna-in-wiskott-aldrich-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cryotherapy-combined-with-tirbanibulin-ointment-for-actinic-keratosis-on-the-scalp-and-forehead-in-adults-aged-18-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ctdna-clearance-in-stage-iii-and-high-risk-stage-ii-resected-colon-cancer-using-folfoxiri-trifluridine-tipiracil-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ctdna-guided-genomic-based-targeted-therapy-versus-conventional-adjuvant-chemotherapy-in-stage-iii-and-high-risk-stage-ii-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cultured-autologous-oral-mucosa-epithelial-sheet-in-the-management-of-bilateral-limbal-stem-cell-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cumulative-fludarabine-exposure-in-hematological-malignancy-patients-undergoing-reduced-intensity-allogeneic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cusp06-in-platinum-refractory-ovarian-cancer-cdh6-positive-advanced-cancers-and-advanced-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-customized-antibiotic-treatment-duration-in-hospitalized-patients-with-moderately-severe-community-acquired-pneumonia-using-pristinamycin-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cvgbm-vaccine-efficacy-and-safety-in-patients-with-surgically-resected-glioblastoma-or-astrocytoma-with-unmethylated-glioblastoma-signature2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cvhnlc-and-pembrolizumab-combination-therapy-in-metastatic-squamous-non-small-cell-lung-cancer-unamenable-to-curative-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cyclosporine-and-clarithromycin-on-the-pharmacokinetics-of-pf-07328948-in-healthy-adults-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cyp2c19-genotype-guided-p2y12-inhibitor-selection-with-ticagrelor-and-clopidogrel-in-patients-with-coronary-artery-disease-undergoing-pci2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cytisine-for-cessation-of-nicotine-containing-electronic-and-tobacco-cigarette-use-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cytisinicline-versus-nicotine-replacement-therapy-in-nicotine-dependent-patients-with-chronic-kidney-disease-a-randomized-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cytokine-release-assay-for-t-cell-responses-in-tick-borne-encephalitis-using-fsme-immun-vuxen-and-encepur-vaccines-in-healthy-and-immunosuppressed-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cytokine-release-syndrome-optimization-for-glofitamab-with-gemcitabine-and-oxaliplatin-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-with-docetaxel-and-oxaliplatin-in-gastric-cancer-with-peritoneal-dissemination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-d-cycloserine-augmentation-of-accelerated-transcranial-magnetic-stimulation-in-major-depressive-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-d-glucose-13c6-test-for-detecting-sdhx-mutations-in-patients-with-paraganglioma-or-pheochromocytoma-eligible-for-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-d3s-001-monotherapy-and-combination-therapy-with-pembrolizumab-cisplatin-and-pemetrexed-in-kras-p-g12c-mutant-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dabigatran-etexilate-apixaban-edoxaban-and-drug-combination-for-secondary-prevention-in-acute-ischemic-stroke-patients-without-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dabrafenib-trametinib-and-imatinib-in-the-treatment-of-rare-and-hard-to-treat-cancers-a-clinical-trial-on-drug-repurposing2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daily-versus-alternate-day-oral-iron-supplementation-in-treating-iron-deficiency-anemia-during-pregnancy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-danegaptide-for-safety-tolerability-pharmacokinetics-and-biological-activity-in-diabetic-macular-edema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dantrolene-sodium-in-the-treatment-of-darier-disease-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-and-balcinrenone-on-renal-glucose-excretion-and-metabolic-parameters-in-stage-3-chronic-kidney-disease-patients-aged-over-502026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-and-lifestyle-intervention-on-complication-risk-in-prediabetes-with-early-chronic-kidney-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-and-oral-semaglutide-in-phenotyping-and-personalized-treatment-of-type-2-diabetes-based-on-insulin-resistance-and-secretion-deficit2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-and-semaglutide-in-reverting-prediabetes-to-normoglycemia-in-patients-with-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-cardioprotection-in-acute-myocardial-infarction-with-reduced-ejection-fraction-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-cardiotoxicity-prevention-in-breast-cancer-patients-undergoing-anthracycline-chemotherapy-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-cardiovascular-and-renal-outcomes-in-post-icu-patients-with-elevated-cardiac-or-renal-biomarkers-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-nephroprotection-in-patients-with-chronic-renal-failure-post-renal-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-safety-in-patients-with-decompensated-liver-cirrhosis-a-phase-iib-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-for-the-prevention-of-acute-kidney-injury-in-patients-undergoing-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-in-reducing-chemotherapy-induced-cardiotoxicity-in-breast-cancer-patients-receiving-anthracycline-based-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-cardiopulmonary-exercise-capacity-and-hemodynamics-in-pulmonary-arterial-hypertension-patients-a-double-blind-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-cardiovascular-outcomes-in-hemodialysis-patients-with-chronic-kidney-disease-a-randomized-double-blind-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-chronic-kidney-disease-progression-in-adolescents-and-young-adults-with-alport-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-diuresis-natriuresis-and-sodium-elimination-in-refractory-heart-failure-patients-undergoing-peritoneal-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-endothelial-function-in-patients-with-chronic-kidney-disease-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-exercise-capacity-in-patients-with-amyloid-transthyretin-cardiac-amyloidosis-a-phase-2b-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-immunological-modulation-in-patients-with-membranous-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-myocardial-and-renal-function-post-transcatheter-aortic-valve-replacement-in-aortic-stenosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-renal-allograft-function-in-non-diabetic-kidney-transplant-recipients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-renal-and-cardiovascular-outcomes-in-patients-with-severe-chronic-kidney-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-renal-function-in-heart-transplant-recipients-with-kidney-failure-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-renal-function-preservation-in-kidney-transplant-recipients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-renal-morphology-and-perfusion-in-chronic-kidney-disease-post-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-on-serum-magnesium-in-patients-with-hnf1beta-associated-renal-hypomagnesemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-propanediol-finerenone-and-semaglutide-in-biomarker-targeted-therapy-for-chronic-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-propanediol-monohydrate-on-cardiovascular-outcomes-in-stabilized-acute-heart-failure-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-propanediol-on-atrial-fibrillation-recurrence-post-cardioversion-in-patients-a-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-propanediol-on-echocardiographic-cardiac-structure-and-function-in-chronic-kidney-disease-a-6-month-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapagliflozin-versus-placebo-in-patients-with-chronic-right-heart-failure-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dapirolizumab-pegol-efficacy-and-safety-in-moderately-to-severely-active-systemic-lupus-erythematosus-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-plasmablastic-lymphoma-patients-ineligible-for-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-bortezomib-cyclophosphamide-and-dexamethasone-in-multiple-myeloma-with-extramedullary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-in-combination-with-bortezomib-cyclophosphamide-and-dexamethasone-for-transplant-ineligible-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-in-myalgic-encephalomyelitis-chronic-fatigue-syndrome-a-randomized-placebo-controlled-double-blind-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-in-patients-with-monoclonal-gammopathy-of-renal-significance-mgrs-in-finland2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-in-preventing-event-free-survival-decline-in-multiple-myeloma-patients-with-minimal-residual-disease-reappearance-or-biochemical-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-plus-standard-chemotherapy-in-adult-patients-with-very-high-risk-t-lineage-acute-lymphoblastic-leukemia-t-all2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-pomalidomide-and-dexamethasone-in-del-17p-positive-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daratumumab-with-cyclophosphamide-bortezomib-and-dexamethasone-versus-cybord-in-newly-diagnosed-systemic-al-amyloidosis-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darbepoetin-alfa-in-reducing-brain-injury-in-neonates-with-perinatal-arterial-ischemic-stroke-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daridorexant-as-an-adjunct-to-buprenorphine-maintenance-therapy-in-patients-with-opioid-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-addition-to-androgen-deprivation-and-radiation-therapy-in-hormone-naive-prostate-cancer-with-pelvic-lymph-node-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-addition-to-standard-first-line-therapy-in-metastatic-castration-resistant-prostate-cancer-a-randomized-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-and-pcai-immunoscore-in-neoadjuvant-treatment-for-high-risk-localized-or-locally-advanced-prostate-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-and-stereotactic-dose-escalated-radiotherapy-in-high-risk-localized-prostate-cancer-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-combined-with-stereotactic-body-radiation-therapy-in-castration-resistant-prostate-cancer-with-oligometastases-detected-by-functional-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-darolutamide-in-combination-with-androgen-deprivation-therapy-and-radiation-for-high-risk-localized-prostate-cancer-a-phase-3-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dasatinib-and-quercetin-in-the-treatment-of-fibrotic-non-alcoholic-fatty-liver-disease-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dasatinib-as-prophylaxis-for-cytokine-release-syndrome-in-idecabtagene-vicleucel-therapy-for-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dasatinib-monotherapy-in-chemotherapy-ineligible-acute-myeloid-leukemia-patients-refractory-to-venetoclax-azacitidine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dasatinib-s-safety-and-effects-on-viral-persistence-and-inflammation-in-hiv-patients-on-suppressive-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dasatinib-safety-and-tolerability-in-asymptomatic-patients-with-recent-hiv-1-infection-a-pilot-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-datopotamab-deruxtecan-monotherapy-and-combination-therapy-in-advanced-metastatic-solid-tumors-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-daunorubicin-cytarabine-and-mitoxantrone-efficacy-in-pediatric-acute-myeloid-leukemia-treatment-a-nopho-dbh-aml-2012-protocol-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dazodalibep-efficacy-and-safety-in-patients-with-moderate-to-severe-sjogren-s-syndrome-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dazostinag-tak-676-alone-and-in-combination-with-pembrolizumab-in-advanced-or-metastatic-solid-neoplasms-a-phase-1-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dazucorilant-cort113176-efficacy-and-safety-in-amyotrophic-lateral-sclerosis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-db-oto-safety-and-efficacy-in-pediatric-patients-with-biallelic-otoferlin-gene-mutations-inducing-congenital-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ddr-gene-alterations-in-predicting-response-to-platinum-based-chemotherapy-in-metastatic-or-locally-advanced-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-de-escalation-from-prasugrel-and-ticagrelor-to-clopidogrel-in-acute-coronary-syndrome-using-verifynow-r-platelet-aggregation-measurement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-debio-0123-combined-with-carboplatin-and-etoposide-in-adults-with-recurrent-or-progressive-small-cell-lung-cancer-post-platinum-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-default-mode-network-functional-connectivity-in-multiple-sclerosis-patients-treated-with-cladribine-a-phase-iv-unicentric-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deferiprone-for-long-term-iron-chelation-in-preventing-secondary-neurodegeneration-post-stroke-in-patients-with-proximal-sylvian-artery-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deferiprone-s-efficacy-on-gross-motor-function-in-pediatric-pelizaeus-merzbacher-disease-a-proof-of-concept-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deferoxamine-mesilate-in-patients-with-aneurysmal-subarachnoid-hemorrhage-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deferoxamine-mesilate-on-hypoxic-response-in-type-1-diabetes-a-randomized-double-blind-placebo-controlled-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deflazacort-efficacy-in-lmna-related-congenital-muscular-dystrophy-a-study-on-clinical-outcomes-and-biomarker-identification2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dehydroepiandrosterone-as-an-adjunct-to-standard-antidepressants-in-treatment-resistant-depression-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dendritic-cell-therapy-combined-with-surgical-resection-in-adult-patients-with-resectable-epithelioid-malignant-pleural-mesothelioma-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-and-letrozole-in-the-treatment-of-male-infertility-due-to-non-obstructive-azoospermia-a-clinical-intervention-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-and-topical-zoledronic-acid-on-implant-fixation-and-bone-density-in-cementless-total-knee-arthroplasty-for-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-for-breast-cancer-prevention-in-women-with-brca1-germline-mutation-a-randomized-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-in-the-management-of-fibrous-dysplasia-mccune-albright-syndrome-in-adults-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-on-bone-fracture-healing-and-total-contact-cast-duration-in-diabetic-patients-with-acute-charcot-foot2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-on-insulin-sensitivity-and-muscle-strength-in-patients-with-diabetes-mellitus-and-postmenopausal-osteoporosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-denosumab-on-semen-quality-in-male-infertility-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dermal-pharmacokinetics-of-metronidazole-cream-in-healthy-subjects-using-open-flow-microperfusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dermal-tolerability-and-irritation-potential-of-topical-formulations-on-intact-skin-using-mean-cumulative-irritation-score-cis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-desflurane-sevoflurane-and-propofol-on-postoperative-delirium-in-elderly-patients-undergoing-major-non-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-desmopressin-acetate-for-hemostasis-in-percutaneous-kidney-biopsy-in-patients-with-rare-and-ultra-rare-glomerulonephritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-desmopressin-acetate-trihydrate-in-preventing-serum-sodium-overcorrection-in-patients-with-severe-hyponatremia-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-detection-and-classification-of-breast-pathology-using-iodixanol-enhanced-digital-mammography-and-tomosynthesis-versus-gadolinium-enhanced-mri2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deucravacitinib-efficacy-and-safety-in-active-psoriatic-arthritis-patients-naive-to-biologic-dmards-or-previously-treated-with-tnfa-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-deucravacitinib-on-inflammatory-gene-expression-and-immune-cell-distribution-in-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-and-betamethasone-sodium-phosphate-on-postoperative-lower-limb-edema-in-total-hip-arthroplasty-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-as-initial-therapy-in-advanced-relapsed-refractory-multiple-myeloma-a-randomized-open-label-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-efficacy-via-intraoral-and-extraoral-routes-in-preoperative-management-of-retained-lower-third-molar-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-hydrocortisone-prednisolone-and-oseltamivir-in-the-treatment-of-pneumonia-in-hospitalized-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-in-the-treatment-of-herpes-simplex-virus-encephalitis-an-open-label-randomized-controlled-trial-with-observer-blinded-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-intravitreal-implant-loading-dose-efficacy-in-diabetic-macular-edema-a-pilot-and-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-orodispersible-film-in-acute-allergic-reaction-a-phase-iv-open-non-randomised-low-intervention-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-phosphate-and-diclofenac-sodium-in-postoperative-management-of-medically-uncontrolled-glaucoma-following-trabeculectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-phosphate-eye-drops-in-preventing-proliferative-retinopathy-of-prematurity-in-neonates-a-randomized-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-phosphate-for-reducing-respiratory-distress-post-extubation-in-pediatric-intensive-care-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-phosphate-on-complication-reduction-and-mortality-in-severe-burn-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-sodium-phosphate-dosing-in-acute-hypoxemic-respiratory-failure-due-to-infections-including-ards-and-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-sodium-phosphate-in-acute-aneurysmal-subarachnoid-hemorrhage-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamethasone-versus-prednisone-in-induction-therapy-for-pediatric-and-adolescent-lymphoblastic-lymphoma-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamfetamine-sulfate-formulations-in-adults-with-adhd-and-moderate-to-severe-depression-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexamfetamine-sulfate-in-reducing-illicit-amphetamine-use-in-adults-with-comorbid-amphetamine-and-opioid-dependence-undergoing-opioid-agonist-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexmedetomidine-and-clonidine-hydrochloride-for-delirium-prevention-in-post-open-heart-surgery-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexmedetomidine-on-glymphatic-cerebrospinal-fluid-dynamics-neural-activity-and-cerebral-blood-flow-in-neurodegenerative-and-acute-neurological-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexmedetomidine-on-neuroinflammation-in-post-covid-19-ards-patients-using-18f-dpa-714-pet-mri2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dexpanthenol-mouth-rinse-for-the-prevention-of-radiation-induced-oral-mucositis-in-patients-undergoing-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dff332-monotherapy-and-combination-with-everolimus-or-immuno-oncology-agents-in-advanced-relapsed-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dfv890-for-safety-tolerability-and-efficacy-in-patients-with-myeloid-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dhea-and-prolonged-release-melatonin-on-sleep-quality-and-mood-in-postmenopausal-women-with-sleep-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-accuracy-and-clinical-utility-of-68ga-fapi-46-and-fludeoxyglucose-18f-pet-in-malignant-pleural-mesothelioma-staging-and-response-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-accuracy-of-18f-psma-1007-pet-mri-in-detecting-clinically-significant-prostate-cancer-in-patients-with-suspected-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-accuracy-of-18f-ro6958948-and-flutemetamol-18f-in-identifying-high-risk-neurodegenerative-disorders-with-tau-pathology2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-accuracy-of-owl-evo1-breath-biopsy-test-for-differentiating-lung-cancer-using-d5-ethyl-beta-d-glucuronide-in-clinical-presentations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-efficacy-and-safety-of-metal-panel-allergens-in-allergic-contact-dermatitis-a-study-of-gold-sodium-thiosulfate-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-efficacy-and-safety-of-metal-panel-allergens-in-allergic-contact-dermatitis-and-eczema-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-efficacy-of-18f-labelled-tracer-syn2-in-positron-emission-tomography-for-suspected-coronary-artery-disease-using-adenosine-and-regadenoson2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-performances-of-18f-fdopa-pet-kinetics-as-biomarkers-for-the-improvement-of-care-of-mri-non-contrast-enhanced-gliomas-a-phase-iiib-exploratory-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diagnostic-quality-and-accuracy-of-pulmonary-ct-angiography-using-spectral-ct-with-iomeprol-in-pulmonary-embolism-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diamyd-recombinant-human-glutamate-decarboxylase-2-and-colecalciferol-in-preserving-beta-cell-function-in-hla-dr3-dq2-positive-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diarrhea-related-discontinuations-in-early-stage-her2-hr-breast-cancer-with-neratinib-loperamide-and-colesevelam-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diazepam-and-oxazepam-stabilization-versus-tapering-in-benzodiazepine-dependent-patients-undergoing-opioid-agonist-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diclofenac-diethylamine-and-simvastatin-in-the-management-of-mild-to-moderate-graves-ophthalmopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diclofenac-diethylamine-gel-on-mobility-and-quality-of-life-in-patients-with-mild-knee-osteoarthritis-a-prospective-real-world-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diclofenac-in-combination-with-pd-1-inhibitors-nivolumab-or-pembrolizumab-in-metastatic-melanoma-with-stable-disease-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diclofenac-skin-reservoir-formation-and-depletion-following-topical-application-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diclofenac-sodium-and-dexamethasone-phosphate-in-postoperative-management-of-medically-uncontrolled-glaucoma-requiring-trabeculectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dienogest-pharmacokinetics-and-safety-in-women-with-endometriosis-and-diverse-genetic-variants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dietary-sodium-intake-on-ertugliflozin-induced-renal-and-hemodynamic-changes-in-overweight-obese-adults-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-differential-effects-of-combined-oral-contraceptives-drospirenone-estetrol-and-ethinylestradiol-levonorgestrel-on-brain-structure-and-function2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diffusion-characteristics-of-letibotulinumtoxina-compared-to-onabotulinumtoxina-and-abobotulinumtoxina-in-patients-with-moderate-to-severe-forehead-wrinkling2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-digital-symptom-monitoring-in-patients-with-advanced-clear-cell-renal-carcinoma-treated-with-cabozantinib-and-nivolumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-digoxin-activated-charcoal-and-digoxin-immune-fab-in-patients-with-heart-failure-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dihydropyrimidine-dehydrogenase-activity-on-capecitabine-efficacy-in-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-diltiazem-hydrochloride-on-coronary-microvascular-dysfunction-in-symptomatic-angina-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dimethyl-fumarate-in-adrenomyeloneuropathy-a-multicenter-placebo-controlled-phase-iib-iii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dinutuximab-beta-combined-with-chemotherapy-in-patients-with-refractory-relapsed-or-progressive-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-discontinuation-of-anti-tnf-therapy-with-infliximab-and-adalimumab-in-patients-with-ulcerative-colitis-and-crohn-s-disease-in-remission2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-disease-activity-guided-dose-reduction-of-janus-kinase-inhibitors-filgotinib-tofacitinib-upadacitinib-and-baricitinib-in-inflammatory-rheumatic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-disease-modifying-therapy-discontinuation-in-inactive-relapsing-remitting-multiple-sclerosis-patients-aged-55-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-disease-modifying-therapy-withdrawal-versus-continuation-in-inactive-secondary-progressive-multiple-sclerosis-patients-aged-over-50-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-disulfiram-and-copper-efficacy-in-metastatic-breast-cancer-a-phase-ii-open-label-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dky709-monotherapy-and-dky709-plus-pdr001-in-advanced-non-small-cell-lung-cancer-cutaneous-melanoma-microsatellite-stable-colorectal-cancer-nasopharyngeal-carcinoma-and-triple-negative-b2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dlx-001-in-the-treatment-of-unipolar-depression-a-phase-i-study-on-safety-and-tolerability-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dlx-001-on-pharmacodynamics-safety-tolerability-and-pharmacokinetics-in-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dmt-in-healthy-subjects-for-stroke-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dnajb1-prkaca-fusion-transcript-based-peptide-vaccine-and-immune-checkpoint-inhibition-in-fibrolamellar-hepatocellular-carcinoma-and-oncogenic-driver-fusion-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dnajb1-prkaca-trifluoroacetate-peptide-vaccine-in-fibrolamellar-hepatocellular-carcinoma-and-oncogenic-driver-fusion-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dnth103-safety-tolerability-and-efficacy-in-adults-with-multifocal-motor-neuropathy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dobutamine-hydrochloride-and-glucose-monohydrate-in-septic-cardiomyopathy-with-tissue-hypoperfusion-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dolutegravir-lamivudine-and-cabotegravir-rilpivirine-for-virologic-suppression-in-antiretroviral-naive-hiv-1-infected-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-domperidone-on-glycemic-control-in-asymptomatic-type-1-diabetic-patients-with-delayed-gastric-emptying2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donanemab-florbetapir-18f-and-flortaucipir-18f-in-early-symptomatic-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donepezil-hydrochloride-in-anorexia-nervosa-a-multicenter-double-blind-randomized-controlled-trial-versus-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donepezil-hydrochloride-on-cognitive-and-motor-function-in-elderly-patients-with-neurological-disorders-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donepezil-igala-combination-therapy-for-maintenance-in-chronic-post-stroke-aphasia-biomarker-identification-for-efficacy-prediction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donepezil-versus-non-pharmacological-management-in-patients-with-alzheimer-s-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-donor-specific-immunomodulatory-cells-dsimc-for-tolerance-induction-in-deceased-donor-liver-transplantation-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doravirine-and-dolutegravir-dual-therapy-efficacy-in-hiv-patients-transitioning-from-suppressive-triple-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doravirine-on-hepatic-steatosis-and-fibrosis-in-asymptomatic-hiv-patients-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doravirine-tenofovir-disoproxil-and-lamivudine-in-virologically-controlled-hiv-1-patients-with-historical-m184v-i-mutation-a-phase-ii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-dense-cyclophosphamide-in-patients-with-tp53-mutated-or-wild-type-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-equivalence-between-oral-and-transdermal-estradiol-administration-in-turner-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-flexibility-and-efficacy-of-upadacitinib-in-adults-with-moderate-to-severe-atopic-dermatitis-a-phase-3b-4-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-reduction-strategy-of-tyrosine-kinase-inhibitors-in-chronic-myeloid-leukemia-imatinib-ponatinib-bosutinib-nilotinib-and-dasatinib2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-reduction-versus-maintenance-treatment-in-schizophrenia-spectrum-disorder-using-pipotiazine-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dose-tapering-versus-continuation-of-jak-inhibitors-baricitinib-upadacitinib-tofacitinib-and-filgotinib-in-low-disease-activity-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dosimetry-kinetics-and-test-retest-properties-of-the-novel-norepinephrine-transporter-radiotracer-18f-ns12137-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doxapram-hydrochloride-monohydrate-versus-placebo-in-the-management-of-apnea-of-prematurity-in-preterm-neonates-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doxorubicin-hydrochloride-and-temozolomide-post-radiotherapy-in-pediatric-and-young-adult-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doxycycline-monohydrate-postexposure-prophylaxis-on-antimicrobial-resistance-in-bacterial-sexually-transmitted-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-doxylamine-hydrogen-succinate-and-pyridoxine-hydrochloride-in-pregnant-women-with-nausea-and-vomiting-a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dpyd-genotyping-on-the-safety-and-efficacy-of-fluoropyrimidine-based-therapy-in-breast-and-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dr-01-in-adult-patients-with-large-granular-lymphocytic-leukemia-or-cytotoxic-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dried-blood-spot-method-for-recombinant-erythropoietin-repo-detection-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dronabinol-and-cannabidiol-for-symptom-burden-reduction-in-palliative-oncology-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dronabinol-and-cannabidiol-oral-solution-in-neurodegenerative-diseases-a-randomized-double-blind-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dronabinol-and-cannabidiol-oral-solution-on-symptom-burden-in-advanced-oncologic-patients-undergoing-opioid-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dronabinol-for-alleviating-severe-breathlessness-in-patients-with-severe-and-very-severe-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-drug-drug-interaction-between-finasteride-and-tadalafil-in-healthy-male-subjects-under-fasting-conditions-a-randomized-open-label-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-drug-drug-interaction-potential-of-prax-628-in-a-phase-1-open-label-multiple-part-trial-in-healthy-participants-with-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-drug-drug-interactions-and-food-effect-on-leriglitazone-pharmacokinetics-in-healthy-male-subjects-with-gemfibrozil-itraconazole-and-carbamazepine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-drug-eluting-bead-chemoembolization-and-radioembolization-in-colorectal-liver-metastases-the-debir90y-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-drug-transporters-impact-on-erlotinib-distribution-in-brain-and-organs-in-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dsb2455-monotherapy-and-combination-therapy-in-patients-with-mcrpc-breast-ovarian-cancer-and-active-brain-metastases-with-brca1-2-or-hrr-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dt-9081-in-patients-with-advanced-unresectable-recurrent-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dual-64cu-dotatate-and-18f-fdg-pet-ct-imaging-for-predicting-progression-free-survival-in-neuroendocrine-neoplasm-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dual-antiplatelet-therapy-duration-with-d-l-lysine-acetylsalicylate-and-clopidogrel-in-patients-post-percutaneous-coronary-intervention-for-chronic-total-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dual-antiplatelet-therapy-with-ticagrelor-and-acetylsalicylic-acid-versus-acetylsalicylic-acid-monotherapy-post-coronary-artery-bypass-grafting-in-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dual-antithrombotic-therapy-with-dabigatran-and-ticagrelor-in-acute-coronary-syndrome-and-non-valvular-atrial-fibrillation-undergoing-pci2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dulaglutide-for-prevention-of-new-onset-diabetes-mellitus-post-kidney-transplantation-in-immediate-recipients-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dulaglutide-for-reversal-of-metabolic-syndrome-in-patients-awaiting-renal-transplantation-a-single-arm-interventional-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-duloxetine-and-benztropine-mesylate-in-functional-somatic-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-duloxetine-and-furosemide-for-management-of-endocrine-therapy-related-musculoskeletal-pain-in-er-her2-stage-i-ii-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-and-fexofenadine-hydrochloride-in-indolent-systemic-mastocytosis-with-cutaneous-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-dose-reduction-in-patients-with-controlled-atopic-eczema-a-multicenter-non-inferiority-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-efficacy-and-safety-in-adult-patients-with-chronic-pruritus-of-unknown-origin-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-on-airway-inflammation-via-mucus-plugging-and-lung-imaging-in-chronic-obstructive-pulmonary-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-on-auditory-function-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps-and-eosinophilic-otitis-media2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-on-mucus-plugging-and-inflammatory-patterns-in-patients-with-severe-asthma-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-on-nasal-epithelial-barrier-function-in-chronic-rhinosinusitis-with-nasal-polyps-an-exploratory-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-dupilumab-s-long-term-impact-on-lung-function-decline-in-adults-with-uncontrolled-moderate-to-severe-asthma-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-bevacizumab-as-adjuvant-therapy-in-high-risk-hepatocellular-carcinoma-post-curative-resection-or-ablation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-genomic-analysis-as-therapeutic-decision-tools-in-metastatic-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-rintatolimod-combination-therapy-in-metastatic-pancreatic-ductal-adenocarcinoma-patients-a-phase-ib-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-tremelimumab-combined-with-stereotactic-body-radiotherapy-in-metastatic-squamous-cell-carcinoma-of-various-sites2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-tremelimumab-in-pediatric-patients-with-advanced-solid-tumors-and-hematological-malignancies-a-phase-i-ii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-and-tremelimumab-in-resectable-locally-advanced-squamous-cell-carcinoma-of-the-oral-cavity-a-window-of-opportunity-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-as-adjuvant-therapy-in-mismatch-repair-deficient-high-risk-endometrial-cancer-post-surgery-a-phase-iii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-combined-with-platinum-based-chemotherapy-and-olaparib-in-first-line-treatment-of-advanced-or-recurrent-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-combined-with-total-neoadjuvant-therapy-in-locally-advanced-rectal-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-in-combination-with-cisplatin-carboplatin-and-etoposide-with-radiotherapy-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-plus-oleclumab-and-durvalumab-plus-monalizumab-in-stage-iii-unresectable-non-small-cell-lung-cancer-post-platinum-based-chemoradiation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-durvalumab-tremelimumab-and-bevacizumab-in-advanced-hepatocellular-carcinoma-safety-tolerability-and-clinical-activity-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-e7386-and-pembrolizumab-with-lenvatinib-in-combination-in-previously-treated-patients-with-colorectal-cancer-melanoma-and-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-e7386-combined-with-lenvatinib-and-other-anticancer-agents-in-patients-with-hepatocellular-carcinoma-colorectal-cancer-endometrial-cancer-or-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-antibiotic-discontinuation-versus-standard-management-in-elderly-patients-with-viral-pneumonia-using-amoxicillin-clavulanic-acid-piperacillin-tazobactam-and-pristinamycin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-bactericidal-activity-of-tedizolid-phosphate-and-linezolid-in-patients-with-suspected-pulmonary-mycobacterium-tuberculosis-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-central-nervous-system-pain-response-via-bold-fmri-in-axial-spondyloarthritis-patients-treated-with-ixekizumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-continuous-intravenous-infusion-of-hypertonic-saline-solution-on-neurological-outcomes-in-traumatic-brain-injury-patients-at-high-risk-of-intracranial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-discontinuation-of-nivolumab-in-patients-with-unresectable-stage-iii-or-metastatic-melanoma-treated-with-first-line-ipilimumab-nivolumab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-empagliflozin-administration-on-mortality-and-cardiac-function-in-cardiogenic-shock-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-immunotherapy-with-human-normal-immunoglobulin-cyclophosphamide-and-methylprednisolone-in-anti-hu-associated-paraneoplastic-sensory-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-levosimendan-administration-versus-placebo-in-cardiogenic-shock-patients-on-conventional-inotrope-therapy-a-morbidity-mortality-endpoint-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-noradrenaline-hydrochloride-versus-standard-fluid-therapy-in-non-bleeding-hypotensive-patients-a-multi-center-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-oral-step-down-therapy-with-fluoroquinolones-or-trimethoprim-sulfamethoxazole-versus-continued-intravenous-antibiotics-in-gram-negative-bacteraemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-proactive-therapeutic-drug-monitoring-on-infliximab-efficacy-and-durability-in-pediatric-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-psma-pet-changes-with-68ga-gozetotide-in-predicting-treatment-response-in-metastatic-clear-cell-renal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-psychological-response-to-hormonal-therapy-in-transgender-men-with-gender-dysphoria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-recurrence-rates-in-non-muscle-invasive-bladder-cancer-using-chemohyperthermia-with-mitomycin-c-versus-normothermic-mitomycin-c-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-rhythm-control-therapy-with-dronedarone-hydrochloride-in-combination-with-antiarrhythmic-agents-for-acute-ischemic-stroke-and-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-risankizumab-administration-on-trm-cell-modulation-in-moderate-to-severe-psoriasis-a-phase-4-longitudinal-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-vasopressin-and-norepinephrine-administration-on-renal-replacement-therapy-utilization-in-septic-shock-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-versus-delayed-resumption-of-oral-anticoagulants-in-patients-with-chronic-subdural-hematoma-and-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-versus-delayed-supplementary-parenteral-nutrition-on-postoperative-nosocomial-infection-risk-in-major-emergency-abdominal-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-early-versus-delayed-zoledronic-acid-administration-in-post-surgical-hip-fracture-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ebastine-and-docetaxel-combination-therapy-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-echo-guided-scalp-blocks-with-epinephrine-bitartrate-lidocaine-hydrochloride-and-ropivacaine-hydrochloride-in-postoperative-pain-management-for-supratentorial-intracranial-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ecopipam-hydrochloride-for-maintenance-of-efficacy-in-pediatric-and-adolescent-patients-with-tourette-s-disorder-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-edoxaban-apixaban-and-dabigatran-versus-vitamin-k-antagonists-in-post-cardiac-surgery-patients-with-atrial-fibrillation-requiring-anticoagulation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-edoxaban-versus-nonanticoagulant-therapy-in-high-risk-atrial-fibrillation-patients-with-prior-intracranial-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-edoxaban-versus-vitamin-k-antagonists-in-patients-with-chronic-thromboembolic-pulmonary-hypertension-undergoing-balloon-pulmonary-angioplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-edp-938-zelicapavir-efficacy-and-safety-in-non-hospitalized-adults-with-acute-respiratory-syncytial-virus-infection-at-high-risk-for-complications2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efavaleukin-alfa-for-induction-therapy-in-moderately-to-severely-active-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-abemaciclib-inavolisib-and-ribociclib-in-combination-therapies-for-metastatic-breast-cancer-subtypes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-alectinib-entrectinib-and-atezolizumab-based-combinations-in-advanced-or-metastatic-nsclc-with-actionable-somatic-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-anitocabtagene-autoleucel-in-combination-with-cyclophosphamide-and-fludarabine-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-antithrombin-iii-human-in-patients-with-congenital-antithrombin-deficiency-undergoing-surgical-procedures-or-parturition2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-aro-apoc3-in-adults-with-familial-chylomicronemia-syndrome-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-betahistine-dihydrochloride-pr-48-mg-vs-ir-24-mg-in-adult-meniere-s-disease-a-multicenter-double-blind-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-bevacizumab-atezolizumab-docetaxel-camonsertib-and-linagliptin-in-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-ciltacabtagene-autoleucel-talquetamab-and-teclistamab-with-daratumumab-in-standard-risk-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-drug-combination-in-patients-with-pulmonary-hypertension-associated-with-chronic-obstructive-pulmonary-disease-ph-copd2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-early-transition-to-dolutegravir-lamivudine-from-insti-based-regimens-in-virologically-suppressed-hiv-1-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-electromotive-mitomycin-c-versus-bacillus-calmette-guerin-in-high-grade-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-etrumadenant-based-combinations-in-metastatic-colorectal-cancer-a-phase-1b-2-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-evx-01-and-pembrolizumab-in-checkpoint-inhibitor-naive-adults-with-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-fixed-dose-combination-of-irbesartan-and-amlodipine-in-patients-with-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-immunotherapy-combinations-including-atezolizumab-bevacizumab-and-tiragolumab-in-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-immunotherapy-combinations-including-ro7247669-in-advanced-liver-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-intravenous-human-igg1-lambda-monoclonal-antibody-against-alpha-synuclein-tak-341-in-multiple-system-atrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-intravitreal-eye103-versus-ranibizumab-in-diabetic-macular-edema-a-randomized-double-masked-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-low-dose-oral-immunotherapy-combined-with-omalizumab-in-pediatric-patients-with-severe-ige-mediated-cow-s-milk-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-oral-controlled-ileocolonic-release-nicotinamide-in-mild-to-moderately-active-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-oral-ozanimod-in-pediatric-patients-with-moderately-to-severely-active-ulcerative-colitis-unresponsive-to-conventional-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-oral-paclitaxel-dhp107-versus-intravenous-paclitaxel-in-recurrent-or-metastatic-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-peginterferon-alfa-2a-tobevibart-elebsiran-and-tenofovir-disoproxil-in-chronic-hepatitis-b-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-selective-internal-radiation-therapy-with-xelox-bevacizumab-and-atezolizumab-in-liver-dominant-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-subconjunctival-allogeneic-adipose-derived-mesenchymal-stem-cells-in-graft-versus-host-disease-associated-dry-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-subcutaneous-immunotherapy-with-modified-allergen-extracts-in-allergic-rhinitis-rhinoconjunctivitis-with-or-without-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-subcutaneous-navepegritide-in-adolescents-with-achondroplasia-a-phase-2b-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-sublingual-mm09-in-patients-with-allergic-rhinitis-rhinoconjunctivitis-and-mild-to-moderate-asthma-due-to-dermatophagoides-spp2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-switching-from-insulin-glargine-100-u-ml-to-insulin-glargine-300-u-ml-in-type-2-diabetes-patients-with-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-therasphere-followed-by-durvalumab-and-tremelimumab-in-hepatocellular-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-tiragolumab-atezolizumab-and-drug-combinations-in-metastatic-urothelial-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-transitioning-from-anti-c5-antibody-therapy-to-iptacopan-in-patients-with-atypical-hemolytic-uremic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-trastuzumab-deruxtecan-in-patients-with-metastatic-or-unresectable-her2-expressing-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-utreglutide-gl0034-in-adults-with-type-2-diabetes-mellitus-uncontrolled-on-metformin-or-lifestyle-modifications2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-safety-of-vir-2218-elebsiran-and-vir-3434-tobevibart-in-chronic-hepatitis-d-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-and-tolerability-of-diclofenac-orphenadrine-and-paracetamol-combination-in-acute-severe-low-back-pain-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-bms-986435-in-symptomatic-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-glycopyrronium-bromide-in-pediatric-asthma-patients-aged-6-to-12-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-pharmacokinetics-safety-and-immunogenicity-of-subcutaneous-ustekinumab-and-guselkumab-in-pediatric-patients-with-active-juvenile-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-biomarkers-of-bulevirtide-in-combination-with-peginterferon-alfa-2a-for-chronic-hepatitis-d-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-pharmacokinetics-of-human-normal-immunoglobulin-igpro20-in-adults-with-dermatomyositis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-pharmacokinetics-of-increased-ocrelizumab-dose-in-adults-with-primary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-pharmacokinetics-of-increased-ocrelizumab-dose-in-adults-with-relapsing-multiple-sclerosis-a-phase-iiib-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-pharmacokinetics-of-inhaled-etd001-in-cystic-fibrosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-pharmacokinetics-of-vx-407-in-autosomal-dominant-polycystic-kidney-disease-with-specific-pkd1-gene-variants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-tolerability-of-fipaxalparant-in-patients-with-diffuse-cutaneous-systemic-sclerosis-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-and-tolerability-of-switching-from-bictegravir-emtricitabine-tenofovir-alafenamide-to-dolutegravir-lamivudine-in-virologically-suppressed-hiv-patients-aged-502026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-pharmacokinetics-and-immunogenicity-of-ly06006-versus-denosumab-in-postmenopausal-osteoporosis-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-emicizumab-in-infants-with-hemophilia-a-without-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-tolerability-and-safety-of-spironolactone-pioglitazone-and-metformin-in-adolescents-and-young-adults-with-polycystic-ovary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efficacy-tolerability-safety-and-dose-response-of-deupirfenidone-lyt-100-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-alfa-efficacy-and-tolerability-in-early-treatment-of-generalized-myasthenia-gravis-with-anti-achr-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-alfa-ph20-sc-efficacy-and-safety-in-adults-with-thyroid-eye-disease-a-phase-3-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-alfa-ph20-subcutaneous-for-safety-and-efficacy-in-adult-patients-with-primary-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-ph20-sc-efficacy-and-safety-in-adult-systemic-sclerosis-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-ph20-sc-pharmacokinetics-pharmacodynamics-safety-and-efficacy-in-pediatric-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-efgartigimod-s-impact-on-emasiprubart-pharmacokinetics-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-egf816-combined-with-targeted-agents-in-egfr-mutant-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-egfr-as-a-predictor-for-dose-adjustment-in-staphylococcus-aureus-bacteremia-using-therapeutic-drug-monitoring-of-cloxacillin-concentrations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-egfr-inhibitor-sequencing-in-egfr-mutated-non-small-cell-lung-cancer-a-randomized-study-of-osimertinib-afatinib-and-dacomitinib2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eh-301-n-acetylcysteine-and-riluzole-combination-therapy-in-ambulatory-amyotrophic-lateral-sclerosis-patients-a-phase-ii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ehsg-kf-a-bilayer-engineered-collagen-hydrogel-based-skin-graft-in-pediatric-partial-deep-dermal-and-full-thickness-burns2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ehsg-kf-a-bilayer-engineered-collagen-hydrogel-based-skin-graft-versus-autologous-split-thickness-skin-grafts-in-full-thickness-skin-defects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eik1001-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-advanced-melanoma-a-randomized-double-blind-phase-2-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eik1004-bis-tartrate-monotherapy-in-advanced-solid-tumors-a-phase-1-2-dose-escalation-and-dose-optimization-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ela026-in-secondary-hemophagocytic-lymphohistiocytosis-a-phase-2-3-open-label-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elacestrant-and-olaparib-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer-with-gbrca1-2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elacestrant-monotherapy-versus-elacestrant-plus-leuprorelin-acetate-in-premenopausal-stage-i-ii-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elafibranor-80-mg-on-alkaline-phosphatase-normalization-in-adults-with-primary-biliary-cholangitis-unresponsive-or-intolerant-to-ursodeoxycholic-acid2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elafibranor-safety-and-efficacy-in-adult-patients-with-primary-sclerosing-cholangitis-a-phase-ii-multicenter-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elamipretide-subcutaneous-injections-in-patients-with-dry-age-related-macular-degeneration-a-phase-3-randomized-double-masked-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elasomeran-mrna-1273-vaccine-efficacy-and-safety-in-preventing-severe-sars-cov-2-outcomes-in-adults-aged-50-64-without-severe-covid-19-risk-factors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elecoglipron-compared-with-semaglutide-for-blood-sugar-control-in-adults-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-electrochemotherapy-with-bleomycin-versus-cetuximab-platinum-based-therapy-and-5-fluorouracil-in-recurrent-oral-and-oropharyngeal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-electrochemotherapy-with-carboplatin-and-bleomycin-versus-bleomycin-monotherapy-in-recurrent-vulvar-carcinoma-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-elinzanetant-pharmacokinetics-and-safety-in-healthy-subjects-with-vasomotor-symptoms-as-a-sex-hormone-dependent-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eltrekibart-a-humanised-igg4-kappa-monoclonal-antibody-in-adults-with-moderate-to-severe-hidradenitis-suppurativa-a-phase-2b-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eltrombopag-in-the-management-of-thrombocytopenia-in-patients-with-low-and-intermediate-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emapalumab-in-macrophage-activation-syndrome-associated-with-systemic-juvenile-idiopathic-arthritis-adult-onset-still-s-disease-and-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emapalumab-in-patients-with-interferon-gamma-driven-sepsis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emavusertib-and-ibrutinib-in-relapsed-refractory-primary-central-nervous-system-lymphoma-a-dose-escalation-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emicizumab-prophylaxis-efficacy-and-safety-in-type-3-von-willebrand-disease-a-phase-iii-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emicizumab-prophylaxis-on-joint-health-and-physical-activity-in-patients-aged-13-to-70-with-severe-or-moderate-hemophilia-a-without-fviii-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emodepside-pharmacokinetics-and-food-effect-in-healthy-subjects-for-onchocerciasis-and-soil-transmitted-helminth-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-emp22-and-emp16-pharmacodynamics-and-pharmacokinetics-compared-to-orlistat-in-a-phase-i-randomized-study-in-healthy-volunteers-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-and-dapagliflozin-on-clinical-outcomes-in-patients-hospitalized-with-acute-decompensated-heart-failure-a-phase-iii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-and-finerenone-for-albuminuria-reduction-in-type-2-diabetes-a-remote-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-continuation-versus-placebo-in-patients-with-acute-decompensated-heart-failure-on-sglt2-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-for-neutropenia-management-in-glycogen-storage-disease-type-ib-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-in-patients-with-metabolic-dysfunction-associated-steatohepatitis-a-48-week-histological-assessment-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-exercise-capacity-in-patients-with-hypertrophic-cardiomyopathy-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-glycemic-control-in-patients-with-hnf1a-mody-a-randomized-double-blind-crossover-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-left-atrial-volume-in-non-diabetic-pre-heart-failure-patients-using-cmr-and-mhealth-exercise-prescription2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-plasma-sodium-levels-in-euvolemic-and-hypervolemic-hyponatremia-a-multicenter-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-renal-growth-in-autosomal-dominant-polycystic-kidney-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-on-right-ventricular-diastolic-function-in-patients-with-pulmonary-arterial-hypertension-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-pioglitazone-and-semaglutide-on-adipose-tissue-function-in-type-2-diabetes-a-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empagliflozin-versus-placebo-in-reducing-left-ventricular-mass-post-aortic-valve-replacement-in-aortic-stenosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-empasiprubart-safety-and-efficacy-in-adult-dermatomyositis-a-phase-2-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-encapsulated-fecal-microbiota-transfer-using-intestifix-for-immune-modulation-in-cirrhosis-and-ascites-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-encorafenib-and-binimetinib-followed-by-cemiplimab-and-fianlimab-in-braf-mutated-melanoma-with-symptomatic-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-encorafenib-and-cetuximab-with-folfiri-in-braf-v600e-mutated-metastatic-colorectal-cancer-post-progression-on-encorafenib-and-cetuximab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-endoscopic-endonasal-surgery-versus-cabergoline-in-biochemical-remission-of-microprolactinomas-in-treatment-naive-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-endothelin-1-receptor-antagonist-bosentan-on-endothelial-function-in-patients-with-uncontrolled-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enfortumab-vedotin-monotherapy-and-in-combination-with-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enoxaparin-sodium-and-human-serum-albumin-combination-therapy-in-high-risk-decompensated-cirrhosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enoxaparin-sodium-for-prophylaxis-of-localized-intravascular-coagulopathy-in-pediatric-patients-with-slow-flow-vascular-malformations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enoxaparin-sodium-in-the-management-of-early-fetal-growth-restriction-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enpatoran-efficacy-and-safety-in-systemic-and-cutaneous-lupus-erythematosus-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enpatoran-on-cardiac-repolarization-in-healthy-subjects-a-thorough-qt-qtc-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-entr-601-44-in-duchenne-muscular-dystrophy-patients-amenable-to-exon-44-skipping-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enx-104-in-a-single-ascending-dose-study-for-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-enzalutamide-s-impact-on-edoxaban-and-morphine-pharmacokinetics-in-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ep0042-monotherapy-and-in-combination-with-venetoclax-and-azacitidine-in-relapsed-refractory-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ep102-for-safety-and-efficacy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ep262-efficacy-and-safety-in-adults-with-chronic-spontaneous-urticaria-a-phase-2-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ep395-on-inhaled-endotoxin-challenge-in-healthy-adults-implications-for-chronic-obstructive-pulmonary-disease-copd2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epcoritamab-combined-with-anti-neoplastic-agents-in-b-cell-non-hodgkin-lymphoma-a-phase-1b-2-open-label-safety-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epcoritamab-in-combination-with-chemotherapeutic-agents-in-b-cell-non-hodgkin-lymphoma-a-phase-1b-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ephedrine-hydrochloride-on-rocuronium-onset-time-in-patients-aged-80-and-above-undergoing-elective-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epi-ee-in-eosinophilic-esophagitis-a-study-on-tolerability-toxicity-pharmacokinetics-and-molecular-mechanisms-of-action2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epi-his-in-healthy-volunteers-a-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epicutaneous-versus-intramuscular-administration-of-live-attenuated-measles-mumps-and-rubella-vaccine-in-inducing-mucosal-immune-response-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epidural-analgesia-using-dural-puncture-technique-with-ultra-low-concentration-levobupivacaine-in-pregnant-women-requesting-labor-analgesia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epiflux-in-patients-with-focal-epilepsy-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epinephrine-efficacy-in-cardiopulmonary-resuscitation-for-term-neonates-with-cardiorespiratory-arrest-in-the-delivery-room2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-epinephrine-norepinephrine-and-phenylephrine-on-intraoperative-hemodynamic-performance-in-patients-undergoing-open-major-abdominal-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eplerenone-altizide-and-micronised-spironolactone-in-heart-failure-with-reduced-ejection-fraction-and-severe-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eplerenone-on-arterial-stiffness-in-stable-renal-transplant-recipients-on-cyclosporine-a-randomized-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eplerenone-spironolactone-and-torasemide-in-the-management-of-resistant-hypertension-in-patients-with-uncontrolled-blood-pressure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-eptinezumab-on-central-and-peripheral-sensitization-in-migraine-patients-a-12-week-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erap-inhibition-in-patients-with-axial-spondyloarthritis-the-east-1-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erbb2-mrna-cut-point-for-predicting-trastuzumab-deruxtecan-efficacy-in-advanced-or-metastatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erdafitinib-monotherapy-and-erdafitinib-cetrelimab-combination-in-cisplatin-ineligible-muscle-invasive-bladder-cancer-with-fgfr-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erectile-function-recovery-in-unfavorable-intermediate-risk-prostate-cancer-patients-post-relugolix-therapy-cessation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erector-spinae-muscle-block-with-ropivacaine-hydrochloride-monohydrate-and-dexamethasone-phosphate-for-acute-low-back-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erector-spinae-plane-block-with-levobupivacaine-hydrochloride-for-postoperative-analgesia-in-lumbar-arthrodesis-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erector-spinae-plane-block-with-ropivacaine-hydrochloride-dexamethasone-phosphate-and-ketoprofen-in-acute-low-back-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erk1-2-inhibitor-ipn01194-monotherapy-in-adult-patients-with-advanced-solid-tumors-including-melanoma-hnscc-pdac-and-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erythromycin-lactobionate-on-gastric-emptying-in-ischemic-stroke-patients-undergoing-mechanical-thrombectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-erythromycin-s-effect-on-bi-1291583-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-escalated-prasugrel-or-ticagrelor-with-direct-oral-anticoagulation-in-atrial-fibrillation-and-acute-coronary-syndrome-undergoing-pci2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-escherichia-coli-strain-nissle-1917-in-the-management-of-autoimmune-non-infectious-uveitis-a-12-month-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-escitalopram-naltrexone-and-their-combination-versus-placebo-in-reducing-symptoms-of-compulsive-sexual-behavior-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-escitalopram-on-serotonin-mediated-learning-and-decision-making-in-a-behavioral-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-escitalopram-paroxetine-naltrexone-and-combination-therapy-in-compulsive-sexual-behavior-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esflurbiprofen-patch-adhesion-in-healthy-volunteers-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esflurbiprofen-topical-system-bioavailability-and-adhesion-compared-to-oral-flurbiprofen-in-a-phase-i-crossover-study-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esketamine-hydrochloride-on-cortical-spreading-depolarization-in-severe-acute-brain-injury-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esketamine-hydrochloride-versus-placebo-in-reducing-negative-and-depressive-symptoms-in-schizophrenia-and-schizoaffective-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esketamine-nasal-spray-versus-aripiprazole-in-combination-with-antidepressants-for-refractory-major-depressive-disorder-in-elderly-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esketamine-on-hypoxic-ventilatory-response-and-reversal-of-remifentanil-induced-respiratory-depression-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esomeprazole-on-structural-integrity-post-endoscopic-sleeve-gastroplasty-in-obesity-a-randomized-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-esomeprazole-s-effect-on-bi-3000202-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-estradiol-and-micronised-progesterone-combined-with-online-cbti-and-crs-on-insomnia-and-climacteric-symptoms-in-perimenopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-estradiol-transdermal-patch-in-adolescent-females-with-anorexia-nervosa-an-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-estriol-releasing-vaginal-ring-for-vaginal-atrophy-in-postmenopausal-women-a-placebo-controlled-double-blind-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-etavopivat-a-pyruvate-kinase-activator-in-a-randomized-placebo-controlled-study-for-sickle-cell-disease-in-patients-aged-12-to-65-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ethinylestradiol-levonorgestrel-and-ethinylestradiol-chlormadinone-acetate-on-neurobehavioral-outcomes-in-hormonal-contraception-users2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ethnicity-s-impact-on-viral-outcomes-post-cessation-of-tenofovir-alafenamide-and-entecavir-in-hbeag-negative-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ethyl-esters-of-iodised-fatty-acids-from-poppyseed-oil-in-tubal-flushing-for-infertility-in-women-with-patent-tubes-at-hyfosy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-etidronate-disodium-in-preventing-systemic-ectopic-mineralization-in-pseudoxanthoma-elasticum-a-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-etifoxine-hydrochloride-as-an-adjunctive-treatment-in-unipolar-and-bipolar-depressive-disorders-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-etrasimod-in-a-hybrid-decentralized-clinical-trial-for-immune-mediated-inflammatory-disorders-ulcerative-colitis-alopecia-areata-atopic-dermatitis-and-eosinophilic-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-event-driven-pre-exposure-prophylaxis-with-tenofovir-alafenamide-emtricitabine-for-hiv-prevention-in-men-who-have-sex-with-men-in-thailand-and-france2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-and-exemestane-in-patients-with-metastatic-breast-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-and-physical-training-on-bone-formation-in-postmenopausal-women-a-24-week-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-and-resistance-training-on-bone-formation-in-healthy-postmenopausal-women-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-in-mitigating-age-related-musculoskeletal-decline-in-elderly-patients-with-stable-medical-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-in-preventing-nk-mediated-rejection-in-adult-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-everolimus-substitution-for-mycophenolate-mofetil-to-enhance-covid-19-vaccine-immunogenicity-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-evolocumab-and-atorvastatin-on-cholesterol-and-bile-acid-metabolism-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-evolocumab-in-carotid-plaque-stabilization-and-regression-in-patients-with-carotid-stenosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-evolocumab-in-reducing-cardiovascular-events-in-patients-with-acute-myocardial-infarction-and-dyslipidemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-evolocumab-on-cardiovascular-outcomes-in-high-risk-patients-without-prior-myocardial-infarction-or-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-evolocumab-on-coronary-microvascular-dysfunction-in-patients-with-atherosclerotic-cardiovascular-disease-undergoing-coronary-angiography2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ex-vivo-generated-allogeneic-natural-killer-cells-and-subcutaneous-aldesleukin-in-acute-myeloid-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exenatide-in-oxytocin-deficient-state-among-hypopituitarism-patients-a-randomized-crossover-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exenatide-on-disease-progression-in-early-parkinson-s-disease-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exercise-and-mediterranean-diet-versus-acetylsalicylic-acid-on-live-birth-rate-in-women-undergoing-in-vitro-fertilization-a-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exl01-and-nivolumab-combination-therapy-in-patients-with-advanced-non-small-cell-lung-cancer-refractory-to-prior-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exl01-for-the-prevention-of-post-operative-recurrence-in-crohn-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exogenous-progesterone-administration-routes-and-dosages-on-endometrial-function-in-female-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-exposure-to-world-anti-doping-agency-prohibited-substances-in-healthy-volunteers-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-extended-adjuvant-endocrine-therapy-with-tamoxifen-exemestane-anastrozole-and-letrozole-in-high-risk-luminal-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-extended-dosing-interval-of-osimertinib-in-egfr-mutated-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-extended-fosaprepitant-prophylaxis-for-delayed-chemotherapy-induced-nausea-and-vomiting-in-pediatric-patients-a-double-blind-placebo-controlled-crossover-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-extended-omalizumab-dosing-intervals-in-adults-with-well-controlled-chronic-spontaneous-urticaria-a-multicenter-randomized-open-label-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ezabenlimab-and-bi-907828-in-adult-patients-with-locally-advanced-or-metastatic-solid-tumors-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-f-18-psma-11-pet-ct-for-diagnostic-accuracy-in-staging-hepatocellular-carcinoma-compared-to-f-18-fdg-and-f-18-choline-pet-ct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fadraciclib-cyc065-in-advanced-solid-tumors-and-lymphoma-a-phase-1-2-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fapi-pet-imaging-for-detection-of-tumor-associated-fibrosis-in-colorectal-peritoneal-metastases-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-faricimab-efficacy-and-safety-in-neovascular-age-related-macular-degeneration-a-phase-iiib-iv-multicenter-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-faricimab-loading-doses-in-treatment-naive-patients-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-faricimab-versus-aflibercept-in-high-frequency-treated-neovascular-age-related-macular-degeneration-a-randomized-double-masked-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fasudil-hydrochloride-safety-tolerability-and-efficacy-in-idiopathic-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fazirsiran-in-subjects-with-hepatic-impairment-and-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fdg-pet-ct-versus-conventional-ct-for-response-monitoring-in-metastatic-breast-cancer-using-fludeoxyglucose-18f2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiome-transplantation-in-decompensated-cirrhosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transfer-for-secondary-prevention-of-recurrent-urinary-tract-infections-in-premenopausal-women-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transfer-to-overcome-atezolizumab-and-bevacizumab-resistance-in-advanced-hepatocellular-carcinoma-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-as-maintenance-therapy-post-anti-tnf-withdrawal-in-crohn-s-disease-patients-in-steroid-free-remission2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-combined-with-atezolizumab-and-bevacizumab-in-hepatocellular-carcinoma-refractory-to-prior-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-combined-with-infliximab-or-vedolizumab-in-ulcerative-colitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-on-cytochrome-p450-enzyme-activities-in-patients-with-irritable-bowel-syndrome-and-clostridioides-difficile-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-safety-and-feasibility-in-stage-ii-iii-nsclc-patients-using-immune-checkpoint-inhibitor-responders-as-donors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fecal-microbiota-transplantation-with-atezolizumab-and-bevacizumab-in-unresectable-hepatocellular-carcinoma-progressing-on-first-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fedratinib-and-azacitidine-combination-therapy-in-patients-with-accelerated-phase-myeloproliferative-neoplasm2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-felzartamab-in-patients-with-late-antibody-mediated-renal-transplant-rejection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-felzartamab-in-patients-with-membranous-nephropathy-resistant-to-anti-cd20-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fenofibrate-micronised-on-pancreatic-beta-cell-function-in-pediatric-patients-with-newly-diagnosed-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ferric-derisomaltose-with-or-without-dopaminergic-therapy-in-restless-legs-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ferumoxytol-versus-iron-sucrose-in-pediatric-iron-deficiency-anemia-a-phase-3-randomized-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fg001-imaging-agent-for-diagnostic-performance-in-patients-with-oropharyngeal-and-oral-squamous-cell-carcinoma-undergoing-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fibrin-based-adhesive-in-reducing-esophagojejunal-anastomosis-dehiscence-in-total-gastrectomies-for-cancer-a-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fibrin-matrix-and-autologous-growth-factor-eye-drops-versus-amniotic-membrane-graft-in-primary-pterygium-surgery-recurrence-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ficerafusp-alfa-and-pembrolizumab-combination-in-pd-l1-positive-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-filgotinib-efficacy-and-safety-in-refractory-idiopathic-inflammatory-myopathies-behcet-s-disease-and-igg4-related-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-filgotinib-efficacy-safety-and-pharmacokinetics-in-pediatric-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-filgotinib-on-cardiac-function-myocardial-inflammation-and-coronary-plaque-morphology-in-rheumatoid-arthritis-patients-without-cardiovascular-history2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-filgotinib-on-quality-of-life-disease-activity-and-safety-in-refractory-behcet-s-disease-idiopathic-inflammatory-myopathies-and-igg4-related-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-filgotinib-versus-triamcinolone-acetonide-in-combination-with-methotrexate-and-hydroxychloroquine-for-newly-diagnosed-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-and-drug-combination-in-reducing-cardiovascular-disease-risk-in-type-1-diabetes-patients-at-high-cardiovascular-risk2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-and-drug-combinations-in-slowing-egfr-decline-in-patients-with-chronic-kidney-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-and-semaglutide-for-albuminuria-reduction-in-patients-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-and-sglt2-inhibitors-on-cardio-renal-outcomes-in-type-2-diabetes-and-chronic-kidney-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-dapagliflozin-and-ambrisentan-in-biomarker-guided-treatment-of-chronic-kidney-disease-associated-albuminuria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-efficacy-and-safety-in-heart-failure-patients-with-reduced-ejection-fraction-intolerant-or-ineligible-for-steroidal-mineralocorticoid-receptor-antagonists2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-in-combination-with-acei-or-arb-for-proteinuria-and-chronic-kidney-disease-in-pediatric-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-in-slowing-egfr-decline-in-patients-with-chronic-kidney-disease-a-randomized-placebo-controlled-adaptive-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-in-the-management-of-early-diabetic-cardiovascular-autonomic-neuropathy-in-type-2-diabetes-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-on-renal-hemodynamics-and-oxidative-stress-in-patients-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-finerenone-pharmacokinetics-in-single-vs-dual-tablet-administration-in-healthy-male-subjects-with-heart-failure-and-left-ventricular-ejection-fraction-402026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fingolimod-versus-interferon-beta-1a-in-pediatric-multiple-sclerosis-a-two-year-double-blind-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fisetin-pharmacokinetics-safety-and-efficacy-in-multimorbidity-and-healthy-subjects-a-phase-i-iia-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fitusiran-for-bleed-prevention-in-patients-with-severe-hemophilia-a-previously-treated-with-emicizumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-five-year-immunogenicity-of-single-dose-intramuscular-rabies-virus-inactivated-strain-flury-lep-pre-exposure-prophylaxis-in-viral-infection-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fixed-dose-follitropin-delta-for-ovarian-stimulation-in-infertility-a-study-on-ovarian-response-during-intrauterine-insemination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fixed-duration-ibrutinib-and-obinutuzumab-therapy-in-treatment-naive-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-flecainide-for-reducing-atrial-arrhythmia-risk-post-patent-foramen-ovale-closure-in-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-flortaucipir-18f-pet-imaging-for-diagnostic-enhancement-in-patients-with-mild-cognitive-impairment-and-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-flubhpve6e7-and-placebo-in-women-with-human-papillomavirus-type-16-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluciclovine-18f-pet-ct-imaging-in-multiple-myeloma-patients-a-comparative-analysis-with-fdg-pet-ct-in-the-remnant-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluconazole-and-cefalexin-monohydrate-in-the-antimicrobial-management-of-laryngeal-leukoplakia-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluconazole-for-reducing-diuresis-in-congenital-nephrogenic-diabetes-insipidus-due-to-avpr2-gene-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluconazole-s-impact-on-intestinal-microbiota-in-healthy-volunteers-a-randomized-controlled-proof-of-concept-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluconazole-s-impact-on-the-pharmacokinetics-of-pf-07248144-in-patients-with-locally-advanced-or-metastatic-hr-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-flumazenil-for-benzodiazepine-reversal-in-electroconvulsive-therapy-in-patients-with-depression-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluocinolone-acetonide-versus-dexamethasone-intravitreal-implants-in-resistant-diabetic-macular-edema-in-pseudophakic-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fluvoxamine-maleate-for-reducing-fatigue-severity-in-post-covid-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-folic-acid-supplementation-versus-placebo-for-mitigating-mucositis-in-metastatic-renal-cell-carcinoma-patients-undergoing-targeted-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-effect-and-pharmacokinetics-of-df2755a-in-single-and-multiple-ascending-doses-in-healthy-subjects-with-interstitial-cystitis-bladder-pain-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-effect-on-pharmacokinetics-of-bi-3731579-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-effect-on-pharmacokinetics-of-mesalazine-oral-formulation-in-healthy-volunteers-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-impact-on-bms-986158-bioavailability-in-patients-with-advanced-solid-tumors-a-phase-1-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-impact-on-pharmacokinetics-and-gastrointestinal-tolerability-of-selumetinib-in-adolescents-with-neurofibromatosis-type-1-related-plexiform-neurofibromas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-food-impact-on-silexan-80-mg-pharmacokinetics-in-a-randomized-open-label-crossover-study-with-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fosfomycin-trometamol-cefixime-and-ciprofloxacin-hydrochloride-in-acute-bacterial-prostatitis-a-randomized-open-label-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fosfomycin-trometamol-efficacy-in-treating-male-urinary-tract-infections-in-primary-care-a-pragmatic-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fosigotifator-sodium-tromethamine-in-adult-and-pediatric-patients-with-vanishing-white-matter-disease-a-phase-1b-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-four-factor-prothrombin-complex-concentrate-for-reversal-of-factor-xa-inhibitor-associated-major-bleeding-in-patients-on-doac-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fractionated-stereotactic-radiotherapy-combined-with-abiraterone-acetate-and-enzalutamide-in-oligometastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fracture-risk-following-discontinuation-of-alendronic-acid-in-osteoporosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fremanezumab-efficacy-in-pain-management-for-complex-regional-pain-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-frexalimab-sar441344-efficacy-and-safety-in-active-systemic-lupus-erythematosus-a-randomized-double-blind-placebo-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fs120-monotherapy-and-fs120-with-pembrolizumab-in-patients-with-advanced-malignancies-a-first-in-human-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ft819-in-the-treatment-of-b-cell-mediated-autoimmune-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-futibatinib-and-pembrolizumab-in-advanced-or-metastatic-urothelial-carcinoma-non-candidates-for-platinum-based-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-futibatinib-combined-with-pembrolizumab-and-chemotherapy-in-patients-with-solid-tumors-a-phase-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-fx06-glutenin-on-time-to-unassisted-breathing-in-acute-respiratory-distress-syndrome-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ga2-sporozoites-co-administered-with-adjuvants-in-patients-with-falciparum-malaria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gabapentin-versus-placebo-for-acute-lumbosacral-radiculalgia-due-to-disc-herniation-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gabapentin-versus-placebo-for-the-treatment-of-sub-acute-radicular-leg-pain-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gadopiclenol-enhanced-multiparametric-mri-for-correlating-radiological-and-histopathological-findings-in-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gallium-68-citrate-pet-ct-for-diagnosing-prosthetic-valve-infective-endocarditis-in-suspected-cases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gallium-68-tilmanocept-pet-ct-for-sentinel-lymph-node-mapping-in-stage-i-ii-high-high-intermediate-risk-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gastric-acid-reduction-on-sisunatovir-pharmacokinetics-in-healthy-adults-with-respiratory-syncytial-virus-rsv2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gastrointestinal-tolerability-of-oral-tegomil-fumarate-versus-dimethyl-fumarate-in-healthy-volunteers-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gaxilose-0-45-g-as-a-marker-of-intestinal-barrier-integrity-in-patients-with-celiac-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gaxilose-efficacy-for-diagnosing-hypolactasia-in-pediatric-patients-with-lactose-intolerance-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gdc-6036-monotherapy-and-combination-therapy-in-advanced-or-metastatic-solid-tumors-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gdc-9545-monotherapy-and-combination-therapy-with-palbociclib-and-or-lhrh-agonist-in-locally-advanced-or-metastatic-er-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gefurulimab-alxn1720-efficacy-and-safety-in-adults-with-generalized-myasthenia-gravis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-geh121224-18f-injection-for-her2-receptor-visualization-via-pet-imaging-in-metastatic-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-geh200486-0-5-m-injection-on-qt-qtc-interval-in-a-phase-1-crossover-study-with-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-geh200486-injection-doses-for-contrast-enhanced-mri-in-head-and-neck-imaging-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gemcitabine-cisplatin-trastuzumab-and-pembrolizumab-in-her2-positive-biliary-tract-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gemcitabine-in-targeting-cancer-stem-cells-in-recurrent-glioblastoma-through-individualized-systems-medicine-approach2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gemtuzumab-ozogamicin-and-drug-combination-in-pediatric-acute-myeloid-leukemia-a-nopho-db-ship-consortium-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gemtuzumab-ozogamicin-with-chemotherapy-on-minimal-residual-disease-in-adult-patients-with-favorable-intermediate-risk-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gene-expression-driven-adjuvant-chemotherapy-versus-standard-care-in-premenopausal-hr-positive-her2-negative-breast-cancer-using-paclitaxel-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-genetic-polymorphisms-on-ranibizumab-and-bevacizumab-efficacy-in-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-genicular-arteries-embolization-using-ioversol-and-ethyl-esters-of-iodised-fatty-acids-in-symptomatic-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-genotype-guided-antithrombotic-therapy-with-carbasalate-calcium-telmisartan-and-rivaroxaban-in-peripheral-arterial-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-genotype-guided-clopidogrel-monotherapy-versus-acetylsalicylic-acid-in-patients-with-non-st-segment-elevation-acute-coronary-syndrome-post-pci2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gentamicin-and-narrow-spectrum-beta-lactams-versus-broad-spectrum-beta-lactams-in-empirical-treatment-of-suspected-community-acquired-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gentamicin-vancomycin-and-cefazolin-for-prophylaxis-against-implant-loss-in-postoperative-breast-reconstruction-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-geriatric-assessment-guided-dose-optimization-of-cdk-4-6-inhibitors-in-vulnerable-elderly-patients-with-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-germinal-center-formation-post-pneumococcal-vaccination-in-hiv-infected-and-non-infected-adults-using-pneumococcal-polysaccharide-conjugate-vaccine-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ginkgo-biloba-extract-egb-761-on-cognitive-impairment-in-post-covid-19-syndrome-a-randomized-placebo-controlled-triple-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-giredestrant-efficacy-and-safety-in-patients-with-grade-1-endometrial-cancer-a-phase-ii-single-arm-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glioblastoma-infiltration-using-mri-with-ultrasmall-superparamagnetic-iron-oxide-particles-in-patients-with-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glofitamab-and-obinutuzumab-in-relapsed-refractory-b-cell-non-hodgkin-s-lymphoma-safety-efficacy-and-pharmacokinetics-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glofitamab-atezolizumab-and-polatuzumab-vedotin-in-relapsed-refractory-b-cell-non-hodgkin-s-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glofitamab-combined-with-rituximab-cyclophosphamide-doxorubicin-vincristine-and-prednisone-in-ctdna-high-risk-untreated-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glofitamab-monotherapy-and-combination-with-r-ice-in-pediatric-and-young-adult-relapsed-refractory-cd20-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glpg5101-for-safety-tolerability-and-efficacy-in-adults-with-treatment-refractory-active-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glucagon-and-insulin-lispro-co-administration-on-insulin-absorption-kinetics-in-type-1-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glucagon-and-semaglutide-on-energy-expenditure-and-glucose-variability-in-obesity-a-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glucothera-plus-solution-for-peritoneal-dialysis-in-pediatric-end-stage-kidney-disease-a-safety-assessment-of-levocarnitine-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-glycogen-metabolism-in-treatment-naive-pompe-disease-patients-undergoing-avalglucosidase-alfa-enzyme-replacement-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-goal-directed-fluid-removal-using-furosemide-versus-placebo-in-adult-icu-patients-with-moderate-to-severe-fluid-overload2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-goal-directed-fluid-therapy-with-plasma-lyte-148-and-noradrenaline-in-arterial-hypotension-during-diep-flap-breast-reconstruction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-goal-directed-hemodynamic-therapy-using-starling-tm-sv-system-on-postoperative-complications-in-elective-neurosurgery-with-isolyte-and-gelaspan-infusions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-goal-directed-low-oxygen-concentration-versus-fixed-oxygen-concentration-during-anesthesia-in-patients-undergoing-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-goblet-cell-density-in-ocular-hypertension-and-primary-open-angle-glaucoma-patients-treated-with-benzalkonium-chloride-and-preservative-free-latanoprost2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-golcadomide-roginolisib-and-azacitidine-in-relapsed-refractory-peripheral-t-cell-lymphomas-a-phase-1-2-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-golimumab-versus-conventional-synthetic-dmards-in-inducing-remission-in-peripheral-spondyloarthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gr1014-cutaneous-gel-for-prevention-of-radiodermatitis-in-patients-undergoing-adjuvant-radiotherapy-for-localized-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gs-0151-in-patients-with-rheumatoid-arthritis-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gs-4528-in-adult-patients-with-solid-tumors-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gsk3862995b-in-healthy-subjects-and-patients-with-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gsk3965193-monotherapy-and-gsk3965193-with-bepirovirsen-in-chronic-hepatitis-b-safety-tolerability-pharmacokinetics-and-pharmacodynamics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gsk4527363-in-systemic-lupus-erythematosus-and-healthy-participants-including-chinese-and-japanese-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gsk5764227-combined-with-standard-of-care-or-other-agents-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gt-002-and-oxazepam-on-cognitive-impairment-in-schizophrenia-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-and-golimumab-combination-therapy-efficacy-and-safety-in-moderate-to-severe-ulcerative-colitis-a-phase-2b-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-efficacy-and-safety-in-fistulizing-perianal-crohn-s-disease-a-phase-3-randomized-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-in-prolonged-treatment-intervals-for-moderate-to-severe-plaque-psoriasis-a-phase-3b-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-on-ultrasound-confirmed-enthesitis-resolution-in-bdmard-naive-psoriatic-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-subcutaneous-induction-therapy-efficacy-and-safety-in-moderate-to-severe-ulcerative-colitis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-guselkumab-subcutaneous-induction-therapy-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gut-microbiome-impact-on-tacrolimus-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-gut-microbiota-impact-on-energy-metabolism-in-inflammatory-bowel-disease-using-amphotericin-b-vancomycin-and-gentamicin-sulfate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-handheld-multimedia-versus-midazolam-premedication-on-perioperative-anxiety-in-pediatric-day-care-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-handling-and-ocular-safety-of-aflibercept-pre-filled-syringe-in-chorioretinal-vascular-diseases-a-single-arm-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hdm201-and-pazopanib-in-p53-wild-type-advanced-metastatic-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-healthcare-and-patient-time-efficiency-in-subcutaneous-fixed-dose-combination-of-pertuzumab-and-trastuzumab-for-her2-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-heart-rate-and-quality-of-life-in-patients-with-transthyretin-cardiac-amyloidosis-the-harley-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodialysis-efficacy-in-chronic-hemodialysis-patients-using-medium-chain-triglycerides-and-soya-oil-emulsion-versus-sodium-chloride-infusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-and-acid-base-effects-of-0-5m-sodium-lactate-versus-3-sodium-chloride-in-septic-shock-patients-a-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-and-hemostatic-effects-of-intravenous-ringer-s-lactate-at-10degc-and-22degc-in-healthy-adults-a-randomized-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-effects-and-safety-of-riociguat-in-patients-with-pulmonary-hypertension-due-to-left-ventricular-systolic-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-effects-and-volume-kinetics-of-ringer-s-acetate-in-experimental-hypovolemia-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-effects-of-sacubitril-valsartan-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-secondary-mitral-valve-regurgitation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemodynamic-optimization-protocols-using-urapidil-phenylephrine-hydrochloride-and-labetalol-hydrochloride-in-acute-ischemic-stroke-post-endovascular-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemorrhagic-and-thrombotic-risks-in-cold-snare-polypectomy-of-subcentimeter-colorectal-polyps-in-patients-on-edoxaban-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemostasis-in-patients-undergoing-percutaneous-closure-of-patent-foramen-ovale-or-atrial-septal-defect-rivaroxaban-versus-clopidogrel-and-acetylsalicylic-acid2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hemostatic-parameters-in-postmenopausal-women-undergoing-vaginal-administration-of-nomegestrol-acetate-and-estradiol-hemihydrate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-heparin-dexamethasone-acetate-and-floxuridine-in-patients-with-colorectal-liver-metastases-and-heavy-tumor-burden2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-heparin-free-extracorporeal-membrane-oxygenation-in-lung-transplantation-impact-on-clinical-outcomes-and-inflammatory-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-heparin-sodium-bolus-for-mobilization-in-peripheral-hematopoietic-cell-collection-in-lymphoma-and-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-heparin-sodium-versus-placebo-for-optimizing-periprocedural-anticoagulation-in-patients-undergoing-transseptal-interventions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hepatic-arterial-infusion-of-floxuridine-dexamethasone-and-sirt-with-systemic-gemcitabine-oxaliplatin-in-unresectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hepatic-arterial-infusion-of-floxuridine-with-systemic-chemotherapy-irinotecan-folinic-acid-fluorouracil-oxaliplatin-in-resectable-colorectal-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hepatic-arterial-infusion-of-floxuridine-with-systemic-therapy-in-unresectable-colorectal-liver-metastases-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hepatic-impairment-on-pharmacokinetics-safety-and-tolerability-of-aticaprant-jnj-67953964-in-healthy-adult-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hepatic-radiotherapy-combined-with-tebentafusp-in-hla-a-02-01-positive-metastatic-uveal-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hexaminolevulinate-assisted-photodynamic-diagnosis-versus-white-light-in-transurethral-resection-of-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hfb200301-monotherapy-and-its-combination-with-tislelizumab-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hfb200603-monotherapy-and-combination-with-tislelizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hfb301001-in-adult-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-concentration-oxygen-supplementation-on-hemodynamics-in-pulmonary-hypertension-coronary-microvascular-dysfunction-hypoxia-and-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-cholecalciferol-as-an-adjunctive-therapy-in-elderly-patients-hospitalized-with-pneumonia-or-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-colecalciferol-and-glycerol-on-soft-tissue-healing-post-mandibular-third-molar-extraction-in-patients-with-vitamin-d-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-hydroxocobalamin-for-reducing-plasma-total-homocysteine-in-patients-with-hydroxocobalamin-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-intravenous-ascorbic-acid-on-mortality-and-organ-dysfunction-in-septic-ards-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-intravenous-ascorbic-acid-on-persistent-organ-dysfunction-and-mortality-in-patients-with-severe-burn-injury-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-nusinersen-in-spinal-muscular-atrophy-patients-previously-treated-with-risdiplam-a-phase-3b-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-pulse-intravenous-methylprednisolone-sodium-succinate-in-patients-with-complicated-fulminant-acute-myocarditis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-ras-antagonists-and-beta-blockers-in-preventing-cardiac-events-in-type-2-diabetes-mellitus-patients-with-elevated-nt-probnp-levels2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-rifampicin-moxifloxacin-and-linezolid-regimen-in-bacilliferous-pulmonary-tuberculosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-rifampicin-safety-in-adult-patients-with-complex-drug-susceptible-pulmonary-and-extrapulmonary-tuberculosis-using-a-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-treosulfan-and-melphalan-as-consolidation-therapy-in-newly-diagnosed-high-risk-ewing-sarcoma-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-versus-low-dose-serratus-anterior-plane-block-with-bupivacaine-hydrochloride-and-epinephrine-in-post-aortic-valve-replacement-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-dose-vs-standard-dose-quadrivalent-influenza-vaccine-efficacy-in-preventing-hospitalization-in-adults-aged-65-79-years-in-galicia-spain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-flow-oxygen-and-nitrous-oxide-for-acute-management-of-paroxysmal-dystonic-and-plegic-episodes-in-alternating-hemiplegia-of-childhood2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-high-flow-oxygen-therapy-versus-conventional-oxygen-therapy-in-enhancing-oxygenation-during-pulmonary-rehabilitation-in-ild-patients-with-exercise-induced-desaturation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hla-dr3dq2-influence-on-lada-status-and-immune-parameters-post-intralymphatic-glutamate-decarboxylase-2-human-recombinant-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hlx10-combined-with-chemotherapy-and-radiotherapy-in-limited-stage-small-cell-lung-cancer-a-phase-iii-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-holmium-166-tare-with-maintenance-therapy-using-fluoropyrimidine-anti-egfr-and-anti-vegf-in-unresectable-liver-limited-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hormonal-treatment-efficacy-with-estradiol-hemihydrate-and-testosterone-in-adolescents-with-gender-dysphoria-post-social-transition2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hpv-specific-antibody-virion-interactions-in-human-papillomavirus-infection-using-gardasil-9-vaccine-in-a-first-void-urine-based-model2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hro761-monotherapy-and-combination-therapy-in-patients-with-msi-high-or-dmmr-advanced-unresectable-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hsp-car19m-immunotherapy-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-with-cyclophosphamide-bendamustine-fludarabine-and-tocilizumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hsp-car30-immunotherapy-in-refractory-or-relapsed-cd30-classical-hodgkin-and-non-hodgkin-t-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-albumin-solution-and-sodium-chloride-in-modulating-ischemic-stroke-induced-endothelial-glycocalyx-damage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-albumin-solution-on-acute-kidney-injury-incidence-post-liver-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-albumin-solution-versus-electrolyte-solution-for-plasma-volume-and-hemodynamic-optimization-in-laparoscopic-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-alpha1-proteinase-inhibitor-and-prednisolone-in-patients-with-severe-alcohol-associated-hepatitis-a-prospective-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-alpha1-proteinase-inhibitor-for-prevention-of-acute-graft-versus-host-disease-in-hematopoietic-cell-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-cancellous-bone-allografts-for-partial-meniscal-replacement-in-patients-with-incomplete-meniscal-loss-a-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-fetal-neural-precursor-cells-and-tacrolimus-in-progressive-multiple-sclerosis-a-randomized-assessor-blind-multicenter-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-fibrinogen-in-hematological-malignancy-patients-with-thrombocytopenia-and-bleeding-post-chemotherapy-refractory-to-platelet-transfusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-fibrinogen-replacement-for-prevention-of-intracranial-hemorrhage-in-ischemic-stroke-patients-with-post-rtpa-hypofibrinogenemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-hepatitis-b-immunoglobulin-for-hbsag-clearance-in-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-normal-immunoglobulin-dosing-on-lung-disease-progression-in-patients-with-primary-antibody-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-normal-immunoglobulin-for-primary-prophylaxis-of-infections-in-transplant-ineligible-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-plasma-proteins-with-96-albumin-and-glutathione-reduced-sodium-salt-in-decompensated-cirrhosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-plasma-proteins-with-96-albumin-in-acute-critical-illness-requiring-intensive-care-unit-admission-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-scfv-2-fab-fusion-protein-against-cd40l-in-moderate-to-severe-thyroid-eye-disease-an-open-label-long-term-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-human-serum-albumin-infusion-on-renal-function-in-critically-ill-patients-with-septic-shock-and-high-risk-of-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-humanized-car-t-cell-therapy-ari0002h-targeting-bcma-in-patients-with-relapsed-refractory-multiple-myeloma-resistant-to-proteasome-inhibitors-immunomodulators-and-anti-cd38-antibody2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-huvr-cartemis-1-t-lymphocyte-therapy-in-relapsed-multiple-myeloma-post-allogeneic-transplant-with-egfr-expression-control2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydralazine-hydrochloride-isosorbide-dinitrate-and-metformin-hydrochloride-in-chronic-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-and-argipressin-efficacy-on-30-day-survival-and-neurological-outcomes-in-post-resuscitation-syndrome-with-hemodynamic-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-and-fludrocortisone-efficacy-in-critically-ill-patients-with-corticosteroid-insufficiency-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-augmentation-on-safety-learning-in-ptsd-patients-with-hpa-axis-dysregulation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-enhanced-exposure-and-response-prevention-therapy-versus-placebo-in-reducing-food-craving-in-binge-eating-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-hemisuccinate-and-fludrocortisone-in-icu-patients-with-sepsis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-octreotide-and-teres-ligament-patch-in-reducing-postoperative-complications-following-high-risk-pancreaticoduodenectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydrocortisone-supplementation-on-quality-of-life-in-glucocorticoid-induced-adrenal-insufficiency-in-polymyalgia-rheumatica-and-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydromethylthionine-mesylate-tablet-formulations-in-alzheimer-s-disease-a-phase-1-bioavailability-study-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxycarbamide-addition-to-cytarabine-and-daunorubicin-regimen-in-newly-diagnosed-adult-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxychloroquine-sulfate-and-low-dose-corticosteroid-efficacy-in-pulmonary-sarcoidosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxychloroquine-sulfate-in-patients-with-isolated-cutaneous-mastocytosis-or-indolent-systemic-mastocytosis-with-skin-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxychloroquine-sulfate-in-resectable-head-and-neck-squamous-cell-carcinoma-and-non-small-cell-lung-cancer-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxychloroquine-sulfate-on-pregnancy-outcomes-in-women-with-antiphospholipid-antibodies-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxychloroquine-with-leflunomide-and-hydroxychloroquine-with-mycophenolate-mofetil-in-primary-sjogren-s-syndrome-a-stratified-interventional-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hydroxypropylbetadex-and-standard-of-care-versus-placebo-in-niemann-pick-disease-type-c1-a-phase-3-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-as-an-adjunct-to-biologic-therapy-in-moderate-to-severe-ulcerative-colitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-as-an-adjunctive-treatment-for-ischemic-diabetic-foot-ulcers-to-prevent-major-amputations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-combined-with-standard-care-in-acute-idiopathic-sudden-sensorineural-hearing-loss-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-in-acute-hamstring-injury-for-athletes-and-military-personnel-a-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-on-molecular-mechanisms-in-moderate-to-severe-ulcerative-colitis-refractory-to-medical-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbaric-oxygen-therapy-regimens-in-acute-acoustic-trauma-a-comparative-study-of-daily-versus-twice-daily-administration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperbolic-versus-linear-tapering-of-antidepressants-in-adults-with-remitted-depressive-disorders-amitriptyline-fluoxetine-paroxetine-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperemic-myocardial-perfusion-in-chronic-coronary-syndrome-using-adenosine-at-standard-and-high-doses2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperfractionated-accelerated-radiotherapy-and-high-dose-thiotepa-therapy-in-high-risk-medulloblastoma-patients-aged-over-3-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperpolarized-1-13c-pyruvate-mri-for-early-detection-of-hepatocellular-carcinoma-in-patients-with-primary-liver-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hypersensitivity-reactions-in-solid-tumor-patients-undergoing-paclitaxel-chemotherapy-with-and-without-dexamethasone-premedication2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hyperthermic-intraperitoneal-chemotherapy-with-cisplatin-in-stage-iii-epithelial-ovarian-cancer-a-randomized-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hypertonic-sodium-lactate-infusion-for-reducing-post-anoxic-brain-injury-in-comatose-survivors-of-cardiac-arrest2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hypnosis-versus-premedication-in-managing-perioperative-anxiety-in-patients-undergoing-gynecological-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hypoglycemic-response-in-type-2-diabetes-mellitus-patients-administered-once-weekly-retatrutide2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-hypothalamic-phospholipids-and-citalopram-hydrobromide-in-enhancing-antidepressant-response-in-elderly-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ia-14069-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-rheumatoid-arthritis-and-drug-drug-interaction-with-methotrexate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iadademstat-in-the-management-of-sickle-cell-disease-in-affected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iama-6-in-neurodevelopmental-disorder-a-placebo-controlled-study-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ianalumab-efficacy-safety-and-tolerability-in-diffuse-cutaneous-systemic-sclerosis-a-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ianalumab-vay736-efficacy-and-safety-in-autoimmune-hepatitis-patients-with-incomplete-response-or-intolerance-to-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iberdomide-maintenance-therapy-post-autologous-stem-cell-transplantation-in-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ibuprofen-and-paracetamol-co-administration-for-patent-ductus-arteriosus-management-in-extremely-low-gestational-age-neonates2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ibuprofen-versus-conventional-analgesic-therapy-in-acute-myocarditis-with-preserved-left-ventricular-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-icatibant-s-analgesic-efficacy-in-mitigating-propofol-injection-induced-pain-in-a-randomized-double-blind-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iclepertin-on-cardiac-safety-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-icosapent-ethyl-on-aortic-valve-calcification-progression-in-patients-with-aortic-valve-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-icotrokinra-pharmacokinetics-and-pharmacodynamics-in-inflammatory-conditions-a-study-in-healthy-volunteers-with-various-tablet-formulations-and-dietary-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-idor-1134-2831-vaccine-in-healthy-participants-for-prevention-of-clostridioides-difficile-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ifinatamab-deruxtecan-and-combination-therapies-in-metastatic-castration-resistant-prostate-cancer-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ifinatamab-deruxtecan-and-pembrolizumab-with-or-without-chemotherapy-in-first-line-treatment-of-locally-advanced-unresectable-metastatic-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iks03-in-patients-with-advanced-b-cell-non-hodgkin-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ilofotase-alfa-for-renal-protection-in-patients-at-risk-of-renal-damage-post-cardiac-surgery-a-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iloprost-trometamol-for-enhancing-bone-healing-in-proximal-humeral-fracture-a-phase-i-iia-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-image-guided-de-escalation-of-neoadjuvant-chemotherapy-with-trastuzumab-pertuzumab-and-drug-combination-in-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imatinib-in-the-conversion-of-triple-negative-breast-cancer-to-estrogen-receptor-positive-phenotype-in-primary-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imatinib-pharmacodynamics-in-healthy-subjects-for-immuno-oncology-assessments2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imetelstat-sodium-in-transfusion-dependent-patients-with-ipss-low-or-intermediate-1-risk-myelodysplastic-syndromes-refractory-to-esa-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imipramine-hydrochloride-on-histological-and-clinical-outcomes-in-fascin1-overexpressing-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imlifidase-for-achieving-negative-virtual-crossmatch-in-highly-sensitized-patients-undergoing-living-donor-renal-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imlifidase-for-acute-inflammation-in-aqp4-igg-associated-neuromyelitis-optica-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imm-101-and-stereotactic-body-radiotherapy-in-limited-metastatic-pancreatic-cancer-a-phase-ii-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immediate-versus-deferred-febuxostat-administration-in-gout-management-a-non-inferiority-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immediate-versus-delayed-administration-of-bisoprolol-ramipril-and-dapagliflozin-in-patients-with-st-elevation-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immediate-versus-delayed-azathioprine-or-rituximab-therapy-in-pediatric-anti-mog-antibody-associated-acute-demyelinating-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immediate-versus-delayed-chemotherapy-initiation-on-quality-adjusted-survival-in-asymptomatic-metastatic-pancreatic-cancer-using-paclitaxel-albumin-bound-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immediate-versus-delayed-intrauterine-levonorgestrel-insertion-post-medical-abortion-a-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-biomarkers-for-checkpoint-inhibitor-related-toxicity-in-solid-tumor-patients-using-atezolizumab-durvalumab-and-avelumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-checkpoint-inhibition-and-high-intensity-focused-ultrasound-histotripsy-in-metastatic-or-unresectable-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-checkpoint-inhibitor-combinations-with-axitinib-in-untreated-locally-advanced-or-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-modulatory-radiotherapy-with-cisplatin-docetaxel-and-durvalumab-in-resectable-stage-iii-n2-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-and-safety-of-rmenb-omv-nz-vaccine-in-adolescents-and-young-adults-previously-primed-for-invasive-meningococcal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-and-safety-of-rsvpref3-oa-and-raxtozinameran-co-administration-in-adults-aged-50-and-above-with-respiratory-syncytial-virus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-and-safety-of-rsvpref3-oa-vaccine-in-adults-aged-18-49-at-increased-risk-for-respiratory-syncytial-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-and-safety-of-rsvpref3-oa-vaccine-in-lung-and-renal-transplant-recipients-and-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-differences-to-4cmenb-vaccine-in-healthy-transgender-and-cisgender-adults-aged-18-402026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-in-early-alzheimer-s-disease-patients-treated-with-posdinemab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-kinetics-and-revaccination-impact-in-post-covid-19-patients-treated-with-monoclonal-antibodies-tozinameran-elasomeran-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-persistence-and-safety-of-adjuvanted-rsvpref3-vaccine-in-lung-and-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-persistence-and-safety-of-gbs-nn-nn2-vaccine-in-preventing-group-b-streptococcus-infection-in-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-to-mmr-0-immunization-in-infants-under-12-months-during-measles-outbreak-a-study-of-measles-mumps-and-rubella-vaccine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-to-recombinant-varicella-zoster-virus-glycoprotein-e-vaccine-in-hiv-positive-individuals-aged-over-50-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-response-to-tetravalent-menacwy-tt-conjugate-vaccine-in-elderly-patients-with-invasive-meningococcal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-responses-induced-by-a-turkey-turkey-1-05-h5n1-like-strain-and-quadrivalent-influenza-vaccine-in-avian-and-seasonal-influenza-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-responses-to-diphtheria-tetanus-and-pertussis-vaccination-timing-in-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immune-signature-profiling-for-predicting-response-to-neoadjuvant-atezolizumab-carboplatin-and-nab-paclitaxel-in-resectable-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-booster-efficacy-of-recombinant-vesicular-stomatitis-virus-zaire-ebolavirus-vaccine-in-occupationally-exposed-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-20-valent-pneumococcal-conjugate-vaccine-during-acute-febrile-illness-in-adults-at-risk-for-pneumococcal-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-dtap-vaccine-booster-in-healthcare-workers-for-diphtheria-tetanus-and-pertussis-immunity-enhancement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-fractional-subcutaneous-booster-dose-of-modified-vaccinia-ankara-bavarian-nordic-live-virus-in-adults-with-mpox2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-gskvx000000025896-compared-to-varicella-virus-oka-merck-strain-in-healthy-pediatric-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-intramuscular-gskvx000000025896-and-priorix-versus-subcutaneous-varicella-virus-oka-merck-strain-in-healthy-children-aged-12-15-months2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-menacyw-conjugate-vaccine-booster-in-pediatric-and-adolescent-populations-with-prior-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-meningococcal-b-vaccine-strategies-in-asplenic-adults-a-phase-iii-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-mrna-based-multivalent-influenza-vaccine-candidates-in-adults-aged-18-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-ovx836-influenza-vaccine-in-healthy-adults-a-randomized-double-blind-phase-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-pentavalent-meningococcal-abcyw-vaccine-in-pediatric-populations-compared-to-licensed-meningococcal-vaccines2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-rsvpref3-oa-vaccine-in-adults-aged-60-following-revaccination-schedules-in-a-phase-3b-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-safety-of-the-9-valent-human-papillomavirus-vaccine-in-hiv-positive-women-under-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-and-skin-resident-memory-t-cell-induction-by-intradermal-subcutaneous-and-intramuscular-yellow-fever-virus-strain-17d-204-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-of-co-administered-tozinameran-and-mf59-adjuvanted-influenza-vaccine-in-adults-aged-65-and-over-with-covid-19-and-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-of-combined-pneumococcal-vaccination-with-pcv13-and-ppv23-in-adults-with-acute-myeloblastic-leukemia-or-lymphoma-undergoing-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-safety-and-reactogenicity-of-gbs-nn-nn2-and-tdap-vaccines-in-preventing-group-b-streptococcus-in-non-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-safety-and-reactogenicity-of-jnj-78901563-and-high-dose-quadrivalent-influenza-vaccine-in-adults-aged-65-years-or-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunogenicity-safety-and-reactogenicity-of-rsvpref3-oa-vaccine-in-adults-aged-60-with-respiratory-syncytial-virus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunological-activity-of-peginterferon-alfa-2a-in-patients-with-extramembranous-glomerulonephritis-and-th17-cytokine-profile2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunological-responses-to-covid-19-vaccination-with-raxtozinameran-bretovameran-and-drug-combination-in-patients-with-covid-19-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunosuppression-management-using-bk-polyomavirus-specific-t-cells-in-bkpyv-dnaemia-post-kidney-transplantation-with-prednisolone-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunosuppressive-regimen-reduction-in-kidney-transplant-recipients-with-septic-shock-or-acute-respiratory-failure-a-phase-iv-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunosuppressive-therapy-discontinuation-versus-maintenance-in-anca-associated-vasculitis-with-end-stage-renal-disease-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunosuppressive-therapy-individualization-using-biomarkers-in-living-donor-kidney-transplant-recipients-a-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-immunotherapy-combinations-including-sym024-sym023-sym025-and-cemiplimab-in-advanced-non-small-cell-lung-cancer-with-high-pd-l1-expression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imp1734-a-parp1-selective-inhibitor-alone-and-in-combination-with-abiraterone-paclitaxel-and-prednisolone-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-imvt-1402-efficacy-and-safety-in-active-subacute-and-chronic-cutaneous-lupus-erythematosus-a-phase-2b-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inca033989-efficacy-and-safety-in-patients-with-myelofibrosis-or-essential-thrombocythemia-within-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inclisiran-in-reducing-major-adverse-cardiovascular-events-in-high-risk-primary-prevention-of-atherosclerotic-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inclisiran-in-the-management-of-primary-hypercholesterolaemia-and-mixed-dyslipidaemia-in-high-risk-atherosclerotic-cardiovascular-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inclisiran-s-efficacy-in-reducing-major-adverse-cardiovascular-events-in-patients-with-atherosclerotic-cardiovascular-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inclisiran-versus-placebo-in-pediatric-patients-with-homozygous-familial-hypercholesterolemia-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indapamide-hemihydrate-on-urinary-calcium-excretion-in-chronic-post-surgical-hypoparathyroidism-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-individualized-antibiotic-duration-using-ampicillin-sodium-for-community-acquired-pneumonia-in-adults-a-randomized-open-label-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-individualized-thrombosis-prophylaxis-with-apixaban-nadroparin-calcium-and-dabigatran-in-patients-undergoing-total-hip-or-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-individualized-versus-standard-dosing-of-ravulizumab-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-pnh2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-and-technetium-99mtc-nanocolloid-for-sentinel-node-biopsy-in-head-neck-melanoma-oral-malignancies-and-penile-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-angiography-for-parathyroid-detection-and-hypoparathyroidism-prevention-post-thyroidectomy-in-patients-with-thyroid-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-arteriography-for-parathyroid-preservation-in-total-thyroidectomy-with-or-without-central-cervical-lymph-node-dissection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-dosing-and-timing-in-near-infrared-fluorescence-cholangiography-for-symptomatic-cholelithiasis-during-laparoscopic-cholecystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-for-vascular-assessment-in-ileal-conduit-anastomosis-during-pelvic-exenteration-in-recurrent-gynecological-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-lymph-fluoroscopy-for-assessing-superficial-lymphatic-vessel-porosity-in-lipedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-retention-in-axillary-lymph-nodes-post-subdermal-injection-in-breast-carcinoma-patients-with-metastatic-lymph-nodes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-indocyanine-green-with-autologous-extracellular-vesicles-for-in-vivo-diagnostics-in-surgical-resection-of-solid-digestive-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-induction-chemotherapy-with-folfoxiri-in-high-risk-locally-advanced-rectal-cancer-a-study-on-pathological-and-clinical-response-rates2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-induction-radiochemotherapy-with-low-dose-ionizing-radiation-paclitaxel-and-carboplatin-in-advanced-throat-and-larynx-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inebilizumab-efficacy-and-safety-in-anti-nmda-receptor-encephalitis-a-phase-2b-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-infliximab-withdrawal-in-sarcoidosis-patients-in-remission-a-randomized-controlled-trial-of-tnf-alpha-antagonists-methotrexate-and-azathioprine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-influenza-vaccination-on-post-myocardial-infarction-coronary-inflammation-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-influenza-vaccine-administration-timing-on-strain-specific-antibody-titers-in-adults-aged-60-85-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-influenza-vaccine-on-systemic-inflammatory-markers-in-stable-coronary-artery-disease-patients-a-randomized-delayed-start-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-infusion-related-reactions-in-oncology-patients-receiving-trastuzumab-bevacizumab-atezolizumab-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-budesonide-glycopyrronium-bromide-and-formoterol-fumarate-dihydrate-on-tidal-breathing-complexity-in-stable-copd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-colistimethate-sodium-in-adult-bronchiectasis-patients-with-asymptomatic-pseudomonas-aeruginosa-infection-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-dornase-alfa-versus-placebo-in-reducing-moderate-to-severe-ards-incidence-in-ventilated-severe-trauma-patients-in-icu2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-furosemide-and-oral-levodropropizine-on-dyspnea-in-advanced-lung-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-isoflurane-for-sedation-in-adult-patients-with-severe-cardiogenic-shock-on-venoarterial-ecmo-a-comparative-study-with-propofol-and-dobutamine-hydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-levofloxacin-and-sodium-chloride-in-community-acquired-pneumonia-patients-with-and-without-pre-existing-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-levofloxacin-versus-intravenous-piperacillin-tazobactam-in-the-management-of-community-acquired-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-nitric-oxide-on-right-ventricular-function-and-pulmonary-vascular-mechanics-post-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-phospholipid-fraction-bovine-lung-in-idiopathic-pulmonary-fibrosis-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-pirfenidone-ap01-efficacy-and-safety-in-progressive-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-phase-2b-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-sevoflurane-versus-intravenous-sedation-in-icu-patients-at-high-risk-for-acute-respiratory-distress-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inhaled-tobramycin-and-colistimethate-sodium-in-adult-bronchiectasis-with-chronic-bronchial-infection-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-innate-immune-response-to-bretovameran-mrna-vaccine-in-healthy-adults-aged-18-40-following-covid-19-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inno8-for-prophylaxis-in-adult-and-pediatric-patients-6-years-with-moderate-or-severe-hemophilia-a-with-or-without-factor-viii-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inositol-trispyrophosphate-hexasodium-as-adjunctive-therapy-for-progressive-respiratory-failure-in-covid-19-and-pulmonary-parenchymal-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-insulin-human-ophthalmic-drops-for-efficacy-and-safety-in-treating-dry-eye-disease-in-patients-using-topical-hypotensive-agents2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-insulin-human-ophthalmic-drops-for-persistent-corneal-epithelial-defect-a-multicenter-randomized-observer-blinded-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-insulin-human-titration-via-leuven-algorithm-for-glycemic-control-in-critically-ill-patients-with-stress-hyperglycemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-int-787-in-severe-alcohol-associated-hepatitis-a-phase-2a-randomized-double-blind-placebo-controlled-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intensified-pharmacological-regimen-with-clozapine-and-drug-combination-in-schizophrenia-patients-experiencing-first-line-treatment-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intensified-pharmacological-regimen-with-lithium-sertraline-and-bupropion-hydrochloride-in-bipolar-depression-post-first-line-treatment-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intensified-pharmacological-treatment-with-esketamine-for-major-depressive-disorder-in-patients-with-first-line-treatment-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intensive-versus-standard-adjuvant-chemotherapy-with-folfoxiri-and-capox-in-stage-ii-iii-localized-colon-cancer-with-circulating-tumor-dna2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intermittent-ibrutinib-administration-in-patients-with-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-interpectoral-pectoserratus-plane-block-with-levobupivacaine-for-analgesia-in-aortic-valve-replacement-via-right-anterior-minithoracotomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-interpersonal-sensorimotor-synchronization-therapy-and-intranasal-oxytocin-in-autism-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intestinal-gel-therapy-with-levodopa-entacapone-and-carbidopa-monohydrate-in-parkinson-s-disease-to-mitigate-dopaminergic-desensitization-and-neuropsychiatric-complications2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-abdominal-pressure-and-ultrasound-guided-diuretic-therapy-with-furosemide-and-hydrochlorothiazide-in-acute-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-amniotic-er004-for-efficacy-and-safety-in-male-patients-with-x-linked-hypohidrotic-ectodermal-dysplasia-xlhed2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-arterial-autologous-mesoangioblast-administration-in-patients-with-m-3243a-g-mutation-induced-mitochondrial-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-arterial-chemotherapy-with-topotecan-and-drug-combination-for-conservative-management-of-retinoblastoma-in-eligible-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-clodronate-disodium-for-efficacy-and-tolerability-in-patients-with-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-corticosteroid-injection-and-suprascapular-nerve-block-in-patients-with-adhesive-capsulitis-using-methylprednisolone-acetate-and-ropivacaine-hydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-incobotulinumtoxina-versus-placebo-in-symptomatic-trapezometacarpal-osteoarthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-injection-of-allogeneic-adipose-tissue-derived-mesenchymal-stem-cells-versus-placebo-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-injection-tolerance-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-in-adults-with-rhizarthrosis-stages-dell-1-32026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-tranexamic-acid-for-reducing-blood-loss-in-unilateral-total-hip-arthroplasty-in-osteoarthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-articular-triamcinolone-hexacetonide-injections-in-juvenile-idiopathic-arthritis-patients-initiating-tumor-necrosis-factor-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-dermal-hepatitis-b-surface-antigen-vaccination-with-topical-imiquimod-in-cirrhotic-patients-unresponsive-to-conventional-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-discal-allogeneic-bone-marrow-stromal-mesenchymal-cell-therapy-in-lumbar-degenerative-disc-disease-related-chronic-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intra-lesional-bo-112-polyinosinic-polycytidylic-acid-in-resectable-primary-low-and-high-risk-basal-cell-carcinoma-a-phase-2b-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracochlear-triamcinolone-acetonide-in-patients-with-persistent-sudden-sensorineural-hearing-loss-a-prospective-observer-blinded-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracochlear-vsf1-01-for-safety-in-cochlear-implantation-associated-trauma-in-hearing-loss-a-phase-i-iia-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracoronary-ab-1002-efficacy-and-safety-in-nyha-class-iii-non-ischemic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracranial-efficacy-of-jdq443-in-patients-with-kras-g12c-mutant-non-small-cell-lung-cancer-and-brain-metastases-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracranial-efficacy-of-sacituzumab-govitecan-and-bevacizumab-in-asymptomatic-brain-metastases-from-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intracranial-efficacy-of-tarlatamab-in-patients-with-asymptomatic-brain-metastases-from-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intradermal-administration-of-tozinameran-and-famtozinameran-mrna-vaccine-in-elderly-patients-aged-75-and-older-with-stable-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intradermal-lipopolysaccharide-induced-vascular-responses-in-patients-with-immunological-and-cardiovascular-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intradialytic-parenteral-nutrition-on-muscle-protein-synthesis-in-chronic-hemodialysis-patients-a-study-of-amino-acid-and-electrolyte-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intralesional-mitazalimab-for-the-prevention-of-malignant-transformation-in-high-risk-oral-potentially-malignant-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intralesional-triamcinolone-acetonide-injections-for-prevention-of-refractory-strictures-in-pediatric-esophageal-atresia-repair2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intralymphatic-administration-of-recombinant-human-glutamate-decarboxylase-2-in-hla-dr3-dq2-positive-individuals-at-risk-for-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intralymphatic-immunotherapy-enhanced-by-vitamin-d-in-patients-with-moderate-to-severe-allergic-rhinitis-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intramuscular-allogeneic-human-mesenchymal-stem-cell-therapy-for-digital-ulcers-in-systemic-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intramuscular-versus-intranasal-naloxone-hydrochloride-for-reversal-of-opioid-induced-respiratory-depression-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intramyocardial-conduction-disorders-post-percutaneous-aortic-valve-using-18f-fludeoxyglucose-pet-ct-in-aortic-stenosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-administration-of-chf6467-in-neonatal-hypoxic-ischemic-encephalopathy-pharmacokinetics-safety-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-esketamine-and-oral-midazolam-for-rapid-symptom-reduction-in-adolescent-major-depressive-disorder-with-acute-suicidal-ideation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-lysine-aspirin-on-patient-reported-outcomes-in-nsaid-exacerbated-respiratory-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-and-self-compassion-training-efficacy-in-borderline-personality-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-and-sensorimotor-synchronization-therapy-on-social-attunement-in-autism-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-as-an-adjunct-to-psychoeducational-interventions-in-pediatric-autism-spectrum-disorders-with-intellectual-disability2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-in-central-diabetes-insipidus-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-in-mitigating-benzodiazepine-withdrawal-symptoms-a-randomized-placebo-controlled-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-oxytocin-on-neural-plasticity-and-learning-in-youth-with-autism-spectrum-disorder-a-randomized-placebo-controlled-double-blind-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intranasal-sufentanil-and-intravenous-morphine-for-analgesia-in-pediatric-sickle-cell-vaso-occlusive-crisis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-cellvizio-with-intravenous-fluorescein-sodium-for-determining-ileal-resection-margins-in-crohn-s-ileal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-clonidine-hydrochloride-for-postoperative-analgesia-in-elective-spine-surgery-patients-with-degenerative-spine-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-indocyanine-green-fluorescence-angiography-for-reducing-anastomotic-leakage-in-colorectal-cancer-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-indocyanine-green-fluorescence-imaging-for-surgical-margin-assessment-in-primary-invasive-early-breast-cancer-during-breast-conserving-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-low-dose-argipressin-and-noradrenaline-tartrate-on-post-transplant-acute-kidney-injury-in-liver-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-methadone-hydrochloride-versus-sufentanil-for-postoperative-analgesia-in-orthopedic-surgery-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraoperative-sufentanil-administration-on-chronic-postsurgical-pain-incidence-in-patients-undergoing-non-major-scheduled-abdominal-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraovarian-platelet-concentrate-and-sodium-chloride-injection-on-ivf-outcomes-in-women-with-low-ovarian-reserve-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrapartum-clindamycin-phosphate-and-benzylpenicillin-sodium-for-preventing-group-g-c-streptococcal-infections-in-pregnant-carriers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraperitoneal-furosemide-sodium-versus-oral-administration-on-hydration-status-in-stable-peritoneal-dialysis-patients-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intraperitoneal-ropivacaine-hydrochloride-on-chemotherapy-timing-post-cytoreductive-surgery-in-advanced-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrapleural-photodynamic-therapy-with-aminolevulinic-acid-hydrochloride-and-nivolumab-in-malignant-pleural-mesothelioma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrarectal-botulinum-toxin-type-a-on-rectal-motility-in-fecal-incontinence-a-study-with-ascorbic-acid-sodium-ascorbate-and-bisacodyl2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrathecal-aln-app-efficacy-and-safety-in-cerebral-amyloid-angiopathy-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrathecal-morphine-and-bupivacaine-versus-intravenous-lidocaine-on-postoperative-recovery-in-robot-assisted-upper-urologic-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrathecal-morphine-with-or-without-ropivacaine-in-suprainguinal-fascia-iliaca-block-for-analgesia-post-total-hip-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrathecal-ng004-monoclonal-antibody-in-patients-with-acute-incomplete-cervical-spinal-cord-injury-a-first-in-human-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intrathecal-ropivacaine-hydrochloride-versus-bupivacaine-hydrochloride-for-postoperative-analgesia-in-primary-total-hip-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intratracheal-budesonide-and-poractant-alfa-for-bronchopulmonary-dysplasia-prevention-in-preterm-infants-32-weeks-gestational-age2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intratumoral-influenza-vaccine-and-systemic-pembrolizumab-in-patients-with-early-pmmr-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intratumoral-ipilimumab-and-nivolumab-as-neoadjuvant-therapy-in-resectable-stage-iii-cutaneous-or-mucosal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intratympanic-ac102-versus-oral-prednisolone-in-idiopathic-sudden-sensorineural-hearing-loss-a-randomized-blinded-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intratympanic-methylprednisolone-versus-placebo-for-reducing-vertigo-in-unilateral-meniere-s-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravaginal-oxybutynin-delivery-via-medring-system-for-overactive-bladder-management-in-a-28-day-feasibility-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravaginal-prasterone-on-genitourinary-syndrome-in-postmenopausal-women-with-prior-breast-cancer-or-undergoing-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-amisulpride-dexamethasone-phosphate-and-ondansetron-for-prevention-of-post-operative-nausea-and-vomiting-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-attr-01-in-adult-patients-with-select-epithelial-solid-tumors-a-phase-1-2-master-protocol-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-busulfan-fludarabine-and-rabbit-anti-human-thymocyte-immunoglobulin-in-allogeneic-stem-cell-transplantation-for-high-risk-myeloid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-cangrelor-in-acute-ischemic-stroke-with-large-vessel-occlusion-and-emergent-carotid-artery-stenting2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-dalbavancin-versus-standard-antibiotic-regimen-in-staphylococcus-aureus-catheter-related-bloodstream-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-dexmedetomidine-as-an-adjuvant-to-locoregional-anesthesia-in-pediatric-surgical-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-dornase-alfa-for-functional-independence-post-subarachnoid-hemorrhage-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-dornase-alfa-for-reducing-systemic-inflammation-in-acute-ischemic-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-carboxymaltose-for-preoperative-anemia-in-patients-with-chronic-lower-limb-ischemia-undergoing-revascularization-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-carboxymaltose-on-mortality-and-cardiovascular-morbidity-in-iron-deficient-patients-post-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-carboxymaltose-on-quality-of-life-and-exercise-capacity-in-elderly-patients-with-severe-aortic-stenosis-and-iron-deficiency-undergoing-tavi2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-carboxymaltose-versus-oral-ferrous-sulfate-and-ascorbic-acid-in-post-caesarean-iron-deficiency-anemia-and-postpartum-depression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-derisomaltose-for-postoperative-iron-deficiency-anemia-in-elderly-cardiac-surgery-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-derisomaltose-on-cognitive-function-in-chronic-heart-failure-patients-with-iron-deficiency-and-mild-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-derisomaltose-on-physical-capacity-and-immunological-parameters-in-non-anemic-iron-deficient-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ferric-derisomaltose-on-postoperative-mobility-in-elderly-patients-with-hip-fracture-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-fish-oil-based-lipid-emulsion-for-atrial-fibrillation-prevention-in-high-risk-cardiac-surgery-patients-a-phase-ii-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-fosfomycin-versus-best-available-therapy-in-hospitalized-patients-with-complicated-urinary-tract-infections-due-to-third-generation-cephalosporin-resistant-enterobacterales2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-fosnetupitant-palonosetron-for-chemotherapy-induced-nausea-and-vomiting-in-pediatric-patients-undergoing-highly-emetogenic-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-g-strophanthin-as-an-adjunctive-therapy-in-patients-with-acute-heart-failure-nyha-class-iii-or-higher-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-human-normal-immunoglobulin-and-prednisone-versus-prednisone-alone-in-newly-diagnosed-idiopathic-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-human-normal-immunoglobulin-for-prevention-of-bk-virus-viremia-in-kidney-transplant-recipients-with-low-neutralizing-antibody-titers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-human-normal-immunoglobulin-oral-prednisone-and-high-dose-dexamethasone-in-adult-immune-thrombocytopenia-with-bleeding2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-human-serum-albumin-versus-sodium-chloride-in-decompensated-cirrhosis-patients-with-acute-kidney-injury-stage-1b-or-greater2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ibuprofen-arginate-tramadol-hydrochloride-combination-for-analgesic-efficacy-in-acute-severe-postoperative-pain-a-phase-iii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ketamine-for-treatment-of-post-comatose-disorders-of-consciousness-in-patients-with-severe-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ketamine-hydrochloride-maintenance-therapy-in-treatment-resistant-major-depressive-disorder-a-multicenter-open-label-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-ketamine-versus-placebo-as-adjunct-to-venlafaxine-in-severe-unipolar-major-depressive-episodes-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-l-glutamic-acid-for-prevention-of-acute-kidney-injury-post-coronary-artery-bypass-grafting-in-non-diabetic-high-risk-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-lidocaine-hydrochloride-monohydrate-for-analgesia-in-chronic-inflammatory-bowel-disease-with-abdominal-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-lidocaine-hydrochloride-monohydrate-versus-placebo-in-patients-undergoing-major-gastrointestinal-or-abdominal-surgery-with-intrathecal-morphine-analgesia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-lidocaine-on-postoperative-recovery-in-patients-undergoing-minor-hepatectomy-for-liver-tumors-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-lidocaine-on-propofol-ec50-during-target-controlled-infusion-for-gastroscopy-in-adults-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-magnesium-sulfate-for-postoperative-analgesia-in-cesarean-section-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-metoprolol-tartrate-efficacy-in-acute-respiratory-distress-syndrome-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-omega-3-fatty-acids-in-reducing-organ-failure-and-mortality-in-predicted-severe-acute-pancreatitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-opioid-agonist-therapy-with-hydromorphone-hydrochloride-for-opioid-dependence-in-a-clinical-setting2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-oxytocin-on-peripheral-sensory-afferents-in-healthy-volunteers-a-triple-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-prasinezumab-efficacy-and-safety-in-early-parkinson-s-disease-a-phase-iib-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-sabirnetug-efficacy-and-safety-in-early-alzheimer-s-disease-a-phase-2-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-sildenafil-combined-with-therapeutic-hypothermia-on-neuroprotection-in-term-neonates-with-hypoxic-ischemic-encephalopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-thrombolysis-with-alteplase-or-tenecteplase-in-acute-ischemic-stroke-patients-on-direct-oral-anticoagulants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-thrombolysis-with-tenecteplase-in-acute-ischemic-stroke-patients-on-factor-xa-inhibitors-a-comparative-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravenous-tranexamic-acid-on-postoperative-pain-management-in-patients-undergoing-arthroscopic-shoulder-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravesical-bacillus-calmette-guerin-and-nogapendekin-alfa-inbakicept-in-non-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravesical-bacillus-calmette-guerin-and-sequential-bacillus-calmette-guerin-electromotive-mitomycin-c-in-high-risk-non-muscle-invasive-bladder-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravesical-neoadjuvant-chemotherapy-with-cisplatin-for-recurrence-prevention-in-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravesical-oncofid-p-b-paclitaxel-obaluronate-in-bcg-unresponsive-carcinoma-in-situ-of-the-bladder-with-or-without-ta-t1-papillary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravitreal-bi-764524-in-moderately-severe-to-severe-non-proliferative-diabetic-retinopathy-a-randomized-sham-controlled-double-masked-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravitreal-opt-302-and-aflibercept-versus-aflibercept-monotherapy-in-neovascular-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-intravitreal-opt-302-and-ranibizumab-versus-ranibizumab-monotherapy-in-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-inz-701-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-infants-with-enpp1-or-abcc6-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iodine-based-contrast-agents-in-contrast-enhanced-mammography-and-breast-mri-for-breast-cancer-detection-and-safety-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ion363-ulefnersen-efficacy-safety-pharmacokinetics-and-pharmacodynamics-in-amyotrophic-lateral-sclerosis-with-fused-in-sarcoma-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ion373-efficacy-and-safety-in-alexander-disease-a-phase-1-3-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ionized-calcium-target-adjustment-on-regional-citrate-anticoagulation-efficacy-in-continuous-renal-replacement-therapy-using-sodium-chloride-and-sodium-citrate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iopener-melanoma-test-for-predicting-response-to-pembrolizumab-nivolumab-and-ipilimumab-in-stage-iii-iv-cutaneous-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ipilimumab-and-nivolumab-in-immunotherapy-for-cutaneous-squamous-cell-carcinoma-in-patients-typically-undergoing-surgery-and-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ipilimumab-nivolumab-temozolomide-and-capecitabine-in-chemo-refractory-pmmr-mgmt-silenced-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ipn01195-monotherapy-in-adult-patients-with-advanced-solid-tumors-a-phase-i-ii-dose-escalation-and-confirmation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iptacopan-in-combination-with-standard-of-care-for-efficacy-and-safety-in-adult-patients-with-active-lupus-nephritis-class-iii-iv-v2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iptacopan-lnp023-efficacy-and-safety-in-complement-inhibitor-naive-adult-patients-with-atypical-hemolytic-uremic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-iptacopan-lnp023-efficacy-in-achieving-sustained-remission-in-patients-with-active-anca-associated-vasculitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-irbesartan-on-cardiovascular-and-global-outcomes-post-acute-kidney-injury-in-icu-discharged-patients-a-randomized-double-blind-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-irinotecan-hydrochloride-trihydrate-based-folfoxiri-regimen-as-perioperative-therapy-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-irinotecan-ifosfamide-vincristine-and-dactinomycin-in-frontline-and-relapsed-rhabdomyosarcoma-in-pediatric-and-adult-populations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isa104-synthetic-long-peptide-vaccination-in-patients-with-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-and-dexamethasone-in-autologous-hematopoietic-stem-cell-transplantation-for-relapsed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-efficacy-in-patients-with-type-i-igg-cryoglobulinemia-a-prospective-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-evorpacept-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma-a-phase-1-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-pomalidomide-and-dexamethasone-efficacy-in-al-amyloidosis-patients-lacking-vgpr-post-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-sar445761-belumosudil-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma-a-phase-1-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isatuximab-with-or-without-dexamethasone-in-combination-with-novel-agents-in-relapsed-or-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ischemic-and-bleeding-outcomes-with-angiolite-stent-and-abbreviated-dual-antiplatelet-therapy-in-coronary-artery-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isis-678354-sodium-salt-in-patients-with-severe-hypertriglyceridemia-a-randomized-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isocyclosporin-a-eye-drop-solution-efficacy-and-safety-in-adult-atopic-keratoconjunctivitis-a-randomized-double-masked-vehicle-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isoflurane-inhalation-sedation-versus-intravenous-propofol-and-midazolam-in-neurocritical-care-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isoflurane-inhalation-versus-intravenous-propofol-and-sufentanil-for-delirium-prevention-in-mechanically-ventilated-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-isoprenaline-hydrochloride-and-epinephrine-in-out-of-hospital-cardiac-arrest-with-non-shockable-rhythm2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-istaroxime-in-cardiogenic-shock-scai-stage-c-a-multicenter-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-istradefylline-for-reducing-microglial-activation-in-progressive-multiple-sclerosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itepekimab-s-mechanism-of-action-on-airway-inflammation-in-chronic-obstructive-pulmonary-disease-a-phase-2a-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itolizumab-and-corticosteroids-for-initial-management-of-acute-graft-versus-host-disease-in-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itraconazole-and-cyclosporine-on-danuglipron-pharmacokinetics-in-healthy-adults-with-type-2-diabetes-mellitus-obesity-or-overweight-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itraconazole-s-effect-on-bi-1584862-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itraconazole-s-effect-on-bi-3031185-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itraconazole-s-effect-on-the-pharmacokinetics-of-bi-1815368-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-itraconazole-s-impact-on-emodepside-pharmacokinetics-in-healthy-subjects-with-soil-transmitted-helminth-infection-and-onchocerciasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivabradine-administration-on-heart-rate-in-pediatric-patients-with-acute-heart-failure-due-to-dilated-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivabradine-in-preventing-myocardial-injury-post-noncardiac-surgery-in-patients-with-or-at-risk-of-atherosclerotic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivonescimab-as-second-third-line-therapy-in-relapsed-pleural-mesothelioma-post-immunotherapy-and-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivosidenib-and-azacitidine-with-or-without-venetoclax-in-idh1-mutated-acute-myeloid-leukemia-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivosidenib-as-maintenance-therapy-post-allogeneic-stem-cell-transplantation-in-idh1-mutated-acute-myeloid-leukemia-and-high-risk-myelodysplastic-neoplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivosidenib-durvalumab-and-gemcitabine-cisplatin-in-idh1-mutant-locally-advanced-or-metastatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ivosidenib-or-enasidenib-mesilate-with-azacitidine-in-idh1-idh2-mutant-acute-myeloid-leukemia-unfit-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ixekizumab-on-endogenous-insulin-preservation-in-newly-diagnosed-type-1-diabetes-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ixekizumab-on-inflammatory-burden-in-axial-spondyloarthritis-and-psoriatic-arthritis-using-whole-body-mri2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-jab-21822-monotherapy-and-combination-therapy-in-advanced-solid-tumors-with-kras-g12c-mutation-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-jdq443-in-combination-with-trametinib-cetuximab-and-ribociclib-in-advanced-kras-g12c-mutant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-jnj-74856665-in-patients-with-acute-myeloid-leukemia-or-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-karxt-efficacy-and-safety-in-treating-psychosis-associated-with-alzheimer-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-karxt-trospium-chloride-xanomeline-tartrate-for-treating-psychosis-in-alzheimer-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ker-050-monotherapy-and-ker-050-with-ruxolitinib-in-myelofibrosis-patients-with-anemia-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-and-esketamine-hydrochloride-on-brain-activation-and-metabolism-in-healthy-volunteers-using-pet-mr-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-and-fentanyl-premedication-for-less-invasive-surfactant-administration-in-neonatal-respiratory-distress-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-and-midazolam-hydrochloride-in-obsessive-compulsive-disorder-a-randomized-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-for-relapse-prevention-in-opioid-use-disorder-a-clinical-trial-assessing-efficacy-and-biomarker-identification2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-hydrochloride-and-cbasp-in-the-augmentation-of-pharmacologic-treatment-for-chronic-depression-a-randomized-double-blind-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-hydrochloride-and-electroconvulsive-stimulation-in-treatment-resistant-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-hydrochloride-and-magnesium-sulfate-heptahydrate-infusion-efficacy-in-refractory-chronic-cluster-headache-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-hydrochloride-combined-with-electroconvulsive-therapy-in-treatment-resistant-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-hydrochloride-infusion-for-symptom-reduction-in-severe-borderline-personality-disorder-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-on-therapy-intensity-and-intracranial-pressure-in-acute-traumatic-brain-injury-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketamine-s-antidepressant-effects-in-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketoanalogue-supplementation-on-sarcopenia-in-stage-4-and-5-chronic-kidney-disease-patients-on-a-moderately-low-protein-diet2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketoanalogues-of-essential-amino-acids-for-prophylaxis-of-protein-energy-wasting-in-moderate-to-very-severe-nephrotic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketoprofen-paracetamol-and-nefopam-in-managing-postoperative-pain-following-cardiac-surgery-a-multicenter-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ketorolac-trometamol-in-non-surgical-management-of-uncomplicated-acute-appendicitis-in-pediatric-patients-aged-7-18-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-kite-222-in-patients-with-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ko-2806-as-monotherapy-and-in-combination-therapies-for-advanced-colorectal-nsclc-pancreatic-and-renal-cell-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-kqb198-monotherapy-and-combination-therapy-in-patients-with-advanced-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-kyv-101-anti-cd19-car-t-cell-therapy-in-refractory-primary-and-secondary-progressive-multiple-sclerosis-a-phase-2-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-l-ascorbic-acid-on-the-incidence-of-complex-regional-pain-syndrome-type-i-post-upper-limb-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-l-nac-and-naloxone-hydrochloride-dihydrate-on-fentanyl-induced-respiratory-depression-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ladarixin-on-beta-cell-function-preservation-in-recent-onset-type-1-diabetes-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lamivudine-on-neurocognitive-biomarkers-and-type-i-ifn-genes-in-mild-cognitive-impairment-due-to-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-landiolol-hydrochloride-and-sodium-chloride-in-reducing-postoperative-low-cardiac-output-syndrome-in-mitral-valve-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-landiolol-hydrochloride-for-atrial-fibrillation-prevention-in-elective-on-pump-cardiac-surgery-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-landiolol-hydrochloride-in-patients-with-out-of-hospital-cardiac-arrest-a-randomized-double-blind-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-landiolol-hydrochloride-on-microcirculatory-vascular-reactivity-in-patients-with-septic-shock-associated-microcirculatory-abnormalities2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-landiolol-hydrochloride-versus-standard-care-in-reducing-mortality-in-septic-shock-patients-with-hypercontractility-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-laparoscopic-electrochemotherapy-with-bleomycin-sulfate-in-locally-advanced-pancreatic-cancer-a-phase-iib-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-laparoscopic-peritoneal-lavage-with-gentamicin-and-clindamycin-for-reducing-intra-abdominal-abscess-in-complicated-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-large-field-of-view-pet-for-quantitative-lung-imaging-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-laroprovstat-azd0780-on-ldl-c-levels-in-heterozygous-familial-hypercholesterolemia-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-laroprovstat-azd0780-on-ldl-c-levels-in-patients-with-hyperlipidemia-and-atherosclerotic-cardiovascular-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-laroprovstat-azd0780-on-major-adverse-cardiovascular-events-in-patients-with-atherosclerotic-cardiovascular-disease-or-high-ascvd-risk2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-larotrectinib-sulfate-monotherapy-and-combination-chemotherapy-in-pediatric-patients-with-newly-diagnosed-high-grade-glioma-with-ntrk-fusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lb101-in-patients-with-advanced-solid-tumors-a-phase-1-2a-dose-escalation-and-expansion-study-on-safety-tolerability-and-preliminary-activity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lebrikizumab-efficacy-and-safety-in-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lebrikizumab-efficacy-and-safety-in-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis-a-phase-3b-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lecanemab-e2814-and-florquinitau-18f-in-dominantly-inherited-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lecanemab-in-preclinical-alzheimer-s-disease-with-elevated-and-intermediate-amyloid-a-216-week-placebo-controlled-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenacapavir-and-emtricitabine-tenofovir-disoproxil-fumarate-for-hiv-1-pre-exposure-prophylaxis-in-individuals-at-risk2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenalidomide-bortezomib-and-dexamethasone-in-early-versus-standard-treatment-of-multiple-myeloma-relapse-from-mrd-negativity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leniolisib-on-pharmacokinetics-of-caffeine-midazolam-rosuvastatin-furosemide-and-metformin-in-healthy-subjects-with-activated-pi3k-delta-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leniolisib-phosphate-for-safety-tolerability-and-efficacy-in-patients-with-common-variable-immunodeficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leniolisib-phosphate-in-pediatric-patients-aged-4-11-with-activated-phosphoinositide-3-kinase-delta-syndrome-safety-pharmacokinetics-and-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenvatinib-efficacy-and-safety-in-pediatric-patients-with-relapsed-or-refractory-high-grade-glioma-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenvatinib-efficacy-in-hepatocellular-carcinoma-patients-on-liver-transplantation-waiting-list-post-tace-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenvatinib-pembrolizumab-and-chemotherapy-in-advanced-metastatic-gastroesophageal-adenocarcinoma-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lenzumestrocel-on-3d-scaffold-for-knee-cartilage-defects-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leriglitazone-efficacy-and-safety-in-pediatric-patients-with-rett-syndrome-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leriglitazone-on-disease-progression-in-male-pediatric-patients-with-cerebral-x-linked-adrenoleukodystrophy-prior-to-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lesion-specific-expression-of-psma-and-fap-in-metastatic-prostate-cancer-using-al-18f-f-fapi-74-and-piflufolastat-18f2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letermovir-and-valganciclovir-combination-therapy-versus-valganciclovir-monotherapy-in-cytomegalovirus-infections-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letermovir-prophylaxis-in-cmv-seronegative-allogeneic-stem-cell-transplant-recipients-with-cmv-seropositive-donors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letermovir-prophylaxis-versus-valganciclovir-for-cmv-prevention-in-lung-transplant-recipients-d-r2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letermovir-versus-valaciclovir-for-prenatal-treatment-of-congenital-cytomegalovirus-infection-in-pregnant-women-with-first-trimester-maternal-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letetresgene-autoleucel-in-hla-a2-patients-with-ny-eso-1-and-or-lage-1a-positive-synovial-sarcoma-and-myxoid-round-cell-liposarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-letrozole-versus-gonadotropins-for-ovulation-induction-in-polycystic-ovary-syndrome-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leucettinib-21-safety-pharmacokinetics-and-pharmacodynamics-in-healthy-subjects-down-syndrome-and-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-leukocyte-platelet-rich-fibrin-for-enhancing-vasculogenesis-and-angiogenesis-post-endovascular-reperfusion-in-critical-limb-ischemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levamisole-hydrochloride-as-an-adjunct-to-prednisolone-in-preventing-relapse-of-steroid-sensitive-idiopathic-nephrotic-syndrome-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levetiracetam-for-delirium-prevention-in-adult-icu-patients-with-septic-shock-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levocarnitine-and-cobamamide-as-adjunctive-therapy-in-septic-shock-with-acute-kidney-injury-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levodopa-and-carbidopa-in-neurodevelopmental-disorder-associated-with-ctnnb1-pathogenic-variant-a-prospective-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levosimendan-administration-during-cardiopulmonary-resuscitation-in-out-of-hospital-cardiac-arrest-a-randomized-double-blind-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levosimendan-in-enhancing-left-ventricular-ejection-fraction-recovery-in-takotsubo-syndrome-with-low-ejection-fraction-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levosimendan-in-facilitating-weaning-from-venoarterial-extracorporeal-membrane-oxygenation-in-cardiogenic-shock-a-randomized-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levosimendan-in-the-management-of-acute-aneurysmal-subarachnoid-hemorrhage-in-high-risk-patients-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levosimendan-versus-placebo-in-preoperative-management-of-right-ventricular-dysfunction-in-patients-undergoing-tricuspid-valve-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levothyroxine-and-liothyronine-combination-therapy-versus-levothyroxine-monotherapy-in-autoimmune-hypothyroidism-with-persistent-fatigue2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levothyroxine-and-sildenafil-citrate-on-erectile-function-in-patients-with-subclinical-hypothyroidism-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levothyroxine-for-tsh-suppression-to-mitigate-radiation-induced-hypothyroidism-in-medulloblastoma-and-pediatric-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-levothyroxine-sodium-as-an-adjunct-to-hypocaloric-diet-in-obesity-management-in-patients-with-subclinical-hypothyroidism-or-euthyroidism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lib-01-monohydrate-for-safety-and-efficacy-in-erectile-dysfunction-a-phase-2a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lidocaine-hydrochloride-and-ropivacaine-hydrochloride-combination-on-infraclavicular-brachial-plexus-block-efficacy-in-hand-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lidocaine-hydrochloride-and-sodium-chloride-for-opioid-reduction-in-vaso-occlusive-crisis-management-in-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linaprazan-glurate-versus-lansoprazole-in-healing-erosive-esophagitis-due-to-gastroesophageal-reflux-disease-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linezolid-versus-benzathine-benzylpenicillin-in-the-treatment-of-early-syphilis-a-non-inferiority-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linezolid-versus-vancomycin-for-surgical-site-infection-prophylaxis-in-surgical-patients-a-non-inferiority-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linvoseltamab-combined-with-additional-therapeutics-in-adults-with-relapsed-refractory-multiple-myeloma-resistant-to-standard-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linvoseltamab-in-combination-with-dupilumab-for-severe-ige-mediated-food-allergy-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-linvoseltamab-in-combination-with-sarilumab-for-relapsed-or-refractory-systemic-light-chain-amyloidosis-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lipiodol-r-embolization-safety-in-refractory-symptomatic-digital-osteoarthritis-a-pilot-study-on-15-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-liraglutide-3-0-mg-for-weight-management-in-pediatric-obesity-a-56-week-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-liraglutide-on-migrating-motor-complex-activity-and-gastrointestinal-hormones-in-obesity-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lisocabtagene-maraleucel-as-first-line-therapy-in-transplant-ineligible-patients-with-primary-central-nervous-system-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lithium-carbonate-in-tbr1-related-neurocognitive-disorder-a-24-month-multicenter-open-label-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lithium-efficacy-on-overall-survival-in-patients-with-amyotrophic-lateral-sclerosis-a-multi-arm-adaptive-group-sequential-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-live-attenuated-vaccines-for-inducing-trained-immunity-and-reducing-inflammation-in-chronic-obstructive-pulmonary-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-livmoniplimab-and-budigalimab-combination-therapy-in-systemic-treatment-naive-patients-with-locally-advanced-or-metastatic-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-livmoniplimab-and-budigalimab-with-chemotherapy-versus-pembrolizumab-with-chemotherapy-in-metastatic-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-local-and-systemic-safety-of-top-n53-and-sildenafil-citrate-in-digital-ulcers-associated-with-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-local-injection-of-allogeneic-bone-marrow-derived-mesenchymal-adult-stromal-cells-for-refractory-crohn-s-disease-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-local-surgical-or-radiotherapeutic-interventions-in-patients-with-brafv600-mutated-melanoma-undergoing-encorafenib-and-binimetinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-locoregional-analgesia-with-mepivacaine-hydrochloride-in-preventing-persistent-postoperative-pain-in-pediatric-orthopedic-trauma-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-loncastuximab-tesirine-and-epcoritamab-combination-therapy-in-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-loncastuximab-tesirine-and-epcoritamab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-follicular-lymphoma-grade-3b-and-high-grade-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-acting-cabotegravir-and-rilpivirine-administration-in-hiv-infected-patients-in-spain-acceptability-safety-and-feasibility-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-effects-of-repeated-gadolinium-based-contrast-agents-on-motor-and-cognitive-functions-in-neurologically-normal-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-effects-of-semaglutide-versus-placebo-on-diabetic-retinopathy-progression-in-type-2-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-efficacy-and-safety-of-cagrilintide-and-semaglutide-combination-therapy-versus-placebo-in-obesity-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-efficacy-and-safety-of-ocrelizumab-in-patients-with-progressive-multiple-sclerosis-consonance-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-efficacy-and-safety-of-tev-48574-in-adults-with-moderate-to-severe-ulcerative-colitis-or-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-efficacy-of-efanesoctocog-alfa-prophylaxis-on-joint-health-in-patients-with-hemophilia-a-a-low-interventional-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-efficacy-safety-and-tolerability-of-iptacopan-in-patients-with-c3-glomerulopathy-or-idiopathic-immune-complex-membranoproliferative-glomerulonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-encapsulated-fecal-microbiota-transfer-in-active-ulcerative-colitis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-graft-survival-in-immunologically-low-risk-kidney-transplant-recipients-using-tacrolimus-monotherapy-versus-tacrolimus-and-mycophenolate-mofetil-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-immune-response-following-a-single-immunization-with-ga2-sporozoites-in-individuals-with-falciparum-malaria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-immunogenicity-following-single-immunization-with-genetically-attenuated-plasmodium-falciparum-dmei2-sporozoites-in-falciparum-malaria-rechallenge2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-neurocognitive-outcomes-in-pediatric-phenylketonuria-patients-treated-with-s-2-amino-6-2-hydroxypropanoyl-7-8-dihydropteridin-4-3h-one2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-oral-anticoagulation-with-rivaroxaban-versus-acetylsalicylic-acid-in-moderate-risk-post-catheter-ablation-atrial-fibrillation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-pertussis-immunity-in-children-following-maternal-vaccination-with-diphtheria-pertussis-poliomyelitis-tetanus-vaccine-in-finland2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-clinical-activity-of-briquilimab-in-patients-with-chronic-urticaria-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-alpelisib-in-patients-with-pik3ca-related-overgrowth-spectrum-pros-following-participation-in-study-cbyl719f120022026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-avacopan-in-patients-with-antineutrophil-cytoplasmic-antibody-associated-vasculitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-baricitinib-in-pediatric-patients-with-juvenile-idiopathic-arthritis-a-phase-3-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-bexicaserin-lp352-in-pediatric-and-adult-patients-with-developmental-and-epileptic-encephalopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-bi-1291583-in-patients-with-bronchiectasis-a-randomized-double-blind-parallel-group-roll-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-bimatoprost-sr-implant-in-patients-with-open-angle-glaucoma-or-ocular-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-deucrictibant-extended-release-tablets-for-prophylactic-management-of-hereditary-angioedema-in-adolescents-and-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-efavaleukin-alfa-in-patients-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-enpatoran-in-subacute-cutaneous-discoid-and-systemic-lupus-erythematosus-post-willow-study-completion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-garadacimab-csl312-in-prophylactic-management-of-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-gsk1070806-in-moderate-to-severe-atopic-dermatitis-a-humanised-igg1-kappa-monoclonal-antibody-against-interleukin-18-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-litifilimab-in-adults-with-active-systemic-lupus-erythematosus-a-phase-3-multicenter-randomized-dose-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-nedosiran-in-patients-with-primary-hyperoxaluria-an-open-label-roll-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-pegcetacoplan-in-patients-with-c3-glomerulopathy-or-immune-complex-membranoproliferative-glomerulonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-ptc518-in-huntington-s-disease-a-phase-2b-double-blind-randomized-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-recombinant-adamts13-radamts13-in-prophylactic-and-on-demand-treatment-of-congenital-thrombotic-thrombocytopenic-purpura2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-sar447537-in-adults-with-alpha-1-antitrypsin-deficiency-emphysema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-star-0215-in-adult-patients-with-type-1-or-type-2-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-tegoprubart-with-mycophenolate-in-prophylaxis-of-renal-allograft-rejection-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-tezacaftor-deutivacaftor-and-vanzacaftor-combination-therapy-in-patients-with-cystic-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-treprostinil-palmitil-inhalation-powder-in-pulmonary-hypertension-associated-with-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-upadacitinib-in-patients-with-ulcerative-colitis-a-phase-3-multicenter-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-efficacy-of-xtmab-16-in-pulmonary-sarcoidosis-with-or-without-extrapulmonary-manifestations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-pregnancy-outcomes-of-pariglasgene-brecaparvovec-in-patients-with-glycogen-storage-disease-type-ia-gsdia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-acp-204-tartrate-in-adults-with-alzheimer-s-disease-psychosis-a-52-week-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-apraglutide-in-patients-with-short-bowel-syndrome-intestinal-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-brivaracetam-in-pediatric-patients-with-childhood-or-juvenile-absence-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-cariprazine-in-adolescent-patients-with-schizophrenia-a-2-year-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-cenerimod-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus-on-background-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-dazodalibep-in-patients-with-sjogren-s-syndrome-a-multicenter-randomized-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-human-normal-immunoglobulin-and-hyaluronidase-human-recombinant-in-primary-immunodeficiency-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-inclisiran-in-patients-with-heterozygous-or-homozygous-familial-hypercholesterolemia-post-orion-16-13-studies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-iptacopan-in-patients-with-paroxysmal-nocturnal-hemoglobinuria-post-phase-ii-iii-studies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-lasmiditan-for-acute-migraine-treatment-in-pediatric-patients-a-12-month-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-nbi-1065845-as-adjunctive-therapy-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-pimavanserin-tartrate-in-pediatric-patients-with-irritability-associated-with-autism-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-ranibizumab-via-port-delivery-system-in-neovascular-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-seladelpar-in-patients-with-primary-biliary-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-sotatercept-mk-7962-in-patients-with-pulmonary-arterial-hypertension-on-standard-care2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-staccato-alprazolam-in-patients-aged-12-and-older-with-stereotypical-prolonged-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-tak-861-in-patients-with-narcolepsy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-and-tolerability-of-tavapadon-in-patients-with-parkinson-s-disease-a-58-week-open-label-multinational-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-of-capmatinib-gefitinib-and-nazartinib-in-patients-with-cmet-dependent-malignancies-in-a-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-of-intravenous-and-subcutaneous-efgartigimod-alfa-in-pediatric-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-of-oral-deucrictibant-pha-022121-for-acute-hereditary-angioedema-attacks-in-c1-inhibitor-deficient-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-of-ribociclib-in-combination-therapy-for-hr-her2-advanced-or-metastatic-breast-cancer-in-post-trial-access-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-of-salbutamol-sulfate-via-mdi-with-propellants-hfa-152a-and-hfa-134a-in-adults-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-biological-activity-of-sar421869-in-patients-with-usher-syndrome-type-1b2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-pozelimab-and-cemdisiran-in-paroxysmal-nocturnal-hemoglobinuria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-subcutaneous-amlitelimab-in-patients-with-moderate-to-severe-atopic-dermatitis-from-previous-trials2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-subcutaneous-sibeprenlimab-in-patients-with-immunoglobulin-a-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-treprostinil-palmitil-inhalation-powder-in-pulmonary-arterial-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-vosoritide-in-pediatric-patients-with-achondroplasia-a-phase-2-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-safety-tolerability-and-efficacy-of-zasocitinib-tak-279-in-patients-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-long-term-treatment-response-durability-in-chronic-hepatitis-b-patients-post-bepirovirsen-therapy-with-or-without-nucleos-t-ide-analogue-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lorigerlimab-and-docetaxel-versus-docetaxel-monotherapy-in-metastatic-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-losartan-potassium-and-hydrochlorothiazide-in-reducing-bone-resorption-in-osteogenesis-imperfecta-patients-aged-16-and-above2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-losartan-potassium-on-mild-to-moderate-aortic-stenosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-losartan-potassium-on-perfusion-and-mechanical-solid-stress-in-brain-metastases-from-nsclc-and-glioblastoma-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-losmapimod-s-safety-tolerability-and-biomarker-impact-in-facioscapulohumeral-muscular-dystrophy-1-fshd1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-acetylsalicylic-acid-for-chemoprevention-of-colorectal-adenomas-in-lynch-syndrome-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-acetylsalicylic-acid-for-preeclampsia-prevention-in-pregnant-women-post-frozen-embryo-transfer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-acetylsalicylic-acid-plus-prasugrel-versus-low-and-high-dose-acetylsalicylic-acid-on-graft-patency-in-stable-coronary-artery-disease-post-cabg2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-aldesleukin-and-sodium-chloride-in-immunomodulation-for-early-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-aldesleukin-ilt-101-on-regulatory-t-cell-stimulation-in-pediatric-autism-spectrum-disorder-with-maternal-autoimmune-status2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-aldesleukin-in-chronic-inflammatory-barrier-diseases-a-randomized-double-blind-placebo-controlled-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-atropine-sulfate-eye-drops-for-myopia-progression-control-in-pediatric-caucasian-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-carbasalate-calcium-and-intensive-blood-pressure-management-in-patients-with-intradural-saccular-unruptured-aneurysms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-digoxin-on-heart-failure-hospitalizations-and-cardiovascular-mortality-in-chronic-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-dobutamine-and-tocilizumab-in-acute-myocardial-infarction-patients-at-high-risk-for-cardiogenic-shock-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-epinephrine-versus-standard-dose-epinephrine-on-neurological-outcomes-in-out-of-hospital-cardiac-arrest-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-epirubicin-hydrochloride-as-adjunctive-therapy-in-hospitalized-patients-with-sepsis-and-septic-shock2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-ketamine-hydrochloride-on-opioid-consumption-in-patients-with-severe-traumatism-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-peginterferon-alfa-2a-on-perioperative-immune-modulation-in-patients-with-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-rabbit-anti-human-thymocyte-immunoglobulin-for-gvhd-prophylaxis-in-elderly-patients-with-hematological-malignancies-undergoing-haploidentical-hsct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-dose-rivaroxaban-for-cardiovascular-event-reduction-in-patients-with-advanced-chronic-kidney-disease-or-dialysis-dependency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-low-intensity-therapy-with-gilteritinib-venetoclax-and-glasdegib-versus-high-intensity-therapy-in-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lsta1-combined-with-temozolomide-versus-temozolomide-alone-in-newly-diagnosed-glioblastoma-multiforme-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lsta1-in-combination-with-standard-of-care-versus-standard-of-care-alone-in-advanced-solid-tumors-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ltp001-in-pulmonary-arterial-hypertension-a-randomized-double-blind-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lu-af28996-in-the-treatment-of-parkinson-s-disease-in-affected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lu-ag13909-in-patients-with-congenital-adrenal-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lufepirsen-ophthalmic-gel-for-safety-and-efficacy-in-persistent-corneal-epithelial-defects-a-randomized-double-masked-vehicle-controlled-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lumasiran-efficacy-and-safety-in-advanced-primary-hyperoxaluria-type-1-patients-a-phase-3-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luspatercept-and-epoetin-alfa-in-low-risk-myelodysplastic-syndromes-without-ring-sideroblasts-post-erythropoiesis-stimulating-agent-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luspatercept-efficacy-and-safety-in-patients-with-lower-risk-myelodysplastic-syndromes-with-ring-sideroblasts-requiring-red-blood-cell-transfusions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luspatercept-in-anemia-management-for-myelodysplastic-syndromes-with-del-5q-refractory-to-lenalidomide-and-esa-therapy-requiring-rbc-transfusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luspatercept-on-cerebral-oxygen-metabolism-in-non-transfusion-dependent-beta-thalassemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luteal-phase-ovarian-stimulation-with-follitropin-delta-and-dydrogesterone-in-oocyte-donors-a-randomized-crossover-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lutetium-177-labeled-6a10-antibody-fab-fragments-in-radioimmunotherapy-for-surgically-treated-high-grade-glioma-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lutetium-177lu-edotreotide-versus-standard-care-in-aggressive-grade-2-3-sstr-gastroenteropancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lutetium-177lu-vipivotide-tetraxetan-in-oligo-metastatic-hormone-sensitive-prostate-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lutetium-177lu-vipivotide-tetraxetan-in-recurrent-metastatic-adenoid-cystic-carcinoma-of-salivary-glands-safety-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lutikizumab-versus-adalimumab-for-safety-and-efficacy-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-luveltamab-tazevibulin-stro-002-monotherapy-in-pediatric-patients-with-cbfa2t3-glis2-acute-myeloid-leukemia-aml2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly2880070-monotherapy-and-ly2880070-plus-gemcitabine-in-advanced-or-metastatic-cancer-with-emphasis-on-brca1-2-wildtype-hgsoc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly3200882-in-patients-with-metastatic-cancer-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly3484356-in-patients-with-endometrial-and-breast-cancer-a-phase-study-on-efficacy-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly3537031-pharmacokinetics-in-subjects-with-normal-and-impaired-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly3541860-versus-placebo-in-reducing-new-t1-gadolinium-enhancing-lesions-in-adults-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly3556050-in-a-randomized-double-blind-placebo-controlled-dose-ranging-phase-2-study-for-diabetic-peripheral-neuropathic-pain-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly4050784-in-patients-with-advanced-or-metastatic-solid-tumors-including-non-small-cell-lung-cancer-and-smarca4-deficient-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly4052031-in-patients-with-advanced-or-metastatic-urothelial-carcinoma-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ly4057996-in-healthy-subjects-and-individuals-with-type-1-and-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lymph-node-microenvironment-alterations-in-chronic-lymphocytic-leukemia-patients-treated-with-venetoclax-based-regimens2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lymphocyte-sparing-radiotherapy-and-all-trans-retinoic-acid-in-lateralized-oropharyngeal-laryngeal-and-hypopharyngeal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lyophilized-bacterial-lysates-for-reducing-respiratory-infections-and-wheezing-in-moderate-late-preterm-infants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lyr-210-and-dexamethasone-in-adults-with-chronic-rhinosinusitis-without-nasal-polyps-a-randomized-blinded-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-lysergide-d-tartrate-minidosing-in-chronic-cluster-headache-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-m1774-an-oral-atr-inhibitor-in-combination-with-plx038-a-topo1-inhibitor-in-patients-with-advanced-solid-tumors-including-atm-mutated-and-triple-negative-breast-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-m2rlab-mononuclear-cell-therapy-for-acute-kidney-injury-post-cardiac-surgery-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-m9466-combined-with-topoisomerase-1-inhibitors-in-patients-with-advanced-solid-tumors-and-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-m9466-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maat013-efficacy-in-gastrointestinal-acute-graft-versus-host-disease-refractory-to-ruxolitinib-a-phase-iii-multicenter-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-macitentan-dosing-on-endothelin-1-clearance-endothelial-function-and-hemodynamics-in-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-macro-and-microvascular-responses-to-lipopolysaccharide-and-exenatide-in-cardiovascular-and-metabolic-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-macrogol-3350-and-electrolytes-for-second-line-bowel-preparation-in-colonoscopy-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-main-substance-in-combination-with-other-agents-for-patients-with-braf-v600e-mutated-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-main-substance-in-combination-with-other-agents-for-patients-with-metastatic-clear-cell-or-papillary-renal-cell-carcinoma-and-end-stage-renal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-main-substance-in-combination-with-other-agents-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-main-substance-in-patients-with-retinitis-pigmentosa-due-to-cnga1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mannitol-versus-normal-saline-on-delayed-graft-function-in-kidney-transplant-recipients-from-brain-death-donors-a-double-blind-placebo-controlled-rct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maq-001-monotherapy-and-combination-therapy-in-advanced-cancers-with-approved-immune-checkpoint-blockade-options2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maribavir-for-cytomegalovirus-infection-in-pediatric-hematopoietic-stem-cell-and-solid-organ-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maridebart-cafraglutide-efficacy-and-safety-in-adults-with-obesity-or-overweight-without-type-2-diabetes-mellitus-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maridebart-cafraglutide-efficacy-and-safety-in-adults-with-type-2-diabetes-mellitus-and-obesity-or-overweight-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mas825-efficacy-and-safety-in-monogenic-il-18-driven-autoinflammatory-diseases-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-masupirdine-suvn-502-efficacy-and-safety-in-treating-agitation-in-alzheimer-s-dementia-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-materno-fetal-hyperoxygenation-with-oxygen-therapy-in-third-trimester-for-fetal-left-ventricular-hypoplasia-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mavacamten-in-adults-with-symptomatic-non-obstructive-hypertrophic-cardiomyopathy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mavacamten-on-left-ventricular-outflow-tract-obstruction-in-adolescents-with-symptomatic-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-maximum-tolerated-dose-safety-and-efficacy-of-iberdomide-monotherapy-and-combinations-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mb-cart19-1-in-patients-with-refractory-systemic-lupus-erythematosus-sle2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mb-cart2019-1-in-patients-with-refractory-multiple-sclerosis-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mb-dnpm-1-tcr-1-safety-and-efficacy-in-relapsed-or-refractory-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mcla-129-a-bispecific-antibody-targeting-egfr-and-c-met-alone-and-in-combination-with-chemotherapy-and-osimertinib-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mdna11-and-pembrolizumab-in-advanced-solid-tumors-a-phase-1-2-dose-escalation-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mecasermin-rinfabate-for-the-prevention-of-bronchopulmonary-dysplasia-in-extremely-premature-neonates-a-randomized-open-label-phase-2b-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mechanical-thrombectomy-plus-acetylsalicylic-acid-versus-acetylsalicylic-acid-alone-in-acute-ischemic-stroke-with-large-vessel-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-medi5752-in-patients-with-advanced-solid-tumors-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-melatonin-efficacy-in-chronic-low-back-pain-a-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-melatonin-efficacy-in-reducing-pain-intensity-in-patients-with-chronic-back-pain-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-meldonium-and-individualized-physical-activity-in-patients-with-chronic-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-melflufen-and-dexamethasone-efficacy-in-elderly-patients-with-relapsed-multiple-myeloma-at-second-or-subsequent-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-melphalan-based-chemotherapy-regimens-in-low-and-intermediate-risk-neuroblastoma-a-multicenter-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-melphalan-hds-induction-followed-by-trifluridine-tipiracil-and-bevacizumab-versus-trifluridine-tipiracil-and-bevacizumab-in-refractory-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-memantine-hydrochloride-as-an-adjunct-to-aripiprazole-in-reducing-negative-symptoms-in-first-episode-psychosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-menstrual-bleeding-patterns-tolerability-and-compliance-with-norgestimate-and-ethinylestradiol-in-italian-women-using-monophasic-oral-contraceptives2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-meperidine-and-buspirone-for-inducing-hypothermia-in-healthy-volunteers-a-double-blind-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mepivacaine-hydrochloride-efficacy-and-safety-in-neurological-sequelae-post-ischemic-stroke-via-subcutaneous-injection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mepolizumab-and-dupilumab-discontinuation-in-achieving-sustained-remission-in-severe-chronic-rhinosinusitis-with-nasal-polyps-a-danish-rct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mepolizumab-and-in-office-nasal-polypectomy-in-chronic-rhinosinusitis-a-three-arm-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mepolizumab-based-regimen-versus-conventional-therapy-for-remission-induction-in-eosinophilic-granulomatosis-with-polyangiitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mepolizumab-for-achieving-clinical-remission-in-patients-with-severe-asthma-a-prospective-real-world-interventional-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-meropenem-and-linezolid-administration-regimens-in-icu-patients-with-serious-infections-requiring-broad-spectrum-antibiotics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesalazine-for-colorectal-neoplasia-prevention-in-lynch-syndrome-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stem-cell-therapy-in-women-over-50-with-refractory-stress-or-mixed-urinary-incontinence2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stem-cells-and-human-albumin-solution-on-organ-failure-in-severe-community-acquired-septic-shock-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stem-cells-in-the-treatment-of-diabetic-foot-ulcers-a-phase-i-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stromal-cell-therapy-for-biopsy-proven-acute-rejection-in-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stromal-cell-therapy-for-post-operative-recovery-in-frail-elderly-patients-following-hip-fracture-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesenchymal-stromal-cells-in-severe-traumatic-brain-injury-a-multicenter-double-blind-randomized-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mesotherapy-in-the-management-of-irritable-bowel-syndrome-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metamizole-sodium-monohydrate-for-pain-management-in-patients-with-chronic-pancreatitis-a-multicenter-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metastasis-directed-radiotherapy-with-or-without-leuprorelin-acetate-in-biochemically-recurrent-oligo-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-and-colchicine-for-post-acute-sequelae-of-sars-cov-2-infection-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-and-metformin-hydrochloride-for-cancer-prevention-in-adolescents-and-adults-with-li-fraumeni-syndrome-a-phase-iiib-randomized-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-and-sirolimus-in-combination-with-lifestyle-interventions-for-frailty-in-post-acute-covid-19-syndrome-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-and-temozolomide-with-radiotherapy-in-newly-diagnosed-idh-wild-type-glioblastoma-grade-4-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-as-maintenance-therapy-in-patients-with-high-risk-relapse-bone-sarcomas-a-focus-on-osteosarcoma-and-ewing-s-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-embonate-as-adjunctive-therapy-in-patients-with-idh-wildtype-glioblastoma-a-phase-2-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-embonate-on-growth-rate-reduction-in-small-abdominal-aortic-aneurysms-in-non-diabetic-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-for-hyperglycemia-prevention-in-hr-her2-pik3ca-mutated-advanced-breast-cancer-patients-on-alpelisib-and-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-and-lifestyle-intervention-on-pubertal-progression-in-overweight-girls-with-precocious-puberty-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-as-a-metabolic-intervention-in-oesophageal-adenocarcinoma-to-enhance-neoadjuvant-chemoradiotherapy-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-as-an-adjunctive-therapy-in-non-active-progressive-multiple-sclerosis-a-phase-iib-randomized-triple-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-extended-release-and-immediate-release-in-pediatric-obesity-a-randomized-multicenter-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-for-gestational-prolongation-in-preterm-preeclampsia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-for-leukemia-prevention-in-patients-with-clonal-cytopenia-of-undetermined-significance-and-lower-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-for-reversal-of-accelerated-biological-aging-in-hiv-infected-individuals-aged-50-with-suppressed-virologic-replication2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-in-gestational-diabetes-mellitus-a-longitudinal-randomized-controlled-trial-assessing-maternal-and-neonatal-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-on-cognitive-progression-in-huntington-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-on-endometrial-function-in-women-with-idiopathic-infertility-a-randomized-controlled-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-on-fertility-in-women-with-papillary-thyroid-carcinoma-post-131i-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-on-peripheral-arterial-calcification-in-patients-with-type-1-diabetes-without-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-hydrochloride-on-pulmonary-function-in-patients-with-chronic-obstructive-pulmonary-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-on-hepatic-venous-pressure-gradient-in-cirrhotic-patients-with-portal-hypertension-under-carvedilol-therapy-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-pioglitazone-and-spironolactone-in-slowing-accelerated-maturation-in-early-pubertal-girls-with-advanced-puberty-and-pcos2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metformin-s-effect-on-unplanned-coronary-revascularization-in-metformin-naive-nondiabetic-patients-undergoing-pci-for-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methotrexate-and-glucocorticoid-regimen-with-optional-etanercept-in-early-rheumatoid-arthritis-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methotrexate-and-tumor-necrosis-factor-inhibitor-withdrawal-strategies-in-juvenile-idiopathic-arthritis-remission-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methotrexate-efficacy-and-safety-in-erosive-inflammatory-hand-osteoarthritis-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methotrexate-efficacy-in-achieving-clinical-disease-activity-index-remission-in-patients-with-active-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methotrexate-sodium-and-tl01-uvb-phototherapy-efficacy-in-adults-with-progressive-vitiligo-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methoxyflurane-versus-morphine-for-analgesia-in-prehospital-management-of-acute-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methoxyflurane-versus-placebo-for-pain-management-in-adult-oral-and-dental-emergencies-a-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylone-for-safety-tolerability-and-efficacy-in-treating-post-traumatic-stress-disorder-a-randomized-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylphenidate-for-alleviating-cancer-related-fatigue-in-pediatric-brain-tumor-survivors-a-randomized-double-blind-placebo-controlled-crossover-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylphenidate-hydrochloride-efficacy-on-attention-deficit-and-adhd-symptoms-in-pediatric-patients-with-kbg-syndrome-an-n-of-1-trial-series2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-and-human-normal-immunoglobulin-in-fulminant-myocarditis-a-double-blind-randomized-controlled-adaptive-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-and-isavuconazonium-sulfate-in-immunocompromised-patients-with-acute-respiratory-failure-of-undetermined-etiology2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-and-prednisone-in-acute-myocarditis-with-severe-left-ventricular-dysfunction-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-efficacy-in-neuroendocrine-cell-hyperplasia-of-infancy-a-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-hydrogen-succinate-versus-placebo-on-ventilator-free-days-in-severe-copd-exacerbations-in-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-methylprednisolone-on-postoperative-recovery-in-elderly-patients-undergoing-major-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metoprolol-tartrate-as-an-adjunct-to-standard-care-in-preventing-cardiomyopathy-in-male-patients-with-duchenne-muscular-dystrophy-aged-8-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metoprolol-tartrate-in-patients-with-chronic-obstructive-pulmonary-disease-without-cardiovascular-comorbidities-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metyrapone-in-patients-with-mild-autonomous-cortisol-secretion-a-6-month-clinical-trial-assessing-hypertension-glucose-metabolism-and-cortisol-levels2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-metyrapone-on-cardiovascular-risk-factors-in-patients-with-adrenal-incidentalomas-and-subclinical-mild-cushing-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mevrometostat-in-relapsed-refractory-follicular-lymphoma-diffuse-large-b-cell-lymphoma-castration-resistant-prostate-cancer-and-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mezagitamab-in-adults-with-primary-immunoglobulin-a-nephropathy-on-stable-background-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mezagitamab-tak-079-efficacy-and-safety-in-adults-with-primary-iga-nephropathy-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mezigdomide-dexamethasone-and-elotuzumab-in-relapsed-refractory-and-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mfolfirinox-with-or-without-bnt321-as-adjuvant-therapy-in-resected-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mibavademab-regn4461-in-treating-monogenic-obesity-due-to-biallelic-lep-gene-variants-in-pediatric-and-adult-populations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-microglial-activation-in-schizophrenia-patients-stratified-by-c4-complement-using-18f-dpa-714-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-micronized-progesterone-versus-norethisterone-acetate-with-estradiol-in-menopausal-hormone-therapy-a-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-midazolam-and-morphine-for-symptom-management-in-terminal-geriatric-patients-on-acute-wards2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-midostaurin-and-gemtuzumab-ozogamicin-in-combination-with-standard-induction-chemotherapy-for-adult-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-midostaurin-with-chemotherapy-in-pediatric-patients-with-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-milrinone-infusion-versus-placebo-for-neurological-outcomes-in-aneurysmal-subarachnoid-hemorrhage-induced-vasospasm2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-milrinone-versus-placebo-for-cerebral-hemodynamic-optimization-in-preventing-delayed-cerebral-ischemia-in-severe-aneurysmal-subarachnoid-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-milvexian-pharmacokinetics-and-food-effect-in-atherothrombotic-and-thromboembolic-disorders-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minimal-residual-disease-based-strategy-with-teclistamab-post-daratumumab-bortezomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minimal-residual-disease-in-newly-diagnosed-multiple-myeloma-patients-ineligible-for-transplant-treated-with-isatuximab-bortezomib-and-lenalidomide2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minimal-residual-disease-in-newly-diagnosed-transplant-eligible-multiple-myeloma-patients-treated-with-ixazomib-lenalidomide-and-dexamethasone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minimal-residual-disease-monitoring-via-ctdna-in-hr-positive-her2-negative-early-breast-cancer-using-abemaciclib-inavolisib-and-giredestrant2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minimal-residual-disease-techniques-in-untreated-multiple-myeloma-with-daratumumab-bortezomib-lenalidomide-and-dexamethasone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minocycline-colchicine-and-metformin-for-improving-physical-health-in-adults-with-long-covid-post-acute-sequelae-of-sars-cov-2-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-minocycline-hydrochloride-on-peripheral-inflammatory-biomarkers-in-patients-with-depression-a-stratification-approach-using-pet-and-mri2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mipasetamab-uzoptirine-adct-601-monotherapy-and-combination-therapy-in-advanced-solid-tumors-a-phase-1b-dose-escalation-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mirikizumab-in-pediatric-patients-with-moderately-to-severely-active-crohn-s-disease-a-phase-3-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-misoprostol-for-hemorrhagic-risk-reduction-in-myomectomy-for-uterine-fibroids-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mitapivat-on-cerebral-perfusion-and-oxygen-metabolism-in-patients-with-sickle-cell-anemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mitapivat-sulfate-efficacy-and-safety-in-adult-patients-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mitapivat-sulfate-safety-and-efficacy-in-adult-patients-with-erythrocyte-membranopathies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mitazalimab-combined-with-chemotherapy-in-metastatic-pancreatic-ductal-adenocarcinoma-a-phase-1b-2-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-0472-in-patients-with-malignant-neoplasm-of-solid-tumors-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-0482-monotherapy-and-mk-0482-plus-pembrolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1084-in-single-and-multiple-doses-for-patients-with-solid-tumor-and-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1084-with-pembrolizumab-and-berahyaluronidase-alfa-versus-mk-3475a-with-pemetrexed-platinum-in-kras-g12c-mutant-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1200-monotherapy-safety-and-efficacy-in-patients-with-advanced-solid-tumors-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1289-for-the-treatment-of-covid-19-infection-in-healthy-adult-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1403-in-the-management-of-atherosclerosis-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1403-in-the-management-of-atherosclerosis-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1484-monotherapy-and-combination-with-pembrolizumab-in-adults-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1708-in-a-single-rising-dose-study-for-amyotrophic-lateral-sclerosis-and-alzheimer-s-disease-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-1942-as-adjunctive-therapy-in-mild-to-moderate-alzheimer-s-disease-a-phase-2a-2b-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2420-in-male-subjects-with-rheumatoid-arthritis-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2420-in-the-management-of-rheumatoid-arthritis-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2828-in-the-management-of-atherosclerosis-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2828-in-the-management-of-atherosclerosis-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2870-enfortumab-vedotin-and-pembrolizumab-in-advanced-urothelial-carcinoma-a-phase-1-2-randomized-umbrella-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2870-monotherapy-and-combination-therapy-in-colorectal-pancreatic-and-biliary-tract-cancers-a-phase-1-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-2870-pembrolizumab-and-chemotherapy-in-first-line-treatment-of-locally-advanced-unresectable-metastatic-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-3214-in-the-management-of-hypercholesterolaemia-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-3508-for-the-treatment-of-respiratory-syncytial-virus-infection-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-4082-for-weight-management-in-healthy-individuals-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-4318-target-engagement-in-patients-with-pain-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-4646-in-individuals-with-hiv-infection-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-4646-in-the-treatment-of-hiv-infection-in-adult-patients-a-phase-iii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-4830-monotherapy-and-mk-4830-plus-pembrolizumab-in-advanced-solid-tumors-including-pancreatic-cancer-glioblastoma-and-other-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-5661-for-pain-management-in-healthy-volunteers-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-5661-versus-placebo-in-the-management-of-pain-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-5684-based-treatment-combinations-and-monotherapy-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-5684-on-pharmacokinetics-in-patients-with-refractory-metastatic-prostate-cancer-under-varying-dietary-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-6050-in-the-treatment-of-hidradenitis-suppurativa-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-6552-in-the-management-of-narcolepsy-in-healthy-adult-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-6916-for-the-management-of-acute-and-chronic-pain-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-6916-versus-placebo-in-the-management-of-acute-and-chronic-pain-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-7091-formulations-in-healthy-adult-participants-with-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-7228-in-the-management-of-atherosclerosis-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mk-8527-in-patients-with-hiv-1-infection-a-phase-1-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-modafinil-on-observational-performance-and-residual-capacity-in-healthy-military-personnel-a-field-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-modified-antiplatelet-therapy-with-prasugrel-ticagrelor-and-acetylsalicylic-acid-in-acute-myocardial-infarction-patients-post-revascularization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-modified-osimertinib-dosing-with-cobicistat-for-pharmacokinetic-enhancement-in-advanced-egfr-mutated-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-modified-release-hydrocortisone-versus-immediate-release-hydrocortisone-on-circadian-rhythms-and-quality-of-life-in-addison-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-modified-vaccinia-ankara-bavarian-nordic-live-virus-vaccine-for-immunogenicity-and-durability-in-preventing-mpox-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-molecular-bacterial-load-assay-and-rna-synthesis-ratio-as-biomarkers-in-pulmonary-tuberculosis-patients-treated-with-isoniazid-and-rifampicin-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-molecular-changes-induced-by-budesonide-in-copd-patients-stratified-by-eosinophil-levels2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-molecular-targeted-maintenance-therapy-with-binimetinib-futibatinib-and-drug-combination-in-advanced-biliary-cancer-a-phase-3-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-molgramostim-fosfomycin-and-metronidazole-for-pouchitis-in-ulcerative-colitis-post-restorative-ileal-pouch-anal-anastomosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-moma-313-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-momelotinib-dihydrochloride-monohydrate-and-luspatercept-in-transfusion-dependent-myelofibrosis-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mometasone-furoate-and-motivational-interviewing-in-reducing-rhinitis-medicamentosa-from-nasal-decongestant-overuse2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-monalizumab-and-volrustomig-in-combination-for-msi-and-or-dmmr-metastatic-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-montelukast-in-reducing-atherosclerosis-and-endothelial-dysfunction-in-patients-with-peripheral-artery-disease-undergoing-endovascular-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-montelukast-sodium-as-a-disease-modifying-agent-in-early-to-moderate-parkinson-s-disease-a-double-blind-randomized-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morf-057-efficacy-and-safety-in-adults-with-moderately-to-severely-active-crohn-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morf-057-efficacy-safety-and-tolerability-in-adults-with-moderately-to-severely-active-ulcerative-colitis-a-phase-2a-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morphine-for-reducing-early-non-invasive-ventilation-failure-in-acute-exacerbation-of-chronic-obstructive-pulmonary-disease-phase-i-iia-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morphine-hydrochloride-clearance-and-glomerular-filtration-rate-in-sickle-cell-disease-patients-during-vaso-occlusive-crisis-using-iohexol2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morphine-hydrochloride-on-neural-and-physiological-responses-to-emotional-distress-in-healthy-volunteers-a-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morphine-sulfate-for-dyspnea-and-cough-management-in-fibrotic-interstitial-lung-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-morphologic-complete-response-in-early-stage-nodal-follicular-lymphoma-with-rituximab-or-obinutuzumab-plus-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mosunetuzumab-and-polatuzumab-vedotin-combination-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mosunetuzumab-and-venetoclax-regimen-in-relapsed-refractory-chronic-lymphocytic-leukemia-patients-safety-efficacy-and-pharmacokinetics-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mosunetuzumab-as-consolidation-therapy-and-in-combination-with-polatuzumab-vedotin-in-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mosunetuzumab-efficacy-safety-and-pharmacokinetics-in-systemic-lupus-erythematosus-patients-with-or-without-active-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-motixafortide-and-g-csf-versus-placebo-and-g-csf-for-hematopoietic-stem-cell-mobilization-in-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mp-101-on-biomarkers-in-patients-with-huntington-s-alzheimer-s-amyotrophic-lateral-sclerosis-and-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mrna-3210-safety-and-tolerability-in-phenylketonuria-a-phase-1-2-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mrna-4359-monotherapy-and-combined-pembrolizumab-therapy-in-advanced-solid-tumors-a-phase-1-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mt-302-in-combination-with-capecitabine-and-oxaliplatin-regimens-for-metastatic-esophagogastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mucosal-immune-response-to-intranasal-live-attenuated-influenza-vaccine-in-pediatric-patients-with-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mucosal-visualization-and-diagnostic-efficacy-in-small-bowel-capsule-endoscopy-using-ascorbic-acid-sodium-ascorbate-and-simeticone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-multi-donor-fecal-microbiota-transfer-via-intestifix-001-capsules-for-remission-maintenance-in-crohn-s-disease-post-exclusive-enteral-nutrition2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-multi-omics-biomarkers-for-predicting-antihypertensive-response-in-primary-hypertension-amlodipine-olmesartan-medoxomil-and-hydrochlorothiazide2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-multi-peptide-vaccination-with-tlr1-2-ligand-xs15-in-acute-myeloid-leukemia-patients-in-complete-remission-post-first-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-multiplex-pcr-procalcitonin-and-sputum-appearance-in-reducing-antibiotic-duration-in-severe-copd-exacerbation-with-cefotaxime-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-multiplexed-pet-imaging-with-gallium-68ga-edotreotide-fluorocholine-18f-and-fludeoxyglucose-18f-in-hepatocellular-carcinoma-and-gastro-entero-pancreatic-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-murcidencel-based-immunotherapy-in-pediatric-patients-with-progressive-recurrent-or-metastatic-high-risk-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mycophenolate-mofetil-and-prednisolone-in-virus-negative-inflammatory-cardiomyopathy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mycophenolate-mofetil-and-tacrolimus-on-gut-microbiome-diversity-and-pharmacokinetics-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mycophenolate-mofetil-rituximab-ciclosporin-and-drug-combination-in-patients-with-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-mytx-011-an-antibody-drug-conjugate-in-patients-with-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-n-acetyl-l-leucine-efficacy-in-ataxia-telangiectasia-a-phase-iii-randomized-placebo-controlled-double-blind-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-n-acetylcysteine-in-the-treatment-of-cannabis-dependence-mechanistic-insights-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-n-methyl-2-4-methylaminophenyl-6-hydroxybenzothiazole-and-ly3372993-in-preventing-progression-of-dominantly-inherited-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-n-tec-implantation-for-patellofemoral-osteoarthritis-a-randomized-controlled-multicenter-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nabpaclitaxel-pipac-combined-with-systemic-nabpaclitaxel-gemcitabine-in-pancreatic-cancer-with-peritoneal-metastases-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nacystelyn-dry-powder-inhaler-in-the-treatment-of-obstructive-sleep-apnea-a-double-blind-placebo-controlled-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nadofaragene-firadenovec-instillation-in-renal-pelvis-for-safety-and-efficacy-in-low-grade-upper-tract-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nalbuphine-hydrochloride-extended-release-tablets-for-cough-management-in-idiopathic-pulmonary-fibrosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-naldemedine-on-opioid-induced-bowel-dysfunction-in-patients-receiving-tramadol-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-naloxegol-and-codeine-on-gastrointestinal-motility-in-opioid-induced-constipation-a-double-blind-placebo-controlled-cross-over-mri-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nandrolone-decanoate-physiotherapy-and-diet-in-sarcopenia-treatment-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nanostructured-fibrin-agarose-artificial-cornea-nanoulcor-in-severe-corneal-ulcers-using-allogenic-limbal-cells-and-keratocytes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-napabucasin-with-folfiri-and-best-supportive-care-versus-napabucasin-with-best-supportive-care-in-metastatic-colorectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-naproxen-sodium-on-synovial-fluid-cytokine-levels-and-clinical-outcomes-in-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-navitoclax-monotherapy-and-combination-with-ruxolitinib-in-myeloproliferative-neoplasms-safety-tolerability-and-pharmacokinetics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-navtemadlin-and-ruxolitinib-combination-therapy-in-patients-with-myelofibrosis-exhibiting-suboptimal-response-to-ruxolitinib2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-navtemadlin-versus-best-available-therapy-in-myelofibrosis-patients-refractory-to-jak-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nbi-1065845-as-adjunctive-therapy-for-maintenance-of-effect-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nebivolol-hydrochloride-efficacy-and-safety-in-adolescent-arterial-hypertension-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nebulized-amikacin-sulfate-in-combination-with-piperacillin-sodium-and-tazobactam-sodium-for-gram-negative-pneumonia-in-va-ecmo-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nebulized-bx004-in-adult-cystic-fibrosis-patients-with-chronic-pseudomonas-aeruginosa-pulmonary-infection-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nefopam-and-oxycodone-for-pain-assessment-in-patients-with-chronic-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nefopam-and-sodium-chloride-in-multimodal-analgesia-post-total-hip-arthroplasty-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nemvaleukin-alfa-monotherapy-and-combination-with-pembrolizumab-in-advanced-cutaneous-and-mucosal-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neo-adjuvant-chemotherapy-with-folfox-regimen-in-elderly-patients-with-locally-advanced-resectable-colon-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neo-antigen-specific-t-cell-induction-by-xp-dc-tl-klh-in-epithelial-ovarian-cancer-patients-undergoing-neoadjuvant-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-abemaciclib-and-giredestrant-in-er-positive-her2-negative-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-and-adjuvant-durvalumab-with-chemotherapy-in-resectable-stage-ii-iii-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-and-adjuvant-mrna-4157-with-pembrolizumab-versus-standard-of-care-in-resectable-locally-advanced-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-and-adjuvant-pembrolizumab-with-standard-chemo-radiotherapy-in-newly-diagnosed-glioblastoma-multiforme-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-and-adjuvant-ribociclib-and-letrozole-in-high-risk-estrogen-receptor-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-and-adjuvant-therapies-with-durvalumab-and-drug-combination-in-resectable-early-stage-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-aspirin-and-metformin-in-combination-with-induction-chemotherapy-and-chemoradiotherapy-for-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-atezolizumab-and-bevacizumab-following-radiotherapy-in-low-to-intermediate-risk-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-atezolizumab-with-platinum-based-chemotherapy-in-resectable-stage-ii-iiib-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-cemiplimab-and-imiquimod-with-laser-therapy-in-high-risk-resectable-cutaneous-basal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-chemotherapy-with-capecitabine-and-oxaliplatin-in-locally-advanced-colon-cancer-a-comparative-study-with-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-chemotherapy-with-oxaliplatin-and-capecitabine-in-locally-advanced-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-durvalumab-with-gemcitabine-cisplatin-or-gemcitabine-carboplatin-in-high-risk-localized-urothelial-carcinoma-of-the-upper-urinary-tract2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-electrochemotherapy-with-bleomycin-versus-electroporation-alone-in-colorectal-cancer-patients-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-folfirinox-versus-gemcitabine-based-chemoradiotherapy-in-borderline-resectable-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-folfox-with-without-hyperthermic-intraperitoneal-chemotherapy-using-mitomycin-c-in-locally-advanced-colon-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-ifosfamide-and-doxorubicin-in-high-grade-soft-tissue-sarcoma-of-extremities-and-trunk-wall2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-metronomic-capecitabine-and-cyclophosphamide-in-high-tumor-burden-pseudomyxoma-peritonei-prior-to-cytoreductive-surgery-and-hipec2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-nivolumab-efficacy-in-reducing-tumor-size-in-oral-squamous-cell-carcinoma-patients-prior-to-surgical-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-nivolumab-ipilimumab-relatlimab-anti-il-8-mab-and-celecoxib-in-early-stage-colon-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-patritumab-deruxtecan-with-or-without-endocrine-therapy-in-treatment-naive-hr-her2-high-risk-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-trastuzumab-deruxtecan-based-combinations-in-her2-resectable-esophagogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neoadjuvant-trastuzumab-pertuzumab-and-tucatinib-regimen-without-chemotherapy-in-stage-ii-iii-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-netrin-antibodies-combined-with-azacitidine-and-venetoclax-in-refractory-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neu-411-maleate-in-lrrk2-driven-early-parkinson-s-disease-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurexan-on-sleep-efficiency-daytime-performance-and-stress-response-in-patients-with-short-term-insomnia-a-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurochemical-alterations-in-migraine-patients-with-fremanezumab-treatment-a-randomized-controlled-open-label-mr-spectroscopy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurocognitive-and-quality-of-life-outcomes-in-diffuse-low-grade-glioma-patients-treated-with-temozolomide-a-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurodevelopmental-outcomes-in-very-low-birthweight-infants-using-30-versus-60-oxygen-concentration-for-initial-resuscitation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurohormonal-therapy-withdrawal-in-super-responders-with-non-ischemic-cardiomyopathy-post-cardiac-resynchronization-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurological-effects-of-dexamethasone-sodium-phosphate-encapsulated-in-autologous-erythrocytes-in-pediatric-ataxia-telangiectasia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurometabolic-impairment-in-amyotrophic-lateral-sclerosis-and-transient-ischemic-attack-using-hyperpolarized-1-13c-pyruvate-mri2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neuroprotective-efficacy-of-esketamine-hydrochloride-versus-propofol-in-sedation-post-out-of-hospital-cardiac-arrest2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-neurotrophin-mimetic-compound-in-modulating-ischemia-reperfusion-injury-in-liver-transplantation-with-extended-criteria-donors-a-phase-i-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ngm707-monotherapy-and-ngm707-pembrolizumab-combination-in-advanced-or-metastatic-solid-tumor-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nicotinamide-efficacy-and-tolerance-in-patients-with-persistent-acute-kidney-injury-a-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nicotinamide-safety-and-efficacy-in-patients-with-opa1-dominant-optic-atrophy-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nicotinamide-supplementation-in-preventing-major-adverse-kidney-events-in-septic-shock-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nicotine-resinate-1-5mg-lozenge-on-craving-reduction-in-moderate-smokers-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nilotinib-efficacy-in-sustaining-molecular-remission-post-tki-discontinuation-in-chronic-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nintedanib-and-tocilizumab-combination-therapy-versus-standard-treatment-in-systemic-sclerosis-associated-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nio752-safety-tolerability-pharmacodynamics-and-pharmacokinetics-in-early-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nipocalimab-and-certolizumab-pegol-combination-therapy-in-active-rheumatoid-arthritis-resistant-to-advanced-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nipocalimab-efficacy-and-safety-in-adults-with-seropositive-generalized-myasthenia-gravis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nipocalimab-efficacy-and-safety-in-adults-with-warm-autoimmune-hemolytic-anemia-a-multicenter-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nipocalimab-for-reducing-severe-fetal-and-neonatal-alloimmune-thrombocytopenia-risk-in-at-risk-pregnancies-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-niraparib-and-abemaciclib-combination-therapy-in-advanced-ovarian-cancer-a-phase-ib-ii-single-center-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-niraparib-and-dostarlimab-in-induction-and-maintenance-therapy-for-hpv-negative-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-niraparib-combined-with-abiraterone-acetate-and-prednisone-versus-abiraterone-acetate-and-prednisone-in-metastatic-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nirmatrelvir-and-ritonavir-for-the-prevention-of-long-covid-19-in-patients-with-acute-covid-19-a-randomized-placebo-controlled-trial-in-norway2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nirmatrelvir-ritonavir-co-administration-with-rosuvastatin-in-healthy-volunteers-for-covid-19-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nirsevimab-and-maternal-rsv-vaccine-abrysvo-for-prevention-of-respiratory-syncytial-virus-infection-in-infants-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nirsevimab-immunization-on-humoral-immune-response-in-healthy-infants-following-respiratory-syncytial-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nitrous-oxide-and-oxygen-as-adjunctive-therapy-to-antidepressants-in-treating-depressive-symptoms-in-neurocognitive-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nitrous-oxide-and-oxygen-detection-in-healthy-volunteers-for-nitrous-oxide-intoxication-studies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nitrous-oxide-and-oxygen-in-treatment-resistant-depression-in-elderly-patients-a-randomized-double-blind-comparator-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nitrous-oxide-and-oxygen-inhalation-for-acute-suicidal-ideation-management-in-emergency-settings-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-autologous-dendritic-cell-therapy-in-combination-with-cytoreductive-surgery-and-hipec-for-peritoneal-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-cisplatin-in-metastatic-triple-negative-breast-cancer-a-study-on-immune-induction-strategies-to-enhance-checkpoint-blockade-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-ipilimumab-combination-regimens-in-dmmr-msi-metastatic-colorectal-cancer-a-phase-ii-gercor-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-ipilimumab-in-dmmr-msi-metastatic-colorectal-cancer-resistant-to-anti-pd1-monotherapy-an-open-label-phase-ii-gercor-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-relatlimab-combination-in-advanced-or-metastatic-soft-tissue-sarcoma-a-phase-ii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-and-tisagenlecleucel-reinfusion-in-pediatric-and-young-adult-acute-lymphoblastic-leukemia-with-early-b-cell-aplasia-loss2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-efficacy-in-active-surveillance-post-neoadjuvant-chemoradiation-for-esophageal-cancer-sano-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-efficacy-post-induction-therapy-in-metastatic-triple-negative-breast-cancer-a-phase-ii-randomized-non-comparative-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-followed-by-bendamustine-gemcitabine-and-dexamethasone-with-autologous-hematopoietic-stem-cell-transplantation-in-refractory-hodgkin-s-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-ipilimumab-and-platinum-based-chemotherapy-in-stage-iv-non-small-cell-lung-cancer-with-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-ipilimumab-tgfb-15-peptide-vaccine-and-radiotherapy-in-advanced-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-monotherapy-and-combinatorial-regimens-in-recurrent-and-metastatic-msi-h-and-non-msi-h-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nivolumab-monotherapy-and-nivolumab-ipilimumab-combination-in-advanced-or-metastatic-solid-tumors-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nlm-001-and-zalifrelimab-in-combination-with-standard-chemotherapy-for-safety-and-efficacy-in-advanced-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nm26-2198-in-moderate-to-severe-atopic-dermatitis-a-randomized-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nmd670-efficacy-safety-and-tolerability-in-adult-patients-with-achr-musk-ab-myasthenia-gravis-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nmra-335140-efficacy-in-major-depressive-disorder-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc0194-0499-interaction-with-oral-contraceptives-in-women-with-non-alcoholic-steatohepatitis-nash-unable-to-bear-children2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc0194-0499-monotherapy-and-combination-with-semaglutide-on-glycemic-control-in-type-1-diabetes-mellitus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc0363-1063-in-healthy-subjects-and-individuals-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc0519-0130-versus-semaglutide-and-placebo-in-chronic-kidney-disease-with-or-without-type-2-diabetes-and-obesity-a-dose-response-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc05190130-on-pharmacokinetics-of-oral-contraceptive-and-gastric-emptying-in-healthy-postmenopausal-women-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc0650-0013-for-weight-management-and-type-2-diabetes-mellitus-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nnc9733-0001-in-healthy-individuals-and-patients-with-type-2-diabetes-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nocturnal-dexmedetomidine-on-postoperative-sleep-quality-and-fatigue-in-elderly-patients-undergoing-major-thoracoscopic-lung-resection-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-non-invasive-vagus-nerve-stimulation-and-sodium-oxybate-on-amyloid-beta-clearance-in-cerebral-amyloid-angiopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-non-irritant-concentrations-of-atezolizumab-daratumumab-and-nivolumab-in-skin-tests-for-biotherapy-hypersensitivity-in-oncology-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-non-total-body-irradiation-conditioning-regimens-with-fludarabine-thiotepa-and-busulfan-in-pediatric-acute-lymphoblastic-leukemia-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-non-vitamin-k-oral-anticoagulants-for-stroke-prevention-in-patients-with-perioperative-atrial-fibrillation-post-noncardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nonavalent-human-papillomavirus-vaccine-efficacy-in-refractory-palmar-and-plantar-warts-in-immunocompetent-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-norepinephrine-infusion-versus-standard-blood-pressure-management-in-perioperative-hypotension-during-non-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-norepinephrine-versus-dobutamine-plus-norepinephrine-in-cardiogenic-shock-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-norfloxacin-versus-epidemiologically-guided-antimicrobial-strategies-in-hospitalized-patients-with-decompensated-cirrhosis-and-bacterial-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-norucholic-acid-in-the-treatment-of-primary-sclerosing-cholangitis-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nous-209-genetic-vaccine-and-pembrolizumab-in-microsatellite-instability-high-or-dmmr-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-novel-immunotherapy-combinations-versus-pembrolizumab-in-pd-l1-high-non-small-cell-lung-cancer-a-phase-2-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-np137-combined-with-carboplatin-paclitaxel-and-pembrolizumab-in-advanced-endometrial-or-cervical-carcinoma-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nt-0796-in-healthy-volunteers-and-individuals-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntla-2001-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-hereditary-transthyretin-amyloidosis-with-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntla-2002-a-crispr-cas9-gene-editing-therapy-for-safety-and-efficacy-in-adults-with-hereditary-angioedema-hae2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntla-2002-efficacy-and-safety-in-hereditary-angioedema-patients-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntla-3001-safety-and-pharmacokinetics-in-adults-with-alpha-1-antitrypsin-deficiency-associated-pulmonary-emphysema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntx-1088-monotherapy-and-combination-with-pembrolizumab-in-patients-with-advanced-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ntx-1955-in-a-co2-challenge-model-for-generalized-anxiety-disorder-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nuclear-magnetic-resonance-derived-metabolomics-and-mri-techniques-using-gadoteric-acid-and-pyruvic-acid-in-ovarian-cancer-diagnostics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nvd-003-autologous-osteogenic-bone-graft-for-congenital-pseudarthrosis-of-the-tibia-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nvdx3-osteogenic-implant-for-interbody-spine-fusion-in-low-grade-degenerative-lumbar-spondylolisthesis-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nx-5948-in-adults-with-relapsed-refractory-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-post-bruton-s-tyrosine-kinase-and-bcl-2-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-nxp800-in-platinum-resistant-arid1a-mutated-ovarian-fallopian-tube-and-primary-peritoneal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obefazimod-efficacy-and-safety-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-phase-2b-multicenter-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obicetrapib-and-ezetimibe-fixed-dose-combination-on-coronary-plaque-in-atherosclerotic-cardiovascular-disease-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obicetrapib-on-major-adverse-cardiovascular-events-in-atherosclerotic-cardiovascular-disease-patients-on-maximal-lipid-modifying-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obinutuzumab-and-venetoclax-sequential-regimen-in-first-line-chronic-lymphocytic-leukemia-patients-ineligible-for-fcr-like-regimens2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obinutuzumab-efficacy-safety-and-pharmacokinetics-in-adolescents-with-class-iii-iv-lupus-nephritis-and-pediatric-safety-and-pk-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obinutuzumab-in-rituximab-resistant-or-rituximab-dependent-primary-membranous-nephropathy-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obinutuzumab-on-anti-pla2r-antibody-kinetics-in-primary-membranous-nephropathy-patients-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obinutuzumab-vemurafenib-and-cobimetinib-in-hairy-cell-leukemia-patients-refractory-to-purine-analogues-or-unfit-for-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-obturator-nerve-anesthesia-frequency-in-hip-pain-ropivacaine-hydrochloride-sodium-chloride-and-gadoteric-acid-in-suprainguinal-fascia-iliaca-block2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocrelizumab-efficacy-and-safety-in-multiple-sclerosis-patients-from-a-prior-phase-iiib-iv-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocrelizumab-efficacy-and-safety-in-progressive-multiple-sclerosis-a-4-year-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocrelizumab-pharmacokinetics-safety-and-immunogenicity-following-subcutaneous-administration-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocrelizumab-s-impact-on-physical-function-in-multiple-sclerosis-patients-from-previous-genentech-roche-trials-lacking-post-trial-access2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocrelizumab-versus-fingolimod-in-pediatric-and-adolescent-patients-with-relapsing-remitting-multiple-sclerosis-a-phase-iii-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-octreotide-on-intraoperative-blood-loss-and-vasoactive-drug-requirement-in-laparoscopic-hepatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ocular-toxicity-mitigation-with-mirvetuximab-soravtansine-brimonidine-tartrate-and-prednisolone-acetate-in-recurrent-ovarian-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-odm-111-and-paracetamol-in-the-management-of-chronic-pain-associated-with-knee-osteoarthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-odm-111-efficacy-and-tolerability-in-chronic-pain-management-for-diabetic-peripheral-neuropathy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-odm-212-in-patients-with-advanced-solid-tumors-a-phase-i-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-odronextamab-loncastuximab-tesirine-and-car-t-cell-therapy-in-pediatric-and-adolescent-relapsed-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-odronextamab-s-anti-tumor-efficacy-and-safety-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ofatumumab-concentration-in-breast-milk-of-lactating-women-with-relapsing-multiple-sclerosis-receiving-ofatumumab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ofatumumab-efficacy-and-patient-reported-outcomes-in-relapsing-multiple-sclerosis-patients-transitioning-from-fumarate-based-therapies-or-fingolimod2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olaparib-and-durvalumab-in-metastatic-pancreatic-cancer-with-dna-damage-repair-gene-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olaparib-durvalumab-and-uv1-as-maintenance-therapy-in-brca-wild-type-recurrent-ovarian-cancer-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olaparib-efficacy-in-advanced-cancers-with-germline-or-somatic-mutations-in-homologous-recombination-genes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olaparib-maintenance-therapy-in-newly-diagnosed-brca-wild-type-advanced-ovarian-fallopian-tube-and-primary-peritoneal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olaparib-monotherapy-safety-tolerability-and-pharmacokinetics-in-pediatric-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-olpasiran-in-reducing-first-major-cardiovascular-events-in-patients-with-elevated-lipoprotein-a-levels-a-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-om85-for-the-prevention-of-respiratory-tract-infections-in-elderly-patients-with-recurrent-infections-in-long-term-care-facilities2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-omalizumab-discontinuation-versus-continuation-in-patients-with-well-controlled-severe-allergic-asthma-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-omalizumab-dose-adjustment-in-patients-with-severe-allergic-asthma-a-clinical-trial-on-dose-reduction-and-administration-frequency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-omalizumab-in-inhibiting-mast-cell-activation-in-atherosclerotic-lesions-in-patients-with-carotid-artery-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-omaveloxolone-in-the-treatment-of-friedreich-s-ataxia-a-phase-2-study-on-safety-efficacy-and-pharmacodynamics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oms906-in-paroxysmal-nocturnal-hemoglobinuria-patients-with-sub-optimal-response-to-c5-inhibitor-ravulizumab-a-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oms906-safety-and-efficacy-in-patients-with-c3-glomerulopathy-and-idiopathic-immune-complex-mediated-glomerulonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-on-body-injection-system-for-home-subcutaneous-administration-of-ocrelizumab-in-patients-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-onc201-and-paxalisib-combination-therapy-in-pediatric-and-young-adult-diffuse-midline-gliomas-including-diffuse-intrinsic-pontine-gliomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oncological-safety-of-rectal-preserving-therapy-with-capecitabine-in-intermediate-risk-early-rectal-cancer-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oncolytic-virus-tilt-123-with-lymphocyte-depleting-chemotherapy-and-tumor-infiltrating-lymphocytes-in-melanoma-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-onfekafusp-alfa-and-dacarbazine-in-advanced-or-metastatic-soft-tissue-sarcoma-post-two-systemic-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oocyte-embryo-cryopreservation-efficacy-in-young-breast-cancer-patients-undergoing-adjuvant-chemotherapy-with-follitropin-alfa-and-follitropin-beta2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-opioid-consumption-with-nociceptive-monitoring-in-neurocritical-patients-undergoing-deep-sedation-with-propofol-isoflurane-and-dobutamine-hydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-opioid-free-analgesia-using-nefopam-hydrochloride-ketamine-hydrochloride-and-paracetamol-in-mechanically-ventilated-icu-patients-with-intubation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-opioid-free-anesthesia-with-ketamine-hydrochloride-on-oxygenation-in-patients-undergoing-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-opioid-free-multimodal-anesthesia-on-functional-neuroimaging-and-electroencephalogram-in-healthy-volunteers-undergoing-induced-sedation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-opioid-sparing-pathway-using-esketamine-dexmedetomidine-and-lidocaine-hydrochloride-monohydrate-in-postoperative-pain-management-for-obesity-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-optimal-dosing-of-beltavac-with-polymerized-grass-pollen-extract-in-allergic-rhinoconjunctivitis-with-or-without-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-optimal-dosing-of-rabbit-anti-human-t-lymphocyte-immunoglobulin-and-mycophenolic-acid-in-low-immunological-risk-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-optimized-ceftazidime-dosing-regimen-versus-standard-regimen-in-critical-care-patients-with-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-optimized-initial-dosing-of-beta-lactam-antibiotics-in-critically-ill-icu-patients-with-sepsis-a-study-of-flucloxacillin-amoxicillin-and-ceftriaxone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-and-buccal-absorption-of-hydrocortisone-from-2d-printed-dissolvable-films-in-healthy-volunteers-and-adults-with-adrenal-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-and-enema-fecal-microbiota-transplantation-for-maintenance-therapy-in-pediatric-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-anticoagulation-with-apixaban-rivaroxaban-and-dabigatran-etexilate-in-new-onset-post-operative-atrial-fibrillation-post-cabg2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-baricitinib-for-safety-and-efficacy-in-pediatric-patients-with-active-juvenile-idiopathic-arthritis-associated-uveitis-or-chronic-anterior-antinuclear-antibody-positive-uveitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-colchicine-for-prevention-of-restenosis-in-superficial-femoral-artery-in-patients-with-lower-extremity-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-difelikefalin-efficacy-and-safety-in-moderate-to-severe-pruritus-associated-with-notalgia-paresthetica-in-adults-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-erythromycin-and-neomycin-sulphate-in-reducing-surgical-site-infections-in-elective-colorectal-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-fosfomycin-tromethamol-for-acute-multidrug-resistant-escherichia-coli-bacterial-prostatitis-treatment-in-a-phase-iv-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-glibenclamide-efficacy-in-managing-transient-hyperglycemia-in-premature-infants-weighing-less-than-1500g2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-isotretinoin-versus-standard-care-in-moderate-acne-among-skin-of-color-patients-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-lidocaine-hydrochloride-monohydrate-ore-001-for-reducing-abdominal-discomfort-and-early-satiety-in-anorexia-nervosa-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-magnesium-l-aspartate-hydrochloride-trihydrate-for-reducing-chronic-postoperative-hypoparathyroidism-following-thyroidectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-minoxidil-1-mg-efficacy-and-safety-in-female-androgenetic-alopecia-a-phase-iii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-nefopam-hydrochloride-for-reducing-morphine-consumption-in-postoperative-pain-management-following-total-knee-arthroplasty-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-prednisolone-sodium-phosphate-in-rhinovirus-induced-wheezing-in-pediatric-patients-aged-6-months-to-2-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-propranolol-hydrochloride-for-the-prevention-of-threshold-retinopathy-of-prematurity-in-extremely-preterm-infants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-semaglutide-efficacy-and-safety-in-hyperglycemic-patients-post-renal-transplantation-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-semaglutide-efficacy-and-safety-in-patients-with-early-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-semaglutide-for-neuroprotection-in-patients-with-open-angle-glaucoma-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-semaglutide-on-bone-turnover-in-type-2-diabetes-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-tazemetostat-in-patients-with-advanced-solid-tumors-or-hematological-malignancies-and-varying-degrees-of-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-vancomycin-for-prophylaxis-of-clostridium-difficile-infections-in-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-verapamil-for-preserving-residual-insulin-secretion-in-pediatric-patients-with-recent-onset-type-1-diabetes-a-phase-i-ii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-versus-intravenous-paracetamol-and-ibuprofen-for-postoperative-pain-management-in-knee-arthroscopy-a-randomized-double-blind-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oral-zinc-acetate-dihydrate-for-safety-and-feasibility-in-patients-with-gnao1-associated-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-orforglipron-hemicalcium-in-hypertension-management-for-patients-with-obesity-or-overweight-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-organ-preservation-in-early-stage-rectal-cancer-using-oxaliplatin-capecitabine-and-radiotherapy-with-additional-local-or-systemic-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-organ-preservation-in-locally-advanced-rectal-cancer-using-neoadjuvant-therapy-followed-by-electrochemotherapy-with-bleomycin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-organoid-based-adjuvant-therapy-selection-in-resectable-pancreatic-ductal-adenocarcinoma-using-capecitabine-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oric-114-monotherapy-and-in-combination-with-carboplatin-pemetrexed-in-advanced-solid-tumors-with-egfr-or-her2-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-orismilast-and-semaglutide-combination-therapy-on-body-weight-reduction-in-obese-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-orticumab-on-coronary-inflammation-in-post-myocardial-infarction-patients-with-elevated-fat-attenuation-index-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oseltamivir-and-drug-combinations-in-hospitalized-patients-with-acute-respiratory-tract-infection-a-randomized-adaptive-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-osimertinib-as-first-line-therapy-in-egfr-mutated-non-small-cell-lung-cancer-with-comprehensive-translational-analyses2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-osimertinib-as-induction-and-maintenance-therapy-in-egfr-mutation-positive-stage-iii-unresectable-non-small-cell-lung-cancer-with-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-osimertinib-combined-with-chemotherapy-in-first-line-treatment-of-stage-iv-non-small-cell-lung-cancer-with-atypical-egfr-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-osu6162-hydrochloride-as-an-adjunct-to-ssri-snri-therapy-in-treatment-resistant-major-depressive-disorder-a-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-osu6162-hydrochloride-in-the-treatment-of-bipolar-depression-an-open-label-flexible-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-outpatient-versus-inpatient-induction-of-labor-using-misoprostol-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ovarian-stimulation-intensity-on-embryo-euploidy-in-advanced-age-women-using-follitropin-delta-triptorelin-and-progesterone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ovarian-stimulation-intensity-on-embryo-quality-in-infertility-a-randomized-controlled-trial-of-clomifene-citrate-and-recombinant-follitropin-alfa2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-overall-survival-in-metastatic-pancreatic-ductal-adenocarcinoma-with-sbp-101-nab-paclitaxel-and-gemcitabine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxaliplatin-and-capecitabine-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-adenocarcinoma-a-prospective-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxaliplatin-based-chemotherapy-for-lean-body-mass-normalization-in-patients-with-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxycodone-hydrochloride-trihydrate-for-efficacy-safety-and-neonatal-outcomes-in-labor-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxygen-administration-techniques-on-postoperative-complications-in-patients-undergoing-lung-resection-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxygen-saturation-targets-in-pediatric-respiratory-distress-a-randomized-controlled-trial-on-bronchiolitis-and-lower-respiratory-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxygen-supplementation-to-enhance-antibiotic-efficacy-in-chronic-pulmonary-pseudomonas-aeruginosa-infection-in-cystic-fibrosis-and-primary-ciliary-dyskinesia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxygen-therapy-on-physical-activity-in-patients-with-fibrotic-interstitial-lung-disease-and-exertional-hypoxemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxygen-therapy-on-postoperative-complication-reduction-in-at-risk-ankle-trauma-surgery-patients-a-randomized-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxytocin-enhanced-mindfulness-based-training-on-stress-regulation-in-adults-with-psychological-distress-complaints2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxytocin-nasal-spray-on-core-symptoms-in-pediatric-autism-spectrum-disorder-with-comorbid-intellectual-disability2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxytocin-on-the-trigeminovascular-system-in-healthy-volunteers-implications-for-migraine-pathophysiology2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxytocin-s-effects-on-trust-learning-and-cognitive-flexibility-in-healthy-children-using-virtual-reality-and-probabilistic-reversal-learning-task2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-oxytocin-s-efficacy-in-reducing-psychosocial-stress-among-breast-cancer-survivors-a-randomized-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ozanimod-efficacy-and-safety-in-pediatric-patients-with-moderate-to-severe-crohn-s-disease-unresponsive-to-conventional-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ozanimod-on-meningeal-inflammation-and-glial-activation-in-relapsing-multiple-sclerosis-a-phase-4-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ozanimod-on-myelin-dynamics-and-neurodegeneration-in-relapsing-remitting-multiple-sclerosis-patients-a-2-year-longitudinal-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ozone-therapy-efficacy-in-chemotherapy-induced-peripheral-neuropathy-pain-a-randomized-triple-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ozone-therapy-in-chemotherapy-induced-peripheral-neuropathy-related-paresthesia-a-randomized-triple-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-p2y12-inhibitor-de-escalation-regimens-on-platelet-reactivity-in-high-bleeding-risk-patients-with-acute-coronary-syndrome-post-stenting2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-p2y12-inhibitor-monotherapy-followed-by-direct-oral-anticoagulant-in-atrial-fibrillation-patients-post-sirolimus-eluting-stent-implantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-padeliporfin-vascular-targeted-photodynamic-therapy-in-low-grade-upper-tract-urothelial-carcinoma-a-phase-3-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pain-and-usability-of-injection-techniques-for-purified-chick-embryo-cell-culture-rabies-vaccine-in-pediatric-pre-exposure-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pain-medication-tapering-protocols-in-persistent-spinal-pain-syndrome-type-ii-patients-undergoing-spinal-cord-stimulation-buprenorphine-naloxone-oxycodone-and-clonidine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-palbociclib-combined-with-endocrine-therapy-in-er-her2-metastatic-breast-cancer-using-circulating-dna-esr1-mutation-monitoring2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-palbociclib-olaparib-and-pertuzumab-in-personalized-treatment-of-high-risk-breast-cancer-a-molecular-marker-based-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-palbociclib-with-irinotecan-and-temozolomide-or-topotecan-and-cyclophosphamide-in-pediatric-recurrent-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-palonosetron-and-netupitant-as-antiemetic-therapy-in-chemotherapy-naive-endometrial-cancer-patients-receiving-paclitaxel-carboplatin-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-paltusotine-efficacy-and-safety-in-acromegaly-patients-on-long-acting-somatostatin-receptor-ligands-a-randomized-controlled-multi-center-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-paltusotine-efficacy-and-safety-in-non-pharmacologically-treated-acromegaly-a-randomized-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pamidronate-disodium-for-pain-management-in-sternocostoclavicular-hyperostosis-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pancreas-powder-as-pancreatic-enzyme-replacement-therapy-in-pancreatic-exocrine-insufficiency-post-total-gastrectomy-in-adults-aged-18-802026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pancreatic-enzyme-replacement-therapy-with-pancreas-powder-in-pancreatic-exocrine-insufficiency-post-pancreatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pantoprazole-co-administration-on-mycophenolate-mofetil-pharmacokinetics-in-post-transplantation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-paracetamol-withdrawal-versus-continuous-use-with-strong-opioids-for-pain-management-in-patients-with-metastatic-cancer-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-paraffin-white-soft-cream-for-prophylaxis-of-atopic-dermatitis-in-high-risk-pediatric-populations-a-randomized-investigator-blinded-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-parecoxib-and-sodium-chloride-in-hospitalized-patients-with-spontaneous-subarachnoid-hemorrhage-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-parenteral-nutrition-route-on-post-oesophagectomy-cachexia-using-smofkabiven-emulsion-for-infusion-a-randomized-controlled-observer-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-parp-pet-imaging-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pasireotide-as-maintenance-therapy-in-sstr2-3-5-expressing-synovial-sarcoma-and-desmoplastic-small-round-cell-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pasireotide-pharmacokinetics-administered-subcutaneously-via-reusable-pen-versus-syringe-in-post-bariatric-hypoglycaemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patient-acceptability-of-a-new-pancreas-powder-formulation-in-cystic-fibrosis-patients-with-pancreatic-exocrine-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patient-preference-for-home-administration-of-subcutaneous-fixed-dose-combination-of-pertuzumab-and-trastuzumab-in-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patient-reported-preference-for-subcutaneous-pembrolizumab-coformulated-with-hyaluronidase-versus-intravenous-pembrolizumab-in-multiple-tumor-types2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patiromer-in-facilitating-raas-inhibitor-optimization-in-patients-with-stage-3b-4-chronic-kidney-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patiromer-on-dietary-potassium-restriction-and-quality-of-life-in-end-stage-kidney-disease-patients-undergoing-chronic-dialysis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patiromer-on-vascular-function-and-mineral-metabolism-in-chronic-kidney-disease-a-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patritumab-deruxtecan-in-pediatric-patients-with-relapsed-or-refractory-hepatoblastoma-and-rhabdomyosarcoma-a-phase-1-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-patritumab-deruxtecan-safety-and-efficacy-in-colorectal-biliary-tract-and-hepatocellular-carcinomas-a-phase-1-2-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pc14586-in-patients-with-locally-advanced-or-metastatic-solid-tumors-harboring-tp53-y220c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pd-1-inhibitor-discontinuation-strategy-with-nivolumab-and-pembrolizumab-in-advanced-melanoma-patients-achieving-complete-or-partial-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pd-l1-expression-via-89zr-atezolizumab-pet-ct-imaging-in-diffuse-large-b-cell-lymphoma-patients-undergoing-cd19-directed-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegaspargase-and-rituximab-in-pediatric-non-mature-b-acute-lymphoblastic-leukemia-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegaspargase-efficacy-and-tolerance-in-pediatric-acute-lymphoblastic-leukemia-stratified-by-risk-and-immunophenotype2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegcetacoplan-for-reducing-proteinuria-in-adults-and-adolescents-with-focal-segmental-glomerulosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegcetacoplan-for-safety-and-efficacy-in-post-transplant-recurrence-of-complement-3-glomerulopathy-or-immune-complex-membranoproliferative-glomerulonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegcetacoplan-pharmacokinetics-pharmacodynamics-efficacy-and-safety-in-transplant-associated-thrombotic-microangiopathy-post-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegfilgrastim-efficacy-in-maintaining-neutrophil-counts-in-patients-with-severe-chronic-neutropenia-undergoing-g-csf-and-anti-infective-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peginterferon-alfa-2a-and-ruxolitinib-combination-therapy-in-newly-diagnosed-polycythemia-vera-patients-a-danish-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegozafermin-efficacy-and-safety-in-patients-with-metabolic-dysfunction-associated-steatohepatitis-and-fibrosis-a-phase-3-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegozafermin-efficacy-and-safety-in-severe-hypertriglyceridemia-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegvaliase-subcutaneous-injections-for-safety-and-efficacy-in-adolescents-with-phenylketonuria-a-phase-3-multi-center-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pegvisomant-and-somatropin-on-hepatic-lipid-metabolism-in-acromegaly-and-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pelacarsen-tqj230-in-reducing-major-cardiovascular-events-in-patients-with-established-cardiovascular-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pelacarsen-tqj230-versus-placebo-on-lipoprotein-apheresis-frequency-in-hyperlipoproteinemia-a-and-cardiovascular-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-ataluren-in-metastatic-pmmr-dmmr-colorectal-adenocarcinomas-and-metastatic-dmmr-endometrial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-atezolizumab-in-combination-with-chemotherapy-for-non-small-cell-lung-carcinoma-in-patients-with-advanced-or-metastatic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-axitinib-combination-versus-sunitinib-monotherapy-in-first-line-treatment-of-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-bevacizumab-on-12-month-progression-free-survival-in-patients-with-metastatic-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-enfortumab-vedotin-efficacy-in-collecting-duct-carcinoma-and-renal-medullary-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-epacadostat-versus-sunitinib-or-pazopanib-in-first-line-treatment-of-locally-advanced-or-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-lenvatinib-in-first-line-treatment-of-advanced-metastatic-non-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-lenvatinib-in-recurrent-persistent-metastatic-or-locally-advanced-vulvar-cancer-unamenable-to-curative-surgery-or-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-metronomic-cyclophosphamide-in-metastatic-urothelial-carcinoma-a-phase-2-single-arm-monocentric-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-olaparib-in-adult-patients-with-recurrent-metastatic-platinum-resistant-nasopharyngeal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-olaparib-in-homologous-recombination-deficient-metastatic-colorectal-cancer-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-paclitaxel-in-hr-her2-advanced-breast-cancer-post-cdk-4-6-inhibitor-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-and-temozolomide-in-mmr-proficient-metastatic-colorectal-cancer-with-extended-ras-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-as-neoadjuvant-therapy-in-patients-with-high-risk-thyroid-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-atezolizumab-nivolumab-and-cemiplimab-with-carbon-ion-radiotherapy-in-advanced-solid-tumors-with-stable-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-based-combination-therapies-in-metastatic-castration-resistant-prostate-cancer-a-phase-ib-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-based-combinations-in-first-line-treatment-of-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-chemotherapy-and-radiotherapy-in-advanced-non-small-cell-lung-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-combined-with-autologous-dendritic-cell-vaccine-in-advanced-mesothelioma-patients-post-therapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-combined-with-salvage-radiotherapy-in-patients-with-biochemical-recurrence-of-prostate-cancer-post-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-combined-with-xelox-and-bevacizumab-in-microsatellite-stable-metastatic-colorectal-cancer-with-high-immune-infiltrate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-eftilagimod-alfa-and-radiotherapy-in-neoadjuvant-treatment-of-resectable-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-epacadostat-and-extreme-regimen-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-favezelimab-and-vibostolimab-in-pediatric-and-young-adult-patients-with-hematologic-malignancies-or-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-favezelimab-vibostolimab-and-lenvatinib-in-pd-1-refractory-melanoma-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-lenvatinib-and-belzutifan-combination-therapy-in-patients-with-advanced-solid-tumors-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-lenvatinib-tretinoin-vibostolimab-and-quavonlimab-in-pd-1-refractory-melanoma-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-monotherapy-versus-pembrolizumab-combined-with-chemotherapy-in-first-line-treatment-of-advanced-stage-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-patritumab-deruxtecan-and-drug-combinations-in-stage-iv-non-small-cell-lung-cancer-a-phase-2-umbrella-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-neoadjuvant-adjuvant-treatment-of-gastric-and-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-quavonlimab-and-lenvatinib-in-advanced-melanoma-with-brain-metastases-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-quavonlimab-belzutifan-lenvatinib-and-mk-4830-in-second-line-metastatic-renal-cell-carcinoma-a-phase-1b-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-quavonlimab-favezelimab-lenvatinib-and-raludotatug-deruxtecan-in-pd-1-l1-refractory-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-vibostolimab-and-mk-4830-in-neoadjuvant-therapy-for-stage-iiib-d-melanoma-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-with-etoposide-and-cisplatin-or-carboplatin-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pembrolizumab-with-or-without-olaparib-in-tertiary-lymphoid-structures-positive-resectable-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pemigatinib-trastuzumab-pertuzumab-and-drug-combination-in-patients-with-advanced-cancer-with-known-molecular-profile2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pentaglobin-as-an-early-adjuvant-in-febrile-neutropenia-for-acute-myeloid-leukemia-and-allogeneic-hsct-patients-colonized-by-carbapenem-resistant-bacteria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pentosan-polysulfate-sodium-in-a-drug-combination-for-adults-with-knee-osteoarthritis-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peptide-based-immunotherapy-with-io102-hydrochloride-and-io103-acetate-in-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peptide-receptor-radionuclide-therapy-enhancement-with-parp-inhibitors-in-advanced-gastroenteropancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perampanel-as-adjunctive-therapy-in-pediatric-patients-with-childhood-epilepsy-an-open-label-study-with-extension-phase2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perampanel-efficacy-and-safety-in-behavioral-symptom-management-for-white-sutton-syndrome-a-multicentric-self-controlled-case-series-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perampanel-efficacy-in-pre-surgical-treatment-of-patients-with-progressive-glioblastoma-a-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-percutaneous-embolectomy-ultrasound-assisted-low-dose-thrombolysis-with-alteplase-and-heparin-in-intermediate-high-risk-pulmonary-embolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perflubutane-enhanced-ultrasound-for-sentinel-node-detection-in-melanoma-breast-cancer-and-head-neck-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perflubutane-enhanced-ultrasound-for-superficial-lymphatic-vessel-visualization-in-lymphatic-imaging-a-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perflubutane-for-contrast-enhanced-ultrasound-in-differentiating-benign-and-malignant-focal-liver-lesions-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peri-operative-acetylsalicylic-acid-versus-placebo-in-elective-endovascular-coiling-of-unruptured-intracranial-aneurysms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peri-operative-antibiotic-strategy-versus-antibiotic-sparing-in-asymptomatic-bacteriuria-with-botulinum-toxin-a-in-ms-and-sci-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perianal-infiltration-with-ropivacaine-and-ropivacaine-hydrochloride-in-radiofrequency-thermodestruction-for-hemorrhoidal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pericapsular-nerve-group-block-with-ropivacaine-hydrochloride-versus-placebo-for-postoperative-pain-management-in-periacetabular-osteotomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perinatal-outcomes-with-active-management-using-oxytocin-dinoprostone-and-mifepristone-in-pregnant-patients-with-pre-labor-rupture-of-membranes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perineural-botulinum-toxin-type-a-injection-for-chronic-cutaneous-neuropathic-pain-in-patients-with-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perineural-dexmedetomidine-doses-with-ropivacaine-and-intravenous-dexamethasone-for-analgesia-in-shoulder-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perineural-dexmedetomidine-dosing-with-ropivacaine-and-intravenous-dexamethasone-in-interscalene-plexus-block-for-shoulder-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-analgesic-efficacy-of-levomethadone-hydrochloride-versus-placebo-in-elderly-patients-undergoing-hip-fracture-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-dexamethasone-sodium-phosphate-versus-sodium-chloride-on-postoperative-pain-in-anterior-cruciate-ligament-reconstruction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-doxorubicin-ifosfamide-and-dacarbazine-in-cinsarc-high-risk-localized-soft-tissue-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-empagliflozin-for-the-prevention-of-cardiac-surgery-associated-acute-kidney-injury-in-patients-undergoing-elective-extracorporeal-circulation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-flot4-and-preoperative-intraperitoneal-chemotherapy-with-hyperthermic-intraperitoneal-chemotherapy-in-advanced-gastric-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-fluconazole-prophylaxis-versus-placebo-in-reducing-postoperative-complications-following-radical-cystectomy-in-patients-with-fungal-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-hydrocortisone-infusion-versus-placebo-in-patients-undergoing-pancreatic-resection-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-inhaled-formoterol-fumarate-for-reducing-postoperative-pulmonary-complications-in-high-risk-thoracic-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-intravenous-esketamine-on-postoperative-craniotomy-pain-in-drug-resistant-temporal-lobe-epilepsy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-mfolfirinox-and-surgical-resection-versus-mfolfirinox-monotherapy-in-oligometastatic-pancreatic-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-pembrolizumab-and-enfortumab-vedotin-with-cystectomy-versus-cystectomy-alone-in-cisplatin-ineligible-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-pembrolizumab-efficacy-in-patients-with-resectable-oligometastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-selective-digestive-decontamination-with-colistin-sulfate-tobramycin-and-amphotericin-b-in-resectable-esophageal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-perioperative-systemic-therapy-with-bevacizumab-folinic-acid-oxaliplatin-capecitabine-fluorouracil-and-irinotecan-in-resectable-colorectal-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peripheral-dilute-norepinephrine-for-functional-independence-in-acute-progressive-perforating-artery-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peripheral-edema-resolution-in-patients-transitioned-from-amlodipine-besilate-to-levamlodipine-succinate-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peritoneal-ultrafiltration-with-polycore-in-patients-with-congestive-heart-failure-and-cardio-renal-syndrome-impact-on-mortality-and-condition-worsening2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-peritumoral-immunotherapy-in-early-stage-cervical-cancer-safety-toxicity-and-immunological-effects-in-the-ithaca-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-b-cell-tailored-ocrelizumab-versus-standard-ocrelizumab-in-relapsing-remitting-multiple-sclerosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-ct-guided-antithrombotic-therapy-versus-standard-single-antiplatelet-therapy-in-aortic-valve-stenosis-post-tavi-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-extended-interval-dosing-of-natalizumab-in-patients-with-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-maintenance-therapy-using-anti-desmoglein-antibodies-versus-standard-rituximab-and-corticosteroids-in-pemphigus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-neoantigen-specific-tcr-t-cells-for-the-treatment-of-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-pharmacokinetic-pharmacodynamic-dosing-versus-standard-dosing-of-linezolid-in-patients-with-sepsis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-personalized-risk-adapted-therapy-with-sonidegib-and-chemotherapy-in-post-pubertal-patients-with-newly-diagnosed-medulloblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pert-ijs-biosimilar-versus-eu-perjeta-with-trastuzumab-and-chemotherapy-in-hr-negative-her2-positive-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pet-dopa-with-fluorodopa-18f-for-detection-of-untreated-brain-metastases-in-non-small-cell-lung-breast-cancer-and-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-petosemtamab-monotherapy-and-combination-therapy-in-advanced-metastatic-colorectal-cancer-and-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-petosemtamab-versus-investigator-s-choice-monotherapy-in-previously-treated-metastatic-recurrent-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pevonedistat-venetoclax-and-azacitidine-versus-venetoclax-and-azacitidine-in-newly-diagnosed-acute-myeloid-leukemia-unfit-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pex010-psilocybin-capsules-on-prolonged-grief-disorder-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07054894-in-japanese-patients-with-inflammatory-bowel-disease-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07220060-and-pf-07104091-with-endocrine-therapy-in-hr-positive-her2-negative-advanced-breast-cancer-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07220060-monohydrate-alone-and-in-combination-with-letrozole-or-fulvestrant-in-advanced-solid-tumors-a-phase-1-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07258669-in-older-adults-at-risk-of-malnutrition-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07293893-in-patients-with-heart-failure-with-preserved-ejection-fraction-hfpef-a-dose-tolerance-and-pharmacokinetic-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07293893-pharmacokinetics-and-tolerability-in-healthy-adults-with-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07328948-tolerability-and-pharmacokinetics-in-healthy-adult-subjects-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07899895-tolerability-and-pharmacokinetics-in-healthy-adults-for-ulcerative-colitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07940369-pharmacokinetics-and-tolerability-in-healthy-adult-subjects-with-clonal-hematopoiesis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07940369-tolerability-and-pharmacokinetics-in-healthy-adults-with-clonal-hematopoiesis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07941944-tolerability-in-healthy-adults-for-respiratory-syncytial-virus-rsv-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07985631-pharmacokinetics-and-tolerability-in-healthy-adults-with-iga-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-07999415-pharmacokinetics-and-tolerability-in-healthy-adult-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-08046031-in-adults-with-advanced-melanoma-non-small-cell-lung-cancer-head-and-neck-squamous-cell-carcinoma-and-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-08046032-in-patients-with-advanced-lymphomas-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-08046049-sgn-bb228-in-patients-with-advanced-pancreatic-colorectal-non-small-cell-lung-mesothelioma-and-cutaneous-melanoma-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-08046050-sgn-ceacam5c-in-adults-with-advanced-non-small-cell-lung-cancer-colorectal-cancer-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pf-08046054-sgn-pdl1v-in-patients-with-advanced-oesophageal-ovarian-gastric-melanoma-breast-head-and-neck-and-non-small-cell-lung-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pg413-versus-apixaban-in-the-prevention-of-stroke-and-systemic-embolism-in-adults-with-non-valvular-atrial-fibrillation-and-treatment-of-thromboembolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacodynamic-effects-safety-and-tolerability-of-patiromer-in-pediatric-patients-with-hyperkalemia-a-phase-2-open-label-multiple-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacodynamics-and-safety-of-alxn2220-re-treatment-in-transthyretin-amyloid-cardiomyopathy-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacodynamics-pharmacokinetics-and-safety-of-efavirenz-in-early-alzheimer-s-disease-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-insulin-gzr33-versus-insulin-degludec-in-type-1-diabetes-mellitus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacogenetic-guided-therapy-versus-standard-treatment-in-patients-with-uncontrolled-type-2-diabetes-using-dapagliflozin-dulaglutide-and-metformin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-enhancement-of-olaparib-with-cobicistat-in-high-grade-ovarian-cancer-post-chemotherapy-maintenance-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-interaction-between-alogliptin-and-empagliflozin-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-interaction-between-empagliflozin-and-alogliptin-in-healthy-subjects-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-interactions-between-levonorgestrel-vaginal-delivery-system-and-miconazole-in-healthy-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-interactions-between-levonorgestrel-vaginal-delivery-system-and-tampons-and-lubricants-in-healthy-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-interactions-between-ro7795081-and-approved-medications-in-patients-with-type-2-diabetes-and-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetic-monitoring-of-meropenem-cefepime-piperacillin-tazobactam-linezolid-and-daptomycin-in-critically-ill-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-palatability-of-jnj-77242113-in-various-formulations-and-dietary-conditions-in-healthy-volunteers-with-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-pharmacodynamics-of-a-novel-long-acting-insulin-in-type-2-diabetes-patients-during-exercise-and-prolonged-fasting2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-pharmacodynamics-of-ndec-decitabine-and-tetrahydrouridine-in-sickle-cell-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-safety-of-anti-integrin-beta-3-human-monoclonal-antibody-rlyb212-in-pregnant-women-at-risk-for-hpa-1a-alloimmunization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-safety-of-intravenous-abbv-969-in-adults-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-safety-of-oral-abbv-453-in-adults-with-relapsed-or-refractory-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-and-tolerability-of-esflurbiprofen-topical-system-under-heat-occlusion-and-exercise-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-bat3306-with-chemotherapy-versus-pembrolizumab-with-chemotherapy-in-stage-iv-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-human-apotransferrin-in-patients-with-congenital-atransferrinemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-mirabegron-prolonged-release-suspension-in-pediatric-neurogenic-detrusor-overactivity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-risankizumab-in-pediatric-patients-with-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-subcutaneous-ct-p13-as-induction-therapy-in-patients-with-active-crohn-s-disease-or-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-and-safety-of-subcutaneous-pembrolizumab-coformulated-with-hyaluronidase-in-relapsed-refractory-chl-and-pmbcl2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-efficacy-safety-and-pharmacodynamics-of-satralizumab-in-pediatric-patients-with-aqp4-antibody-positive-neuromyelitis-optica-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-of-bi-685509-in-healthy-volunteers-impact-of-tablet-formulation-food-intake-and-esomeprazole-co-administration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-and-safety-of-subcutaneous-versus-intravenous-ocrelizumab-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-and-safety-of-subcutaneous-vs-intravenous-ublituximab-in-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-and-tolerability-of-osilodrostat-in-pediatric-and-adolescent-patients-with-cushing-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-efficacy-and-safety-of-apitegromab-in-infants-under-2-years-with-spinal-muscular-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-efficacy-and-safety-of-ravulizumab-in-pediatric-patients-with-primary-immunoglobulin-a-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-pharmacodynamics-efficacy-safety-and-immunogenicity-of-bp16-compared-to-denosumab-in-post-menopausal-osteoporosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-antiviral-efficacy-of-bictegravir-and-lenacapavir-in-pediatric-and-adolescent-patients-with-hiv-1-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-efficacy-of-empagliflozin-in-pediatric-patients-with-chronic-kidney-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-efficacy-of-golexanolone-in-primary-biliary-cholangitis-patients-with-fatigue-and-cognitive-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-efficacy-of-risankizumab-in-pediatric-patients-aged-6-to-18-years-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-efficacy-of-selumetinib-granule-formulation-in-pediatric-patients-with-nf1-related-inoperable-plexiform-neurofibromas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-pharmacodynamics-of-subcutaneous-belimumab-in-pediatric-patients-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-aztreonam-avibactam-metronidazole-in-neonates-and-infants-with-gram-negative-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-bia-28-6156-in-patients-with-parkinson-s-disease-and-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-crinecerfont-in-pediatric-patients-aged-0-to-2-years-with-congenital-adrenal-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-inhaled-chf10073-in-male-healthy-adults-with-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-intravenous-and-oral-posaconazole-in-pediatric-patients-with-invasive-fungal-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-intravenous-zanamivir-in-neonates-and-infants-under-6-months-with-complicated-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacokinetics-safety-and-tolerability-of-obefazimod-in-patients-with-renal-impairment-and-normal-renal-function-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacological-optimization-in-heart-failure-prevention-impact-of-spironolactone-and-drug-combination-on-female-patient-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pharmacological-treatment-withdrawal-in-heart-failure-patients-with-cardiac-resynchronization-therapy-eplerenone-valsartan-bisoprolol-and-furosemide2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-phosphocreatine-sodium-versus-sodium-chloride-in-patients-treated-by-medical-emergency-teams-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-piflufolastat-18f-pet-ct-for-monitoring-prostate-cancer-recurrence-in-patients-after-focal-hifu-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pioglitazone-and-avelumab-in-combination-with-tyrosine-kinase-inhibitors-for-chronic-phase-chronic-myelogenous-leukemia-in-cytogenetic-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pioglitazone-and-metformin-hydrochloride-in-metabolic-associated-fatty-liver-disease-with-prediabetes-a-pharmacogenetic-approach2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pioglitazone-and-tyrosine-kinase-inhibitors-in-chronic-phase-chronic-myelogenous-leukemia-post-tki-discontinuation-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-piperacillin-tazobactam-and-temocillin-as-carbapenem-alternatives-in-icu-patients-with-esbl-producing-enterobacteriaceae-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pirfenidone-and-nintedanib-combination-therapy-versus-monotherapy-in-progressive-idiopathic-pulmonary-fibrosis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pirfenidone-in-preventing-fibrosis-in-acute-respiratory-distress-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pirfenidone-inhalation-solution-ap01-for-progressive-fibrosing-interstitial-lung-diseases-including-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pirtobrutinib-safety-and-efficacy-in-adult-immune-thrombocytopenia-a-phase-1-2-dose-finding-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pit565-in-patients-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma-and-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pitolisant-efficacy-and-safety-in-pediatric-autism-spectrum-disorders-a-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pitolisant-efficacy-and-safety-in-pediatric-narcolepsy-with-without-cataplexy-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pitolisant-on-cardiac-repolarization-and-pharmacokinetics-in-narcolepsy-with-cataplexy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pivekimab-sunirine-monotherapy-and-in-combination-with-venetoclax-and-or-azacitidine-in-cd123-positive-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pivmecillinam-and-amoxicillin-clavulanic-acid-for-oral-step-down-therapy-in-febrile-utis-due-to-esbl-producing-enterobacterales2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-plasma-pharmacokinetics-of-leniolisib-in-subjects-with-impaired-hepatic-function-and-normal-hepatic-function-in-activated-phosphoinositide-3-kinase-delta-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-platelet-aggregation-and-acetylsalicylic-acid-response-in-type-1-diabetes-patients-with-atherosclerotic-cardiovascular-and-diabetic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-platinum-pemetrexed-chemotherapy-plus-lorlatinib-in-alk-positive-nsclc-with-extracranial-progression-on-lorlatinib2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-plitidepsin-efficacy-and-safety-in-adults-with-post-covid-19-condition-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pneumococcal-antibody-response-to-pcv20-in-healthy-adults-aged-78-84-following-booster-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pneumococcal-vaccine-immunogenicity-in-asplenic-patients-a-controlled-study-of-pcv20-and-pcv21-vaccination-timing-relative-to-splenectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-polatuzumab-vedotin-bendamustine-hydrochloride-and-rituximab-in-relapsed-refractory-mantle-cell-lymphoma-a-phase-ii-single-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-polygenic-risk-driven-rosuvastatin-and-atorvastatin-therapy-for-cardiovascular-event-reduction-in-high-coronary-artery-disease-risk-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pomalidomide-for-safety-and-immunomodulatory-effects-in-chronic-hepatitis-b-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pomalidomide-for-virological-control-in-hiv-1-infected-individuals-undergoing-analytical-treatment-interruption2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ponatinib-alone-or-with-chemotherapy-for-minimal-residual-disease-and-hematologic-relapse-in-adult-ph-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ponatinib-combined-with-chemotherapy-in-adult-patients-with-philadelphia-chromosome-negative-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ponatinib-efficacy-and-safety-in-resistant-chronic-phase-chronic-myeloid-leukemia-with-t315i-mutation-a-randomized-open-label-phase-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ponatinib-for-achieving-treatment-free-remission-in-patients-with-chronic-phase-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ponatinib-in-pediatric-patients-with-recurrent-or-refractory-leukemias-lymphomas-and-solid-tumors-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-posaconazole-prophylaxis-in-hematopoietic-stem-cell-transplant-recipients-at-high-risk-for-invasive-fungal-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-positron-emission-tomography-with-fludeoxyglucose-18f-for-preoperative-assessment-of-endometriosis-lesions-in-symptomatic-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-post-surgical-liquid-biopsy-guided-management-in-stage-iii-and-high-risk-stage-ii-colon-cancer-using-capecitabine-oxaliplatin-and-fluorouracil2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-post-transplant-renal-function-in-living-donor-renal-transplantation-using-acetylcysteine-and-amino-acid-solution-for-infusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-antibiotic-therapy-with-metronidazole-ceftriaxone-and-ofloxacin-in-complicated-acute-appendicitis-a-phase-iii-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-chemotherapy-reintroduction-with-folfiri-and-targeted-therapy-in-colorectal-cancer-patients-with-hepatic-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-intraocular-pressure-in-patients-with-macular-hole-vitreomacular-traction-or-macular-pucker-using-diclofenac-sodium-versus-dexamethasone-phosphate-eye-drops2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-oxygen-therapy-to-mitigate-hypoxemia-in-patients-at-risk-for-complications-following-non-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-piperacillin-tazobactam-therapy-versus-prophylaxis-for-surgical-site-infection-in-pancreaticoduodenectomy-patients-with-preoperative-biliary-stent2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-rebound-pain-in-radius-fracture-surgery-using-infraclavicular-brachial-plexus-block-with-ropivacaine-hydrochloride-at-two-concentrations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-recovery-when-combining-intravenous-lidocaine-with-ropivacaine-infiltration-in-laparoscopic-colorectal-oncologic-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postoperative-residual-neuromuscular-blockade-with-rocuronium-in-thoracic-surgery-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postpartum-b-cell-depletion-in-infants-exposed-to-ocrelizumab-in-utero-in-mothers-with-multiple-sclerosis-or-clinically-isolated-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-postprandial-glycemic-control-with-insulin-lispro-and-insulin-human-in-type-1-diabetes-patients-with-variable-gastric-emptying-rates2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-povidone-chlorhexidine-and-vancomycin-for-infection-prophylaxis-in-primary-or-aseptic-revision-total-joint-replacement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pozelimab-and-cemdisiran-alone-or-in-combination-on-geographic-atrophy-progression-in-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pozelimab-and-cemdisiran-combination-therapy-versus-ravulizumab-and-eculizumab-in-complement-inhibitor-naive-paroxysmal-nocturnal-hemoglobinuria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ppv-06-and-paracetamol-in-inflammatory-knee-osteoarthritis-a-phase-2-randomized-double-blind-placebo-controlled-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pralsetinib-on-pharmacokinetics-of-cyp3a4-cyp2c8-cyp2c9-substrates-and-hormones-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pramipexole-as-an-adjuvant-therapy-for-anhedonia-in-major-depressive-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pramipexole-dihydrochloride-monohydrate-for-restless-legs-syndrome-in-women-with-x-linked-adrenoleukodystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pramipexole-dihydrochloride-monohydrate-in-treatment-resistant-obsessive-compulsive-disorder-a-randomized-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prasugrel-monotherapy-at-reduced-dose-in-patients-with-acute-and-chronic-coronary-syndrome-post-percutaneous-coronary-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pravastatin-sodium-and-e-pros-on-quality-of-life-in-patients-with-severe-radio-induced-breast-fibrosis-post-breast-cancer-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prax-628-efficacy-and-safety-in-adults-with-focal-onset-or-primary-generalized-tonic-clonic-seizures-an-open-label-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prax-628-on-photoparoxysmal-eeg-response-in-epilepsy-patients-with-intermittent-photic-stimulation-a-phase-2-single-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pre-emptive-genotyping-for-optimizing-tacrolimus-dosing-in-pretransplant-chronic-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pre-emptive-noradrenaline-tartrate-infusion-to-mitigate-cardiovascular-collapse-in-critically-ill-adults-undergoing-endotracheal-intubation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pre-extubation-loading-dose-of-caffeine-citrate-on-extubation-success-in-patients-with-extubation-failure-and-bronchopulmonary-dysplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pre-surgical-human-papillomavirus-9-valent-vaccine-efficacy-in-women-undergoing-leep-for-high-grade-cervical-intraepithelial-neoplasia-and-early-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pre-vaccination-immune-status-in-healthy-volunteers-receiving-mycobacterium-bovis-danish-strain-1331-and-rabies-virus-inactivated-vaccines2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-precision-medicine-in-myocardial-infarction-with-non-obstructive-coronary-arteries-using-warfarin-lysine-aspirin-clopidogrel-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-acetate-and-placebo-eye-drops-in-patients-with-chronic-central-serous-chorioretinopathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-and-spi-62-in-the-management-of-polymyalgia-rheumatica-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-dosing-frequency-on-glycemic-control-in-anca-associated-vasculitis-patients-using-continuous-glucose-monitoring2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-efficacy-in-acute-interstitial-nephritis-a-randomized-prospective-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-efficacy-in-women-with-unexplained-recurrent-miscarriages-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisolone-with-clofutriben-spi-62-or-placebo-in-polymyalgia-rheumatica-patients-a-dose-adjustment-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisone-and-antihistamine-combination-versus-antihistamine-monotherapy-in-acute-urticaria-management-in-emergency-department-settings2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisone-as-an-adjunct-to-enzyme-replacement-or-chaperone-therapy-in-cardiac-manifestations-of-fabry-disease-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prednisone-efficacy-and-safety-in-patients-with-idiosyncratic-hepatotoxicity-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preemptive-genotyping-strategy-on-statin-induced-musculoskeletal-adverse-events-in-cardiovascular-risk-patients-using-atorvastatin-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-aqueous-iodine-solution-in-reducing-postoperative-hypoparathyroidism-risk-in-thyroidectomy-for-graves-disease-and-toxic-nodular-goiter2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-cholecalciferol-supplementation-on-post-thyroidectomy-hypocalcemia-incidence-in-patients-undergoing-total-thyroidectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-durvalumab-medi4736-in-patients-with-early-stage-untreated-small-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-electromotive-mitomycin-c-administration-in-non-muscle-invasive-bladder-carcinoma-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-intra-articular-ropivacaine-hydrochloride-and-adrenaline-in-reducing-postoperative-analgesic-requirements-in-total-hip-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-intramasseteric-methylprednisolone-hemisuccinate-injection-on-postoperative-sequelae-in-lower-third-molar-surgery-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-ketorolac-and-postoperative-low-dose-aspirin-with-hypoglycemic-diet-on-postoperative-morbidity-in-oncologic-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-methylprednisolone-hemisuccinate-and-hydrogen-succinate-on-postoperative-complications-in-elective-digestive-cancer-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-nepafenac-and-dexamethasone-on-postoperative-intraocular-inflammation-in-patients-undergoing-cataract-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-retifanlimab-plus-platinum-etoposide-chemo-immunotherapy-in-resectable-merkel-cell-carcinoma-the-mercury-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-preoperative-single-dose-versus-continuous-antibiotic-therapy-with-ertapenem-ciprofloxacin-and-cefuroxime-in-acute-cholecystitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pressurized-intraperitoneal-aerosol-chemotherapy-combined-with-systemic-chemotherapy-in-patients-with-advanced-ovarian-peritoneal-carcinomatosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pressurized-intraperitoneal-aerosol-chemotherapy-with-doxorubicin-hydrochloride-and-cisplatin-in-high-risk-gastric-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pressurized-intrathoracic-aerosol-chemotherapy-in-malignant-pleural-effusion-a-phase-i-study-in-danish-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-primary-tumor-ablation-on-survival-in-metastatic-renal-cell-carcinoma-treated-with-anti-pd1-based-therapies-a-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-proactive-therapeutic-drug-monitoring-versus-standard-care-in-sustaining-disease-control-in-rheumatoid-arthritis-patients-on-subcutaneous-adalimumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-probenecid-efficacy-on-cluster-seizures-during-anti-seizure-medication-tapering-in-presurgical-focal-epilepsy-video-eeg-monitoring2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-procalcitonin-guided-and-molecular-guided-therapy-with-vaborbactam-and-drug-combination-in-patients-with-severe-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-progesterone-for-the-prevention-of-preterm-birth-in-women-with-placenta-previa-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-progression-free-survival-in-high-risk-non-muscle-invasive-bladder-cancer-treated-with-mycobacterium-bovis-bacillus-calmette-guerin-strain-moreau-rj2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prolonged-anticoagulation-with-enoxaparin-and-apixaban-for-venous-thromboembolism-prevention-in-autoimmune-hemolytic-anemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prolonged-hydrocortisone-and-fludrocortisone-therapy-in-intermediate-high-risk-cardiac-surgery-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prolonged-prednisolone-and-n-acetylcysteine-in-severe-alcoholic-hepatitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-promethazine-hydrochloride-on-bimanual-coordination-in-healthy-volunteers-under-altered-gravitational-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prophylactic-amiodarone-hydrochloride-in-critically-ill-patients-post-out-of-hospital-cardiac-arrest-with-initial-shockable-rhythm2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prophylactic-amoxicillin-clavulanic-acid-or-clindamycin-in-preventing-bloodstream-infections-in-hemodialysis-patients-with-central-venous-catheters2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prophylactic-efficacy-of-weekly-atovaquone-proguanil-in-non-immune-healthy-volunteers-exposed-to-plasmodium-falciparum-via-pfspz-challenge2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prophylactic-strategies-for-talquetamab-induced-dysgeusia-in-multiple-myeloma-patients-using-pregabalin-clonazepam-and-dexamethasone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prophylactic-treatment-with-verapamil-nebivolol-and-amiodarone-hydrochloride-on-left-ventricular-function-in-asymptomatic-patients-with-frequent-pvcs2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-propofol-sedation-versus-placebo-in-less-invasive-surfactant-administration-for-respiratory-distress-syndrome-in-preterm-infants-32-weeks-gestation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-propranolol-for-early-secondary-prevention-of-post-traumatic-stress-disorder-in-adult-female-victims-of-sexual-violence-a-randomized-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-propranolol-on-preoperative-anxiety-and-tumorigenic-gene-expression-in-pancreatic-ductal-adenocarcinoma-a-randomized-triple-blinded-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-protamine-sulfate-for-heparin-reversal-in-adult-patients-undergoing-transfemoral-transcatheter-aortic-valve-replacement-for-severe-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-protamine-sulfate-for-heparin-reversal-to-mitigate-neurologic-and-hemorrhagic-events-post-transcatheter-aortic-valve-implantation-in-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-protoporphyrin-ix-formation-in-healthy-skin-following-topical-application-of-2-methyl-aminolevulinate-creams-a-randomized-investigator-masked-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-prs-ck-storm-in-preventing-cytokine-storm-in-sars-cov-2-infection-a-double-blind-randomized-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pseudoephedrine-hydrochloride-on-endurance-performance-in-healthy-volunteers-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pseudovax-hydrochloride-tislelizumab-and-molgramostim-in-patients-with-pseudomyxoma-peritonei-a-phase-i-safety-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-and-apomorphine-hydrochloride-hemihydrate-in-enhancing-consciousness-in-comatose-patients-with-acute-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-and-midazolam-assisted-psychotherapy-on-atherosclerotic-plaque-regression-in-patients-with-ischemic-heart-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-and-oxazepam-in-chemotherapy-induced-chronic-neuropathic-pain-a-randomized-controlled-pilot-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-and-trazodone-efficacy-in-adult-patients-with-treatment-resistant-depression-a-randomized-controlled-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-assisted-therapy-on-alcohol-consumption-in-patients-with-severe-alcohol-use-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-dry-extract-from-psilocybe-cubensis-for-safety-and-tolerability-in-young-adults-with-anorexia-nervosa2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-on-anhedonia-in-patients-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-on-pain-modulation-and-bdnf-levels-in-fibromyalgia-a-multicenter-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybin-s-efficacy-in-reducing-alcohol-consumption-in-patients-with-alcohol-use-disorder-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-and-ketamine-hydrochloride-as-rapid-antidepressants-in-treatment-resistant-depression-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-efficacy-and-safety-in-alleviating-psychological-distress-in-palliative-patients-with-copd-als-ms-and-atypical-parkinsonian-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-efficacy-in-alcohol-use-disorder-with-comorbid-depression-a-randomized-double-blind-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-efficacy-in-patients-with-treatment-resistant-depression-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-for-major-depressive-disorder-in-cancer-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psilocybine-ketamine-hydrochloride-and-midazolam-in-treating-depression-comorbid-with-cancer-a-randomized-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psma-pet-and-mpmri-in-high-risk-prostate-cancer-using-histopathologic-validation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psma-targeted-radionuclide-therapy-in-adults-with-metastatic-clear-cell-renal-cancer-post-anti-vegfr-and-immunotherapy-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-psychotropic-agents-quetiapine-lorazepam-and-olanzapine-for-agitated-behavior-in-dementia-unresponsive-to-standard-interventions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ptc-vs-tc-for-refractory-viral-infections-post-allogeneic-hematopoietic-stem-cell-transplantation-in-pediatric-and-young-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pulmonary-and-sleep-related-effects-of-intrathecal-baclofen-administration-in-cervical-spinal-cord-injury-a-safety-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pulmonary-function-post-rituximab-versus-placebo-in-granulomatous-lymphocytic-interstitial-lung-disease-a-phase-ii-double-blind-rct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pxs-5505-combined-with-5-azacitidine-in-patients-with-myelodysplastic-syndromes-and-chronic-myelomonocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pyridoxine-hydrochloride-efficacy-in-reducing-alkaline-phosphatase-levels-in-patients-with-primary-sclerosing-cholangitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-pyrimethamine-lenalidomide-and-panobinostat-combination-therapy-for-hiv-1-latency-reversal-in-hiv-1-infected-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-quadratus-lumborum-block-with-ropivacaine-hydrochloride-dexamethasone-sodium-phosphate-and-sodium-chloride-in-postoperative-analgesia-for-renal-cancer-nephrectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-quantitative-sensory-testing-qst-using-subcutaneous-administration-of-single-escalating-doses-of-halneuron-r-tetrodotoxin-ttx-for-injection-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-quercus-ilex-and-quercus-robur-allergen-extracts-in-skin-prick-testing-for-histamine-equivalent-papule-size-in-patients-with-oak-pollen-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-quizartinib-in-combination-with-chemotherapy-for-pediatric-flt3-itd-positive-npm1-wild-type-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-r-azasetron-besilate-sens-401-for-prevention-of-cisplatin-induced-ototoxicity-in-adults-with-neoplastic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-r3r01-for-safety-tolerability-and-efficacy-in-alport-syndrome-and-primary-steroid-resistant-focal-segmental-glomerulosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-r3r01-on-albuminuria-reduction-in-diabetic-kidney-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-raas-inhibitor-withdrawal-or-down-titration-in-non-dialysis-ckd-stage-iiib-v-patients-using-patiromer-versus-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-radial-nerve-block-duration-in-opioid-tolerant-versus-opioid-naive-individuals-using-lidocaine-hydrochloride-for-postoperative-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-radical-resection-rates-in-stage-iii-pd-l1-positive-nsclc-patients-treated-with-tislelizumab-and-platinum-based-chemotherapy-as-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-radiprodil-s-safety-tolerability-and-pharmacokinetics-in-pediatric-grin-related-disorder-a-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-radiprodil-s-safety-tolerability-and-pharmacokinetics-in-tuberous-sclerosis-complex-and-focal-cortical-dysplasia-type-ii-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ralinepag-efficacy-and-safety-in-pulmonary-arterial-hypertension-a-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-raludotatug-deruxtecan-in-the-treatment-of-gastrointestinal-cancers-a-phase-2-nonrandomized-open-label-multisite-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-raludotatug-deruxtecan-with-carboplatin-paclitaxel-or-bevacizumab-in-relapsed-high-grade-serous-ovarian-peritoneal-or-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ramucirumab-and-dacarbazine-efficacy-in-progressive-well-differentiated-metastatic-pancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ranibizumab-port-delivery-system-refill-regimen-in-neovascular-age-related-macular-degeneration-a-phase-iiib-multicenter-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ranibizumab-port-delivery-system-refill-regimens-in-neovascular-age-related-macular-degeneration-a-phase-iiib-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ranibizumab-with-or-without-early-targeted-peripheral-laser-photocoagulation-in-macular-edema-secondary-to-central-retinal-vein-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ranolazine-for-the-prevention-of-coronary-microvascular-dysfunction-in-st-elevation-myocardial-infarction-with-multivessel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rapcabtagene-autoleucel-versus-standard-of-care-in-systemic-lupus-erythematosus-patients-with-active-refractory-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rapcabtagene-autoleucel-versus-standard-treatment-in-severe-refractory-idiopathic-inflammatory-myopathies-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rapid-sedation-with-propofol-and-midazolam-versus-high-dose-intravenous-antiseizure-drug-combination-in-refractory-non-convulsive-status-epilepticus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rasburicase-on-renal-function-in-septic-patients-with-hyperuricemia-a-randomized-placebo-controlled-double-blind-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ravagalimab-and-lutikizumab-monotherapy-and-combination-therapy-in-adults-with-moderately-to-severely-active-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ravulizumab-efficacy-and-safety-in-adult-patients-with-immunoglobulin-a-nephropathy-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ravulizumab-efficacy-and-safety-in-pediatric-patients-with-aquaporin-4-antibody-positive-neuromyelitis-optica-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-raxtozinameran-vaccination-in-children-with-elevated-genetic-risk-for-type-1-diabetes-impact-on-islet-autoantibody-incidence2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reactogenicity-safety-and-immunogenicity-of-mrna-1345-vaccine-for-respiratory-syncytial-virus-in-pregnant-women-and-their-infants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reactogenicity-safety-immunogenicity-and-efficacy-of-gsk-hbv-viral-vector-and-adjuvanted-protein-vaccines-in-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reactogenicity-safety-immunogenicity-and-efficacy-of-hsv-targeted-immunotherapy-gskvx000000030810-in-adults-with-recurrent-genital-herpes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-coagulation-factor-viia-eptacog-alfa-activated-for-acute-hemorrhagic-stroke-in-early-administration-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-human-interferon-gamma-1b-as-adjunctive-therapy-in-candidemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-human-interferon-gamma-1b-for-reducing-secondary-infections-in-icu-patients-with-sustained-immunosuppression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-human-interferon-gamma-1b-in-post-aggressive-immunosuppression-in-icu-patients-a-randomized-double-blind-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-human-luteinizing-hormone-rhlh-pre-treatment-to-enhance-ovarian-reserve-in-patients-undergoing-ivf-icsi-due-to-tubal-male-or-idiopathic-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-human-plasma-gelsolin-in-moderate-to-severe-acute-respiratory-distress-syndrome-due-to-pneumonia-or-other-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-recombinant-lh-addition-to-follitropin-alfa-in-suboptimal-responders-with-infertility-aged-35-years-in-a-gnrh-antagonist-protocol2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-anticoagulation-targets-using-unfractionated-heparin-and-nadroparin-calcium-in-extracorporeal-membrane-oxygenation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-chemotherapy-cycles-with-pembrolizumab-in-pd-l1-positive-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-dexamethasone-dosage-in-preventing-prenatal-virilization-in-females-with-classic-congenital-adrenal-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-dose-alteplase-in-intermediate-high-risk-acute-pulmonary-embolism-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-dose-bleomycin-in-electrochemotherapy-for-cutaneous-malignancies-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-dose-cyclophosphamide-in-haploidentical-hematopoietic-stem-cell-transplantation-for-hematological-malignancies-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-duration-of-adjuvant-endocrine-therapy-with-exemestane-anastrozole-and-letrozole-in-postmenopausal-women-with-low-risk-hr-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-dwell-time-bacillus-calmette-guerin-bcg-instillation-regimen-in-high-risk-non-muscle-invasive-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-immunosuppression-regimen-with-tacrolimus-prednisolone-and-mycophenolate-sodium-in-older-adult-kidney-transplant-recipients-with-end-stage-renal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reduced-noradrenaline-tartrate-use-in-cardiogenic-shock-post-acute-myocardial-infarction-impact-on-mortality-and-renal-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regenerative-stem-cell-therapy-in-patients-with-stroke-in-europe2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regional-p-tau-protein-aggregates-using-f18-mk6240-pet-ct-in-alzheimer-s-disease-and-neurodegenerative-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regn4018-monotherapy-and-combination-with-cemiplimab-in-recurrent-ovarian-and-muc16-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regn6569-and-cemiplimab-in-adults-with-advanced-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regn7257-an-anti-il2rg-monoclonal-antibody-in-adults-with-severe-aplastic-anemia-refractory-or-relapsed-to-immunosuppressive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regn7508-versus-enoxaparin-sodium-for-venous-thromboembolism-prevention-in-patients-undergoing-elective-unilateral-total-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regorafenib-combined-with-metronomic-chemotherapy-and-low-dose-aspirin-versus-regorafenib-alone-in-chemo-resistant-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regorafenib-therapeutic-monitoring-for-personalized-treatment-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regorafenib-vemurafenib-and-dacomitinib-in-advanced-solid-tumors-multiple-myeloma-and-non-hodgkin-lymphoma-with-targetable-genomic-variants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regorafenib-with-metronomic-cyclophosphamide-capecitabine-and-low-dose-aspirin-in-second-line-metastatic-colorectal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regulatory-t-cells-for-immune-hyperactivation-in-covid-19-and-acute-respiratory-distress-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-regv131-and-lnp1265-a-crispr-cas9-based-gene-insertion-therapy-in-adult-patients-with-hemophilia-b2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-relative-bioavailability-and-palatability-of-etrasimod-arginine-mini-tablets-in-various-food-vehicles-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-relative-bioavailability-of-two-tozorakimab-dosage-forms-via-subcutaneous-administration-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-remdesivir-for-preventing-severe-covid-19-in-asymptomatic-or-paucisymptomatic-sars-cov-2-positive-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-remission-maintenance-with-extended-prednisone-administration-in-anca-associated-vasculitis-using-rituximab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-remternetug-ly3372993-versus-placebo-in-early-alzheimer-s-disease-patients-at-risk-for-cognitive-and-functional-decline2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-renal-denervation-via-ethanol-mediated-neurolysis-using-the-peregrine-system-tm-kit-in-patients-with-uncontrolled-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-renal-impairment-and-dialysis-on-pharmacokinetics-of-single-3-mg-cytisinicline-dose-in-nicotine-addiction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-renal-impairment-impact-on-aticaprant-jnj-67953964-pharmacokinetics-in-healthy-adults-an-open-label-single-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-renal-impairment-on-pharmacokinetics-of-efgartigimod-in-patients-with-kidney-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-repeated-intraglandular-injections-of-adrc001-for-radiation-induced-xerostomia-in-head-and-neck-cancer-survivors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-repeated-methylprednisolone-acetate-injections-around-the-greater-occipital-nerve-for-prophylaxis-in-chronic-cluster-headache2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-repotrectinib-and-cyp450-probe-cocktail-in-tki-pretreated-ros1-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-resamirigene-bilparvovec-gene-therapy-in-x-linked-myotubular-myopathy-a-phase-1-2-3-randomized-open-label-ascending-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-residual-platelet-function-following-administration-of-d-l-lysine-acetylsalicylate-in-patients-with-immune-thrombocytopenia-and-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-resmetirom-on-liver-related-outcomes-in-patients-with-well-compensated-non-alcoholic-steatohepatitis-cirrhosis-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-respiratory-effects-of-oxycodone-hydrochloride-and-paracetamol-in-patients-with-coronary-or-valvular-heart-disease-post-cardiac-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-respiratory-microbiota-alterations-following-nitrous-oxide-and-oxygen-administration-in-pediatric-patients-with-suspected-lower-respiratory-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-response-predictors-to-omalizumab-and-mepolizumab-in-severe-allergic-and-eosinophilic-asthma-a-multinational-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retatrutide-on-insulin-secretion-and-sensitivity-in-adults-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retifanlimab-capecitabine-and-oxaliplatin-in-first-line-treatment-of-dmmr-metastatic-esophagogastric-cancer-a-proof-of-principle-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retinol-palmitate-administration-and-serum-levels-in-preterm-infants-with-bronchopulmonary-dysplasia-a-phase-2a-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retinol-palmitate-fluorometholone-and-sodium-hyaluronate-carbomer-981-in-managing-chronic-mucopurulent-discharge-in-ocular-prosthesis-users2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retinol-palmitate-sodium-hyaluronate-and-fluorometholone-in-managing-chronic-mucopurulent-discharge-in-ocular-prosthesis-wearers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-retreatment-protocols-with-lutetium-177lu-oxodotreotide-in-patients-with-progressive-intestinal-well-differentiated-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-revumenib-combined-with-azacitidine-and-venetoclax-in-newly-diagnosed-npm1-mutated-or-kmt2a-rearranged-aml-patients-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-reward-specific-dopamine-synthesis-alterations-in-major-depression-effects-of-escitalopram-oxalate-and-bupropion-hydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rezafungin-acetate-for-chronic-pulmonary-aspergillosis-in-patients-with-limited-treatment-options-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rezafungin-acetate-plasma-concentrations-in-critically-ill-patients-with-invasive-candidiasis-undergoing-extracorporeal-membrane-oxygenation-renal-replacement-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rgx-314-gene-therapy-efficacy-and-safety-in-neovascular-age-related-macular-degeneration-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ribociclib-combined-with-endocrine-therapy-in-hormone-receptor-positive-her2-negative-early-breast-cancer-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rifampicin-efficacy-and-safety-in-cutibacterium-acnes-prosthetic-joint-infections-with-amoxicillin-moxifloxacin-clindamycin-and-doxycycline2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rifamycin-based-regimens-isoniazid-plus-rifapentine-rifampicin-and-isoniazid-plus-rifampicin-for-latent-tuberculosis-in-end-stage-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rifaximin-and-lactulose-for-prevention-of-hepatic-encephalopathy-in-alcoholic-liver-cirrhosis-patients-undergoing-transjugular-intrahepatic-portosystemic-shunt-placement2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rifaximin-on-psychobiological-stress-and-fear-responses-in-healthy-male-volunteers-a-randomized-triple-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rilpivirine-based-antiretroviral-regimen-in-hiv-infected-patients-with-metabolic-liver-disease-maintaining-undetectable-viral-load2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-riluzole-efficacy-in-reducing-spasticity-in-chronic-traumatic-spinal-cord-injury-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rilvegostomig-trastuzumab-deruxtecan-and-azd0901-as-perioperative-treatment-in-locally-advanced-resectable-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rimegepant-and-capsaicin-in-modulating-trigeminovascular-reactivity-in-obesity-and-migraine-a-controlled-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rimegepant-for-migraine-prophylaxis-in-pediatric-patients-aged-6-to-18-years-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-riociguat-discontinuation-post-balloon-pulmonary-angioplasty-in-chronic-thromboembolic-pulmonary-hypertension-a-randomized-controlled-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-riociguat-on-right-ventricular-function-in-pulmonary-arterial-hypertension-and-chronic-thromboembolic-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ripretinib-on-pharmacokinetics-of-midazolam-in-patients-with-advanced-gastrointestinal-stromal-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risankizumab-800cw-safety-and-optimal-imaging-dose-in-inflammatory-bowel-disease-using-fluorescence-molecular-endoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risankizumab-abbv-382-and-lutikizumab-in-adult-patients-with-moderate-to-severe-crohn-s-disease-a-phase-2a-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risdiplam-as-early-intervention-in-pediatric-spinal-muscular-atrophy-post-onasemnogene-abeparvovec-gene-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risdiplam-efficacy-and-safety-in-pediatric-spinal-muscular-atrophy-patients-post-onasemnogene-abeparvovec-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risdiplam-efficacy-in-infants-with-genetically-diagnosed-presymptomatic-spinal-muscular-atrophy-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risdiplam-safety-tolerability-and-pharmacokinetics-pharmacodynamics-in-adult-and-pediatric-patients-with-spinal-muscular-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-risedronate-sodium-in-patients-with-dilated-cardiomyopathy-due-to-troponin-t-k210-deletion-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-and-chemotherapy-regimens-in-pediatric-aggressive-b-cell-lymphoma-and-leukemia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-and-cyclophosphamide-in-inducing-and-sustaining-remission-in-anca-associated-vasculitis-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-and-mycophenolate-mofetil-in-interstitial-lung-disease-associated-with-systemic-sclerosis-a-multicenter-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-and-obinutuzumab-on-lymphocyte-subsets-in-peripheral-blood-and-lymphoid-tissues-of-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-and-sodium-chloride-infusions-in-active-systemic-sclerosis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-based-combination-tocilizumab-and-tofacitinib-in-granulomatosis-with-polyangiitis-patients-unresponsive-to-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-discontinuation-versus-maintenance-therapy-in-anca-associated-vasculitis-patients-in-stable-remission-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-efficacy-and-safety-in-generalized-achr-antibody-positive-myasthenia-gravis-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-efficacy-in-inducing-remission-in-pediatric-idiopathic-nephrotic-syndrome-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-for-relapse-prevention-in-adult-minimal-change-nephrotic-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-gemcitabine-dexamethasone-platinum-with-or-without-selinexor-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rituximab-induced-remission-in-chronic-inflammatory-demyelinating-polyneuropathy-with-adjunctive-intravenous-immunoglobulin-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-and-warfarin-sodium-in-anticoagulation-management-for-acute-coronary-syndrome-with-atrial-fibrillation-using-telecardiology2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-dabigatran-etexilate-and-fluindione-in-patients-with-non-device-related-intra-cardiac-thrombus-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-for-antithrombotic-management-in-patients-with-hypertrophic-cardiomyopathy-and-abnormal-left-atrial-reservoir-strain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-for-thromboprophylaxis-in-patients-undergoing-elective-unilateral-primary-hip-arthroplasty-following-eras-protocol2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-monotherapy-and-cyp2c19-genotype-testing-in-atrial-fibrillation-patients-undergoing-percutaneous-coronary-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-on-atherosclerotic-carotid-plaque-stabilization-in-patients-with-stable-peripheral-artery-disease-using-3d-contrast-enhanced-ultrasound2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-on-clinical-and-laboratory-outcomes-in-short-bowel-syndrome-patients-on-long-term-parenteral-nutrition2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivaroxaban-versus-low-molecular-weight-heparin-for-thromboembolism-prevention-in-high-risk-patients-with-lower-limb-trauma-requiring-immobilization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rivastigmine-and-eeg-in-predicting-ect-response-and-mitigating-cognitive-side-effects-in-patients-with-severe-depression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rl-007-on-cognitive-impairment-in-schizophrenia-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rls-0071-in-hospitalized-patients-with-steroid-refractory-acute-graft-versus-host-disease-a-phase-2-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rmc-035-efficacy-and-safety-in-preventing-renal-dysfunction-post-cardiac-surgery-in-high-risk-patients-a-phase-2b-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rmc-6236-and-pembrolizumab-with-or-without-chemotherapy-in-patients-with-ras-mutated-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rmc-6291-and-rmc-6236-in-combination-with-pembrolizumab-and-chemotherapy-in-ras-g12c-mutated-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rmc-9805-and-rmc-6236-in-combination-with-pembrolizumab-and-chemotherapy-in-ras-g12d-mutated-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7204239-a-humanized-igg1-monoclonal-antibody-against-latent-myostatin-in-facioscapulohumeral-muscular-dystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7204239-on-insulin-sensitivity-and-muscle-composition-in-type-2-diabetes-mellitus-patients-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7269162-on-amyloid-biomarkers-in-prodromal-alzheimer-s-disease-a-phase-iia-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7276389-monotherapy-and-combination-with-cobimetinib-in-braf-v600-mutation-positive-advanced-solid-tumors-or-melanoma-with-cns-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7284755-monotherapy-and-in-combination-with-atezolizumab-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7496353-combined-with-a-checkpoint-inhibitor-and-optional-standard-of-care-chemotherapy-in-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7502175-monotherapy-and-combination-with-checkpoint-inhibitor-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7566802-monotherapy-and-combination-with-atezolizumab-in-locally-advanced-or-metastatic-solid-tumor-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7616789-safety-tolerability-pharmacokinetics-pharmacodynamics-and-anti-tumor-activity-in-advanced-small-cell-lung-cancer-and-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ro7795081-efficacy-and-safety-compared-to-placebo-and-semaglutide-in-type-2-diabetes-mellitus-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rocuronium-bromide-induced-neuromuscular-block-duration-in-infants-undergoing-craniosynostosis-surgery-with-sevoflurane-and-propofol-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rocuronium-bromide-sugammadex-and-suxamethonium-chloride-in-reducing-post-intubation-morbidity-in-adult-respiratory-distress2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-roginolisib-combined-with-dostarlimab-and-or-docetaxel-in-advanced-non-squamous-non-small-cell-lung-cancer-post-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-romosozumab-and-zoledronic-acid-in-optimizing-treatment-strategies-for-osteoporosis-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-romosozumab-versus-bisphosphonates-in-pediatric-osteogenesis-imperfecta-a-phase-3-open-label-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rondaptivon-pegol-bt200-efficacy-and-safety-in-type-2b-von-willebrand-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ropeginterferon-alfa-2b-efficacy-and-safety-in-essential-thrombocythaemia-patients-intolerant-refractory-or-ineligible-for-cytoreductive-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ropivacaine-concentrations-on-sensory-block-duration-in-ultrasound-guided-ankle-blocks-for-hallux-valgus-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ropivacaine-hydrochloride-versus-lidocaine-hydrochloride-for-postoperative-pain-management-in-patients-with-chronic-tonsillitis-undergoing-tonsillectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rosnilimab-efficacy-and-safety-in-moderate-to-severe-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rosuvastatin-calcium-for-reducing-recurrent-venous-thromboembolism-in-patients-with-pulmonary-embolism-or-deep-vein-thrombosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rotigotine-and-rivastigmine-combination-therapy-on-cognitive-function-in-mild-to-moderate-alzheimer-s-disease-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rotigotine-safety-in-autosomal-dominant-polycystic-kidney-disease-patients-a-24-month-transdermal-administration-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-routine-versus-selective-protamine-sulfate-administration-on-bleeding-complications-post-transcatheter-aortic-valve-implantation-in-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-roxadustat-on-glucose-and-lipid-metabolism-and-cardiovascular-function-in-patients-with-cardiovascular-disease-risk-factors-and-metabolic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rp2-monotherapy-and-rp2-combined-with-pd1-inhibition-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rp3-monotherapy-and-rp3-plus-nivolumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rtp-026-sodium-in-a-randomized-double-blind-placebo-controlled-trial-for-safety-and-efficacy-in-st-elevation-myocardial-infarction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ruxolitinib-combined-with-aieop-bfm-2017-chemotherapy-in-pediatric-acute-lymphoblastic-leukemia-with-jak-stat-pathway-activation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ruxolitinib-combined-with-standard-care-in-reversing-organ-failure-in-critically-ill-adults-with-acquired-hemophagocytic-syndrome-in-icu2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ruxolitinib-versus-best-available-therapy-in-high-risk-polycythemia-vera-and-essential-thrombocythemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rvu120-and-venetoclax-combination-therapy-in-acute-myeloid-leukemia-patients-refractory-to-prior-venetoclax-and-hypomethylating-agent-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rvu120-monotherapy-and-rvu120-ruxolitinib-combination-in-intermediate-or-high-risk-primary-or-secondary-myelofibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-rvu120-monotherapy-in-relapsed-refractory-high-risk-myelodysplastic-syndrome-and-acute-myeloid-leukemia-with-without-npm1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-s-337395-efficacy-and-safety-in-high-risk-nonhospitalized-adults-with-respiratory-syncytial-virus-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-s095035-and-tng462-in-mtap-deleted-advanced-or-metastatic-solid-tumors-a-phase-1-2-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-s227928-and-venetoclax-in-relapsed-refractory-acute-myeloid-leukemia-myelodysplastic-syndrome-aml-or-chronic-myelomonocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-saccharomyces-boulardii-cncm-i-745-and-amoxicillin-on-gut-microbiota-in-patients-with-erythema-migrans-undergoing-antibiotic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacituzumab-govitecan-in-metastatic-esophagogastric-adenocarcinoma-a-phase-ib-ii-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacituzumab-tirumotecan-in-patients-with-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacituzumab-tirumotecan-lenvatinib-and-pembrolizumab-in-advanced-esophageal-squamous-cell-carcinoma-post-pd-1-pd-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacituzumab-tirumotecan-with-carboplatin-paclitaxel-and-pembrolizumab-in-high-risk-early-stage-triple-negative-or-hr-low-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacituzumab-tirumotecan-with-or-without-bevacizumab-versus-standard-of-care-in-platinum-sensitive-recurrent-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacubitril-valsartan-for-primary-prevention-of-anthracycline-induced-cardiotoxicity-in-breast-cancer-treatment-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacubitril-valsartan-in-preventing-disease-progression-in-patients-with-arrhythmogenic-right-ventricular-cardiomyopathy-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacubitril-valsartan-on-systolic-function-in-transthyretin-cardiac-amyloidosis-and-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacubitril-valsartan-versus-enalapril-on-pulmonary-hemodynamics-in-patients-with-heart-failure-with-reduced-ejection-fraction-and-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sacubitril-valsartan-versus-ramipril-on-left-ventricular-function-in-ischemic-heart-failure-with-mid-range-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-anti-tumor-activity-of-gen1042-with-pembrolizumab-and-chemotherapy-in-patients-with-advanced-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-anti-tumor-activity-of-intravesical-tara-002-in-high-grade-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-anti-tumor-activity-of-tt125-802-with-adagrasib-or-osimertinib-in-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-anti-tumor-efficacy-of-t-cell-therapy-in-patients-with-advanced-hepatocellular-carcinoma-and-afp-expressing-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-antineoplastic-activity-of-oatd-02-in-patients-with-advanced-or-metastatic-solid-tumours-a-multicentre-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-clinical-activity-of-atl001-and-pembrolizumab-in-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-clinical-response-of-intra-arterial-autologous-mesenchymal-stem-cells-in-pediatric-autoimmune-refractory-epilepsy-and-rasmussen-encephalitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-dosage-of-intra-arterial-177lu-lu-psma-i-t-in-patients-with-progressive-or-recurrent-intracranial-diffuse-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-dosimetry-of-lutetium-177lu-oxodotreotide-in-adolescent-patients-with-sstr-positive-gep-nets-pheochromocytoma-and-paragangliomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-in-switching-from-dolutegravir-lamivudine-to-bictegravir-emtricitabine-tenofovir-alafenamide-in-hiv-patients-with-neuropsychiatric-vulnerabilities2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-166holmium-sirt-with-atezolizumab-and-bevacizumab-in-non-resectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-abbv-cls-628-in-adults-with-autosomal-dominant-polycystic-kidney-disease-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-allogeneic-adipose-tissue-derived-mesenchymal-stromal-cells-in-epidermolysis-bullosa-congenita-phase-i-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-allogeneic-peripheral-blood-derived-cd56-nk-cells-co-cultured-with-k562-mb15-41bbi-in-refractory-sarcomas-in-pediatric-and-young-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ari0002h-car-t-cells-targeting-bcma-in-initial-treatment-of-primary-plasma-cell-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-auto1-car-t-cells-targeting-cd19-in-adults-with-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-autologous-cd19-specific-car-t-cells-caba-201-in-active-systemic-lupus-erythematosus-a-phase-1-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-autologous-crispr-cas9-modified-cd34-hematopoietic-stem-cells-exagamglogene-autotemcel-in-severe-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-autologous-crispr-cas9-modified-cd34-hhspcs-in-transfusion-dependent-b-thalassemia-with-busulfan-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-autologous-t-cells-modified-with-lentiviral-vector-encoding-cd1a-specific-car-in-relapsed-refractory-t-cell-acute-lymphoblastic-leukemia-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-cenobamate-in-pediatric-patients-with-partial-onset-seizures-an-open-label-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-cls12311-in-patients-with-relapsing-remitting-multiple-sclerosis-a-phase-ib-iia-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-crn04894-in-patients-with-congenital-adrenal-hyperplasia-an-open-label-long-term-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-debio-0123-and-sacituzumab-govitecan-in-advanced-metastatic-triple-negative-or-hr-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-delandistrogene-moxeparvovec-and-imlifidase-in-duchenne-muscular-dystrophy-patients-with-pre-existing-raavrh74-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-divarasib-with-pembrolizumab-and-chemotherapy-in-kras-g12c-mutant-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-dt-dec01-in-duchenne-muscular-dystrophy-a-phase-1-2-open-label-exploratory-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ecur-506a-and-ecur-506d-in-male-infants-with-neonatal-onset-ornithine-transcarbamylase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-elacestrant-in-combination-therapies-for-patients-with-metastatic-breast-cancer-a-phase-1b-2-open-label-umbrella-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-engineered-human-myocardium-implant-in-patients-with-terminal-heart-failure-using-allogeneic-induced-pluripotent-stem-cells-derived-cardiomyocytes-and-stromal-cell2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-epicardial-collagen-membranes-with-allogeneic-adipose-derived-stem-cells-in-ischemic-left-ventricular-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-fluocinolone-acetonide-intravitreal-implant-in-pediatric-patients-with-recurrent-non-infectious-uveitis-of-the-posterior-segment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-gb1211-and-atezolizumab-in-non-small-cell-lung-cancer-patients-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-gdc-4198-and-giredestrant-versus-abemaciclib-and-giredestrant-in-er-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-genetically-modified-autologous-cd34-hematopoietic-stem-cells-in-pediatric-mucopolysaccharidosis-type-i-hurler-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-human-plasma-protein-and-saline-in-patients-with-early-symptomatic-alzheimer-s-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-in-vitro-expanded-regulatory-t-cell-therapy-and-tocilizumab-with-donor-bone-marrow-infusion-in-hla-mismatched-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-inavolisib-letrozole-and-ribociclib-in-neoadjuvant-treatment-for-early-stage-pik3ca-mutated-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-inobrodib-betamethasone-sodium-phosphate-and-dimethyl-fumarate-in-advanced-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-intracerebral-administration-of-ifezuntirgene-inilparvovec-in-adults-with-early-manifest-huntington-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-intravenous-allogeneic-fetal-mesenchymal-stem-cells-in-severe-osteogenesis-imperfecta-types-iii-and-iv2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ipn10200-in-adults-with-moderate-to-severe-upper-facial-lines-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-jr-441-in-mucopolysaccharidosis-type-iiia-via-weekly-intravenous-infusions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-l19tnf-and-lomustine-in-patients-with-glioblastoma-at-first-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-lower-inr-range-in-patients-with-bileaflet-aortic-mechanical-valves-on-warfarin-acenocoumarol-and-phenprocoumon-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ly3884961-in-parkinson-s-disease-patients-with-gba1-mutation-a-phase-1-2a-open-label-ascending-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-mk-2870-and-paclitaxel-in-second-line-treatment-of-advanced-metastatic-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-mk-6070-and-ifinatamab-deruxtecan-in-relapsed-refractory-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-nebulised-sodium-nitrite-formulations-in-non-cystic-fibrosis-bronchiectasis-with-pseudomonas-aeruginosa2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-novel-targeted-therapy-combinations-in-adults-with-advanced-or-metastatic-braf-v600-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-od-07656-and-vedolizumab-in-moderately-to-severely-active-ulcerative-colitis-a-phase-2a-open-label-and-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-onfekafusp-alfa-and-temozolomide-chemoradiotherapy-in-patients-with-newly-diagnosed-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-osimertinib-with-concomitant-radiation-therapy-in-stage-iv-egfr-mutation-positive-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-platelet-rich-plasma-injection-for-intraovarian-growth-in-patients-with-low-ovarian-reserve2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-plx-pad-cells-in-mild-to-moderate-knee-osteoarthritis-a-phase-i-iia-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-polycore-a-combination-of-xylitol-l-carnitine-and-polydextrin-in-end-stage-kidney-disease-patients-initiating-peritoneal-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-pri-002-in-patients-with-mild-cognitive-impairment-or-mild-dementia-due-to-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ptc518-in-a-randomized-placebo-controlled-dose-ranging-phase-2a-study-in-huntington-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-recombinant-adenovirus-advince-in-patients-with-metastatic-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-recombinant-nerve-growth-factor-chf6467-in-pediatric-patients-with-optic-pathway-glioma-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-ro7204239-and-risdiplam-in-spinal-muscular-atrophy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-skb410-mk-3120-monotherapy-in-patients-with-advanced-metastatic-solid-tumors-a-phase-1-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-sodium-zirconium-cyclosilicate-in-pediatric-hyperkalemia-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-targeted-therapies-in-metastatic-colorectal-cancer-subpopulations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-tecaginlimab-and-pembrolizumab-with-radiotherapy-in-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-telisotuzumab-adizutecan-combinations-in-metastatic-colorectal-cancer-a-phase-2-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-thor-707-monotherapy-and-combination-therapy-in-adults-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-topical-sxr1096-cream-in-patients-with-netherton-syndrome-a-phase-i-ii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-tri-001-in-patients-with-chronic-limb-threatening-ischemia-due-to-peripheral-arterial-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-umbilical-cord-derived-mesenchymal-stem-cells-bp-cc-001-in-cartilage-defect-of-the-knee-joint2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-xl092-with-nivolumab-ipilimumab-and-relatlimab-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-efficacy-of-zilovertamab-vedotin-and-nemtabrutinib-in-aggressive-and-indolent-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-expression-of-delandistrogene-moxeparvovec-in-pediatric-patients-with-duchenne-muscular-dystrophy-under-four-years-of-age2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-bimervax-and-seasonal-influenza-vaccine-coadministration-in-sars-cov-2-and-influenza-vaccinated-adults-aged-652026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-cd40-pan-cov-vaccine-with-or-without-adjuvant-as-a-booster-in-healthy-adult-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-duochol-oral-vaccine-for-cholera-prevention-in-healthy-adults-aged-18-45-in-sweden-a-phase-i-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-intranasal-sars-cov-2-vaccine-for-booster-immunization-against-covid-19-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-meningococcal-and-pneumococcal-vaccines-in-hiv-positive-adults-a-randomized-non-blinded-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-mrna-vaccine-against-respiratory-syncytial-virus-in-healthy-adult-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-ovx033-sarbecovirus-vaccine-in-adults-a-phase-1-2a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-phh-1v81-booster-in-adults-vaccinated-against-covid-19-with-mrna-vaccine-comparing-to-raxtozinameran2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-recombinant-varicella-zoster-virus-glycoprotein-e-vaccine-in-patients-with-psoriasis-or-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-tetralite-influenza-vaccine-with-litevax-adjuvant-in-adults-aged-18-50-and-60-years-a-phase-1b-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-two-investigational-rna-based-vaccines-for-tuberculosis-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-v116-in-pediatric-patients-at-increased-risk-for-pneumococcal-disease-a-phase-3-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-immunogenicity-of-v116-versus-ppsv23-in-pneumococcal-vaccine-naive-adults-aged-50-years-or-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-local-tolerability-of-a24110he-in-patients-with-moderate-to-severe-hypertriglyceridemia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacodynamic-effects-of-investigational-agents-in-patients-with-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacodynamics-of-biib122-in-lrrk2-associated-parkinson-s-disease-a-phase-2a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-bdt272-in-single-and-multiple-ascending-doses-in-healthy-volunteers-with-moderate-to-severe-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-forimtamig-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-intravenous-fixed-dose-combination-of-tiragolumab-and-atezolizumab-in-advanced-recurrent-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-lazertinib-monotherapy-or-combined-with-jnj-61186372-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-modified-tafasitamab-iv-dosing-with-lenalidomide-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-pharmacokinetics-of-ro7198457-alone-and-with-atezolizumab-in-patients-with-locally-advanced-or-metastatic-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-anti-tumor-activity-of-debio-0123-monotherapy-in-adults-with-advanced-uterine-serous-carcinoma-epithelial-ovarian-cancer-or-biomarker-driven-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-efficacy-of-auto1-in-pediatric-patients-with-cd19-positive-relapsed-refractory-b-all-and-b-nhl2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-efficacy-of-autologous-3d-osteogenic-implant-nvd-003-in-recalcitrant-lower-limb-nonunion-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-efficacy-of-cldn6-car-t-and-cldn6-rna-lpx-in-cldn6-positive-relapsed-or-refractory-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-efficacy-of-il12-l19l19-in-patients-with-advanced-or-metastatic-carcinomas-post-immune-checkpoint-blockade-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-preliminary-efficacy-of-intramyocardial-injection-of-allogeneic-cardiac-atrial-stem-cells-in-advanced-ischemic-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-5-aminolevulinic-acid-and-ultrasound-mediated-sonodynamic-therapy-in-newly-diagnosed-high-grade-glioma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-azd6244-in-patients-with-advanced-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-ceb-01-plga-membrane-in-patients-with-recurrent-or-locally-advanced-retroperitoneal-soft-tissue-sarcoma-post-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-edv2209-in-patients-with-non-traumatic-subarachnoid-hemorrhage-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-eganelisib-and-cytarabine-in-relapsed-refractory-acute-myeloid-leukemia-and-higher-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-genetically-modified-t-cells-in-ror1-positive-tumors-a-study-in-mantle-cell-lymphoma-ovarian-adrenocortical-breast-cancer-and-cll2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-gp120-activated-regulatory-t-cells-in-post-hsct-patients-to-mitigate-acute-graft-versus-host-disease-in-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-grwd5769-monotherapy-and-in-combination-with-cemiplimab-in-patients-with-advanced-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-gs030-dp-in-non-syndromic-retinitis-pigmentosa-via-intravitreal-injection-and-light-stimulation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-hiv-1-inducers-in-hiv-sub-type-b-patients-on-cart-with-undetectable-viral-load2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-intra-articular-resiniferatoxin-and-ropivacaine-hydrochloride-in-moderate-to-severe-knee-osteoarthritis-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-kand567-and-carboplatin-in-recurrent-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-mze829-in-adults-with-proteinuric-apol1-associated-chronic-kidney-disease-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-neoantigen-selected-tumor-infiltrating-lymphocyte-therapy-in-advanced-epithelial-and-icb-resistant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-optimized-rifampicin-dosing-in-tuberculosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-oral-pd-l-506-and-diagnostic-utility-of-urinary-porphyrin-levels-in-colorectal-carcinoma-and-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-roginolisib-and-ruxolitinib-in-myelofibrosis-patients-unresponsive-to-jak-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-sar446959-in-patients-with-knee-osteoarthritis-a-first-in-human-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-single-ascending-doses-of-agmb-101-in-healthy-subjects-and-patients-with-liver-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-single-dose-intravenous-oritavancin-versus-standard-care-in-pediatric-acute-bacterial-skin-and-skin-structure-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-sodium-glycocholate-and-sodium-butyrate-in-enhancing-calcium-absorption-post-roux-en-y-gastric-bypass-in-females2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-sonrotoclax-and-zanubrutinib-in-patients-with-previously-untreated-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-spartalizumab-monotherapy-or-in-combination-with-other-agents-in-patients-with-advanced-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-tamoxifen-citrate-in-cystic-fibrosis-patients-ineligible-for-cftr-modulator-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-teprotumumab-dosing-durations-in-patients-with-thyroid-eye-disease-a-phase-3b-4-randomized-double-masked-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-tp-122-bacteriophage-cocktail-in-adult-patients-with-ventilator-associated-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-tp-122a-bacteriophage-cocktail-in-adults-with-ventilator-associated-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-transcon-il-2-b-g-pembrolizumab-and-transcon-tlr7-8-agonist-in-advanced-or-metastatic-solid-tumor-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-treg02-as-adjunctive-therapy-in-deceased-donor-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-treprostinil-sodium-in-pediatric-patients-with-pulmonary-arterial-hypertension-an-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-ttx-381-gene-therapy-in-ocular-manifestations-of-neuronal-ceroid-lipofuscinosis-type-2-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-tx200-tr101-in-prophylaxis-against-renal-transplant-rejection-in-living-donor-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerability-of-vrdn-003-in-patients-with-thyroid-eye-disease-a-randomized-double-masked-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-and-tolerance-of-cryopreserved-autologous-stromal-vascular-fraction-and-micrograft-in-refractory-ano-perineal-fistulas-in-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-biological-response-and-efficacy-of-temferon-in-metastatic-renal-cell-carcinoma-with-cabozantinib-pembrolizumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-cellular-kinetics-and-exploratory-efficacy-of-rapcabtagene-autoleucel-in-refractory-sjogren-s-disease-and-difficult-to-treat-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-disease-progression-and-cellular-kinetics-of-ytb323-in-non-active-progressive-multiple-sclerosis-with-cyclophosphamide-tocilizumab-and-fludarabine-phosphate2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-cellular-kinetics-of-rapcabtagene-autoleucel-in-relapsing-multiple-sclerosis-with-breakthrough-disease-activity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-cellular-kinetics-of-rapcabtagene-autoleucel-in-severe-refractory-systemic-lupus-erythematosus-with-fludarabine-cyclophosphamide-and-tocilizumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-immunogenicity-of-mrna-1010-influenza-vaccine-versus-inactivated-influenza-vaccine-in-adults-aged-50-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-immunogenicity-of-sequential-bepirovirsen-and-gskvx000000008866-in-chronic-hepatitis-b-patients-on-nucleos-t-ide-analogue-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-optimal-dosing-of-abbv-400-with-budigalimab-in-advanced-or-metastatic-non-squamous-nsclc-lacking-actionable-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-pharmacokinetics-of-7-ethyl-10-hydroxycamptothecin-ceb-01-in-pediatric-patients-with-locally-resectable-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-pharmacokinetics-of-csl889-human-hemopexin-in-sickle-cell-disease-patients-experiencing-vaso-occlusive-crisis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-pharmacokinetics-of-mosunetuzumab-and-atezolizumab-in-relapsed-refractory-b-cell-non-hodgkin-s-lymphoma-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-pharmacokinetics-of-pra023-induction-therapy-in-moderate-to-severe-ulcerative-colitis-a-phase-2-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-and-pharmacokinetics-of-tulisokibart-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-phase-2a-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-bezuclastinib-in-advanced-systemic-mastocytosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-crovalimab-in-healthy-volunteers-and-patients-with-paroxysmal-nocturnal-hemoglobinuria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-emicizumab-in-patients-with-mild-or-moderate-hemophilia-a-without-fviii-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-engraftment-and-initial-clinical-activity-of-mb097-with-pembrolizumab-in-advanced-melanoma-patients-with-primary-anti-pd-1-resistance2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-engraftment-and-initial-clinical-activity-of-mb310-in-patients-with-active-mild-to-moderate-ulcerative-colitis-a-phase-1b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-feasibility-and-optimal-dosing-of-fluorescently-labeled-adalimumab-680lt-in-patients-with-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-immunogenicity-and-anti-tumor-activity-of-vb10-16-and-pembrolizumab-in-hpv16-positive-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-immunogenicity-and-efficacy-of-gskvx000000046019-vaccine-in-preventing-escherichia-coli-induced-urinary-tract-infections-in-adults-aged-18-642026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-immunogenicity-and-preliminary-efficacy-of-a-candida-vaccine-in-women-with-recurrent-vulvovaginal-candidiasis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-immunogenicity-and-psa-response-of-vtp-850-in-men-with-biochemical-recurrence-post-definitive-local-therapy-for-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-in-hbv-virological-control-using-darunavir-ritonavir-dolutegravir-sodium-and-lamivudine-in-hiv-1-hbv-co-infected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-in-hereditary-angioedema-patients-aged-12-years-transitioning-to-garadacimab-from-current-prophylactic-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacodynamics-efficacy-and-pharmacokinetics-of-pegunigalsidase-alfa-in-pediatric-patients-with-fabry-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-activity-of-ro7656594-in-patients-with-advanced-or-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-antitumor-activity-of-furmonertinib-in-non-small-cell-lung-cancer-with-egfr-or-her2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-antitumor-activity-of-gtaexs617-in-advanced-solid-tumors-a-phase-1-2-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-antitumor-activity-of-odm-208-in-metastatic-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-antiviral-activity-of-imc-m113v-in-hla-a-2-01-positive-patients-with-virologically-suppressed-chronic-hiv-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-biologic-activity-of-pegcetacoplan-in-adolescents-with-paroxysmal-nocturnal-hemoglobinuria-a-phase-2-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-clinical-effects-of-intravenous-imifoplatin-in-patients-with-metastatic-castrate-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-dose-response-of-paltusotine-and-octreotide-acetate-in-patients-with-carcinoid-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-ab8939-and-azacitidine-in-patients-with-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-azd8421-monotherapy-and-combination-therapy-in-er-her2-advanced-breast-cancer-and-hgsoc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-bictegravir-emtricitabine-tenofovir-alafenamide-in-virologically-suppressed-hiv-1-patients-transitioning-from-cabotegravir-rilpivirine2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-cannabidiol-oral-solution-in-pediatric-patients-with-tuberous-sclerosis-complex-dravet-syndrome-or-lennox-gastaut-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-ep-104iar-and-tetracosactide-in-adults-with-eosinophilic-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-erdafitinib-cetrelimab-and-chemotherapy-in-metastatic-or-locally-advanced-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-gs-5245-in-pediatric-patients-with-covid-19-a-phase-2-3-single-arm-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-hmpl-523-in-patients-with-primary-immune-thrombocytopenia-itp2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-img-007-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-intravenous-abbv-319-in-adults-with-systemic-lupus-erythematosus-and-sjogren-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-mezigdomide-cc-92480-monotherapy-and-combined-with-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-mezigdomide-with-dexamethasone-and-drug-combinations-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-ro7782493-and-panitumumab-in-advanced-solid-tumors-with-kras-g12d-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-sebetralstat-in-pediatric-patients-with-hereditary-angioedema-type-i-or-ii2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-subcutaneous-cevostamab-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-subcutaneous-versus-intravenous-mosunetuzumab-plus-lenalidomide-in-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-efficacy-of-xmab24306-and-cevostamab-in-patients-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-pharmacodynamics-of-azd8630-in-adults-with-asthma-on-medium-to-high-dose-inhaled-corticosteroids-and-long-acting-beta-agonists2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-pharmacodynamics-of-selnoflast-in-patients-with-moderate-to-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-rbd4059-in-stable-coronary-artery-disease-patients-on-low-dose-aspirin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-and-preliminary-efficacy-of-amx-500-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-pharmacodynamics-and-clinical-activity-of-cetrelimab-in-patients-with-advanced-stage-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-rilvegostomig-azd2936-in-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-intravenous-ntr-641-in-healthy-adults-and-acute-ischemic-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-activity-of-ot-c001-in-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-analgesic-efficacy-of-intranasal-ketamine-hydrochloride-and-sufentanil-citrate-in-pediatric-patients-with-moderate-to-severe-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-anti-tumor-activity-of-ima402-in-recurrent-refractory-solid-tumors-a-phase-i-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-antineoplastic-activity-of-iph6501-in-relapsed-refractory-cd20-expressing-non-hodgkin-lymphoma-a-phase-1-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-biodistribution-of-inhaled-rct2100-in-cystic-fibrosis-a-phase-1-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-biological-activity-of-tqs-168-in-patients-with-amyotrophic-lateral-sclerosis-a-phase-1b-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-clinical-activity-of-forimtamig-based-combinations-in-relapsed-or-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-acetylcysteine-amide-in-hereditary-cystatin-c-amyloid-angiopathy-patients-aged-12-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-allogenic-natural-killer-cells-with-trastuzumab-and-pertuzumab-in-refractory-metastatic-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-dyne-251-in-duchenne-muscular-dystrophy-patients-amenable-to-exon-51-skipping2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-farletuzumab-ecteribulin-in-patients-with-platinum-resistant-ovarian-cancer-triple-negative-breast-cancer-endometrial-cancer-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-ict01-with-aldesleukin-and-pembrolizumab-in-advanced-solid-tumors-melanoma-and-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-inhaled-bi-3720931-gene-therapy-in-adults-with-cystic-fibrosis-ineligible-for-cftr-modulators2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-inhaled-phage-cocktail-in-patients-with-chronic-pseudomonas-aeruginosa-lung-colonization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-intravenous-nvg-2089-and-human-normal-immunoglobulin-in-patients-with-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-intravenous-nvg-2089-in-chronic-inflammatory-demyelinating-polyneuropathy-cidp-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-intravenous-vanglusagene-ensiparvovec-in-adults-with-late-onset-pompe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-lutetium-177lu-rhpsma-10-1-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-ly3962673-in-patients-with-kras-g12d-mutant-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-peginterferon-beta-1a-in-pediatric-patients-with-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-recombinant-chimeric-bacteriophage-endolysin-hy-133-in-mssa-nasal-colonization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-relaxin-agonist-r2r01-with-terlipressin-in-hepatorenal-syndrome-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-rtx001-autologous-macrophages-and-filgrastim-in-patients-with-decompensated-liver-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-tak-360-in-a-randomized-double-blinded-placebo-controlled-trial-for-idiopathic-hypersomnia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-tgd001-in-acute-ischemic-stroke-patients-with-or-without-endovascular-thrombectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-tz-161-in-early-acute-spinal-cord-injury-a-phase-1b-2a-randomized-single-blinded-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-vir-2218-vir-3434-and-peginterferon-alfa-2a-in-chronic-hepatitis-b-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-volrustomig-with-anticancer-agents-in-patients-with-solid-tumors-a-phase-ii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-vx-264-implant-in-patients-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-efficacy-of-xstem-vlu-in-patients-with-refractory-venous-leg-ulcers-a-phase-i-iia-randomized-single-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-explorative-efficacy-of-nsc001-and-trospium-chloride-in-mild-to-moderate-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-exploratory-efficacy-of-intrathecal-amt-162-gene-therapy-in-adults-with-sod1-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-imaging-quality-of-perflutren-microbubbles-in-harmono-t-for-renal-ultrasound-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-immunogenicity-of-fractional-intradermal-mrna-sars-cov-2-vaccine-bretovameran-in-fibrodysplasia-ossificans-progressiva2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-immunogenicity-of-menabcwy-2nd-gen-vaccine-in-healthy-infants-with-meningococcal-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-immunogenicity-of-mva-hbvac-and-hepatitis-b-surface-antigen-rdna-in-adults-with-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-immunogenicity-of-pcv-lite-with-litevax-adjuvant-in-healthy-adults-aged-18-50-for-pneumococcal-infection-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-immunological-response-of-asp2390-in-adults-with-house-dust-mite-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pet-imaging-effects-of-geh200520-and-geh200521-18f-in-patients-with-irresectable-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-aly688er-in-overweight-or-obese-adults-with-nonalcoholic-steatohepatitis-nash2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-apc148-in-a-randomized-double-blind-placebo-controlled-single-ascending-dose-study-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-ascending-single-oral-doses-of-octreotide-lipora-peptide-in-healthy-volunteers-with-acromegaly2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-biib115-in-healthy-adult-males-and-pediatric-spinal-muscular-atrophy-patients-post-onasemnogene-abeparvovec-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-ceb-01-plga-membrane-in-patients-with-pancreatic-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-cor-1389-in-obesity-and-right-heart-failure-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-debio-1453p-in-single-and-multiple-oral-doses-for-the-treatment-of-sexually-transmitted-infections-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-exidavnemab-in-patients-with-mild-to-moderate-parkinson-s-disease-and-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-fbt-002-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-grt7040-in-a-randomized-double-blind-placebo-controlled-study-for-pain-management-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-guanabenz-acetate-in-pediatric-patients-with-early-childhood-onset-vanishing-white-matter2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-hjb647-in-healthy-subjects-and-subjects-with-elevated-blood-pressure-in-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-intra-articular-4p-004-in-patients-with-kellgren-and-lawrence-grade-2-4-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-intranasal-cbt101-in-healthy-male-subjects-with-neurological-disease-a-phase-1-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-ion269-in-down-syndrome-patients-at-risk-for-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-ion464-in-adult-patients-with-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-jnj-70035108-in-single-and-repeated-doses-in-healthy-participants-with-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-meropenem-vaborbactam-in-pediatric-patients-with-complicated-urinary-tract-infection-including-acute-pyelonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-meropenem-vaborbactam-in-pediatric-patients-with-complicated-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-mk-8527-in-a-multiple-dose-study-in-healthy-participants-with-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-mtx46943-in-patients-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-multiple-doses-of-nnc0113-6856-in-healthy-participants-including-a-subset-of-healthy-japanese-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-prosetin-in-amyotrophic-lateral-sclerosis-and-healthy-volunteers-a-phase-1-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-rcs-21-in-healthy-volunteers-through-single-and-multiple-ascending-dose-administration2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-riociguat-in-pediatric-patients-aged-6-to-18-years-with-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-ro7303509-in-patients-with-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-runimotamab-and-trastuzumab-in-her2-expressing-locally-advanced-or-metastatic-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-single-ascending-doses-of-stk-002-in-autosomal-dominant-optic-atrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-subcutaneous-dx243-in-healthy-volunteers-and-patients-with-mild-age-related-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-tb0010-in-patients-with-egfr-positive-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-tideglusib-in-patients-with-hepatic-impairment-compared-to-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-topical-lactobacillus-expressing-cxcl12-in-wound-healing-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-of-topical-ocular-ds101-in-diabetic-retinopathy-a-phase-i-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-pharmacokinetics-pharmacodynamics-of-ly3962681-in-healthy-volunteers-and-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-preliminary-efficacy-of-bispecific-cd276xcd3-antibody-cc-3-in-patients-with-progressive-metastatic-solid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-preliminary-efficacy-of-bispecific-psmaxcd3-antibody-cc-1-in-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-preliminary-efficacy-of-subretinal-sb-007-injection-in-stargardt-disease-with-bi-allelic-abca4-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-and-systemic-exposure-of-intraarticular-syn321-in-symptomatic-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-biodistribution-and-efficacy-of-90y-y-pentixather-in-recurrent-or-refractory-cns-lymphoma-with-cxcr4-positivity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-dosimetry-and-preliminary-activity-of-177lu-lu-nns309-in-advanced-unresectable-or-metastatic-nsclc-bc-pdac-and-crc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-efficacy-and-pharmacokinetics-of-aneratrigine-mesilate-in-post-herpetic-neuralgia-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-efficacy-and-pharmacokinetics-of-intra-articular-amb-05x-in-patients-with-tenosynovial-giant-cell-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-immunogenicity-pharmacokinetics-and-pharmacodynamics-of-intravenous-glofitamab-post-ocrelizumab-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-maximum-tolerated-dose-and-clinical-activity-of-tnb-383b-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-ap-101-in-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-dyne-101-in-myotonic-dystrophy-type-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-activity-of-efpegerglucagon-in-pediatric-patients-with-congenital-hyperinsulinism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-anti-tumor-activity-of-novel-therapeutics-in-early-relapsed-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-antitumor-efficacy-of-sunvozertinib-in-advanced-nsclc-with-egfr-or-her2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-antiviral-activity-of-bjt-778-in-chronic-hepatitis-b-and-d-infections-a-phase-1-2a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-clinical-activity-of-gsk5733584-with-anti-cancer-agents-in-advanced-gynecological-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-cln-081-in-patients-with-egfr-exon-20-insertion-mutant-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-hdp-101-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-intranasal-ev25-in-healthy-adults-and-influenza-h3n2-challenge-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-radotinib-dihydrochloride-in-patients-with-parkinson-s-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-rem0045392-versus-placebo-in-patients-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-efficacy-of-ro7443904-with-glofitamab-in-relapsed-refractory-b-cell-non-hodgkin-s-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ab-101-in-healthy-volunteers-and-patients-with-chronic-hepatitis-b-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-abo-101-in-primary-hyperoxaluria-type-1-a-phase-1-2-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-anb033-in-patients-with-celiac-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-aro-c3-in-adults-with-complement-mediated-renal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-aro-dux4-in-adult-patients-with-facioscapulohumeral-muscular-dystrophy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd5305-with-hormonal-agents-in-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bay-3713372-in-mtap-deleted-solid-tumors-a-first-in-human-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bi-765250-in-patients-with-moderate-to-severe-plaque-psoriasis-a-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-budoprutug-tnt119-in-patients-with-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-cs014-in-healthy-volunteers-following-single-and-repeated-doses-a-first-in-human-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-dnl593-in-frontotemporal-dementia-patients-and-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk4771261-in-healthy-subjects-and-subjects-with-autosomal-dominant-polycystic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hm15912-in-adults-with-short-bowel-syndrome-associated-intestinal-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intrathecal-ion440-in-mecp2-duplication-syndrome-a-phase-1-2-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intrathecal-ion582-in-angelman-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intrathecal-ion717-in-patients-with-prion-diseases-a-phase-1-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intrathecal-vo659-in-spinocerebellar-ataxia-types-1-3-and-huntington-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-77730614-in-healthy-volunteers-following-single-and-multiple-doses2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-90106848-in-healthy-volunteers-with-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ly3938577-in-healthy-subjects-and-individuals-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mbf-015-in-huntington-s-disease-a-phase-iia-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mrna-3745-in-glycogen-storage-disease-type-1a-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-msd-001-in-healthy-subjects-with-mental-health-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nbi-1076986-in-adults-with-movement-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nbi-1117570-in-neurological-and-neuropsychiatric-conditions-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0582-0001-following-single-subcutaneous-administration-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ntrx-07-in-mild-cognitive-impairment-and-mild-to-moderate-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ocrelizumab-in-pediatric-patients-with-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pf-07868489-in-pulmonary-arterial-hypertension-a-phase-1-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pimozide-in-rheumatoid-arthritis-a-phase-1-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-rugonersen-in-angelman-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-mosunetuzumab-in-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-tuspetinib-hm43239-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-vtx-pid-in-healthy-male-volunteers-with-circulating-neutralizing-antibodies-against-aav2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-vx-670-in-adult-patients-with-myotonic-dystrophy-type-1-a-phase-1-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-wve-006-in-patients-with-pi-zz-alpha-1-antitrypsin-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-preliminary-anti-tumor-activity-of-inavolisib-with-paclitaxel-in-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-preliminary-anti-tumor-activity-of-subcutaneous-tarlatamab-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-hmpl-523-in-patients-with-relapsed-or-refractory-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-spl84-in-cystic-fibrosis-patients-with-3849-10-kb-c-t-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-immunogenicity-and-antitumor-activity-of-volrustomig-with-axitinib-in-advanced-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-pharmacodynamics-and-efficacy-of-ro7589655-in-severe-or-moderate-hemophilia-a-with-or-without-factor-viii-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-pharmacodynamics-and-efficacy-of-subcutaneous-glofitamab-post-obinutuzumab-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerability-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-ray121-in-a-phase-i-dose-ascending-study-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safety-tolerance-and-preliminary-efficacy-of-itf3756-alone-or-with-anti-protein-4-agent-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-safinamide-versus-placebo-on-pain-management-in-parkinson-s-disease-patients-with-motor-fluctuations-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sage-319-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-disorders-of-gabaergic-signaling-and-cerebellar-circuitry2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-salbutamol-monotherapy-versus-salbutamol-plus-ipratropium-bromide-in-moderate-acute-asthma-exacerbations-in-pediatric-emergency-settings2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-samuraciclib-and-elacestrant-combination-in-metastatic-or-locally-advanced-hr-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-san711-in-absence-seizure-a-placebo-controlled-multiple-ascending-dose-study-in-healthy-adults-assessing-safety-tolerability-pharmacokinetics-and-pharmacodynamics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sar442501-for-safety-tolerability-pharmacokinetics-and-efficacy-in-pediatric-achondroplasia-a-phase-2-open-label-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sar443820-oditrasertib-on-serum-neurofilament-levels-in-multiple-sclerosis-a-phase-2-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sar444656-bioavailability-and-food-effect-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sar445514-in-relapsed-refractory-multiple-myeloma-and-light-chain-amyloidosis-a-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sar445611-on-inflammatory-responses-post-lps-challenge-in-healthy-subjects-with-immune-system-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-saracatinib-azd0530-on-heterotopic-ossification-in-fibrodysplasia-ossificans-progressiva-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sargramostim-combined-with-daratumumab-cyclophosphamide-bortezomib-and-dexamethasone-in-untreated-light-chain-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sarilumab-on-clinical-mri-and-synovial-tissue-outcomes-in-rheumatoid-arthritis-patients-unresponsive-to-anti-tnf-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-saruparib-safety-and-pharmacodynamics-in-adults-with-advanced-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sasanlimab-as-maintenance-therapy-in-molecularly-categorized-muscle-invasive-bladder-cancer-a-bladder-sparing-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-satralizumab-efficacy-and-safety-in-anti-nmdar-and-anti-lgi1-autoimmune-encephalitis-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-satralizumab-efficacy-and-safety-in-moderate-to-severe-thyroid-eye-disease-a-phase-iii-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-satralizumab-efficacy-and-safety-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-a-phase-iii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-satralizumab-efficacy-and-safety-in-pediatric-duchenne-muscular-dystrophy-a-phase-ii-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sb11-pre-filled-syringe-usability-in-patients-with-neovascular-amd-macular-edema-secondary-to-rvo-or-myopic-choroidal-neovascularization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sb27-pembrolizumab-eu-and-us-sourced-in-early-or-locally-advanced-non-small-cell-lung-cancer-post-surgery-and-adjuvant-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-scaav9-u1a-hsgsh-gene-transfer-therapy-with-rebisufligene-etisparvovec-in-mucopolysaccharidosis-type-iiia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-secukinumab-for-maintenance-of-remission-in-non-radiographic-axial-spondyloarthritis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-secukinumab-in-the-treatment-of-non-type-2-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sedative-effects-and-local-tolerability-of-intranasal-remimazolam-with-lidocaine-in-patients-with-anxiety2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-seladelpar-on-clinical-outcomes-in-primary-biliary-cholangitis-patients-with-compensated-cirrhosis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-selinexor-bortezomib-lenalidomide-and-dexamethasone-in-transplant-ineligible-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-selinexor-dexamethasone-and-bortezomib-in-penta-refractory-and-triple-class-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-selinexor-monotherapy-versus-physician-s-choice-in-patients-with-previously-treated-myelofibrosis-a-phase-2-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-selpercatinib-in-patients-aged-12-and-older-with-advanced-ret-altered-solid-tumors-a-phase-1-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-selumetinib-bicalutamide-and-olaparib-in-metastatic-breast-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-and-dulaglutide-on-axonal-damage-and-neurodegeneration-in-multiple-sclerosis-patients-with-high-disease-activity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-and-finerenone-for-renal-and-vascular-protection-in-chronic-kidney-disease-patients-with-and-without-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-and-low-energy-diet-in-adolescents-with-obesity-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-and-pramlintide-acetate-on-metabolic-parameters-in-obesity-and-pre-diabetes-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-and-very-low-calorie-diet-on-body-weight-and-intracranial-pressure-in-new-onset-idiopathic-intracranial-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-as-an-adjunctive-therapy-for-metabolic-control-in-patients-with-schizophrenia-spectrum-disorders-on-antipsychotics2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-for-weight-reduction-in-patients-with-hiv-and-obesity-a-randomized-controlled-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-in-glycemic-control-for-patients-with-type-1-diabetes-and-insulin-resistance-a-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-in-patients-with-non-cirrhotic-non-alcoholic-steatohepatitis-and-fibrosis-stages-2-or-3-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-in-patients-with-obesity-and-resistant-hypertension-a-randomized-parallel-group-multicenter-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-central-and-peripheral-inflammation-in-patients-with-mild-cognitive-impairment-or-mild-alzheimer-s-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-diabetic-foot-ulcer-healing-in-type-2-diabetes-a-randomized-placebo-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-embryo-quality-in-overweight-and-obese-patients-undergoing-in-vitro-fertilization-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-hepatic-fat-content-and-acute-hepatic-fat-response-to-high-fat-load-in-obese-patients-with-non-alcoholic-fatty-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-inflammatory-and-endothelial-biomarkers-in-type-2-diabetes-mellitus-patients-without-ascvd-or-severe-target-organ-damage2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-on-metabolic-state-in-prediabetic-or-diabetic-schizophrenia-patients-under-clozapine-or-olanzapine-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-pharmacokinetics-in-a-novel-tablet-formulation-under-varying-dosing-conditions-in-healthy-subjects-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-s-efficacy-in-alleviating-depressive-symptoms-in-patients-with-major-depressive-disorder-and-comorbid-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-s-efficacy-in-reducing-alcohol-consumption-in-patients-with-alcohol-use-disorder-and-comorbid-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-semaglutide-versus-calorie-restricted-diet-on-peak-oxygen-uptake-in-patients-with-obesity-and-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-senicapoc-in-progressive-fibrotic-interstitial-lung-disease-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sens-501-efficacy-and-safety-in-pediatric-patients-with-severe-to-profound-hearing-loss-due-to-otoferlin-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sentinel-lymph-node-detection-in-early-oral-cancer-using-gallium-68-tilmanocept-pet-ct-and-technetium-99m-lymphoscintigraphy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sentinel-lymph-node-detection-using-technetium-99m-albumin-nanocolloid-and-indocyanine-green-in-early-stage-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sepofarsen-efficacy-safety-and-tolerability-in-leber-congenital-amaurosis-patients-with-cep290-c-2991-1655a-g-mutation-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sequential-chemotherapy-and-avelumab-immunotherapy-in-locally-advanced-urothelial-carcinoma-patients-with-non-progressive-disease-post-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sequential-cryotherapy-and-topical-tirbanibulin-1-for-actinic-keratosis-in-solid-organ-transplant-recipients-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sequential-versus-up-front-administration-of-durvalumab-tremelimumab-and-bevacizumab-in-non-resectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-seralutinib-efficacy-and-safety-in-pulmonary-arterial-hypertension-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serotonergic-5-ht2a-receptor-availability-and-impulsivity-in-tourette-disorder-using-18f-altanserin-and-aripiprazole2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serotonergic-transmission-in-anorexia-nervosa-using-sodium-chloride-and-multimodal-brain-imaging-techniques2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serotoninergic-system-alterations-in-prodromal-parkinson-s-disease-with-snca-mutations-using-11c-dasb-and-11c-sb207145-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serratus-plane-block-analgesia-using-ropivacaine-lidocaine-hydrochloride-and-dexamethasone-sodium-phosphate-in-pleural-drainage-for-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serratus-plane-block-capsaicin-and-botulinum-toxin-type-a-for-chronic-neuropathic-pain-in-post-mastectomy-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sertraline-in-combination-with-first-line-immunochemotherapy-in-metastatic-gastroesophageal-adenocarcinoma-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sertraline-on-anxiety-depressive-symptoms-and-endothelial-dysfunction-in-heart-failure-patients-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-serum-concentrations-of-nebivolol-carvedilol-bisoprolol-fumarate-spironolactone-sacubitril-valsartan-and-metoprolol-succinate-in-chronic-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-setanaxib-s-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-alport-syndrome-a-phase-2a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-setmelanotide-on-hypothalamic-dysfunction-in-rohhad-syndrome-a-proof-of-concept-study-in-a-mono-center-cohort2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sevoflurane-versus-propofol-for-cardioprotective-and-nephroprotective-effects-in-double-valve-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sexual-health-and-quality-of-life-in-cervical-cancer-patients-using-estriol-estradiol-hemihydrate-and-promestriene-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sglt2-inhibitors-and-semaglutide-on-cardiovascular-autonomic-neuropathy-in-type-2-diabetes-mellitus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgm-101-a-fluorochrome-labeled-anti-carcinoembryonic-antigen-monoclonal-antibody-for-fluorescence-guided-imaging-in-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgm-101-a-fluorochrome-labeled-anti-carcinoembryonic-antigen-monoclonal-antibody-for-intraoperative-detection-of-colorectal-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgm-101-a-fluorochrome-labeled-anti-cea-monoclonal-antibody-in-locally-advanced-or-recurrent-rectal-cancer-undergoing-curative-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgm-101-and-indocyanine-green-for-fluorescence-guided-resection-of-colorectal-liver-metastases-in-surgical-oncology2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgm-101-tumor-targeted-fluorescence-endoscopy-in-patients-with-suspected-t1-adenocarcinoma-or-high-grade-dysplasia-of-rectal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgn-b6a-in-patients-with-advanced-solid-tumors-a-multicenter-study-on-breast-head-and-neck-pancreatic-nsclc-bladder-esophageal-ovarian-cervical-skin-and-gastric-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sgn-b7h4v-in-patients-with-advanced-solid-tumors-including-fallopian-tube-gallbladder-and-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-course-radiotherapy-versus-total-neoadjuvant-therapy-in-elderly-patients-with-locally-advanced-rectal-cancer-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-dual-antiplatelet-therapy-followed-by-p2y12-inhibitor-monotherapy-in-elderly-patients-post-percutaneous-coronary-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-duration-antifungal-therapy-with-voriconazole-anidulafungin-and-caspofungin-in-uncomplicated-candidemia-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-span-versus-long-span-amoxicillin-therapy-on-peri-implant-tissue-healing-and-antimicrobial-resistance-in-healthy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-term-estradiol-administration-for-prevention-of-postpartum-depression-in-women-with-prior-postpartum-depression-history2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-term-gnrh-antagonist-therapy-on-lh-pulsatility-and-hormonal-function-in-women-with-polycystic-ovary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-term-interruption-versus-continuous-anticoagulation-with-apixaban-in-colorectal-polypectomy-for-patients-on-oral-anticoagulant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-term-versus-long-term-acetylsalicylic-acid-therapy-post-transfemoral-transcatheter-aortic-valve-implantation-in-symptomatic-aortic-stenosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-short-vs-prolonged-antibiotic-prophylaxis-with-phenoxymethylpenicillin-potassium-and-amoxicillin-in-oral-bone-augmentation-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-shortened-12-month-androgen-receptor-signaling-inhibitor-therapy-with-androgen-deprivation-in-low-volume-metastatic-castration-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-shortened-antibiotic-regimen-with-tobramycin-and-ciprofloxacin-in-gram-negative-bacteremia-from-urinary-tract-infections-in-immunocompetent-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sildenafil-and-vacuum-erection-device-therapy-for-penile-rehabilitation-post-nerve-sparing-robot-assisted-radical-prostatectomy-in-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sildenafil-citrate-on-claudication-distance-in-peripheral-arterial-disease-with-intermittent-claudication-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sildenafil-for-early-erectile-rehabilitation-post-proctectomy-in-rectal-cancer-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sildenafil-on-exercise-capacity-in-adults-with-functionally-single-ventricle-post-fontan-procedure-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-silibinin-efficacy-and-safety-in-active-cushing-s-disease-a-multicenter-open-label-dose-titration-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-simvastatin-for-the-prevention-of-recurrent-pancreatitis-a-triple-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-simvastatin-in-reducing-liver-fibrosis-in-patients-with-advanced-alcoholic-liver-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-ascending-dose-of-zp9830-in-healthy-male-volunteers-for-autoimmune-disease-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-ascending-doses-of-2-methoxyestradiol-in-healthy-non-pregnant-female-subjects-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-dose-bms-986326-at-two-dose-levels-in-patients-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-dose-ilofotase-alfa-in-adult-patients-with-hypophosphatasia-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-dose-nnc0614-0001-in-healthy-adults-and-hereditary-haemochromatosis-type-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-single-versus-dual-antiplatelet-therapy-with-clopidogrel-and-acetylsalicylic-acid-in-elderly-or-high-bleeding-risk-patients-post-pci-with-drug-coated-balloons2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-siplizumab-versus-rabbit-anti-thymocyte-globulin-in-induction-therapy-for-de-novo-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-siponimod-on-chronic-intrathecal-inflammation-in-secondary-progressive-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-siponimod-on-imaging-and-immunological-markers-in-secondary-progressive-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sirolimus-and-prednisolone-metasulfobenzoate-sodium-in-the-treatment-of-superficial-arteriovenous-malformations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sirolimus-and-trametinib-in-molecularly-targeted-therapy-for-pediatric-diffuse-intrinsic-pontine-glioma-dipg2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sirolimus-efficacy-in-treating-poor-prognosis-cervico-facial-lymphatic-malformations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sirolimus-topical-solution-for-lingual-microcystic-lymphatic-malformations-in-pediatric-and-adult-populations-a-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-skb264-monotherapy-and-combination-therapy-in-advanced-or-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-skb264-monotherapy-in-patients-with-metastatic-or-locally-advanced-unresectable-solid-tumors-refractory-to-standard-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-slco1b1-abcg2-and-cyp2c9-genotyping-on-statin-induced-musculoskeletal-adverse-reactions-in-cardiovascular-risk-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sleep-microstructure-and-brain-connectivity-in-patients-with-peripheral-neuropathic-pain-impact-of-pregabalin-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-benzoate-as-an-adjunct-to-clozapine-for-residual-symptoms-in-refractory-schizophrenia-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-chloride-and-glucose-monohydrate-infusion-strategies-in-critically-ill-patients-impact-on-mortality-and-organ-support2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-chloride-subcutaneous-injection-for-chronic-low-back-pain-management-in-adults-a-phase-ii-non-randomized-single-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-cromoglicate-as-an-adjuvant-therapy-in-mild-to-moderate-amyotrophic-lateral-sclerosis-a-phase-iib-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-cromoglicate-efficacy-and-safety-in-symptomatic-management-of-fatigue-in-multiple-sclerosis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-oxybate-for-reducing-alcohol-consumption-and-sustaining-abstinence-in-patients-with-alcohol-dependence-at-high-drinking-risk-levels2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-oxybate-for-the-treatment-of-catatonia-in-patients-with-depression-bipolar-disorder-or-psychotic-disorders-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-thiosulfate-in-calcinosis-cutis-associated-with-systemic-sclerosis-a-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-zirconium-cyclosilicate-efficacy-in-managing-hyperkalemia-in-chronic-kidney-disease-patients-a-phase-iii-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-zirconium-cyclosilicate-for-optimizing-mineralocorticoid-receptor-antagonist-therapy-in-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-zirconium-cyclosilicate-for-potassium-management-in-patients-with-chronic-kidney-disease-stages-3b-and-42026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sodium-zirconium-cyclosilicate-in-managing-heart-failure-and-chronic-kidney-disease-in-elderly-patients-at-risk-of-hyperkalemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sofosbuvir-on-yf17d-replication-in-healthy-volunteers-a-prophylactic-approach-to-yellow-fever2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-solifenacin-mirabegron-and-their-combination-in-pediatric-overactive-bladder-and-daytime-urinary-incontinence2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-somapacitan-versus-somatropin-on-growth-in-pediatric-patients-with-short-stature-born-small-for-gestational-age-without-catch-up-growth2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-somatropin-and-letrozole-in-enhancing-adult-height-in-boys-with-short-predicted-stature-a-4-year-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sonocloud-9-with-carboplatin-versus-lomustine-or-temozolomide-in-first-recurrence-glioblastoma-post-resection-a-randomized-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sonoporation-enhanced-gemcitabine-nab-paclitaxel-and-folfirinox-in-inoperable-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotagliflozin-in-the-management-of-post-bariatric-hypoglycemia-a-randomized-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotagliflozin-on-renal-oxygenation-in-type-1-diabetes-mellitus-with-chronic-kidney-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-in-adults-with-combined-postcapillary-and-precapillary-pulmonary-hypertension-due-to-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-in-combination-with-maximum-tolerated-background-therapy-in-patients-with-who-functional-class-iii-iv-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-in-the-management-of-combined-postcapillary-and-precapillary-pulmonary-hypertension-due-to-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-mk-7962-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-pediatric-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-on-right-ventricular-function-in-pulmonary-arterial-hypertension-a-phase-iv-single-arm-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-pharmacokinetics-and-safety-in-pulmonary-arterial-hypertension-patients-undergoing-standard-of-care-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotatercept-plus-background-therapy-versus-placebo-in-intermediate-and-high-risk-pulmonary-arterial-hypertension-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotorasib-amg-510-in-patients-with-advanced-solid-tumors-harboring-kras-p-g12c-mutation-a-master-protocol-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotorasib-efficacy-in-advanced-kras-g12c-mutated-non-small-cell-lung-cancer-with-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotorasib-in-combination-with-chemotherapy-for-kras-p-g12c-mutated-advanced-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotorasib-in-previously-treated-locally-advanced-or-metastatic-nsclc-with-kras-p-g12c-mutation-a-translational-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sotorasib-monotherapy-and-sotorasib-pembrolizumab-combination-in-kras-p-g12c-mutant-advanced-solid-tumors-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sovateltide-efficacy-and-safety-in-acute-cerebral-ischemic-stroke-a-randomized-double-blind-placebo-controlled-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sparsentan-in-pediatric-patients-with-proteinuric-glomerular-diseases-a-phase-2-open-label-single-arm-cohort-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sparsentan-versus-irbesartan-on-renal-outcomes-in-patients-with-primary-focal-segmental-glomerulosclerosis-fsgs2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spartalizumab-and-low-dose-pazopanib-in-refractory-or-relapsed-solid-tumors-in-pediatric-and-adult-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spartalizumab-docetaxel-cisplatin-and-fluorouracil-with-radiotherapy-in-metastatic-squamous-cell-anal-carcinoma-a-phase-iia-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spesolimab-efficacy-and-safety-in-adult-patients-with-ulcerative-pyoderma-gangrenosum-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sphenopalatine-block-efficacy-in-reducing-morphine-use-in-non-traumatic-subarachnoid-hemorrhage-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spi-62-for-the-management-of-hypercortisolism-associated-with-benign-adrenal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spironolactone-for-sinus-rhythm-maintenance-in-hypertensive-atrial-fibrillation-patients-with-preserved-left-ventricular-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spironolactone-on-right-ventricular-function-and-arrhythmia-in-arrhythmogenic-right-ventricular-dysplasia-a-double-blind-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spontaneous-retinal-arterial-pulsations-as-prognostic-indicators-in-central-retinal-vein-occlusion-with-aflibercept-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-spvn06-gene-therapy-safety-and-tolerability-in-patients-with-inherited-retinal-dystrophies-specifically-rod-cone-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-standard-immunosuppression-with-tacrolimus-and-mycophenolate-mofetil-versus-low-dose-tacrolimus-and-everolimus-in-elderly-de-novo-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-standard-vs-reduced-dose-amiodarone-hydrochloride-for-sinus-rhythm-maintenance-post-cardioversion-in-persistent-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-statin-therapy-on-major-adverse-cardiovascular-events-in-frail-elderly-patients-with-recent-ischemic-stroke-or-transient-ischemic-attack2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-stem-cell-infused-gel-dressing-for-the-treatment-of-hard-to-heal-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-step-up-versus-step-down-therapeutic-strategies-in-juvenile-idiopathic-arthritis-using-etanercept-and-methotrexate-combination-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-stx-478-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-tumors-including-breast-cancer-and-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-stx-721-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-harboring-specific-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-administration-of-nnc0537-1482-in-patients-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-amivantamab-lazertinib-and-pemetrexed-disodium-in-advanced-or-metastatic-solid-tumors-including-egfr-mutated-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-anifrolumab-120-mg-weekly-in-immunosuppressant-naive-and-biologic-naive-patients-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-cladribine-efficacy-and-safety-in-secondary-progressive-multiple-sclerosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-daratumumab-in-patients-with-moderate-to-severe-myalgic-encephalomyelitis-chronic-fatigue-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-glucagon-on-metabolic-and-physical-performance-in-hfpef-patients-with-or-without-masld2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-immunotherapy-with-der-p-1-der-p-2-der-p-23-allergens-in-moderate-severe-allergic-rhinitis-rhinoconjunctivitis-with-without-controlled-allergic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-immunotherapy-with-polymerized-allergen-extracts-of-dermatophagoides-in-allergic-rhinoconjunctivitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-infliximab-administration-following-intravenous-dose-optimization-in-patients-with-ulcerative-colitis-ibdu-and-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-isis-678354-sodium-salt-in-patients-with-familial-chylomicronemia-syndrome-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-methotrexate-efficacy-and-safety-compared-to-placebo-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-nivolumab-with-intravenous-ipilimumab-and-chemotherapy-in-treatment-naive-metastatic-or-recurrent-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-palopegteriparatide-in-adults-with-hypoparathyroidism-a-phase-2-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-sodium-thiosulfate-pentahydrate-for-ectopic-calcifications-and-ossifications-in-dermatomyositis-systemic-sclerosis-and-ippsd2-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-subcutaneous-versus-intravenous-human-normal-immunoglobulin-in-treatment-naive-patients-with-chronic-inflammatory-demyelinating-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sublingual-sufentanil-for-moderate-to-severe-monotraumatic-pain-management-in-emergency-patients-a-comparative-study-with-standard-analgesic-protocols2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-substance-name-in-patients-with-non-cystic-fibrosis-bronchiectasis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-substance-name-in-the-treatment-of-invasive-aspergillosis-in-patients-a-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sugammadex-for-reversal-of-pipecuronium-induced-neuromuscular-blockade-during-propofol-anesthesia-a-randomized-controlled-trial-on-patient-safety2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sugammadex-for-reversal-of-pipecuronium-induced-neuromuscular-blockade-during-sevoflurane-anesthesia-in-anesthesia-and-analgesia-safety2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sulfur-hexafluoride-and-technetium-99mtc-in-diagnosing-vesicoureteral-reflux-in-pediatric-patients-via-cystography-and-ultrasonography2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sulfur-hexafluoride-enhanced-ultrasound-and-elastography-in-neonatal-cerebral-perfusion-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sulfur-hexafluoride-enhanced-ultrasound-in-assessing-placental-vascularization-in-fetal-growth-restriction-and-non-restriction-pregnancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sulodexide-for-the-prevention-of-recurrent-venous-thromboembolism-in-elderly-patients-post-first-episode-of-deep-vein-thrombosis-or-pulmonary-embolism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sumatriptan-and-rimegepant-in-nitroglycerin-induced-headache-for-biomarker-analysis-in-episodic-migraine-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-sunobinop-tosilate-on-alcohol-consumption-and-craving-in-patients-with-moderate-to-severe-alcohol-use-disorder-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-superficial-cervical-plexus-block-with-ropivacaine-and-sodium-chloride-in-oncological-throat-and-neck-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-supplemental-oxygen-efficacy-in-intermediate-risk-acute-pulmonary-embolism-a-registry-based-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-suprachoroidal-dexamethasone-acetate-oxu-001-versus-intravitreal-dexamethasone-implant-in-diabetic-macular-edema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-swallowing-outcomes-and-quality-of-life-in-advanced-oropharyngeal-cancer-patients-undergoing-prophylactic-versus-reactive-peg-tube-placement-with-cisplatin-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-synaptic-density-using-in-vivo-pet-in-cognitive-disorders-including-alzheimer-s-frontotemporal-dementia-and-lewy-body-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-synovial-biomarkers-for-predicting-response-to-ixekizumab-in-refractory-psoriatic-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-synovial-cd80-cd86-biomarkers-as-predictors-of-clinical-response-to-abatacept-in-early-rheumatoid-arthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-systemic-antibiotic-prophylaxis-with-piperacillin-tazobactam-and-cefazolin-in-excision-autograft-surgery-for-burn-patients-a-multicenter-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-systemic-chemotherapy-and-targeted-therapy-with-or-without-pipac-in-advanced-colorectal-peritoneal-metastases-a-phase-ii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-syx-5219-on-immune-response-modulation-in-patients-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tacrolimus-and-ciclosporin-in-preventing-hla-sensitization-in-patients-with-late-renal-graft-failure-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tacrolimus-and-mtor-inhibitors-with-anticipatory-therapy-versus-tacrolimus-and-mycophenolic-acid-in-high-risk-renal-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tacrolimus-and-mycophenolate-mofetil-in-immunosuppressive-regimens-for-liver-transplant-recipients-a-comparative-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tacrolimus-lcpt-dose-reduction-versus-tacrolimus-er-in-achieving-therapeutic-levels-in-kidney-transplant-recipients-with-high-tacrolimus-dose-requirements2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tacrolimus-monotherapy-versus-standard-triple-immunosuppressive-regimen-in-elderly-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tafamidis-on-cardiac-magnetic-resonance-imaging-parameters-in-transthyretin-cardiac-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tafasitamab-and-lenalidomide-efficacy-and-safety-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-patients-ineligible-for-hdc-asct2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tafasitamab-in-pediatric-patients-with-relapsed-or-refractory-acute-b-lineage-leukemia-a-phase-i-ii-single-arm-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tailored-antibiotic-and-steroid-therapy-based-on-il-6-in-amniotic-fluid-for-prolonging-pregnancy-in-preterm-premature-rupture-of-membranes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tak-861-efficacy-and-safety-in-patients-with-narcolepsy-type-1-with-cataplexy-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-talazoparib-and-enzalutamide-efficacy-in-metastatic-castration-resistant-prostate-cancer-post-abiraterone-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-talazoparib-efficacy-in-advanced-breast-cancer-patients-using-the-recap-test-for-functional-selection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-talimogene-laherparepvec-and-atezolizumab-combination-in-residual-breast-cancer-post-neoadjuvant-chemotherapy-in-pre-and-post-menopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-talquetamab-and-teclistamab-combination-therapy-in-relapsed-or-refractory-multiple-myeloma-a-phase-1b-2-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-talquetamab-and-tocilizumab-in-relapsed-or-refractory-multiple-myeloma-a-phase-1-2-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tamibarotene-venetoclax-and-azacitidine-in-rara-positive-acute-myeloid-leukemia-patients-ineligible-for-standard-induction-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tamsulosin-and-furosemide-for-enhancing-stone-fragment-clearance-post-extracorporeal-shock-wave-lithotripsy-in-nephrolithiasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tamsulosin-and-furosemide-for-stone-fragment-clearance-post-extracorporeal-shock-wave-lithotripsy-in-nephrolithiasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tamuzimod-acetate-in-moderately-to-severely-active-ulcerative-colitis-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tapering-systemic-immunosuppressive-therapy-on-maintaining-minimal-disease-activity-in-psoriatic-arthritis-using-methotrexate-disodium-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tar-200-and-cetrelimab-in-muscle-invasive-urothelial-carcinoma-of-the-bladder-prior-to-radical-cystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tar-200-and-cetrelimab-versus-bacillus-calmette-guerin-in-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tar-200-and-cetrelimab-versus-chemoradiotherapy-in-muscle-invasive-urothelial-carcinoma-of-the-bladder-without-radical-cystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-targeted-anti-cancer-therapy-using-vemurafenib-and-drug-combinations-in-patients-with-advanced-cancer-and-genomic-variants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-targeted-antibiotic-prophylaxis-versus-empiric-prophylaxis-in-reducing-infection-related-readmissions-post-cystectomy-a-multicenter-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tarlatamab-dosing-regimens-in-patients-with-small-cell-lung-cancer-a-phase-2-open-label-randomized-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tarlatamab-monotherapy-and-combination-therapy-with-folfiri-in-advanced-neuroendocrine-carcinomas-of-digestive-or-unknown-primary-origin2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tarlatamab-with-carboplatin-etoposide-and-pd-l1-inhibitor-in-extensive-stage-small-cell-lung-cancer-es-sclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tas2940-in-patients-with-locally-advanced-or-metastatic-solid-tumors-exhibiting-egfr-and-or-her2-aberrations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tasimelteon-versus-placebo-in-delayed-sleep-wake-phase-disorder-a-multicenter-double-blind-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-taste-profiles-of-pf-07923568-suspensions-in-healthy-adults-for-rsv-respiratory-syncytial-virus-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tau-4r-protein-deposition-via-pet-imaging-with-izaflortaucipir-18f-in-progressive-supranuclear-palsy-compared-to-non-tauopathy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tcrab-cd19-depleted-haploidentical-stem-cell-transplantation-and-immunotherapy-in-relapsed-resistant-high-risk-neuroblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tebentafusp-as-neoadjuvant-therapy-in-patients-with-metastatic-uveal-melanoma-with-resectable-liver-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-technetium-99mtc-certolizumab-pegol-in-axial-spondyloarthritis-a-molecular-imaging-approach-to-optimize-treatment-strategy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teclistamab-and-talquetamab-based-regimens-in-newly-diagnosed-transplant-eligible-multiple-myeloma-a-phase-2-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teg001-safety-in-patients-with-relapsed-refractory-acute-myeloid-leukemia-high-risk-myelodysplastic-syndrome-or-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tegoprubart-versus-tacrolimus-in-prophylaxis-of-renal-allograft-rejection-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teicoplanin-for-infection-prophylaxis-in-pediatric-patients-with-acute-myeloid-leukemia-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-telisotuzumab-adizutecan-and-osimertinib-in-egfr-mutated-non-squamous-nsclc-a-phase-2-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-telmisartan-amlodipine-and-telmisartan-amlodipine-hydrochlorothiazide-on-24-hour-blood-pressure-control-in-arterial-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-telmisartan-on-hepatic-venous-pressure-gradient-in-compensated-advanced-chronic-liver-disease-with-portal-hypertension-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-temozolomide-and-irinotecan-consolidation-in-mgmt-silenced-microsatellite-stable-colorectal-cancer-with-persistent-minimal-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-temozolomide-and-lomustine-chemotherapy-versus-radiotherapy-and-pcv-in-newly-diagnosed-who-grade-2-or-3-glioma-with-1p-19q-co-deletion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-temozolomide-monotherapy-in-adult-patients-with-non-enhancing-diffuse-brainstem-gliomas-exhibiting-infiltrative-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-temozolomide-topotecan-and-dinutuximab-beta-in-high-risk-relapsed-neuroblastoma-a-multi-arm-multi-stage-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tenecteplase-versus-acetylsalicylic-acid-in-central-retinal-artery-occlusion-a-phase-3-randomized-double-blind-double-dummy-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tenecteplase-versus-alteplase-in-acute-ischaemic-stroke-due-to-basilar-artery-occlusion-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tenofovir-alafenamide-and-natalizumab-combination-therapy-on-epstein-barr-virus-activity-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tenofovir-alafenamide-as-an-adjunct-to-anti-cd20-therapy-in-reducing-neuronal-damage-in-multiple-sclerosis-a-phase-2b-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tenofovir-alafenamide-pharmacokinetics-safety-and-antiviral-efficacy-in-pediatric-and-adolescent-patients-with-chronic-hepatitis-b-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tepotinib-and-cetuximab-in-platinum-resistant-head-and-neck-squamous-cell-carcinoma-post-immunotherapy-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tepotinib-and-osimertinib-in-met-amplified-egfr-mutant-advanced-or-metastatic-non-small-cell-lung-cancer-resistant-to-prior-osimertinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teprenone-for-the-prevention-of-postoperative-atrial-fibrillation-in-patients-undergoing-cardiothoracic-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teriparatide-and-zoledronic-acid-in-the-management-of-osteogenesis-imperfecta-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teriparatide-efficacy-in-improving-bone-metabolism-in-patients-with-adynamic-bone-disorder-and-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-decanoate-isocaproate-phenylpropionate-and-propionate-on-quality-of-life-in-androgen-deficient-patients-under-palliative-care2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-gel-on-physical-performance-in-patients-requiring-prolonged-invasive-mechanical-ventilation-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-replacement-therapy-on-body-composition-in-adolescent-males-with-klinefelter-syndrome-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-replacement-therapy-on-sexual-function-outcomes-in-testosterone-deficient-prostate-cancer-patients-undergoing-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-undecanoate-for-neuroprotection-and-myelin-repair-in-relapsing-remitting-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-undecanoate-on-muscle-hypertrophy-and-epigenetic-memory-in-sarcopenia-and-anabolic-resistance-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-testosterone-undecanoate-on-muscle-strength-and-mass-in-hypogonadal-males-post-bariatric-surgery-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tetanus-toxoid-induced-b-cell-activation-in-systemic-sclerosis-systemic-lupus-erythematosus-and-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tev-48574-duvakitug-in-adults-with-moderate-to-severe-ulcerative-colitis-or-crohn-s-disease-a-randomized-double-blind-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-teverelix-dp-a-gnrh-antagonist-in-pharmacokinetics-pharmacodynamics-efficacy-and-safety-for-advanced-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tezepelumab-in-reversing-airway-remodeling-in-patients-with-severe-asthma-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tezepelumab-on-eosinophilic-inflammation-in-chronic-obstructive-pulmonary-disease-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tezepelumab-on-epithelial-barrier-function-in-severe-asthma-patients-with-and-without-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tg4001-and-avelumab-in-hpv-16-positive-recurrent-or-metastatic-malignancies-a-phase-ib-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-th9619-safety-and-anticancer-efficacy-in-patients-with-advanced-solid-tumors-including-nsclc-crc-hnscc-and-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-acute-impact-of-empagliflozin-on-renal-allograft-oxygen-tension-in-kidney-transplant-recipients-a-randomized-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-analgesic-efficacy-and-safety-of-clonidine-hydrochloride-in-postoperative-pain-management-following-colectomy-in-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-analgesic-efficacy-and-safety-of-dfl24412-versus-ketoprofen-lysine-salt-in-patients-with-chronic-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-analgesic-efficacy-and-safety-of-ibuprofen-arginine-and-tramadol-hydrochloride-in-postoperative-dental-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-analgesic-efficacy-of-lu-ag06474-in-healthy-adult-subjects-with-induced-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-analgesic-efficacy-of-sage-319-in-patients-with-gabaergic-signaling-and-cerebellar-circuitry-deficits2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-anti-anginal-efficacy-of-t89-and-glyceryl-trinitrate-in-patients-with-stable-angina-pectoris-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-antiviral-efficacy-and-safety-of-gsk3739937-in-treatment-naive-adults-with-hiv-1-infection-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-atr-kinase-inhibitor-art0380-as-monotherapy-in-patients-with-biologically-selected-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-bioavailability-and-hemodynamic-effects-of-ox640-nasal-epinephrine-powder-versus-intramuscular-epinephrine-in-anaphylaxis-patients-with-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-biological-effects-of-saruparib-azd5305-and-darolutamide-alone-and-in-combination-in-patients-with-newly-diagnosed-prostate-cancer-undergoing-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-cardiac-safety-of-multiple-doses-of-bi-456906-in-overweight-or-obese-individuals-a-healthy-volunteer-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-decolonization-rate-and-acceptance-of-a-complete-nasal-decolonization-kit-with-povidone-iodine-for-mrsa-patients-mrsad-pvp-i2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-effectiveness-of-the-reconsolidation-therapy-in-a-clinical-population-suffering-from-post-traumatic-stress-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-effects-of-a-novel-pharmacological-agent-on-nerve-sensitivity-in-healthy-volunteers-with-hyperexcitability-nerve-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-effects-of-music-and-herbal-medicine-on-perioperative-anxiety-and-pain-in-patients-undergoing-retrobulbar-anesthesia-for-vitrectomy-or-cataract-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-effects-of-oral-ntx-1955-on-neurophysiological-parameters-in-patients-with-generalized-anxiety-disorder-gad2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-5-escharex-concentrate-of-proteolytic-enzymes-enriched-in-bromelain-in-debridement-of-venous-leg-ulcers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-adjunctive-trospium-chloride-and-xanomeline-tartrate-in-patients-with-inadequately-controlled-schizophrenia-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-bay-2927088-in-patients-with-metastatic-or-unresectable-solid-tumors-harboring-her2-activating-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-bi-690517-and-empagliflozin-in-patients-with-symptomatic-heart-failure-and-lvef-40-a-phase-iii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-cagrilintide-and-semaglutide-in-combination-for-weight-reduction-in-patients-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-cagrilintide-and-semaglutide-in-type-2-diabetes-with-painful-diabetic-peripheral-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-ehsg-kf-a-bilayer-engineered-collagen-hydrogel-based-skin-graft-in-adults-and-adolescents-with-deep-dermal-and-full-thickness-burns2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-extended-release-levetiracetam-as-adjunctive-therapy-in-refractory-partial-onset-epilepsy-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-finerenone-and-empagliflozin-combination-therapy-in-hospitalized-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-fluticasone-propionate-salbutamol-sulfate-in-reducing-severe-asthma-exacerbations-in-asthma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-fore8394-in-patients-with-braf-altered-solid-tumors-melanoma-thyroid-or-cns-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-glpg3667-in-adults-with-active-systemic-lupus-erythematosus-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-gs-1720-and-gs-4182-versus-bictegravir-emtricitabine-tenofovir-alafenamide-in-virologically-suppressed-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-intracameral-phenylephrine-hydrochloride-tropicamide-and-lidocaine-hydrochloride-in-pediatric-cataract-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-intravenous-aoc-1001-in-myotonic-dystrophy-type-1-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-lysergide-mm120-in-adults-with-generalized-anxiety-disorder-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-mannan-conjugated-allergoids-in-moderate-to-severe-allergic-rhinitis-rhinoconjunctivitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-mannan-conjugated-allergoids-in-moderate-to-severe-allergic-rhinitis-rhinoconjunctivitis-with-or-without-controlled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-mk-8690-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-obeticholic-acid-and-bezafibrate-in-patients-with-primary-biliary-cholangitis-unresponsive-or-intolerant-to-ursodeoxycholic-acid2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-oral-1-3-5-tris-6-methylpyridin-2-yloxy-benzene-in-moderate-to-severe-ulcerative-colitis-a-phase-2-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-oral-midazolam-in-patients-with-moderate-to-severe-neurocognitive-disorders-and-treatment-resistance2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-panguian-in-patients-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-plasma-rich-in-growth-factors-versus-hypromellose-and-sodium-chloride-in-patients-with-dry-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-platelet-concentrate-eye-drops-versus-hypromellose-in-patients-with-dry-eye-disease-a-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-platelet-concentrate-versus-betamethasone-acetate-and-betamethasone-sodium-phosphate-in-chronic-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-prolonged-cytisinicline-regimens-in-active-smokers-a-phase-iv-randomized-open-label-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-recombinant-von-willebrand-factor-with-or-without-octocog-alfa-in-pediatric-severe-hereditary-von-willebrand-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-retatrutide-ly3437943-in-type-2-diabetes-mellitus-patients-with-obesity-or-overweight-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-semaglutide-with-reduced-dose-insulin-glargine-versus-titrated-insulin-glargine-in-type-2-diabetes-with-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-subcutaneous-ct-p13-in-patients-with-moderately-to-severely-active-rheumatoid-arthritis-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-subcutaneous-human-igg2-monoclonal-antibody-against-il-6-tour006-in-adults-with-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-topical-human-insulin-in-moderate-to-severe-dry-eye-disease-compared-to-ciclosporin-and-artificial-tears2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-trospium-chloride-and-xanomeline-tartrate-in-treating-manic-episodes-in-bipolar-i-disorder-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-ves001-in-asymptomatic-patients-with-grn-associated-frontotemporal-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-and-safety-of-xanomeline-tartrate-and-trospium-chloride-in-cognitive-impairment-associated-with-mild-to-moderate-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-of-diclofenac-sodium-and-thiocolchicoside-combination-versus-diclofenac-sodium-and-placebo-in-acute-moderate-severe-low-back-pain2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-of-respiratory-syncytial-virus-vaccine-bivalent-recombinant-in-preventing-rsv-hospitalizations-in-adults-aged-60-and-above2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-safety-and-tolerability-of-bhv-2100-and-bhv-7000-in-the-management-of-pain-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-safety-and-tolerability-of-oral-dronabinol-and-palmidrol-in-adult-patients-with-tourette-syndrome-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-safety-and-tolerability-of-subcutaneous-regn7999-in-adults-with-iron-overload-due-to-non-transfusion-dependent-beta-thalassemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-efficacy-safety-tolerability-and-pharmacokinetics-of-pkn605-in-patients-with-atrial-fibrillation-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-eleveld-pharmacokinetic-model-for-propofol-and-remifentanil-in-cardiac-anesthesia-with-cardiopulmonary-bypass-in-patients-with-heart-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-feasibility-of-short-term-discontinuation-of-serotonin-reuptake-inhibitors-in-patients-with-hip-and-knee-osteoarthritis-undergoing-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-hemostatic-efficacy-of-topical-tranexamic-acid-in-anticoagulated-patients-undergoing-pacemaker-implantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-iavi-c110-hiv-vaccine-in-individuals-with-human-immunodeficiency-virus-hiv-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-immunogenicity-of-intradermal-administration-of-inactivated-japanese-encephalitis-vaccine-ixiaro-in-healthy-adults-aged-18-64-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-a-broadly-neutralizing-antibody-and-attachment-inhibitor-on-viral-reservoirs-in-hiv-patients-on-integrase-inhibitor-based-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-a-high-calorie-high-fat-meal-on-the-bioavailability-of-40-mg-extended-release-deucrictibant-in-hereditary-angioedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-a-high-fat-meal-on-the-pharmacokinetics-of-the-selective-met-kinase-inhibitor-do-2-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-alirocumab-rosuvastatin-and-evolocumab-on-steroid-hormones-in-patients-with-hyperlipidemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-anti-rheumatic-treatments-on-herpes-zoster-vaccine-immunogenicity-in-patients-with-inflammatory-rheumatic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-co-administered-oral-liquids-on-the-relative-oral-bioavailability-of-jnj-77242113-in-healthy-subjects-with-inflammatory-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-fluvoxamine-itraconazole-and-paroxetine-on-asn51-pharmacokinetics-in-healthy-volunteers-with-proteinopathies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-food-on-the-pharmacokinetics-of-ca-4948-in-healthy-male-subjects-with-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-immunomodulating-antirheumatic-treatments-on-humoral-response-to-rsv-vaccines-in-patients-with-inflammatory-rheumatic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-lf111-and-drospirenone-on-bone-mineral-density-in-adolescent-and-adult-females-using-hormonal-contraceptives2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-oral-ad-700-on-ct-detection-of-activated-brown-adipose-tissue-in-individuals-with-metabolic-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-ropivacaine-para-sternal-block-on-postoperative-respiratory-function-in-cardiac-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-impact-of-tolinapant-astx660-on-oct1-oct2-and-mate1-substrate-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-local-and-systemic-effects-of-ketorolac-and-pregabalin-in-estrogen-receptor-positive-early-breast-cancer-patients-undergoing-primary-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-persistency-of-the-preoperative-anxiolytic-effect-of-music-therapy-vs-midazolam-electroencephalographic-and-clinical-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacodynamic-efficacy-and-clinical-benefit-of-govorestat-at-007-in-patients-with-sorbitol-dehydrogenase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-between-brensocatib-and-midazolam-in-adults-with-non-cystic-fibrosis-bronchiectasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-between-carbamazepine-and-pf-07248144-in-patients-with-locally-advanced-or-metastatic-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-between-ibuzatrelvir-and-dabigatran-etexilate-in-healthy-adults-with-sars-cov-22026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-between-jnj-81241459-and-co-administered-drugs-in-healthy-adults-with-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-between-obefazimod-and-ethinyl-estradiol-drospirenone-in-healthy-female-subjects-of-childbearing-potential2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-azd5462-with-itraconazole-and-carbamazepine-in-healthy-adults-with-chronic-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-bi-1015550-with-nintedanib-and-pirfenidone-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-calcium-and-colecalciferol-supplementation-with-tacrolimus-and-mycophenolate-mofetil-in-stable-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-carbamazepine-and-itraconazole-on-jnj-55308942-in-healthy-adults-with-bipolar-depression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-gemfibrozil-itraconazole-and-phenytoin-on-ipn60250-plasma-levels-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetic-interaction-of-survodutide-with-bupropion-caffeine-and-midazolam-in-individuals-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-and-safety-of-bay3401016-in-healthy-male-subjects-with-alport-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-and-safety-of-nt-0150-in-patients-with-cryopyrin-associated-periodic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-and-safety-profile-of-ro7795068-in-healthy-volunteers-for-potential-obesity-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-of-jnj-77242113-in-adult-patients-with-renal-impairment-an-open-label-single-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-of-subcutaneous-administration-of-piperacillin-tazobactam-an-open-label-multicentric-non-inferiority-randomized-clinical-trial-stupita012026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-safety-and-tolerability-of-nts-521-in-adult-and-elderly-subjects-following-intravenous-infusion2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-pharmacokinetics-safety-and-tolerability-of-ro7268489-and-its-interaction-with-itraconazole-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-quadrivalent-human-papillomavirus-vaccine-for-recurrence-prevention-of-external-genital-warts-in-previously-treated-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-and-food-effect-of-agmb-129-in-healthy-participants-with-fibrostenotic-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-and-food-effect-on-pharmacokinetics-of-minzasolmin-in-healthy-subjects-an-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-of-apraglutide-compared-to-reference-formulation-in-healthy-subjects-a-randomized-open-label-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-of-dimenhydrinate-50-mg-in-healthy-volunteers-a-crossover-study-comparing-administration-with-and-without-water2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-of-ly03010-compared-to-paliperidone-palmitate-after-intramuscular-injection-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-of-tafamidis-free-acid-tablets-versus-capsules-in-fasted-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-relative-bioavailability-of-two-nerandomilast-formulations-and-the-impact-of-food-on-pharmacokinetics-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-anti-tumor-activity-of-intravenous-omo-103-in-advanced-high-grade-osteosarcoma-a-phase-2-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-antitumor-efficacy-of-gen1056-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-antitumor-efficacy-of-gen1057-in-patients-with-metastatic-or-advanced-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-abobotulinumtoxina-versus-onabotulinumtoxina-in-adult-upper-limb-spasticity-a-randomized-double-blind-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-adipose-derived-stromal-vascular-fraction-therapy-in-patients-with-autoimmune-xerostomia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-amx0035-phenylbutyrate-and-ursodoxicoltaurine-in-patients-with-progressive-supranuclear-palsy-a-phase-2b-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-amx0035-phenylbutyrate-ursodoxicoltaurine-in-adult-patients-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-an-investigational-compound-in-parkinson-s-disease-in-healthy-individuals-and-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-atidarsagene-autotemcel-infusion-in-late-juvenile-metachromatic-leukodystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-bilateral-subretinal-raav-hcnga3-injection-in-adult-and-pediatric-patients-with-cnga3-linked-achromatopsia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-ct-01-monotherapy-and-in-combination-with-everolimus-in-patients-with-inoperable-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-dantrolene-sodium-and-botulinum-toxin-type-a-combination-in-patients-with-severe-glabellar-lines2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-delandistrogene-moxeparvovec-in-non-ambulatory-and-ambulatory-duchenne-muscular-dystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-dlq03-iodine-formulation-in-a-wound-healing-model-for-patients-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-enlicitide-chloride-mk-0616-in-an-open-label-extension-study-for-adults-with-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-ep262-in-adult-patients-with-chronic-inducible-urticaria-a-multicenter-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-esflurbiprofen-topical-system-and-paracetamol-in-acute-limb-contusion-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-favezelimab-and-pembrolizumab-in-patients-with-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-gsk-neisseria-gonorrhoeae-gmma-investigational-vaccine-in-healthy-adults-aged-18-to-50-years2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-imiquimod-gel-versus-imiquimod-cream-in-the-treatment-of-actinic-keratosis-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-karxt-and-karx-ec-in-treating-agitation-associated-with-alzheimer-s-disease-in-a-phase-3-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-kin-2787-in-patients-with-braf-and-or-nras-mutation-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-local-injection-of-allogeneic-bone-marrow-derived-mesenchymal-adult-stromal-cells-in-crohn-s-disease-related-intestinal-strictures2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-mosunetuzumab-and-pirtobrutinib-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-nebulized-opelconazole-combined-with-systemic-antifungal-therapy-in-refractory-invasive-pulmonary-aspergillosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-nedosiran-in-patients-with-primary-hyperoxaluria-type-1-and-severe-renal-impairment-including-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-ocrelizumab-and-melatonin-in-primary-progressive-multiple-sclerosis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-oral-fosfomycin-calcium-versus-fosfomycin-trometamol-in-adult-women-with-uncomplicated-urinary-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-oral-semaglutide-in-managing-hyperglycemia-in-post-renal-transplant-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-rhinophage-2a-in-patients-with-chronic-rhinosinusitis-due-to-staphylococcus-aureus-infection-a-phase-i-ii-adaptive-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-shortened-antibiotic-regimens-in-left-sided-infectious-endocarditis-using-vancomycin-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-subcutaneous-medi0618-in-reducing-migraine-headache-days-in-adults-with-episodic-migraine-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-subcutaneous-sar446523-in-adults-with-relapsed-refractory-plasma-cell-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-subcutaneous-tertomotide-gv1001-in-mild-to-moderate-alzheimer-s-disease-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-subretinal-cpk850-gene-therapy-in-patients-with-rlbp1-associated-retinitis-pigmentosa2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-topical-bacteriophage-therapy-tp-102-in-diabetic-foot-ulcers-infected-by-acinetobacter-baumannii-pseudomonas-aeruginosa-or-staphylococcus-aureus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-efficacy-of-trospium-chloride-and-xanomeline-tartrate-in-treating-agitation-in-alzheimer-s-disease-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-feasibility-of-irradiation-combined-with-nivolumab-in-patients-with-esophageal-cancer-a-phase-i-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-pharmacokinetics-of-cvn293-in-healthy-volunteers-for-neurodegenerative-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-pharmacokinetics-of-intranasal-ev25-in-healthy-adults-for-influenza-virus-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-pharmacokinetics-of-oral-berotralstat-in-pediatric-patients-aged-2-to-12-years-with-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-pharmacokinetics-of-ucb3101-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-preliminary-efficacy-of-vay736-monotherapy-and-in-combination-with-antineoplastic-agents-in-relapsed-refractory-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-a-timolol-releasing-intraocular-implant-in-patients-with-primary-open-angle-glaucoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-abelacimab-versus-rivaroxaban-in-patients-with-atrial-fibrillation-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-ac01-in-patients-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-bhv-7000-in-adults-with-refractory-focal-onset-epilepsy-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-inhaled-teicoplanin-in-cystic-fibrosis-patients-with-persistent-staphylococcus-aureus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-intravenous-difelikefalin-in-adolescents-aged-12-17-years-undergoing-hemodialysis-with-moderate-to-severe-pruritus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-long-term-sodium-hydrogen-carbonate-and-sodium-dihydrogen-phosphate-treatment-in-chronic-constipation-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-lu-ah69593-in-healthy-adults-and-adults-with-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-single-and-multiple-ascending-doses-of-lunsekimig-sar443765-in-healthy-participants-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-and-tolerability-of-subcutaneous-isis-678354-in-familial-chylomicronemia-syndrome-patients-previously-treated-with-volanesorsen2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-efficacy-and-pharmacokinetics-of-subcutaneous-abbv-383-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-povetacicept-in-patients-with-autoimmune-cytopenias-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-of-10-day-daily-bucco-oral-administration-of-transfer-factor-in-healthy-adult-human-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-of-dafsolimab-setaritox-and-grisnilimab-setaritox-in-patients-with-early-diffuse-cutaneous-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-of-sequential-rituximab-and-cladribine-treatment-in-patients-with-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-of-somatic-cell-based-therapy-for-post-radical-prostatectomy-urinary-incontinence-an-open-label-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-arv-102-in-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-jnj-64619178-in-patients-with-advanced-lymphoma-or-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-ker-0193-in-adult-patients-with-fragile-x-syndrome-following-single-and-multiple-oral-doses2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-clinical-activity-of-blu-808-a-wild-type-kit-inhibitor-in-patients-with-chronic-inducible-and-spontaneous-urticaria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-effectiveness-of-cth120-in-adult-males-with-fragile-x-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-efficacy-of-azetukalner-as-adjunctive-therapy-in-adults-with-focal-onset-epilepsy-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-efficacy-of-the-pan-kras-inhibitor-ly4066434-in-patients-with-kras-mutant-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-efficacy-of-zimislecel-vx-880-in-type-1-diabetes-mellitus-with-impaired-hypoglycemic-awareness-and-severe-hypoglycemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-immunogenicity-of-jjp-1212-in-patients-with-linear-iga-dermatosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-fe-999301-in-healthy-subjects-with-inflammatory-gastrointestinal-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-m6229-in-sepsis-and-septic-shock-a-randomized-single-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-regn7999-in-healthy-subjects-for-iron-overload-related-disease-treatment-development2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-tpt0301-in-healthy-volunteers-for-adjunctive-neuropathic-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ine963-in-patients-with-malaria2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-tolerability-of-multiple-doses-of-bi-3810477-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-tolerability-of-multiple-doses-of-bi-765423-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-tolerability-of-repeated-doses-of-bi-3032950-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-the-virucidal-efficacy-of-povidone-iodine-hydrogen-peroxide-and-water-for-injection-against-respiratory-viruses-in-covid-19-influenza-a-and-rsv-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-de-escalation-in-her2-positive-metastatic-breast-cancer-using-trastuzumab-and-drug-combination-in-patients-with-controlled-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-drug-monitoring-in-mitigating-risperidone-and-aripiprazole-induced-weight-gain-in-pediatric-autism-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-drug-monitoring-optimized-teicoplanin-dosing-versus-standard-dosing-in-patients-with-sepsis-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-equivalence-and-safety-of-fluticasone-furoate-vilanterol-inhalation-powder-versus-placebo-in-adults-with-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-escalation-with-infliximab-in-postoperative-recurrence-of-crohn-s-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-therapeutic-versus-prophylactic-doses-of-nadroparin-calcium-in-patients-with-subarachnoid-hemorrhage-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-thiamine-and-biotin-combination-therapy-in-patients-with-huntington-s-disease-a-multicentric-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-thiopental-sodium-dosing-in-electroconvulsive-therapy-for-major-depressive-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-thoracic-radiotherapy-and-durvalumab-in-elderly-frail-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-unfit-for-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-thoracic-radiotherapy-combined-with-durvalumab-and-chemotherapy-in-extensive-stage-small-cell-lung-cancer-a-randomized-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-thymalfasin-efficacy-and-tolerability-in-adult-patients-with-cystic-fibrosis-a-phase-ii-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ticagrelor-monotherapy-post-coronary-stenting-in-acute-myocardial-infarction-a-phase-ii-single-center-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ticagrelor-monotherapy-versus-ticagrelor-plus-acetylsalicylic-acid-on-ischemic-events-and-intramyocardial-hemorrhage-in-stemi-patients-post-pci2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ticagrelor-plus-acetylsalicylic-acid-versus-acetylsalicylic-acid-alone-on-ischemic-events-and-graft-failure-in-coronary-artery-bypass-grafting-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ticagrelor-versus-acetylsalicylic-acid-for-single-antiplatelet-therapy-post-transcatheter-aortic-valve-implantation-in-severe-symptomatic-aortic-stenosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tildacerfont-in-reducing-supraphysiologic-glucocorticoid-use-in-adults-with-classic-congenital-adrenal-hyperplasia-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tildrakizumab-in-refractory-chronic-spontaneous-urticaria-a-phase-ii-single-arm-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tildrakizumab-in-the-treatment-of-ocular-sequelae-in-lyell-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-timbetasin-acetate-ophthalmic-solution-0-1-for-neurotrophic-keratopathy-a-phase-3-randomized-double-masked-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-time-restricted-eating-and-metformin-hydrochloride-in-luminal-invasive-breast-cancer-and-ductal-carcinoma-in-situ-a-phase-iib-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tin816-for-safety-tolerability-and-efficacy-in-adult-patients-at-risk-for-acute-kidney-injury-post-cardiac-surgery-a-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tinlarebant-efficacy-and-safety-in-adolescents-with-stargardt-disease-a-phase-3-randomized-double-masked-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tinzaparin-sodium-and-enoxaparin-sodium-for-thromboprophylaxis-in-neoadjuvant-treated-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tinzaparin-sodium-for-venous-thromboembolism-prophylaxis-in-patients-with-metastatic-colorectal-cancer-initiating-first-line-systemic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tinzaparin-sodium-on-biomarker-modulation-in-figo-stage-iii-iv-epithelial-ovarian-cancer-patients-undergoing-neoadjuvant-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tinzaparin-sodium-on-progression-free-survival-in-patients-with-advanced-pancreatic-cancer-undergoing-nab-paclitaxel-based-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tiotropium-bromide-2-5mg-soft-mist-inhaler-device-in-patients-with-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tiragolumab-and-atezolizumab-combination-therapy-in-chemotherapy-naive-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tiratricol-in-pediatric-patients-with-monocarboxylate-transporter-8-deficiency-a-longitudinal-neurodevelopmental-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tiratricol-withdrawal-on-serum-t3-levels-in-males-with-monocarboxylate-transporter-8-deficiency-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tirzepatide-and-letrozole-on-tumor-response-in-postmenopausal-women-with-hormone-receptor-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tirzepatide-for-ovarian-dysfunction-in-overweight-or-obese-patients-with-polycystic-ovary-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tirzepatide-on-alcohol-consumption-and-reward-processing-in-patients-with-schizophrenia-and-alcohol-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tirzepatide-on-coronary-plaque-composition-and-microvascular-function-in-overweight-and-obese-patients-with-stable-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tisagenlecleucel-in-adult-b-cell-acute-lymphoblastic-leukemia-with-resistance-relapse-or-measurable-residual-disease-phase-i-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tislelizumab-lbl-007-and-surzebiclimab-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tl-895-in-myelofibrosis-indolent-systemic-mastocytosis-and-mast-cell-activation-syndrome-a-phase-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tng908-safety-tolerability-and-anti-tumor-activity-in-patients-with-mtap-deleted-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tobemstomig-tiragolumab-and-atezolizumab-in-untreated-locally-advanced-or-metastatic-urothelial-cancer-ineligible-for-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tobevibart-and-elebsiran-efficacy-and-safety-in-chronic-hepatitis-d-virus-infection-unresponsive-to-bulevirtide-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-and-biologic-drug-combinations-in-rheumatoid-and-psoriatic-arthritis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-and-biologic-drug-combinations-in-rheumatoid-and-psoriatic-arthritis-patients-for-safety-and-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-based-drug-combination-in-patients-with-severe-resistant-non-classified-inflammatory-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-discontinuation-strategies-on-relapse-free-survival-in-patients-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-efficacy-and-safety-in-treating-acute-chest-syndrome-in-pediatric-and-adult-sickle-cell-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-in-enhancing-chemoradiotherapy-efficacy-in-patients-with-esophageal-adenocarcinoma-and-activated-stromal-response2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocilizumab-in-the-management-of-painful-chronic-pancreatitis-a-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tocotrienol-and-bevacizumab-in-combination-with-standard-chemotherapy-for-metastatic-colorectal-cancer-a-randomized-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tofacitinib-efficacy-in-psoriatic-arthritis-a-stratification-study-using-clinical-transcriptomic-metabolomic-and-proteomic-data2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tofacitinib-for-induction-and-maintenance-of-remission-in-dmard-naive-psoriatic-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tofacitinib-on-coagulation-and-platelet-function-in-ulcerative-colitis-patients-a-comparative-study-with-golimumab-infliximab-and-adalimumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tofersen-in-presymptomatic-adults-with-confirmed-sod1-mutation-associated-amyotrophic-lateral-sclerosis-a-phase-3-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tol2-safety-tolerability-and-immune-response-in-generalized-myasthenia-gravis-patients-a-phase-i-iia-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolcapone-efficacy-as-a-genotype-specific-cognitive-enhancer-in-schizophrenia-with-comt-rs4680-polymorphism2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-acceptance-of-oral-hydrocortisone-formulations-in-pediatric-patients-with-adrenal-hyperplasia-or-adrenal-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-dosage-of-rmc-6291-and-rmc-6236-in-patients-with-advanced-krasg12c-mutated-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-dose-response-of-bi-3776528-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-efficacy-of-asciminib-hydrochloride-versus-nilotinib-in-newly-diagnosed-philadelphia-chromosome-positive-chronic-myeloid-leukemia-in-chronic-phase2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-safety-of-bi-3731579-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-safety-of-bi-3802876-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-safety-of-bi-3810477-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-and-safety-of-s221237-in-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-of-concurrent-external-beam-radiation-therapy-and-lutetium-177-psma-in-patients-with-node-positive-metastasis-free-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-of-o3r-5671-pro-in-single-and-multiple-doses-in-healthy-adults-with-inflammatory-bowel-diseases-and-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-of-spesolimab-administered-via-two-routes-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerability-safety-and-efficacy-of-topical-terbinafine-hydrochloride-solution-in-pediatric-patients-with-mild-to-moderate-distal-subungual-onychomycosis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolerance-and-efficacy-of-total-body-irradiation-and-cladribine-in-allogeneic-hematopoietic-cell-transplantation-for-acute-myeloid-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tolinapant-astx660-in-advanced-solid-tumors-and-lymphomas-a-phase-1-2-study-on-safety-pharmacokinetics-and-preliminary-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tominersen-safety-biomarkers-and-efficacy-in-prodromal-and-early-manifest-huntington-s-disease-a-phase-ii-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-topical-clonazepam-for-pain-management-in-patients-with-burning-mouth-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-topical-glyceryl-trinitrate-on-genitourinary-syndrome-of-menopause-and-female-sexual-dysfunction-in-peri-and-postmenopausal-women-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-topical-metformin-embonate-as-an-adjuvant-to-daylight-photodynamic-therapy-with-methyl-aminolevulinate-in-actinic-keratoses-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-topical-tacrolimus-in-the-management-of-stage-i-and-ii-breast-cancer-related-lymphedema-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-topical-tranexamic-acid-on-postoperative-hemorrhagic-and-thromboembolic-events-in-adult-plastic-surgery-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-toripalimab-combined-with-chemotherapy-in-first-line-treatment-of-recurrent-and-or-metastatic-nasopharyngeal-carcinoma-in-non-endemic-populations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-total-neoadjuvant-therapy-with-folinic-acid-fluorouracil-and-docetaxel-in-lymph-node-positive-oesophagogastric-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-total-pancreatectomy-with-autologous-islet-transplantation-in-periampullary-carcinoma-patients-at-high-risk-for-postoperative-pancreatic-fistula2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tovinontrine-on-nt-probnp-levels-in-adults-with-chronic-heart-failure-with-preserved-ejection-fraction-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tovorafenib-in-pediatric-patients-with-raf-altered-recurrent-or-progressive-low-grade-glioma-and-advanced-solid-tumors-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tozorakimab-efficacy-and-safety-in-chronic-obstructive-pulmonary-disease-patients-with-exacerbation-history-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tozorakimab-efficacy-and-safety-in-chronic-obstructive-pulmonary-disease-with-exacerbation-history-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tozorakimab-efficacy-and-safety-in-hospitalized-patients-with-severe-viral-lung-infections-requiring-supplemental-oxygen-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tpex-regimen-followed-by-avelumab-and-cetuximab-maintenance-in-first-line-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trametinib-for-inducing-tumor-volume-reduction-in-neurofibromatosis-type-1-associated-symptomatic-plexiform-neurofibromas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tranexamic-acid-and-sodium-chloride-in-reducing-blood-loss-and-fibrinolysis-during-excisional-burn-surgery-in-patients-with-burn-injury2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tranexamic-acid-in-reducing-hemorrhage-and-transfusion-requirements-in-major-abdominal-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tranexamic-acid-in-reducing-intraoperative-blood-loss-in-pediatric-patients-undergoing-proximal-femoral-and-pelvic-osteotomies-for-hip-dysplasia-and-related-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tranexamic-acid-in-reducing-postpartum-hemorrhage-in-cesarean-deliveries-with-placenta-previa-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tranexamic-acid-in-reducing-surgical-intervention-in-patients-with-chronic-subdural-hematoma-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transabdominal-ultrasound-with-perflubutane-and-laxative-combination-for-small-bowel-assessment-in-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transanal-irrigation-versus-glycerol-suppositories-in-the-management-of-low-anterior-resection-syndrome-in-post-rectal-cancer-surgery-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transarterial-chemoembolization-combined-with-durvalumab-and-bevacizumab-in-locoregional-hepatocellular-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transbronchial-needle-injection-of-tremelimumab-in-early-stage-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transcon-tlr7-8-agonist-and-pembrolizumab-alone-or-combined-with-transcon-il-2-b-g-in-stage-iii-iva-resectable-la-hnscc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transcon-tlr7-8-agonist-and-pembrolizumab-in-locally-advanced-or-metastatic-solid-tumor-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transdermal-estradiol-and-exercise-in-reducing-adverse-effects-of-androgen-deprivation-therapy-in-prostate-cancer-patients-undergoing-radiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transdermal-nicotine-on-delayed-gastric-emptying-post-pancreatoduodenectomy-a-randomized-double-blind-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transdermal-testosterone-pretreatment-in-patients-with-low-ovarian-reserve-and-androgen-receptor-polymorphism-undergoing-icsi2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transdermal-testosterone-replacement-therapy-on-endocrine-cardiovascular-and-neurocognitive-outcomes-in-women-with-turner-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transfer-factor-tfi-on-recurrent-respiratory-urinary-tract-and-herpetic-infections-in-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transmural-healing-and-disease-modifying-effects-of-guselkumab-in-patients-with-crohn-s-disease-a-phase-3b-open-label-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transmural-healing-as-a-treatment-target-in-moderately-to-severely-active-crohn-s-disease-using-upadacitinib-risankizumab-and-ustekinumab2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-transtympanic-sodium-thiosulfate-for-prevention-of-cisplatin-induced-ototoxicity-in-patients-with-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-and-pertuzumab-addition-to-neoadjuvant-chemoradiation-in-resectable-her2-positive-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-and-pertuzumab-with-fdg-pet-response-adapted-strategy-in-her2-positive-breast-cancer-the-phergain-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-and-fluoropyrimidine-versus-standard-chemotherapy-in-her2-positive-gastric-or-gastroesophageal-cancer-with-minimal-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-and-pembrolizumab-in-patients-with-locally-advanced-or-metastatic-breast-cancer-or-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-capecitabine-and-bevacizumab-in-her2-positive-metastatic-colorectal-cancer-patients-the-chimera-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-in-combination-with-anti-cancer-agents-for-safety-and-efficacy-in-metastatic-her2-low-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-in-combination-with-anti-cancer-agents-in-her2-positive-metastatic-breast-cancer-with-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-in-metastatic-her2-positive-breast-cancer-liquid-biopsy-for-resistance-and-her2-status-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-in-multi-modality-treatment-for-her2-positive-oligometastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-in-unresectable-metastatic-her2-low-or-her2-ihc0-breast-cancer-a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-monotherapy-and-combinations-in-her2-expressing-gastric-gej-and-esophageal-cancer-a-phase-1b-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-deruxtecan-with-immunotherapy-and-chemotherapy-in-first-line-treatment-of-her2-overexpressing-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trastuzumab-with-chemotherapy-and-pembrolizumab-in-first-line-treatment-of-her2-positive-esophageal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treatment-free-interval-feasibility-in-newly-diagnosed-multiple-myeloma-patients-undergoing-daratumumab-lenalidomide-and-dexamethasone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treatment-free-remission-in-chronic-myeloid-leukemia-patients-following-second-discontinuation-of-dasatinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treatment-strategies-for-severe-gram-negative-bacterial-infections-using-antimicrobial-agents-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treatment-strategies-in-haemophilia-a-patients-with-fviii-inhibitors-using-simoctocog-alfa-emicizumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treosulfan-versus-melphalan-conditioning-with-fludarabine-and-ptcy-in-allogeneic-transplantation-for-aml-and-mds-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-treprostinil-palmitil-inhalation-powder-on-pulmonary-vascular-resistance-in-pulmonary-arterial-hypertension-a-phase-2b-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triamcinolone-acetonide-cetrimide-and-lidocaine-in-combination-with-physiotherapy-for-the-treatment-of-adhesive-capsulitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tricortin-1000-diclofenac-sodium-and-paracetamol-in-chronic-low-back-pain-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trifluridine-tipiracil-and-nanoliposomal-irinotecan-as-second-line-therapy-in-advanced-cholangiocarcinoma-post-gemcitabine-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trifluridine-tipiracil-capecitabine-and-bevacizumab-combination-in-metastatic-colorectal-cancer-patients-unfit-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triheptanoin-versus-even-chain-medium-chain-triglycerides-on-major-clinical-events-in-pediatric-long-chain-fatty-acid-oxidation-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trilac-lacidofil-and-ofatumumab-in-reducing-clinical-activity-in-multiple-sclerosis-a-phase-ii-multicenter-randomized-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trimetazidine-dihydrochloride-on-endothelial-function-and-prognostic-biomarkers-in-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trimodality-therapy-with-or-without-adjuvant-durvalumab-in-patients-with-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triple-therapy-with-beclometasone-dipropionate-glycopyrronium-bromide-and-formoterol-fumarate-dihydrate-in-copd-patients-with-asthma-features2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triptorelin-administration-prior-to-frozen-embryo-transfer-in-patients-with-endometriosis-and-or-adenomyosis-a-randomized-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triptorelin-estradiol-hemihydrate-and-testosterone-on-bone-markers-in-postmenopausal-women-a-randomized-single-blinded-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-triptorelin-for-ovarian-reserve-preservation-in-young-females-undergoing-chemotherapy-for-breast-cancer-leukemia-lymphomas-and-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-trontinemab-distribution-binding-and-retention-in-the-brain-of-healthy-subjects-and-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-troriluzole-and-pegargiminase-in-newly-diagnosed-and-recurrent-glioblastoma-a-phase-ii-iii-adaptive-randomization-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-troriluzole-as-adjunctive-therapy-in-patients-with-obsessive-compulsive-disorder-with-inadequate-response-to-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tryptophan-and-tamsulosin-hydrochloride-in-patients-with-benign-prostatic-hyperplasia-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tsr-022-a-monoclonal-antibody-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tucatinib-and-trastuzumab-in-her3-mutant-her2-non-amplified-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tucatinib-pertuzumab-and-trastuzumab-in-her2-positive-metastatic-breast-cancer-with-isolated-brain-progression2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-heterogeneity-in-breast-cancer-using-proliferation-radiotracers-with-dedicated-breast-pet-for-early-treatment-response-detection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-infiltrating-lymphocytes-in-advanced-or-metastatic-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-infiltrating-lymphocytes-with-or-without-dendritic-cell-vaccination-in-advanced-metastatic-malignant-melanoma-stage-3-or-42026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-lysis-syndrome-risk-in-chronic-lymphocytic-leukemia-patients-treated-with-venetoclax-obinutuzumab-or-acalabrutinib-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-treating-fields-with-atezolizumab-gemcitabine-and-nab-paclitaxel-in-first-line-treatment-of-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tumor-treating-fields-with-modified-folfirinox-in-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tuvusertib-m1774-combined-with-dna-damage-response-or-immune-checkpoint-inhibitors-in-metastatic-or-locally-advanced-unresectable-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tuvusertib-m1774-in-human-mass-balance-and-absolute-bioavailability-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tuvusertib-m1774-in-patients-with-metastatic-or-locally-advanced-unresectable-solid-tumors-a-phase-3-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-two-corticosteroid-tapering-strategies-in-newly-diagnosed-untreated-rheumatoid-arthritis-a-randomized-open-label-non-inferiority-trial-of-prednisolone2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-two-dosage-regimens-of-colecalciferol-in-critically-ill-patients-with-vitamin-d3-deficiency-undergoing-continuous-renal-replacement-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tyk2-inhibition-in-the-treatment-of-vitiligo-a-clinical-trial-targeting-immune-mediated-pathways2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-typology-based-coaching-on-treatment-persistence-in-hr-her2-early-breast-cancer-patients-undergoing-ribociclib-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-tyrosine-kinase-inhibitor-discontinuation-post-dose-reduction-in-chronic-myeloid-leukemia-patients-in-deep-molecular-remission2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-u3-1402-in-patients-with-metastatic-or-unresectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ucan-diagnostic-test-for-drug-sensitivity-in-metastatic-colorectal-cancer-with-fluorouracil2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ucpvax-and-pembrolizumab-with-standard-therapy-in-adjuvant-treatment-of-unmethylated-mgmt-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-udonitrectag-mt8-in-combination-with-standard-care-for-safety-and-pharmacokinetics-in-diabetic-foot-ulcer-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ugn-103-mitomycin-efficacy-and-safety-in-intermediate-risk-low-grade-nonmuscle-invasive-bladder-cancer-a-phase-3-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultevursen-efficacy-safety-and-tolerability-in-retinitis-pigmentosa-patients-with-ush2a-exon-13-mutations-a-double-masked-randomized-sham-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultevursen-efficacy-safety-and-tolerability-in-retinitis-pigmentosa-patients-with-ush2a-exon-13-mutations-a-two-year-randomized-sham-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultra-hypofractionated-radiotherapy-combined-with-oral-relugolix-in-patients-with-intermediate-risk-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultrasonography-with-ti-rads-and-dual-tracer-scintigraphy-mibi-tc99m-iodine-123-in-detecting-malignancy-in-bethesda-iii-iv-thyroid-nodules2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultrasound-guided-betamethasone-infiltration-for-degenerative-meniscal-pain-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultrasound-guided-bleomycin-sulfate-sclerotherapy-in-the-management-of-warthin-s-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultrasound-guided-brachial-plexus-nerve-block-with-epinephrine-and-lidocaine-hydrochloride-for-closed-reduction-of-distal-radius-fracture-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ultrasound-guided-lateral-infraclavicular-brachial-plexus-block-using-lidocaine-hydrochloride-or-ropivacaine-hydrochloride-in-distal-radius-fracture-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-umeclidinium-bromide-vilanterol-on-exercise-induced-stroke-volume-in-copd-patients-with-hyperinflation-and-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-unilateral-subretinal-administration-of-adenovirus-associated-viral-vector-serotype-5-containing-human-pde6b-gene-in-retinitis-pigmentosa-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-and-prednisolone-combination-therapy-in-patients-with-giant-cell-arteritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-efficacy-and-safety-in-adult-and-adolescent-patients-with-severe-alopecia-areata-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-efficacy-safety-and-pharmacokinetics-in-pediatric-patients-with-moderate-to-severe-crohn-s-disease-a-phase-3-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-efficacy-safety-and-tolerability-in-adults-and-adolescents-with-non-segmental-vitiligo-eligible-for-systemic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-on-axial-symptoms-and-inflammation-in-patients-with-active-psoriatic-arthritis-and-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-upadacitinib-on-central-nervous-system-pain-response-in-psoriatic-arthritis-a-blood-oxygenation-level-dependent-fmri-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-urea-propylene-glycol-creams-for-maintenance-therapy-in-atopic-dermatitis-a-controlled-split-body-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ursodeoxycholic-acid-as-a-neuroprotective-adjunct-in-pseudophakic-or-aphakic-patients-undergoing-rhegmatogenous-retinal-detachment-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ursodeoxycholic-acid-in-preventing-recurrence-of-acute-biliary-pancreatitis-a-double-blind-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-uspio-enhanced-mri-with-ferumoxtran-10-for-lymph-node-staging-in-esophageal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ustekinumab-adalimumab-and-baricitinib-in-patients-with-refractory-folliculitis-decalvans-an-adaptive-immunomodulatory-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-v540a-vaccine-efficacy-in-preventing-human-papillomavirus-infection-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-v540c-vaccine-efficacy-in-preventing-human-papillomavirus-infection-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vafidemstat-on-negative-symptoms-and-cognitive-impairment-in-adult-schizophrenia-a-double-blind-randomized-placebo-controlled-phase-iib-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vaginal-estradiol-pretreatment-on-colposcopic-diagnosis-of-cervical-dysplasia-in-postmenopausal-women-with-hpv-positive-or-dysplastic-cervical-cells2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vaginal-progesterone-for-luteal-phase-support-in-enhancing-live-birth-rates-in-infertility-patients-undergoing-frozen-thawed-ivf-natural-cycles2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vaginal-slice-vascularization-post-total-laparoscopic-hysterectomy-using-indocyanine-green-injection-a-prospective-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vaginal-tamoxifen-citrate-for-improvement-of-sexual-function-in-women-with-breast-cancer-a-randomized-double-blind-placebo-controlled-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-valbenazine-as-adjunctive-therapy-in-schizophrenia-patients-with-inadequate-antipsychotic-response-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-valiltramiprosate-alz-801-on-plasma-biomarkers-and-brain-volumes-in-early-alzheimer-s-disease-patients-with-apoe4-genotype2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-valsartan-in-renal-transplant-recipients-with-post-transplant-glomerulopathy-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vancomycin-hydrochloride-versus-placebo-in-optimizing-antibiotic-treatment-duration-for-clostridioides-difficile-infection2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vancomycin-tobramycin-and-saline-in-antibiotic-impregnated-bone-grafts-for-reducing-prosthetic-joint-infection-post-hip-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-varegacestat-al102-in-patients-with-progressing-desmoid-tumors-a-phase-2-3-randomized-multicenter-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vasoconstriction-effects-of-clascoterone-cream-and-solution-versus-marketed-topical-corticosteroids-in-topical-steroid-potency-classification2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vasopressin-epinephrine-and-steroids-for-enhanced-30-day-survival-in-cardiac-arrest-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vedolizumab-and-upadacitinib-efficacy-and-safety-in-adults-with-moderate-to-severe-crohn-s-disease-a-randomized-double-blind-phase-3b-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vedolizumab-in-achieving-corticosteroid-free-remission-in-patients-with-moderately-to-severely-active-ulcerative-colitis-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vedolizumab-intravenous-as-maintenance-therapy-in-pediatric-patients-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vedolizumab-intravenous-efficacy-and-safety-in-pediatric-patients-with-active-chronic-pouchitis-a-phase-3-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vedolizumab-intravenous-maintenance-therapy-efficacy-and-safety-in-pediatric-patients-with-moderate-to-severe-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-velusetrag-pharmacokinetics-in-chronic-intestinal-pseudo-obstruction-a-two-part-study-on-intravenous-and-oral-administration-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-addition-to-rituximab-bendamustine-and-cytarabine-regimen-in-high-risk-elderly-patients-with-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-azacitidine-combination-therapy-in-treatment-naive-patients-with-higher-risk-myelodysplastic-syndromes-mds2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-azacitidine-combination-therapy-versus-placebo-and-azacitidine-in-treatment-naive-patients-with-higher-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-azacitidine-discontinuation-in-acute-myeloid-leukemia-patients-responding-to-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-azacitidine-for-measurable-residual-disease-clearance-in-acute-myeloid-leukemia-pre-allogeneic-hematopoietic-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-low-dose-cytarabine-versus-low-dose-cytarabine-alone-in-treatment-naive-acute-myeloid-leukemia-patients-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-mercaptopurine-combination-therapy-in-patients-with-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-and-obinutuzumab-with-or-without-zanubrutinib-in-high-risk-chronic-lymphocytic-leukemia-in-young-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-azacitidine-and-donor-lymphocyte-infusion-in-relapsed-myelodysplastic-syndromes-or-acute-myeloid-leukemia-post-allogeneic-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-combined-with-polatuzumab-vedotin-rituximab-cyclophosphamide-doxorubicin-and-prednisone-in-untreated-bcl-2-ihc-positive-dlbcl-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-delayed-rituximab-and-ibrutinib-for-achieving-undetectable-minimal-residual-disease-in-treatment-naive-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-efficacy-in-chronic-myeloid-leukemia-patients-post-tyrosine-kinase-inhibitor-discontinuation-in-deep-molecular-remission2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-for-inducing-apoptosis-in-hiv-1-infected-cells-and-reducing-hiv-reservoirs-in-patients-on-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-treosulfan-and-fludarabine-phosphate-in-reduced-intensity-conditioning-for-allogeneic-stem-cell-transplantation-in-aml-and-mds-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venetoclax-with-flamsa-treosulfan-conditioning-for-allogeneic-stem-cell-transplantation-in-high-risk-mds-cmml-and-saml-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venglustat-and-imiglucerase-combination-therapy-in-adult-patients-with-gaucher-disease-type-3-safety-tolerability-and-biomarker-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venglustat-on-neuropathic-and-abdominal-pain-in-treatment-naive-or-untreated-fabry-disease-patients-aged-16-years-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venglustat-versus-standard-care-on-left-ventricular-mass-index-in-fabry-disease-patients-with-left-ventricular-hypertrophy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-venlafaxine-s-efficacy-and-gut-microbiome-interaction-in-major-depressive-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ventricular-absorption-capacity-of-oxygen-15-water-in-adult-hydrocephalus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vepdegestrant-s-impact-on-midazolam-pharmacokinetics-in-patients-with-er-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-verapamil-hydrochloride-on-beta-cell-function-preservation-in-adults-with-newly-diagnosed-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vericiguat-on-microvascular-function-in-patients-with-documented-epicardial-and-microvascular-vasospastic-angina-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vericiguat-on-physical-function-in-sf-36-in-adults-aged-18-50-with-post-covid-19-syndrome-with-without-me-cfs-criteria-a-phase-2a-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vericiguat-palatability-in-liquid-formulation-in-healthy-male-adults-aged-18-45-implications-for-pediatric-heart-failure-management2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vg801-subretinal-injection-in-patients-with-biallelic-abca4-mutation-associated-retinal-dystrophy-a-phase-1-2-open-label-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vibegron-for-safety-efficacy-and-pharmacokinetics-in-pediatric-patients-with-neurogenic-detrusor-overactivity-on-clean-intermittent-catheterization2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vicadrostat-and-empagliflozin-in-simultaneous-vs-staggered-initiation-for-chronic-kidney-disease-progression-risk2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vicadrostat-bi-690517-and-empagliflozin-efficacy-and-safety-in-patients-with-symptomatic-chronic-heart-failure-and-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vicadrostat-bi-690517-and-empagliflozin-efficacy-and-safety-in-type-2-diabetes-hypertension-and-cardiovascular-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vidofludimus-calcium-imu-838-in-reducing-inflammatory-activity-in-patients-with-post-covid-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vildagliptin-for-the-prevention-of-new-onset-diabetes-mellitus-post-renal-transplantation-in-the-early-post-transplant-period2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vimseltinib-dcc-3014-safety-pharmacokinetics-and-efficacy-in-advanced-tumors-and-tenosynovial-giant-cell-tumor-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vinorelbine-and-cisplatin-sequential-chemotherapy-with-psma-pet-ct-guided-stereotactic-ablative-radiotherapy-in-castration-and-taxane-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vinorelbine-and-vinorelbine-tartrate-in-inhibiting-oncogenic-mkk3-functions-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-viral-specific-t-cell-therapy-for-refractory-cytomegalovirus-infections-in-adults-post-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-virological-efficacy-of-entecavir-selgantolimod-and-tenofovir-disoproxil-in-hbeag-negative-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-viscous-budesonide-formulation-efficacy-in-pediatric-eosinophilic-esophagitis-a-pilot-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vitamin-d-and-sucrosomial-iron-versus-intravenous-ferric-carboxymaltose-in-chronic-heart-failure-with-iron-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vitamin-d-supplementation-regimens-on-hypercalciuria-incidence-in-pediatric-patients-a-randomized-controlled-trial-of-cholecalciferol2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vixarelimab-efficacy-and-safety-in-patients-with-moderate-to-severe-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vmx-c001-for-coagulation-restoration-in-patients-on-doacs-experiencing-bleeding-or-requiring-anticoagulation-reversal-prior-to-urgent-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-volrustomig-with-folfiri-and-bevacizumab-versus-folfiri-and-bevacizumab-in-colorectal-cancer-patients-without-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vorasidenib-and-temozolomide-combination-therapy-in-patients-with-idh1-or-idh2-mutant-glioma-a-phase-1b-2-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vorbipiprant-cr6086-and-balstilimab-agen2034-in-pretreated-mss-metastatic-colorectal-and-other-gi-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vormatrigine-and-prax-628-in-adult-patients-with-focal-onset-or-primary-generalized-tonic-clonic-seizures-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vortioxetine-for-the-treatment-of-major-depressive-episodes-in-adult-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vortioxetine-hydrobromide-on-cognitive-impairments-in-early-schizophrenia-a-randomized-controlled-trial-with-comparator-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vosoritide-safety-and-efficacy-in-infants-and-young-children-with-hypochondroplasia-a-phase-2-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-voxelotor-on-intravascular-hemolysis-reduction-in-sickle-cell-disease-an-open-label-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vrdn-001-an-igf-1r-inhibitor-for-safety-tolerability-and-efficacy-in-chronic-thyroid-eye-disease-a-randomized-double-masked-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vrdn-001-an-igf-1r-inhibitor-in-a-multiple-ascending-dose-study-for-safety-tolerability-and-efficacy-in-thyroid-eye-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vs-01-efficacy-and-safety-in-overt-hepatic-encephalopathy-with-acute-decompensation-or-aclf-grade-1-a-phase-2-randomized-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vudalimab-and-pembrolizumab-with-chemotherapy-in-advanced-non-small-cell-lung-cancer-a-phase-1b-2-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vutrisiran-efficacy-and-safety-in-transthyretin-amyloidosis-with-cardiomyopathy-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vutrisiran-safety-and-efficacy-in-transthyretin-amyloidosis-with-cardiomyopathy-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vvd-130850-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-advanced-solid-and-hematologic-tumors-with-checkpoint-inhibition2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vvd130037-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-advanced-solid-tumors-and-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-vx-522-and-ivacaftor-in-adults-with-cystic-fibrosis-unresponsive-to-cftr-modulator-therapy-a-phase-1-2-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-whole-body-her2-expression-using-89zr-trastuzumab-pet-ct-in-her2-mutated-or-her2-overexpressing-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-wt1-il15-il15ra-mrna-dc-vaccine-in-patients-with-advanced-or-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-wt1-lamp-mrna-dc-vaccination-combined-with-chemotherapy-in-first-line-treatment-of-malignant-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-wt1-lamp-mrna-dc-vaccine-as-adjuvant-therapy-in-pediatric-high-grade-glioma-and-diffuse-intrinsic-pontine-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-xl092-and-belzutifan-combination-therapy-in-patients-with-recurrent-clear-cell-renal-cell-carcinoma-post-anti-pd-l-1-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-xmab541-in-patients-with-advanced-solid-tumors-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-xmab819-in-patients-with-advanced-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-xylocore-efficacy-and-safety-compared-to-standard-glucose-solutions-in-peritoneal-dialysis-for-end-stage-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-xylometazoline-hydrochloride-nasal-spray-on-exercise-capacity-in-adults-with-chronic-obstructive-pulmonary-disease-copd2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-yl201-in-patients-with-advanced-solid-tumors-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-yohimbine-hydrochloride-and-hydrocortisone-on-acute-stress-induced-moral-judgment-in-military-personnel2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zanidatamab-in-adult-patients-with-her2-overexpressing-or-mutant-solid-tumors-including-endometrial-colorectal-head-neck-sarcoma-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zanubrutinib-and-obinutuzumab-efficacy-in-untreated-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zasocitinib-efficacy-safety-and-tolerability-in-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zasocitinib-tak-279-efficacy-and-safety-in-active-psoriatic-arthritis-patients-stratified-by-prior-biologic-use-a-phase-3-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zavatar-test-guided-therapeutic-decisions-versus-standard-of-care-in-relapsed-ovarian-cancer-and-metastatic-breast-cancer-with-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zibotentan-and-dapagliflozin-combination-versus-dapagliflozin-monotherapy-in-chronic-kidney-disease-with-high-proteinuria-a-phase-iii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ziftomenib-combinations-for-safety-and-tolerability-in-relapsed-refractory-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ziltivekimab-s-anti-inflammatory-effects-on-arterial-wall-inflammation-in-coronary-artery-disease-patients-using-advanced-imaging-and-cellular-phenotyping2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ziltivekimab-versus-placebo-on-cardiovascular-outcomes-in-patients-with-atherosclerotic-cardiovascular-disease-chronic-kidney-disease-and-systemic-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-ziltivekimab-versus-placebo-on-heart-failure-symptoms-and-physical-function-in-patients-with-hfmref-or-hfpef-and-systemic-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zilucoplan-sodium-auto-injector-for-subcutaneous-self-administration-in-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zl-1218-with-or-without-pembrolizumab-in-patients-with-advanced-solid-tumors-dose-finding-and-tolerability-study2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zn-a-1041-monotherapy-and-combination-therapy-in-her2-positive-advanced-solid-tumors-efficacy-and-safety-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zoledronic-acid-monohydrate-efficacy-following-denosumab-discontinuation-in-postmenopausal-osteoporosis-a-biomarker-driven-versus-standardized-approach2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zoledronic-acid-on-tendon-healing-post-arthroscopic-repair-in-chronic-rotator-cuff-lesions-a-randomized-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/evaluation-of-zw171-in-patients-with-advanced-or-metastatic-mesothelin-expressing-cancers-including-ovarian-cancer-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/evasayil-tm-a-placebo-controlled-trial-to-evaluate-the-efficacy-and-safety-of-spesolimab-in-the-treatment-of-patients-with-netherton-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/ever-ild-2-evaluation-of-efficacy-and-safety-of-rituximab-in-patients-with-progressive-interstitial-lung-disease-ild-with-inflammatory-component-a-multicentre-double-blind-placebo-controlled-randomize2026-10-07 https://dev.clinicalresearch.eu/trial/everolimus-based-drug-combination-to-protect-kidney-function-in-patients-one-year-after-liver-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/expanded-access-program-for-mepolizumab-in-patients-with-hypereosinophilic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/expanded-access-program-for-selpercatinib-in-patients-with-locally-advanced-or-metastatic-ret-activated-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/expectation-training-with-olfactory-conditioning-to-improve-tocilizumab-based-combination-therapy-bdmard-tapering-in-rheumatoid-arthritis-top-ra2026-10-07 https://dev.clinicalresearch.eu/trial/experimental-study-on-alcohol-use-and-behavior-in-young-adults2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-analysis-of-t-memory-like-cells-in-plaque-psoriasis-treated-with-deucravacitinib2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-evaluation-of-danicamtiv-safety-and-efficacy-in-ambulatory-patients-with-primary-dilated-cardiomyopathy-due-to-myh7-or-ttn-variants2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-pilot-study-to-determine-the-tolerability-and-effectiveness-of-tirbanibulin-in-the-treatment-of-actinic-cheilitis2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-study-evaluating-the-relevance-of-68ga-ga-pentixafor-for-initial-staging-and-detection-of-minimal-residual-disease-in-multiple-myeloma-patients-eligible-for-autologous-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-study-of-ianalumab-in-adults-with-primary-immune-thrombocytopenia-itp-and-warm-antibody-autoimmune-hemolytic-anemia-waiha-who-have-previously-benefited-from-ianalumab-vay-re-hit2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-study-on-botulinum-toxin-type-a-efficacy-in-dystonic-tremor-syndrome-of-the-upper-extremity2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-study-on-the-effects-of-fe-999302-during-controlled-ovarian-stimulation-with-follitropin-delta-in-women-undergoing-art-for-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/exploratory-study-on-the-effects-of-fentanyl-citrate-on-ventilatory-patterns-in-healthy-subjects-with-naloxone-hydrochloride-as-an-auxiliary-agent2026-10-07 https://dev.clinicalresearch.eu/trial/exploring-the-psychoactive-effects-of-paracetamol-a-parallel-group-basic-science-double-blind-two-armed-study-to-investigate-potential-emotional-and-cognitive-effects-of-paracetamol-tablet-form-compar2026-10-07 https://dev.clinicalresearch.eu/trial/exposure-response-study-of-siplizumab-in-adults-with-new-onset-type-1-diabetes-a-12-month-randomized-single-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/extended-access-study-of-momelotinib-dihydrochloride-monohydrate-in-patients-with-primary-myelofibrosis-or-post-polycythemia-vera-essential-thrombocythemia-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/extended-multiple-dose-study-of-mk-8507-in-patients-with-hiv-1-infection2026-10-07 https://dev.clinicalresearch.eu/trial/extension-study-for-continued-treatment-in-cancer-patients-using-atezolizumab-tiragolumab-ipatasertib-and-abiraterone-or-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/extension-study-of-astx727-decitabine-and-cedazuridine-in-patients-with-acute-myeloid-leukemia-myelodysplastic-syndromes-chronic-myelomonocytic-leukemia-or-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/extension-study-of-pertuzumab-and-trastuzumab-in-solid-malignant-tumors-for-patients-from-previous-pertuzumab-trials2026-10-07 https://dev.clinicalresearch.eu/trial/extension-study-of-trastuzumab-emtansine-monotherapy-or-combination-therapy-in-her2-positive-metastatic-cancer-patients-from-genentech-roche-trials2026-10-07 https://dev.clinicalresearch.eu/trial/ezurpimtrostat-autophagy-inhibitor-in-association-with-atezolizumab-bevacizumab-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma-a-phase-2b-randomized-trial-abe-liver2026-10-07 https://dev.clinicalresearch.eu/trial/f-puff-se-20242026-10-07 https://dev.clinicalresearch.eu/trial/famodrep-interest-of-famotidine-in-reducing-endothelial-expression-of-p-selectin-in-children-with-sickle-cell-disease-pilot-study-single-center-prospective-non-comparative2026-10-07 https://dev.clinicalresearch.eu/trial/fapi-molecular-imaging-for-diagnosis-of-csm4-subtype-in-colorectal-cancer-with-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/fdg-pet-based-accelerated-chemoradiotherapy-followed-by-durvalumab-in-locally-advanced-unresectable-nsclc-with-pd-l1-12026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-and-safety-evaluation-of-intravenous-99mtc-tc-psma-t4-in-prostate-cancer-diagnosis-and-treatment-planning2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-and-safety-evaluation-of-subcutaneous-elranatamab-self-administration-in-home-settings-for-patients-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-and-tolerability-of-alternate-day-oral-ferrous-sulfate-in-adolescent-girls-with-iron-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-fluorescence-bronchoscopy-with-bevacizumab-800cw-in-patients-with-suspected-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-intraoperative-fluorescence-imaging-with-crgd-zw800-1-in-identifying-laryngeal-and-hypopharyngeal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-ovarian-stimulation-with-tamoxifen-and-follitropin-beta-for-fertility-preservation-in-breast-cancer-patients-prior-to-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-sentinel-lymph-node-biopsy-in-parotid-gland-carcinoma-using-99mtc-nanocolloid-and-68ga-tilmanocept-pet-ct2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-surgery-and-durvalumab-consolidation-post-chemoradiotherapy-in-stage-iii-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-of-urinary-proteomic-signatures-in-identifying-type-2-diabetes-patients-for-dapagliflozin-semaglutide-and-finerenone-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-botulinum-toxin-a-for-chronic-postsurgical-pain-in-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-dry-extract-from-psilocybe-cubensis-15-25-1-with-methanol-solvent-in-military-veterans-with-posttraumatic-stress-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-hyperpolarized-1-13c-pyruvate-and-18f-fludeoxyglucose-pet-mr-imaging-in-breast-cancer-neuroendocrine-neoplasms-lymphomas-and-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-inductive-apalutamide-therapy-with-radical-prostatectomy-in-locally-advanced-t4-high-risk-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-lutetium-177lu-zadavotide-guraxetan-and-radium-ra-223-dichloride-in-bone-metastatic-hormone-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-mr-hyperpolarization-scanning-with-hyperpolarized-1-13c-pyruvate-in-patients-with-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-neoadjuvant-chemotherapy-and-immunotherapy-with-ipilimumab-pemetrexed-cisplatin-and-nivolumab-in-inoperable-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-normothermic-intraperitoneal-chemotherapy-in-colorectal-cancer-with-peritoneal-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-oxaliplatin-based-vs-irinotecan-based-chemotherapy-in-mss-pmmr-metastatic-colorectal-cancer-using-patient-derived-tumouroids2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-study-of-semaglutide-for-obesity-in-adolescents-undergoing-antipsychotic-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/feasibility-trial-of-alocelyvir-and-autologous-tumor-infiltrating-t-lymphocytes-il-7-il-15-il-21-expanded-in-children-and-young-adults-with-relapsed-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/fecal-microbiota-transplantation-for-primary-sclerosing-cholangitis-randomized-study-versus-sham-transplantation-fmt-scler2026-10-07 https://dev.clinicalresearch.eu/trial/fentanyl-or-esketamine-for-traumatic-pain-trial2026-10-07 https://dev.clinicalresearch.eu/trial/filo-aml-01-mivonu-a-single-arm-phase-ii-study-investigating-the-efficacy-and-safety-of-the-addition-of-ivosidenib-to-oral-azacitidine-onureg-r-in-patients-over-55-with-acute-myeloid-leukemia-aml-and-2026-10-07 https://dev.clinicalresearch.eu/trial/filoaml-rr-01-ogilar-open-label-phase-2-study-investigating-the-efficacy-and-safety-of-the-addition-of-oral-azacitidine-to-salvage-treatment-by-gilteritinib-in-subjects-18-years-of-age-with-relapsed-r2026-10-07 https://dev.clinicalresearch.eu/trial/filocll015-glorify-a-phase-2-study-evaluating-the-bispecific-cd3xcd20-antibody-glofitamab-in-combination-with-rituximab-or-obinutuzumab-plus-cyclophosphamide-doxorubicin-vincristine-and-prednisone-cho2026-10-07 https://dev.clinicalresearch.eu/trial/fine-start-a-parallel-group-randomized-prospective-interventional-double-blind-multicenter-global-phase-3-study-to-investigate-the-efficacy-and-safety-of-finerenone-versus-placebo-in-participants-with2026-10-07 https://dev.clinicalresearch.eu/trial/fire-stones-impact-of-furosemide-on-the-residual-fragment-rate-after-flexible-ureteroscopy-for-destruction-of-kidney-stones-with-laser-a-controlled-two-parallel-group-multicenter-trial-with-blinding-e2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-evaluation-of-11c-ucb-1a-pet-imaging-of-synaptic-vesicle-glycoprotein-2c-in-healthy-volunteers-and-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-open-label-dose-escalation-trial-with-expansion-cohorts-to-evaluate-the-safety-of-gen1053-as-monotherapy-and-in-combination-with-an-immunomodulator-in-subjects-with-malignant-solid-tumo2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-open-label-multi-site-phase-i-iia-dose-escalation-trial-with-expansion-cohorts-to-evaluate-safety-and-preliminary-efficacy-of-bnt329-in-participants-with-advanced-solid-tumors-known-to-2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-open-label-phase-1-study-of-nbim-1008-safety-tolerability-pk-pd-and-preliminary-efficacy-in-adults-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-open-label-study-assessing-safety-and-feasibility-of-intra-articular-allogeneic-engineered-gingival-fibroblasts-aegf-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-open-label-study-of-inca035784-in-adults-with-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-phase-1-study-assessing-safety-tolerability-and-pharmacokinetics-of-ab102-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-proof-of-concept-study-of-intranasal-staphylococcus-lugdunensis-for-decolonization-of-persistent-nasal-staphylococcus-aureus-carriage2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-randomized-double-blind-placebo-controlled-phase-ib-study-of-tir-c-2-cutaneous-emulsion-in-adults-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-randomized-double-blind-placebo-controlled-study-of-gl0071-assessing-safety-pk-pd-and-12-week-proof-of-concept-efficacy-in-overweight-obese-adults-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-study-of-bay-3620122-a-novel-therapeutic-for-vasodilatory-shock-evaluating-safety-pharmacokinetics-and-pharmacodynamics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-study-of-bim2b-in-patients-with-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-study-of-gsk5533524-monotherapy-and-combination-therapy-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/first-in-human-study-of-sar447971-in-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/first-line-percutaneous-stellate-ganglion-block-with-bupivacaine-and-lidocaine-versus-amiodarone-in-patients-with-electrical-storm2026-10-07 https://dev.clinicalresearch.eu/trial/first-line-treatment-with-pembrolizumab-or-cemiplimab-in-advanced-non-small-cell-lung-cancer-patients-with-pd-l1-50-and-pti-score-02026-10-07 https://dev.clinicalresearch.eu/trial/flecainide-vs-bisoprolol-for-first-line-treatment-of-premature-ventricular-contractions-in-adults-a-randomized-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/flucloric-randomized-multicentric-phase-iii-study-comparing-the-efficacy-of-two-reduced-intensity-conditioning-regimens-clofarabine-busulfan-versus-fludarabine-busulfan-in-adults-with-acute-myeloid-le2026-10-07 https://dev.clinicalresearch.eu/trial/fludarabine-and-treosulfan-drug-combination-for-older-or-frail-patients-with-acute-myeloid-leukemia-undergoing-haploidentical-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/fluorescence-bronchoscopy-of-durvalumab-680lt-distribution-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-after-chemoradiation2026-10-07 https://dev.clinicalresearch.eu/trial/fluorescence-intraoperative-surgical-margin-analysis-in-head-and-neck-cancer-clinical-validation2026-10-07 https://dev.clinicalresearch.eu/trial/fluoroethyltyrosine-f-18-pet-for-adults-18-with-suspected-functional-pituitary-adenoma-and-inconclusive-mri2026-10-07 https://dev.clinicalresearch.eu/trial/follitropin-alfa-and-chorionic-gonadotrophin-for-men-with-male-infertility-and-oligozoospermia-low-testosterone-and-normal-fsh-levels2026-10-07 https://dev.clinicalresearch.eu/trial/fosfomycin-trometamol-versus-drug-combination-for-treating-acute-e-coli-kidney-infection-in-women-aged-75-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/fosfomycin-versus-drug-combination-as-oral-step-down-therapy-for-febrile-urinary-tract-infections-in-men-caused-by-escherichia-coli2026-10-07 https://dev.clinicalresearch.eu/trial/framework-for-optimizing-refining-and-unifying-management-of-hsct-in-pediatric-all2026-10-07 https://dev.clinicalresearch.eu/trial/functional-lung-avoidance-planning-using-68ga-ga-maa-pet-ct-versus-anatomical-planning-in-sbrt-for-primary-or-secondary-lung-tumors-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/gb-0895-as-add-on-treatment-for-adults-and-adolescents-with-severe-uncontrolled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/gene-therapy-using-pde6a-for-treatment-of-pde6a-linked-retinitis-pigmentosa-in-affected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/gene-therapy-with-hematopoietic-stem-cells-for-glioblastoma-multiforme-in-patients-with-malignant-central-nervous-system-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/genepid-a-44-weeks-monocentric-open-study-assessing-the-efficacy-and-safety-of-deucravacitinib-in-adults-with-inflammatory-epidermal-genodermatoses-epidermolysis-bullosa-simplex-and-inflammatory-conge2026-10-07 https://dev.clinicalresearch.eu/trial/gfm-vexas-mmb-a-single-arm-phase-ii-with-safety-run-in-multicenter-study-of-momelotinib-in-patients-with-vexas-syndrome-with-or-without-associated-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/glucagon-enhanced-insulin-absorption-in-diabetes-mellitus-type-12026-10-07 https://dev.clinicalresearch.eu/trial/guttmann-neurorecovery-feasibility-safety-and-efficacy-of-intrathecal-wharton-s-jelly-derived-mesenchymal-stem-cells-and-transcutaneous-spinal-cord-stimulation-in-the-rehabilitation-of-chronic-spinal-2026-10-07 https://dev.clinicalresearch.eu/trial/heart-rate-control-betablockers-or-ivabradine-therapy-before-cardiac-computed-tomography2026-10-07 https://dev.clinicalresearch.eu/trial/hemodynamic-effects-of-dobutamine-on-cardiac-output-and-filling-pressures-in-symptomatic-wild-type-transthyretin-amyloid-cardiomyopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/hepastem-long-term-safety-registry-registry-for-patients-who-have-been-administered-hepastem2026-10-07 https://dev.clinicalresearch.eu/trial/hepatic-arterial-infusion-of-gemcitabine-hydrochloride-and-oxaliplatin-for-second-line-treatment-in-non-metastatic-unresectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/her2-molecular-imaging-with-89zr-trastuzumab-pet-ct-as-a-predictive-biomarker-for-antibody-drug-conjugate-sequencing-in-patients-with-advanced-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/her2dx-guided-treatment-versus-standard-care-in-her2-positive-early-stage-breast-cancer-evaluation-of-trastuzumab-pertuzumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/hermes-effects-of-ziltivekimab-versus-placebo-on-morbidity-and-mortality-in-patients-with-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction-and-systemic-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/herpes-zoster-after-recombinant-herpes-zoster-vaccination-immediate-post-rhz-vaccination-evolution-of-cmi-hmi-and-lymphocyte-count-and-typing2026-10-07 https://dev.clinicalresearch.eu/trial/high-dosage-fluoride-toothpaste-for-root-caries-control-in-situ-a-randomized-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/high-dose-steroids-in-children-with-stroke-and-unilateral-focal-arteriopathy-a-multicentre-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/high-dose-thiamine-hydrochloride-for-fatigue-in-rheumatoid-arthritis-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/high-flow-oxygen-to-reduce-hypoxemia-in-high-risk-adults-undergoing-gastroscopy-colonoscopy-or-endoscopic-ultrasound-with-deep-sedation2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-150-aml-a-phase-3-multicenter-double-blind-randomized-placebo-controlled-study-of-ivosidenib-or-enasidenib-in-combination-with-induction-therapy-and-consolidation-therapy-followed-by-maintenance2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-151-dlbcl-a-phase-ii-study-evaluating-the-feasibility-and-clinical-efficacy-of-atezolizumab-consolidation-treatment-in-high-risk-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-152-dlbcl-a-phase-ii-study-evaluating-the-effect-of-da-epoch-r-induction-followed-by-nivolumab-consolidation-in-patients-with-newly-diagnosed-high-grade-b-cell-lymphoma-hgbl-with-myc-and-bcl2-an2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-156-aml-a-phase-3-multicenter-open-label-randomized-study-of-gilteritinib-versus-midostaurin-in-combination-with-induction-and-consolidation-therapy-followed-by-one-year-maintenance-in-patients-2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-158-cll-first-line-treatment-with-venetoclax-and-ibrutinib-induction-followed-by-obinutuzumab-intensification-exclusively-in-cll-sll-patients-not-in-complete-remission-and-or-with-detectable-bon2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-164-hl-tislelizumab-plus-gemcitabine-and-cisplatin-for-relapsed-or-refractory-hodgkin-lymphoma-followed-by-tislelizumab-consolidation-in-patients-in-metabolic-complete-remission-tigerr-hl-an-ope2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-165-cll-a-prospective-randomized-phase-i-ii-trial-of-venetoclax-treatment-26-cycles-with-6-cycles-or-12-cycles-of-epcoritamab-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/hovon-181-aml-bleximenib-or-placebo-in-combination-with-standard-induction-and-consolidation-therapy-followed-by-maintenance-for-the-treatment-of-patients-with-newly-diagnosed-kmt2a-rearranged-or-npm12026-10-07 https://dev.clinicalresearch.eu/trial/hu-f-aim-a-prospective-interventional-study-to-evaluate-hu-resistance-in-polycythemia-vera-patients-who-meet-predictive-parameters-identified-in-the-machine-learning-project-pv-aim2026-10-07 https://dev.clinicalresearch.eu/trial/human-papillomavirus-vaccine-effectiveness-study-among-men-who-have-sex-with-men2026-10-07 https://dev.clinicalresearch.eu/trial/human-recombinant-interferon-gamma-in-the-treatment-of-ventilator-acquired-pneumonia-in-icu-patients-ignorant-study2026-10-07 https://dev.clinicalresearch.eu/trial/hydrochlorothiazide-compared-to-valsartan-to-treat-arterial-hypertension-in-patients-with-hypertrophic-obstructive-cardiomyopathy-the-multicenter-randomized-double-blind-controlled-crossover-hyde-hcm-2026-10-07 https://dev.clinicalresearch.eu/trial/hydrochlorothiazide-to-protect-polycystic-kidney-disease-patients-and-improve-their-quality-of-life-hydro-protect2026-10-07 https://dev.clinicalresearch.eu/trial/hydroxychloroquine-as-steroid-sparing-agent-in-extra-pulmonary-sarcoidosis-a-multicenter-prospective-placebo-controlled-randomized-trial-caesar2026-10-07 https://dev.clinicalresearch.eu/trial/hydroxyurea-plus-drug-combination-for-safety-and-efficacy-in-adults-with-relapsed-or-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/hyperpolarized-129-xenon-mri-in-fibrosing-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/hysteroscopic-resection-versus-medical-management-of-early-pregnancy-loss-hyme-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/i3y-mc-jpeh-a-randomized-open-label-phase-2-study-evaluating-abemaciclib-in-combination-with-temozolomide-compared-to-temozolomide-monotherapy-in-children-and-young-adults-with-newly-diagnosed-high-gr2026-10-07 https://dev.clinicalresearch.eu/trial/i4v-mc-jaio-a-phase-3-double-blind-randomized-placebo-controlled-trial-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-baricitinib-in-children-from-6-years-to-less-than-18-years-of-age-with-al2026-10-07 https://dev.clinicalresearch.eu/trial/i5t-mc-aacq-investigating-the-effect-of-different-donanemab-dosing-regimens-on-aria-e-and-amyloid-lowering-in-adults-with-early-symptomatic-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/i6t-mc-amax-a-phase-3-multicenter-open-label-long-term-extension-study-to-evaluate-the-long-term-efficacy-and-safety-of-mirikizumab-in-patients-with-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/i6t-mc-amba-a-multicenter-phase-3-open-label-study-to-investigate-the-efficacy-pharmacokinetics-and-safety-of-mirikizumab-in-participants-2-years-to-less-than-18-years-of-age-with-moderately-to-severe2026-10-07 https://dev.clinicalresearch.eu/trial/i6t-mc-ambz-a-multicenter-phase-3b-open-label-single-arm-study-to-investigate-bowel-urgency-and-its-relationship-with-other-outcome-measures-in-adults-with-moderately-to-severely-active-ulcerative-col2026-10-07 https://dev.clinicalresearch.eu/trial/i8f-mc-gphj-a-phase-3b-randomized-controlled-study-to-evaluate-the-efficacy-and-safety-of-tirzepatide-compared-to-semaglutide-2-4-mg-in-adults-who-have-obesity-or-overweight-with-weight-related-comorb2026-10-07 https://dev.clinicalresearch.eu/trial/icp-332-for-adults-with-prurigo-nodularis2026-10-07 https://dev.clinicalresearch.eu/trial/identifying-who-benefits-most-from-semaglutide-for-weight-management-in-adults-with-obesity-and-binge-eating2026-10-07 https://dev.clinicalresearch.eu/trial/ifct-2201-adaptable-a-non-comparative-randomized-phase-ii-trial-evaluating-the-combination-of-paclitaxel-bevacizumab-atezolizumab-in-patients-with-advanced-non-squamous-nsclc-progressing-after-immunot2026-10-07 https://dev.clinicalresearch.eu/trial/ifinatamab-deruxtecan-for-advanced-esophageal-squamous-cell-carcinoma-in-patients-after-2-or-3-prior-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/ikervis-in-the-treatment-of-atopic-keratoconjunctivitis-a-prospective-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/imagine-1-study-of-investigational-combination-therapy-in-patients-with-cholangiocarcinoma-pancreatic-cancer-and-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/imcision-towards-organ-preservation-and-cure-via-ultra-short-immunotherapy-in-advanced-oral-cancer-the-imcision-ii-trial-an-investigator-initiated-multicentre-randomised-phase-3-trial-m24ims2026-10-07 https://dev.clinicalresearch.eu/trial/immune-modulation-for-hla-compatible-kidney-transplantation-in-hyperimmunized-patients-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-and-efficacy-of-pembrolizumab-with-anthracycline-or-carboplatin-paclitaxel-in-tils-positive-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-and-safety-evaluation-of-recombinant-neisseria-meningitidis-group-b-vaccine-in-asplenic-adults-a-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-and-safety-of-investigational-mmrv-vaccine-gskvx000000025896-versus-standard-mmrv-vaccine-as-second-dose-in-healthy-children-15-months-to-6-years2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-and-safety-of-rsv-847a-847b-vaccine-and-rsv-f-vaccine-adjuvanted-with-as01e-in-lung-or-allogeneic-stem-cell-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-assessment-of-inactivated-enterobacterial-vaccine-strovac-in-adults-with-recurrent-urinary-tract-infection-elisa-opa-agglutination-and-neutralization-assays2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-of-9-valent-hpv-vaccine-in-immunocompromised-children-and-adolescents2026-10-07 https://dev.clinicalresearch.eu/trial/immunogenicity-of-adjuvanted-rsvpref3-vaccine-in-elderly-patients-aged-80-and-60-65-with-rsv-infection-an-open-label-phase-iiib-study2026-10-07 https://dev.clinicalresearch.eu/trial/immunological-evaluation-of-airway-response-to-nasal-live-attenuated-influenza-vaccine-vs-quadrivalent-inactivated-influenza-vaccine-in-influenza-patients2026-10-07 https://dev.clinicalresearch.eu/trial/immunomodulatory-effects-of-dexamethasone-tocilizumab-and-anakinra-in-healthy-volunteers-undergoing-experimental-human-endotoxemia2026-10-07 https://dev.clinicalresearch.eu/trial/immunopet-imaging-with-89zr-dfo-fianlimab-in-advanced-solid-tumors-during-cemiplimab-and-platinum-based-chemotherapy-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/immunopet-with-89zr-trastuzumab-to-predict-metabolic-response-to-trastuzumab-deruxtecan-in-patients-with-locally-advanced-metastatic-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/immunotherapy-in-patients-with-early-dmmr-rectal-cancer-a-danish-dccg-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-beta-blocker-administration-on-cardiac-computed-tomography-image-quality-in-patients-with-atrial-fibrillation-and-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-exercise-on-quality-of-life-of-early-breast-cancer-patients-on-treatment-with-adjuvant-aromatase-inhibitors-with-or-without-cdk4-6-inhibitors-the-ex-ai-study2026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-influenza-vaccination-on-nasal-resident-memory-immune-responses-and-respiratory-peripheral-memory-immune-responses-mucovac-22026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-mepolizumab-on-nasal-microbiome-and-immune-response-in-eosinophilic-granulomatosis-with-polyangiitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-opioids-on-heart-rate-during-rapid-sequence-intubation-double-blind-randomized-controlled-study-candy-crash2026-10-07 https://dev.clinicalresearch.eu/trial/impact-of-post-dose-meal-timing-and-dosing-water-volume-on-zenagamtide-pharmacokinetics-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/impact-on-delirium-of-the-use-of-dexmedetomidine-as-first-line-sedation-in-pediatric-intensive-care-the-pediadex-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/improved-baseline-staging-with-68ga-fapi-46-pet-in-non-small-cell-lung-cancer-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/improved-recovery-by-iron-following-surgery-with-blood-loss-a-double-blind-multi-centre-randomized-controlled-phase-iii-drug-trial-the-iris-trial2026-10-07 https://dev.clinicalresearch.eu/trial/in-vivo-analysis-of-microglial-activation-and-tau-pathology-in-alzheimer-s-disease-using-18f-dpa-714-18f-ro948-and-11c-ucb-j-pet-tracers2026-10-07 https://dev.clinicalresearch.eu/trial/in-vivo-assessment-of-histamine-equivalent-prick-test-units-for-phleum-pratense-and-dactylis-glomerata-allergen-extracts-in-allergic-patients2026-10-07 https://dev.clinicalresearch.eu/trial/inca33890-with-bevacizumab-calcium-folinate-oxaliplatin-and-fluorouracil-for-first-line-treatment-of-metastatic-microsatellite-stable-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/inca34176-254-a-phase-2-open-label-randomized-multicenter-study-to-evaluate-the-safety-and-efficacy-of-axatilimab-in-combination-with-ruxolitinib-in-participants-with-newly-diagnosed-chronic-graft-ver2026-10-07 https://dev.clinicalresearch.eu/trial/incb-18424-319-a-phase-3-double-blind-randomised-vehicle-controlled-efficacy-and-safety-study-of-ruxolitinib-cream-in-participants-with-purigo-nodularis-topical-ruxolitinib-evaluation-in-prurigo-nodul2026-10-07 https://dev.clinicalresearch.eu/trial/incb-18424-320-a-phase-3-double-blind-randomised-vehicle-controlled-efficacy-and-safety-study-of-ruxolitinib-cream-in-participants-with-prurigo-nodularis-topical-ruxolitinib-evaluation-in-prurigo-nodu2026-10-07 https://dev.clinicalresearch.eu/trial/incb-39110-801-a-phase-2-open-label-multicenter-rollover-study-to-provide-continued-treatment-for-participants-previously-enrolled-in-studies-of-itacitinib-incb0391102026-10-07 https://dev.clinicalresearch.eu/trial/incb-50465-801-a-phase-2-open-label-multicenter-rollover-study-to-provide-continued-treatment-for-participants-previously-enrolled-in-studies-of-parsaclisib-incb0504652026-10-07 https://dev.clinicalresearch.eu/trial/incidence-of-neuromuscular-blockade-reappearance-post-reversal-with-glycopyrronium-bromide-and-neostigmine-methylsulfate-in-general-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/incmga-0012-204-an-umbrella-study-of-incmga00012-alone-and-in-combination-with-other-therapies-in-participants-with-advanced-or-metastatic-endometrial-cancer-who-have-progressed-on-or-after-platinum-b2026-10-07 https://dev.clinicalresearch.eu/trial/increasing-the-dose-of-glimepiride-to-manage-blood-sugar-levels-in-patients-with-hnf1a-mody-or-hnf4a-mody-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/increasing-the-dosing-interval-of-osimertinib-in-patients-with-egfr-mutated-locally-advanced-or-meta-static-non-small-cell-lung-cancer-osi-save2026-10-07 https://dev.clinicalresearch.eu/trial/indapamide-hemihydrate-to-reduce-disability-progression-in-adults-with-primary-or-secondary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/indie-phase-ii-trial-of-individualized-immunotherapy-in-early-stage-unfavorable-classical-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/individualized-beta-lactam-dosing-with-meropenem-drug-combination-in-icu-patients-with-sepsis-caused-by-gram-negative-bacilli2026-10-07 https://dev.clinicalresearch.eu/trial/individualized-multiplex-pathophysiological-treatment-of-severe-acute-infections-impact2026-10-07 https://dev.clinicalresearch.eu/trial/indocyanine-green-enhances-intraoperative-detection-of-liver-tumors-in-imaging-guided-surgery-a-phase-iv-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/indocyanine-green-fluorescence-imaging-for-flap-perfusion-in-head-and-neck-cancer-reconstruction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/induction-in-sensitized-kidney-transplant-recipients-without-pre-existing-donor-specific-antibodies-a-randomized-multicentre-trial-between-a-lymphocyte-depleting-and-basiliximab-instead2026-10-07 https://dev.clinicalresearch.eu/trial/infliximab-for-non-crohn-anal-fistulas2026-10-07 https://dev.clinicalresearch.eu/trial/influence-of-patient-s-morphological-characteristics-on-pharmacokinetic-and-toxicity-of-trastuzumab-deruxtecan-administered-for-metastatic-breast-cancers-tdxdose2026-10-07 https://dev.clinicalresearch.eu/trial/influenza-vaccination-to-mitigate-type-1-diabetes-invited-trial2026-10-07 https://dev.clinicalresearch.eu/trial/inhaled-corticosteroids-in-young-children-with-episodic-wheezing-a-multicenter-cluster-rct2026-10-07 https://dev.clinicalresearch.eu/trial/inhaled-levodopa-vs-oral-levodopa-benserazide-for-early-morning-off-in-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/inhibiting-the-anti-apoptotic-factor-bcl-2-at-the-time-of-art-initiation-to-promote-apoptosis-of-hiv-infected-cells-and-restrict-the-seeding-of-the-hiv-reservoir-an-investigator-initiated-randomised-c2026-10-07 https://dev.clinicalresearch.eu/trial/initiation-of-angiotensin-receptor-neprilysin-inhibitor-arni-and-sodium-glucose-cotransporter-2-inhibitors-sglt2i-in-patients-with-heart-failure-with-reduced-ejection-fraction-hfref-the-initiate-hfref2026-10-07 https://dev.clinicalresearch.eu/trial/insta-md-inflammation-based-stratification-for-immune-targeted-augmentation-in-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/insulin-resistance-and-statin-treatment-in-renal-transplant-recipients-and-patients-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/insulin-resistance-in-type-2-diabetes-evaluating-the-pathogenic-mechanisms-of-insulin-resistance-in-the-myocardium-and-the-effects-of-the-treatments-with-glp-1ra-and-sglt2i2026-10-07 https://dev.clinicalresearch.eu/trial/integration-of-pharmacokinetic-and-neurometabolic-data-with-functional-mri-to-assess-central-effects-of-paracetamol-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/intensified-monitoring-of-cabozantinib-in-patients-with-renal-cell-carcinoma-to-reduce-treatment-interruptions-from-toxicity2026-10-07 https://dev.clinicalresearch.eu/trial/intensive-intraperitoneal-chemotherapy-in-patients-with-advanced-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/interest-of-systematic-treatment-with-ppi-after-endoscopic-myotomy-compared-to-ppi-treatment-in-case-of-symptoms-in-prevention-of-gastroesophageal-reflux-after-poem-for-esophageal-achalasia-randomized2026-10-07 https://dev.clinicalresearch.eu/trial/interfant-21-international-collaborative-treatment-protocol-for-infants-under-one-year-with-kmt2a-rearranged-acute-lymphoblastic-leukemia-or-mixed-phenotype-acute-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/intermediate-versus-standard-dose-enoxaparin-to-prevent-venous-thromboembolism-in-severe-trauma-patients-a-multicenter-double-blind-randomised-controlled-trial-heptrauma2026-10-07 https://dev.clinicalresearch.eu/trial/international-cooperative-prospective-study-for-children-and-adolescents-with-standard-risk-alk-positive-anaplastic-large-cell-lymphoma-alcl-estimating-the-efficacy-of-vinblastine2026-10-07 https://dev.clinicalresearch.eu/trial/international-euro-ewing-ieuroewing-trial-for-treatment-optimisation-in-patients-with-ewing-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/international-multi-center-open-label-treatment-extension-study-in-patients-with-multiple-myeloma-who-are-still-benefitting-from-isatuximab-based-therapy-following-completion-of-a-phase-1-2-or-3-paren2026-10-07 https://dev.clinicalresearch.eu/trial/international-multicenter-open-label-clinical-trial-for-the-treatment-of-acute-myeloid-leukemia-in-children-and-adolescents2026-10-07 https://dev.clinicalresearch.eu/trial/international-multicentre-open-label-phase-iv-clinical-trial-to-evaluate-the-efficacy-safety-and-effect-on-quality-of-life-of-bilastine-in-children-with-allergic-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/international-proof-of-concept-therapeutic-stratification-trial-of-molecular-anomalies-in-relapsed-or-refractory-hematological-malignancies-in-children-sub-protocol-d2026-10-07 https://dev.clinicalresearch.eu/trial/international-study-for-treatment-of-childhood-relapsed-precursor-b-cell-all-2020-a-randomized-phase-iii-study-conducted-by-the-resistant-disease-committee-of-the-international-bfm-study-group-intreal2026-10-07 https://dev.clinicalresearch.eu/trial/intra-arterial-alteplase-infusion-during-mechanical-thrombectomy-in-acute-ischemic-stroke-due-to-anterior-circulation-large-vessel-occlusion-a-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intra-arterial-hepatic-infusion-of-177lu-dota-peptides-in-gastroenteropancreatic-neuroendocrine-tumors-with-dominant-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/intra-arterial-tenecteplase-administration-post-endovascular-recanalization-in-acute-anterior-circulation-ischemic-stroke-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intra-arterial-thrombolysis-with-alteplase-post-successful-reperfusion-in-acute-anterior-circulation-ischemic-stroke-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intra-tumoral-microdosing-of-anti-pd1-therapy-in-patients-with-advanced-malignant-melanoma-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/intracerebroventricular-administration-of-anaerobically-conserved-dopamine-for-motor-fluctuations-in-parkinson-s-disease-a-pilot-safety-and-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/intracerebroventricular-administration-of-human-neural-stem-cells-in-amyotrophic-lateral-sclerosis-a-randomized-placebo-controlled-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intraclass-safety-and-efficacy-evaluation-of-sglt2-inhibitors-in-elderly-patients-with-type-2-diabetes-a-phase-iv-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intracranial-administration-of-nk-92-5-28-z-cells-and-intravenous-ezabenlimab-in-recurrent-her2-positive-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/intraglandular-administration-of-cl-ad-msc-002-for-xerostomia-in-primary-sjogren-s-syndrome-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intralesional-cemiplimab-in-adult-patients-with-cutaneous-squamous-cell-carcinoma-or-basal-cell-carcinoma-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/intralymphatic-allergen-immunotherapy-ilit-in-grass-pollen-allergy-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intramuscular-botulinum-toxin-type-a-injection-in-upper-esophageal-sphincter-for-retrograde-cricopharyngeus-dysfunction-a-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intramyometrial-injection-of-clostridium-botulinum-neurotoxin-type-a-for-severe-primary-dysmenorrhea-a-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intranasal-cenegermin-for-adults-with-non-arteritic-anterior-ischemic-optic-neuropathy-naion-a-randomized-double-masked-vehicle-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intranasal-remestemcel-for-newborns-with-hypoxic-ischemic-brain-injury-a-phase-ii-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intraoperative-evaluation-of-emi-137-for-fluorescence-imaging-in-penile-and-tongue-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/intraoperative-lidocaine-hydrochloride-injection-for-acute-postoperative-pain-reduction-in-breast-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intraperitoneal-administration-of-fosfomycin-metronidazole-and-molgramostim-in-multiquadrant-peritonitis-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intraperitoneal-fosfomycin-metronidazole-plus-molgramostim-for-multiquadrant-peritonitis-undergoing-abdominal-surgery-placebo-controlled-trial-triple2026-10-07 https://dev.clinicalresearch.eu/trial/intraperitoneal-paclitaxel-in-primary-malignant-peritoneal-mesothelioma-a-phase-i-ii-dose-escalation-and-safety-study2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-aav9-abcd1-gene-therapy-sbt101-safety-and-efficacy-in-adrenomyeloneuropathy-a-phase-1-2-randomized-blinded-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-administration-of-cebsulfase-alfa-in-pediatric-patients-with-late-infantile-metachromatic-leukodystrophy-a-single-arm-matched-external-control-study2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-administration-of-gadobutrol-for-evaluating-cerebrospinal-fluid-dynamics-in-idiopathic-normal-pressure-hydrocephalus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-administration-of-nivolumab-in-patients-with-metastatic-solid-tumors-and-leptomeningeal-disease-a-dose-and-safety-assessment-study2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-baclofen-pump-versus-selective-dorsal-rhizotomy-for-non-ambulatory-children-with-cerebral-palsy2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-gadobutrol-enhanced-mri-for-assessing-cerebrospinal-fluid-dynamics-in-adults-with-hydrocephalus-and-related-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/intrathecal-morphine-for-analgesia-in-proximal-femoral-fracture-surgery-a-monocentric-single-blinded-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intravascular-administration-of-mesenchymal-stromal-cells-from-wharton-s-jelly-for-systemic-immunomodulation-in-severe-traumatic-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/intravenous-ferric-carboxymaltose-for-drug-resistant-restless-legs-syndrome-a-randomized-delayed-start-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intravenous-infusion-of-extracellular-vesicle-enriched-secretome-from-cardiovascular-progenitor-cells-in-non-ischemic-dilated-cardiomyopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/intravenous-melatonin-for-prophylaxis-of-postoperative-agitation-and-emergence-delirium-in-pediatric-patients-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intravenous-vs-intraosseous-vascular-access-during-out-of-hospital-cardiac-arrest-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/intravesical-administration-of-enfortumab-vedotin-for-non-muscle-invasive-bladder-cancer-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/intravitreal-mk-8748-compared-with-aflibercept-in-patients-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-5-ht4-receptor-expression-in-mild-to-moderate-parkinson-s-disease-using-c11-sb207145-injection2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-68ga-ga-dota-cys-ath001-pet-tracer-binding-in-mash-psc-and-crohn-s-disease-patients-compared-to-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-abcb1-s-impact-on-11c-metoclopramide-neuropharmacokinetics-in-healthy-volunteers-and-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-abiraterone-s-impact-on-oxycodone-pharmacokinetics-in-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-agmb-129-and-midazolam-interaction-in-healthy-subjects-for-fibrostenotic-crohn-s-disease-management2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-antibiotic-penetration-in-skin-inflammation-models-for-subcutaneous-tissue-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-aprocitentan-s-pharmacokinetic-interaction-with-combined-hormonal-contraceptives-in-healthy-female-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-atorvastatin-as-an-adjuvant-in-immunotherapy-for-triple-negative-breast-cancer-and-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-azd5492-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-adults-with-systemic-lupus-erythematosus-or-idiopathic-inflammatory-myopathies2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-bgb-53038-monotherapy-and-combinations-in-advanced-metastatic-solid-tumors-with-kras-mutations-amplifications2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-biomarkers-predicting-response-to-clozapine-in-schizophrenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-cilostazol-induced-headache-in-migraine-without-aura-a-randomized-double-blind-placebo-controlled-study-in-male-and-female-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-clonal-dynamics-in-progressive-chronic-lymphocytic-leukemia-with-subclonal-tp53-aberrations-treated-with-ibrutinib-as-first-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-colchicine-on-arterial-stiffness-in-hypertensive-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-corticosteroid-excretion-patterns-in-healthy-volunteers-for-enhanced-anti-doping-detection2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-cyclosporine-s-impact-on-chf6001-pharmacokinetics-in-chronic-obstructive-pulmonary-disease-via-p-glycoprotein-and-bcrp-inhibition2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-dapagliflozin-on-pathophysiological-mechanisms-in-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-eos006215-in-adult-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-eos301984-in-adult-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-fe-999302-and-follitropin-delta-in-controlled-ovarian-stimulation-for-infertility-in-women-undergoing-assisted-reproductive-technologies2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-fibrotic-pathways-in-ulcerative-colitis-using-filgotinib-and-gallium-68ga-chloride-fapi-pet-ct-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-flutemetamol-18f-in-identifying-amyloid-pathology-in-cognitively-normal-elderly-subjects-with-preclinical-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-hdp-102-in-patients-with-relapsed-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-iag933-in-adults-with-advanced-mesothelioma-and-solid-tumors-exhibiting-hippo-pathway-molecular-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-immune-challenge-induced-skin-reactions-with-sar445399-canakinumab-and-spesolimab-versus-placebo-in-healthy-adults-aged-18-552026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-immune-genetic-and-viroimmunologic-biomarkers-in-hiv-1-patients-undergoing-antiretroviral-therapy-interruption-with-dolutegravir-and-rilpivirine2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-initial-glucose-distribution-volume-in-adults-with-severe-burns-using-glucose-30-injectable-solution2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-intrathecal-autologous-mesenchymal-stromal-cells-for-neuroregeneration-in-progressive-multiple-sclerosis-a-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-intratumoral-distribution-of-anastrozole-letrozole-and-ribociclib-in-er-her2-early-breast-cancer-in-postmenopausal-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-intravenous-lenomorelin-on-decision-making-and-loss-sensitivity-in-gambling-disorder-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-itraconazole-s-impact-on-ro7269162-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-izaflortaucipir-18f-in-assessing-sleep-and-temperature-disturbances-as-risk-factors-for-alzheimer-s-disease-in-down-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-kd033-sar445710-safety-pharmacokinetics-pharmacodynamics-and-efficacy-in-metastatic-or-locally-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-kqb198-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-leo-158968-on-pharmacokinetics-safety-and-tolerability-in-patients-with-gout-flares2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-loxo-783-in-pik3ca-h1047r-mutant-advanced-breast-cancer-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-mass-balance-absolute-bioavailability-pharmacokinetics-and-metabolism-of-14c-alogabat-and-13c-alogabat-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-maternal-determinants-on-infant-immunity-to-bordetella-pertussis-using-diphtheria-tetanus-pertussis-hepatitis-b-poliomyelitis-haemophilus-influenzae-type-b-vaccine2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-nb003-in-patients-with-advanced-melanoma-gastrointestinal-stromal-tumors-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-neurogenic-inflammation-via-aitc-induced-trpa1-activation-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-neuronal-resilience-mechanisms-in-alzheimer-s-disease-using-18f-av-1451-pet-and-mri-imaging-techniques2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-nucleoside-reverse-transcriptase-inhibitors-on-innate-immune-system-modulation-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-nx-5948-in-adult-patients-with-relapsed-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-obefazimod-and-rosuvastatin-pharmacokinetics-in-healthy-male-subjects-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-ovulation-inhibition-with-levonorgestrel-0-135-mg-tablet-in-contraception-despite-scheduled-intake-delays2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-peripheral-afferents-role-in-modulating-central-neuropathic-pain-post-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-pharmacokinetic-interactions-between-bia-28-6156-clarithromycin-midazolam-and-dabigatran-etexilate-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-pharmacokinetic-variability-of-tacrolimus-monohydrate-and-mycophenolate-mofetil-in-chronic-renal-failure-post-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-pharmacokinetics-and-drug-drug-interactions-in-a-novel-7-drug-combination-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-predictive-biomarkers-for-tofacitinib-efficacy-in-active-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-pregabalin-therapy-and-complex-rehabilitation-in-treating-chronic-fatigue-associated-with-post-covid-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-rabeprazole-s-impact-on-deucrictiban-pharmacokinetics-in-hereditary-angioedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-reboxetine-methylphenidate-hydrochloride-and-placebo-on-neurotransmitter-modulation-in-exercise-induced-fatigue-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-repeated-transient-blood-brain-barrier-opening-in-amyotrophic-lateral-sclerosis-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-risankizumab-on-disease-activity-in-patients-with-very-early-axial-spondyloarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-ro7121932-safety-tolerability-immunogenicity-pharmacokinetics-and-pharmacodynamics-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-ro7486967-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-early-idiopathic-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-ro7504109-s-impact-on-immune-cell-modulation-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-ro7507062-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-safety-pharmacodynamics-and-pharmacokinetics-of-subcutaneous-deuterated-dmt-cyb004-in-depression-and-anxiety-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-semaglutide-on-insulin-resistance-and-lipid-kinetics-in-obese-women-with-non-alcoholic-fatty-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-sex-differences-in-acute-cannabis-effects-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-sildenafil-induced-headache-in-male-and-female-patients-with-episodic-migraine-without-aura-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-siplizumab-cyclophosphamide-and-splenectomy-for-inducing-allogeneic-tolerance-in-deceased-donor-liver-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-sodium-phenylbutyrate-on-glycemic-control-in-type-2-diabetes-patients-through-enhanced-branched-chain-amino-acid-oxidation2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-tarp-g8-receptor-occupancy-by-rap-219-using-tarp-g8-pet-tracer-in-healthy-adults-with-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-tau-and-amyloid-accumulation-in-cognitively-normal-elderly-using-flortaucipir-18f-pet-imaging-a-twin-study-approach2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-tau-propagation-in-alzheimer-s-disease-using-18f-mk-6240-in-preclinical-and-prodromal-stages2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-the-effects-of-dimethyltryptamine-on-major-depressive-disorder-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-the-pharmacokinetics-and-safety-of-nnc0705-0001-in-patients-with-inflammation-driven-cardiometabolic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-the-pharmacokinetics-and-safety-of-radioactively-labeled-ro7269162-in-healthy-male-volunteers-for-potential-alzheimer-s-disease-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-tissue-resident-memory-t-cells-and-disease-memory-in-psoriasis-vulgaris-during-guselkumab-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-vmx-c001-for-coagulation-restoration-in-patients-on-doacs-experiencing-bleeding-or-requiring-anticoagulation-reversal-prior-to-urgent-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-of-zolpidem-tartrate-and-mannitol-in-paradoxical-responses-among-disorders-of-consciousness-and-vision-impairment-patients2026-10-07 https://dev.clinicalresearch.eu/trial/investigation-specific-appendix-2to-master-protocol-platformpansc2001-kaleidoscope-a-phase-1-2-study-evaluating-the-safety-and-efficacy-of-amivantamab-and-cetrelimab-combination-therapy-in-metastatic-2026-10-07 https://dev.clinicalresearch.eu/trial/iodixanol-injection-protocols-for-adults-with-unruptured-intracranial-aneurysms-undergoing-cerebral-angiography2026-10-07 https://dev.clinicalresearch.eu/trial/ion356-cs1-a-phase-1b-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-intrathecally-administered-ion356-in-patients-with-pelizaeus-merzbacher-disease2026-10-07 https://dev.clinicalresearch.eu/trial/irinotecan-drug-combination-versus-folfox-in-patients-with-locally-advanced-or-metastatic-small-bowel-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/is-18f-dpa-714-pet-a-good-marker-of-neuroinflammation-in-autoimmune-encephalitis-eai-7142026-10-07 https://dev.clinicalresearch.eu/trial/is-magnesium-sulfate-an-alternative-with-an-analgesic-and-safety-profile-equivalent-to-dexmedetomidine-as-an-adjuvant-to-ropivacaine-in-erector-block-in-mastectomy2026-10-07 https://dev.clinicalresearch.eu/trial/iside-open-label-multicentric-single-arm-phase-iiib-trial-to-evaluate-the-safety-and-efficacy-of-sacituzumab-govitecan-in-triple-negative-metastatic-breast-cancer-patients-with-a-biomarker-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/isis-678354-cs6-a-randomized-double-blind-placebo-controlled-phase-3-study-of-olezarsen-isis-678354-administered-subcutaneously-to-patients-with-severe-hypertriglyceridemia2026-10-07 https://dev.clinicalresearch.eu/trial/ivonescimab-plus-chemotherapy-drug-combination-versus-bevacizumab-plus-chemotherapy-in-patients-with-metastatic-colorectal-cancer-without-liver-metastases-second-line2026-10-07 https://dev.clinicalresearch.eu/trial/ivonescimab-plus-enfortumab-vedotin-versus-pembrolizumab-plus-enfortumab-vedotin-in-treatment-naive-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/izabright-bladder01-a-randomized-open-label-phase-2-3-trial-of-izalontamab-brengitecan-versus-platinum-based-chemotherapy-for-metastatic-urothelial-cancer-in-participants-with-disease-progression-on-o2026-10-07 https://dev.clinicalresearch.eu/trial/izabright-breast01-a-randomized-open-label-inferentially-seamless-phase-2-3-study-of-izalontamab-brengitecan-bms-986507-versus-treatment-of-physician-s-choice-in-patients-with-previously-untreated-loc2026-10-07 https://dev.clinicalresearch.eu/trial/izabright-lung01-a-randomized-open-label-phase-2-3-study-of-izalontamab-brengitecan-bms-986507-versus-platinum-based-chemotherapy-in-patients-with-egfr-mutated-non-small-cell-lung-cancer-and-disease-p2026-10-07 https://dev.clinicalresearch.eu/trial/j1a-mc-kdaf-a-phase-2b-double-blind-placebo-controlled-study-to-evaluate-peresolimab-in-adult-participants-with-moderately-to-severely-active-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/j2a-mc-gzgp-a-phase-3-randomized-double-blind-study-to-investigate-the-efficacy-and-safety-of-once-daily-oral-orforglipron-compared-with-placebo-in-adult-participants-with-obesity-or-overweight-with-w2026-10-07 https://dev.clinicalresearch.eu/trial/j2a-mc-gzgq-a-phase-3-randomized-double-blind-study-to-investigate-the-efficacy-and-safety-of-once-daily-oral-ly3502970-compared-with-placebo-in-adult-participants-with-obesity-or-overweight-and-type-2026-10-07 https://dev.clinicalresearch.eu/trial/j2a-mc-gzgs-a-phase-3-open-label-study-of-once-daily-orforglipron-compared-with-insulin-glargine-in-adult-participants-with-type-2-diabetes-and-obesity-or-overweight-at-increased-cardiovascular-risk-a2026-10-07 https://dev.clinicalresearch.eu/trial/j2a-mc-gzps-a-master-protocol-to-investigate-the-efficacy-and-safety-of-orforglipron-tablet-once-daily-compared-with-placebo-in-female-participants-with-stress-urinary-incontinence-who-have-obesity-or2026-10-07 https://dev.clinicalresearch.eu/trial/j2a-mc-gzpt-a-phase-3-study-to-investigate-the-efficacy-and-safety-of-orfor-glipron-once-daily-in-participants-who-have-obesity-or-overweight-and-osteoar-thritis-of-the-knee-a-multicenter-randomized-d2026-10-07 https://dev.clinicalresearch.eu/trial/j2j-mc-jzlh-ember-4-a-randomized-open-label-phase-3-study-of-adjuvant-imlunestrant-vs-standard-adjuvant-endocrine-therapy-in-patients-who-have-previously-received-2-to-5-years-of-adjuvant-endocrine-th2026-10-07 https://dev.clinicalresearch.eu/trial/j2o-mc-ekbc-kraken-a-phase-2-randomized-double-blind-placebo-controlled-study-to-investigate-the-efficacy-and-safety-of-oral-once-daily-ly3473329-in-adults-with-elevated-lipoprotein-a-at-high-risk-for2026-10-07 https://dev.clinicalresearch.eu/trial/j2s-mc-gzmp-a-phase-3-multicenter-randomized-double-blind-study-to-investigate-the-efficacy-and-safety-of-brenipatide-compared-with-placebo-for-the-treatment-of-adult-participants-with-alcohol-use-dis2026-10-07 https://dev.clinicalresearch.eu/trial/j2s-mc-gzmr-a-phase-2-multicenter-randomized-double-blind-52-week-study-to-investigate-the-efficacy-and-safety-of-brenipatide-compared-with-placebo-for-the-treatment-of-adult-participants-with-uncontr2026-10-07 https://dev.clinicalresearch.eu/trial/j2t-mc-kgbi-drm06-ad13-a-randomized-double-blind-placebo-controlled-phase-3-study-to-assess-the-efficacy-safety-and-pharmacokinetics-of-lebrikizumab-compared-to-placebo-in-participants-6-months-to-18-2026-10-07 https://dev.clinicalresearch.eu/trial/j3l-mc-ezeb-a-phase-2-randomized-double-blind-placebo-controlled-study-to-investigate-the-efficacy-and-safety-of-ly3819469-in-adults-with-elevated-lipoprotein-a2026-10-07 https://dev.clinicalresearch.eu/trial/j4e-mc-immb-a-master-protocol-for-randomized-controlled-phase-2-clinical-trials-of-multiple-interventions-for-the-treatment-of-adults-with-moderate-to-severe-atopic-dermatitis-j4e-mc-fr01-a-phase-2-ra2026-10-07 https://dev.clinicalresearch.eu/trial/j4f-mc-cyab-a-phase-2-randomized-double-blind-placebo-controlled-dose-finding-study-evaluating-ly3848575-in-chronic-neuropathic-pain-associated-with-distal-sensory-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/jnj-95597528-for-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/justification-and-evaluation-in-polymyalgia-rheumatica-of-baricitinib-versus-placebo-jadore-bari-study2026-10-07 https://dev.clinicalresearch.eu/trial/ketosteril-added-to-usual-nutrition-in-patients-starting-incremental-haemodialysis-for-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/lerodalcibep-for-heterozygous-familial-hypercholesterolemia-in-children-and-adolescents-aged-6-to-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/letrozole-during-ivf-icsi-for-women-with-endometriosis2026-10-07 https://dev.clinicalresearch.eu/trial/levofloxacin-prophylaxis-to-prevent-bloodstream-infections-in-adults-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-acting-cabotegravir-plus-rilpivirine-in-people-living-with-hiv-1-plhiv-aged-60-years-for-96-weeks2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-access-to-ibrutinib-and-drug-combinations-for-patients-with-lymphomas-leukemias-urothelial-carcinoma-breast-cancer-and-graft-vs-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-effects-of-acoramidis-on-heart-function-and-amyloid-burden-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-and-safety-evaluation-of-lerodalcibep-in-familial-hypercholesterolemia-and-cardiovascular-disease-patients-on-stable-lipid-lowering-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-and-safety-evaluation-of-methylone-in-post-traumatic-stress-disorder-a-52-week-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-and-safety-of-ustekinumab-in-crohn-s-disease-patients-with-secondary-loss-of-response-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-and-tolerability-of-add-on-pramipexole-for-anhedonic-depression-an-open-label-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-safety-and-tolerability-of-remibrutinib-in-chronic-spontaneous-urticaria-an-extension-study-for-phase-3-completers2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-efficacy-safety-and-tolerability-of-repeated-upadacitinib-administration-in-crohn-s-disease-a-phase-2-multicenter-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-aflibercept-in-retinopathy-of-prematurity-an-extension-study-of-visual-function-and-safety-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-alglucosidase-alfa-enzyme-replacement-therapy-in-pediatric-and-adult-pompe-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-carbetocin-nasal-spray-for-hyperphagia-management-in-prader-willi-syndrome-safety-and-tolerability-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-dbv712-in-pediatric-peanut-allergy-an-open-label-extension-study-on-clinical-benefit-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-efficacy-safety-and-immune-response-persistence-of-recombinant-varicella-zoster-virus-glycoprotein-e-vaccine-in-herpes-zoster-prevention-in-older-adults2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-efgartigimod-alfa-safety-and-efficacy-in-adult-patients-with-primary-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-givinostat-in-jak2v617f-positive-chronic-myeloproliferative-neoplasms-safety-tolerability-and-efficacy-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-infigratinib-an-fgfr1-3-selective-tyrosine-kinase-inhibitor-in-pediatric-patients-with-achondroplasia-a-phase-2-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-nmra-335140-for-safety-and-efficacy-in-major-depressive-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-riliprubart-sar445088-safety-and-efficacy-in-chronic-inflammatory-demyelinating-polyneuropathy-cidp-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-safety-and-efficacy-of-verekitug-upb-101-a-human-igg1-kappa-monoclonal-antibody-against-crlf2-in-adults-with-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-safety-tolerability-and-efficacy-of-al002-and-florquinitau-18f-in-patients-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-safety-tolerability-and-treatment-durability-of-alks-2680-in-patients-with-narcolepsy-type-1-and-type-22026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-safety-tolerability-efficacy-pharmacodynamics-pharmacokinetics-and-immunogenicity-of-empasiprubart-in-adults-with-multifocal-motor-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-semaglutide-for-bmi-maintenance-in-adolescents-with-obesity-following-initial-weight-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-evaluation-of-sotatercept-in-combination-with-background-therapy-for-pulmonary-arterial-hypertension-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-extension-study-evaluating-safety-and-efficacy-of-deupsilocin-besilate-cyb003-in-major-depressive-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-extension-study-for-participants-with-geographic-atrophy-ga-secondary-to-age-related-macular-degeneration-amd-in-jnj-81201887-parent-clinical-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-extension-study-of-apremilast-in-pediatric-patients-aged-6-17-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-ltfu-for-gene-therapy-of-leukocyte-adhesion-deficiency-i-lad-i-phase-i-ii-clinical-study-to-evaluate-the-safety-and-efficacy-of-the-infusion-of-autologous-hematopoietic-stem-cells-2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-ltfu-for-gene-therapy-of-pyruvate-kinase-deficiency-pkd-a-phase-i-clinical-trial-to-evaluate-the-safety-of-the-infusion-of-autologous-cd34-cells-transduced-with-a-lentiviral-vector2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-autologous-cd34-cells-transduced-with-lentiviral-vector-carrying-fanca-gene-in-patients-with-fanconi-anemia-subtype-a2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-avencell-sponsored-car-t-cell-therapy-in-patients-with-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-gene-modified-cell-therapy-with-brexucabtagene-autoleucel-and-axicabtagene-ciloleucel-in-solid-and-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-melanoma-patients-treated-with-fianlimab-and-cemiplimab-in-expansion-cohorts-from-r3767-onc-1613-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-mitomycin-ugn-103-in-patients-with-recurrent-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-patients-treated-with-miltenyi-cell-and-gene-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-patients-with-myxoid-round-cell-liposarcoma-multiple-myeloma-nsclc-and-synovial-sarcoma-treated-with-letetresgene-autoleucel2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-of-relapsed-refractory-cd1a-positive-t-cell-acute-lymphoblastic-leukemia-lymphoma-patients-treated-with-autologous-hcd1a-car-t-cells2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-phase-i-ii-clinical-study-to-evaluate-the-safety-and-efficacy-of-the-infusion-of-rp-l1022026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-of-century-therapeutics-cellular-therapy-in-hematological-malignancies-solid-tumors-and-autoimmune-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-of-early-stage-breast-cancer-patients-included-in-geicam-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-of-idecabtagene-vicleucel-and-lisocabtagene-maraleucel-in-patients-previously-treated-with-gene-modified-t-cells2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-of-tisagenlecleucel-phe885-and-rapcabtagene-autoleucel-in-patients-previously-treated-with-lentiviral-based-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-of-tx200-tr101-in-patients-with-kidney-transplant-rejection2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-on-delayed-adverse-events-and-safety-profile-of-ciltacabtagene-autoleucel-in-patients-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-follow-up-study-on-safety-and-efficacy-of-onasemnogene-abeparvovec-in-patients-with-spinal-muscular-atrophy-from-novartis-sponsored-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-immune-response-in-children-after-measles-mumps-and-rubella-live-attenuated-vaccine-given-at-6-months-of-age2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-neuropsychologic-outcome-of-pre-emptive-mtor-inhibitor-treatment-in-children-with-tuberous-sclerosis-complex-tsc-under-4-months-of-age-protect2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-observational-study-of-atezolizumab-in-cancer-patients-from-previous-genentech-roche-sponsored-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-open-label-evaluation-of-vatiquinone-safety-and-efficacy-in-friedreich-ataxia-patients-previously-exposed-to-vatiquinone2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-open-label-extension-assessing-safety-tolerability-and-clinical-outcomes-of-intrathecal-ly4256984-in-adults-with-sporadic-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-open-label-extension-study-of-inhaled-treprostinil-palmitil-for-patients-with-pulmonary-hypertension-associated-with-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-open-label-study-of-infigratinib-to-assess-safety-and-height-growth-in-children-with-hypochondroplasia2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-open-label-study-on-the-safety-and-tolerability-of-tofacitinib-in-juvenile-idiopathic-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-outcomes-evaluation-of-aflibercept-in-pediatric-retinopathy-of-prematurity-an-extension-of-the-vgfte-rop-1920-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-prospective-study-of-pompe-disease-natural-history-and-treatment-response-to-avalglucosidase-alfa-combination-therapy-alglucosidase-alfa-cipaglucosidase-alfa-miglustat2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-remibrutinib-treatment-for-patients-with-chronic-spontaneous-urticaria-who-benefited-in-a-previous-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-biomarker-assessment-of-edg-5506-in-adults-and-adolescents-with-becker-muscular-dystrophy-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-botaretigene-sparoparvovec-in-x-linked-retinitis-pigmentosa-with-rpgr-gene-variants2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-etranacogene-dezaparvovec-in-adult-males-with-hemophilia-b2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-ianalumab-in-sjogren-s-syndrome-a-randomized-double-blind-two-arm-neptunus-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-intravenous-cipaglucosidase-alfa-co-administered-with-oral-miglustat-in-adults-with-late-onset-pompe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-nemolizumab-cd14152-in-moderate-to-severe-atopic-dermatitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-assessment-of-nemolizumab-cd14152-in-prurigo-nodularis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-aav2-rep1-and-aav8-rpgr-gene-therapy-in-choroideremia-and-x-linked-retinitis-pigmentosa-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-aavanc80-hotof-gene-therapy-in-patients-with-otoferlin-gene-mediated-sensorineural-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-abrocitinib-in-pediatric-patients-aged-2-years-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-afimkibart-ro7790121-in-atopic-dermatitis-patients-from-previous-afimkibart-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-apg777-in-patients-with-moderate-to-severe-atopic-dermatitis-an-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-apitegromab-in-type-2-and-type-3-spinal-muscular-atrophy-patients-post-previous-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-aro-apoc3-in-adults-with-mixed-dyslipidemia-a-phase-2-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-atacicept-in-patients-with-iga-nephropathy-following-completion-of-parent-study-treatment-period2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-betibeglogene-autotemcel-in-transfusion-dependent-beta-thalassemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-cpi-0610-in-patients-with-myeloproliferative-neoplasms-an-open-label-multicenter-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-danicopan-as-an-add-on-to-complement-component-5-inhibitors-in-paroxysmal-nocturnal-hemoglobinuria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-delandistrogene-moxeparvovec-in-duchenne-muscular-dystrophy-patients-from-previous-clinical-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-donidalorsen-in-hereditary-angioedema-prophylaxis-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-dupilumab-in-pediatric-patients-aged-6-months-to-18-years-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-elexacaftor-tezacaftor-ivacaftor-in-cystic-fibrosis-patients-aged-12-months-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-elexacaftor-tezacaftor-ivacaftor-in-cystic-fibrosis-patients-aged-2-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-elexacaftor-tezacaftor-ivacaftor-in-cystic-fibrosis-patients-with-non-f508del-cftr-genotypes2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-eplontersen-in-hereditary-transthyretin-mediated-amyloid-polyneuropathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-etavopivat-in-patients-with-sickle-cell-disease-or-thalassaemia-transitioning-from-previous-etavopivat-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-etuvetidigene-autotemcel-in-patients-with-wiskott-aldrich-syndrome-following-autologous-ex-vivo-lentiviral-gene-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-fazirsiran-in-alpha-1-antitrypsin-deficiency-associated-liver-disease-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-filgotinib-in-rheumatoid-arthritis-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-fitusiran-in-hemophilia-a-or-b-patients-with-or-without-factor-viii-or-ix-inhibitory-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-glepaglutide-in-adult-patients-with-short-bowel-syndrome-a-104-week-phase-3-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-glepaglutide-in-patients-with-short-bowel-syndrome-a-phase-3-double-blind-extension-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-gsk4527226-in-early-alzheimer-s-disease-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-gtx-102-in-angelman-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-inhaled-lentiviral-vector-gene-therapy-bi-3720931-in-cystic-fibrosis-patients-from-previous-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-inhaled-seralutinib-in-pulmonary-arterial-hypertension-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-inhaled-seralutinib-in-who-group-1-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-intravitreal-pegcetacoplan-in-geographic-atrophy-secondary-to-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-liposomal-ciclosporin-a-in-bronchiolitis-obliterans-syndrome-post-lung-transplantation-a-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-litifilimab-biib059-in-adults-with-active-subacute-or-chronic-cutaneous-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-lovotibeglogene-autotemcel-gene-therapy-in-sickle-cell-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-maralixibat-in-patients-with-alagille-syndrome-in-the-european-union2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-mexiletine-hydrochloride-in-myotonic-dystrophy-type-1-and-2-post-mex-dm-302-completion2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-mexiletine-in-pediatric-patients-with-nondystrophic-myotonias-or-myotonic-dystrophies-post-mex-nm-301-completion2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-mezagitamab-in-adults-with-chronic-primary-immune-thrombocytopenia-a-phase-3-open-label-multicenter-continuation-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-n-acetyl-ged-0507-34-levo-gel-5-in-patients-with-acne-vulgaris2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-obefazimod-abx464-in-moderate-to-severe-ulcerative-colitis-a-phase-ii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-ocrelizumab-in-multiple-sclerosis-patients-from-phase-iii-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-odevixibat-in-alagille-syndrome-patients-completing-study-a4250-012-assert2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-oral-bi-1015550-in-patients-with-idiopathic-and-progressive-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-oral-ozanimod-in-moderate-to-severe-ulcerative-colitis-a-phase-3-multicenter-open-label-extension-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-oral-ozanimod-in-patients-with-moderately-to-severely-active-crohn-s-disease-a-phase-3-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-pabinafusp-alfa-in-patients-with-mucopolysaccharidosis-type-ii-hunter-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-paltusotine-in-patients-with-acromegaly-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-pariglasgene-brecaparvovec-gene-transfer-in-adults-with-glycogen-storage-disease-type-ia2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-pegunigalsidase-alfa-prx-102-2-mg-kg-iv-infusion-every-4-weeks-in-adult-patients-with-fabry-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-povorcitinib-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-3-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-ralinepag-in-pulmonary-arterial-hypertension-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-repeat-darvadstrocel-administration-in-adults-with-perianal-fistulising-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-ritlecitinib-tosilate-in-adult-and-adolescent-patients-with-alopecia-areata2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-spesolimab-in-patients-with-generalized-pustular-psoriasis-following-prior-spesolimab-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-subcutaneous-dasiglucagon-infusion-in-pediatric-congenital-hyperinsulinism-an-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-surabgene-lomparvovec-abbv-rgx-314-in-neovascular-age-related-macular-degeneration-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-tulisokibart-in-patients-with-crohn-s-disease-or-ulcerative-colitis-a-phase-3-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-ulviprubart-abc008-in-patients-with-inclusion-body-myositis-following-completion-of-prior-ulviprubart-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-vamorolone-in-duchenne-muscular-dystrophy-patients-post-completion-of-prior-vamorolone-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-vanzacaftor-tezacaftor-deutivacaftor-in-cystic-fibrosis-patients-aged-1-year-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-vosoritide-in-pediatric-achondroplasia-a-phase-3-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-evaluation-of-zilucoplan-sodium-in-adult-patients-with-generalized-myasthenia-gravis-a-phase-3-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-follow-up-of-belzupacap-sarotalocan-in-patients-with-early-indeterminate-small-choroidal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-monitoring-of-elivaldogene-autotemcel-in-patients-with-cerebral-adrenoleukodystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-abrocitinib-in-moderate-to-severe-atopic-dermatitis-a-phase-3-multicenter-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-aticaprant-as-adjunctive-therapy-in-adults-and-elderly-with-major-depressive-disorder-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-aurocell-tx-in-neobladder-reconstruction-for-muscle-invasive-bladder-cancer-extension-of-u-laserprint-12026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-avalglucosidase-alfa-in-french-patients-with-glycogen-storage-disease-type-ii-a-phase-4-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-b-cell-directed-therapy-in-adults-with-systemic-autoimmune-diseases-a-prospective-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-bimekizumab-in-adults-with-active-axial-spondyloarthritis-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-etranacogene-dezaparvovec-in-adults-with-severe-or-moderately-severe-hemophilia-b-a-phase-i-iib-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-ibrutinib-in-b-cell-non-hodgkin-s-lymphoma-and-chronic-graft-versus-host-disease-a-phase-3b-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-intrathecal-cebsulfase-alfa-in-pediatric-patients-with-late-metachromatic-leukodystrophy-an-extension-of-study-hgt-mld-0702026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-kl1333-in-adults-with-primary-mitochondrial-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-lebrikizumab-in-children-6-months-to-18-years-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-oral-danicamtiv-in-adults-with-symptomatic-genetic-and-familial-dilated-cardiomyopathy-open-label-extension-study-kinship-ole2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-oral-ribitol-in-adults-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-remibrutinib-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-ro7790121-in-adults-with-moderate-to-severe-rheumatoid-arthritis-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-rozanolixizumab-in-adults-with-ocular-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-semaglutide-s-c-once-weekly-on-weight-management-in-children-and-adolescents-aged-6-to-18-years-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-spy001-001-spy002-and-spy003-in-adults-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-subcutaneous-belimumab-in-adults-with-systemic-sclerosis-associated-interstitial-lung-disease-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-of-zasocitinib-in-adults-with-active-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-efficacy-study-of-entr-601-45-and-entr-601-44-in-participants-with-duchenne-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-outcomes-of-repeated-rituximab-treatment-in-adults-with-schizophrenia-spectrum-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-response-durability-of-flt201-adeno-associated-viral-vector-in-gaucher-disease-type-1-a-multicenter-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-adjunctive-trospium-chloride-and-xanomeline-tartrate-in-patients-with-inadequately-controlled-schizophrenia-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-batoclimab-in-adults-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-dapirolizumab-pegol-in-patients-with-systemic-lupus-erythematosus-a-multicenter-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-dexpramipexole-in-severe-eosinophilic-asthma-an-open-label-phase-iii-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-ianalumab-in-systemic-lupus-erythematosus-a-randomized-double-blind-placebo-controlled-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-oral-lucerastat-in-adult-patients-with-fabry-disease-an-open-label-uncontrolled-single-arm-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-assessment-of-trospium-chloride-and-xanomeline-tartrate-in-psychosis-associated-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-aficamten-ck-3773274-in-adults-with-symptomatic-hypertrophic-cardiomyopathy-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-bepranemab-in-patients-with-progressive-supranuclear-palsy-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-emraclidine-in-adult-patients-with-schizophrenia-a-52-week-phase-2-open-label-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-inhaled-treprostinil-in-patients-with-idiopathic-pulmonary-fibrosis-or-progressive-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-itepekimab-in-patients-with-moderate-to-severe-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-niraparib-tosilate-monohydrate-in-patients-with-advanced-ovarian-breast-or-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-open-label-iptacopan-in-adult-patients-with-primary-iga-nephropathy-a-rollover-extension-program2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-oral-dersimelagon-mt-7117-in-erythropoietic-protoporphyria-and-x-linked-protoporphyria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-oral-zasocitinib-in-moderate-to-severe-ulcerative-colitis-and-crohn-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-pelacarsen-in-patients-with-elevated-lipoprotein-a-and-established-atherosclerotic-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-pelacarsen-tqj230-in-cardiovascular-disease-patients-post-frontiers-apheresis-study-completion2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-rebisufligene-etisparvovec-in-mucopolysaccharidosis-type-iiia-patients-from-gene-therapy-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-sar422459-in-stargardt-s-macular-degeneration-patients-an-open-label-phase-i-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-evaluation-of-trospium-chloride-and-xanomeline-tartrate-in-agitation-associated-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-admilparant-in-adults-with-idiopathic-and-progressive-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-atogepant-for-migraine-prevention-in-chronic-or-episodic-migraine-a-phase-3-156-week-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-avelumab-in-patients-with-solid-tumors-an-open-label-multicenter-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-high-dose-nusinersen-in-spinal-muscular-atrophy-an-extension-study-for-previous-nusinersen-trial-participants2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-inhaled-pirfenidone-in-progressive-pulmonary-fibrosis-and-idiopathic-pulmonary-fibrosis-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-itepekimab-in-adults-with-inadequately-controlled-chronic-rhinosinusitis-with-nasal-polyps-crswnp-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-linerixibat-in-cholestatic-pruritus-associated-with-primary-biliary-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-montelukast-in-patients-with-mild-moderate-parkinson-s-disease-an-open-label-phase-ii-extension-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-nintedanib-in-pediatric-patients-with-clinically-significant-fibrosing-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-obeticholic-acid-and-bezafibrate-in-primary-biliary-cholangitis-a-phase-3-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-oral-fesoterodine-in-adults-with-alzheimer-s-disease-psychosis-hallucinations-and-delusions2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-probenecid-pti5803-as-adjunctive-therapy-in-patients-14-years-with-drug-resistant-focal-epilepsy-due-to-focal-cortical-dysplasia2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-repeated-adalimumab-administration-in-pediatric-ulcerative-colitis-a-multi-center-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-riliprubart-in-cold-agglutinin-disease-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-tolebrutinib-in-relapsing-and-progressive-multiple-sclerosis-a-phase-3-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-of-zyn002-transdermal-gel-in-pediatric-and-young-adult-patients-with-fragile-x-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-and-tolerability-study-of-oral-kt-621-in-adults-with-uncontrolled-moderate-to-severe-eosinophilic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-assessment-of-dabrafenib-mesylate-and-trametinib-in-pediatric-patients-with-cancers-harboring-v600-mutation-a-multi-center-roll-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-assessment-of-fenfluramine-hydrochloride-as-adjunctive-therapy-in-patients-with-dravet-or-lennox-gastaut-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-assessment-of-onasemnogene-abeparvovec-in-patients-with-spinal-muscular-atrophy-following-intrathecal-or-intravenous-administration2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-assessment-of-tazemetostat-in-patients-continuing-from-antecedent-studies-an-open-label-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-assessment-of-trastuzumab-deruxtecan-in-patients-with-advanced-her2-expressing-mutated-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-efficacy-and-response-durability-of-envudeucitinib-in-moderate-to-severe-plaque-psoriasis-an-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-adjunctive-troriluzole-in-patients-with-obsessive-compulsive-disorder-unresponsive-to-ssri-clomipramine-venlafaxine-or-desvenlafaxine2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-allogeneic-crispr-cas9-modified-car-t-cells-targeting-cd19-antigen-in-hematologic-and-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-autologous-cd34-hematopoietic-progenitor-cells-transduced-with-lentiviral-vector-encoding-interferon-alpha-2-in-glioblastoma-multiforme2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-autologous-t-cells-genetically-modified-with-viral-vectors-in-patients-with-potential-malignancy-post-autolus-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-bcn-cp01-19cp02-and-bcmacp03-in-patients-with-relapsed-refractory-cll-sll-b-cell-nhl-or-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-bimekizumab-in-patients-with-moderate-to-severe-hidradenitis-suppurativa-a-phase-3-open-label-multicenter-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-bone-marrow-derived-mesenchymal-stem-cells-in-a-non-specified-condition-a-single-center-open-non-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-cendakimab-in-adult-and-adolescent-patients-with-eosinophilic-esophagitis-a-phase-3-multicenter-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-cenobamate-as-adjunctive-therapy-in-patients-with-primary-generalized-tonic-clonic-seizures-a-multicenter-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-ceritinib-in-patients-with-alk-positive-non-small-cell-lung-cancer-post-completion-of-prior-novartis-sponsored-ceritinib-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-cholic-acid-in-patients-with-bile-acid-synthesis-defects2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-continuous-subcutaneous-infusion-of-nd0612-carbidopa-levodopa-in-advanced-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-dabrafenib-mesylate-and-trametinib-dimethyl-sulfoxide-in-patients-continuing-treatment-from-previous-novartis-or-gsk-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-depemokimab-in-adults-and-adolescents-with-severe-eosinophilic-asthma-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-ecopipam-hydrochloride-tablets-in-pediatric-adolescent-and-adult-patients-with-tourette-s-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-everolimus-in-patients-with-tuberous-sclerosis-complex-and-refractory-seizures-post-study-crad001m2304-completion2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-exagamglogene-autotemcel-in-patients-with-transfusion-dependent-thalassemia-or-severe-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-fenfluramine-hydrochloride-as-adjunctive-therapy-in-patients-with-myoclonic-astatic-epilepsy-doose-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-filgotinib-in-patients-with-ulcerative-colitis-an-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-gd2il18cart-in-patients-with-neuroblastoma-osteosarcoma-ewing-sarcoma-and-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-gt005-in-geographic-atrophy-secondary-to-age-related-macular-degeneration-post-antecedent-gyroscope-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-guselkumab-in-pediatric-patients-with-moderately-to-severely-active-crohn-s-disease-ulcerative-colitis-or-juvenile-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-ibutamoren-mesilate-in-pediatric-patients-with-idiopathic-growth-hormone-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-iclepertin-in-schizophrenia-patients-post-completion-of-phase-iii-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-inhaled-imatinib-av-101-in-patients-with-pulmonary-arterial-hypertension-following-completion-of-study-av-101-0022026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-intracerebroventricular-a-dopamine-administration-in-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-intrathecal-idursulfase-it-with-intravenous-idursulfase-in-hunter-syndrome-with-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-inz-701-in-patients-with-enpp1-and-abcc6-deficiencies-a-follow-up-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-isaralgagene-civaparvovec-gene-therapy-in-patients-with-fabry-disease2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-lutetium-177lu-vipivotide-tetraxetan-in-adult-prostate-cancer-patients-a-phase-iv-post-authorization-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-nivolumab-monotherapy-or-in-combination-with-other-cancer-therapies-in-patients-with-pan-tumor-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-ntla-2001-in-patients-with-hereditary-transthyretin-amyloidosis-with-polyneuropathy-and-transthyretin-amyloidosis-related-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-ntla-2002-in-patients-with-hereditary-angioedema-a-follow-up-study-on-ziclumeran-and-lonvoguran2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-nvdx3-osteogenic-implant-in-patients-with-low-grade-degenerative-lumbar-spondylolisthesis-and-distal-radius-fracture2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-octreotide-hydrochloride-subcutaneous-depot-cam2029-in-patients-with-acromegaly-a-phase-3-open-label-single-arm-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-oral-azacitidine-in-patients-with-hematological-disorders-from-previous-celgene-clinical-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-oral-brigimadlin-monotherapy-in-patients-with-solid-tumors-a-phase-ii-single-arm-open-label-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-oral-povorcitinib-in-patients-with-hidradenitis-suppurativa-prurigo-nodularis-or-vitiligo-a-phase-3b-rollover-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-oxytocin-nasal-spray-in-children-with-prader-willi-syndrome-from-the-otbb3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-sacituzumab-govitecan-in-patients-with-metastatic-solid-tumors-benefiting-from-continued-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-satoreotide-tetraxetan-lutetium-177-in-patients-with-somatostatin-receptor-positive-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-sebetralstat-kvd900-for-on-demand-treatment-of-angioedema-attacks-in-hereditary-angioedema-type-i-or-ii-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-secukinumab-in-patients-with-psoriatic-arthritis-ankylosing-spondylitis-axial-spondyloarthritis-and-chronic-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-spesolimab-in-patients-with-hidradenitis-suppurativa-following-completion-of-initial-spesolimab-treatment-phases2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-tadalafil-and-macitentan-in-pulmonary-arterial-hypertension-and-chronic-thromboembolic-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-teplizumab-in-pediatric-and-adolescent-patients-with-recent-onset-type-1-diabetes-mellitus-an-extension-of-study-prv-031-0012026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-tislelizumab-pamiparib-and-ociperlimab-in-patients-with-advanced-solid-tumors-and-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-trospium-chloride-and-xanomeline-tartrate-in-treating-mania-or-mixed-features-in-bipolar-i-disorder-a-phase-3-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-valoctocogene-roxaparvovec-in-patients-with-severe-hemophilia-a-following-prior-gene-therapy-with-bmn-2702026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-vedolizumab-intravenous-in-pediatric-patients-with-active-ulcerative-colitis-or-crohn-s-disease-a-phase-3b-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-vedolizumab-intravenous-in-pediatric-patients-with-ulcerative-colitis-or-crohn-s-disease-a-phase-2b-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-weekly-intravenous-alpha-1-proteinase-inhibitor-human-in-pulmonary-emphysema-due-to-alpha-1-antitrypsin-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-evaluation-of-zanubrutinib-regimens-in-patients-with-b-cell-malignancies-an-open-label-multi-center-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-follow-up-of-autologous-cd34-cells-transduced-with-w1-6-hwasp-wpre-vsvg-lentiviral-vector-in-wiskott-aldrich-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-follow-up-study-of-ornithine-transcarbamylase-deficiency-patients-treated-with-ecur-506d-and-ecur-506a2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-of-adagrasib-plus-drug-combination-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-of-adx-324-compared-with-sterile-normal-saline-in-hereditary-angioedema2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-of-asciminib-in-patients-with-chronic-myeloid-leukemia-or-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-who-continue-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-of-karxt-in-teens-with-schizophrenia-and-of-karxt-karx-ec-in-children-and-teens-with-autism-related-irritability2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-of-s68587-in-patients-with-advanced-lymphoid-leukemia-previously-treated-with-ucart192026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-study-of-autologous-prame-directed-tcr-t-cell-therapies-ima203-and-ima203cd8-in-adults-with-previously-treated-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-givinostat-in-duchenne-muscular-dystrophy-patients-previously-enrolled-in-givinostat-trials2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-iptacopan-in-patients-with-atypical-hemolytic-uremic-syndrome-post-phase-3-completion2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-ofatumumab-in-patients-with-relapsing-multiple-sclerosis-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-oms906-in-patients-with-paroxysmal-nocturnal-hemoglobinuria-an-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-subcutaneous-sonelokimab-in-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-evaluation-of-vx-670-in-adult-patients-with-myotonic-dystrophy-type-i2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-azetukalner-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-bimekizumab-in-adults-with-active-psoriatic-arthritis-a-multicenter-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-dazukibart-in-idiopathic-inflammatory-myopathies-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-efgartigimod-ph20-sc-in-adults-with-bullous-pemphigoid-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-fremanezumab-in-pediatric-episodic-and-chronic-migraine-a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-iduronate-2-sulfatase-fc-polypeptide-in-mucopolysaccharidosis-type-ii-patients-from-dnli-e-0002-0007-studies2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-lunsekimig-in-adults-with-chronic-rhinosinusitis-with-nasal-polyps-post-completion-of-prior-lunsekimig-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-subcutaneous-efgartigimod-ph20-in-chronic-inflammatory-demyelinating-polyneuropathy-an-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-safety-tolerability-and-efficacy-of-subcutaneous-orka-001-in-adults-with-moderate-to-severe-plaque-psoriasis-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-study-to-monitor-cancer-risk-in-early-onset-metachromatic-leukodystrophy-patients-treated-with-atidarsagene-autotemcel2026-10-07 https://dev.clinicalresearch.eu/trial/long-term-verapamil-hydrochloride-therapy-in-type-1-diabetes-mellitus-a-multi-center-study-on-beta-cell-function-preservation2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-assessment-of-sars-cov-2-immunity-in-immunocompromised-adults-using-raxtozinameran-and-bretovameran-in-belgium2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-evaluation-of-18f-pi-2620-pet-tracer-for-tau-pathology-in-alzheimer-s-disease-associated-with-down-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-evaluation-of-anti-fibrotic-effect-of-upadacitinib-in-patients-with-crohn-s-disease-and-ileal-strictures2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-multicentric-hr-pqct-evaluation-of-tocilizumab-on-bone-erosion-in-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-pet-mr-study-on-myelin-repair-and-neuroinflammation-in-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-phase-iv-study-of-buprenorphine-in-adults-with-moderate-to-severe-opioid-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-positron-emission-tomography-study-using-18f-pi-2620-in-patients-with-corticobasal-syndrome-progressive-supranuclear-palsy-and-behavioral-variant-frontotemporal-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/longitudinal-study-of-clinical-outcome-measures-in-adult-patients-with-spinal-muscular-atrophy-sma-treated-with-risdiplam2026-10-07 https://dev.clinicalresearch.eu/trial/longterm-openlabel-doseblinded-extension-study-of-eptinezumab-in-children-and-adolescents-with-chronic-or-episodic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/low-dose-human-serum-albumin-versus-standard-dose-during-large-volume-paracentesis-in-patients-with-liver-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/low-dose-nivolumab-in-patients-with-tmb-high-advanced-neoplasms-a-pilot-efficacy-study2026-10-07 https://dev.clinicalresearch.eu/trial/loxo-ras-20001-a-phase-1a-1b-study-of-ly3537982-in-patients-with-kras-g12c-mutant-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/luspara-a-basket-phase-ii-clinical-trial-evaluating-luspatercept-in-patients-affected-with-rare-inherited-anemias2026-10-07 https://dev.clinicalresearch.eu/trial/luteal-phase-support-in-moh-iui-treatment-lumo-study2026-10-07 https://dev.clinicalresearch.eu/trial/magrolimab-plus-intensive-chemotherapy-in-newly-diagnosed-eln-intermediate-or-poor-risk-aml-patients-intended-to-undergo-allogeneic-stem-cell-transplantation-a-phase-2-single-arm-open-label-study-magr2026-10-07 https://dev.clinicalresearch.eu/trial/maintenance-therapy-study-of-rinatabart-sesutecan-plus-bevacizumab-in-recurrent-platinum-sensitive-ovarian-cancer-after-second-line-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/maintenance-versus-tapered-therapy-with-adalimumab-etanercept-or-golimumab-in-children-and-adolescents-with-juvenile-idiopathic-arthritis-in-sustained-inactive-disease2026-10-07 https://dev.clinicalresearch.eu/trial/mami-use-of-the-methoxyflurane-as-pain-killer-in-the-prehospital-management-of-acute-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/maribavir-for-high-epstein-barr-virus-infection-in-young-adult-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/marsun-phase-iii-multicenter-open-label-randomized-controlled-study-investigating-mosunetuzumab-lenalidomide-versus-investigator-choices-in-patients-with-relapsed-or-refractory-marginal-zone-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-and-absolute-oral-bioavailability-of-14c-vh4524184-in-adults-with-human-immunodeficiency-virus-hiv2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-14c-bms986504-in-patients-with-homozygous-mtap-deletion-and-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-14c-navlimetostat-in-healthy-female-participants-to-characterize-pharmacokinetics-for-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-14c-tev-56286-absorption-metabolism-and-excretion-in-healthy-male-subjects-following-multiple-doses-of-nonlabeled-tev-562862026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-radiolabeled-14c-abbv-932-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-radiolabeled-14c-ipn60250-in-healthy-adults-for-primary-sclerosing-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/mass-balance-study-of-radiolabeled-14c-vad044-in-patients-with-vascular-malformation2026-10-07 https://dev.clinicalresearch.eu/trial/master-protocol-a-phase-1b-2-multicenter-multi-arm-study-of-evorpacept-in-combination-with-anti-cancer-therapies-in-advanced-metastatic-malignancies-aspen-09-substudy-protocol-a-single-arm-phase-2-mul2026-10-07 https://dev.clinicalresearch.eu/trial/master-protocol-a-phase-2-open-label-multi-arm-study-of-tislelizumab-in-combination-with-investigational-agents-with-or-without-chemotherapy-in-patients-with-previously-untreated-locally-advanced-unre2026-10-07 https://dev.clinicalresearch.eu/trial/mdma-assisted-psychotherapy-in-treatment-refractory-posttraumatic-stress-disorder-an-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/mechanistic-evaluation-of-lebrikizumab-in-moderate-to-severe-atopic-dermatitis-a-phase-iv-multinational-non-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/mechanistic-study-on-ianalumab-pharmacokinetics-pharmacodynamics-safety-and-tolerability-in-sjogren-s-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/medical-air-versus-oxygen-with-salbutamol-and-berodual-drug-combination-in-patients-with-acute-exacerbation-of-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/melatonin-versus-placebo-for-bipolar-disorder-a-double-blinded-randomised-controlled-trial-the-m-bipolar-rct2026-10-07 https://dev.clinicalresearch.eu/trial/melflufen-pharmacokinetics-and-tumor-effects-in-recurrent-glioblastoma-patients-undergoing-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/memento-a-phase-3b-4-randomized-double-blind-placebo-controlled-clinical-study-to-evaluate-mavacamten-in-adults-with-symptomatic-obstructive-hypertrophic-cardiomyopathy-to-assess-the-impact-on-myocard2026-10-07 https://dev.clinicalresearch.eu/trial/menthacarin-r-in-the-treatment-of-functional-gastrointestinal-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/mesenchymal-stromal-cell-therapy-in-acute-respiratory-distress-syndrome-mechanistic-pathway-validation-and-clinical-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/metaddon-methadone-as-co-analgesic-for-patients-with-metastatic-bone-pain-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/metastasis-directed-therapy-for-oligorecurrent-prostate-cancer-a-randomized-phase-iii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/metastasis-directed-therapy-in-oligoprogressive-castration-refractory-prostate-cancer-a-randomized-phase-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/metformin-plus-drug-combination-in-a-clinical-trial-to-reduce-biological-aging-pain-and-inflammation-in-adults-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/methotrexate-and-drug-combination-tapering-versus-usual-care-in-elderly-patients-with-rheumatoid-arthritis-in-low-disease-activity2026-10-07 https://dev.clinicalresearch.eu/trial/methotrexate-treatment-in-hand-osteoarthritis-refractory-to-usual-treatments-a-randomised-double-blind-placebo-controlled-trial-adem2-study2026-10-07 https://dev.clinicalresearch.eu/trial/methoxyflurane-versus-oral-oxycodone-hydrochloride-and-morphine-sulfate-for-pain-relief-in-sickle-cell-disease-vaso-occlusive-crises-emergency-department-patients2026-10-07 https://dev.clinicalresearch.eu/trial/methoxyflurane-vs-standard-care-for-rapid-pain-relief-in-adults-with-non-traumatic-pain-in-the-emergency-department-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/metimmox-2-metastatic-pmmr-mss-colorectal-cancer-shaping-anti-tumor-immunity-by-oxaliplatin2026-10-07 https://dev.clinicalresearch.eu/trial/metronidazole-based-drug-combination-versus-standard-therapy-for-helicobacter-pylori-infection-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/metrowilms-1906-phase-1-2-trial-evaluating-metronomic-chemotherapy-in-patients-with-relapsed-or-refractory-wilms-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/microdosing-with-lysergide-20-g-lsd-to-improve-symptoms-emotional-regulation-and-sleep-in-adults-with-attention-deficit-hyperactivity-disorder-adhd2026-10-07 https://dev.clinicalresearch.eu/trial/migraine-and-high-flow-oxygenotherapy-at-the-emergency-department-miox2026-10-07 https://dev.clinicalresearch.eu/trial/minimal-residual-disease-adapted-strategy-in-multiple-myeloma-evaluation-of-isatuximab-carfilzomib-lenalidomide-and-dexamethasone-in-transplant-eligible-patients2026-10-07 https://dev.clinicalresearch.eu/trial/mk-1824-in-heart-failure-with-preserved-ejection-fraction-a-clinical-trial-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/modafims-an-open-label-single-center-clinical-trial-to-evaluate-predictors-of-response-to-modafinil-in-the-treatment-of-cognitive-deficits-in-patients-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/model-informed-precision-dosing-of-amoxicillin-clavulanic-acid-piperacillin-tazobactam-and-meropenem-in-critically-ill-pediatric-patients-with-systemic-infections2026-10-07 https://dev.clinicalresearch.eu/trial/model-informed-precision-dosing-of-infliximab-in-steroid-refractory-acute-severe-ulcerative-colitis-an-exploratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/model-informed-precision-dosing-of-linezolid-in-icu-patients-with-bacterial-pneumonia-skin-or-soft-tissue-infections2026-10-07 https://dev.clinicalresearch.eu/trial/model-informed-precision-dosing-of-vedolizumab-and-ustekinumab-in-maintaining-remission-of-inflammatory-bowel-disease-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/molecular-alterations-in-localized-prostate-cancer-post-robotic-assisted-radical-prostatectomy-with-enzalutamide-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/molecular-imaging-of-zirconium-89-labeled-brentuximab-for-investigating-biodistribution-in-cd30-positive-stage-ii-iv-high-risk-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/molecular-pd-l1-pet-ct-imaging-with-89zr-atezolizumab-to-monitor-immune-responses-in-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/molecularly-tailored-therapy-with-olaparib-erlotinib-crizotinib-trametinib-pemigatinib-selpercatinib-axitinib-vismodegib-pembrolizumab-larotrectinib-dabrafenib-versus-standard-care-in-patients-with-advanced-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/monocentric-pilot-trial-evaluating-the-safety-and-efficacy-of-regorafenib-in-arterio-venous-malformations-that-are-refractory-to-standard-care2026-10-07 https://dev.clinicalresearch.eu/trial/morning-versus-afternoon-pembrolizumab-carboplatin-and-pemetrexed-in-adults-with-stage-iv-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/morphine-hydrochloride-for-resting-breathlessness-in-adults-with-serious-chronic-life-limiting-disease-receiving-palliative-care-a-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/morphine-pca-vs-morphine-and-lidocaine-pca-for-the-treatment-of-vaso-occlusive-crisis-related-pain-in-sickle-cell-anaemia-patients-a-prospective-randomized-double-blind-monocentric-trial2026-10-07 https://dev.clinicalresearch.eu/trial/morphine-pharmacokinetics-and-dynamics-in-healthy-volunteers-and-patients-with-obesity-and-obstructive-sleep-apnoea-an-investigator-initiated-clinical-study-of-the-impact-of-obesity-and-sleep-apnoea-o2026-10-07 https://dev.clinicalresearch.eu/trial/mrd-guided-pembrolizumab-and-azacitidine-therapy-in-npm1-mutated-acute-myeloid-leukemia-with-imminent-hematological-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/mrna-therapy-to-restore-lymphatic-flow-in-secondary-lymphedema2026-10-07 https://dev.clinicalresearch.eu/trial/mtx325-in-healthy-volunteers-and-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-open-label-phase-2-extension-trial-to-study-the-long-term-safety-in-participants-with-pros-or-proteus-syndrome-who-are-currently-being-treated-with-miransertib-in-other-studies2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-open-label-phase-2-study-of-carboplatin-plus-mirvetuximab-soravtansine-followed-by-mirvetuximab-soravtansine-continuation-in-folate-receptor-alpha-positive-recurrent-platinum-sensitive-hig2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-phase-2-study-to-evaluate-the-efficacy-and-safety-of-cetuximab-in-combination-with-encorafenib-plus-binimetinib-as-induction-treatment-in-braf-v600e-mutated-mss-initially-resectable-or-pot2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-phase-ii-iii-trial-of-18f-alf-fapi-74-pet-ct-in-treatment-naive-oesophagogastric-and-pancreatic-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-prospective-open-label-randomized-crossover-study-to-evaluate-pharmacokinetics-pk-safety-and-tolerability-of-tak-881-in-primary-immunodeficiency-diseases-pidd2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-randomized-controlled-clinical-trial-comparing-ebastine-and-mebeverine-as-treatment-of-irritable-bowel-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-randomized-double-blinded-placebo-controlled-phase-3-trial-to-evaluate-nonavalent-hpv-vaccine-as-a-secondary-prevention-in-patients-treated-for-human-papilloma-virus-related-high-grade-squ2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-randomized-trial-of-standard-vs-reduced-intensity-consolidation-in-mrd-negative-aml-and-cll-patients-using-cytarabine-and-drug-combinations2026-10-07 https://dev.clinicalresearch.eu/trial/multicenter-trial-on-alveolar-bone-augmentation-using-autologous-mesenchymal-stromal-cells-and-biphasic-calcium-phosphate-in-patients-with-jaw-bone-defects2026-10-07 https://dev.clinicalresearch.eu/trial/multicentre-open-label-randomized-controlled-non-inferiority-trial-comparing-single-dose-intrathecal-morphine-and-continuous-thoracic-epidural-analgesia-for-multimodal-analgesia-in-open-colorectal-sur2026-10-07 https://dev.clinicalresearch.eu/trial/multimodal-metformin-and-finger-lifestyle-intervention-to-prevent-cognitive-impairment-and-disability-in-older-adults-at-risk-for-dementia-a-phase-iib-multi-national-randomised-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/multiparametric-dynamic-whole-body-68ga-psma-pet-imaging-for-recurrence-detection-in-hepatocellular-carcinoma-himiko-study2026-10-07 https://dev.clinicalresearch.eu/trial/multiple-ascending-dose-evaluation-of-ly4256984-in-patients-with-sporadic-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/multiple-ascending-dose-study-of-mk-7602-in-healthy-participants-for-malaria-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/multiple-dose-ro7795068-study-of-gastric-emptying-and-oral-contraceptive-pharmacokinetics-in-healthy-overweight-or-obese-adults2026-10-07 https://dev.clinicalresearch.eu/trial/mv140-for-women-with-recurrent-uncomplicated-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/n1t-mc-malo-a-master-protocol-for-a-randomized-controlled-clinical-trial-of-multiple-pharmacologic-agents-in-adult-participants-with-metabolic-dysfunction-associated-steatotic-liver-disease-who-are-at2026-10-07 https://dev.clinicalresearch.eu/trial/nac-attack-a-phase-iii-multicenter-randomized-parallel-double-masked-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-oral-n-acetylcysteine-in-patients-with-retinitis-pigmentosa2026-10-07 https://dev.clinicalresearch.eu/trial/nacre-2-randomized-phase-iii-study-evaluating-two-treatment-strategies-for-locally-advanced-rectal-cancer-in-patients-75-years-old2026-10-07 https://dev.clinicalresearch.eu/trial/nalmefene-versus-placebo-in-addition-to-treatment-as-usual-on-craving-in-behavioural-addictions-nabab2026-10-07 https://dev.clinicalresearch.eu/trial/naxitamab-added-to-standard-induction-therapy-for-children-and-teenagers-with-newly-diagnosed-high-risk-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/near-infrared-fluorescence-imaging-of-adalimumab-800cw-in-inflammatory-bowel-disease-and-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/neo-adjuvant-peritumoral-immunotherapy-in-vulvar-cancer-a-clinical-trial-for-patients-with-vulvar-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-177lu-psma-617-and-ipilimumab-in-very-high-risk-prostate-cancer-candidates-for-radical-prostatectomy-a-phase-i-ii-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-administration-of-capecitabine-oxaliplatin-docetaxel-and-atezolizumab-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-and-adjuvant-durvalumab-and-tremelimumab-in-hepatocellular-carcinoma-patients-undergoing-curative-percutaneous-ablation2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-and-adjuvant-iph5201-and-durvalumab-in-resectable-early-stage-non-small-cell-lung-cancer-a-phase-ii-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-and-adjuvant-lenvatinib-in-bclc-a-hepatocellular-carcinoma-with-percutaneous-ablation-a-multicenter-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-and-adjuvant-therapy-with-dabrafenib-and-trametinib-in-patients-with-papillary-craniopharyngioma-a-clinical-evaluation-of-tumor-volume-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-and-adjuvant-therapy-with-vemurafenib-cobimetinib-and-atezolizumab-in-high-risk-surgically-resectable-braf-mutated-and-wild-type-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-atezolizumab-and-adjuvant-atezolizumab-plus-bevacizumab-with-percutaneous-radiofrequency-ablation-in-small-hepatocellular-carcinoma-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-atezolizumab-and-biologic-agents-in-early-stage-triple-negative-and-her2-positive-breast-cancer-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-atezolizumab-pertuzumab-and-trastuzumab-with-chemotherapy-in-her2-positive-early-high-risk-and-locally-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-axitinib-and-avelumab-in-localized-renal-cell-carcinoma-with-moderate-to-high-recurrence-risk-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-chemoradiotherapy-for-esophageal-squamous-cell-carcinoma-versus-definitive-chemoradiotherapy-with-salvage-surgery-as-needed-the-needs-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-chemotherapy-and-immunotherapy-with-durvalumab-tremelimumab-cisplatin-and-gemcitabine-in-locally-advanced-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-chemotherapy-with-cisplatin-carboplatin-and-paclitaxel-followed-by-fertility-sparing-surgery-in-figo-2018-stage-ib2-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-dostarlimab-and-short-course-radiotherapy-in-microsatellite-unstable-or-mismatch-repair-deficient-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-durvalumab-and-adaptive-low-dose-radiotherapy-for-tumor-microenvironment-modification-in-early-stage-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-durvalumab-immunotherapy-in-unresectable-early-stage-or-locally-advanced-nsclc-followed-by-radical-radiotherapy-or-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-efficacy-and-safety-of-botensilimab-and-balstilimab-in-dmmr-and-pmmr-tumors-a-pan-tumor-basket-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-encorafenib-and-cetuximab-in-braf-v600e-mutated-localized-colon-or-upper-rectum-cancer-a-multicenter-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-endocrine-therapy-with-palbociclib-versus-standard-chemotherapy-in-estrogen-receptor-positive-early-breast-cancer-with-high-or-low-proliferation2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-evaluation-of-darovasertib-in-patients-with-localized-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-folfirinox-pembrolizumab-and-sabr-in-borderline-resectable-pancreatic-cancer-a-phase-i-ii-trial-by-the-dutch-pancreatic-cancer-group2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-folfirinox-versus-upfront-surgery-in-resectable-pancreatic-head-cancer-a-multicenter-randomized-phase-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-gemcitabine-cisplatin-and-perioperative-pembrolizumab-versus-surgery-in-resectable-perihilar-and-distal-cholangiocarcinoma-a-phase-2b-3-rct2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-immunotherapy-with-nivolumab-ipilimumab-mdna11-and-tocilizumab-in-high-risk-resectable-melanoma-a-phase-ib-multicentre-randomised-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-nivolumab-and-ipilimumab-in-patients-with-high-risk-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-nivolumab-and-relatlimab-combination-therapy-in-resectable-non-small-cell-lung-cancer-evaluating-immunological-response-determinants2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-and-watch-and-wait-strategy-in-dmmr-msi-h-localized-colon-cancer-a-phase-ii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-efficacy-in-vulvar-squamous-cell-carcinoma-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-immunotherapy-for-organ-sparing-treatment-in-patients-with-stage-i-iii-localised-dmmr-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-in-high-risk-stage-iib-iic-cutaneous-melanoma-a-phase-iia-single-arm-study-assessing-major-pathological-response2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-plus-chemotherapy-in-locally-advanced-sinonasal-carcinoma-a-safety-and-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-pembrolizumab-versus-placebo-in-stage-iib-c-melanoma-a-phase-ii-double-blind-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-phase-ii-study-of-relatlimab-ipilimumab-and-nivolumab-in-high-risk-non-metastatic-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-sacituzumab-govitecan-and-pembrolizumab-for-patients-with-stage-ii-iii-triple-negative-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-therapy-comparison-of-trastuzumab-deruxtecan-versus-paclitaxel-docetaxel-carboplatin-trastuzumab-and-pertuzumab-in-her2-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/neoadjuvant-trial-of-anti-pd-1-monotherapy-versus-combined-anti-ctla-4-anti-pd-1-blockade-in-resectable-stage-iii-malignant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/neobreastim-a-phase-2-study-of-atezolizumab-plus-rp1-oncolytic-immunotherapy-in-the-neoadjuvant-setting-of-triple-negative-breast-cancer-tnbc2026-10-07 https://dev.clinicalresearch.eu/trial/neomatryx-neoadjuvant-merkel-cell-carcinoma-therapy-tx-with-the-pd-1-inhibitor-cemiplimab-a-randomized-double-blind-placebo-controlled-non-comparative-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/neurobiological-effects-of-5-ht2a-receptor-modulation-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/neurocognitive-outcomes-in-low-risk-medulloblastoma-methotrexate-etoposide-cyclophosphamide-carboplatin-vincristine-cisplatin-and-thiotepa-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/neuroimaging-assessment-of-lysergic-acid-diethylamide-lsd-concentrations-in-the-human-brain-a-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/next-generation-star-trec-save-the-rectum-by-watchful-waiting-after-chemo-radiotherapy-or-total-mesorectal-excision-for-early-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/nhs7108-for-exocrine-pancreatic-insufficiency-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/nifedipine-tocolysis-in-preterm-premature-rupture-of-membranes-before-34-weeks-a-double-blind-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/nipocalimab-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/nitraattien-vaikutus-matalapaineglaukoomassa2026-10-07 https://dev.clinicalresearch.eu/trial/nitrous-oxide-for-adults-with-post-traumatic-stress-disorder-randomized-trial-of-nitrous-oxide-versus-medical-air2026-10-07 https://dev.clinicalresearch.eu/trial/nivolumab-and-ipilimumab-uv1-vaccination-as-second-line-treatment-in-patients-with-malignant-mesothelioma-the-nipu-study2026-10-07 https://dev.clinicalresearch.eu/trial/nivolumab-drug-combination-in-metastatic-renal-cell-carcinoma-comparing-two-immunotherapy-versus-immunotherapy-tki-sequence-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/nivolumab-in-combination-with-cisplatin-and-5-fluorouracil-as-induction-therapy-in-children-and-adults-with-ebv-positive-nasopharyngeal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/nivolumab-plus-drug-combination-versus-brentuximab-vedotin-drug-combination-as-first-line-treatment-in-patients-with-advanced-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/noisy-rebels-non-inferiority-study-of-rituximab-compared-to-ocrelizumab-in-relapsing-ms2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-of-intradermal-fractional-dose-of-recombinant-vzv-ge-as01b-vaccine-versus-full-dose-intramuscular-recombinant-vzv-ge-as01b-vaccine-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-of-ketoprofen-in-pleurodesis-for-pneumothorax-a-randomized-double-blind-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-phase-iii-study-of-treatment-interruption-vs-continuation-with-pembrolizumab-and-axitinib-in-intermediate-risk-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-phase-iii-trial-of-budesonide-orodispersible-tablets-for-inducing-histological-remission-in-adult-eosinophilic-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-randomized-controlled-trial-of-short-vs-standard-amoxicillin-sodium-course-in-adults-with-lower-limb-erysipelas2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-bimervax-as-a-heterologous-booster-for-sars-cov-2-in-adolescents-aged-12-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-custodiol-n-versus-custodiol-for-organ-preservation-in-kidney-liver-and-pancreas-transplantation-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-early-oral-antibiotic-transition-in-pyogenic-vertebral-osteomyelitis-ceftriaxone-moxifloxacin-and-cloxacillin-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-esketamine-hydrochloride-and-propofol-versus-methohexital-sodium-anesthesia-in-major-depression-electroconvulsive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-intravenous-esketamine-hydrochloride-for-complex-regional-pain-syndrome-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-mannitol-versus-macrogol-combination-in-bowel-preparation-for-elective-colonoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-ofatumumab-and-siponimod-versus-fingolimod-in-pediatric-multiple-sclerosis-patients-over-two-years2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-pembrolizumab-maintenance-therapy-at-standard-vs-reduced-dose-in-metastatic-non-squamous-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-reduced-dose-pembrolizumab-versus-standard-dose-in-advanced-non-small-cell-lung-carcinoma-for-overall-survival-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-remibrutinib-versus-ocrelizumab-in-relapsing-multiple-sclerosis-patients-transitioning-to-remibrutinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-study-of-rifampin-free-versus-rifampin-containing-regimens-in-staphylococcal-prosthetic-valve-endocarditis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-assessing-immunogenicity-and-safety-of-intradermal-vs-intramuscular-rabies-virus-inactivated-strain-flury-lep-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-comparing-7-day-versus-14-day-linezolid-and-drug-combination-regimens-for-uncomplicated-enterococcal-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-200-mg-rituximab-vs-1-g-rituximab-in-maintenance-therapy-for-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-amoxicillin-versus-amoxicillin-clavulanic-acid-in-elderly-patients-with-community-acquired-pneumonia-hospitalized-in-non-icu-wards2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-anti-cd20-maintenance-versus-de-escalation-strategy-in-relapsing-remitting-multiple-sclerosis-with-ofatumumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-brimonidine-tartrate-timolol-maleate-eye-drops-versus-combigan-in-open-angle-glaucoma-or-ocular-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-brinzolamide-timolol-versus-azarga-in-reducing-intraocular-pressure-in-open-angle-glaucoma-and-ocular-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-ceftriaxone-sodium-amikacin-sulfate-and-cefixime-trihydrate-in-pediatric-acute-pyelonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-cilastatin-sodium-vs-sodium-thiosulfate-for-nephroprotection-in-crs-hipec-cisplatin-patients-with-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-compression-therapy-versus-phenoxymethylpenicillin-and-compression-therapy-in-recurrent-erysipelas-of-the-lower-limbs2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-cotrimoxazole-versus-standard-care-in-ventilator-associated-pneumonia-management-in-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-custodiol-crystalloid-cardioplegia-versus-buckberg-blood-cardioplegia-in-major-cardiac-surgery-with-extracorporeal-circulation2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-depemokimab-versus-mepolizumab-or-benralizumab-in-severe-eosinophilic-asthma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-dolutegravir-lamivudine-for-virological-suppression-maintenance-in-pediatric-hiv-patients-aged-2-to-15-years2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-glucocorticoid-withdrawal-versus-maintenance-in-systemic-lupus-erythematosus-patients-on-standard-of-care-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-ibuprofen-lysine-suspension-versus-ibuprofen-suspension-for-acute-pediatric-pain-management2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-intra-articular-autologous-microfat-and-platelet-rich-plasma-in-radiocarpal-osteoarthritis-versus-total-wrist-denervation2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-magnesium-hydroxide-versus-macrogol-electrolytes-for-opioid-induced-constipation-prevention-in-advanced-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-mifepristone-and-letrozole-versus-methotrexate-in-the-management-of-ectopic-pregnancy2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-ocrelizumab-versus-rituximab-in-active-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-oral-antibiotics-versus-intravenous-antibiotics-in-patients-with-bacterial-brain-abscess-moxifloxacin-linezolid-clindamycin-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-rectal-progesterone-for-luteal-phase-support-in-hrt-fet-cycles-in-infertility-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-sphenopalatine-ganglion-block-versus-scalp-block-in-supratentorial-intracranial-surgery-for-craniotomy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-of-topical-mupirocin-gel-versus-ointment-in-pediatric-impetigo-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-on-3-week-vs-6-week-antibiotic-regimen-in-drained-pyogenic-liver-abscess-using-meropenem-linezolid-and-tedizolid2026-10-07 https://dev.clinicalresearch.eu/trial/non-inferiority-trial-on-dupilumab-withdrawal-versus-continuation-in-patients-with-controlled-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/normothermic-intraperitoneal-chemotherapy-nipec-with-carboplatin-following-cytoreductive-surgery-in-elderly-and-fragile-ovarian-cancer-patients-a-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/nuwiq-dosing-and-outcomes-in-the-management-of-women-girls-with-haemophilia-a-needing-fviii-treatment-for-surgery-an-international-open-label-non-controlled-study-nudimension2026-10-07 https://dev.clinicalresearch.eu/trial/nuwiq-for-perioperative-management-of-patients-with-haemophilia-a-on-emicizumab-regular-prophylaxis-study-nupower2026-10-07 https://dev.clinicalresearch.eu/trial/obi-wan-obinutuzumab-for-remission-induction-in-patients-with-relapsing-pr3-anca-granulomatosis-with-polyangiitis-wegener-s-phase-2-prospective-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/obinutuzumab-in-patients-with-systemic-lupus-erythematosus-pure-membranous-nephropathy-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/obrixtamig-carboplatin-and-etoposide-for-advanced-or-metastatic-extrapulmonary-neuroendocrine-carcinoma-in-dll3-positive-patients2026-10-07 https://dev.clinicalresearch.eu/trial/octreotide-treatment-to-improve-nutritional-recovery-after-surgery-for-patients-with-esophageal-or-gastric-cancer-a-prospective-randomized-open-label-phase-ii-study-otis2026-10-07 https://dev.clinicalresearch.eu/trial/odm-212-in-combination-with-cancer-treatments-in-adults-with-advanced-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/omalizumab-as-monotherapy-for-patients-with-vegetable-allergy-caused-by-ltp-and-profilin-sensitization2026-10-07 https://dev.clinicalresearch.eu/trial/onc201-for-the-treatment-of-newly-diagnosed-h3-k27m-mutant-diffuse-glioma-following-completion-of-radiotherapy-a-randomized-double-blind-placebo-controlled-multicenter-study-the-action-study2026-10-07 https://dev.clinicalresearch.eu/trial/one-year-study-of-guselkumab-in-adults-with-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-clinical-phase-1-2-study-to-assess-the-safety-and-efficacy-of-the-spectracure-p18-system-interstitial-multiple-diode-lasers-and-idose-r-software-and-verteporfin-for-injection-vfi-for-the-tr2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-dose-escalation-and-dose-expansion-study-to-evaluate-the-safety-expansion-persistence-and-clinical-activity-of-ucart22-allogeneic-engineered-t-cells-expressing-anti-cd22-chimeric-antigen-re2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-dose-finding-and-dose-expansion-study-to-evaluate-the-safety-expansion-persistence-and-clinical-activity-of-ucart20x22-in-subjects-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-b-2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-drug-drug-interaction-study-of-duvakitug-on-cytochrome-p450-substrate-pharmacokinetics-in-patients-with-ulcerative-colitis-and-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-evaluation-of-adhesion-performance-of-an-esflurbiprofen-transdermal-patch-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-evaluation-of-vrdn-001-in-non-responders-with-thyroid-eye-disease-from-vrdn-001-101-and-vrdn-001-301-studies2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-and-safety-evaluation-of-acoramidis-hydrochloride-in-symptomatic-transthyretin-amyloid-cardiomyopathy-post-phase-3-attribute-cm-completion2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-assessing-long-term-safety-of-etrasimod-arginine-in-patients-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-evaluating-long-term-safety-and-efficacy-of-ublituximab-in-patients-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-evaluating-long-term-safety-and-tolerability-of-subcutaneous-secukinumab-in-patients-with-polymyalgia-rheumatica2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-evaluating-long-term-safety-of-efgartigimod-alfa-in-adults-with-primary-sjogren-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-ath434-for-patients-with-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-dexamethasone-sodium-phosphate-in-patients-with-ataxia-telangiectasia-following-iedat-04-2022-participation2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-donidalorsen-isis-721744-for-safety-evaluation-in-hereditary-angioedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-long-term-safety-and-efficacy-of-nnc6019-0001-in-participants-with-transthyretin-amyloid-cardiomyopathy-attr-cm2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-prx012-in-patients-with-alzheimer-s-disease-previously-enrolled-in-studies-prx012-101-or-prx012-1022026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-tadekinig-alfa-in-patients-with-il-18-driven-monogenic-autoinflammatory-conditions-nlrc4-mutation-and-xiap-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-of-vericiguat-in-pediatric-patients-with-heart-failure-due-to-systemic-left-ventricular-systolic-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-on-long-term-safety-of-enzalutamide-in-prostate-cancer-patients-from-previous-clinical-trials2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-on-long-term-safety-of-zagociguat-in-melas-patients-post-tis6463-203-completion2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-on-the-long-term-safety-of-relacorilant-in-patients-with-endogenous-cushing-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-extension-study-on-the-safety-and-long-term-efficacy-of-oral-efavirenz-in-adult-or-late-onset-juvenile-niemann-pick-type-c-disease-with-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-induction-and-maintenance-study-of-oral-tofacitinib-in-pediatric-patients-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-multinational-study-of-fitusiran-prophylaxis-in-pediatric-patients-aged-1-to-12-years-with-severe-hemophilia-a-or-b2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-1-study-of-itraconazole-interaction-on-engasertib-pharmacokinetics-in-healthy-adults-for-planned-treatment-of-hereditary-hemorrhagic-telangiectasia2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-2a-study-of-oral-vafidemstat-for-safety-tolerability-and-efficacy-in-adults-with-phelan-mcdermid-syndrome-hope-22026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-3-study-of-mk-7684a-coformulation-of-vibostolimab-with-pembrolizumab-in-combination-with-concurrent-chemoradiotherapy-followed-by-mk7684a-versus-concurrent-chemoradiotherapy-followed-2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-3b-study-assessing-safety-of-oral-ivosidenib-in-pretreated-patients-with-locally-advanced-or-metastatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-3b-study-to-evaluate-effectiveness-safety-and-pharmacokinetic-parameters-of-metreleptin-in-patients-under-6-years-of-age-with-generalised-lipodystrophy-and-associated-diabetes-mellitu2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-i-ii-basket-trial-of-ukt-cart19-1-in-adults-with-relapsed-refractory-autoimmune-diseases-aav-itp-ms-ra-pv-ssc-iim2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-phase-ii-study-of-bbo-11818-in-adults-with-kras-mutant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-pilot-study-of-esketamine-nasal-spray-for-treatment-resistant-bipolar-depression2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-proof-of-concept-trial-of-topical-delgocitinib-in-patients-with-facial-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-randomized-crossover-bioavailability-study-of-test-versus-reference-valsartan-320-mg-tablets-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-randomized-crossover-study-assessing-bioequivalence-of-test-betahistine-dihydrochloride-24-mg-tablets-versus-reference-under-fasting-conditions-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-randomized-single-dose-two-period-crossover-bioavailability-study-of-empagliflozin-metformin-12-5-mg-1000-mg-versus-synjardy-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-randomized-single-dose-two-way-crossover-study-of-tolerability-and-pharmacokinetics-of-nrt001-buccal-film-vs-oro-mucosal-nicotine-spray-in-occasional-users2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-randomized-two-period-crossover-bioequivalence-of-pyridostigmine-bromide-180-mg-prolonged-release-tablet-in-healthy-volunteers-for-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-roll-over-study-of-rilpivirine-with-antiretroviral-regimen-in-hiv-1-infected-pediatric-subjects-from-previous-rilpivirine-trials2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-rollover-study-for-continued-treatment-and-safety-monitoring-in-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-rollover-study-of-futibatinib-monotherapy-or-in-combination-with-fulvestrant-in-patients-with-malignant-solid-tumors-from-prior-futibatinib-trials2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-rollover-study-of-jdq443-opnurasib-with-drug-combination-in-patients-with-kras-g12c-mutated-metastatic-non-small-cell-lung-cancer-or-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-safety-study-in-adults-and-adolescents-with-haemophilia-a-with-and-without-fviii-inhibitors-switching-directly-from-emicizumab-prophylaxis-to-nnc0365-3769-mim8-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-single-arm-phase-3-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-fenfluramine-hydrochloride-in-infants-1-year-to-less-than-2-years-of-age-with-dravet-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-single-arm-study-of-elranatamab-for-safety-monitoring-in-multiple-myeloma-patients-continuing-from-pfizer-sponsored-trials2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-single-center-pharmacokinetic-and-cerebrospinal-fluid-distribution-study-of-oral-bp1-15205-in-healthy-volunteers-for-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-single-dose-trial-to-evaluate-pharmacokinetics-safety-and-acceptability-palatability-of-oveporexton-in-children-from-6-years-to-less-than-18-years-of-age-with-narcolepsy-type-1-nt12026-10-07 https://dev.clinicalresearch.eu/trial/open-label-study-of-ide034-in-adults-with-locally-advanced-or-metastatic-solid-tumors-including-nsclc-escc-endometrial-hgsoc-hnscc-tnbc-crc-and-crpc2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-study-of-tx000045-in-adults-with-pulmonary-hypertension-secondary-to-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/open-label-study-on-long-term-safety-of-berotralstat-in-hereditary-angioedema-patients-from-previous-clinical-trials2026-10-07 https://dev.clinicalresearch.eu/trial/open-labelled-single-centre-investigation-of-safety-and-tolerability-of-multiple-ascending-doses-of-nebulised-ss0331-in-healthy-participants-followed-by-investigation-of-preliminary-efficacy-of-nebuli2026-10-07 https://dev.clinicalresearch.eu/trial/ophthalmic-safety-evaluation-of-investigational-drug-in-patients-with-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/opioid-free-anesthesia-with-dexmedetomidine-compared-to-remifentanil-and-sufentanil-in-patients-undergoing-video-assisted-or-robot-assisted-lung-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/optimisation-of-antiviral-therapy-in-immunocompromised-covid-19-patients-a-randomized-factorial-controlled-strategy-trial-the-opticov-study2026-10-07 https://dev.clinicalresearch.eu/trial/optimisation-of-lymph-node-fine-needle-aspiration-to-study-pneumococcal-vaccine-induced-immunity2026-10-07 https://dev.clinicalresearch.eu/trial/optimise-optimized-immunosuppression-for-corneal-transplantation-a-multi-centre-randomized-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/optimization-of-cyclosporin-therapy-in-atopic-dermatitis-through-multiomic-predictive-models-of-treatment-response-dermatomics2026-10-07 https://dev.clinicalresearch.eu/trial/optimization-of-intraputaminal-administration-of-aav2-gdnf-using-a-prescriptive-infusion-algorithm-in-patients-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/optimization-of-trametinib-dimethyl-sulfoxide-dosage-and-duration-in-braf-negative-pediatric-patients-with-refractory-histiocytic-cell-proliferation2026-10-07 https://dev.clinicalresearch.eu/trial/optimization-of-vemurafenib-dosage-and-duration-in-braf-mutant-refractory-histiocytic-cell-proliferation-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/optimized-pharmacological-treatment-for-broken-heart-takotsubo-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/optimizing-ceftazidime-avibactam-dosing-in-critically-ill-patients-undergoing-continuous-renal-replacement-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/optimizing-de-escalation-with-pembrolizumab-based-drug-combination-in-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/optimizing-fludarabine-phosphate-exposure-to-improve-event-free-survival-in-children-and-young-adults-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/optimmize-2-a-phase-3-multicenter-single-arm-open-label-extension-study-to-assess-the-safety-tolerability-and-efficacy-of-risankizumab-in-subjects-with-moderate-to-severe-plaque-psoriasis-who-have-com2026-10-07 https://dev.clinicalresearch.eu/trial/oral-administration-of-tramadol-in-healthy-subjects-to-enhance-detection-in-biological-matrices-for-anti-doping-control2026-10-07 https://dev.clinicalresearch.eu/trial/oral-antibiotics-to-prevent-infection-and-wound-dehiscence-after-obstetric-perineal-tear-a-double-blinded-placebo-controlled-randomized-trail2026-10-07 https://dev.clinicalresearch.eu/trial/oral-bioavailability-of-hydrocortisone-and-hydrocortisone-sodium-phosphate-from-2-dimensional-printed-odf-versus-tablets-in-children-and-adolescents-with-adrenal-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/oral-colchicine-to-reduce-dependency-and-major-cardiovascular-events-in-survivors-of-spontaneous-intracerebral-hemorrhage-with-atherosclerosis-risk-factors2026-10-07 https://dev.clinicalresearch.eu/trial/oral-semaglutide-in-people-with-mild-cognitive-impairment-or-mild-alzheimer-s-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/oral-semaglutide-once-daily-for-weight-loss-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/oral-vs-intravenous-tranexamic-acid-to-reduce-bleeding-in-patients-undergoing-off-pump-coronary-artery-bypass-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/orelabrutinib-in-patients-with-primary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/orismilast-for-the-treatment-of-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/osilodrostat-plus-drug-combination-for-patients-with-hypertension-caused-by-cushing-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/outcome-adaptive-randomized-multi-arm-study-of-radium-223-dichloride-abiraterone-acetate-and-drug-combinations-in-metastatic-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/ovacure-2-adoptive-t-cell-therapy-plus-low-dose-il-2-il-2ld-as-first-line-neoadjuvant-therapy-in-patients-with-stage-iii-iv-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/overall-survival-analysis-in-resectable-pancreatic-adenocarcinoma-with-risk-factors-using-neoadjuvant-mfolfirinox-radiotherapy-and-adjuvant-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/oxytocin-nasal-spray-for-reducing-cravings-and-preventing-relapse-in-adults-with-substance-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/pain-relief-with-intranasal-dexmedetomidine-and-drug-combination-in-preterm-infants-undergoing-retinopathy-of-prematurity-screening2026-10-07 https://dev.clinicalresearch.eu/trial/pain-relief-with-ropivacaine-for-women-undergoing-second-trimester-medical-abortion-13-weeks-gestation2026-10-07 https://dev.clinicalresearch.eu/trial/palatability-assessment-of-oral-dispersible-zonisamide-formulations-in-a-randomized-open-label-three-period-crossover-study-with-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/palette-adaptive-platform-trial-for-personalisation-of-sepsis-treatment-in-children-and-adults-a-multi-national-treatable-traits-guided-adaptive-exploratory-bayesian-basket-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pan-european-proof-of-concept-study-comparing-decentralised-clinical-trial-dct-and-hybrid-approaches-to-conventional-clinical-trial-approaches-in-patients-with-type-2-diabetes-mellitus-treated-with-to2026-10-07 https://dev.clinicalresearch.eu/trial/pan-lesions-sbrt-combined-with-lymphocyte-support-through-atra-driven-blockade-of-mdsc-in-patients-with-oligometastatic-solid-cancer-lysatra2026-10-07 https://dev.clinicalresearch.eu/trial/panacea-effect-of-prehabilitation-by-nutritional-supplementation-with-cannabidiol-on-skeletal-muscle-mass-and-mitochondrial-function-in-head-and-neck-cancer-a-proof-of-concept-controlled-randomized-tr2026-10-07 https://dev.clinicalresearch.eu/trial/passion-olaparib-maintenance-in-chemotherapy-sensitive-metastatic-pancreatic-adenocarcinoma-mpdac-a-phase-ii-proof-of-principle-study2026-10-07 https://dev.clinicalresearch.eu/trial/pathophysiology-of-pain-in-parkinson-s-disease-exploration-of-the-serotonin-system-in-positron-emission-tomography-pet-18f-mppf-pd-pain2026-10-07 https://dev.clinicalresearch.eu/trial/patient-centered-study-of-trastuzumab-deruxtecan-t-dxd-in-first-line-her2-positive-metastatic-breast-cancer-with-proactive-toxicity-managementreflecting-real-world-clinical-practice-top-real-trial2026-10-07 https://dev.clinicalresearch.eu/trial/patient-chosen-antibiotics-amoxicillin-sodium-clavulanic-acid-versus-routine-appendectomy-in-adults-with-uncomplicated-acute-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/patient-controlled-propofol-versus-alfentanil-and-midazolam-sedation-in-patients-undergoing-colonoscopy-for-adenoma2026-10-07 https://dev.clinicalresearch.eu/trial/patient-controlled-remimazolam-midazolam-and-alfentanil-sedation-versus-physician-controlled-sedation-in-adults-undergoing-outpatient-colonoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/patient-walking-rehabilitation-program-with-osteoarthritis-of-the-hip-or-knee-helped-by-a-one-off-anti-inflammatory-treatment-pilot-cohort-study-with-short-walking-objectives-peripatei2026-10-07 https://dev.clinicalresearch.eu/trial/peace-6-poor-responders-a-randomized-phase-iii-trial-evaluating-the-efficacy-and-safety-of-177lu-psma-617-in-addition-to-standard-of-care-soc-versus-soc-alone-in-de-novo-metastatic-hormone-sensitive-p2026-10-07 https://dev.clinicalresearch.eu/trial/peace-6-vulnerable-a-double-blind-randomised-phase-iii-trial-evaluating-the-efficacy-of-adt-darolutamide-in-de-novo-metastatic-prostate-cancer-patients-with-vulnerable-functional-ability-and-not-elect2026-10-07 https://dev.clinicalresearch.eu/trial/peak-a-phase-3-randomized-open-label-multicenter-clinical-study-of-cgt9486-sunitinib-vs-sunitinib-in-subjects-with-locally-advanced-unresectable-or-metastatic-gastrointestinal-stromal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/pegcetacoplan-in-patients-with-c3-glomerulopathy-or-ic-mpgn-real-world-effectiveness-and-safety-study2026-10-07 https://dev.clinicalresearch.eu/trial/pembro-core-pilot-phase-ii-trial-of-pembrolizumab-in-combination-with-salvage-chemotherapy-for-first-relapsed-or-refractory-classical-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/pembro-flash-phase-ii-trial-of-pembrolizumab-in-first-line-treatment-of-advanced-stage-classic-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/percutaneous-hepatic-perfusion-with-melphalan-plus-ipilimumab-and-nivolumab-versus-ipilimumab-and-nivolumab-in-uveal-melanoma-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/percutaneous-needle-fasciotomy-corticosteroid-injection-for-dupuytren-contracture-affecting-the-metacarpophalangeal-joint-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pereli-a-phase-2-open-label-study-of-pemigatinib-and-retifanlimab-in-advanced-dedifferentiated-liposarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/perineural-incobotulinumtoxin-a-for-complex-regional-pain-syndrome-an-open-label-feasibility-study-pincom2026-10-07 https://dev.clinicalresearch.eu/trial/perineural-injections-of-incobotulinumtoxin-a-for-diabetic-neuropathic-pain-of-the-lower-extremities-a-double-blind-randomized-placebo-controlled-study-pinbot2026-10-07 https://dev.clinicalresearch.eu/trial/perioperative-administration-of-tranexamic-acid-to-reduce-hemorrhage-in-morbid-obesity-patients-undergoing-gastric-bypass-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/perioperative-capecitabine-within-flot-regimen-for-patients-with-gastric-or-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/perioperative-durvalumab-and-tremelimumab-therapy-in-resectable-hepatocellular-carcinoma-a-phase-ii-safety-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/perioperative-evaluation-of-spartalizumab-with-fluorouracil-leucovorin-oxaliplatin-and-docetaxel-in-resectable-gastric-cancer-a-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/perioperative-treatment-with-tranexamic-acid-txa-in-melanoma-prognostic-and-treatment-related-impact-of-the-plasminogen-plasmin-pathway2026-10-07 https://dev.clinicalresearch.eu/trial/personalized-long-term-human-serum-albumin-therapy-versus-saline-in-decompensated-cirrhosis-patients-with-ascites-biomarker-driven-response-validation2026-10-07 https://dev.clinicalresearch.eu/trial/personalized-tacrolimus-dosing-algorithm-for-pediatric-renal-transplant-recipients-evaluation-of-once-daily-tacrolimus-formulation2026-10-07 https://dev.clinicalresearch.eu/trial/personalizing-treatment-for-patients-with-hr-positive-her2-negative-metastatic-breast-cancer-using-fulvestrant-elacestrant-capivasertib-capecitabine-or-a-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/pet-ct-imaging-of-neuroendocrine-tumors-in-adults-using-copper-64-chloride-v-cu64-compared-with-gallium-68-chloride-v-ga682026-10-07 https://dev.clinicalresearch.eu/trial/pet-ct-imaging-with-18f-alf-fapi-74-to-differentiate-active-fibrotic-and-inflammatory-phenotypes-in-patients-with-progressive-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/pet-study-of-11c-az14132516-uptake-post-azd7798-administration-in-healthy-subjects-and-crohn-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pet-study-of-m4-muscarinic-acetylcholine-receptor-occupancy-by-bms-986521-in-healthy-adult-participants2026-10-07 https://dev.clinicalresearch.eu/trial/pf-08634404-with-chemotherapy-drug-combination-in-treatment-naive-patients-with-advanced-gastric-or-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamic-evaluation-of-0-34-tropicamide-and-2-5-phenylephrine-hydrochloride-ophthalmic-solution-for-mydriasis-in-pre-operative-and-diagnostic-applications2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamic-evaluation-of-tev-56192-in-a-double-blind-randomized-placebo-controlled-phase-1b-trial-for-pruritus-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamic-study-of-ov329-3s-3-amino-4-difluoromethylidene-cyclopentene-1-carboxylic-acid-hydrochloride-in-participants-with-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamics-and-safety-evaluation-of-recombinant-human-luteinising-hormone-in-hypogonadotropic-hypogonadal-men2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamics-of-early-vs-delayed-ticagrelor-administration-during-cangrelor-infusion-in-stemi-patients-undergoing-primary-pci2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-insulin-gzr4-vs-insulin-degludec-and-insulin-icodec-in-type-2-diabetes-mellitus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-insulin-gzr4-vs-insulin-icodec-in-type-2-diabetes-a-phase-i-randomized-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacogenetic-based-dosing-of-sertraline-aripiprazole-risperidone-and-escitalopram-in-mood-anxiety-and-psychotic-disorders-a-comparative-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-analysis-of-capecitabine-and-oxaliplatin-in-ces1-variant-carriers-with-advanced-gastrointestinal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-analysis-of-cefazolin-in-patients-undergoing-chronic-hemodialysis-with-concurrent-infections2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-analysis-of-rezafungin-acetate-in-suspected-intra-abdominal-candidiasis-peritoneal-diffusion-and-antifungal-activity-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-glucodynamic-evaluation-of-ly3209590-in-patients-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-hematological-toxicity-analysis-of-niraparib-tosilate-monohydrate-in-high-grade-serous-ovarian-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-immunologic-evaluation-of-residual-pembrolizumab-levels-and-post-immunotherapy-chemotherapy-efficacy-in-nsclc-and-head-and-neck-scc2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-metabolic-profiling-of-bi-3034701-in-healthy-male-subjects-with-normal-weight-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-assessment-of-ublituximab-in-myasthenia-gravis-and-relapsing-multiple-sclerosis-with-methylprednisolone-combination2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-characterization-of-trientine-dihydrochloride-in-wilson-s-disease-a-multicenter-open-label-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-comparison-of-cholecalciferol-0-266-mg-vs-25-000-iu-in-patients-with-vitamin-d-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-comparison-of-desmopressin-formulations-in-pediatric-nocturnal-enuresis-minirin-oral-lyophilisate-vs-sandoz-sublingual-tablet2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-axn-027-in-adults-with-chronic-pain-refractory-epilepsy-and-e-i-imbalance-neurological-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-clindamycin-with-rifampicin-in-obesity-related-fracture-hidradenitis-suppurativa-and-prosthetic-joint-infections2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-intravenous-vs-oral-aspirin-in-healthy-adults-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-jnj-101556143-in-healthy-volunteers-effects-of-formulation-and-food-on-exposure-for-prostate-cancer-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-qrl-101-in-a-randomized-placebo-controlled-double-blind-single-dose-phase-1-study-in-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-evaluation-of-topical-tar-0520-gel-for-mitigating-adverse-reactions-in-anticancer-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-study-of-aticaprant-with-and-without-food-and-fluconazole-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-study-of-aticaprant-with-and-without-rabeprazole-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-pharmacodynamic-study-of-naloxone-nalmefene-fentanyl-and-sufentanil-in-opioid-induced-respiratory-depression-in-opioid-naive-and-chronic-users2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-assessment-of-substances-prohibited-by-the-world-anti-doping-agency-in-healthy-volunteers-a-proof-of-concept-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-evaluation-of-baricitinib-in-pediatric-patients-aged-1-to-18-years-hospitalized-with-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-evaluation-of-oral-decitabine-and-cedazuridine-in-patients-with-acute-myeloid-leukemia-myelodysplastic-syndrome-or-solid-tumors-with-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-evaluation-of-oral-decitabine-and-cedazuridine-in-patients-with-solid-tumors-myelodysplastic-syndrome-or-acute-myeloid-leukemia-with-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-evaluation-of-personalized-folfirinox-dosing-in-pancreatic-cancer-a-phase-2-study-on-5-fluorouracil-irinotecan-oxaliplatin-and-calcium-folinate2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-safety-evaluation-of-subcutaneous-co-administration-of-two-investigational-drugs-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-taste-assessment-of-osivelotor-pf-07940367-formulations-under-fasted-fed-and-acid-reducing-conditions-in-healthy-adults-for-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-and-tolerance-assessment-of-high-dose-favipiravir-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-assessment-of-amorphous-sorafenib-formulation-in-mesoporous-magnesium-carbonate-versus-sorafenib-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-assessment-of-amorphous-sorafenib-in-mesoporous-magnesium-carbonate-versus-sorafenib-in-hepatocellular-renal-and-thyroid-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-assessment-of-atr-258-oral-capsule-versus-solution-in-type-2-diabetes-a-randomized-open-label-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-assessment-of-nic24-01-and-nic24-02-oromucosal-pouches-versus-nicotine-gum-in-nicotine-dependent-adult-smokers-under-fasted-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-bridging-study-of-tozorakimab-using-an-accessorised-prefilled-syringe-and-autoinjector-in-patients-with-respiratory-inflammation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparability-study-of-pre-and-post-change-teclistamab-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparability-study-of-tak-881-and-human-normal-immunoglobulin-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-abp-206-and-nivolumab-in-adjuvant-treatment-of-resected-stage-iii-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-abp-234-and-pembrolizumab-in-adjuvant-therapy-for-early-stage-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-continuous-versus-intermittent-meropenem-infusion-in-patients-with-foreign-body-bone-and-joint-infections2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-fyb206-and-pembrolizumab-in-adjuvant-treatment-of-stage-iib-iic-or-iii-melanoma-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-mab-22-and-prolia-r-eu-and-us-in-healthy-male-volunteers-a-randomized-double-blind-controlled-parallel-group-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-oral-budesonide-formulations-with-and-without-food-in-patients-with-acute-eosinophilic-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-pembrolizumab-formulations-in-adjuvant-therapy-for-resected-stage-iib-iic-and-iii-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-rosuvastatin-digoxin-metformin-and-furosemide-in-healthy-subjects-and-patients-with-compensated-and-decompensated-liver-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-salbutamol-via-hfa-152a-and-hfa-134a-metered-dose-inhalers-in-healthy-adults-aged-18-552026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-subcutaneous-ianalumab-delivery-methods-in-adults-with-systemic-lupus-erythematosus-sjogren-s-disease-and-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-subcutaneous-versus-intravenous-midazolam-hydrochloride-in-terminally-ill-patients-requiring-palliative-care2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-subcutaneous-versus-intravenous-paracetamol-in-adult-palliative-care-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-tacrolimus-in-stable-pediatric-allograft-recipients-transitioning-from-prograf-to-advagraf-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-three-survodutide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-two-injectable-survodutide-formulations-in-healthy-men-and-women-with-and-without-overweight-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-two-oral-mesalazine-formulations-in-healthy-volunteers-under-fed-conditions-for-chronic-idiopathic-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-two-survodutide-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-two-tablet-strengths-and-solution-formulation-in-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-two-vicadrostat-empagliflozin-tablet-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-zongertinib-tablet-formulations-from-two-manufacturers-under-fed-and-fasted-conditions-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-comparison-of-zongertinib-tablets-from-two-manufacturers-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-distribution-of-linezolid-in-prostatic-tissue-of-patients-undergoing-endoscopic-prostate-enucleation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-dose-escalation-study-of-cenobamate-in-pediatric-patients-with-partial-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-efficacy-and-tolerability-assessment-of-prolonged-release-tacrolimus-in-pediatric-kidney-transplant-recipients-a-multicenter-interventional-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-equivalence-study-of-ql2107-and-pembrolizumab-in-adjuvant-therapy-for-resected-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-afabicin-in-subjects-with-renal-impairment-and-normal-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-afamelanotide-in-adolescent-and-adult-patients-with-erythropoietic-protoporphyria-epp2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-alendronic-acid-oral-formulations-in-healthy-volunteers-under-fasted-conditions-a-randomized-open-label-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-amoxicillin-clavulanic-acid-ciprofloxacin-and-drug-combination-in-pediatric-patients-with-malignant-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-amx0035-in-subjects-with-hepatic-impairment-and-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-amx0035-in-subjects-with-renal-impairment-and-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-apixaban-and-teduglutide-in-patients-with-short-bowel-syndrome-on-long-term-parenteral-nutrition2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-apixaban-pre-and-post-roux-en-y-gastric-bypass-in-patients-a-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-aticaprant-jnj-67953964-following-carbamazepine-administration-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-bi-1291583-in-healthy-volunteers-comparative-analysis-of-two-doses-across-three-formulations2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-bi-1358894-on-contraceptive-plasma-levels-in-healthy-female-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-bi-1584862-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-bi-456906-on-contraceptive-plasma-levels-in-women-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-bp1-4979-in-sustained-vs-immediate-release-formulations-in-binge-eating-disorder-a-two-part-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-chf-5993-via-nexthaler-r-and-pmdi-with-aerochamber-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-colistimethate-sodium-in-treating-serious-infections-by-aerobic-gram-negative-pathogens-in-patients-with-limited-treatment-options2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-efanesoctocog-alfa-versus-other-extended-half-life-recombinant-factor-viii-products-in-severe-haemophilia-a-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-elexacaftor-tezacaftor-ivacaftor-in-cystic-fibrosis-patients-a-prospective-retrospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-etrasimod-arginine-in-lactating-women-with-ulcerative-colitis-and-immune-mediated-inflammatory-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-follitropin-alfa-from-two-manufacturing-processes-in-pituitary-suppressed-premenopausal-females-with-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-infliximab-in-pediatric-patients-with-crohn-s-disease-a-prospective-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-intrathecal-nusinersen-via-thecaflex-drx-system-in-adult-and-pediatric-patients-with-spinal-muscular-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-lepodisiran-in-subjects-with-normal-and-impaired-hepatic-function-a-single-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-ly03010-and-its-relative-bioavailability-compared-to-paliperidone-palmitate-in-schizophrenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-metamizole-s-impact-on-imatinib-metabolism-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-mevrometostat-in-healthy-adults-for-small-cell-lung-cancer-castration-resistant-prostate-cancer-and-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-minocycline-in-patients-with-nontuberculous-mycobacterial-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-nex-22a-in-patients-with-type-2-diabetes-a-phase-1-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-nicorandil-40-mg-extended-release-capsules-in-healthy-volunteers-under-fasting-and-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-oral-and-intranasal-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-oral-pkl-021-in-single-and-multiple-doses-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-prazosin-and-cyproheptadine-in-healthy-volunteers-with-single-dose-oral-administration-of-kt110-tablet-and-marketed-tablets-in-alcohol-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-prifetrastat-in-healthy-adults-implications-for-treatment-of-locally-advanced-or-metastatic-er-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-qrl-101-formulations-in-healthy-subjects-for-amyotrophic-lateral-sclerosis-als2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-rifaximin-soluble-solid-dispersion-in-adults-with-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-rilzabrutinib-tablet-in-adults-with-severe-renal-impairment-versus-matched-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-ro7434656-in-patients-with-varying-degrees-of-hepatic-impairment-following-a-single-subcutaneous-dose2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-s221237-tablets-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-stiripentol-in-patients-with-renal-impairment-versus-healthy-controls-an-open-label-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-subcutaneous-nivolumab-with-or-without-recombinant-human-hyaluronidase-ph20-in-multi-tumor-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-systemic-exposure-to-high-dose-aflibercept-in-bilateral-intravitreal-administration-for-dme-and-namd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-tanimilast-chf-6001-in-adolescent-and-adult-asthma-patients-following-single-dose-inhalation-administration2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-three-bi-764198-formulations-in-healthy-volunteers-impact-of-food-on-drug-absorption2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-tvb-2640-in-subjects-with-varying-degrees-of-hepatic-impairment-and-normal-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-two-formulations-of-pramipexole-tablets-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-two-high-dose-formulations-of-bi-1015550-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-two-low-dose-formulations-of-bi-1015550-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-various-oral-formulations-of-prazosin-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-zongertinib-on-dabigatran-rosuvastatin-metformin-and-furosemide-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-evaluation-of-zongertinib-on-plasma-concentrations-of-three-co-administered-drugs-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-guided-dosing-of-emicizumab-in-patients-with-congenital-hemophilia-a-a-non-inferiority-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-amlitelimab-on-cytochrome-p450-substrates-in-patients-with-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-doxepin-and-epinephrine-in-anaphylaxis-using-anapen-r-device-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-itraconazole-and-azd5004-and-azd5004-with-ethinyl-estradiol-and-levonorgestrel-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-itraconazole-quinidine-and-rifampicin-on-single-dose-zed1227-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-ketamine-cannabidiol-and-cobicistat-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-naronapride-with-food-itraconazole-and-rifampicin-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-oral-ticagrelor-and-rosuvastatin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-rivaroxaban-and-sotorasib-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-interaction-study-of-vicadrostat-and-empagliflozin-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-pharmacodynamic-and-tolerability-assessment-of-an-investigational-nicotine-therapy-in-healthy-adult-smokers-with-nicotine-dependence2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-profiling-of-norucholic-acid-in-patients-with-primary-sclerosing-cholangitis-a-clinical-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-safety-and-efficacy-evaluation-of-astx727-and-venetoclax-in-adult-patients-with-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-safety-and-immunogenicity-comparison-of-bmab1700-versus-nivolumab-as-adjuvant-monotherapy-in-stage-iib-c-iv-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-safety-and-tolerability-evaluation-of-itf2357-in-chronic-hepatic-impairment-and-normal-hepatic-function-participants2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-safety-pharmacodynamic-and-immunogenicity-assessment-of-lt-01-vs-eu-approved-omalizumab-in-allergic-asthma-rhinosinusitis-and-urticaria2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-similarity-study-of-avt32-drl-pb-and-pembrolizumab-in-patients-with-fully-resected-stage-iib-c-iii-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-14c-dlx313-minzasolmin-in-healthy-male-subjects-with-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-alverine-citrate-simeticone-60-mg-300-mg-soft-capsules-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-balinatunfib-tablet-formulations-and-food-effect-in-healthy-adults-with-immune-system-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bay3283142-with-atazanavir-in-chronic-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1015550-in-healthy-volunteers-evaluation-of-food-effect-on-drug-absorption2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1291583-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1569912-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1810631-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1810631-in-healthy-male-volunteers-evaluation-of-food-effect-on-drug-absorption2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-1839100-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-bi-764198-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-budesonide-glycopyrronium-and-formoterol-fumarate-with-hydrofluoroolefin-vs-hydrofluoroalkane-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-caffeine-warfarin-omeprazole-metoprolol-and-midazolam-in-healthy-subjects-and-patients-with-compensated-and-decompensated-liver-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-cefazolin-and-human-plasma-proteins-in-adult-cardiac-surgery-patients-with-heart-disease-and-hypoalbuminemia2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-combined-oral-contraceptive-alone-and-with-gsk3036656-in-non-childbearing-potential-females-with-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-ctb-avp-in-complicated-urinary-tract-infection-including-pyelonephritis-in-healthy-adults-under-fed-and-fasted-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-empagliflozin-in-healthy-volunteers-comparison-of-whole-tablet-versus-dissolved-formulation-with-food2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-first-line-antiretroviral-agents-in-healthy-lactating-women2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-gastro-resistant-pitolisant-hydrochloride-in-narcolepsy-with-cataplexy-bioequivalence-drug-interaction-and-food-effect-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-mk-3475a-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-nitrous-oxide-and-oxygen-on-blood-concentrations-and-driving-ability-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-ntrx-07-in-fed-and-fasted-healthy-volunteers-for-neuroinflammation-related-diseases-including-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-pf-07817883-in-healthy-adults-following-oral-administration-with-varying-formulations-for-covid-19-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-remibrutinib-in-cerebrospinal-fluid-of-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-ro7268489-in-healthy-participants-evaluation-of-absorption-and-metabolism-pre-and-post-meal-administration2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-ro7269162-capsules-and-food-effect-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-sar441566-in-healthy-male-adults-assessment-of-absorption-metabolism-and-excretion-following-oral-administration2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-single-dose-mk-1403-in-patients-with-atherosclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-sisunatovir-formulations-in-relation-to-food-intake-in-healthy-adults-with-focus-on-rsv-respiratory-syncytial-virus2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-the-use-of-nefopam-30-mg-tablet-in-patients-suffering-from-acute-pain-in-rheumatology-nefopain-kinetics2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-tucatinib-and-osimertinib-in-patients-with-breast-cancer-glioblastoma-and-non-small-cell-lung-carcinoma-with-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-two-formulations-of-bi-690517-and-the-impact-of-probenecid-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-vepdegestrant-in-er-her2-breast-cancer-comparison-of-oral-tablet-and-intravenous-infusion-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-vepdegestrant-tablet-formulations-in-healthy-adult-subjects-with-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetic-study-of-vicadrostat-and-empagliflozin-formulations-in-healthy-volunteers-impact-of-food-on-drug-absorption2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetically-adapted-bevacizumab-based-chemotherapy-in-first-line-treatment-of-unresectable-metastatic-colorectal-cancer-a-phase-3-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-acid-suppression-and-food-effect-of-linaprazan-glurate-in-healthy-volunteers-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-bioavailability-of-medroxyprogesterone-acetate-via-upper-arm-injection-compared-to-anterior-thigh-and-abdomen-for-long-term-female-contraception2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-bone-tissue-penetrability-of-clindamycin-and-cefalexin-in-patients-undergoing-extremity-amputation-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-ecg-effects-of-linaprazan-glurate-in-erosive-gastroesophageal-reflux-disease-a-phase-i-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-food-effect-on-tw102-in-healthy-volunteers-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-pharmacodynamics-of-68ga-ga-r54-a-cxcr4-targeted-radiopharmaceutical-in-patients-with-advanced-cxcr4-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-pharmacodynamics-of-azd4604-via-turbuhaler-r-in-adults-with-mild-asthma-a-phase-ib-multicentre-randomised-single-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-pharmacodynamics-of-intravenous-versus-enteral-amiodarone-hydrochloride-in-critically-ill-patients-with-new-onset-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-pharmacodynamics-of-reduced-dose-rivaroxaban-in-chronic-hemodialysis-patients-without-oral-anticoagulation-indication2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-assessment-of-ant3310-with-meropenem-in-adults-with-renal-impairment-a-phase-1-open-label-single-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-assessment-of-buloxibutid-c21-oral-formulations-in-idiopathic-pulmonary-fibrosis-a-randomized-open-label-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-comparison-of-single-subcutaneous-dose-of-pbp1502-eu-adalimumab-and-us-adalimumab-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-bimekizumab-in-pediatric-patients-with-active-juvenile-idiopathic-arthritis-subtypes2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-bimekizumab-in-pubertal-patients-with-moderate-to-severe-hidradenitis-suppurativa-a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-cefiderocol-in-hospitalized-neonates-with-suspected-or-confirmed-aerobic-gram-negative-bacterial-infections2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-givinostat-in-pediatric-duchenne-muscular-dystrophy-a-phase-2-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-gs-5245-in-subjects-with-renal-impairment-and-normal-renal-function-a-phase-1-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-jnj-63733657-via-subcutaneous-and-intravenous-infusion-in-healthy-adults-with-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-letrozole-lebe-in-healthy-post-menopausal-women-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-risdiplam-in-infants-with-spinal-muscular-atrophy-a-phase-ii-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-rupatadine-and-metabolites-in-renal-impairment-and-normal-renal-function-in-allergic-rhinitis-and-urticaria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-evaluation-of-tralokinumab-in-pediatric-patients-with-moderate-to-severe-atopic-dermatitis-a-randomized-assessor-blinded-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-of-oral-ro7795081-in-healthy-male-volunteers-for-weight-management-and-glucose-regulation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-of-rupatadine-in-hepatic-impairment-a-comparative-study-with-matched-controls-in-urticaria-and-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-and-safety-of-subcutaneous-human-normal-immunoglobulin-20-vs-intravenous-human-normal-immunoglobulin-10-in-adults-with-cidp2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-efficacy-and-safety-of-hydroxycarbamide-dispersible-tablets-in-pediatric-sickle-cell-disease-a-single-group-non-randomized-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-immunogenicity-and-safety-comparison-of-pb016-and-us-licensed-vedolizumab-in-healthy-volunteers-after-subcutaneous-administration2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-14c-pf-07054894-in-patients-with-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-albendazole-in-plasma-intra-cystic-fluid-and-cystic-tissue-in-human-cystic-and-alveolar-echinococcosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-ale-f02-in-patients-with-advanced-liver-fibrosis-and-mild-cirrhosis-a-double-blind-placebo-controlled-randomized-phase-1b-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-ambroxol-in-early-parkinson-s-disease-patients-a-clinical-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-anti-infective-agents-in-healthy-individuals-and-critically-ill-patients-with-severe-burns-in-intensive-care-settings2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-anti-lymphocyte-serum-in-the-prevention-of-gvhd-in-children-and-adults-receiving-allogeneic-hematopoietic-stem-cell-transplantation-phasal-ga-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-antibiotics-in-bile-fluid-of-patients-with-cholangitis-undergoing-external-biliary-drainage2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-antiretroviral-agents-in-hiv-infected-pregnant-women-abacavir-sulfate-etravirine-emtricitabine-and-drug-combination-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-azd6793-alone-and-with-itraconazole-in-healthy-adults-a-phase-i-study-on-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-aztreonam-avibactam-in-critically-ill-patients-with-sepsis-receiving-extracorporeal-membrane-oxygenation-support-a-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-bay2927088-in-healthy-male-subjects-with-advanced-non-small-cell-lung-cancer-harboring-egfr-and-or-her2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-bi-456906-in-subjects-with-varying-degrees-of-renal-impairment-and-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-cefiderocol-in-plasma-and-intraperitoneal-fluid-of-patients-undergoing-peritoneal-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-cefuroxime-vancomycin-gentamicin-ampicillin-linezolid-piperacillin-tazobactam-and-cefazolin-in-csf-of-pediatric-patients-with-external-ventricular-drain2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-clindamycin-phosphate-in-maternal-plasma-and-amniotic-fluid-during-obstetric-or-fetal-surgery-a-population-pharmacokinetic-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-continuous-fentanyl-citrate-infusion-in-neonates-with-hypoxic-ischemic-encephalopathy-undergoing-therapeutic-hypothermia2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-enpatoran-in-healthy-volunteers-and-patients-with-renal-impairment-implications-for-autoimmune-diseases-including-sle-cle-dm-and-pm2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-extended-infusion-fosfomycin-in-healthy-volunteers-and-critically-ill-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-fluconazole-in-pediatric-and-adolescent-patients-with-invasive-fungal-infections-oral-and-intravenous-administration2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-ganfeborole-combined-with-an-oral-contraceptive-in-non-childbearing-female-participants-with-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-imu-838-alone-and-with-gemfibrozil-or-rifampicin-in-healthy-subjects-a-phase-1-study-on-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-inhaled-levosimendan-in-patients-with-heart-failure-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-insulin-nnc0471-0119-administered-via-insulin-pump-in-patients-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-insulin-nnc0471-0119-in-type-1-diabetes-patients-administered-via-insulin-pump2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-intranasal-mupirocin-in-healthy-volunteers-a-single-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-intraperitoneal-cefepime-administration-in-apd-patients-with-ckd-stage-5-without-peritonitis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-mavodelpar-in-subjects-with-varying-degrees-of-hepatic-impairment-a-phase-1-open-label-single-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-methotrexate-and-novobiocin-combination-in-patients-with-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-methylphenidate-hydrochloride-in-adults-with-adhd-comparative-analysis-in-obese-and-non-obese-patients2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-nanatinostat-in-patients-with-advanced-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-nnc0519-0130-in-patients-with-type-2-diabetes-mellitus-and-varying-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-norucholic-acid-in-patients-with-nonalcoholic-fatty-liver-disease-and-primary-sclerosing-cholangitis-with-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-petrelintide-in-participants-with-impaired-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-petrelintide-in-patients-with-renal-impairment-for-weight-management2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-pf-07220060-in-healthy-adults-implications-for-metastatic-advanced-breast-cancer-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-pf-07976016-in-healthy-adults-a-study-on-obesity-and-overweight-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-piperacillin-tazobactam-and-levofloxacin-in-copd-and-cystic-fibrosis-epithelial-lining-fluid-microdialysis-and-tissue-biopsy-comparison2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-piperacillin-tazobactam-cefazolin-ampicillin-sodium-and-clindamycin-in-twin-pregnancies-a-comparative-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-polymyxin-e1-following-single-inhaled-and-intravenous-colistimethate-sodium-in-healthy-adults-and-patients-with-non-cystic-fibrosis-bronchiectasis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-quabodepistat-in-adults-with-impaired-hepatic-function-compared-to-normal-hepatic-function-in-patients-with-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-radioactively-labeled-bay-3283142-in-healthy-male-subjects-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-radium-223-dichloride-in-patients-with-prostate-cancer-undergoing-radium-223-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-ritlecitinib-in-healthy-adults-impact-of-fasting-and-fed-states-on-drug-absorption-in-ulcerative-colitis-crohn-s-disease-alopecia-areata-rheumatoid-arthritis-and-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-sertraline-in-female-anorexia-nervosa-patients-and-healthy-volunteers-following-oral-administration-an-exploratory-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-single-dose-antibiotics-in-plasma-and-soft-tissues-of-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-single-dose-nnc0537-1482-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-normal-or-impaired-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-vimseltinib-in-patients-with-tenosynovial-giant-cell-tumor-or-malignant-solid-tumors-and-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-of-zilucoplan-administered-via-two-routes-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-and-safety-evaluation-of-bempedoic-acid-in-pediatric-patients-with-heterozygous-familial-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-and-safety-evaluation-of-efgartigimod-alfa-in-pediatric-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-and-safety-evaluation-of-inebilizumab-in-pediatric-neuromyelitis-optica-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-and-safety-of-inhaled-and-intravenous-d-l-lysine-acetylsalicylate-glycine-in-healthy-adults-a-phase-i-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-safety-and-efficacy-of-gefurulimab-in-pediatric-patients-with-acetylcholine-receptor-antibody-positive-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-an-acetonic-milk-thistle-extract-standardized-to-silymarin-in-subjects-with-metabolic-dysfunction-associated-steatotic-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-naronapride-in-idiopathic-or-diabetic-gastroparesis-a-phase-1-randomized-single-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-repeatability-and-diagnostic-accuracy-of-68ga-ga-fapi-46-pet-ct-in-pancreatic-and-bile-duct-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-efficacy-of-bimekizumab-in-adolescents-with-moderate-to-severe-plaque-psoriasis-a-multicenter-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-efficacy-of-eliglustat-with-or-without-imiglucerase-in-pediatric-gaucher-disease-types-1-and-3-a-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-efficacy-of-macitentan-versus-standard-care-in-pediatric-pulmonary-arterial-hypertension-a-multicenter-open-label-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-efficacy-of-nemolizumab-with-topical-corticosteroids-in-pediatric-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-immunogenicity-comparison-of-mb04-eu-sourced-etanercept-and-us-licensed-etanercept-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-pharmacodynamics-of-atx-304-na-salt-in-obesity-with-prediabetes-or-type-2-diabetes-mellitus-a-phase-1b-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-pharmacodynamics-of-elinzanetant-in-vasomotor-symptoms-associated-with-sex-hormone-dependent-disorders-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-comparison-of-two-subcutaneous-dapiglutide-concentrations-in-weight-management2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-azd4144-in-severe-renal-impairment-end-stage-kidney-disease-and-healthy-subjects-a-single-dose-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-azd5462-in-patients-with-renal-impairment-a-clinical-investigation2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-filgotinib-in-pediatric-patients-with-juvenile-idiopathic-arthritis-a-multicenter-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-intramuscular-bedaquiline-long-acting-injection-in-healthy-subjects-with-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-iptacopan-hydrochloride-in-pediatric-patients-with-paroxysmal-nocturnal-hemoglobinuria-a-phase-3-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-nnc0487-0111-in-obesity-and-type-2-diabetes-patients-with-varying-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-obefazimod-in-patients-with-mild-and-moderate-hepatic-impairment-a-phase-i-study-in-ulcerative-colitis-and-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-secukinumab-in-patients-with-polymyalgia-rheumatica-or-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-safety-and-tolerability-of-upadacitinib-in-pediatric-patients-with-polyarticular-course-juvenile-idiopathic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-study-comparing-gme751-and-us-eu-approved-pembrolizumab-in-stage-ii-and-iii-melanoma-patients-requiring-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacokinetics-tolerability-and-safety-of-danegaptide-in-healthy-subjects-and-diabetic-retinopathy-patients-a-phase-1-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacological-imaging-in-depression-a-single-blind-randomized-placebo-controlled-cross-over-study2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacological-therapeutic-follow-up-in-drepanocytosis-patients-treated-with-hydroxycarbamide-a-comparative-study-of-methodologies2026-10-07 https://dev.clinicalresearch.eu/trial/pharmacometric-modeling-of-nebulized-fentanyl-administration-a-pilot-study-comparing-facial-and-intranasal-aerosol-delivery-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-basket-trial-of-pet-imaging-with-vartumabs-f8scfv-and-c9scfv-in-patients-with-multiple-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-evaluation-of-cannabidiol-in-patients-with-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-ia-study-of-bi-907828-brigimadlin-and-radiation-therapy-in-patients-with-glioblastoma-to-assess-tumor-uptake-and-maximum-tolerated-dose2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-lead-in-trial-of-pitavastatin-in-patients-with-primary-and-recurrent-glioblastoma-multiforme2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-pilot-study-on-prognostic-and-theranostic-potential-of-68ga-ga-pentixafor-pet-ct-in-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-spect-ct-imaging-of-fpi-2505-in-patients-with-solid-tumors-a-molecular-imaging-basket-trial-in-lung-colorectal-breast-pancreatic-and-gastric-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-0-study-on-biodistribution-and-pet-imaging-kinetics-of-64cu-cu-psma-r2-in-patients-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-evaluation-of-iam1363-in-patients-with-relapsed-refractory-her2-altered-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-evaluation-of-rp-6306-monotherapy-and-in-combination-with-rp-3500-or-debio-0123-in-advanced-solid-tumors-with-specific-genetic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-multicenter-open-label-study-of-rmc-6291-in-advanced-krasg12c-mutant-solid-tumors-nsclc-crc-and-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-multicohort-study-of-alta2618-in-patients-with-advanced-solid-tumors-harboring-akt1-e17k-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-multiple-ascending-dose-study-of-df6215-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-open-label-study-of-rndo-564-in-patients-with-relapsed-refractory-locally-advanced-or-metastatic-urothelial-carcinoma-and-nectin-4-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-1b-study-of-bms-986463-in-patients-with-advanced-malignant-tumors-including-high-grade-serous-ovarian-carcinoma-uterine-serous-carcinoma-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-3-open-label-dose-escalation-and-randomized-controlled-study-of-atsn-201-gene-therapy-in-patients-with-rs1-associated-x-linked-retinoschisis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-adaptive-open-label-multicenter-trial-of-cctx-001-cyclophosphamide-monohydrate-and-fludarabine-phosphate-in-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-clinical-evaluation-of-parg-inhibitor-etx-19477-in-patients-with-advanced-solid-malignancies-following-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-dose-escalation-study-of-clofarabine-in-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-alx148-and-azacitidine-in-untreated-higher-risk-myelodysplastic-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-amcenestrant-monotherapy-and-combination-therapy-in-postmenopausal-women-with-estrogen-receptor-positive-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-amivantamab-and-capmatinib-in-unresectable-metastatic-non-small-cell-lung-cancer-with-met-exon-14-skipping-mutation-and-met-amplification2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-avutometinib-and-sotorasib-in-kras-g12c-mutant-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-azenosertib-and-niraparib-in-platinum-resistant-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-bleximenib-in-patients-with-acute-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-bms-986253-with-nivolumab-or-nivolumab-plus-ipilimumab-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-bms-986340-monotherapy-and-combination-with-nivolumab-or-docetaxel-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-cobolimab-and-dostarlimab-in-pediatric-and-young-adult-patients-with-newly-diagnosed-and-relapsed-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-ctps1-inhibitor-stp938-in-adults-with-relapsed-refractory-b-cell-and-t-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-davutamig-regn5093-in-met-altered-advanced-non-small-cell-lung-cancer-patients-safety-tolerability-and-preliminary-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-detalimogene-voraplasmid-in-bcg-unresponsive-and-high-risk-non-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-egl-001-monotherapy-and-combination-with-anti-pd-l-1-in-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-epi-7386-and-enzalutamide-combination-versus-enzalutamide-monotherapy-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-etentamig-and-iberdomide-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-gen3014-and-daratumumab-in-relapsed-or-refractory-multiple-myeloma-and-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-genetically-modified-autologous-t-cells-expressing-tcr-targeting-cancer-germline-antigen-with-nivolumab-in-recurrent-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-isatuximab-and-pegenzileukin-in-relapsed-refractory-multiple-myeloma-post-anti-cd38-and-anti-bcma-exposure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-isatuximab-belantamab-mafodotin-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-linvoseltamab-in-relapsed-refractory-multiple-myeloma-safety-tolerability-and-efficacy-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-liposomal-annamycin-and-cytarabine-in-acute-myeloid-leukemia-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-nvl-655-a-selective-alk-inhibitor-in-advanced-alk-positive-nsclc-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-oncobax-ak-with-pd-l1-inhibitors-in-metastatic-nsclc-and-rcc-with-akkermansia-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-pirtobrutinib-monotherapy-and-combination-therapy-in-previously-treated-cll-sll-and-b-cell-nhl-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-relatlimab-and-nivolumab-in-pediatric-and-young-adult-patients-with-recurrent-or-refractory-classical-hodgkin-and-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-relatlimab-with-nivolumab-and-bms-986205-or-ipilimumab-in-advanced-malignant-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-selpercatinib-in-pediatric-patients-with-advanced-ret-altered-solid-or-primary-cns-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-star0602-for-t-cell-activation-in-patients-with-unresectable-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-synthetic-cannabinoid-art27-13-for-cancer-anorexia-and-weight-loss-in-oncology-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-tulmimetostat-cpi-0209-monotherapy-and-combination-with-enzalutamide-in-advanced-solid-tumors-and-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-v940-and-pembrolizumab-with-or-without-enfortumab-vedotin-in-muscle-invasive-urothelial-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-valproic-acid-and-capecitabine-with-short-course-radiotherapy-as-neoadjuvant-therapy-in-low-moderate-risk-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-vusolimogene-oderparepvec-monotherapy-and-combined-with-nivolumab-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-zidesamtinib-nvl-520-in-advanced-ros1-positive-nsclc-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-evaluation-of-zilovertamab-vedotin-in-pd-1-l1-refractory-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-first-in-human-study-of-diag723-a-bispecific-alk-1-bmprii-agonist-antibody-safety-and-tolerability-in-adults-with-hereditary-hemorrhagic-telangiectasia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-dose-escalation-study-of-acalabrutinib-in-chronic-lymphocytic-leukemia-richter-s-syndrome-and-prolymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-dose-escalation-study-of-idp-121-in-relapsed-refractory-hematologic-malignancies-multiple-myeloma-b-cell-lymphoma-and-cll2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-randomized-study-of-belzutifan-and-palbociclib-versus-belzutifan-monotherapy-in-advanced-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-study-evaluating-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-ona-255-in-advanced-cancer-hr-her2-breast-cancer-and-metastatic-gastric-gastroesophageal-junc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-study-of-pivekimab-sunirine-monotherapy-in-cd123-positive-acute-myeloid-leukemia-and-other-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-study-of-subcutaneous-kk8123-in-adult-patients-with-x-linked-hypophosphatemia-safety-tolerability-and-pharmacokinetics-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-study-of-tyra-300-in-advanced-urothelial-carcinoma-and-solid-tumors-with-fgfr3-gene-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-open-label-study-on-safety-and-efficacy-of-sgt-003-gene-therapy-in-ambulant-males-with-duchenne-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-randomized-study-on-safety-and-immunogenicity-of-cd40-rbdv-bivalent-covid-19-vaccine-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-evaluating-safety-and-antitumor-activity-of-adce-d01-in-metastatic-unresectable-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-evaluating-safety-and-efficacy-of-avb-101-via-bilateral-intrathalamic-infusion-in-frontotemporal-dementia-with-progranulin-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-belumosudil-mesilate-in-pediatric-patients-with-moderate-to-severe-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-jk06-a-5t4-antibody-drug-conjugate-in-patients-with-unresectable-locally-advanced-or-metastatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-jk08-pembrolizumab-and-lenvatinib-in-unresectable-locally-advanced-or-metastatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-kyv-101-anti-cd19-car-t-cell-therapy-in-refractory-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-ose-279-and-ose2101-in-advanced-solid-tumors-lymphomas-and-hla-a2-positive-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-of-venetoclax-daratumumab-dexamethasone-and-bortezomib-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-study-on-safety-and-efficacy-of-intravenous-gnt0006-in-fkrp-related-limb-girdle-muscular-dystrophy-lgmdr9-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-trial-evaluating-sot102-monotherapy-and-combination-therapy-in-advanced-gastric-and-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-multicenter-two-arms-open-label-dose-escalation-study-of-idp-121-in-combination-with-chemotherapy-in-patients-with-relapsed-small-cell-lung-cancer-sclc-mycrocytic2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-and-randomized-study-of-sln124-in-patients-with-polycythemia-vera2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-dose-escalation-study-of-epcoritamab-in-relapsed-progressive-or-refractory-b-cell-lymphoma-with-anakinra-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-dose-escalation-study-of-tak-280-in-patients-with-unresectable-locally-advanced-or-metastatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-multicenter-study-of-ds-3939a-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-multicenter-study-of-incb000928-monotherapy-or-combined-with-ruxolitinib-in-anemia-associated-with-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-bay-2599023-peboctocogene-camaparvovec-in-adults-with-severe-hemophilia-a2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-ctl-002-and-nivolumab-in-advanced-relapsed-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-hst-1011-monotherapy-and-hst-1011-with-cemiplimab-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-prs-344-s095012-and-obinutuzumab-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-pumitamig-alone-or-with-ipilimumab-or-cabozantinib-in-advanced-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-repotrectinib-in-pediatric-and-young-adult-patients-with-advanced-or-metastatic-solid-tumors-with-alk-ros1-or-ntrk1-3-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-of-teclistamab-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-open-label-study-on-safety-and-efficacy-of-spectracure-p18-system-and-verteporfin-in-primary-localized-prostate-cancer-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-randomized-placebo-controlled-study-of-nivolumab-relatlimab-and-bevacizumab-in-treatment-naive-advanced-metastatic-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-investigating-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-activity-of-various-combinations-of-bgb-a425-and-lbl-007-with-tislelizumab-in-patients-with-advanced-solid-2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-aavanc80-hotof-gene-therapy-for-biallelic-otoferlin-gene-mutation-induced-sensorineural-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-avzo-021-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-blu-451-in-advanced-cancers-with-egfr-exon20-insertion-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-bms-986288-monotherapy-and-combination-with-nivolumab-in-advanced-solid-tumors-including-efficacy-comparison-with-regorafenib-in-mss-crc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-bms-986466-with-adagrasib-cetuximab-in-kras-g12c-mutant-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-chm-029-monotherapy-and-combination-therapy-with-standard-aml-regimens-in-relapsed-refractory-or-newly-diagnosed-aml-with-npm1-kmt2a-nup98-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-dcc-3084-monotherapy-and-combination-therapy-in-advanced-mapk-pathway-driven-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-dcc-3116-and-ripretinib-combination-in-advanced-gastrointestinal-stromal-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-df6002-monotherapy-and-df6002-with-nivolumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-elraglusib-9-ing-41-as-monotherapy-and-in-combination-with-chemotherapy-in-refractory-hematologic-malignancies-or-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-eo2463-as-monotherapy-and-in-combination-with-lenalidomide-and-rituximab-in-indolent-non-hodgkin-s-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-eo4010-with-nivolumab-and-or-bevacizumab-in-previously-treated-metastatic-colorectal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-gilteritinib-with-chemotherapy-in-pediatric-and-young-adult-flt3-itd-positive-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-gsk4418959-alone-or-with-dostarlimab-in-dmmr-msi-h-colorectal-and-endometrial-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-gsk5926371-in-adults-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-hesc-derived-retinal-pigment-epithelium-istem-01-implantation-in-monogenic-retinitis-pigmentosa-with-mycophenolate-mofetil2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-inhaled-kb707-and-docetaxel-in-patients-with-advanced-solid-tumor-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-intravenous-aavrh10-vector-expressing-galc-in-infantile-krabbe-disease-post-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-intravenous-mdx2003-in-relapsed-refractory-b-cell-malignancies-safety-tolerability-and-preliminary-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-intravesical-mk-3120-in-bcg-naive-or-bcg-exposed-high-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-lb-208-in-adults-with-relapsed-or-refractory-acute-myeloid-leukemia-and-high-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-linvoseltamab-anti-bcma-x-anti-cd3-bispecific-antibody-in-previously-untreated-patients-with-symptomatic-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-lumc-bob1-b7-tcr-1-in-hla-b-07-02-positive-patients-with-relapsed-or-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-menin-mll-inhibitor-ziftomenib-ko-539-in-relapsed-refractory-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-nivolumab-and-ipilimumab-with-gemcitabine-and-nab-paclitaxel-in-borderline-resectable-locally-advanced-or-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-olaptesed-pegol-with-radiation-and-bevacizumab-or-pembrolizumab-in-unmethylated-mgmt-promoter-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-oral-tri-611-in-patients-with-advanced-alk-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-pelareorep-and-atezolizumab-in-combination-with-standard-chemotherapy-in-advanced-or-metastatic-gastrointestinal-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-quizartinib-in-combination-with-chemotherapy-in-pediatric-and-young-adult-patients-with-flt3-itd-mutated-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-repotrectinib-in-advanced-solid-tumors-with-alk-ros1-or-ntrk1-3-rearrangements2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-rmc-6291-with-ivonescimab-drug-combination-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-rnaivt9315-and-rnacs24757-in-adults-with-pizz-alpha-1-antitrypsin-deficiency-related-lung-or-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-sar445877-and-cetuximab-in-adults-with-advanced-solid-tumors-safety-pharmacokinetics-and-anti-tumor-activity-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-sndx-5613-in-relapsed-refractory-acute-leukemias-with-mll-kmt2a-rearrangement-or-npm1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-star0602-in-patients-with-antigen-rich-unresectable-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-subretinal-aavb-081-administration-in-usher-syndrome-type-1b-retinitis-pigmentosa-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-tcr-modified-t-cell-therapy-targeting-hla-restricted-kras-in-metastatic-or-locally-advanced-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-ter-2013-imlunestrant-and-fulvestrant-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-of-tg01-qs-21-vaccine-in-kras-nras-mutant-high-risk-smoldering-or-active-multiple-myeloma-with-measurable-disease-post-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-ibrutinib-for-dose-finding-safety-and-efficacy-in-pediatric-chronic-graft-versus-host-disease-cgvhd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-efficacy-of-artegene-gene-therapy-in-severe-combined-immunodeficiency-due-to-dclre1c-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-efficacy-of-belantamab-mafodotin-with-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-patients-ineligible-for-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-efficacy-of-belantamab-mafodotin-with-pomalidomide-dexamethasone-daratumumab-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-efficacy-of-zilovertamab-vedotin-in-pediatric-and-young-adult-patients-with-hematologic-malignancies-or-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-feasibility-of-intraoperative-photodynamic-therapy-with-aminolevulinic-acid-hydrochloride-in-grade-iv-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-and-pharmacokinetics-of-rilzabrutinib-in-relapsed-immune-thrombocytopenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-pharmacokinetics-and-efficacy-of-cyc140-monohydrochloride-monohydrate-in-advanced-solid-tumors-and-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-tolerability-pharmacokinetics-and-efficacy-of-hmb-001-in-glanzmann-thrombasthenia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-safety-tolerability-pharmacokinetics-and-efficacy-of-vosilasarm-ep0062-in-relapsed-ar-her2-er-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2-study-on-the-safety-and-efficacy-of-methoxsalen-in-treating-steroid-refractory-immune-related-adverse-events-post-immune-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-double-blind-placebo-controlled-study-of-atx-01-in-adults-with-myotonic-dystrophy-type-1-dm12026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-evaluation-of-intraperitoneal-a-emitting-radionuclide-therapy-in-peritoneal-carcinomatosis-from-colorectal-carcinoma-post-hyperthermic-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-evaluation-of-spk002-safety-pharmacokinetics-and-neutralizing-activity-for-covid-19-prophylaxis-in-healthy-and-immunocompromised-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-monocentric-open-label-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-sqy51-in-paediatric-and-adult-patients-with-a-genetically-confirmed-diagnosis-of-duchenne-muscul2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-multicenter-study-on-safety-tolerability-and-efficacy-of-pbp1510-and-gemcitabine-in-advanced-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-dose-escalation-study-of-gen3017-in-relapsed-refractory-cd30-hodgkin-and-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-multicenter-study-on-safety-tolerability-pharmacokinetics-and-antitumor-activity-of-wef-001-in-advanced-kras-mutant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-study-of-bms-986507-in-combination-with-pembrolizumab-and-osimertinib-mesylate-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-study-of-bms-986517-monotherapy-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-study-of-emavusertib-ca-4948-monotherapy-in-relapsed-refractory-acute-myelogenous-leukemia-and-high-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-study-of-mp0533-in-relapsed-refractory-acute-myeloid-leukemia-and-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-open-label-trial-of-lava-1207-interleukin-2-and-pembrolizumab-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-safety-study-of-bms-986528-and-tocilizumab-in-adults-with-refractory-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-a49-a52-and-litenimod-sodium-in-patients-with-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-bi-1206-and-pembrolizumab-in-advanced-solid-tumors-post-anti-pd-1-pd-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-bi-1206-with-rituximab-acalabrutinib-in-relapsed-refractory-indolent-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-bi-1808-pembrolizumab-and-paclitaxel-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-bi-1910-and-pembrolizumab-in-advanced-solid-tumors-safety-tolerability-and-dose-determination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-otp-01-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-pf-07104091-monohydrate-alone-and-with-fulvestrant-letrozole-and-palbociclib-in-advanced-breast-ovarian-and-lung-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-regn10597-alone-or-combined-with-cemiplimab-in-adults-with-advanced-solid-tumors-including-melanoma-and-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-2a-study-of-relatlimab-and-nivolumab-in-advanced-solid-tumors-safety-tolerability-and-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-3-study-on-pharmacokinetics-efficacy-and-safety-of-subcutaneous-ct-p44-vs-daratumumab-with-lenalidomide-and-dexamethasone-in-refractory-relapsed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-clinical-evaluation-of-imc-p115c-in-patients-with-advanced-prame-positive-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-clinical-evaluation-of-jnj-89402638-in-patients-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-clinical-evaluation-of-pyx-201-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-determining-study-of-exs73565-in-patients-with-relapsed-or-refractory-b-cell-malignancies-including-cll-mcl-dlbcl-fl-and-mzl2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-and-cohort-expansion-study-of-anti-pd-1-monoclonal-antibody-tsr-042-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-and-expansion-study-of-intravenous-arog4-01-in-patients-with-advanced-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-assessing-safety-tolerability-and-pharmacokinetics-of-pf-08103402-in-healthy-adults-and-adults-with-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-cc-92328-in-patients-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-cc-96191-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-intravenous-ck-301-in-patients-with-advanced-unresectable-or-metastatic-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-ioa-289-with-gemcitabine-and-nab-paclitaxel-in-patients-with-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-jnj-75348780-bispecific-antibody-targeting-cd3-and-cd22-in-relapsed-refractory-b-cell-nhl-and-cll2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-jnj-88998377-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-jnj-90189892-in-relapsed-refractory-acute-myeloid-leukemia-and-higher-risk-myelodysplastic-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-omtx705-an-anti-fibroblast-activation-protein-antibody-drug-conjugate-alone-and-with-anti-pd-1-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-sgr-2921-monotherapy-in-relapsed-refractory-acute-myeloid-leukemia-and-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-siltuximab-with-idarubicin-and-cytarabine-in-adult-patients-with-poor-prognosis-acute-myeloblastic-leukemia-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-escalation-study-of-ugn-301-in-patients-with-recurrent-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-dose-finding-study-of-cetuximab-irdye800cw-and-5-ala-in-fluorescent-guided-surgery-for-high-grade-glioma-margin-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-double-blind-placebo-controlled-study-of-cmp-cps-001-in-urea-cycle-disorders-with-abnormal-heterozygous-ornithine-transcarbamylase-genotype2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-14c-pf-07104091-metabolism-in-hr-positive-her2-negative-breast-cancer-nsclc-ovarian-cancer-and-tnbc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-14c-subasumstat-pharmacokinetics-metabolism-and-mass-balance-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-18f-aci-19626-as-a-pet-radioligand-for-imaging-tdp-43-inclusions-in-alzheimer-s-als-ftd-and-late-patients-compared-to-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ab521-monotherapy-and-combination-therapies-in-patients-with-clear-cell-renal-cell-carcinoma-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ag-120-in-patients-with-idh1-mutated-advanced-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ag-120-or-ag-221-with-standard-chemotherapy-in-newly-diagnosed-idh1-idh2-mutant-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-allo-revcar01-t-cd123-in-cd123-positive-hematologic-malignancies-including-acute-myeloid-leukemia-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-aln-f1202-safety-and-tolerability-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-amg-509-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-atv-1601-in-patients-with-advanced-solid-tumors-and-breast-cancer-harboring-akt1-e17k-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-aurora-kinase-a-inhibitor-ly3295668-erbumine-monotherapy-and-combination-therapy-in-relapsed-refractory-neuroblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-azd9833-monotherapy-and-combination-therapy-in-estrogen-receptor-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bgb-b3227-monotherapy-and-combination-with-tislelizumab-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bl-b01d1-safety-tolerability-and-efficacy-in-metastatic-or-unresectable-non-small-cell-lung-cancer-and-other-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bms-986360-and-cc-90001-alone-and-combined-with-chemotherapy-or-nivolumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bms-986406-monotherapy-and-combination-therapy-in-patients-with-advanced-malignant-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bms-986416-with-and-without-nivolumab-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-bms-986453-in-patients-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-cd19-targeted-allogeneic-car-t-cells-in-severe-refractory-systemic-lupus-erythematosus-rheumatoid-arthritis-systemic-sclerosis-and-idiopathic-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-cd19-targeted-nex-t-car-t-cells-in-relapsing-and-progressive-multiple-sclerosis-and-myasthenia-gravis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-cd19-targeted-nex-t-car-t-cells-in-severe-refractory-systemic-lupus-erythematosus-systemic-sclerosis-and-idiopathic-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-erdafitinib-intravesical-delivery-system-tar-210-in-non-muscle-invasive-and-muscle-invasive-bladder-cancer-with-fgfr-mutations-fusions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-exl01-safety-and-target-engagement-in-steroid-induced-remission-maintenance-for-mild-to-moderate-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-flubhpve6e7-immunotherapy-in-hpv16-associated-oropharyngeal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-gb-0895-safety-and-tolerability-in-patients-with-mild-to-moderate-asthma-and-single-dose-in-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-gs-1811-and-anti-pd-1-monoclonal-antibody-in-advanced-solid-tumors-head-and-neck-nsclc-gastric-and-mss-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-gsk2857916-combined-with-standard-of-care-in-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-gsk5764227-in-patients-with-advanced-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-hmpl-306-in-advanced-hematological-malignancies-with-isocitrate-dehydrogenase-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-hmpl-306-in-patients-with-idh-mutant-locally-advanced-or-metastatic-solid-tumors-including-cholangiocarcinoma-chondrosarcoma-and-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ik-930-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-incb099280-and-adagrasib-in-adults-with-advanced-solid-tumors-harboring-krasg12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-intratumoral-jnj-87704916-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-investigational-agent-in-patients-with-infectious-staphylococcus-aureus-endocarditis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-70218902-a-t-cell-redirecting-agent-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-78278343-a-t-cell-redirecting-agent-targeting-klk2-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-79032421-targeting-mesothelin-in-patients-with-advanced-stage-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-87189401-and-jnj-78278343-in-patients-with-advanced-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-87562761-in-patients-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-87801493-with-cd3-t-cell-engagers-in-non-hodgkin-lymphoid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-87890387-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-88549968-a-t-cell-redirecting-antibody-in-patients-with-calr-mutated-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-89853413-in-relapsed-refractory-acute-myeloid-leukemia-and-higher-risk-myelodysplastic-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-jnj-89862175-an-ectonucleotide-pyrophosphatase-phosphodiesterase-family-member-3-antibody-drug-conjugate-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-karonudib-in-advanced-relapsed-refractory-hematological-malignancies-safety-tolerability-and-efficacy-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ly3410738-in-patients-with-advanced-solid-tumors-harboring-idh1-r132-idh2-r140-or-idh2-r172-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-mk-1084-in-patients-with-kras-mutant-advanced-solid-tumors-including-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ndi-219216-in-advanced-solid-tumors-with-without-microsatellite-instability-and-deficient-mismatch-repair2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ng-350a-and-pembrolizumab-in-patients-with-metastatic-or-advanced-epithelial-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-ng-641-and-nivolumab-in-patients-with-metastatic-or-advanced-epithelial-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-oral-ly3410738-in-patients-with-advanced-hematologic-malignancies-harboring-idh1-or-idh2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-oric-944-in-patients-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-pharmacokinetics-and-safety-of-semaglutide-subcutaneous-depot-in-body-weight-management2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-prt2527-monotherapy-and-combination-with-zanubrutinib-or-venetoclax-in-relapsed-refractory-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-prt3789-in-advanced-or-metastatic-solid-tumors-with-smarca4-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-prt7732-an-oral-smarca2-degrader-in-advanced-or-metastatic-solid-tumors-with-smarca4-mutation-including-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-pyx-106-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-radionuclide-therapy-radspherin-in-platinum-sensitive-recurrent-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-rp-1664-sulfate-in-advanced-solid-tumors-safety-pharmacokinetics-pharmacodynamics-and-preliminary-clinical-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-rp-6306-combined-with-folfiri-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-and-anti-tumor-efficacy-of-a-novel-agent-in-patients-with-advanced-solid-tumors-with-met-genetic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-and-tolerability-of-regn9533-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-feasibility-and-immunogenicity-of-allogeneic-cell-based-vaccine-vididencel-in-high-grade-serous-ovarian-cancer-post-primary-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-tolerability-and-immunogenicity-of-a-pdna-vaccine-candidate-for-covid-19-prophylaxis-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-tolerability-and-pharmacokinetics-of-177lu-evg321-in-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-tolerability-and-pharmacokinetics-of-t7-010-in-healthy-volunteers-for-autoimmune-disease-research2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ax-0810-in-cholestatic-liver-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-sar443122-bioavailability-and-food-effect-in-healthy-adults-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-sea-cd70-in-patients-with-myeloid-malignancies-and-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-sgn-alpv-in-patients-with-advanced-solid-tumors-including-gej-carcinoma-nsclc-gastric-cervical-ovarian-and-endometrial-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-sndx-5613-with-intensive-chemotherapy-in-acute-myeloid-leukemia-patients-with-kmt2a-mll-npm1-or-nup98-gene-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-tarlatamab-safety-tolerability-and-pharmacokinetics-in-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-tas0612-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-tern-701-safety-tolerability-pharmacokinetics-and-efficacy-in-chronic-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-topical-rls-1496-cream-in-adult-patients-with-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-unicar02-t-cd123-in-cd123-positive-hematologic-malignancies-including-acute-myeloid-leukemia-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-vis171-safety-tolerability-pharmacodynamics-pharmacokinetics-and-immunogenicity-in-autoimmune-conditions-alopecia-areata-systemic-lupus-erythematosus-and-immune-mediated-focal-se2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-wve-007-in-adults-with-overweight-and-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-evaluation-of-zw191-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-open-label-study-of-eras-0015-monotherapy-and-combination-therapy-assessing-safety-pk-pd-and-preliminary-efficacy-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-evaluating-safety-tolerability-and-pharmacokinetics-of-sar448272-in-healthy-adults-and-patients-with-immunological-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-ax-0811-a-novel-therapeutic-for-cholestatic-disease-evaluating-safety-pharmacokinetics-and-pharmacodynamics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-fb301-for-single-and-multiple-dosing-in-healthy-female-subjects-with-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-gub-ucn2-safety-tolerability-pk-pd-in-healthy-lean-obese-and-type-2-diabetes-participants2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-jnj-95566692-in-participants-with-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-pf-08046033-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-first-in-human-study-of-the-phenylalanine-binding-polymer-phelimin-in-healthy-volunteers-and-adults-with-classical-phenylketonuria2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-fixed-sequence-multiple-dose-study-of-fosmanogepix-drug-interaction-potential-and-qtc-prolongation-in-healthy-adults-for-invasive-fungal-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-multicenter-dose-escalation-study-of-daratumumab-with-idarubicin-and-cytarabine-or-cpx-351-in-patients-aged-60-with-adverse-risk-acute-myeloblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-multicenter-open-label-dose-escalation-study-of-afm28-targeting-cd123-and-cd16a-in-cd123-positive-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-multicenter-open-label-study-of-niraparib-tosilate-monohydrate-and-dostarlimab-in-pediatric-patients-with-recurrent-or-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-multicenter-open-label-study-of-rem-422-a-myb-mrna-degrader-in-recurrent-or-metastatic-adenoid-cystic-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-multicenter-open-label-study-of-rem-422-an-myb-mrna-degrader-in-relapsed-refractory-acute-myeloid-leukemia-or-higher-risk-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-and-expansion-study-of-cln-049-in-acute-myeloid-leukemia-with-measurable-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-and-expansion-study-of-snv1521-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-study-assessing-safety-tolerability-and-pharmacokinetics-of-torl-1-23-in-patients-with-advanced-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-study-of-amivantamab-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-study-of-gen1119-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-study-of-inno8-in-adults-and-adolescents-with-haemophilia-a-with-or-without-inhibitors-assessing-pharmacokinetics-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-dose-escalation-study-of-tilt-123-oncolytic-adenovirus-encoding-tnf-alpha-and-il-2-in-patients-with-injectable-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-evaluation-of-mk-8294-monotherapy-in-advanced-cervical-bladder-endometrial-head-and-neck-breast-and-esophageal-squamous-cell-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-dose-escalation-study-of-hpn217-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-dose-escalation-study-of-srg-1505-monotherapy-in-patients-with-mature-b-cell-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-inca033890-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-inca036873-in-patients-with-advanced-solid-tumors-and-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-inca036978-in-adults-with-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-inca32459-in-advanced-malignancies-metastatic-melanoma-squamous-cell-carcinoma-and-b-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-incb161734-in-advanced-or-metastatic-solid-tumors-with-kras-g12d-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-of-janx007-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-multicenter-study-on-safety-and-pharmacokinetics-of-adu-1805-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-pet-study-on-68ga-ga-fapi-46-liver-uptake-post-azd2389-administration-in-advanced-liver-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-randomized-crossover-study-on-the-bioavailability-of-lazertinib-tablet-formulations-in-healthy-adults-for-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-177lu-lu-aby-271-in-her2-positive-metastatic-breast-cancer-safety-tolerability-and-biodistribution-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-bms-986460-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-ctps1-inhibitor-stp938-in-advanced-solid-tumors-and-ctps2-null-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-imgn151-in-adult-patients-with-recurrent-endometrial-epithelial-ovarian-fallopian-tube-primary-peritoneal-and-cervical-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-incb057643-in-myelofibrosis-myelodysplastic-syndromes-essential-thrombocythemia-and-myelodysplastic-myeloproliferative-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-incb123667-monotherapy-and-combination-therapy-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-jnj-67856633-a-malt1-inhibitor-in-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-lbl-051-in-adults-with-refractory-b-cell-mediated-autoimmune-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-neo-ptc-01-in-patients-with-advanced-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-of-tt125-802-evaluating-safety-tolerability-pharmacokinetics-and-efficacy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-on-safety-and-pharmacokinetics-of-adu-1604-in-adults-with-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-on-safety-pharmacokinetics-and-pharmacodynamics-of-jnj-64264681-in-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-on-safety-tolerability-pharmacokinetics-and-food-effects-of-im-250-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-open-label-study-to-evaluate-the-safety-and-pharmacokinetics-of-mst-0312-monotherapy-and-combination-therapy-in-patients-with-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-crossover-study-of-glp-1-analogue-rose-010-on-appetite-and-food-intake-in-overweight-and-obese-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-of-ak1967-procizumab-safety-tolerability-and-pharmacokinetics-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-of-gtx-11-in-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-of-gtx-b001-in-cold-induced-urticaria-and-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-of-safety-and-pk-of-single-multiple-ascending-doses-of-aik3a305-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-of-vna-318-in-cognitive-impairment-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics-of-atx304-in-obesity-overweight-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics-of-qrl-101-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-study-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-vna-318-in-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-trial-of-lib-01-for-safety-and-pharmacokinetics-in-erectile-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-double-blind-placebo-controlled-trial-of-rbd7007-in-complement-mediated-diseases-in-healthy-participants2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-placebo-controlled-dose-ranging-study-of-subcutaneous-ctx611-in-healthy-adults-for-thromboembolic-disorders-safety-tolerability-pk-pd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-placebo-controlled-single-ascending-dose-study-of-mk-3586-a-novel-therapeutic-for-rheumatoid-arthritis-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-placebo-controlled-study-of-mk-3868-safety-pharmacokinetics-and-antimalarial-activity-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-placebo-controlled-study-of-mk-8210-in-healthy-volunteers-to-evaluate-safety-pk-and-antiretroviral-activity-against-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-randomized-single-ascending-dose-study-of-sublingual-insulin-in-adults-with-type-1-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-safety-and-dose-finding-study-of-131i-tlx101-with-standard-of-care-in-newly-diagnosed-glioblastoma-multiforme-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-safety-study-of-hi-6-dimethyl-sulfonate-in-organophosphorus-poisoning-via-iv-bolus-and-infusion-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-single-and-multiple-ascending-dose-study-of-lca-0321-in-patients-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-single-ascending-dose-study-evaluating-safety-tolerability-and-pharmacokinetics-of-regn22044-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-single-ascending-dose-study-of-jade201-in-adults-with-active-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-evaluating-safety-tolerability-and-anti-tumor-activity-of-cdr404-in-hla-a-02-01-patients-with-mage-a4-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-177lu-lu-akir001-in-cd44v6-expressing-solid-tumors-safety-tolerability-and-biodistribution-evaluation-in-advanced-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-abbv-400-monotherapy-and-combination-with-bevacizumab-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-abbv-706-monotherapy-and-combination-with-budigalimab-carboplatin-or-cisplatin-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-actinomycin-d-plus-venetoclax-in-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-adx-001-dspe-dota-gd-liposomal-injection-for-mri-enhancement-in-alzheimer-s-disease-with-brain-amyloid-deposits2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-aj1-11095-in-adults-with-myelofibrosis-refractory-to-jak2-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-amg-305-safety-tolerability-and-pharmacokinetics-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-amg-355-monotherapy-and-combination-with-pembrolizumab-in-advanced-nsclc-crc-gc-and-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-amx-818-monotherapy-and-combination-with-pembrolizumab-in-advanced-or-metastatic-her2-expressing-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-bms-986500-monotherapy-or-combination-therapy-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-cln-619-alone-or-with-pembrolizumab-in-advanced-solid-tumors-including-nsclc-cervical-endometrial-ovarian-breast-and-gastrointestinal-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-ctim-76-in-patients-with-recurrent-ovarian-endometrial-and-testicular-cancers-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-cvx1-vaccine-with-or-without-immune-checkpoint-inhibitors-in-muscle-invasive-bladder-cancer-or-localized-locally-advanced-renal-cell-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-df-006-safety-tolerability-and-pharmacokinetics-in-healthy-subjects-and-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-dose-dense-high-dose-methotrexate-and-glucarpidase-in-relapsed-primary-cns-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-emavusertib-with-azacitidine-and-venetoclax-in-acute-myeloid-leukemia-patients-with-complete-remission-and-minimal-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-geh300079-68ga-biodistribution-dosimetry-pharmacokinetics-and-safety-in-patients-with-peritoneal-carcinomatosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-gen1046-in-combination-with-paclitaxel-albumin-bound-cisplatin-and-pembrolizumab-in-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-grt-001-in-healthy-volunteers-and-ulcerative-colitis-patients-safety-tolerability-pharmacokinetics-and-pharmacodynamics-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-gsk4381562-as-monotherapy-and-in-combination-with-anticancer-agents-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-idrx-42-in-metastatic-and-unresectable-gastrointestinal-stromal-tumors-gist-to-determine-maximum-tolerated-dose-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-inbrx-109-with-irinotecan-and-temozolomide-in-advanced-solid-tumors-including-sarcomas-ewing-sarcoma-and-colorectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-jnj-80948543-a-t-cell-redirecting-antibody-in-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-jnj-86974680-as-monotherapy-and-in-combination-with-cetrelimab-and-radiotherapy-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-jnj-95597528-safety-tolerability-and-pharmacokinetics-in-healthy-subjects-and-mechanism-proof-in-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-jnj-95804306-in-relapsed-or-refractory-aml-cll-higher-risk-mds-and-sll2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-lava-1266-a-cd123-targeting-bispecific-vg9vd2-t-cell-engager-in-cd123-positive-r-r-aml-and-intermediate-to-extremely-high-risk-mds-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-livmoniplimab-and-budigalimab-in-locally-advanced-or-metastatic-solid-tumors-safety-tolerability-and-pharmacokinetics-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-ly4101174-an-antibody-drug-conjugate-targeting-nectin-4-in-patients-with-recurrent-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-mes-1022-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-metabolic-bone-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-odi-2001-personalized-immunotherapy-vaccine-in-patients-with-metastatic-or-locally-advanced-colorectal-or-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-op-3136-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-oral-debio-0123-and-carboplatin-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-pas-004-a-mek-1-2-inhibitor-in-mapk-pathway-driven-advanced-solid-tumors-with-ras-nf1-or-raf-mutations-or-post-braf-mek-inhibition-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-pf-07985045-in-patients-with-kras-mutated-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-propranolol-hydrochloride-and-vinorelbine-tartrate-in-pediatric-patients-with-refractory-or-relapsing-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-prt12396-in-patients-with-high-risk-polycythemia-vera-and-post-et-or-post-pv-myelofibrosis-and-intermediate-high-risk-primary-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-shp2-inhibitor-bbp-398-and-kras-g12c-inhibitor-sotorasib-in-advanced-solid-tumors-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-single-and-multiple-ascending-doses-and-food-effect-of-lmt503-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-stro-002-and-bevacizumab-in-advanced-epithelial-ovarian-cancer-including-fallopian-tube-and-primary-peritoneal-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-subcutaneous-trastuzumab-deruxtecan-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-tisa-818-inj-5mg-ml-in-idiopathic-pulmonary-fibrosis-safety-tolerability-and-pharmacokinetics-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-trametinib-and-gilteritinib-in-relapsed-refractory-acute-lymphoblastic-or-myeloid-leukemia-lacking-curative-options2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-tt125-802-monotherapy-and-in-combination-with-pomalidomide-dexamethasone-in-relapsed-and-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-valemetostat-and-darolutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-vent-03-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-healthy-volunteers-for-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-of-ziftomenib-with-chemotherapy-in-pediatric-relapsed-refractory-kmt2a-r-nup98-r-or-npm1-m-acute-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-bioavailability-food-effect-and-safety-of-inf904-capsule-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-excretion-balance-pharmacokinetics-and-metabolism-of-14c-dc-806-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-food-impact-on-cytisinicline-bioavailability-and-pharmacokinetics-in-healthy-adult-smokers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-linaprazan-glurate-s-impact-on-pharmacokinetics-of-repeated-antibiotic-doses-in-helicobacter-pylori-infection-and-gerd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-mass-balance-pharmacokinetics-and-metabolism-of-oral-14c-zipalertinib-in-healthy-adult-male-subjects-with-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-mass-balance-pharmacokinetics-metabolism-and-excretion-of-gsbr-1290-with-14c-microtracer-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-oral-bioavailability-absorption-metabolism-and-excretion-of-14c-unesbulin-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-ritlecitinib-bioavailability-in-various-food-matrices-and-its-effect-in-healthy-adults-with-alopecia-areata-rheumatoid-arthritis-vitiligo-ulcerative-colitis-and-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-and-efficacy-of-obecabtagene-autoleucel-in-severe-refractory-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-and-immunogenicity-of-hiv-sosip-v8-2-763-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-and-immunogenicity-of-ovx033-vaccine-in-sarbecovirus-diseases-in-healthy-adults-aged-18-492026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-and-pharmacokinetics-of-selective-met-kinase-inhibitor-do-2-in-patients-with-advanced-or-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-and-preliminary-efficacy-of-ctx112-in-adults-with-refractory-systemic-lupus-erythematosus-systemic-sclerosis-or-idiopathic-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-pharmacokinetics-and-pharmacodynamics-of-siplizumab-in-newly-diagnosed-adult-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-immunogenicity-of-adjuvanted-universal-influenza-vaccine-fh1-dsp-0546lp-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-pharmacokinetics-of-cor-1167-in-healthy-subjects-and-chronic-heart-failure-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-pharmacokinetics-of-ghf-201-in-adult-polyglucosan-body-disease-apbd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-pharmacokinetics-of-im-250-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-pharmacokinetics-of-intravenous-irx-010-in-healthy-subjects-with-inflammatory-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-and-pharmacokinetics-of-ly3876602-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-res-010-in-overweight-and-moderately-obese-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-the-bioavailability-of-arvisol-tablets-compared-to-epidiolex-cannabidiol-oral-solution-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-on-the-pharmacokinetics-of-14c-az-3102-in-glycosphingolipid-lysosomal-storage-disorders-in-healthy-male-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-to-determine-maximum-tolerated-dose-of-terbium-161tb-zadavotide-guraxetan-as-neoadjuvant-treatment-for-very-high-risk-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-study-to-evaluate-the-pharmacokinetics-and-safety-of-three-testosterone-gel-formulations-in-postmenopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-trial-evaluating-safety-and-efficacy-of-gen1055-monotherapy-and-combination-with-pembrolizumab-in-patients-with-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1-trial-of-cit-013-in-immune-mediated-inflammatory-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-evaluation-of-elvn-001-in-patients-with-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-evaluation-of-elvn-002-with-trastuzumab-and-chemotherapy-in-advanced-her2-positive-solid-tumors-colorectal-and-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-evaluation-of-incb081776-safety-and-tolerability-in-patients-with-advanced-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-evaluation-of-km-023-in-healthy-volunteers-and-patients-with-olmsted-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-evaluation-of-loxo-435-in-patients-with-advanced-solid-tumors-harboring-fgfr3-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-open-label-study-of-bg-75098-alone-and-in-combination-assessing-safety-pk-pd-and-preliminary-efficacy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-open-label-study-of-igm-8444-monotherapy-and-combination-therapy-in-relapsed-refractory-or-newly-diagnosed-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-open-label-study-of-pln-101095-monotherapy-and-in-combination-with-pembrolizumab-in-adults-with-advanced-metastatic-solid-tumors-after-ici-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-study-of-cdk4-inhibitor-bgb-43395-in-metastatic-hr-her2-breast-cancer-and-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-1b-study-of-elvn-002-monotherapy-and-combination-therapy-in-her2-altered-solid-tumors-her2-mutant-nsclc-and-her2-positive-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-b-study-of-bgb-58067-an-mta-cooperative-prmt5-inhibitor-in-patients-with-advanced-solid-tumors-with-mtap-deletion-or-loss-of-mtap-expression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1a-study-on-safety-and-immunogenicity-of-heterologous-protein-prime-mva-boost-therapeutic-vaccine-in-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-evaluation-of-bms-986158-alone-and-with-ruxolitinib-or-fedratinib-in-dipss-intermediate-high-risk-myelofibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-evaluation-of-liposomal-annamycin-in-metastatic-soft-tissue-sarcomas-post-systemic-therapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-evaluation-of-mitomycin-c-capecitabine-chemoradiotherapy-with-ipilimumab-and-nivolumab-for-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-evaluation-of-tasquinimod-in-myelofibrosis-patients-refractory-or-intolerant-to-jak2-inhibition2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-multicenter-open-label-study-of-anti-ceacam5-antibody-drug-conjugate-m9140-in-advanced-gastric-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-multicenter-open-label-study-of-anti-ceacam5-antibody-drug-conjugate-m9140-in-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-multicenter-open-label-study-of-anti-ceacam5-antibody-drug-conjugate-m9140-in-advanced-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-multicenter-open-label-study-of-ifinatamab-deruxtecan-with-atezolizumab-carboplatin-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-open-label-multicohort-study-of-disitamab-vedotin-in-her2-expressing-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-open-label-study-of-disitamab-vedotin-and-tucatinib-in-her2-low-and-her2-positive-advanced-breast-and-gastric-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-open-label-study-of-tisotumab-vedotin-monotherapy-and-combination-therapy-in-recurrent-or-stage-ivb-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-evaluating-the-efficacy-and-safety-of-gsk5764227-in-adults-with-previously-treated-unresectable-advanced-or-metastatic-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-5-fluorouracil-leucovorin-irinotecan-temozolomide-and-bevacizumab-in-mgmt-silenced-microsatellite-stable-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-abemaciclib-with-irinotecan-temozolomide-and-dinutuximab-in-pediatric-and-young-adult-relapsed-refractory-solid-tumors-and-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-elacestrant-and-abemaciclib-in-patients-with-brain-metastases-from-er-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-hepatic-percutaneous-perfusion-with-ipilimumab-nivolumab-and-melphalan-in-patients-with-advanced-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-nadunolimab-with-gemcitabine-and-carboplatin-in-advanced-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-s095029-and-pembrolizumab-in-msi-h-dmmr-gastroesophageal-junction-and-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-safety-and-efficacy-of-ifinatamab-deruxtecan-in-pediatric-patients-with-relapsed-or-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-vepdegestrant-and-samuraciclib-in-er-advanced-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-study-of-vepdegestrant-arv-471-pf-07850327-and-pf-07220060-in-er-her2-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2-trial-of-omtx705-an-anti-fibroblast-activation-protein-antibody-drug-conjugate-in-combination-with-carboplatin-pemetrexed-and-tislelizumab-in-patients-with-advanced-metastatic-non-squamous-2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2a-double-blind-placebo-controlled-trial-of-im-250-for-safety-and-efficacy-in-recurrent-genital-herpes-suppressive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2a-safety-and-tolerability-study-of-intrathecal-s233107-in-participants-with-spinocerebellar-ataxia-type-32026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2a-safety-tolerability-and-pharmacokinetics-study-of-dnl952-in-adults-with-late-onset-pompe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-2a-study-of-bi-1607-with-ipilimumab-and-pembrolizumab-in-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-3-evaluation-of-bemarituzumab-chemotherapy-and-nivolumab-in-fgfr2b-overexpressing-advanced-gastric-and-gastroesophageal-junction-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-3-study-of-tazemetostat-with-lenalidomide-and-rituximab-in-relapsed-refractory-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-basket-study-of-etentamig-versus-abbv-519-for-b-cell-depletion-in-moderate-to-severe-systemic-lupus-erythematosus-rheumatoid-arthritis-and-sjogren-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-dose-escalation-study-of-cabozantinib-alone-or-with-atezolizumab-in-locally-advanced-or-metastatic-bladder-and-kidney-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-dose-range-study-of-phenserine-tartrate-vs-donepezil-hydrochloride-in-early-or-mild-alzheimer-s-disease-and-mild-cognitive-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-double-blind-single-dose-study-of-ati-052-assessing-safety-tolerability-pharmacokinetics-pharmacodynamics-and-efficacy-in-adults-with-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-amg-757-in-adult-patients-with-de-novo-or-treatment-emergent-neuroendocrine-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-argx-119-safety-and-tolerability-in-adults-with-dok7-congenital-myasthenic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-arv-471-and-everolimus-in-er-her2-advanced-or-metastatic-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-autologous-dendritic-cell-immunotherapy-with-anti-pd-1-in-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-bispecific-t-cell-redirection-antibodies-with-checkpoint-inhibitors-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-bleximenib-with-aml-directed-therapies-in-acute-myeloid-leukemia-patients-with-kmt2a-or-npm1-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-crizotinib-alone-or-with-temsirolimus-in-pediatric-alk-ros1-or-met-positive-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-ctps1-inhibitor-stp938-in-high-risk-essential-thrombocythaemia-resistant-or-intolerant-to-hydroxycarbamide-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-dato-dxd-and-pembrolizumab-with-without-platinum-chemotherapy-in-advanced-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-imvotamab-in-patients-with-moderate-to-severe-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-imvotamab-in-patients-with-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-inhaled-rct1100-on-mucociliary-clearance-in-adults-with-dnai1-mutated-primary-ciliary-dyskinesia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-jnj-78278343-with-cetrelimab-taxane-chemotherapy-or-androgen-receptor-pathway-inhibitors-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-jnj-79635322-in-combination-with-daratumumab-or-pomalidomide-for-patients-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-jnj-80948543-with-cd3-t-cell-engagers-in-relapsed-refractory-b-cell-non-hodgkin-lymphoid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-jnj-90014496-in-adults-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-malt1-inhibitor-jnj-67856633-and-ibrutinib-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-mk-0482-in-patients-with-relapsed-refractory-acute-myeloid-leukemia-or-chronic-myelomonocytic-leukemia-with-active-cns-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-neoadjuvant-xaluritamig-in-patients-with-newly-diagnosed-localized-intermediate-or-high-risk-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-omo-103-with-drug-combinations-in-advanced-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-procizumab-pcz-ak1967-in-cardiogenic-shock-secondary-to-acute-coronary-syndrome-or-sepsis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-evaluation-of-subcutaneous-daratumumab-with-bispecific-t-cell-redirection-antibodies-in-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-ii-evaluation-of-pembrolizumab-with-standard-imrt-in-hpv-induced-stage-iii-squamous-cell-carcinoma-of-the-anus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-ii-multicenter-trial-of-neoadjuvant-intradermal-ipilimumab-and-nivolumab-in-high-risk-stage-ii-melanoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multi-arm-study-of-talquetamab-with-anticancer-therapies-in-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multi-arm-study-of-teclistamab-combined-with-anticancer-therapies-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-double-blind-placebo-controlled-study-on-safety-tolerability-and-efficacy-of-si-544-in-psoriasis-vulgaris-and-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-open-label-study-of-acalabrutinib-with-bendamustine-and-rituximab-or-venetoclax-and-rituximab-in-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-study-of-cusatuzumab-anti-cd70-monoclonal-antibody-with-background-therapy-in-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-study-of-datopotamab-deruxtecan-with-immunotherapy-carboplatin-in-advanced-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-study-of-tolinapant-with-radiotherapy-chemoradiotherapy-in-neoadjuvant-treatment-of-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-study-of-trk-950-with-anti-cancer-regimens-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-multicenter-study-of-valemetostat-tosylate-with-dxd-adcs-in-her2-low-breast-cancer-her2-positive-gastric-cancer-and-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-dose-escalation-and-expansion-study-of-agent-a-with-agent-b-or-agent-a-plus-standard-of-care-in-second-line-xxx-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-dose-escalation-study-of-vb-10-neo-and-atezolizumab-in-locally-advanced-and-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-evaluation-of-cln-978-in-patients-with-active-moderate-to-severe-sjogren-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-multiple-ascending-dose-study-of-om336-in-participants-with-active-sjogren-s-disease-or-idiopathic-inflammatory-myopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-study-of-eftozanermin-alfa-with-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-study-of-epcoritamab-in-pediatric-patients-with-relapsed-refractory-aggressive-mature-b-cell-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-open-label-study-of-vrg50635-in-sporadic-and-familial-amyotrophic-lateral-sclerosis-patients-with-long-term-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-randomized-blinded-placebo-controlled-study-of-abi-4334-safety-pharmacokinetics-and-antiviral-activity-in-chronic-hepatitis-b-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-randomized-double-blind-placebo-controlled-study-of-sisunatovir-in-pediatric-patients-with-rsv-lower-respiratory-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-randomized-open-label-study-evaluating-safety-and-pharmacodynamics-of-zp9830-in-adults-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-loncastuximab-tesirine-with-anti-cancer-agents-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-mosunetuzumab-and-glofitamab-with-cc-220-and-cc-99282-in-b-cell-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-np137-with-atezolizumab-bevacizumab-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-np137-with-mfolfirinox-in-locally-advanced-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-omtx705-in-patients-with-advanced-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-tarlatamab-and-zl-1310-with-or-without-anti-pd-l1-combination-therapy-in-patients-with-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-tarlatamab-in-combination-with-yl201-with-or-without-anti-pd-l1-in-subjects-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-of-zn-c3-combined-with-chemotherapy-or-bevacizumab-in-patients-with-ovarian-peritoneal-or-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-on-safety-and-immunological-efficacy-of-tolerogenic-dendritic-cell-therapy-in-type-1-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-1b-study-to-evaluate-the-safety-and-pharmacokinetics-of-verve-201-in-patients-with-refractory-hyperlipidemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-adaptive-design-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-dm199-for-the-treatment-of-acute-ischemic-stroke-remedy2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-dose-finding-study-of-atumelnant-in-adults-with-acth-dependent-cushing-s-syndrome-including-open-label-extension-equilibrium-adcs2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-evaluation-of-evorpacept-with-trastuzumab-ramucirumab-and-paclitaxel-in-metastatic-her2-overexpressing-gastric-gej-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-multicenter-randomized-study-of-raludotatug-deruxtecan-in-platinum-resistant-high-grade-ovarian-primary-peritoneal-or-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-controlled-trial-on-nizaracianine-triflutate-for-ureter-visualization-in-abdominopelvic-surgery-patients-aged-182026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-double-blind-placebo-controlled-study-of-elenestinib-in-patients-with-indolent-systemic-mastocytosis-and-smoldering-systemic-mastocytosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-double-blind-study-evaluating-safety-and-tolerability-of-inebilizumab-in-adults-with-autoimmune-hepatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-double-blind-study-of-liposomal-annamycin-and-cytarabine-vs-placebo-and-cytarabine-in-refractory-relapsed-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-study-of-bms-986504-with-nab-paclitaxel-and-gemcitabine-vs-placebo-in-metastatic-pancreatic-ductal-adenocarcinoma-with-homozygous-mtap-deletion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-study-of-ibrutinib-and-rituximab-versus-lenalidomide-rituximab-or-bortezomib-rituximab-in-relapsed-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-study-of-osivelotor-and-placebo-in-adult-and-pediatric-patients-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-randomized-study-of-tebentafusp-as-monotherapy-and-in-combination-with-pembrolizumab-versus-investigator-s-choice-in-hla-a-02-01-positive-participants-with-previously-treated-advanced-melano2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-study-evaluating-safety-and-efficacy-of-sky-0515-in-adults-with-huntington-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-study-of-darovasertib-and-crizotinib-versus-standard-treatment-in-hla-a2-negative-metastatic-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-study-on-safety-pharmacokinetics-and-efficacy-of-nirmatrelvir-ritonavir-in-pediatric-patients-with-sars-cov-2-at-risk-of-severe-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-3-trial-of-mk-1045-combined-with-rituximab-in-adults-with-newly-diagnosed-first-line-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-adaptive-dose-ranging-study-of-eltrekibart-and-mirikizumab-in-adults-with-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-and-3-evaluation-of-adagrasib-and-pembrolizumab-in-advanced-nsclc-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-basket-study-of-disitamab-vedotin-in-adults-with-previously-treated-locally-advanced-unresectable-or-metastatic-her2-expressing-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-biomarker-driven-evaluation-of-nivolumab-ipilimumab-or-vegfr-tyrosine-kinase-inhibitors-in-treatment-naive-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-diagnostic-evaluation-of-68ga-evg321-distribution-and-dosimetry-in-patients-with-histologically-confirmed-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-dose-ranging-study-of-linvoseltamab-in-high-risk-mgus-and-non-high-risk-smm-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-double-blind-placebo-controlled-study-on-the-efficacy-and-safety-of-sar444656-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-double-blind-randomized-study-on-the-efficacy-and-safety-of-elinzanetant-versus-placebo-for-menopausal-sleep-disturbances2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-double-blind-study-of-ly3457263-versus-placebo-in-type-2-diabetes-patients-on-stable-semaglutide-or-tirzepatide-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-double-blind-study-of-sar447537-vs-plasma-derived-alpha1-proteinase-inhibitor-in-adults-with-alpha-1-antitrypsin-deficiency-emphysema2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-double-masked-placebo-controlled-dose-finding-study-of-danicopan-in-geographic-atrophy-secondary-to-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-abemaciclib-irinotecan-and-temozolomide-in-relapsed-or-refractory-ewing-s-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-adagrasib-with-pembrolizumab-and-chemotherapy-in-advanced-nsclc-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-alisertib-with-endocrine-therapy-in-hr-her2-recurrent-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-alx148-and-pembrolizumab-in-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-alx148-pembrolizumab-and-chemotherapy-in-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-amg-193-efficacy-and-safety-in-mtap-deleted-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-atezolizumab-as-neoadjuvant-therapy-in-urothelial-carcinoma-of-the-bladder-and-upper-urinary-tract2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-avutometinib-and-defactinib-in-recurrent-low-grade-serous-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-bb-1701-a-humanized-igg1-kappa-monoclonal-antibody-conjugated-to-eribulin-in-her2-positive-or-her2-low-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-belantamab-mafodotin-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-belantamab-mafodotin-in-relapsed-or-refractory-al-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-capecitabine-in-recurrent-and-metastatic-salivary-duct-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-cemiplimab-and-bnt116-combination-versus-cemiplimab-monotherapy-in-advanced-nsclc-with-pd-l1-expression-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-cladribine-efficacy-and-safety-in-seropositive-myasthenia-gravis-treatment-modification2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-cusatuzumab-and-azacitidine-in-newly-diagnosed-acute-myeloid-leukemia-patients-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-domvanalimab-and-zimberelimab-with-chemotherapy-versus-zimberelimab-with-chemotherapy-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-domvanalimab-zimberelimab-and-quemliclustat-combinations-in-advanced-upper-gastrointestinal-tract-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-donor-derived-cd19-targeted-car-t-cells-cyclophosphamide-and-fludarabine-phosphate-in-relapsed-acute-leukemia-post-allo-hsct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-durdcabtagene-autoleucel-and-bcma-directed-car-t-cells-in-relapsed-refractory-multiple-myeloma-with-fludarabine-cyclophosphamide-and-tocilizumab2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-elranatamab-monotherapy-in-multiple-myeloma-patients-refractory-to-proteasome-inhibitors-immunomodulatory-drugs-and-anti-cd38-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-epcoritamab-with-lenalidomide-and-rituximab-in-relapsed-refractory-primary-cns-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-fianlimab-cemiplimab-and-chemotherapy-versus-cemiplimab-and-chemotherapy-in-resectable-stage-ii-iiib-n2-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-futibatinib-in-advanced-cholangiocarcinoma-with-fgfr2-fusions-or-rearrangements2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-gandotinib-ly2784544-in-myeloproliferative-neoplasms-polycythemia-vera-essential-thrombocythemia-and-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-gemtuzumab-ozogamicin-and-gilteritinib-in-flt3-itd-relapsed-refractory-acute-myeloid-leukemia-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-golcadomide-cc-99282-in-relapsed-refractory-primary-and-secondary-central-nervous-system-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-human-papillomavirus-9-valent-vaccine-post-treatment-in-women-over-45-with-high-grade-cervical-intraepithelial-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-iberdomide-cyclophosphamide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-ifenprodil-for-remyelination-in-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-immunotherapy-combinations-including-dostarlimab-in-pd-l1-positive-recurrent-metastatic-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-inhaled-interferon-beta-1a-sng001-in-mechanically-ventilated-patients-with-lower-respiratory-tract-viral-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-isatuximab-pomalidomide-and-dexamethasone-in-relapsed-multiple-myeloma-post-lenalidomide-and-proteasome-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-isatuximab-with-bortezomib-cyclophosphamide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-with-severe-renal-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-men1703-monotherapy-and-in-combination-with-glofitamab-in-relapsed-refractory-aggressive-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-mk-1308a-and-lenvatinib-in-first-line-treatment-of-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-nanatinostat-and-valganciclovir-in-epstein-barr-virus-positive-relapsed-refractory-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-narsoplimab-in-pediatric-patients-with-high-risk-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-naxitamab-and-sargramostim-in-high-risk-neuroblastoma-with-refractory-or-incomplete-response-in-bone-bone-marrow2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-neoadjuvant-gemcitabine-cisplatin-durvalumab-and-tremelimumab-in-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-nivolumab-and-nivolumab-ipilimumab-combination-in-adjuvant-immunotherapy-post-salvage-surgery-for-high-risk-recurrent-hnscc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-olaparib-and-pembrolizumab-in-hrrm-and-hrd-positive-advanced-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-pembrolizumab-in-relapsed-refractory-classical-hodgkin-s-lymphoma-and-primary-mediastinal-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-prt3789-and-pembrolizumab-in-advanced-or-metastatic-solid-tumors-with-smarca4-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-raav9-lamp2b-gene-therapy-in-male-danon-disease-patients-efficacy-and-safety-assessment-of-intravenous-administration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-relacorilant-nab-paclitaxel-and-bevacizumab-in-advanced-epithelial-ovarian-primary-peritoneal-or-fallopian-tube-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-rly-2608-in-pik3ca-related-overgrowth-spectrum-and-pik3ca-mutation-driven-malformations-in-adult-and-pediatric-populations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-ruxolitinib-and-methoxsalen-in-steroid-refractory-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-sonrotoclax-and-zanubrutinib-versus-zanubrutinib-monotherapy-in-untreated-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-tarlatamab-efficacy-and-safety-in-relapsed-refractory-small-cell-lung-cancer-post-two-or-more-treatment-lines2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-teclistamab-with-daratumumab-or-lenalidomide-in-elderly-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-torl-1-23-monotherapy-in-advanced-platinum-resistant-epithelial-ovarian-primary-peritoneal-and-fallopian-tube-cancers-expressing-claudin-62026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-tremelimumab-durvalumab-and-tace-in-advanced-hepatocellular-carcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-tucatinib-and-trastuzumab-in-her2-altered-previously-treated-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-valemetostat-tosylate-monotherapy-in-relapsed-refractory-peripheral-t-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-varnimcabtagene-autoleucel-in-pediatric-cd19-acute-lymphoblastic-leukemia-resistant-or-refractory-to-standard-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-varnimcabtagene-autoleucel-infusion-in-cd19-acute-lymphoid-leukemia-resistant-or-refractory-to-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-zelenectide-pevedotin-in-nectin4-amplified-advanced-breast-cancer-with-bt8009-infusion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-zelenectide-pevedotin-in-nectin4-amplified-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-evaluation-of-zolbetuximab-monotherapy-and-combination-therapy-in-claudin-18-2-positive-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-lightbeam-u01-substudy-01e-safety-and-efficacy-of-oral-belzutifan-120-mg-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-double-blind-randomized-placebo-controlled-study-on-dextromethadone-hydrochloride-efficacy-in-moderate-to-very-severe-restless-legs-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-double-blind-randomized-placebo-controlled-trial-of-transcon-cnp-in-infants-with-achondroplasia-evaluating-safety-tolerability-and-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-double-blind-study-of-subcutaneous-pf-06480605-in-moderate-to-severe-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-evaluation-of-autologous-tumor-infiltrating-lymphocytes-in-advanced-solid-tumors-with-swi-snf-complex-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-evaluation-of-autologous-tumor-infiltrating-lymphocytes-in-refractory-germ-cell-tumors-with-cyclophosphamide-and-fludarabine-phosphate2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-evaluation-of-axicabtagene-ciloleucel-in-relapsed-refractory-indolent-non-hodgkin-lymphoma-with-tocilizumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-evaluation-of-ln-145-and-drug-combination-in-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-platform-study-investigating-asp3082-in-patients-with-metastatic-locally-advanced-non-small-cell-lung-cancer-nsclc-and-pancreatic-ductal-adenocarcinoma-pdac-with-biomark2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-randomized-study-of-venetoclax-azacitidine-and-cusatuzumab-in-newly-diagnosed-aml-patients-ineligible-for-intensive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-elranatamab-in-high-risk-smoldering-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-ixazomib-iberdomide-and-dexamethasone-in-elderly-patients-with-multiple-myeloma-at-first-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-lifileucel-in-adults-with-previously-treated-advanced-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-mitapivat-on-albumin-creatinine-ratio-in-sickle-cell-disease-with-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-opevesostat-tosilate-in-patients-with-breast-ovarian-and-endometrial-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-raludotatug-deruxtecan-in-advanced-metastatic-solid-tumors-including-gynecological-and-genitourinary-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-sonelokimab-in-moderate-to-severe-palmoplantar-pustulosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-sotorasib-in-stage-iv-nsclc-with-krasg12c-mutation-requiring-first-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-of-tarlatamab-in-metastatic-locally-advanced-small-cell-lung-cancer-and-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-on-efficacy-safety-and-tolerability-of-riliprubart-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-open-label-study-on-the-efficacy-and-safety-of-tyra-300-in-fgfr3-altered-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-double-blind-controlled-study-on-valganciclovir-efficacy-in-newly-diagnosed-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-double-blind-placebo-controlled-trial-evaluating-bp1-7881-efficacy-and-safety-in-adult-eosinophilic-esophagitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-double-blind-study-of-mk-4280a-pembrolizumab-and-lenvatinib-in-patients-with-selected-malignant-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-open-label-study-of-ifinatamab-deruxtecan-in-pretreated-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-open-label-trial-of-acasunlimab-monotherapy-and-combination-with-pembrolizumab-in-relapsed-refractory-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-trial-of-lenomorelin-in-acute-anterior-circulation-ischemic-stroke-with-endovascular-thrombectomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-randomized-trial-of-sacituzumab-govitecan-and-trastuzumab-deruxtecan-in-her2-low-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-evaluating-axatilimab-efficacy-safety-and-tolerability-in-recurrent-refractory-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-evaluating-efficacy-and-safety-of-zanidatamab-in-patients-with-her2-expressing-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-copanlisib-with-rituximab-and-chop-in-untreated-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-elacestrant-in-cdk4-6-inhibitor-naive-er-her2-metastatic-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-haploidentical-transplantation-with-treosulfan-fludarabine-phosphate-and-thiotepa-in-myelofibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-intratumoral-vidutolimod-and-intravenous-cemiplimab-in-advanced-or-metastatic-merkel-cell-squamous-cell-basal-cell-breast-and-lung-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-iopofosine-131i-in-relapsed-refractory-b-cell-malignancies-and-waldenstrom-macroglobulinemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-isatuximab-pomalidomide-dexamethasone-and-carfilzomib-in-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-kyv-101-anti-cd19-car-t-cell-therapy-in-refractory-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-neoadjuvant-immunotherapy-with-anti-gdf-15-antibody-visugromab-and-nivolumab-in-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-patritumab-deruxtecan-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-pembrolizumab-and-lenvatinib-in-patients-with-vulvar-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-regorafenib-in-ras-mutant-metastatic-colorectal-cancer-as-second-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-rituximab-polatuzumab-vedotin-and-glofitamab-in-untreated-aggressive-b-cell-lymphoma-patients-aged-60-ineligible-for-r-chop2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-sacituzumab-govitecan-with-pembrolizumab-and-platinum-agents-in-first-line-treatment-of-advanced-or-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-of-subcutaneous-isatuximab-with-bortezomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-transplant-ineligible-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-on-efficacy-and-safety-of-idecabtagene-vicleucel-in-relapsed-refractory-and-high-risk-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-on-efficacy-and-safety-of-taletrectinib-in-advanced-or-metastatic-ros1-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-study-on-ruxolitinib-and-corticosteroids-as-first-line-therapy-in-pediatric-primary-hemophagocytic-lymphohistiocytosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicenter-trial-of-mesenchymal-stromal-cells-mc0518-vs-best-available-therapy-in-pediatric-steroid-refractory-acute-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicentre-randomized-trial-of-mifamurtide-with-post-operative-chemotherapy-in-high-risk-osteosarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicentric-study-of-venetoclax-and-azacitidine-in-adult-npm1-mutated-acute-myeloid-leukemia-with-molecular-relapse-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicohort-evaluation-of-daratumumab-bortezomib-cyclophosphamide-and-dexamethasone-in-systemic-al-amyloidosis-with-cardiac-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicohort-open-label-study-of-ciltacabtagene-autoleucel-car-t-therapy-targeting-bcma-in-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-multicohort-study-on-efficacy-and-safety-of-ciltacabtagene-autoleucel-in-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-dose-ranging-study-of-rls-0071-in-hospitalized-patients-with-steroid-refractory-acute-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-evaluation-of-bemnifosbuvir-hemisulfate-and-ruzasvir-for-safety-and-efficacy-in-chronic-hepatitis-c-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-evaluation-of-navitoclax-monotherapy-and-navitoclax-ruxolitinib-combination-in-myelofibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-evaluation-of-sacituzumab-govitecan-in-patients-with-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-imaging-study-of-sonelokimab-in-active-psoriatic-arthritis-and-axial-spondyloarthritis-using-68ga-fapi-46-pet-ct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-imaging-study-on-sonelokimab-s-effects-in-active-axial-spondyloarthritis-evaluated-by-18naf-pet-scan-tracer-uptake2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-multicenter-study-of-zoldonrasib-rmc-9805-in-ras-g12d-mutant-non-small-cell-lung-cancer-post-systemic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-randomized-study-of-farletuzumab-ecteribulin-in-metastatic-non-small-cell-lung-cancer-adenocarcinoma-post-therapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-evaluating-safety-and-efficacy-of-pf-06835375-in-adults-with-moderate-to-severe-primary-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-evaluating-safety-tolerability-and-efficacy-of-arct-032-mrna-encoding-human-cftr-gene-in-cystic-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-in-subjects-with-previously-untreated-met-amplified-locally-advanced-metastatic-non-squamous-non-small-cell-lung-cancer-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-acalabrutinib-in-patients-with-relapsed-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-acalabrutinib-in-patients-with-waldenstrom-macroglobulinemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-adp-a2m4cd8-monotherapy-and-combination-with-nivolumab-in-hla-a-02-mage-a4-recurrent-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-axicabtagene-ciloleucel-fludarabine-phosphate-and-cyclophosphamide-in-relapsed-refractory-aggressive-b-nhl-ineligible-for-asct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-brentuximab-vedotin-and-chp-in-frontline-treatment-of-peripheral-t-cell-lymphoma-with-10-cd30-expression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-cabozantinib-in-advanced-or-unresectable-renal-cell-carcinoma-post-anti-pd1-pdl1-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-elritercept-ker-050-for-anemia-in-very-low-to-intermediate-risk-myelodysplastic-syndromes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-encorafenib-and-binimetinib-in-brafv600e-mutant-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-lorlatinib-in-relapsed-alk-positive-anaplastic-large-cell-lymphoma-resistant-to-alk-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-patritumab-deruxtecan-in-hr-her2-negative-advanced-breast-cancer-post-standard-therapy-with-biomarker-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-subcutaneous-isatuximab-with-carfilzomib-and-dexamethasone-in-adults-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-tisotumab-vedotin-pembrolizumab-and-platinum-based-chemotherapy-in-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-of-venetoclax-carfilzomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-efficacy-and-tolerance-of-ponatinib-and-5-azacitidine-in-accelerated-phase-or-myeloid-blast-crisis-chronic-myelogenous-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-safety-and-efficacy-of-telisotuzumab-vedotin-in-c-met-positive-non-small-cell-lung-cancer-patients-with-prior-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-safety-and-pharmacokinetics-of-doxecitine-and-doxribtimine-in-thymidine-kinase-2-deficiency-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-the-efficacy-and-safety-of-rilzabrutinib-in-adult-patients-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-the-safety-and-efficacy-of-ruxolitinib-cream-for-nonsegmental-vitiligo-with-genital-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-open-label-study-on-the-safety-of-mogamulizumab-administered-every-4-weeks-in-relapsed-refractory-mycosis-fungoides-and-sezary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-pilot-study-on-the-efficacy-of-enalapril-maleate-in-adults-aged-18-70-with-painful-venous-malformations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-platform-trial-to-assess-the-efficacy-and-safety-of-long-acting-antibodies-as-single-agents-and-in-combinations-for-moderately-to-severely-active-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-blinded-placebo-controlled-study-of-dnth103-in-adults-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-blinded-placebo-controlled-study-of-inbrx-109-in-adults-with-unresectable-or-metastatic-conventional-chondrosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-blinded-placebo-controlled-trial-of-visugromab-nivolumab-and-docetaxel-in-metastatic-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-controlled-multicenter-study-of-vosoritide-in-pediatric-patients-with-idiopathic-short-stature2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-controlled-study-of-cemiplimab-monotherapy-and-cemiplimab-plus-vusolimogene-oderparepvec-in-advanced-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-controlled-trial-of-taladegib-in-idiopathic-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-dose-finding-study-of-petrelintide-versus-placebo-in-obesity-or-overweight-patients-with-weight-related-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-dose-ranging-study-of-oral-mze782-in-adults-with-phenylketonuria2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-parallel-group-multicenter-study-to-evaluate-the-safety-and-efficacy-of-tarperprumig-in-adult-participants-with-anti-neutrophil-cytoplasmic-antibody-2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-2-deoxy-d-glucose-for-rhinovirus-associated-illness-prophylaxis-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-anti-tslp-antibody-gsk5784283-in-adults-with-uncontrolled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-efgartigimod-alfa-sc-in-antibody-mediated-rejection-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-emrusolmin-in-adult-patients-with-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-fnp-223-in-progressive-supranuclear-palsy-to-evaluate-efficacy-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-ly4100511-in-adults-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-mtx-463-efficacy-and-safety-in-idiopathic-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-oral-azacitidine-and-pembrolizumab-in-previously-treated-advanced-or-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-oral-lidocaine-hydrochloride-monohydrate-for-enhancing-food-intake-in-underweight-elderly-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-ponsegromab-in-adults-with-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-ponsegromab-in-cancer-cachexia-with-elevated-gdf-15-concentrations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-regn9933-and-regn7508-monoclonal-antibodies-for-venous-thromboembolism-prevention-in-picc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-soquelitinib-in-adults-with-moderate-to-severe-atopic-dermatitis-sierra12026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-tovinontrine-in-adults-with-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-ve202-in-mild-to-moderate-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-vhb937-in-amyotrophic-lateral-sclerosis-patients-over-40-weeks-with-open-label-extension2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-vidofludimus-calcium-on-mri-assessed-disease-activity-in-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-of-win378-human-igg1-monoclonal-antibody-against-tslp-in-adults-with-moderate-to-severe-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-on-estetrol-monohydrate-s-effect-on-hair-growth-in-postmenopausal-women-with-female-pattern-hair-loss2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-on-maridebart-cafraglutide-efficacy-and-safety-in-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-study-on-the-efficacy-and-safety-of-mbs2320-in-idiopathic-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-trial-of-crd-4730-in-patients-with-heart-failure-with-reduced-ejection-fraction-hfref2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-trial-of-dapagliflozin-propanediol-for-cardioprotection-in-lymphoma-patients-undergoing-r-cho-e-p-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-trial-of-nido-361-in-spinal-and-bulbar-muscular-atrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-placebo-controlled-trial-of-subcutaneous-anb032-in-adults-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-study-of-alg-000184-vs-tenofovir-disoproxil-fumarate-in-hbeag-positive-and-hbeag-negative-chronic-hepatitis-b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-study-of-dostarlimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-in-metastatic-non-squamous-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-study-of-ilb-dextran-sulfate-low-molecular-weight-vs-riluzole-in-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-double-blind-trial-of-low-dose-exemestane-versus-low-dose-tamoxifen-in-postmenopausal-women-at-high-risk-for-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-evaluation-of-abbv-400-with-fluorouracil-folinic-acid-and-bevacizumab-in-unresectable-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-multicenter-trial-of-vemurafenib-and-rituximab-versus-cladribine-in-treatment-naive-hairy-cell-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-multicentric-trial-of-doravirine-for-early-outpatient-management-of-west-nile-virus-infection-in-patients-at-risk-of-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-dose-finding-study-of-degarelix-extended-release-formulation-in-locally-advanced-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-study-of-bdc-1001-monotherapy-and-combination-with-pertuzumab-in-her2-positive-metastatic-breast-cancer-post-trastuzumab-deruxtecan2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-study-of-darolutamide-versus-androgen-deprivation-therapy-in-hormone-naive-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-study-of-momelotinib-dihydrochloride-monohydrate-in-anemia-due-to-low-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-study-on-safety-and-immunogenicity-of-pf-07831695-and-pneumococcal-polysaccharide-serotype-3-conjugate-in-toddlers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-open-label-trial-of-intradermal-vs-subcutaneous-mva-bn-vaccine-booster-for-mpox-immunogenicity-in-previously-vaccinated-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-placebo-controlled-multicenter-study-of-subcutaneous-argx-121-in-adults-with-primary-iga-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-abemaciclib-plus-tamoxifen-versus-abemaciclib-monotherapy-in-hr-positive-her2-negative-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-adjuvant-apalutamide-versus-standard-of-care-in-high-risk-localized-or-locally-advanced-prostate-adenocarcinoma-post-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-camizestrant-vs-fulvestrant-in-postmenopausal-women-with-advanced-er-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-ceralasertib-and-ceralasertib-plus-durvalumab-in-unresectable-or-advanced-melanoma-with-pd-l-1-inhibitor-resistance2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-conditioning-regimens-with-cyclophosphamide-and-methotrexate-for-graft-versus-host-disease-prophylaxis-in-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-darolutamide-vs-capecitabine-in-triple-negative-androgen-receptor-positive-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-docetaxel-ifinatamab-deruxtecan-and-raludotatug-deruxtecan-in-stage-iv-nonsquamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-elranatamab-and-lenalidomide-versus-daratumumab-and-lenalidomide-for-post-transplant-maintenance-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-emibetuzumab-plus-erlotinib-versus-erlotinib-monotherapy-in-metastatic-nsclc-with-egfr-mutations-after-erlotinib-lead-in2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-encorafenib-binimetinib-and-pembrolizumab-versus-nivolumab-and-ipilimumab-in-braf-v600e-k-mutation-positive-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-encorafenib-cetuximab-and-pembrolizumab-in-braf-v600e-mutant-msi-h-dmmr-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-farletuzumab-ecteribulin-vs-chemotherapy-in-platinum-resistant-high-grade-serous-ovarian-primary-peritoneal-or-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-fulvestrant-with-or-without-samuraciclib-in-metastatic-or-locally-advanced-hr-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-ifinatamab-deruxtecan-raludotatug-deruxtecan-and-docetaxel-in-stage-iv-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-inotuzumab-ozogamicin-monotherapy-versus-allr3-regimen-in-pediatric-high-risk-first-relapse-cd22-positive-b-cell-precursor-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-intraperitoneal-radium-224-in-homologous-recombination-proficient-advanced-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-jnj-90301900-with-chemoradiation-and-durvalumab-in-stage-iii-unresectable-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-liposomal-irinotecan-carboplatin-and-oxaliplatin-in-first-line-treatment-of-metastatic-or-locally-advanced-esophagogastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-livmoniplimab-and-budigalimab-versus-chemotherapy-in-metastatic-urothelial-carcinoma-post-checkpoint-inhibitor-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-mirvetuximab-soravtansine-dosing-schedules-in-platinum-resistant-high-grade-epithelial-ovarian-primary-peritoneal-or-fallopian-tube-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-mrna-4157-and-bcg-versus-bcg-monotherapy-in-high-risk-non-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-mrna-4157-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-first-line-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-neoadjuvant-dostarlimab-plus-capeox-versus-capeox-in-t4n0-or-stage-iii-mmrp-mss-colon-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-nivolumab-pembrolizumab-cemiplimab-and-atezolizumab-with-radiotherapy-in-stage-iv-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-ompenaclid-with-folfiri-and-bevacizumab-in-ras-mutant-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-pembrolizumab-mk-4830-and-chemotherapy-in-neoadjuvant-treatment-of-high-grade-serous-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-pf-07220060-and-letrozole-versus-letrozole-in-postmenopausal-women-with-hr-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-radiotherapy-with-nimotuzumab-and-vinorelbine-in-pediatric-diffuse-intrinsic-pontine-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-radium-224-adsorbed-in-calcium-carbonate-microparticles-for-peritoneal-carcinomatosis-from-colorectal-carcinoma-post-crs-and-hipec2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-relatlimab-and-nivolumab-in-advanced-hepatocellular-carcinoma-post-tyrosine-kinase-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-simvastatin-with-nivolumab-and-oxaliplatin-based-chemotherapy-in-arid1a-mutated-advanced-gastroesophageal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-telisotuzumab-adizutecan-monotherapy-versus-standard-care-in-post-adjuvant-ctdna-positive-colorectal-cancer-without-radiographic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-valproic-acid-simvastatin-and-gemcitabine-nab-paclitaxel-regimens-in-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-valproic-acid-with-bevacizumab-and-oxaliplatin-fluoropyrimidine-regimens-in-ras-mutated-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-valproic-acid-with-panitumumab-and-irinotecan-in-ras-braf-wild-type-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-vosoritide-in-pediatric-patients-with-turner-syndrome-shox-deficiency-and-noonan-syndrome-unresponsive-to-somatropin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-zanubrutinib-and-obinutuzumab-versus-obinutuzumab-monotherapy-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-study-of-zilovertamab-vedotin-plus-r-chp-versus-polatuzumab-vedotin-plus-r-chp-in-treatment-naive-gcb-dlbcl-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-of-dostarlimab-versus-standard-of-care-in-dmmr-msi-non-colorectal-non-endometrial-locally-advanced-or-metastatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-of-extracorporeal-photopheresis-vs-standard-therapy-for-steroid-refractory-immune-related-colitis-hepatitis-in-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-of-relatlimab-and-nivolumab-with-chemotherapy-versus-nivolumab-with-chemotherapy-in-stage-iv-or-recurrent-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-of-stereotactic-radiosurgery-with-binimetinib-encorafenib-and-pembrolizumab-in-brafv600-mutation-positive-melanoma-with-brain-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-of-vq-101-to-evaluate-safety-and-disease-progression-in-participants-with-gba1-associated-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-randomized-trial-on-enhanced-dermatologic-management-in-egfr-mutated-nsclc-patients-treated-with-amivantamab-and-lazertinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-single-arm-open-label-study-of-datopotamab-deruxtecan-in-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-single-arm-open-label-study-of-dostarlimab-monotherapy-in-untreated-stage-ii-iii-dmmr-msi-h-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-assessing-safety-and-efficacy-of-surovatamig-in-adults-with-antibody-mediated-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-89zr-ced88004s-immunopet-imaging-in-large-b-cell-lymphoma-patients-pre-and-post-cd19-directed-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-a-dihydrotetrabenazine-for-tardive-dyskinesia-in-schizophrenia-schizoaffective-mood-gastrointestinal-or-neuroleptic-induced-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-aga2115-to-assess-safety-and-efficacy-in-adults-with-osteogenesis-imperfecta2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-al8326-safety-and-efficacy-in-patients-with-small-cell-lung-cancer-requiring-second-line-or-later-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-aln-6400-in-female-patients-with-von-willebrand-disease-and-heavy-menstrual-bleeding2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-atr-inhibitor-tuvusertib-with-parp-inhibitor-niraparib-or-atm-inhibitor-lartesertib-in-brca-mutant-hrd-positive-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-bemarituzumab-and-flot-chemotherapy-in-resectable-stage-ct2-t4a-or-n-gastric-and-gej-adenocarcinoma-overexpressing-fgfr2b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-bms-986504-monotherapy-in-advanced-metastatic-nsclc-with-homozygous-mtap-deletion-post-therapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-carboplatin-in-neoadjuvant-and-metastatic-breast-cancer-genomic-analysis-of-tumor-dna-for-treatment-optimization2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-cc-97540-cd19-targeted-nex-t-car-t-cells-in-adults-with-chronic-immune-thrombocytopenia-and-autoimmune-hemolytic-anemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-chemo-immunotherapy-and-durvalumab-in-stage-iii-unresectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-chemoimmunotherapy-with-pembrolizumab-and-olaparib-maintenance-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-dacarbazine-followed-by-immunotherapy-re-challenge-in-unresectable-or-metastatic-melanoma-resistant-to-pd-1-pd-l1-or-pd-1-ctla-4-blockade2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-datopotamab-deruxtecan-and-drug-combinations-in-advanced-non-small-cell-lung-cancer-resistant-to-osimertinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-dimethyl-fumarate-to-assess-safety-and-efficacy-in-patients-with-neurodegeneration-with-brain-iron-accumulation-nbia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-dkn-01-and-tislelizumab-chemotherapy-in-inoperable-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-ds-1062a-in-advanced-non-small-cell-lung-cancer-with-biomarker-analysis-for-therapy-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-durvalumab-tremelimumab-and-lenvatinib-in-patients-with-unresectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-empasiprubart-in-deceased-donor-renal-allograft-recipients-at-risk-for-delayed-graft-function2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-encorafenib-and-cetuximab-rechallenge-in-braf-v600e-mutant-metastatic-colorectal-cancer-post-braf-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-enfortumab-vedotin-plus-pembrolizumab-induction-followed-by-response-adapted-bladder-sparing-therapy-in-ct2-4an0-1-muscle-invasive-urothelial-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-fulvestrant-and-alpelisib-in-pik3ca-mutated-hr-her2-advanced-breast-cancer-post-fulvestrant-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-imzokitug-with-pumitamig-and-drug-combination-as-first-line-treatment-for-adults-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-intravesical-gemcitabine-hydrochloride-for-efficacy-in-patients-with-ta-low-grade-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-investigational-agents-with-pembrolizumab-and-chemotherapy-in-resectable-stage-ii-iiib-n2-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-jnj-79635322-in-patients-with-relapsed-or-refractory-multiple-myeloma-after-at-least-3-prior-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-lymphodepletion-with-fludarabine-cyclophosphamide-and-allo-647-in-relapsed-refractory-large-b-cell-lymphoma-receiving-allo-501a-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-methotrexate-dexamethasone-and-montelukast-for-mitigating-amivantamab-infusion-reactions-in-egfr-mutated-nsclc-post-osimertinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-mk-4830-mk-0482-and-pembrolizumab-in-pd-l1-positive-treatment-naive-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-mk-6482-in-participants-with-advanced-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-mk-7684a-pembrolizumab-vibostolimab-with-or-without-additional-anticancer-agents-in-advanced-solid-tumors-expressing-pd-l12026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-neoadjuvant-pembrolizumab-and-68ga-psma-hbed-cc-in-high-risk-prostate-cancer-prior-to-radical-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-neoadjuvant-pembrolizumab-in-high-risk-melanoma-patients-without-clinical-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-neoadjuvant-sacituzumab-govitecan-in-muscle-invasive-bladder-cancer-patients-ineligible-for-cisplatin-based-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-niraparib-vs-platinum-taxane-chemotherapy-in-hr-deficient-stage-iii-iv-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-oral-lirafugratinib-in-previously-treated-patients-with-unresectable-or-metastatic-solid-tumors-with-fgfr2-fusion-excluding-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-patritumab-deruxtecan-in-egfr-mutated-metastatic-or-locally-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pembrolizumab-and-chemotherapy-in-patients-with-newly-diagnosed-classical-hodgkin-lymphoma-keynote-c112026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pembrolizumab-with-boserolimab-and-chemotherapy-in-treatment-naive-advanced-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pembrolizumab-with-investigational-agents-in-pd-l-1-refractory-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-perioperative-pembrolizumab-and-sacituzumab-govitecan-in-muscle-invasive-bladder-cancer-unfit-for-cisplatin-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-perioperative-sacituzumab-govitecan-zimberelimab-and-domvanalimab-in-cisplatin-ineligible-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-personalized-immunotherapy-regimens-in-recurrent-advanced-metastatic-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pf-06823859-in-adults-with-active-cutaneous-or-systemic-lupus-erythematosus-with-cutaneous-manifestations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pf-08634404-with-carboplatin-and-etoposide-in-adults-with-previously-untreated-transformed-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-pharmacogenomic-guided-treatment-with-methotrexate-and-drug-combinations-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-povetacicept-in-adults-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-propranolol-hydrochloride-and-pembrolizumab-in-advanced-angiosarcoma-and-undifferentiated-pleomorphic-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-radamts13-for-safety-and-effectiveness-in-adults-with-acute-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-regorafenib-continuation-in-patients-with-solid-malignant-tumors-from-previous-bayer-trials2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-rinatabart-sesutecan-with-glatiramer-acetate-in-adults-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-rinatabart-sesutecan-with-glatiramer-acetate-in-patients-with-advanced-gastrointestinal-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-ruxolitinib-with-brentuximab-vedotin-or-pembrolizumab-in-relapsed-refractory-classical-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-sar448851-and-mk-6240-safety-and-efficacy-in-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-sequential-thio-and-cemiplimab-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-talazoparib-and-avelumab-as-maintenance-therapy-in-platinum-sensitive-metastatic-or-locally-advanced-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-tamibarotene-and-azacitidine-in-biomarker-positive-adults-with-acute-myeloid-leukemia-or-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-teclistamab-and-talquetamab-in-combination-with-daratumumab-lenalidomide-dexamethasone-and-bortezomib-for-high-risk-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-tusamitamab-ravtansine-with-pembrolizumab-and-platinum-based-chemotherapy-in-ceacam5-positive-advanced-nsq-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-venetoclax-versus-intensive-chemotherapy-in-favorable-risk-acute-myeloid-leukemia-with-molecular-guidance2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-of-vesleteplirsen-srp-5051-for-dose-determination-and-efficacy-in-duchenne-muscular-dystrophy-patients-amenable-to-exon-51-skipping-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-acalabrutinib-discontinuation-and-restart-in-frail-treatment-naive-elderly-patients-with-chronic-lymphocytic-leukemia-cll2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-efficacy-and-safety-of-bcl2-inhibitor-sonrotoclax-and-zanubrutinib-in-relapsed-refractory-waldenstrom-macroglobulinemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-efficacy-and-safety-of-gnt0003-with-imlifidase-pre-treatment-in-adults-with-severe-crigler-najjar-syndrome-and-anti-aav8-antibodies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-efficacy-of-5-fu-with-nal-iri-and-5-fu-with-nal-irinox-in-metastatic-pancreatic-ductal-adenocarcinoma-post-gemcitabine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-efficacy-of-induction-ipilimumab-and-nivolumab-followed-by-chemoradiation-in-urothelial-bladder-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-epcoritamab-monotherapy-or-combined-with-lenalidomide-for-anthracycline-ineligible-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-microneedling-and-photodynamic-therapy-with-methyl-aminolevulinate-hydrochloride-for-frontal-fibrosing-alopecia-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-ono-4578-and-nivolumab-with-mfolfox6-and-bevacizumab-in-non-msi-h-dmmr-pd-l1-positive-advanced-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-patritumab-deruxtecan-and-pembrolizumab-with-chemotherapy-in-high-risk-early-stage-tnbc-or-hr-low-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-pharmacodynamics-safety-and-pharmacokinetics-of-glm101-in-pmm2-cdg-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-pharmacokinetics-safety-and-tolerability-of-cefepime-enmetazobactam-in-pediatric-patients-with-complicated-urinary-tract-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-resistance-mechanisms-in-metastatic-refractory-pancreatic-cancer-treated-with-trametinib-and-hydroxychloroquine2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-safety-and-efficacy-of-al8326-in-2nd-line-treatment-of-small-cell-lung-cancer-with-controlled-brain-metastasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-safety-and-immunogenicity-of-rbcg-n-rsv-vs-conventional-bcg-in-adults-aged-602026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-selexipag-pharmacokinetics-in-pediatric-pulmonary-arterial-hypertension-patients-aged-2-to-18-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-the-efficacy-and-safety-of-riliprubart-in-antibody-mediated-rejection-prevention-and-treatment-in-adult-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-the-efficacy-and-safety-of-tabelecleucel-in-epstein-barr-virus-associated-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-the-efficacy-of-alpelisib-and-drug-combinations-in-advanced-cancer-with-genomic-or-protein-expression-variants-in-norway2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-the-safety-of-mercaptamine-with-standard-therapy-in-hospitalized-covid-19-pneumonia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-venetoclax-with-fludarabine-cytarabine-and-idarubicin-in-induction-therapy-for-newly-diagnosed-non-m3-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-on-zanubrutinib-and-bgb-11417-efficacy-and-tolerance-in-previously-treated-waldenstrom-macroglobulinemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-study-to-assess-the-efficacy-and-safety-of-spy002-072-in-adults-with-moderately-to-severely-active-rheumatologic-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-of-elacestrant-and-exemestane-in-hr-her2-metastatic-breast-cancer-with-18f-fes-avid-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-of-neoadjuvant-trastuzumab-deruxtecan-in-early-stage-her2-positive-breast-cancer-with-response-directed-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-of-oral-cannabidiol-gsl-01-001-for-symptom-management-in-patients-with-irritable-bowel-syndrome-type-d2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-of-pucotenlimab-and-becotatug-vedotin-induction-therapy-versus-becotatug-vedotin-alone-in-locally-advanced-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-on-doxycycline-for-chlamydophila-psittaci-eradication-in-newly-diagnosed-ocular-adnexal-marginal-zone-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2-trial-to-determine-the-efficacy-of-belumosudil-for-patients-with-steroid-refractory-overlap-of-syndrome-graft-versus-host-disease-sr-osgvhd-beat-gvhd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-b-study-evaluating-efficacy-and-safety-of-tyra-300-in-patients-with-low-grade-upper-tract-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-evaluation-of-allogeneic-umbilical-cord-blood-derived-nk-cells-and-rituximab-in-relapsing-b-cell-dependent-rheumatologic-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-evaluation-of-antitumoral-effects-of-cannabis-oil-dronabinol-10-cannabidiol-5-in-patients-with-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-evaluation-of-censavudine-tpn-101-for-safety-and-mechanistic-efficacy-in-aicardi-goutieres-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-evaluation-of-safety-and-tolerability-of-dns-6288-in-genetically-confirmed-catecholaminergic-polymorphic-ventricular-tachycardia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-evaluation-of-zanidatamab-with-palbociclib-and-fulvestrant-in-her2-positive-hr-positive-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-multicenter-evaluation-of-brimonidine-tartrate-gel-for-egfr-inhibitor-induced-folliculitis-in-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-multicenter-randomized-double-blind-placebo-controlled-study-of-vent-03-in-adults-with-active-cutaneous-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-open-label-basket-study-evaluating-safety-and-pharmacokinetics-of-inf904-in-moderate-to-severe-chronic-spontaneous-urticaria-and-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-open-label-study-of-neflamapimod-in-patients-with-dementia-with-lewy-bodies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-open-label-study-on-safety-and-pharmacodynamics-of-imdusiran-and-durvalumab-in-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-open-label-trial-evaluating-ferumoxtran-10-nep-1-dose-and-safety-in-rectal-cancer-patients-using-nanoecho-imaging-device2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-pilot-study-on-eltanexor-for-safety-and-efficacy-in-relapsed-refractory-npm1-mutated-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-randomized-double-blind-placebo-controlled-study-of-cr9114-monoclonal-antibody-for-intranasal-administration-in-healthy-adults-exposed-to-influenza-a-virus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-randomized-double-blind-placebo-controlled-study-of-n-acetylcysteine-amide-in-mild-cognitive-impairment-or-mild-dementia-due-to-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-randomized-double-blind-placebo-controlled-study-of-orx750-in-narcolepsy-and-idiopathic-hypersomnia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-randomized-double-blind-placebo-controlled-study-of-orziloben-nst-6179-in-intestinal-failure-associated-liver-disease-ifald2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-randomized-double-blind-placebo-controlled-study-of-pf-07976016-and-liraglutide-in-adults-with-obesity-to-evaluate-safety-and-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-study-on-safety-tolerability-and-pharmacodynamics-of-omt-28-in-patients-with-primary-mitochondrial-disease-associated-myopathy-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-study-on-terbinafine-efficacy-and-safety-in-chronic-hepatitis-b-patients-with-tenofovir-add-on-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-study-on-the-efficacy-of-ibrutinib-and-venetoclax-in-mrd-guided-treatment-for-relapsed-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2a-study-on-the-safety-and-efficacy-of-brimonidine-tartrate-gel-for-prevention-of-taxanes-induced-peripheral-neuropathy-in-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-double-blind-placebo-controlled-study-of-gsk4532990-for-efficacy-and-safety-in-adults-with-nonalcoholic-steatohepatitis-and-bridging-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-double-blind-placebo-controlled-study-of-oral-ath-063-hydrochloride-in-biologic-relapsed-refractory-moderate-to-severe-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-multicenter-randomized-double-blind-placebo-controlled-study-on-tin816-efficacy-and-safety-in-sepsis-associated-acute-kidney-injury2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-multicenter-randomized-double-blind-study-of-tak-755-radamts13-with-minimal-plasma-exchange-in-immune-mediated-thrombotic-thrombocytopenic-purpura2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-multicenter-trial-evaluating-zipalertinib-in-advanced-or-metastatic-nsclc-with-egfr-exon-20-insertion-and-uncommon-compound-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-open-label-study-evaluating-tolerability-and-safety-of-5-mg-vericiguat-in-chronic-heart-failure-with-reduced-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-open-label-study-of-selinexor-in-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-dlbcl2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-placebo-controlled-clinical-trial-preceded-by-a-single-ascending-dose-portion-and-a-phase-2-open-label-portion-to-evaluate-the-safety-and-efficacy-of-oral-infigratinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-placebo-controlled-dose-ranging-study-of-oral-ontunisertib-in-patients-with-fibrostenosing-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-placebo-controlled-study-of-subcutaneous-imvt-1402-in-adults-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-placebo-controlled-trial-evaluating-mebufotenin-gh001-efficacy-and-safety-in-treatment-resistant-depression-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-placebo-controlled-trial-of-transcon-cnp-in-pediatric-achondroplasia-for-growth-efficacy-and-safety-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-study-of-islatravir-and-ulonivirine-in-hiv-1-virologically-suppressed-adults-on-bictegravir-emtricitabine-tenofovir-alafenamide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-blind-trial-of-tremelimumab-versus-placebo-in-second-or-third-line-treatment-of-unresectable-malignant-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-double-mask-placebo-controlled-trial-of-linsitinib-in-active-moderate-to-severe-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-observer-blinded-trial-on-safety-tolerability-and-immunogenicity-of-menabcwy-vaccine-in-adolescents-aged-11-14-years-with-meningococcal-meningitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-placebo-controlled-observer-blind-study-of-vxb-221-vxb-213-bivalent-protein-vaccine-for-prevention-of-rsv-and-hmpv-lrtd-in-adults-60-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-randomized-study-of-encoberminogene-rezmadenovec-in-refractory-angina-due-to-coronary-artery-disease-with-flurpiridaz-f-18-and-13n-ammonia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-study-of-neflamapimod-in-dementia-with-lewy-bodies-patients-aged-55-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-study-of-ymi024-in-adults-with-stable-coronary-artery-disease-and-elevated-hscrp2026-10-07 https://dev.clinicalresearch.eu/trial/phase-2b-study-on-immune-response-and-safety-of-adjuvanted-rsv-subunit-vaccine-in-immunocompromised-adults-aged-182026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-placebo-controlled-study-on-the-efficacy-and-safety-of-plozasiran-in-adults-with-hypertriglyceridemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-placebo-controlled-trial-evaluating-plozasiran-efficacy-and-safety-in-adults-with-severe-hypertriglyceridemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-placebo-controlled-trial-of-olatorepatide-a-glp-1-gip-receptor-agonist-for-weight-reduction-in-adults-with-overweight-or-obesity-without-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-randomized-placebo-controlled-study-of-oral-mitapivat-on-transfusion-burden-in-patients-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-randomized-study-of-lisaftoclax-apg-2575-and-azacitidine-in-newly-diagnosed-higher-risk-myelodysplastic-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-randomized-study-of-topical-ruxolitinib-1-5-cream-versus-vehicle-in-adults-with-hidradenitis-suppurativa-true-hs22026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-study-comparing-efficacy-and-safety-of-ct-p51-and-pembrolizumab-with-platinum-pemetrexed-chemotherapy-in-metastatic-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-study-of-ibuzatrelvir-versus-placebo-in-non-hospitalized-adults-and-adolescents-with-covid-19-at-high-risk-for-severe-illness2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-study-of-ivosidenib-in-adults-with-idh1-mutant-locally-advanced-or-metastatic-conventional-chondrosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-study-of-zorevunersen-sodium-in-reducing-major-motor-seizure-frequency-in-dravet-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-double-blind-study-on-rimegepant-for-intermittent-prevention-of-menstrual-migraine-in-women-aged-18-452026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-daratumumab-with-bortezomib-lenalidomide-and-dexamethasone-in-untreated-multiple-myeloma-patients-ineligible-for-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-daratumumab-with-bortezomib-lenalidomide-and-dexamethasone-versus-bortezomib-lenalidomide-and-dexamethasone-in-untreated-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-dostarlimab-sequential-therapy-post-chemoradiation-in-locally-advanced-unresected-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-elranatamab-monotherapy-and-elranatamab-plus-daratumumab-versus-daratumumab-pomalidomide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-erdafitinib-versus-vinflunine-docetaxel-or-pembrolizumab-in-advanced-urothelial-carcinoma-with-fgfr-aberrations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-etelcalcetide-for-secondary-hyperparathyroidism-in-pediatric-patients-with-chronic-kidney-disease-on-hemodialysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-exagamglogene-autotemcel-efficacy-and-safety-in-pediatric-transfusion-dependent-b-thalassemia-with-filgrastim-busulfan-and-plerixafor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-exagamglogene-autotemcel-efficacy-and-safety-in-severe-sickle-cell-disease-bs-bc-genotype-with-plerixafor-and-busulfan2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-exagamglogene-autotemcel-plerixafor-and-busulfan-in-pediatric-patients-with-severe-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-expec9v-vaccine-for-preventing-invasive-extraintestinal-pathogenic-escherichia-coli-disease-in-adults-aged-60-with-prior-urinary-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-fianlimab-and-cemiplimab-versus-pembrolizumab-in-treatment-naive-unresectable-locally-advanced-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-ima203-versus-investigator-s-choice-in-previously-treated-unresectable-or-metastatic-cutaneous-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-intratumoral-nbtxr3-with-radiotherapy-cetuximab-in-platinum-ineligible-elderly-patients-with-locally-advanced-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-inz-701-efficacy-and-safety-in-pediatric-ectonucleotide-pyrophosphatase-phosphodiesterase-1-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-inz-701-for-efficacy-and-safety-in-infants-with-ectonucleotide-pyrophosphatase-phosphodiesterase-1-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-itepekimab-efficacy-and-safety-in-adults-with-inadequately-controlled-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-itepekimab-in-reducing-acute-exacerbations-in-moderate-to-severe-chronic-obstructive-pulmonary-disease-in-former-smokers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-lenalidomide-and-daratumumab-sc-versus-lenalidomide-and-dexamethasone-in-frail-newly-diagnosed-multiple-myeloma-patients-ineligible-for-high-dose-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-ly3437943-for-efficacy-and-safety-in-obesity-or-overweight-patients-with-knee-osteoarthritis-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-mk-4280a-favezelimab-and-pembrolizumab-versus-standard-care-in-metastatic-pd-l1-positive-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-nvl-655-versus-alectinib-in-treatment-naive-patients-with-alk-positive-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pegozafermin-efficacy-and-safety-in-metabolic-dysfunction-associated-steatohepatitis-with-compensated-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pembrolizumab-and-olaparib-with-chemoradiation-in-unresectable-stage-iii-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pembrolizumab-plus-carboplatin-taxane-and-maintenance-mk-2870-in-first-line-metastatic-squamous-nsclc-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pembrolizumab-with-carboplatin-taxane-and-maintenance-olaparib-in-metastatic-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pembrolizumab-with-pemetrexed-platinum-and-maintenance-olaparib-vs-pemetrexed-in-first-line-metastatic-nonsquamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-pharmacokinetics-safety-and-tolerability-of-vx-121-tezacaftor-deutivacaftor-combination-in-pediatric-cystic-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-relacorilant-and-nab-paclitaxel-versus-nab-paclitaxel-monotherapy-in-advanced-platinum-resistant-high-grade-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-remibrutinib-efficacy-and-safety-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-ripasudil-k-321-eye-drops-on-visual-acuity-post-descemetorhexis-in-fuchs-endothelial-corneal-dystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-rusfertide-ptg-300-for-hematocrit-control-in-polycythemia-vera-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-setrusumab-versus-bisphosphonates-in-pediatric-osteogenesis-imperfecta-types-i-iii-and-iv-a-randomized-open-label-active-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-tak-330-for-reversal-of-direct-oral-factor-xa-inhibitor-anticoagulation-in-patients-requiring-urgent-surgical-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-teclistamab-with-lenalidomide-versus-lenalidomide-monotherapy-in-maintenance-therapy-for-newly-diagnosed-multiple-myeloma-post-asct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-trastuzumab-deruxtecan-and-rilvegostomig-versus-standard-chemotherapy-in-her2-expressing-advanced-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-trastuzumab-deruxtecan-monotherapy-or-sequential-thp-in-high-risk-her2-positive-early-stage-breast-cancer-compared-to-ddac-thp2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-upadacitinib-efficacy-and-safety-in-adults-with-moderately-to-severely-active-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-vedolizumab-subcutaneous-pharmacokinetics-safety-and-immunogenicity-in-pediatric-patients-with-moderate-to-severe-ulcerative-colitis-or-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-venetoclax-and-azacitidine-post-allogeneic-stem-cell-transplantation-in-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-evaluation-of-zimberelimab-and-domvanalimab-versus-pembrolizumab-in-pd-l1-high-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-extension-study-on-long-term-safety-and-tolerability-of-tolebrutinib-in-relapsing-and-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-global-multicenter-randomized-double-blind-placebo-controlled-study-of-dnth103-claseprubart-in-adults-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-double-blind-randomized-placebo-controlled-trial-evaluating-infigratinib-efficacy-and-safety-in-pediatric-achondroplasia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-double-blind-randomized-study-of-ivosidenib-and-azacitidine-in-untreated-idh1-mutated-acute-myeloid-leukemia-patients-aged-18-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-evaluation-of-68ga-psma-11-pet-mri-for-staging-intermediate-and-high-risk-prostate-cancer-prior-to-radical-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-evaluation-of-tralokinumab-with-topical-corticosteroids-in-pediatric-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-evaluation-of-ugn-102-mitomycin-efficacy-and-safety-in-low-grade-non-muscle-invasive-bladder-cancer-at-intermediate-recurrence-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-randomized-study-of-fedratinib-versus-best-available-therapy-in-intermediate-high-risk-myelofibrosis-post-ruxolitinib-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-randomized-study-of-gilteritinib-gilteritinib-plus-azacitidine-and-azacitidine-in-newly-diagnosed-flt3-mutated-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-randomized-study-of-olverembatinib-vs-bosutinib-in-chronic-phase-chronic-myeloid-leukemia-patients-polaris-22026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-randomized-study-of-rmc-6236-versus-docetaxel-in-patients-with-previously-treated-locally-advanced-or-metastatic-ras-mutant-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-randomized-study-of-rmc-6236-versus-standard-of-care-in-metastatic-pancreatic-ductal-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-rct-of-duvelisib-vs-gemcitabine-or-bendamustine-in-relapsed-refractory-nodal-t-cell-lymphoma-with-tfh-phenotype2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-open-label-study-on-long-term-safety-and-tolerability-of-rimegepant-for-acute-migraine-treatment-in-pediatric-patients-aged-6-to-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-study-of-anifrolumab-in-adults-with-active-proliferative-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-study-of-ianalumab-in-active-sjogren-s-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-study-of-ibrutinib-and-rituximab-in-treatment-naive-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-study-of-remibrutinib-in-adults-with-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-evaluating-ianalumab-efficacy-and-safety-in-active-lupus-nephritis-with-standard-of-care-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-evaluating-lutikizumab-efficacy-and-safety-in-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-of-fordadistrogene-movaparvovec-in-duchenne-muscular-dystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-of-oral-ozanimod-for-maintenance-in-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-blind-trial-of-ceftriaxone-metronidazole-rifampicin-and-moxifloxacin-in-hurley-stage-2-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-double-masked-placebo-controlled-trial-of-tinlarebant-in-geographic-atrophy-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-study-comparing-efficacy-and-safety-of-idecabtagene-vicleucel-versus-standard-regimens-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-study-of-abbv-383-monotherapy-versus-standard-therapy-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-study-of-ifinatamab-deruxtecan-versus-chemotherapy-in-pretreated-advanced-esophageal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-study-of-ifinatamab-deruxtecan-versus-physician-s-choice-in-relapsed-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-study-of-venetoclax-and-dexamethasone-versus-pomalidomide-and-dexamethasone-in-t-11-14-positive-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-trial-of-epcoritamab-rituximab-and-lenalidomide-versus-chemoimmunotherapy-in-untreated-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-trial-of-selpercatinib-vs-cabozantinib-or-vandetanib-in-ret-mutant-medullary-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-open-label-trial-of-trastuzumab-deruxtecan-and-pembrolizumab-vs-pembrolizumab-with-platinum-based-chemotherapy-in-her2-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-placebo-controlled-trial-evaluating-efficacy-safety-and-immunogenicity-of-vla15-vaccine-for-lyme-disease-in-individuals-aged-5-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-comparing-efficacy-and-safety-of-sacituzumab-tirumotecan-versus-physician-s-choice-in-advanced-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-abelacimab-vs-apixaban-on-vte-recurrence-and-bleeding-in-cancer-associated-venous-thromboembolism2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-epcoritamab-and-lenalidomide-vs-rituximab-gemcitabine-and-oxaliplatin-in-relapsed-refractory-dlbcl2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-guselkumab-efficacy-and-safety-in-pediatric-patients-with-moderate-to-severe-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-ivosidenib-and-azacitidine-monotherapy-in-hma-naive-myelodysplastic-syndromes-with-idh1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-rituximab-plus-zanubrutinib-versus-rituximab-monotherapy-in-untreated-symptomatic-splenic-marginal-zone-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-sotorasib-versus-docetaxel-in-kras-p-g12c-mutated-advanced-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-trastuzumab-deruxtecan-vs-ado-trastuzumab-emtansine-in-her2-positive-metastatic-breast-cancer-post-trastuzumab-and-taxane-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-study-of-trastuzumab-deruxtecan-vs-trastuzumab-emtansine-in-high-risk-her2-positive-breast-cancer-with-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-trial-of-selpercatinib-vs-platinum-based-chemotherapy-with-pemetrexed-and-pembrolizumab-in-ret-fusion-positive-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-randomized-trial-of-venetoclax-obinutuzumab-and-pirtobrutinib-in-untreated-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-comparing-tivozanib-plus-nivolumab-versus-tivozanib-monotherapy-in-renal-cell-carcinoma-post-immune-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-of-18f-florbetaben-pet-ct-for-non-invasive-diagnosis-of-cardiac-al-amyloidosis-in-patients-with-monoclonal-component2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-of-ravulizumab-plus-best-supportive-care-in-pediatric-patients-with-hsct-associated-thrombotic-microangiopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-of-tabelecleucel-in-epstein-barr-virus-associated-post-transplant-lymphoproliferative-disease-post-rituximab-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-of-venetoclax-and-azacitidine-as-maintenance-therapy-in-acute-myeloid-leukemia-patients-in-first-remission2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-on-15o-water-pet-imaging-for-coronary-artery-disease-diagnosis-during-pharmacological-stress-and-rest-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-on-abelacimab-vs-dalteparin-for-vte-recurrence-and-bleeding-in-gi-gu-cancer-associated-vte-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-study-on-ferumoxytol-vs-iron-sucrose-for-iron-deficiency-anemia-in-pediatric-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-trial-comparing-bjt-778-and-bulevirtide-in-chronic-hepatitis-d-infection-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-trial-comparing-repotrectinib-and-crizotinib-in-tki-naive-ros1-positive-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicenter-trial-of-neoadjuvant-ipilimumab-and-nivolumab-versus-adjuvant-nivolumab-in-patients-with-macroscopic-stage-iii-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multicentre-study-on-subcutaneous-human-normal-immunoglobulin-newnorm-for-primary-immunodeficiency-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multinational-randomized-double-blind-placebo-controlled-study-on-inhaled-treprostinil-efficacy-and-safety-in-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multinational-randomized-study-of-sasanlimab-with-bacillus-calmette-guerin-in-high-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multinational-study-of-resmetirom-in-non-alcoholic-steatohepatitis-patients-to-assess-nash-resolution-and-fibrosis-progression-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multinational-study-on-the-safety-and-efficacy-of-bidridistrogene-xeboparvovec-in-limb-girdle-muscular-dystrophy-type-2e-r4-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-multiregional-study-of-ivonescimab-with-chemotherapy-vs-pembrolizumab-with-chemotherapy-in-metastatic-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-non-inferiority-trial-of-vincristine-actinomycin-d-and-doxorubicin-versus-vincristine-carboplatin-and-etoposide-in-stage-iv-pediatric-renal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-comparison-of-ifinatamab-deruxtecan-and-docetaxel-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-evaluation-of-danicopan-as-adjunct-to-ravulizumab-or-eculizumab-in-pediatric-paroxysmal-nocturnal-hemoglobinuria-with-extravascular-hemolysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-evaluation-of-epcoritamab-with-rituximab-and-lenalidomide-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-evaluation-of-pegzilarginase-safety-pharmacokinetics-and-efficacy-in-pediatric-patients-with-arginase-1-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-evaluation-of-ptc923-sepiapterin-for-long-term-safety-and-dietary-impact-in-phenylketonuria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-extension-study-on-long-term-safety-and-efficacy-of-plozasiran-in-adults-with-hypertriglyceridemia-using-synthetic-sirna-oligonucleotide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-extension-study-on-the-safety-of-intravitreal-avacincaptad-pegol-in-geographic-atrophy-patients-post-gather2-completion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-extension-study-on-viltolarsen-safety-and-efficacy-in-ambulatory-male-patients-with-duchenne-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-rollover-study-of-doravirine-islatravir-for-hiv-1-treatment-in-participants-from-prior-phase-2-3-trials2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-evaluating-efficacy-and-safety-of-giroctocogene-fitelparvovec-in-adult-males-with-moderately-severe-to-severe-hemophilia-a2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-of-adjunctive-ganaxolone-in-tuberous-sclerosis-complex-related-epilepsy-in-pediatric-and-adult-populations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-of-elranatamab-vs-elotuzumab-pomalidomide-dexamethasone-or-carfilzomib-in-relapsed-refractory-multiple-myeloma-post-anti-cd38-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-on-efficacy-safety-and-tolerability-of-etranacogene-dezaparvovec-in-adolescent-males-with-severe-or-moderately-severe-hemophilia-b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-on-pharmacokinetics-safety-and-tolerability-of-elexacaftor-tezacaftor-ivacaftor-in-cystic-fibrosis-patients-aged-12-to-24-months2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-open-label-study-on-the-safety-of-damoctocog-alfa-pegol-in-prophylaxis-and-treatment-of-bleeding-in-pediatric-patients-with-severe-hemophilia-a2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-adjuvant-mrna-4157-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-high-risk-stage-ii-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-bemnifosbuvir-ruzasvir-versus-sofosbuvir-velpatasvir-in-chronic-hepatitis-c-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-cabozantinib-and-atezolizumab-versus-second-novel-hormonal-therapy-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-cabozantinib-and-atezolizumab-versus-sorafenib-in-treatment-naive-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-pacritinib-versus-physician-s-choice-in-myelofibrosis-patients-with-severe-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-controlled-trial-of-vitrectomy-subretinal-alteplase-and-intravitreal-aflibercept-for-submacular-hemorrhage-in-exudative-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-extension-study-of-amg-133-maridebart-cafraglutide-for-weight-loss-and-safety-in-adults-with-obesity-overweight-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-extension-study-of-maridebart-cafraglutide-for-chronic-weight-management-in-adults-with-obesity-or-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-crossover-study-of-deucrictibant-for-on-demand-treatment-of-hereditary-angioedema-attacks-in-adolescents-and-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-multicenter-study-of-absk021-hydrochloride-hydrate-in-tenosynovial-giant-cell-tumor-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-evaluating-izokibep-efficacy-and-safety-in-moderate-to-severe-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-acoramidis-hydrochloride-for-transthyretin-amyloidosis-prevention-in-asymptomatic-ttr-variant-carriers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-adjuvant-selpercatinib-in-stage-ib-iiia-ret-fusion-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-alxn1850-in-adolescents-and-adults-with-hypophosphatasia-naive-to-asfotase-alfa-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-apalutamide-and-androgen-deprivation-therapy-in-high-risk-localized-or-locally-advanced-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-apalutamide-and-androgen-deprivation-therapy-in-metastatic-hormone-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-apalutamide-and-gnrh-agonist-in-high-risk-localized-or-locally-advanced-prostate-cancer-with-primary-radiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-apalutamide-with-abiraterone-acetate-and-prednisone-in-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-asundexian-for-ischemic-stroke-prevention-in-adults-post-acute-non-cardioembolic-stroke-or-high-risk-tia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-avalotcagene-ontaparvovec-gene-transfer-in-late-onset-ornithine-transcarbamylase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-botulinum-toxin-type-a-in-adult-patients-with-chronic-pelvic-pain-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-camlipixant-in-adults-with-refractory-or-unexplained-chronic-cough2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-carbetocin-nasal-spray-for-hyperphagia-in-prader-willi-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-eneboparatide-azp-3601-efficacy-and-safety-in-chronic-hypoparathyroidism-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-esk-001-and-apremilast-in-moderate-to-severe-plaque-psoriasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-etavopivat-in-pediatric-patients-with-sickle-cell-disease-to-reduce-vaso-occlusive-crises2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-fazirsiran-in-alpha-1-antitrypsin-deficiency-associated-liver-disease-with-metavir-f1-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-ficlatuzumab-and-cetuximab-in-recurrent-or-metastatic-hpv-negative-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-ianalumab-in-patients-with-active-sjogren-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-ianalumab-in-systemic-lupus-erythematosus-patients-on-standard-of-care-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-inhaled-treprostinil-in-progressive-pulmonary-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-intravenous-sodium-iodide-fdy-5301-in-anterior-st-elevation-myocardial-infarction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-itepekimab-in-adults-with-inadequately-controlled-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-karxt-trospium-chloride-xanomeline-tartrate-for-acute-mania-in-bipolar-i-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-lanifibranor-in-adults-with-non-cirrhotic-non-alcoholic-steatohepatitis-and-fibrosis-stages-f2-f32026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-mavorixafor-in-chronic-neutropenia-with-recurrent-or-serious-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-nipocalimab-in-adults-with-moderate-to-severe-sjogren-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-olezarsen-isis-678354-in-hypertriglyceridemia-and-atherosclerotic-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-once-daily-inhaled-treprostinil-palmitil-powder-for-efficacy-and-safety-in-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-oral-cenerimod-in-adults-with-systemic-lupus-erythematosus-and-active-lupus-nephritis-on-background-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-pegcetacoplan-in-c3-glomerulopathy-and-immune-complex-membranoproliferative-glomerulonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-pembrolizumab-with-chemoradiation-and-olaparib-in-limited-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-rimegepant-sulfate-for-migraine-prevention-in-adolescents-with-chronic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-romiplostim-for-chemotherapy-induced-thrombocytopenia-in-gastrointestinal-pancreatic-or-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-tamibarotene-and-azacitidine-in-rara-positive-higher-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-telitacicept-in-moderately-to-severely-active-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-tezepelumab-in-pediatric-patients-aged-5-to-12-years-with-severe-uncontrolled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-tulisokibart-efficacy-and-safety-in-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-upadacitinib-in-moderate-to-severe-hidradenitis-suppurativa-post-anti-tnf-therapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-ve303-for-recurrent-clostridioides-difficile-infection-prevention-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-venetoclax-and-azacitidine-in-treatment-naive-acute-myeloid-leukemia-ineligible-for-standard-induction-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-of-vimseltinib-in-patients-with-tenosynovial-giant-cell-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-on-losmapimod-efficacy-and-safety-in-facioscapulohumeral-muscular-dystrophy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-study-on-maralixibat-chloride-efficacy-and-safety-in-cholestatic-pruritus-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-evaluating-intravenous-efzofitimod-efficacy-and-safety-in-pulmonary-sarcoidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-evaluating-rimegepant-efficacy-and-safety-in-acute-migraine-treatment-in-pediatric-patients-aged-6-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-evaluating-ritlecitinib-efficacy-and-safety-in-pediatric-patients-with-severe-alopecia-areata2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-abacavir-sulfate-lamivudine-and-dolutegravir-sodium-in-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-adx-324-for-hereditary-angioedema-attack-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-atrasentan-in-patients-with-immunoglobulin-a-nephropathy-at-risk-of-renal-function-decline2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-bleximenib-venetoclax-and-azacitidine-in-acute-myeloid-leukemia-with-kmt2a-rearrangements-or-npm1-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-capsaicin-8-patches-for-analgesic-efficacy-in-chronic-coccygodynia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-deucrictibant-xr-for-prophylaxis-of-angioedema-attacks-in-hereditary-angioedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-efruxifermin-in-compensated-cirrhosis-due-to-nash-mash2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-efruxifermin-in-non-cirrhotic-nash-mash-with-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-eftilagimod-alpha-with-paclitaxel-in-her2-negative-low-metastatic-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-elacestrant-and-everolimus-in-er-her2-esr1-mutated-advanced-breast-cancer-post-endocrine-and-cdk4-6-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-elritercept-in-transfusion-dependent-anemia-in-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-etavopivat-in-adolescents-and-adults-with-sickle-cell-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-fostemsavir-in-heavily-treatment-experienced-patients-with-multi-drug-resistant-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-masitinib-and-riluzole-in-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-pariglasgene-brecaparvovec-in-glycogen-storage-disease-type-ia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-povetacicept-in-adults-with-immunoglobulin-a-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-quemliclustat-with-nab-paclitaxel-and-gemcitabine-in-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-retatrutide-ly3437943-in-obesity-overweight-and-chronic-low-back-pain-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-setmelanotide-in-obesity-with-pomc-pcsk1-lepr-ncoa1-or-sh2b1-gene-variants2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-sirolimus-erapa-in-familial-adenomatous-polyposis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-placebo-controlled-trial-of-vorasidenib-in-residual-or-recurrent-grade-2-glioma-with-idh1-idh2-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-sham-controlled-trial-of-gtx-102-efficacy-and-safety-in-pediatric-angelman-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-comparing-efficacy-and-safety-of-ct-p55-and-secukinumab-in-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-aficamten-versus-placebo-in-adults-with-symptomatic-non-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-aficamten-vs-metoprolol-succinate-in-adults-with-symptomatic-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-belrestotug-and-dostarlimab-versus-pembrolizumab-in-pd-l1-high-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-belzutifan-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-adjuvant-treatment-of-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-bemarituzumab-with-mfolfox6-in-fgfr2b-overexpressing-advanced-gastric-or-gastroesophageal-junction-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-brentuximab-vedotin-lenalidomide-and-rituximab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-cabozantinib-nivolumab-and-ipilimumab-in-untreated-advanced-or-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-camlipixant-blu-5937-versus-placebo-in-adults-with-refractory-or-unexplained-chronic-cough2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-cefepime-nacubactam-and-aztreonam-nacubactam-versus-imipenem-cilastatin-in-complicated-uti-and-acute-pyelonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-dotinurad-versus-allopurinol-in-adults-with-hyperuricemia-associated-with-gout2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-empasiprubart-vs-human-normal-immunoglobulin-iv-in-adults-with-multifocal-motor-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-frexalimab-sar441344-versus-placebo-in-adults-with-nonrelapsing-secondary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-frexalimab-sar441344-versus-teriflunomide-in-adults-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-frexalimab-versus-teriflunomide-in-adults-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-ianalumab-and-eltrombopag-versus-placebo-in-primary-immune-thrombocytopenia-post-steroid-treatment-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-ibuzatrelvir-and-remdesivir-in-severely-immunocompromised-adults-with-symptomatic-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-inebilizumab-efficacy-and-safety-in-igg4-related-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-mavorixafor-versus-placebo-in-whim-syndrome-patients-with-open-label-extension2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-mt-7117-dersimelagon-phosphate-in-erythropoietic-protoporphyria-and-x-linked-protoporphyria-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-niraparib-abiraterone-acetate-and-prednisone-in-hrr-gene-mutated-metastatic-castration-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-niraparib-tosilate-monohydrate-maintenance-in-advanced-ovarian-cancer-post-platinum-chemotherapy-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-niraparib-tosilate-monohydrate-versus-placebo-in-her2-negative-brca-mutated-or-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-nt-201-vs-placebo-in-adults-with-moderate-to-severe-platysma-prominence2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-ntla-2001-efficacy-and-safety-in-transthyretin-amyloidosis-with-cardiomyopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-olatorepatide-a-glp-1-gip-receptor-agonist-for-weight-reduction-in-adults-with-overweight-obesity-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-her2-negative-advanced-gastric-or-gej-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-pembrolizumab-with-gemcitabine-cisplatin-vs-placebo-with-gemcitabine-cisplatin-in-advanced-biliary-tract-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-pf-06821497-and-enzalutamide-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-pitolisant-vs-placebo-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-platinum-based-therapy-with-dostarlimab-and-niraparib-vs-standard-care-in-stage-iii-iv-non-mucinous-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-regn7508-regn9933-for-stroke-systemic-embolism-prevention-in-atrial-fibrillation-patients-unsuitable-for-oral-anticoagulation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-safety-tolerability-and-immunogenicity-of-pf-07872412-catch-up-vaccination-vs-20-valent-pcv-in-healthy-children-and-adolescents2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-sodium-sulfide-nonahydrate-and-saccharomyces-cerevisiae-type-d-extract-in-acute-rhinitis-rhinopharyngitis-and-rhinosinusitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-subcutaneous-sonelokimab-in-biologic-dmard-naive-adults-with-active-psoriatic-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-talazoparib-and-enzalutamide-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-tucatinib-with-ado-trastuzumab-emtansine-in-unresectable-locally-advanced-or-metastatic-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-tucatinib-with-trastuzumab-and-pertuzumab-in-maintenance-therapy-for-metastatic-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-tucidinostat-and-nivolumab-versus-placebo-and-nivolumab-in-metastatic-or-unresectable-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-of-vidofludimus-calcium-versus-placebo-in-adults-with-relapsing-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-on-efficacy-and-safety-of-abrocitinib-in-pediatric-patients-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-study-on-efficacy-and-safety-of-subcutaneous-tildrakizumab-in-moderate-to-severe-genital-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-comparing-efficacy-and-safety-of-retatrutide-ly3437943-versus-tirzepatide-ly3298176-in-adults-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-comparing-efficacy-and-safety-of-zasocitinib-vs-deucravacitinib-in-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-deupirfenidone-lyt-100-versus-pirfenidone-in-adults-with-idiopathic-pulmonary-fibrosis-efficacy-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-encorafenib-binimetinib-and-pembrolizumab-in-braf-v600e-k-mutation-positive-metastatic-or-unresectable-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-nivolumab-and-relatlimab-versus-nivolumab-monotherapy-in-stage-iii-iv-melanoma-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-nivolumab-versus-placebo-in-high-risk-hepatocellular-carcinoma-post-hepatic-resection-or-ablation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-ociperlimab-and-tislelizumab-vs-pembrolizumab-in-pd-l1-selected-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-pembrolizumab-and-enzalutamide-with-adt-versus-placebo-and-enzalutamide-with-adt-in-metastatic-hormone-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-regn7508-anti-fxi-monoclonal-antibody-versus-apixaban-for-stroke-and-systemic-embolism-prevention-in-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-riliprubart-versus-intravenous-immunoglobulin-in-chronic-inflammatory-demyelinating-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-rituximab-and-subcutaneous-belimumab-versus-rituximab-and-placebo-in-adults-with-chronic-immune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-selinexor-maintenance-versus-placebo-post-chemotherapy-in-advanced-or-recurrent-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-blind-trial-of-talazoparib-and-enzalutamide-versus-placebo-and-enzalutamide-in-ddr-gene-mutated-metastatic-castration-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-masked-placebo-controlled-study-of-oxymetazoline-hydrochloride-0-1-eye-drops-for-acquired-blepharoptosis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-masked-placebo-controlled-trial-of-brepocitinib-tosilate-in-adults-with-active-non-infectious-intermediate-posterior-and-panuveitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-double-masked-study-of-vorolanib-eyp-1901-versus-aflibercept-in-patients-with-wet-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-multicentric-open-label-study-of-capsaicin-patch-vs-oral-duloxetine-in-chemotherapy-induced-peripheral-neuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-noninferiority-trial-of-subcutaneous-versus-intravenous-nivolumab-in-advanced-or-metastatic-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-observer-blind-non-inferiority-trial-of-mrna-seasonal-influenza-vaccine-gskvx000000077430-077507-vs-high-dose-trivalent-tiv-in-adults-65-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-atebimetinib-added-to-modified-gemcitabine-nab-paclitaxel-versus-standard-gemcitabine-nab-paclitaxel-in-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-avutometinib-and-defactinib-versus-standard-treatment-in-recurrent-low-grade-serous-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-axatilimab-versus-best-available-therapy-in-chronic-graft-versus-host-disease-post-two-systemic-therapy-lines2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-belzutifan-and-zanzalintinib-versus-cabozantinib-in-advanced-renal-cell-carcinoma-post-anti-pd-1-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-imlunestrant-abemaciclib-and-endocrine-therapy-in-er-her2-advanced-breast-cancer-post-endocrine-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-lorlatinib-versus-crizotinib-in-first-line-treatment-of-advanced-alk-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-mesenchymal-stromal-cells-mc0518-versus-best-available-therapy-in-steroid-refractory-acute-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-nivolumab-and-cabozantinib-vs-sunitinib-in-untreated-advanced-or-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-nivolumab-and-ipilimumab-versus-sunitinib-in-treatment-naive-advanced-or-metastatic-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-op-1250-versus-standard-of-care-in-er-her2-advanced-or-metastatic-breast-cancer-post-endocrine-and-cdk4-6-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-opevesostat-versus-abiraterone-acetate-or-enzalutamide-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-oral-orforglipron-versus-weekly-dulaglutide-for-glycemic-control-in-adolescents-10-18-y-with-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-orforglipron-vs-dapagliflozin-in-adults-with-type-2-diabetes-and-inadequate-glycemic-control-on-metformin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-pirtobrutinib-versus-ibrutinib-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-rinatabart-sesutecan-versus-investigator-s-choice-in-platinum-resistant-ovarian-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-of-xl092-and-atezolizumab-versus-regorafenib-in-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-study-on-efficacy-and-safety-of-vutrisiran-vs-patisiran-in-hereditary-transthyretin-amyloidosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-comparing-brentuximab-vedotin-plus-avd-versus-abvd-in-advanced-classical-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-bevacizumab-plus-erlotinib-versus-erlotinib-monotherapy-in-egfr-mutated-advanced-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-datopotamab-deruxtecan-plus-pembrolizumab-versus-pembrolizumab-in-advanced-or-metastatic-pd-l1-high-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-epcoritamab-versus-investigator-s-choice-chemotherapy-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-gsk5733584-versus-standard-of-care-combination-therapy-in-platinum-resistant-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-ose2101-versus-docetaxel-in-hla-a2-positive-metastatic-nsclc-patients-with-secondary-resistance-to-immune-checkpoint-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-selinexor-pomalidomide-and-dexamethasone-vs-elotuzumab-pomalidomide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-open-label-trial-of-tisotumab-vedotin-versus-chemotherapy-in-second-or-third-line-recurrent-or-metastatic-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-placebo-controlled-study-on-the-efficacy-and-safety-of-zalunfiban-in-pre-hospital-st-elevation-myocardial-infarction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-placebo-controlled-trial-evaluating-garetosmab-efficacy-and-safety-in-adult-patients-with-fibrodysplasia-ossificans-progressiva2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-quadruple-blind-study-on-batoclimab-efficacy-and-safety-in-adult-generalized-myasthenia-gravis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-quadruple-masked-placebo-controlled-trial-of-batoclimab-in-active-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-quadruple-masked-placebo-controlled-trial-of-batoclimab-in-active-thyroid-eye-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-comparing-asundexian-and-apixaban-for-stroke-prevention-in-atrial-fibrillation-patients-at-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-comparing-efficacy-and-safety-of-bp05-and-ranibizumab-in-patients-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-comparing-efficacy-and-safety-of-macitentan-75-mg-vs-10-mg-in-pulmonary-arterial-hypertension-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-comparing-nemtabrutinib-ibrutinib-and-acalabrutinib-in-untreated-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-abemaciclib-and-erlotinib-in-stage-iv-kras-mutated-non-small-cell-lung-cancer-post-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-acalabrutinib-versus-idelalisib-rituximab-or-bendamustine-rituximab-in-relapsed-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adagloxad-simolenin-obi-821-in-adjuvant-treatment-of-high-risk-early-stage-globo-h-positive-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adagrasib-and-cetuximab-versus-chemotherapy-in-advanced-colorectal-cancer-with-kras-g12c-mutation-post-first-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adagrasib-versus-docetaxel-in-previously-treated-advanced-non-small-cell-lung-cancer-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adjuvant-mrna-4157-and-pembrolizumab-versus-placebo-and-pembrolizumab-in-resected-stage-ii-iiib-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adjuvant-pembrolizumab-and-mrna-4157-vs-placebo-in-patients-with-completely-resected-high-risk-stage-i-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-adjuvant-pembrolizumab-with-or-without-mrna-4157-in-resectable-stage-ii-iiib-n2-non-small-cell-lung-cancer-not-achieving-pcr2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-alks-2680-and-alixorexton-for-adults-with-narcolepsy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-alnuctamab-versus-standard-regimens-in-relapsed-refractory-multiple-myeloma-efficacy-and-safety-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-alxn1850-versus-asfotase-alfa-in-pediatric-patients-with-hypophosphatasia-previously-treated-with-asfotase-alfa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-amivantamab-lazertinib-and-platinum-based-chemotherapy-in-egfr-mutated-advanced-nsclc-post-osimertinib-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-amivantamab-with-carboplatin-pemetrexed-vs-carboplatin-pemetrexed-in-egfr-exon-20ins-mutated-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-amivantamab-with-mfolfox6-or-folfiri-versus-cetuximab-with-mfolfox6-or-folfiri-in-kras-nras-and-braf-wild-type-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-anitocabtagene-autoleucel-versus-standard-therapy-in-relapsed-refractory-multiple-myeloma-patients-exposed-to-immunomodulatory-and-anti-cd38-agents2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-belantamab-mafodotin-with-lenalidomide-and-dexamethasone-vs-daratumumab-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-belzutifan-and-lenvatinib-versus-cabozantinib-in-advanced-renal-cell-carcinoma-post-anti-pd-1-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-bendamustine-rituximab-and-acalabrutinib-in-untreated-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-bgb-16673-vs-idelalisib-bendamustine-or-venetoclax-with-rituximab-in-cll-sll-patients-post-btk-and-bcl2-inhibitor-exposure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-bms-986365-versus-docetaxel-or-androgen-receptor-pathway-inhibitors-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-bms-986393-car-t-therapy-versus-standard-regimens-in-relapsed-refractory-lenalidomide-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-bomedemstat-vs-hydroxycarbamide-in-cytoreductive-therapy-naive-essential-thrombocythemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-carboplatin-paclitaxel-with-retifanlimab-vs-placebo-in-inoperable-locally-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-anal-canal2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-carfilzomib-lenalidomide-and-dexamethasone-versus-bortezomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-cemiplimab-and-platinum-based-chemotherapy-combinations-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-datopotamab-deruxtecan-durvalumab-vs-investigator-s-choice-in-stage-i-iii-triple-negative-breast-cancer-with-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-datopotamab-deruxtecan-vs-chemotherapy-in-hr-positive-her2-negative-metastatic-breast-cancer-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-datopotamab-deruxtecan-vs-chemotherapy-in-locally-recurrent-inoperable-or-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-db-1303-versus-investigator-s-choice-chemotherapy-in-her2-low-hr-metastatic-breast-cancer-post-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-dostarlimab-plus-carboplatin-paclitaxel-versus-placebo-in-recurrent-or-primary-advanced-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-echinocandin-followed-by-ibrexafungerp-vs-echinocandin-followed-by-fluconazole-in-invasive-candidiasis-candidemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-elacestrant-versus-standard-endocrine-therapy-in-node-positive-er-positive-her2-negative-early-breast-cancer-with-high-recurrence-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-elranatamab-daratumumab-and-lenalidomide-in-transplant-ineligible-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-elranatamab-versus-lenalidomide-in-patients-with-newly-diagnosed-multiple-myeloma-post-autologous-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-enfortumab-vedotin-versus-chemotherapy-in-previously-treated-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-epcoritamab-plus-r-chop-versus-r-chop-in-newly-diagnosed-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-glsi-100-gp2-sargramostim-in-her2-neu-positive-breast-cancer-with-residual-disease-or-high-risk-pcr-post-trastuzumab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-gsk5733584-versus-physician-s-choice-chemotherapy-in-advanced-recurrent-endometrial-cancer-post-platinum-chemotherapy-and-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-gskvx000000077430-077507-mrna-seasonal-influenza-vaccine-versus-standard-inactivated-vaccine-in-adults-18-64-y-immunogenicity-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-iberdomide-daratumumab-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ibrutinib-and-venetoclax-versus-chlorambucil-and-obinutuzumab-in-first-line-treatment-of-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-intermittent-vs-continuous-panitumumab-plus-folfiri-in-unresectable-left-sided-ras-b-raf-wild-type-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-io102-io103-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-untreated-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-isatuximab-with-lenalidomide-and-dexamethasone-in-high-risk-smoldering-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ivonescimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-in-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-jnj-78934804-guselkumab-and-golimumab-in-adults-with-moderately-to-severely-active-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mezigdomide-bortezomib-and-dexamethasone-vs-pomalidomide-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mk-1084-and-pembrolizumab-vs-pembrolizumab-and-placebo-in-first-line-kras-g12c-mutant-metastatic-nsclc-with-pd-l1-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mk-4280a-favezelimab-and-pembrolizumab-versus-chemotherapy-in-pd-l-1-refractory-classical-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mk-7684a-vs-pembrolizumab-in-pd-l1-positive-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mk-7684a-with-chemotherapy-vs-pembrolizumab-with-chemotherapy-in-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-mk-7684a-with-etoposide-and-platinum-vs-atezolizumab-for-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-monalizumab-and-cetuximab-versus-placebo-and-cetuximab-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-navtemadlin-and-ruxolitinib-versus-placebo-and-ruxolitinib-in-myelofibrosis-patients-with-suboptimal-ruxolitinib-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-nemvaleukin-alfa-and-pembrolizumab-versus-chemotherapy-in-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-niraparib-and-pembrolizumab-versus-placebo-in-maintenance-therapy-for-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-niraparib-tosilate-monohydrate-vs-temozolomide-in-newly-diagnosed-mgmt-unmethylated-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-nivolumab-and-ipilimumab-versus-sorafenib-or-lenvatinib-in-first-line-treatment-of-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-nivolumab-and-ipilimumab-with-chemoradiotherapy-in-locally-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-nivolumab-relatlimab-fdc-with-chemotherapy-vs-pembrolizumab-with-chemotherapy-in-stage-iv-recurrent-nsclc-with-pd-l1-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-nvxc19-combined-with-high-dose-influenza-vaccine-matrix-m-in-adults-60-years-safety-and-immunogenicity-against-covid-19-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-obinutuzumab-acalabrutinib-and-chlorambucil-in-untreated-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-onc-392-versus-docetaxel-in-metastatic-non-small-cell-lung-cancer-post-pd-1-pd-l1-inhibitor-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-patritumab-deruxtecan-vs-physician-s-choice-in-hr-positive-her2-negative-unresectable-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-patritumab-deruxtecan-vs-platinum-based-chemotherapy-in-egfr-mutated-nsclc-post-egfr-tki-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pembrolizumab-and-lenvatinib-versus-chemotherapy-in-advanced-or-recurrent-endometrial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pembrolizumab-and-sacituzumab-govitecan-combination-versus-pembrolizumab-monotherapy-in-pd-l1-tps-50-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-hr-her2-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pembrolizumab-versus-platinum-based-chemotherapy-in-mismatch-repair-deficient-advanced-or-recurrent-endometrial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-perioperative-dostarlimab-vs-standard-of-care-in-untreated-t4n0-or-stage-iii-dmmr-msi-h-resectable-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-perioperative-enfortumab-vedotin-and-pembrolizumab-versus-neoadjuvant-gemcitabine-and-cisplatin-in-cisplatin-eligible-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-petosemtamab-and-pembrolizumab-in-first-line-treatment-of-recurrent-metastatic-pd-l1-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pf-06821497-with-enzalutamide-vs-enzalutamide-or-docetaxel-in-metastatic-castration-resistant-prostate-cancer-post-abiraterone2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pf-08046054-sgn-pdl1v-vs-docetaxel-in-pd-l1-positive-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pirtobrutinib-venetoclax-and-rituximab-in-previously-treated-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pirtobrutinib-vs-bendamustine-and-rituximab-in-treatment-naive-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pirtobrutinib-vs-idelalisib-rituximab-or-bendamustine-rituximab-in-btk-inhibitor-pretreated-cll-sll-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-pirtobrutinib-vs-investigator-selected-btk-inhibitor-in-previously-treated-btk-inhibitor-naive-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ponatinib-vs-imatinib-with-reduced-intensity-chemotherapy-in-newly-diagnosed-ph-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-relatlimab-nivolumab-vs-regorafenib-or-trifluridine-tipiracil-in-late-line-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-rezafungin-acetate-vs-standard-antimicrobial-regimen-for-preventing-invasive-fungal-diseases-in-allogeneic-bmt-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ripretinib-versus-sunitinib-in-advanced-gastrointestinal-stromal-tumor-with-kit-exon-11-and-17-18-mutations-post-imatinib-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ripretinib-versus-sunitinib-in-advanced-gastrointestinal-stromal-tumors-post-imatinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-ritlecitinib-tosilate-efficacy-and-safety-in-alopecia-areata-patients-aged-12-and-older-with-dose-adjustment-for-non-responders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-and-pembrolizumab-versus-physician-s-choice-and-pembrolizumab-in-pd-l1-positive-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-versus-standard-of-care-in-previously-treated-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-vs-docetaxel-in-advanced-metastatic-nsclc-post-platinum-chemotherapy-and-anti-pd-1-pd-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-vs-docetaxel-or-pemetrexed-in-advanced-nonsquamous-nsclc-with-egfr-mutations-or-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-vs-physician-s-choice-in-pd-l1-negative-or-anti-pd-l-1-treated-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-govitecan-vs-platinum-based-chemotherapy-in-egfr-mutated-advanced-nsclc-post-tki-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-tirumotecan-and-pembrolizumab-versus-pembrolizumab-in-mismatch-repair-proficient-endometrial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-tirumotecan-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-metastatic-nsclc-with-pd-l1-tps-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sacituzumab-tirumotecan-and-pembrolizumab-versus-physician-s-choice-in-triple-negative-breast-cancer-post-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sitravatinib-and-nivolumab-versus-docetaxel-in-advanced-non-squamous-nsclc-post-platinum-and-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sonrotoclax-and-zanubrutinib-versus-placebo-and-zanubrutinib-in-relapsed-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-sonrotoclax-and-zanubrutinib-versus-venetoclax-and-obinutuzumab-in-untreated-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-subcutaneous-daratumumab-versus-active-monitoring-in-high-risk-smoldering-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tafasitamab-lenalidomide-and-rituximab-in-relapsed-refractory-follicular-and-marginal-zone-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tarlatamab-versus-placebo-in-limited-stage-small-cell-lung-cancer-post-concurrent-chemoradiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tarlatamab-with-durvalumab-carboplatin-and-etoposide-in-untreated-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tebipenem-pivoxil-hydrobromide-vs-imipenem-cilastatin-in-complicated-urinary-tract-infection-and-acute-pyelonephritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-telisotuzumab-vedotin-vs-docetaxel-in-c-met-overexpressing-egfr-wildtype-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-trastuzumab-deruxtecan-vs-chemotherapy-in-her2-low-hr-metastatic-breast-cancer-post-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-trastuzumab-deruxtecan-vs-ramucirumab-and-paclitaxel-in-her2-positive-metastatic-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tucatinib-trastuzumab-and-mfolfox6-vs-mfolfox6-with-cetuximab-or-bevacizumab-in-her2-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tumor-treating-fields-with-temozolomide-and-pembrolizumab-in-newly-diagnosed-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-tusamitamab-ravtansine-versus-docetaxel-in-ceacam5-positive-metastatic-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zanidatamab-plus-chemotherapy-versus-trastuzumab-plus-chemotherapy-in-metastatic-her2-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zanidatamab-with-chemotherapy-tislelizumab-vs-trastuzumab-with-chemotherapy-in-her2-positive-advanced-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zanubrutinib-and-rituximab-versus-bendamustine-and-rituximab-in-untreated-mantle-cell-lymphoma-ineligible-for-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zanubrutinib-vs-bendamustine-and-rituximab-in-untreated-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zimberelimab-and-domvanalimab-with-chemotherapy-vs-pembrolizumab-with-chemotherapy-in-metastatic-nsclc-without-egfr-alk-aberrations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zl-1310-and-topotecan-hydrochloride-in-patients-with-relapsed-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-of-zolbetuximab-pembrolizumab-and-chemotherapy-in-her2-negative-cldn18-2-positive-pd-l1-positive-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-on-efficacy-and-safety-of-ivx-a12-vaccine-for-rsv-and-hmpv-in-adults-aged-602026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-on-efficacy-and-safety-of-oral-azacitidine-vs-investigator-s-choice-in-relapsed-refractory-angioimmunoblastic-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-study-on-safety-and-immunogenicity-of-21-valent-pneumococcal-conjugate-vaccine-in-healthy-infants-and-toddlers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-acalabrutinib-obinutuzumab-and-venetoclax-in-high-risk-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-adagrasib-pembrolizumab-and-chemotherapy-in-kras-g12c-mutant-advanced-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-amivantamab-and-lazertinib-vs-osimertinib-vs-lazertinib-in-egfr-mutated-advanced-or-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-bortezomib-lenalidomide-dexamethasone-and-ciltacabtagene-autoleucel-in-newly-diagnosed-multiple-myeloma-without-planned-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-ciltacabtagene-autoleucel-vs-pomalidomide-bortezomib-and-dexamethasone-or-daratumumab-pomalidomide-and-dexamethasone-in-relapsed-lenalidomide-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-clobetasol-propionate-nanoemulsion-vs-prednisolone-acetate-for-post-cataract-surgery-inflammation-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-cytarabine-midostaurin-and-daunorubicin-hydrochloride-in-flt3-mutated-acute-myeloid-leukemia-with-peripheral-blast-clearance2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-daratumumab-bortezomib-lenalidomide-dexamethasone-and-ciltacabtagene-autoleucel-in-transplant-eligible-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-datopotamab-deruxtecan-versus-docetaxel-in-advanced-or-metastatic-non-small-cell-lung-cancer-with-or-without-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-eftilagimod-alfa-pembrolizumab-and-chemotherapy-in-advanced-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-ensartinib-versus-crizotinib-in-alk-positive-non-small-cell-lung-cancer-patients-with-prior-chemotherapy-and-no-alk-tki-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-enzalutamide-bicalutamide-and-flutamide-in-androgen-deprivation-therapy-for-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-enzalutamide-with-androgen-deprivation-and-radiation-therapy-in-high-risk-localized-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-folfox-versus-gemcitabine-in-metastatic-pancreatic-adenocarcinoma-patients-ineligible-for-folfirinox2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-intravesical-erdafitinib-delivery-system-vs-single-agent-chemotherapy-in-fgfr-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-intravitreal-4d-150-vs-aflibercept-in-adults-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-loncastuximab-tesirine-and-rituximab-versus-immunochemotherapy-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-nadofaragene-firadenovec-with-gemcitabine-docetaxel-or-pembrolizumab-in-bcg-unresponsive-high-grade-nmibc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-neoadjuvant-chemotherapy-with-nivolumab-and-bms-986205-in-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-nivolumab-and-ipilimumab-with-chemotherapy-versus-chemotherapy-alone-in-stage-iv-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-nivolumab-nivolumab-with-ipilimumab-or-chemotherapy-in-msi-h-dmmr-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-pembrolizumab-versus-placebo-in-stage-ib-iiia-nsclc-post-resection-and-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-talquetamab-daratumumab-and-pomalidomide-combinations-in-relapsed-refractory-multiple-myeloma-post-one-therapy-line2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-teclistamab-and-talquetamab-combinations-versus-standard-regimen-in-newly-diagnosed-multiple-myeloma-ineligible-for-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-teclistamab-plus-daratumumab-sc-vs-daratumumab-sc-with-pomalidomide-and-dexamethasone-or-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-teclistamab-vs-pomalidomide-bortezomib-dexamethasone-or-carfilzomib-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-tovorafenib-monotherapy-vs-standard-chemotherapy-in-pediatric-low-grade-glioma-with-raf-alteration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-trial-of-trastuzumab-deruxtecan-and-bevacizumab-versus-bevacizumab-monotherapy-in-her2-expressing-ovarian-cancer-maintenance-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-triple-blind-crossover-study-of-candesartan-for-prophylaxis-in-chronic-cluster-headache2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-randomized-withdrawal-and-dose-up-titration-study-of-ritlecitinib-tosilate-in-adult-and-adolescent-patients-with-nonsegmental-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-safety-and-efficacy-study-of-flt201-gene-therapy-with-drug-combination-in-patients-with-gaucher-disease-type-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-evaluating-elranatamab-lenalidomide-efficacy-in-newly-diagnosed-multiple-myeloma-compared-to-standard-chemotherapy-and-maintenance-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-evaluating-zodasiran-to-lower-ldl-c-in-adolescents-aged-12-17-with-homozygous-familial-hypercholesterolemia-hofh2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-acalabrutinib-with-r-chop-in-patients-aged-75-with-untreated-non-germinal-center-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-acasunlimab-and-pembrolizumab-versus-docetaxel-in-pd-l1-positive-metastatic-nsclc-post-pd-1-pd-l1-inhibitor-and-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-adjuvant-pembrolizumab-with-without-sacituzumab-tirumotecan-in-resectable-stage-ii-iiib-nsclc-post-neoadjuvant-pembrolizumab-and-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-amivantamab-plus-folfiri-versus-cetuximab-bevacizumab-plus-folfiri-in-kras-nras-and-braf-wild-type-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-axicabtagene-ciloleucel-versus-standard-therapy-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-bay-2927088-vs-standard-of-care-in-her2-mutant-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-busulfan-melphalan-and-chemoimmunotherapy-in-high-risk-neuroblastoma-patients-with-insufficient-metastatic-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-cemiplimab-vs-platinum-based-chemotherapy-in-pd-l1-advanced-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-daratumumab-lenalidomide-dexamethasone-and-linvoseltamab-in-newly-diagnosed-transplant-ineligible-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-efficacy-and-safety-of-rozanolixizumab-versus-placebo-in-adults-with-ocular-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-efficacy-and-safety-of-venglustat-compared-with-imiglucerase-in-children-aged-2-11-years-with-gaucher-disease-type-32026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-encorafenib-and-cetuximab-with-or-without-chemotherapy-versus-standard-therapy-in-metastatic-braf-v600e-mutant-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-enfortumab-vedotin-and-pembrolizumab-versus-chemotherapy-in-untreated-locally-advanced-or-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-etripamil-nasal-spray-in-patients-with-atrial-fibrillation-and-rapid-ventricular-rate2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-furmonertinib-vs-platinum-based-chemotherapy-in-first-line-treatment-of-advanced-nsclc-with-egfr-exon-20-insertion-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-gedatolisib-drug-combination-in-patients-with-hr-positive-her2-negative-advanced-breast-cancer-previously-treated-with-cdk4-6-inhibitor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-gildeuretinol-acetate-to-assess-safety-tolerability-and-efficacy-in-slowing-progression-of-stargardt-disease-in-affected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-ianalumab-added-to-standard-of-care-drug-combination-in-adults-and-adolescents-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-idarubicin-daunorubicin-cytarabine-and-mycophenolic-acid-in-acute-myeloid-leukemia-patients-aged-18-602026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-idrx-42-versus-sunitinib-in-patients-with-metastatic-or-unresectable-gastrointestinal-stromal-tumor-after-imatinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-imatinib-with-cytotoxic-chemotherapy-in-pediatric-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-intrathecal-melpida-with-drug-combination-in-patients-with-hereditary-spastic-paraplegia-type-50-spg502026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-intravenous-c1-esterase-inhibitor-for-acute-hereditary-angioedema-in-patients-with-congenital-c1-inh-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-isatuximab-lenalidomide-and-dexamethasone-bortezomib-in-non-frail-transplant-ineligible-elderly-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-isatuximab-with-bortezomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-patients-ineligible-for-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-lepodisiran-on-coronary-plaque-in-adults-with-high-lp-a-and-established-atherosclerotic-heart-disease-or-high-risk-for-first-event2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-lifileucel-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-untreated-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-lisaftoclax-and-azacitidine-in-elderly-patients-with-newly-diagnosed-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-lisaftoclax-apg-2575-and-acalabrutinib-in-previously-treated-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-ly4170156-sofetabart-mipitecan-with-drug-combination-in-adults-with-platinum-resistant-or-platinum-sensitive-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-naporafenib-and-trametinib-versus-physician-s-choice-in-nras-mutant-cutaneous-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-nbtxr3-with-radiotherapy-cetuximab-in-elderly-patients-ineligible-for-platinum-based-chemotherapy-with-locally-advanced-head-and-neck-scc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-olverembatinib-plus-chemotherapy-versus-tki-plus-chemotherapy-in-newly-diagnosed-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-oral-astx030-cedazuridine-and-azacitidine-versus-subcutaneous-azacitidine-in-myelodysplastic-syndromes-cmml-and-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-orelabrutinib-with-rituximab-and-bendamustine-vs-rituximab-and-bendamustine-in-treatment-naive-mantle-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-paclitaxel-carboplatin-oregovomab-vs-paclitaxel-carboplatin-placebo-in-advanced-epithelial-ovarian-fallopian-tube-or-peritoneal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-patidegib-gel-2-for-basal-cell-carcinoma-reduction-in-gorlin-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-pemigatinib-versus-gemcitabine-and-cisplatin-in-first-line-treatment-of-unresectable-or-metastatic-cholangiocarcinoma-with-fgfr2-rearrangement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-pf-07220060-and-fulvestrant-versus-investigator-s-choice-in-hr-positive-her2-negative-advanced-metastatic-breast-cancer-post-cdk-4-6-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-pf-07220060-and-letrozole-versus-cdk4-6-inhibitors-and-letrozole-in-hr-positive-her2-negative-advanced-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-precemtabart-tocentecan-with-or-without-drug-combination-in-previously-treated-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-quizartinib-with-chemotherapy-in-flt3-itd-negative-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-ravulizumab-in-thrombotic-microangiopathy-post-hematopoietic-stem-cell-transplant-in-adults-and-adolescents2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-regn7508-and-regn9933-anti-factor-xi-antibodies-vs-placebo-or-rivaroxaban-in-adults-post-le-revascularization-for-peripheral-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-rinatabart-sesutecan-bevacizumab-vs-standard-platinum-based-chemotherapy-bevacizumab-in-recurrent-platinum-sensitive-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-rituximab-plus-venetoclax-6-cycle-vs-26-cycle-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-romiplostim-plus-prednisolone-versus-prednisolone-alone-in-adults-with-newly-diagnosed-primary-immune-thrombocytopenia-itp2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-rsvpref-bivalent-recombinant-prefusion-f-vaccine-for-prevention-of-lower-respiratory-tract-disease-in-high-risk-children-5-18-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-rucaparib-and-nivolumab-as-maintenance-therapy-in-advanced-high-grade-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sacituzumab-govitecan-vs-physician-s-choice-in-endometrial-cancer-post-platinum-and-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sacituzumab-tirumotecan-and-pembrolizumab-versus-physician-s-choice-in-hr-her2-unresectable-locally-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sacituzumab-tirumotecan-vs-physician-s-choice-in-recurrent-metastatic-cervical-cancer-post-platinum-and-anti-pd-l1-pd-1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sacituzumab-tirumotecan-with-without-pembrolizumab-in-pd-l1-cps-10-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sapablursen-in-adults-with-polycythemia-vera2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sigvotatug-vedotin-and-pembrolizumab-versus-pembrolizumab-monotherapy-in-pd-l1-high-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sonrotoclax-with-obinutuzumab-or-rituximab-vs-venetoclax-with-rituximab-in-relapsed-refractory-cll-sll-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sotorasib-and-panitumumab-versus-trifluridine-tipiracil-or-regorafenib-in-kras-p-g12c-mutated-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-subcutaneous-pembrolizumab-with-hyaluronidase-vs-intravenous-pembrolizumab-in-metastatic-nsclc-with-pd-l1-tps-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-subcutaneous-vs-intravenous-isatuximab-with-pomalidomide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-subcutaneous-vs-intravenous-tarlatamab-with-siltuximab-in-patients-with-relapsed-extensive-stage-small-cell-lung-cancer-after-platinum-based-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-subcutaneous-vs-intravenous-tislelizumab-plus-chemotherapy-in-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-sunvozertinib-vs-platinum-based-chemotherapy-in-egfr-exon-20-insertion-mutant-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-switching-to-lenacapavir-teropavimab-and-zinlirvimab-in-virologically-suppressed-adults-with-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-taletrectinib-vs-placebo-as-adjuvant-therapy-in-patients-with-resected-ros1-positive-stage-ib-iiia-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-thio-and-cemiplimab-vs-chemotherapy-in-advanced-metastatic-non-small-cell-lung-cancer-as-third-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-trastuzumab-deruxtecan-vs-platinum-based-chemotherapy-in-her2-mutant-unresectable-or-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-trastuzumab-deruxtecan-with-chemotherapy-pembrolizumab-vs-chemotherapy-with-trastuzumab-pembrolizumab-in-her2-positive-gastric-gej-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-velzatinib-gsk6042981-versus-imatinib-in-adults-with-previously-untreated-metastatic-or-unresectable-gastrointestinal-stromal-tumor-gist2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-vusolimogene-oderparepvec-and-nivolumab-versus-physician-s-choice-in-advanced-melanoma-post-anti-pd-1-anti-ctla-4-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-of-zilovertamab-vedotin-plus-r-chp-versus-r-chop-in-untreated-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-abelacimab-efficacy-and-safety-in-high-risk-atrial-fibrillation-patients-unsuitable-for-oral-anticoagulation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-cetuximab-continuation-beyond-first-line-progression-in-molecularly-selected-metastatic-colorectal-cancer-with-chemotherapy-doublet-and-bevacizumab2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-efficacy-and-safety-of-human-normal-immunoglobulin-for-infection-prophylaxis-in-multiple-myeloma-patients-on-teclistamab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-empagliflozin-for-cardiotoxicity-prevention-in-cancer-patients-undergoing-anthracycline-based-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-immunogenicity-and-safety-of-high-dose-mf59-adjuvanted-quadrivalent-influenza-vaccine-in-adults-aged-50-with-stable-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-immunogenicity-and-safety-of-rsvpref3-oa-vaccine-in-adults-aged-60-with-respiratory-syncytial-virus-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-long-term-safety-and-efficacy-of-intravenous-aoc-1001-in-myotonic-dystrophy-type-12026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-rilzabrutinib-efficacy-and-safety-in-sickle-cell-disease-patients-aged-10-65-for-vaso-occlusive-crisis-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-safety-and-immunogenicity-of-21-valent-pneumococcal-conjugate-vaccine-in-pediatric-and-adolescent-populations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-the-efficacy-and-safety-of-cenerimod-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-the-efficacy-and-safety-of-cipepofol-vs-propofol-for-induction-of-general-anesthesia-in-adults-undergoing-elective-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-the-efficacy-and-safety-of-fosmanogepix-in-adult-patients-with-invasive-mold-infections-by-aspergillus-fusarium-and-multidrug-resistant-molds2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-the-efficacy-and-safety-of-nizubaglustat-az-3102-in-late-infantile-and-juvenile-niemann-pick-type-c-and-gm1-gm2-gangliosidoses2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-on-the-safety-and-efficacy-of-upadacitinib-versus-dupilumab-in-pediatric-patients-aged-2-12-with-moderate-to-severe-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-study-to-evaluate-the-efficacy-and-safety-of-zodasiran-in-adolescent-and-adult-subjects-with-homozygous-familial-hypercholesterolemia-yosemite2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-comparing-efficacy-safety-and-immunogenicity-of-aflibercept-rbs-001-versus-aflibercept-in-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-bms-986489-bms-986012-nivolumab-with-carboplatin-and-etoposide-vs-atezolizumab-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-bv100-combination-therapy-vs-colistin-ampicillin-sulbactam-in-adults-with-crab-hospital-acquired-ventilator-associated-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-domvanalimab-zimberelimab-and-chemotherapy-vs-nivolumab-and-chemotherapy-in-advanced-gastric-and-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-n-803-tislelizumab-and-docetaxel-vs-docetaxel-in-advanced-metastatic-nsclc-with-acquired-resistance-to-immune-checkpoint-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-octreotide-subcutaneous-depot-vs-octreotide-lar-or-lanreotide-atg-in-unresectable-metastatic-gep-net-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3-trial-of-zipalertinib-with-chemotherapy-vs-chemotherapy-alone-in-egfr-exon-20-insertion-mutant-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3a-randomized-study-on-lot-consistency-immunogenicity-and-safety-of-gskvx000000025896-vs-varicella-virus-oka-merck-strain-in-healthy-children2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-4-randomized-double-blind-placebo-controlled-study-of-saroglitazar-magnesium-1-mg-for-safety-and-efficacy-on-clinical-outcomes-in-primary-biliary-cholangitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-4-study-of-trastuzumab-deruxtecan-in-her2-positive-breast-cancer-patients-with-or-without-brain-metastasis-after-prior-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-evaluation-of-efficacy-and-safety-of-exagamglogene-autotemcel-in-transfusion-dependent-b-thalassemia-and-severe-sickle-cell-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-multicenter-open-label-study-on-tolvaptan-s-safety-tolerability-and-efficacy-in-infants-with-autosomal-recessive-polycystic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-multicenter-study-on-tezepelumab-for-symptom-modulation-in-chronic-rhinosinusitis-with-nasal-polyposis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-open-label-randomized-study-of-ipx203-versus-immediate-release-levodopa-carbidopa-in-advanced-parkinson-s-disease-with-motor-fluctuations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-open-label-study-of-crinecerfont-for-androgen-reduction-in-adults-with-classic-congenital-adrenal-hyperplasia-cah2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-randomized-double-blind-placebo-controlled-study-of-lebrikizumab-in-adults-and-adolescents-with-moderate-to-severe-face-and-neck-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-randomized-study-on-efficacy-and-safety-of-cabotegravir-and-rilpivirine-in-hiv-1-patients-with-viremia-and-suboptimal-oral-art-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-3b-randomized-study-on-efgartigimod-alfa-iv-dosing-regimens-in-generalized-myasthenia-gravis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-multicenter-study-comparing-active-conventional-therapy-with-biologic-agents-and-de-escalation-strategies-in-early-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-open-label-study-of-nirogacestat-in-premenopausal-females-with-desmoid-tumors-aggressive-fibromatosis-to-assess-ovarian-function-recovery-rate2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-randomized-double-blind-placebo-controlled-study-on-rimegepant-efficacy-and-tolerability-in-migraine-prophylaxis-for-adults-with-inadequate-oral-preventive-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-randomized-study-on-acellular-pertussis-vaccine-impact-on-bordetella-pertussis-colonization-in-healthy-adults-using-controlled-human-infection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-study-on-incidence-of-squamous-cell-carcinoma-and-long-term-safety-of-tirbanibulin-ointment-and-diclofenac-sodium-gel-in-actinic-keratosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-4-study-on-synovial-hypertrophy-progression-in-haemophilia-a-patients-undergoing-efanesoctocog-alfa-prophylaxis-using-ultrasound-and-mri2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-clinical-evaluation-of-pm534-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-clinical-trial-evaluating-rectal-administration-of-insulin-for-patients-with-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-clinical-trial-of-ibc-ab002-in-patients-with-early-stage-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-clinical-trial-of-personalized-tissue-engineered-blood-vessel-for-chronic-venous-insufficiency-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-clinical-trial-of-tos-358-in-adult-patients-with-advanced-solid-tumors-colorectal-cervical-endometrial-gastric-urothelial-breast-head-and-neck-ovarian-and-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-cohort-expansion-study-of-intravenous-melatonin-in-ethanol-for-moderate-severe-hypoxic-ischaemic-encephalopathy-in-neonates2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-cohort-expansion-study-of-lb-208-a-htr1b-antagonist-in-adults-with-relapsed-or-refractory-solid-tumors-and-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-expansion-study-of-bi-3819026-monotherapy-and-in-combination-with-ezabenlimab-in-patients-with-unresectable-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-expansion-study-of-byon4228-monotherapy-and-combination-therapy-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-expansion-study-of-oral-arsenic-trioxide-in-low-risk-myelodysplastic-syndromes-unresponsive-to-erythropoiesis-stimulating-agents-and-luspatercept2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-and-expansion-study-of-xb010-monotherapy-and-combination-therapy-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-assessing-safety-and-tolerability-of-bi-3822971-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-asp5834-in-adults-with-kras-mutant-or-kras-amplified-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-autologous-ex-vivo-expanded-regulatory-cd8-t-cells-in-living-donor-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-autologous-p95her2-car-tech2me-t-cells-in-her-2-positive-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-dinutuximab-beta-with-vincristine-doxorubicin-cyclophosphamide-ifosfamide-and-etoposide-in-gd2-positive-ewing-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-dppg2-tsl-dox-with-hyperthermia-in-locally-advanced-or-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-intrapleural-oncofid-p-m-in-patients-with-unresectable-recurrent-progressive-pleural-mesothelioma-post-first-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-mb-cart2219-1-targeting-cd19-cd22-in-adult-and-pediatric-patients-with-relapsed-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-oral-tno155-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-panhpvax-vaccine-targeting-hpv-l2-antigen-with-cyclic-di-amp-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-sar443579-in-adult-and-pediatric-patients-with-relapsed-refractory-aml-b-all-hr-mds-or-bpdcn2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-third-party-suicide-gene-transduced-anti-hla-dpb1-0401-cytotoxic-t-cells-in-hla-dpb1-0401-positive-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-of-tilt-123-and-avelumab-in-melanoma-and-scchn-patients-refractory-to-anti-pd-l-1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-escalation-study-on-safety-and-tolerability-of-anti-cd19-car-t-cells-in-b-cell-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-finding-and-safety-evaluation-of-a-novel-shigella-vaccine-with-adjuvant-in-healthy-adult-populations-in-the-netherlands-and-zambia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-finding-study-of-intra-articular-f8il10-in-rheumatoid-arthritis-patients-with-dmard-resistant-arthritis-flares2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-dose-finding-study-of-regorafenib-and-temozolomide-with-without-radiotherapy-in-newly-diagnosed-mgmt-methylated-idh-wild-type-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-crossover-study-on-pharmacokinetics-and-safety-of-lb-0702-vs-romiplostim-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-placebo-controlled-study-on-safety-and-pharmacokinetics-of-kand145-in-healthy-volunteers-with-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics-of-kand145-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-placebo-controlled-study-on-safety-tolerability-and-pharmacokinetics-of-thn391-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-placebo-controlled-trial-of-gaxilose-for-urinary-xylose-cut-off-in-hypolactasia-diagnosis-in-children-aged-5-11-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-double-blind-randomized-placebo-controlled-trial-of-gz21t-for-safety-tolerability-and-pharmacokinetics-in-actinic-keratosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-177lu-lu-evs459-in-advanced-high-grade-serous-ovarian-cancer-and-locally-advanced-or-metastatic-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-177lu-lu-ff58-in-patients-with-recurrent-glioblastoma-multiforme-advanced-pancreatic-ductal-adenocarcinoma-and-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-177lu-lu-oncofap-23-and-l19-il2-in-metastatic-fap-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-211at-at-girentuximab-safety-and-efficacy-in-non-muscle-invasive-bladder-cancer-refractory-to-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-225ac-psma-i-t-in-patients-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-68ga-ga-dwj155-in-patients-with-advanced-breast-cancer-and-non-small-cell-lung-cancer-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-a-novel-compound-in-healthy-volunteers-for-potential-application-in-psychiatric-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-abbv-525-a-malt1-inhibitor-in-patients-with-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-an-investigational-medicinal-product-for-asthma-treatment-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-anti-gd2-car-t-cells-with-cyclophosphamide-fludarabine-and-rimiducid-in-pediatric-and-young-adult-cns-tumor-relapse-refractory-cases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-autologous-cart-19-22-t-cells-and-allogeneic-cart45ra-nkg2d-cells-in-refractory-relapsed-acute-lymphoblastic-leukemia-in-pediatric-and-young-adult-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-autologous-cd34-cells-transduced-with-lentiviral-vector-encoding-codon-optimized-pklr-gene-in-pyruvate-kinase-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-azd9592-in-patients-with-metastatic-colorectal-cancer-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-belantamab-mafodotin-in-patients-with-relapsed-or-refractory-multiple-myeloma-and-varying-hepatic-function2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-belantamab-mafodotin-in-patients-with-relapsed-refractory-multiple-myeloma-and-varying-renal-function2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-blood-brain-barrier-disruption-via-sonocloud-9-and-intravenous-carboplatin-in-pediatric-recurrent-supratentorial-malignant-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-bms-986497-monotherapy-and-in-combination-with-azacitidine-and-azacitidine-plus-venetoclax-in-relapsed-refractory-aml-or-mds2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-cart45ra-nkg2d-and-cart-19-22-t-cells-in-refractory-relapsed-acute-lymphoblastic-leukemia-in-pediatric-and-young-adult-cohorts2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-cart45ra-nkg2d-cell-infusions-in-pediatric-and-young-adult-patients-with-advanced-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ceacam5-x-cd3-antibody-nilk-2301-in-patients-with-locally-advanced-or-metastatic-low-tumor-volume-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ceacam5-x-cd47-antibody-nilk-2401-alone-or-with-anti-pd-1-antibody-in-ceacam5-expressing-solid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-clone-specific-car-t-cell-therapy-in-patients-with-relapsed-or-refractory-al-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-etanercept-and-repeated-contrast-ultrasound-safety-in-alzheimer-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-fgfr2-inhibitor-rly-4008-in-patients-with-intrahepatic-cholangiocarcinoma-and-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-fs222-for-safety-and-efficacy-in-patients-with-advanced-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-hepatic-arterial-infusion-of-autologous-tumor-infiltrating-lymphocytes-in-melanoma-patients-with-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-hepatic-intra-arterial-ipilimumab-and-intravenous-nivolumab-in-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-idh305-in-patients-with-advanced-malignancies-harboring-idh1r132-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ima970a-montanide-and-durvalumab-in-hepatocellular-carcinoma-post-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-imp761-for-safety-and-tolerability-in-autoimmune-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-incb099280-and-ipilimumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-inp12-safety-tolerability-and-pharmacokinetics-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-intravenous-plitidepsin-in-single-dose-administration-for-virus-diseases-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-irl757-safety-and-tolerability-in-apathy-associated-with-neurodegenerative-disorders-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-local-tolerability-and-pharmacokinetics-of-isoniazid-inhalation-via-wet-nebulization-in-tuberculosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-lutetium-177lu-edotreotide-and-arginine-lysine-in-pediatric-somatostatin-receptor-positive-tumors-and-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-mbf-362-safety-and-tolerability-in-healthy-females-and-efficacy-in-primary-dysmenorrhea-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-mdg1015-safety-and-tolerability-in-epithelial-ovarian-carcinoma-gastroesophageal-adenocarcinoma-myxoid-liposarcoma-and-synovial-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-medi5752-combined-with-stereotactic-radiotherapy-in-metastatic-soft-tissue-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-mgy825-in-adults-with-advanced-non-small-cell-lung-cancer-with-or-without-nfe2l2-keap1-cul3-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ni-1801-monotherapy-and-combination-with-anti-pd-1-or-paclitaxel-in-advanced-mesothelin-expressing-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ox118-in-healthy-volunteers-for-immune-system-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-pharmacokinetics-safety-and-tolerability-of-repeated-topical-parentide-application-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-pm534-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-pm54-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ro7568282-pharmacokinetics-safety-and-tolerability-in-healthy-subjects-under-varied-dosing-regimens-and-nutritional-states2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ro7589831-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-ro7589831-monotherapy-and-combined-with-pembrolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-dosimetry-of-68ga-labelled-oncofap-derivatives-in-patients-with-solid-tumors-breast-colorectal-oesophageal-and-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-dosimetry-of-68ga-oncoacp3-in-prostate-cancer-patients-with-suspected-metastasis-or-recurrence2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-dosimetry-of-68ga-oncocaix-in-patients-with-caix-positive-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-immunogenicity-of-an-hlaii-targeted-dna-vaccine-for-influenza-h7n9-prophylaxis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-immunogenicity-of-dna-vaccine-n-pvax1-in-crimean-congo-hemorrhagic-fever-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-immunogenicity-of-v-212-in-healthy-adult-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-and-tolerability-of-investigational-drug-in-healthy-subjects-with-cardiac-arrhythmia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-safety-tolerability-and-preliminary-efficacy-of-bispecific-psmaxcd3-antibody-cc-1-in-biochemical-recurrence-of-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-sar445611-in-healthy-adults-for-immune-system-disease-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-sta551-monotherapy-and-in-combination-with-atezolizumab-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-tg4070-in-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-tg6050-in-patients-with-metastatic-non-small-cell-lung-cancer-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-evaluation-of-vamorolone-pharmacokinetics-safety-and-pharmacodynamics-in-healthy-male-volunteers-for-duchenne-and-becker-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-first-in-human-open-label-multicenter-study-of-sim0505-in-adults-with-advanced-solid-tumors-safety-tolerability-pk-and-preliminary-antitumor-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-first-in-human-study-of-atx-898-monotherapy-and-atx-898-combination-therapy-with-fulvestrant-and-cdk4-6-inhibitors-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-first-in-human-study-of-ds3610a-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-first-in-human-study-of-ds9051b-in-patients-with-advanced-metastatic-adrenocortical-carcinoma-and-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-first-in-human-study-of-e303-in-patients-with-advanced-refractory-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-clinical-evaluation-of-pm54-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-dose-escalation-and-cohort-expansion-study-of-omx-0407-a-salt-inducible-kinase-inhibitor-in-patients-with-previously-treated-unresectable-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-multicenter-study-of-avelumab-and-lenvatinib-in-pediatric-patients-with-primary-central-nervous-system-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-open-label-study-of-obt076-and-balstilimab-in-recurrent-metastatic-cd205-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-study-of-the-safety-and-immunobiology-of-prophylactic-lymphocyte-and-natural-killer-cell-infusion-following-allogeneic-hematopoietic-cell-transplantation-to-prevent-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ib-study-on-safety-and-immunobiology-of-prophylactic-lymphocyte-and-nk-cell-infusion-post-allogeneic-hematopoietic-cell-transplantation-in-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-basket-trial-of-metronomic-oral-vinorelbine-with-durvalumab-and-tremelimumab-in-advanced-solid-tumors-head-and-neck-prostate-cervix-and-breast-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-clinical-trial-of-atidarsagene-autotemcel-gene-therapy-for-metachromatic-leukodystrophy-in-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-clinical-trial-of-autologous-hematopoietic-stem-cell-gene-therapy-using-rag1-lv-cd34-cells-in-rag1-deficient-severe-combined-immunodeficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-clinical-trial-of-ex-vivo-gene-therapy-using-col7a1-encoding-sin-retroviral-vector-in-recessive-dystrophic-epidermolysis-bullosa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-dose-escalation-study-of-binimetinib-lapatinib-and-vinorelbine-in-ras-mutated-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-dose-escalation-study-of-radiodynamic-therapy-with-aminolevulinic-acid-hydrochloride-in-patients-with-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-dose-escalation-study-of-tocilizumab-in-combination-with-venetoclax-and-azacitidine-in-patients-with-acute-myeloblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-177lu-pentixather-radioligand-therapy-in-relapsed-refractory-cxcr4-positive-acute-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-ab-1001-striatal-administration-in-early-manifest-huntington-s-disease-safety-tolerability-and-dose-selection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-alocelyvir-in-metastatic-uveal-melanoma-with-biopsiable-liver-disease-efficacy-and-objective-response-rate-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-anv600-monotherapy-and-anv600-pembrolizumab-combination-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-axitinib-and-oral-metronomic-etoposide-in-pediatric-and-aya-patients-with-refractory-relapsing-medulloblastoma-and-ependymoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-bosutinib-in-pediatric-patients-with-newly-diagnosed-or-resistant-intolerant-ph-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-brigatinib-in-pediatric-and-young-adult-patients-with-alk-positive-anaplastic-large-cell-lymphoma-and-inflammatory-myofibroblastic-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-bt5528-and-nivolumab-in-advanced-epha2-expressing-solid-tumors-safety-pharmacokinetics-and-clinical-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-bt8009-and-pembrolizumab-in-nectin-4-expressing-advanced-malignancies-safety-pharmacokinetics-and-clinical-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-carboplatin-paclitaxel-and-radiotherapy-in-elderly-patients-with-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-cd19-car-lenti-in-pediatric-relapsed-refractory-cd19-acute-lymphoblastic-leukemia-and-aggressive-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-cd7-cart01-cyclophosphamide-and-fludarabine-phosphate-in-pediatric-and-young-adult-relapsed-refractory-cd7-t-all-lymphoblastic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-cnty-101-and-aldesleukin-in-b-cell-mediated-autoimmune-diseases-idiopathic-inflammatory-myositis-systemic-lupus-erythematosus-and-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-d-l-methadone-hydrochloride-with-mfolfox6-in-metastatic-colorectal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-exl01-for-prevention-of-clostridioides-difficile-infection-recurrence-in-high-risk-patients-treated-with-oral-vancomycin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-gadolinium-chelated-polysiloxane-nanoparticles-with-radiotherapy-and-temozolomide-in-newly-diagnosed-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-galunisertib-and-capecitabine-in-advanced-chemotherapy-resistant-colorectal-cancer-with-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-htlp-injection-for-immune-reconstitution-post-umbilical-cord-blood-transplantation-in-adults-with-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-ic9-gd2-car-t-cells-in-pediatric-patients-with-high-risk-or-relapsed-refractory-neuroblastoma-and-gd2-positive-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-idecabtagene-vicleucel-car-t-cell-therapy-in-autoimmune-diseases-resistant-to-b-cell-depletion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-inducible-hla-g-regulatory-t-cells-ig-tregs-in-hla-matched-sibling-donor-allogeneic-hematopoietic-cell-transplantation-for-gvhd-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-inotuzumab-ozogamicin-monotherapy-and-combined-chemotherapy-in-pediatric-cd22-positive-relapsed-refractory-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-iomx-0675-monoclonal-antibody-alone-or-with-pembrolizumab-in-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-lurbinectedin-and-atezolizumab-in-advanced-small-cell-lung-cancer-post-platinum-chemotherapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-lurbinectedin-and-dostarlimab-in-advanced-recurrent-endometrial-cancer-post-platinum-chemotherapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-mb-cart19-1-in-relapsed-refractory-cd19-b-cell-malignancies-safety-dose-finding-and-feasibility-study2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-mebendazole-and-low-dose-cytarabine-in-elderly-patients-with-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-meclofenamate-sodium-and-temozolomide-in-progressive-mgmt-methylated-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-nivolumab-with-metronomic-chemotherapy-in-pediatric-refractory-solid-tumors-and-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-nms-03305293-and-temozolomide-in-adult-patients-with-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-nms-03592088-a-flt3-kit-and-csf1r-inhibitor-in-relapsed-refractory-acute-myeloid-leukemia-or-chronic-myelomonocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-obinutuzumab-venetoclax-and-ibrutinib-in-relapsed-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-paclitaxel-carboplatin-and-durvalumab-with-without-oleclumab-in-untreated-locally-recurrent-or-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-perioperative-histamine-dihydrochloride-and-low-dose-aldesleukin-in-resectable-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-ptg-carcik-cd19-in-relapsed-refractory-b-cell-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-qel-001-autologous-car-t-regulatory-cells-for-safety-in-hla-a2-mismatch-liver-transplant-rejection-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-regorafenib-and-avelumab-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-sodium-2-hydroxylinoleate-in-pediatric-relapsed-refractory-neuroblastoma-and-solid-tumors-alone-and-with-chemotherapy-or-targeted-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-sodium-2-hydroxylinoleate-irinotecan-and-temozolomide-in-pediatric-relapsed-refractory-neuroblastoma-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-sulfasalazine-idarubicin-and-cytarabine-in-newly-diagnosed-non-favorable-acute-myeloid-leukemia-patients-aged-60-and-above2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-sunitinib-and-nivolumab-with-chemotherapy-in-advanced-soft-tissue-and-bone-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-tarlatamab-and-temozolomide-in-adolescents-and-adults-with-high-grade-central-nervous-system-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-tuvusertib-and-fulvestrant-in-hr-positive-her2-negative-advanced-breast-cancer-resistant-to-cdk4-6-and-aromatase-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-venetoclax-and-blinatumomab-in-adult-patients-with-relapsed-refractory-b-cell-precursor-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-vibrio-alginolyticus-collagenase-and-alprostadil-in-patients-with-peyronie-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-vibrio-alginolyticus-collagenase-for-safety-and-efficacy-in-dupuytren-s-contracture-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-evaluation-of-zenocutuzumab-in-patients-with-solid-tumors-exhibiting-nrg1-fusion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-iii-study-of-raav8-hmd1-gene-therapy-in-ambulatory-boys-with-duchenne-muscular-dystrophy-including-dose-determination-and-long-term-safety-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-double-blind-randomized-placebo-controlled-study-of-inp20-for-safety-tolerability-and-dose-finding-in-peanut-allergy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-evaluation-of-ribociclib-with-topotecan-and-temozolomide-in-pediatric-patients-with-relapsed-or-refractory-neuroblastoma-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-open-label-study-of-dyp688-in-patients-with-metastatic-uveal-melanoma-and-gnaq-11-mutant-melanomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-open-label-study-of-lurbinectedin-and-irinotecan-in-pretreated-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-open-label-study-of-lurbinectedin-and-pembrolizumab-in-relapsed-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-open-label-study-of-trabectedin-and-radiotherapy-in-soft-tissue-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-of-cobimetinib-and-atezolizumab-in-pediatric-and-adult-patients-with-advanced-or-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-of-ecubectedin-and-irinotecan-in-pretreated-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-of-eos884448-with-pembrolizumab-dostarlimab-and-inupadenant-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-of-necvax-neo1-with-anti-pd-1-pd-l1-antibody-therapy-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-of-rapcabtagene-autoleucel-in-cll-sll-dlbcl-all-and-hr-lbcl-with-ibrutinib-combination-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-on-safety-and-immunogenicity-of-intranasal-lvt-001-vs-intramuscular-mrna-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-study-on-safety-and-tolerability-of-low-dose-cytarabine-or-azacitidine-with-venetoclax-and-quizartinib-in-elderly-aml-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-trial-of-hypofractionated-stereotactic-radiation-therapy-and-durvalumab-in-recurrent-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicenter-trial-of-necvax-neo1-with-anti-pd-1-therapy-in-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicentre-double-blind-randomised-study-of-ipn10200-vs-dysport-and-placebo-in-adult-upper-limb-spasticity-post-stroke-or-traumatic-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multicentric-study-on-trifluridine-tipiracil-bevacizumab-with-xb2001-vs-placebo-in-metastatic-colorectal-cancer-post-oxaliplatin-irinotecan-fluoropyrimidine-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-multinational-study-of-nivolumab-and-entinostat-in-pediatric-refractory-high-risk-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-multi-center-trial-of-lutetium-177lu-neobomb1-and-capecitabine-in-grpr-er-her2-metastatic-breast-cancer-post-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-multicenter-study-of-ale-p03-in-adult-patients-with-advanced-or-metastatic-cldn1-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-evaluating-safety-and-efficacy-of-glyco-humanized-polyclonal-antibody-lis1-in-relapsed-refractory-peripheral-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-evaluating-safety-and-efficacy-of-stx-241-in-locally-advanced-or-metastatic-nsclc-resistant-to-egfr-tyrosine-kinase-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-evaluating-safety-of-intravenous-ata-200-gene-therapy-in-pediatric-patients-with-limb-girdle-muscular-dystrophy-type-r52026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-ale-c04-and-pembrolizumab-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-ale-p02-monotherapy-in-adults-with-advanced-or-metastatic-cldn1-squamous-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-autologous-cd34-cells-transduced-with-g1xcgd-lentiviral-vector-in-x-linked-chronic-granulomatous-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-azacitidine-and-venetoclax-in-untreated-higher-risk-myelodysplastic-syndromes-ineligible-for-allogeneic-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-entrectinib-in-pediatric-patients-with-advanced-or-metastatic-solid-or-primary-cns-tumors-lacking-satisfactory-treatment-options2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-gnt0003-for-safety-and-efficacy-in-severe-crigler-najjar-syndrome-requiring-phototherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-of-vert-002-in-patients-with-locally-advanced-or-metastatic-solid-tumors-with-met-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-on-safety-and-efficacy-of-bispecific-t-cell-engaging-antibody-cizutamig-in-severe-treatment-refractory-immune-mediated-inflammatory-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-study-on-safety-efficacy-and-cellular-kinetics-of-rapcabtagene-autoleucel-in-treatment-resistant-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-open-label-trial-evaluating-safety-and-efficacy-of-aav9-based-gene-replacement-therapy-in-pediatric-ctnnb1-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-randomized-blinded-study-of-chadox1-thivconsvx-and-mva-thivconsvx-vaccine-in-early-treated-hiv-1-positive-adults-with-long-term-infection-control2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-randomized-study-of-lb-100-and-doxorubicin-versus-doxorubicin-monotherapy-in-advanced-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-randomized-study-of-selinexor-and-gemcitabine-in-advanced-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-safety-dose-finding-basket-trial-of-cd19-cart01-in-b-cell-driven-autoimmune-diseases-sle-ssc-dm-pm-imnm-aav-mg-nmosd-and-chronic-gvhd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-225ac-ac-psma-r2-in-metastatic-hormone-sensitive-and-castration-resistant-prostate-cancer-with-without-prior-177lu-psma-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-adaptnk-cell-therapy-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-or-myelodysplastic-syndromes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-avelumab-and-methotrexate-in-first-line-treatment-of-low-risk-gestational-trophoblastic-neoplasia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-azd4512-monotherapy-and-combination-therapy-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-belantamab-mafodotin-with-carfilzomib-and-dexamethasone-in-relapsed-multiple-myeloma-refractory-to-lenalidomide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-brentuximab-vedotin-with-r-dhap-in-cd30-diffuse-large-b-cell-lymphoma-refractory-or-relapsed-post-first-line-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-cd19-car-t-cell-therapy-in-patients-with-autoantibody-positive-autoimmune-disease-and-severe-interstitial-lung-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-crispr-engineered-tumor-infiltrating-lymphocytes-in-patients-with-advanced-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-cxcr4-directed-theranostics-using-90y-y-pentixather-and-68ga-ga-pentixafor-in-advanced-non-hodgkin-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-dasatinib-and-venetoclax-in-pediatric-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-or-lymphoblastic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-df1001-nivolumab-and-paclitaxel-albumin-bound-in-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-dinutuximab-beta-irinotecan-hydrochloride-trihydrate-and-sirolimus-in-children-adolescents-and-adults-with-relapsed-refractory-bone-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-dji136-and-drug-combination-in-adults-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-everolimus-olaparib-and-capmatinib-in-pediatric-patients-with-relapsed-or-refractory-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-genetically-modified-yersinia-enterocolitica-strain-t3p-y058-739-in-patients-with-advanced-solid-tumours2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-glyco-humanized-polyclonal-antibody-xon7-in-advanced-or-metastatic-solid-tumors-safety-pharmacokinetics-and-anti-tumor-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-golcadomide-with-rituximab-obinutuzumab-tafasitamab-or-valemetostat-in-relapsed-refractory-non-hodgkin-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-individualized-peptide-vaccine-pervi-fus-pervi-neo-11902a-in-pediatric-and-aya-patients-with-metastatic-fusion-driven-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-intravesical-eciskafusp-alfa-and-bacillus-calmette-guerin-in-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-mc2-tcr16-t-cells-and-epigenetic-drug-combination-in-advanced-melanoma-and-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-relatlimab-nivolumab-and-azacitidine-venetoclax-in-acute-myeloid-leukemia-lacking-npm1-idh1-2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-ro7806767-monotherapy-and-combined-with-pembrolizumab-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-romidepsin-combined-with-choep-for-initial-treatment-in-young-patients-with-nodal-peripheral-t-cell-lymphomas-prior-to-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-ruxolitinib-and-venetoclax-in-pediatric-relapsed-refractory-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma-with-il-7r-jak-stat-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-rv-sfg-cd19-cd28-4-1bbzeta-transduced-t-lymphocytes-in-relapsed-refractory-cd19-lymphoid-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-s65487-and-azacitidine-in-untreated-acute-myeloid-leukemia-patients-ineligible-for-intensive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-saruparib-monotherapy-or-combination-therapy-in-advanced-recurrent-ovarian-cancer-safety-and-tolerability-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-sel120-monohydrochloride-in-patients-with-relapsed-refractory-metastatic-or-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-stereotactic-ablative-reirradiation-with-metformin-for-relapse-in-previously-irradiated-prostate-bed-repair-getug-p162026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-tg4050-in-patients-with-stage-iii-iv-hpv-negative-squamous-cell-carcinoma-of-the-head-and-neck-post-surgery-and-adjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-venetoclax-cytarabine-and-mitoxantrone-in-relapsed-or-refractory-acute-myeloid-leukemia-eligible-for-intensive-salvage-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-of-vtx-801-gene-therapy-in-adult-patients-with-wilson-s-disease-safety-and-tolerability-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-and-efficacy-of-aav9-cag-coh-sgsh-in-pediatric-mucopolysaccharidosis-type-iiia-via-intracerebroventricular-administration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-and-efficacy-of-autologous-cd34-cells-transduced-with-tcirg1-lentiviral-vector-in-pediatric-autosomal-recessive-osteopetrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-and-efficacy-of-gene-therapy-for-fhl3-using-autologous-cd34-cells-and-munc-t3-transduced-with-unc13d-lv-vector2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-and-efficacy-of-smart101-in-hla-mismatched-peripheral-blood-stem-cell-transplantation-for-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-of-cd19-car-t-cells-in-refractory-relapsed-cd19-acute-myeloid-leukemia-with-cyclophosphamide-and-fludarabine2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-safety-tolerability-and-immunogenicity-of-pdc-lung01-with-or-without-anti-pd-1-therapy-in-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-on-the-tolerance-and-efficacy-of-daratumumab-in-patients-with-active-toxic-epidermal-necrolysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-study-to-determine-the-safety-and-efficacy-of-ribociclib-in-combination-with-hormone-therapy-and-hypofractionated-radiotherapy-in-breast-cancer-with-positive-hormone-receptors-and-negative-2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-ii-trial-of-wt1-loaded-autologous-cord-blood-derived-dendritic-cell-vaccine-in-pediatric-and-young-adult-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-dose-escalation-and-cohort-expansion-study-of-stc-1010-immunotherapy-with-standard-of-care-in-unresectable-advanced-or-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-dose-escalation-study-of-bnt142-in-cldn6-positive-advanced-solid-tumors-safety-tolerability-and-preliminary-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-evaluation-of-intratumoral-bt-001-alone-and-combined-with-pembrolizumab-in-metastatic-advanced-solid-tumors-with-injectable-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-evaluation-of-osteodex-odx-for-safety-and-tolerability-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-evaluation-of-tdt-3-autologous-tcr-t-cell-therapy-in-hla-a-02-01-patients-with-relapsed-refractory-tdt-acute-leukemia-or-lymphoblastic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-multicenter-study-of-transpocart19-cell-infusion-in-relapsed-refractory-b-cell-lymphoma-with-cetuximab-bendamustine-cyclophosphamide-fludarabine-and-tocilizumab2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-multicenter-trial-of-tub-030-antibody-drug-conjugate-in-advanced-solid-tumors-safety-tolerability-pharmacokinetics-and-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-open-label-trial-of-autologous-tumor-infiltrating-lymphocyte-based-immunotherapy-with-cc-38-in-metastatic-colorectal-and-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-randomized-double-blind-placebo-controlled-trial-of-bacteriophage-and-sodium-chloride-in-surgical-wound-infections-by-s-aureus-p-aeruginosa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-177lu-neob-in-advanced-solid-tumors-overexpressing-grpr-with-68ga-neob-uptake-including-co-administration-with-nepi-lcz6962026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-azd3470-monotherapy-and-combination-therapy-in-mtap-deficient-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-belantamab-mafodotin-and-venetoclax-in-relapsed-refractory-t-11-14-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-cp-506-and-carboplatin-in-hrd-fad-solid-tumors-and-oligoprogressive-disease-with-immune-checkpoint-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-dmd06-mab-for-exon-51-skipping-in-duchenne-muscular-dystrophy-in-non-ambulant-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-inhaled-cis-dpi-as-adjunctive-therapy-in-stage-iv-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-of-intratumoral-rr001-with-gemcitabine-and-paclitaxel-albumin-bound-in-locally-advanced-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-on-safety-and-efficacy-of-atl001-and-nivolumab-in-metastatic-or-recurrent-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-on-safety-and-efficacy-of-cart84-infusion-in-relapsed-refractory-acute-myeloid-and-lymphoblastic-t-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-study-on-safety-tolerability-and-efficacy-of-napi2b-antibody-drug-conjugate-tub-040-in-platinum-resistant-ovarian-and-refractory-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iia-trial-evaluating-safety-and-efficacy-of-autologous-slamf7-car-t-cells-in-patients-with-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iib-study-of-atezolizumab-with-begev-regimen-in-relapsed-refractory-hodgkin-s-lymphoma-for-autologous-stem-cell-transplantation-candidates2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-iii-study-on-the-efficacy-of-5-fluorouracil-oxaliplatin-and-irinotecan-hydrochloride-in-hyperthermic-intraperitoneal-chemotherapy-for-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicenter-study-of-autologous-skeletal-muscle-derived-cell-microcarrier-combination-for-faecal-incontinence-in-women-with-obstetric-anal-sphincter-injury2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicenter-study-of-dual-wavelength-quantitative-fluorescence-endoscopy-for-pd-1-and-pd-l1-imaging-in-locally-advanced-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicenter-study-of-necvax-neo1-with-anti-pd-1-or-anti-pd-l1-monotherapy-in-solid-tumors-nsclc-melanoma-urothelial-renal-and-head-and-neck-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicenter-study-on-optical-pd-l1-imaging-via-quantitative-fluorescence-endoscopy-in-locally-advanced-esophageal-cancer-with-durvalumab-680lt2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicenter-trial-of-peptide-vaccine-targeting-neoepitope-specific-t-cells-in-h3-mutated-glioma-who-grade-iv2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicentre-open-label-dose-escalation-study-of-intravenous-mbs8-1v270-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-multicentre-open-label-study-on-efficacy-and-safety-of-pharmacotherapy-in-familial-polycythemia-with-epo-gene-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-dose-escalation-study-evaluating-ad-o51-4-safety-in-patients-with-advanced-malignancies-lacking-further-treatment-options2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-dose-escalation-study-of-intravenous-pm14-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-dose-escalation-study-of-skepinone-l-combined-with-sorafenib-safety-pk-pd-and-preliminary-efficacy-in-advanced-non-viral-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-dose-escalation-study-to-evaluate-safety-and-preliminary-efficacy-of-gen1078-in-patients-with-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-dose-escalation-study-to-evaluate-the-safety-and-tolerability-of-gen1047-in-patients-with-malignant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-evaluation-of-cln-978-in-patients-with-treatment-refractory-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-multicenter-dose-escalation-and-cohort-expansion-study-of-mint91-in-combination-therapy-for-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-multiple-dose-study-of-shr-3167-steady-state-pharmacokinetics-pharmacodynamics-and-safety-in-adults-with-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-randomized-crossover-study-assessing-the-pharmacokinetics-and-food-effect-of-iadademstat-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-of-intravenous-ina03-in-adult-patients-with-relapsed-refractory-acute-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-of-kfa115-monotherapy-and-combination-with-pembrolizumab-in-advanced-epithelial-ovarian-thymic-and-other-select-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-of-mb-cart19-1-ibk-car-t-cells-combined-with-zanubrutinib-in-relapsed-refractory-primary-central-nervous-system-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-of-oncolytic-adenovirus-immunotherapy-virago-with-repeated-intratumoral-administration-in-adults-with-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-of-pharmacokinetics-safety-and-tolerability-of-a-new-formulation-of-jnj-77730614-administered-via-buccal-delivery-system-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-open-label-study-on-pharmacokinetics-of-irl757-in-elderly-patients-with-apathy-in-neurodegenerative-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-proof-of-concept-study-of-nvdx3-osteogenic-implant-for-treatment-of-distal-radius-fractures-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-assessor-blinded-study-on-skin-irritation-and-sensitization-of-5-lidocaine-medicated-plaster-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-cross-over-study-of-oral-ketamine-hydrochloride-vs-intranasal-esketamine-in-healthy-male-subjects-with-depression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-assessing-safety-and-tolerability-of-the-cardiometabolic-agent-nnc0705-0002-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-avx70120-and-avx70481-vaccines-for-yellow-fever-and-rabies-in-healthy-adults-aged-18-402026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-azd4144-in-patients-with-cardiorenal-disease-and-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-inhaled-ro7616605-assessing-safety-and-activity-in-healthy-volunteers-and-copd-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-mjk2134025-for-autotaxin-inhibition-in-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-pt00114-in-healthy-volunteers-for-mood-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-of-ro7308480-safety-tolerability-pharmacokinetics-and-drug-interactions-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-placebo-controlled-study-on-safety-and-pharmacokinetics-of-single-ascending-doses-of-tgd001-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-single-ascending-dose-study-of-the-investigational-agent-ela822-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-double-blind-study-on-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-lb-0702-vs-romiplostim-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-placebo-controlled-dose-escalation-study-of-ndi-225673-in-adults-with-moderate-to-severe-inflammatory-bowel-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-placebo-controlled-safety-and-tolerability-study-of-ant3310-monotherapy-and-ant3310-in-combination-with-meropenem-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-placebo-controlled-study-of-lph-5-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-healthy-subjects-with-depression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-study-of-safety-tolerability-and-pk-of-nnc6022-0004-in-healthy-volunteers-and-adults-with-obesity-cardiometabolic-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-randomized-study-of-skin-irritation-and-sensitization-of-investigational-compound-xyz-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-and-multiple-ascending-dose-study-of-dfl23693-in-healthy-volunteers-safety-tolerability-and-pharmacokinetics-for-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-and-multiple-ascending-dose-study-of-m5542-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-arm-dose-escalating-and-phase-ii-double-blind-randomized-placebo-controlled-dose-finding-clinical-trial-assessing-safety-and-efficacy-of-intratracheal-administration-of-allogeneic-umbil2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-ascending-dose-study-of-bi-3821001-to-assess-safety-tolerability-and-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-blind-placebo-controlled-study-of-abo21009-in-healthy-volunteers-and-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-blind-trial-evaluating-safety-and-local-immune-activation-of-toll-like-receptor-5-agonist-flamod-in-pneumonia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-single-dose-pharmacokinetic-study-of-bi-1815368-in-healthy-male-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-assessing-safety-tolerability-and-nasal-retention-of-intranasal-convalescent-plasma-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-evaluating-safety-and-immunogenicity-of-a-multivalent-gonorrhea-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-evaluating-safety-and-pharmacodynamics-of-iph4502-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-161tb-psma-1-and-gallium-68-gozetotide-in-adult-patients-with-metastatic-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-177lu-dota-tate-and-olaparib-in-patients-with-somatostatin-receptor-positive-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-177lu-lu-dfc413-and-68ga-ga-nns309-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-177lu-lu-dwj155-and-68ga-ga-dwj155-in-patients-with-advanced-bladder-breast-nsclc-and-gastric-gej-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-225ac-psma-trillium-bay-3563254-in-advanced-metastatic-castration-resistant-prostate-cancer-with-psma-expression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-abbv-cls-579-monotherapy-and-combination-therapy-in-patients-with-metastatic-or-locally-advanced-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-acetazolamide-with-radiochemotherapy-or-radioimmunotherapy-in-small-cell-lung-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ari0003-cell-infusion-in-patients-with-relapsed-refractory-b-cell-aggressive-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-atezolizumab-tiragolumab-and-stereotactic-body-radiation-therapy-in-metastatic-multiorgan-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-autologous-p95her2-car-tech2me-t-cells-in-patients-with-advanced-her2-positive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-autologous-uncultured-adipose-derived-stromal-vascular-fraction-for-muscle-injection-in-inclusion-body-myositis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bay-3375968-alone-and-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bay-3547926-in-patients-with-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bay2862789-in-patients-with-advanced-solid-tumors-and-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bay2927088-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-egfr-and-or-her2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bay2965501-as-monotherapy-and-in-combination-for-safety-pharmacokinetics-and-efficacy-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bbo-10203-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bgb-b2033-alone-and-in-combination-with-tislelizumab-bevacizumab-in-advanced-metastatic-solid-tumors-safety-pk-pd-and-preliminary-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bi-1823911-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-tumors-harboring-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bi-3923948-monotherapy-and-in-combination-with-an-anti-pd-1-antibody-in-patients-with-advanced-unresectable-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bi-764532-dose-tolerability-in-patients-with-dll3-positive-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-bi-765063-monoclonal-antibody-alone-and-with-bi-754091-pd-1-inhibitor-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-can10-an-anti-il1rap-monoclonal-antibody-in-healthy-subjects-and-subjects-with-mild-to-moderate-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ddr-inhibition-in-neoadjuvant-treatment-for-non-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ds-1103a-in-combination-therapy-for-advanced-her2-expressing-or-her2-mutated-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ds-1471a-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ds-2243a-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-enzomenib-assessing-drug-drug-interaction-potential-and-pharmacokinetics-in-adults-with-advanced-cancer-and-hepatic-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-gsk3745417-with-without-anticancer-agents-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-gsk5733584-injection-in-patients-with-advanced-ovarian-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-iberdomide-and-cc-98282-in-combination-with-r-chop21-for-untreated-aggressive-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ict01-and-pembrolizumab-in-advanced-relapsed-refractory-cancer-and-ict01-with-venetoclax-azacitidine-in-newly-diagnosed-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ima401-tcer-r-in-patients-with-solid-tumors-monotherapy-and-combination-with-checkpoint-inhibitor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-intra-tumoral-ipilimumab-and-intravenous-nivolumab-with-autologous-cd1c-cd141-myeloid-dendritic-cells-in-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-intraperitoneal-aerosolized-nanoliposomal-irinotecan-in-patients-with-advanced-peritoneal-carcinomatosis-from-gastrointestinal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-intravenous-and-intracranial-ipilimumab-and-nivolumab-in-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ioa-244-in-patients-with-advanced-solid-tumors-and-metastatic-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-iph5301-monotherapy-and-combination-with-chemotherapy-and-trastuzumab-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-isb-2001-in-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-itraconazole-with-radiotherapy-and-temozolomide-in-newly-diagnosed-glioblastoma-multiforme-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ktx-1001-safety-and-tolerability-in-patients-with-relapsed-and-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-m7437-an-anti-ly6e-exatecan-antibody-drug-conjugate-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-mk-1824-in-healthy-volunteers-to-evaluate-safety-tolerability-and-pharmacokinetics-for-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-oatd-02-in-advanced-metastatic-solid-tumors-colorectal-ovarian-pancreatic-and-renal-cell-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-oki-219-monotherapy-and-in-combination-with-endocrine-or-her2-targeted-therapy-in-advanced-solid-tumors-and-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-ot-a201-in-patients-with-relapsed-refractory-hematological-malignancies-or-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-pd1-lag3-bispecific-antibody-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-pep-010-alone-and-in-combination-with-paclitaxel-or-gemcitabine-in-recurrent-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-pepticrad-1-and-pembrolizumab-in-patients-with-injectable-solid-tumors-sarcoma-melanoma-nsclc-colorectal-and-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-pf-08032562-in-patients-with-advanced-metastatic-breast-cancer-and-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-phox430-a-glucosaminyltransferase-v-inhibitor-in-adults-with-advanced-or-metastatic-solid-tumors-lacking-effective-treatment-options2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-psma-sstr2-and-grpr-targeted-radioligand-therapy-in-metastatic-neuroendocrine-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-pttl-t-cell-immunotherapy-in-patients-with-advanced-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-radiation-dosimetry-safety-and-tolerability-of-lutetium-177lu-vipivotide-tetraxetan-in-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-rly-2608-in-patients-with-advanced-solid-tumors-harboring-pik3ca-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-safety-and-immunogenicity-of-high-dose-rotavirus-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-safety-pharmacokinetics-and-efficacy-of-investigational-drug-in-advanced-or-unresectable-solid-tumors-and-relapsed-refractory-non-hodgkin-s-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-safety-pk-pd-of-an-investigational-oral-anticoagulant-alone-and-with-standard-anticoagulant-in-healthy-adults-relevant-to-af-tia-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-single-and-escalating-doses-of-a-novel-molecule-in-healthy-volunteers-for-the-treatment-of-post-traumatic-stress-disorder-ptsd2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-sirpa-directed-monoclonal-antibody-byon4228-alone-and-with-rituximab-in-relapsed-refractory-cd20-b-cell-non-hodgkin-s-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-tg4050-and-nivolumab-in-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-the-bispecific-ceacam5-cd3-antibody-nilk-2301-in-patients-with-locally-advanced-or-metastatic-low-tumor-volume-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-vent-02-in-neuroinflammatory-and-neurodegenerative-diseases-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-xl092-monotherapy-and-combination-therapy-in-advanced-solid-tumors-ccrcc-nccrcc-hr-bc-mcrpc-and-crc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-of-zl-1310-pharmacokinetics-and-tolerability-in-patients-with-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-deucrictibant-s-effect-on-pharmacokinetics-of-digoxin-and-rosuvastatin-in-hereditary-angioedema-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-local-and-systemic-exposure-of-minocycline-in-periodontal-pockets-for-recurrent-or-persistent-periodontitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-safety-and-maximum-tolerated-dose-of-177lu-dotatate-in-pediatric-refractory-or-recurrent-neuroblastoma-expressing-somatostatin-receptors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-safety-and-maximum-tolerated-dose-of-bcma-targeting-car-t-cells-in-relapsed-refractory-multiple-myeloma-and-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-safety-and-tolerability-of-cth120-in-fragile-x-syndrome-single-and-multiple-ascending-doses-and-food-interaction-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-safety-tolerability-and-efficacy-of-obe-cel-in-refractory-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-safety-tolerability-and-pharmacokinetics-of-imp21052-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-bioavailability-and-food-effect-of-nizubaglustat-in-glycosphingolipid-lysosomal-storage-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-effects-of-vamorolone-on-midazolam-pharmacokinetics-in-healthy-male-volunteers-for-duchenne-and-becker-muscular-dystrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-efficacy-of-senicapoc-and-perampanel-in-newly-diagnosed-glioblastoma-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-impact-of-erythromycin-mediated-cyp3a4-5-inhibition-on-chf6001-pharmacokinetics-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-safety-and-pharmacokinetics-of-igx12-in-subcutaneous-administration-for-infertility-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-safety-and-tolerability-of-ra0127-for-the-prevention-of-gram-negative-bacterial-infections-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-on-the-safety-tolerability-and-pharmacokinetics-of-szv-1287-in-healthy-male-volunteers-with-neuropathic-pain-after-single-and-multiple-oral-doses2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-to-determine-maximum-tolerated-dose-of-trichostatin-a-in-patients-with-relapsed-or-refractory-hematologic-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-to-evaluate-the-safety-and-dosimetry-of-68ga-oncoacp3-imaging-in-patients-with-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-to-evaluate-the-safety-and-efficacy-of-l19il2-and-ruxolitinib-in-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-to-evaluate-the-safety-of-stab-t19-genetically-modified-t-cells-secreting-cd19x-cd3-bispecific-antibodies-in-patients-with-malignant-b-cell-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-topical-latanoprost-acid-in-healthy-volunteers-for-the-treatment-of-androgenetic-alopecia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-trial-assessing-safety-and-feasibility-of-autologous-ebv-specific-cytotoxic-t-lymphocytes-in-initial-clinical-episode-of-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-trial-evaluating-eftilagimod-alpha-with-immunotherapeutic-targeted-or-chemotherapeutic-agents-in-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-trial-of-cd19-car-lenti-allo-fludarabine-phosphate-and-cyclophosphamide-in-pediatric-and-young-adult-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-i-trial-of-in-situ-anti-angiogenic-injection-in-patients-with-brain-arteriovenous-malformations-ineligible-for-exclusion-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ia-dose-finding-study-on-safety-and-immunogenicity-of-orf-virus-based-sars-cov-2-vaccine-booster-prime-2-cov-beta-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ia-ib-evaluation-of-ubx-303061-in-patients-with-relapsed-refractory-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ia-ii-rct-of-daratumumab-monotherapy-vs-daratumumab-abatacept-for-active-antibody-mediated-rejection-in-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ia-iib-evaluation-of-molidustat-sodium-and-ivosidenib-in-idh1-mutated-relapsed-refractory-aml-or-mds-aml-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-clinical-trial-to-assess-the-safety-tolerability-and-preliminary-efficacy-of-alocelyvir-mesenchymal-allogenic-cells-icovir-5-in-children-adolescent-and-young-adults-with-newly-diagnosed-diffu2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-dose-escalation-study-of-177lu-lu-neob-with-radiotherapy-and-temozolomide-in-newly-diagnosed-glioblastoma-and-as-monotherapy-in-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-dose-escalation-study-of-apn401-in-adult-patients-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-dose-ranging-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-hs235-versus-placebo-in-combination-with-background-therapy-in-pulmonary-arterial-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-br-003-in-patients-undergoing-posterior-spinal-stabilization-with-pedicle-screws-and-potential-concomitant-spinal-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-dinutuximab-beta-with-induction-chemotherapy-in-newly-diagnosed-high-risk-neuroblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-ipatasertib-with-pertuzumab-and-trastuzumab-in-pik3ca-mutant-her2-positive-locally-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-liposomal-daunorubicin-and-cytarabine-with-clofarabine-in-pediatric-relapsed-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-neoadjuvant-tislelizumab-plus-flot-in-resectable-esophagogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-regorafenib-combined-with-standard-chemotherapy-in-newly-diagnosed-multimetastatic-ewing-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-evaluation-of-safety-tolerability-and-pharmacokinetics-of-subcutaneous-her-096-in-healthy-volunteers-and-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-evaluation-of-lisaftoclax-monotherapy-and-combination-regimens-in-relapsed-refractory-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-evaluation-of-tazemetostat-with-r-chop-in-newly-diagnosed-diffuse-large-b-cell-lymphoma-and-high-risk-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-first-in-human-imaging-study-of-anti-gd2-800cw-in-pediatric-neuroblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-multicenter-open-label-study-of-intrathecal-s230815-in-pediatric-kcnt1-related-developmental-and-epileptic-encephalopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-multicenter-study-of-ribociclib-alpelisib-and-letrozole-in-advanced-hr-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-multicohort-evaluation-of-ecubectedin-monotherapy-and-combined-with-radiotherapy-in-advanced-soft-tissue-sarcomas-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-bortezomib-and-temozolomide-in-recurrent-grade-iv-glioma-with-unmethylated-mgmt-promoter2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-jdq443-tno155-and-tislelizumab-in-advanced-solid-tumors-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-lenalidomide-and-ibrutinib-with-r-mpv-in-newly-diagnosed-primary-central-nervous-system-lymphoma-patients-aged-18-652026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-niraparib-and-dostarlimab-with-chemoradiotherapy-in-locally-advanced-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-obrixtamig-bi-764532-zl-1310-atezolizumab-in-poorly-differentiated-neuroendocrine-carcinoma-including-extensive-stage-sclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-of-zongertinib-with-trastuzumab-deruxtecan-or-trastuzumab-emtansine-in-her2-metastatic-breast-and-gastroesophageal-adenocarcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-on-safety-and-efficacy-of-chemoimmunotherapy-with-mek-inhibitor-in-metastatic-non-squamous-nsclc-with-pd-l1-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-on-the-safety-and-efficacy-of-afatinib-in-fanconi-anemia-patients-with-advanced-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-study-on-the-safety-tolerability-and-efficacy-of-atezolizumab-with-thiopurine-therapy-in-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-ii-trial-of-lp-184-to-assess-safety-and-efficacy-in-advanced-metastatic-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-iia-open-label-study-of-theo-260-in-high-grade-serous-or-endometrioid-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-non-randomized-single-arm-open-label-single-center-clinical-trial-to-evaluate-the-safety-of-the-first-in-human-administration-of-the-combination-of-dendritic-cell-dc-immunization-pulsed-with-2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-open-label-basket-trial-of-ray121-targeting-classical-complement-pathway-in-dermatomyositis-immune-thrombocytopenia-behcet-s-syndrome-and-other-immunological-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-open-label-extension-basket-trial-of-ray121-in-classical-complement-pathway-inhibition-for-various-immunological-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-open-label-study-of-pit565-safety-tolerability-and-pharmacokinetics-in-systemic-lupus-erythematosus-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-open-label-study-on-safety-tolerability-and-pharmacokinetics-of-pit565-in-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-randomized-double-blind-placebo-controlled-trial-of-acd856-in-depression-cognitive-dysfunction-and-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-177lu-lu-neob-with-ribociclib-and-fulvestrant-in-er-her2-grpr-advanced-breast-cancer-post-endocrine-therapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-cyclophosphamide-pomalidomide-dexamethasone-and-daratumumab-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-lb-100-and-atezolizumab-in-patients-with-metastatic-microsatellite-stable-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-lb-100-and-azenosertib-in-patients-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-obt076-and-balstilimab-in-recurrent-or-metastatic-adenoid-cystic-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-tu7710-safety-pharmacokinetics-and-pharmacodynamics-in-patients-with-hemophilia-a-or-b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ib-study-of-wharton-s-jelly-derived-mesenchymal-stromal-cells-for-respiratory-complications-in-covid-19-influenza-a-metapneumovirus-and-rsv-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-basket-study-of-sacituzumab-tirumotecan-mk-2870-in-rare-genitourinary-tumors-papillary-rcc-and-variant-histology-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-basket-trial-evaluating-pembrolizumab-and-vorinostat-efficacy-in-recurrent-metastatic-squamous-cell-carcinoma-of-various-anatomical-sites2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-basket-trial-of-atezolizumab-and-tiragolumab-in-patients-with-solid-tumors-including-hnscc-dmmr-msi-h-tumors-and-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-basket-trial-on-niraparib-and-dostarlimab-efficacy-and-safety-in-dna-repair-deficient-or-platinum-sensitive-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-biomarker-trial-of-low-dose-tamoxifen-and-lifestyle-interventions-for-breast-cancer-prevention-in-high-risk-women2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-dose-escalation-study-of-venetoclax-in-acute-graft-versus-host-disease-post-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-dose-finding-study-of-sublingual-phleum-pratense-extract-in-adults-with-grass-pollen-induced-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-dose-selection-study-of-intravenous-bi-764532-in-relapsed-refractory-extensive-stage-small-cell-lung-cancer-and-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-double-blind-placebo-controlled-study-of-pha-022121-for-prophylaxis-of-hereditary-angioedema-attacks-in-c1-inhibitor-deficiency-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-double-blind-placebo-controlled-trial-evaluating-msv-allo-efficacy-and-safety-in-active-lupus-nephritis-remission2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-double-blind-randomized-placebo-controlled-study-of-glycerol-phenylbutyrate-on-neurofilament-light-chain-levels-in-corticobasal-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-177lutetium-dotatate-in-pediatric-patients-with-primary-refractory-or-relapsed-high-risk-neuroblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-5-fluorouracil-panitumumab-and-sotorasib-in-first-line-treatment-of-advanced-kras-g12c-mutated-colorectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-68ga-nota-anti-mmr-vhh2-pet-ct-imaging-for-detecting-cardiac-sarcoidosis-lesions-in-patients-with-probable-diagnosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-68ganota-anti-mmr-vhh2-pet-imaging-in-mmr-expressing-macrophages-in-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-adjuvant-dendritic-cell-vaccine-with-autologous-tumor-lysate-and-aldesleukin-in-resected-stage-iv-neuroendocrine-tumors-and-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-adjuvant-palbociclib-versus-chemotherapy-in-elderly-patients-with-high-risk-er-her2-localized-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-adjuvant-pipac-with-fluorouracil-oxaliplatin-and-levoleucovorin-for-preventing-peritoneal-metastases-in-high-risk-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-alpelisib-efficacy-safety-and-pharmacokinetics-in-pediatric-and-adult-patients-with-pik3ca-related-overgrowth-spectrum-pros2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-amivantamab-and-pemetrexed-in-egfr-exon20-insertion-mutations-in-platinum-unfit-metastatic-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-anakinra-on-cerebral-edema-post-spontaneous-supratentorial-intracerebral-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-and-tiragolumab-with-chemoradiotherapy-in-localized-squamous-cell-carcinoma-of-the-anal-canal2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-carboplatin-and-nab-paclitaxel-in-metastatic-triple-negative-pd-l1-positive-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-combined-with-stereotactic-ablative-radiotherapy-in-metastatic-colorectal-non-small-cell-lung-renal-cell-carcinoma-and-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-in-locally-advanced-unresectable-stage-iii-nsclc-post-platinum-based-concurrent-chemoradiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-maintenance-post-chemo-radiotherapy-in-muscle-invasive-bladder-cancer-patients-ineligible-for-radical-cystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-trastuzumab-and-vinorelbine-in-er-negative-or-non-luminal-her2-positive-advanced-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-vinorelbine-and-cyclophosphamide-in-metastatic-triple-negative-breast-cancer-post-anti-pd-l1-pd-1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-with-induction-chemotherapy-and-chemo-radiotherapy-in-unresectable-stage-iiia-iiib-iiic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-atezolizumab-with-platinum-and-etoposide-in-advanced-large-cell-neuroendocrine-carcinoma-of-the-lung-in-non-curative-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-autologous-skin-derived-keratinocytes-and-fibroblasts-in-fibrin-matrix-for-reconstructive-surgery-in-basal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-axitinib-intensification-plus-standard-of-care-versus-standard-of-care-alone-post-induction-with-nivolumab-and-ipilimumab-in-mrcc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-azacitidine-and-low-dose-venetoclax-in-acute-myeloid-leukemia-with-multi-omics-and-ex-vivo-drug-screening-integration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-azacitidine-and-venetoclax-combination-therapy-in-higher-risk-chronic-myelomonocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-azacitidine-venetoclax-and-tagraxofusp-in-higher-risk-chronic-myelomonocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-azd7789-azd0901-and-rilvegostomig-in-combination-with-chemotherapy-for-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-belimumab-with-rituximab-venetoclax-in-refractory-or-relapsed-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-bnt111-and-cemiplimab-alone-or-combined-in-anti-pd-1-pd-l1-refractory-relapsed-unresectable-stage-iii-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-c1-esterase-inhibitor-in-the-management-of-aneurysmal-subarachnoid-hemorrhage-safety-and-efficacy-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cabozantinib-as-a-biomarker-driven-therapy-in-advanced-radioactive-iodine-refractory-differentiated-thyroid-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cabozantinib-in-advanced-low-proliferative-grade-3-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cannabidiol-as-an-adjunctive-therapy-in-inpatient-alcohol-cessation-for-severe-alcohol-use-disorder-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-carcik-cd19-cell-infusion-strategy-in-pediatric-and-adult-patients-with-relapsed-refractory-b-cell-precursor-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cemiplimab-efficacy-and-safety-as-first-line-therapy-in-advanced-basal-cell-carcinoma-patients-naive-to-hedgehog-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cetuximab-platinum-and-taxane-based-chemotherapy-followed-by-avelumab-and-cetuximab-in-pd-l1-cps-1-recurrent-metastatic-hnscc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-chlorambucil-and-subcutaneous-rituximab-in-extranodal-marginal-zone-b-cell-lymphoma-of-mucosa-associated-lymphoid-tissue2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-cobicistat-boosted-venetoclax-with-azacitidine-in-newly-diagnosed-acute-myeloid-leukemia-ineligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-dasatinib-and-quercetin-senolytic-therapy-in-amnestic-mild-cognitive-impairment-and-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-dasatinib-in-pediatric-patients-with-newly-diagnosed-chronic-phase-cml-or-ph-leukemias-resistant-or-intolerant-to-imatinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-datopotamab-deruxtecan-in-triple-negative-breast-cancer-patients-with-newly-diagnosed-or-progressive-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-de-escalated-therapy-with-etoposide-cisplatin-and-carboplatin-in-stage-iia-iib-seminoma-less-than-3-cm2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-dexamethasone-lenalidomide-and-carfilzomib-in-intermediate-and-high-risk-smoldering-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-domvanalimab-and-zimberelimab-in-advanced-rare-cancers-resistant-to-standard-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-dornase-alfa-and-cisplatin-in-patients-with-refractory-germ-cell-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-dostarlimab-vitamin-d3-and-mfolfirinox-in-untreated-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-and-tremelimumab-combined-with-y-90-sirt-in-intermediate-stage-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-and-tremelimumab-with-or-without-capecitabine-in-adjuvant-treatment-of-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-and-tremelimumab-with-y-90-sirt-in-advanced-intrahepatic-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-ceralasertib-and-trastuzumab-deruxtecan-in-nsclc-patients-post-anti-pd-1-pd-l1-therapy-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-combined-with-radiotherapy-in-t1-t4-n0-n2b-squamous-cell-carcinoma-of-the-head-and-neck-without-prophylactic-neck-irradiation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-in-treatment-naive-patients-with-stage-iv-non-small-cell-lung-cancer-and-high-pd-l1-expression-with-ecog-ps-2-32026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-durvalumab-maintenance-therapy-post-thoracic-chemoradiotherapy-in-frail-patients-with-limited-disease-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-electrochemotherapy-with-bleomycin-and-cisplatin-in-high-grade-vulvar-squamous-lesions-and-non-invasive-paget-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-encorafenib-and-binimetinib-in-brafv600e-mutant-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-eribulin-and-izorlisib-mesilate-in-advanced-pik3ca-pten-altered-triple-negative-and-hr-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-fedratinib-and-nivolumab-in-myelofibrosis-patients-with-jak-inhibitor-resistance-or-suboptimal-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-fexofenadine-hydrochloride-combined-with-immunotherapy-in-patients-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-fg001-for-optical-localization-of-meningiomas-and-presumed-low-grade-gliomas-in-patients-undergoing-neurosurgical-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-fludarabine-and-treosulfan-conditioning-regimen-for-allogeneic-stem-cell-transplantation-in-acute-myeloid-leukemia-patients-aged-40-652026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-folfox-and-panitumumab-with-stop-and-go-strategy-in-metastatic-colorectal-adenocarcinoma-lacking-ras-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-futibatinib-tislelizumab-and-chemotherapy-in-first-line-treatment-of-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-gemcitabine-oxaliplatin-rituximab-and-tafasitamab-in-relapsed-refractory-aggressive-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ginisortamab-with-nab-paclitaxel-and-gemcitabine-or-mek-inhibitor-in-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-glofitamab-and-obinutuzumab-in-relapsed-refractory-lymphomas-post-anti-cd19-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ibrutinib-and-rituximab-in-treatment-naive-cd20-positive-marginal-zone-b-cell-lymphoma-patients-requiring-systemic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-intralesional-bifikafusp-alfa-and-onfekafusp-alfa-in-malignant-skin-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-intratumoral-l19il2-and-l19tnf-in-high-risk-locally-advanced-basal-cell-and-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-intravenous-dornase-alfa-for-arterial-recanalization-post-thrombectomy-in-ischemic-stroke-patients-eligible-for-thrombolysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ipilimumab-and-nivolumab-in-molecularly-selected-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ivonescimab-with-chemotherapy-in-advanced-gastric-and-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ivosidenib-maintenance-therapy-post-standard-adjuvant-chemotherapy-in-curative-midh1-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-jdq443-monotherapy-in-kras-g12c-mutated-nsclc-with-variable-pd-l1-expression-and-stk11-co-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-lacutamab-monotherapy-and-combination-chemotherapy-in-advanced-t-cell-lymphomas-including-sezary-syndrome-and-mycosis-fungoides2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-loncastuximab-tesirine-consolidation-post-immunochemotherapy-in-btki-treated-or-intolerant-relapsed-refractory-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-lurbinectedin-and-irinotecan-in-advanced-desmoplastic-small-round-cell-tumor-in-adults-and-young-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-lutetium-177lu-vipivotide-tetraxetan-in-metastatic-clear-cell-renal-cell-carcinoma-post-ici-and-vegfr-tki-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-mas825-efficacy-safety-and-tolerability-in-pediatric-and-adult-patients-with-still-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-mercaptamine-as-an-adjunct-to-standard-therapy-in-bacilliferous-pulmonary-tuberculosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-metronomic-and-targeted-anti-angiogenic-therapy-with-bevacizumab-in-pediatric-recurrent-progressive-medulloblastoma-ependymoma-and-atrt2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-minimal-residual-disease-negativity-with-talquetamab-and-teclistamab-in-first-line-treatment-for-transplant-eligible-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-mosunetuzumab-and-zanubrutinib-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-mosunetuzumab-combined-with-chop-regimen-in-treatment-naive-patients-with-richter-s-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-myelin-peptide-loaded-tolerogenic-dendritic-cells-in-relapsing-remitting-and-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-neoadjuvant-chemotherapy-with-etoposide-carboplatin-and-cisplatin-in-localized-digestive-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-nivolumab-and-ipilimumab-maintenance-post-chemotherapy-in-unresectable-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-nivolumab-and-nivolumab-plus-relatlimab-in-locally-advanced-metastatic-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-nivolumab-in-pediatric-and-adult-relapsed-refractory-alk-positive-anaplastic-large-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-nms-01940153e-and-atezolizumab-with-or-without-decitabine-priming-in-unresectable-hepatocellular-carcinoma-post-ici-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-overall-survival-in-relapsed-stage-iii-nsclc-with-durvalumab-and-chemotherapy-post-chemoradiotherapy-and-durvalumab-maintenance2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-paclitaxel-carboplatin-and-durvalumab-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-and-carboplatin-in-brca-mutated-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-and-lenvatinib-in-relapsed-refractory-classic-kaposi-sarcoma-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-and-metronomic-cyclophosphamide-in-locally-recurrent-inoperable-and-metastatic-inflammatory-breast-cancer-with-chest-wall-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-in-high-grade-hpv-related-vulvar-and-cervical-pre-neoplastic-lesions2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-lenvatinib-and-chemotherapy-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-trastuzumab-and-flot-regimen-in-perioperative-management-of-her2-positive-localized-esophagogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-with-chemotherapy-in-pediatric-and-young-adult-classical-hodgkin-lymphoma-with-slow-early-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pembrolizumab-with-cisplatin-or-carboplatin-and-pemetrexed-as-neoadjuvant-therapy-in-resectable-epithelioid-and-biphasic-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-pemigatinib-post-curative-local-therapy-in-fgfr2-fusion-rearrangement-positive-locally-advanced-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-preoperative-stereotactic-radiotherapy-and-pembrolizumab-with-chemotherapy-in-her2-negative-non-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-progesterone-addition-to-edp-m-regimen-in-advanced-adrenocortical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-r-hyper-cvad-r-ma-regimen-in-high-risk-aggressive-b-cell-lymphoma-efficacy-of-rituximab-doxorubicin-methotrexate-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-rbd1016-injection-in-combination-with-nucleoside-analogues-for-safety-and-efficacy-in-chronic-hepatitis-b-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-regorafenib-combined-with-braf-mek-inhibitors-in-advanced-braf-v600-mutant-melanoma-post-progression-or-therapy-interruption2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-repotrectinib-efficacy-and-safety-in-ros1-positive-nsclc-patients-with-active-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-rituximab-and-golcadomide-combination-therapy-in-frail-elderly-patients-with-diffuse-large-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ro7247669-in-treatment-naive-patients-with-unresectable-or-metastatic-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-ro7435846-in-combination-with-multiple-agents-for-biomarker-positive-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-safety-and-efficacy-of-chemotherapy-and-craniospinal-irradiation-in-metastatic-medulloblastoma-and-embryonal-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-safety-and-efficacy-of-mb-cart2019-1-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-following-lymphodepletion-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-safety-and-efficacy-of-zamtocabtagene-autoleucel-in-pediatric-relapsed-refractory-mature-b-cell-neoplasms-with-fludarabine-and-cyclophosphamide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-selective-internal-radiation-therapy-with-yttrium-90-and-capecitabine-in-neoadjuvant-treatment-of-resectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-selinexor-ifosfamide-etoposide-and-dexamethasone-in-relapsed-refractory-peripheral-t-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-sequential-gemcitabine-and-paclitaxel-albumin-bound-followed-by-folfirinox-and-mri-guided-radiotherapy-in-locally-advanced-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-sevuparin-in-patients-with-chronic-kidney-disease-pharmacokinetics-and-hematological-biochemical-parameter-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-short-course-radiotherapy-and-folfoxiri-regimen-as-total-neoadjuvant-therapy-in-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-sonidegib-in-nevoid-basal-cell-carcinoma-syndrome-and-sporadic-basal-cell-carcinoma-patients-in-eado-stage-iib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-sotorasib-in-patients-with-unresectable-stage-iii-kras-p-g12c-mutant-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-talazoparib-maintenance-post-platinum-chemotherapy-in-advanced-malignant-pleural-and-peritoneal-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-teclistamab-in-patients-with-relapsed-immunoglobulin-light-chain-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tepotinib-in-advanced-non-small-cell-lung-cancer-with-met-exon-14-skipping-alterations-or-met-amplification2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tip-chemotherapy-paclitaxel-ifosfamide-cisplatin-and-bilateral-lymphadenectomy-in-inguinal-node-metastasis-of-penile-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tisagenlecleucel-in-high-risk-pediatric-and-young-adult-b-cell-acute-lymphoblastic-leukemia-with-end-of-consolidation-minimal-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tislelizumab-efficacy-and-safety-in-de-novo-hodgkin-lymphoma-patients-ineligible-for-standard-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tislelizumab-in-elderly-patients-with-advanced-esophageal-squamous-cell-carcinoma-unfit-for-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-tislelizumab-monotherapy-in-hepatocellular-carcinoma-patients-with-child-pugh-b-and-albi-grade-1-2-liver-function2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-total-marrow-and-lymphoid-irradiation-with-cyclophosphamide-and-etoposide-conditioning-for-allogeneic-hsct-in-high-risk-mds-or-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-total-marrow-and-lymphoid-irradiation-with-fludarabine-and-melphalan-conditioning-in-high-risk-mds-or-aml-for-allogeneic-hsct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trabectedin-in-hey1-ncoa2-positive-advanced-mesenchymal-chondrosarcoma-in-adults-and-young-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trastuzumab-deruxtecan-in-her2-low-breast-cancer-with-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trastuzumab-deruxtecan-in-her2-positive-metastatic-breast-cancer-resistant-to-trastuzumab-pertuzumab-and-taxane-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trastuzumab-tucatinib-and-vinorelbine-in-her2-positive-non-resectable-locally-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trifluridine-tipiracil-in-er-positive-her2-negative-advanced-breast-cancer-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trifluridine-tipiracil-plus-oxaliplatin-nivolumab-versus-folfox-nivolumab-in-her2-negative-advanced-gastric-and-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-trifluridine-tipiracil-safety-in-dihydropyrimidine-dehydrogenase-deficient-patients-with-metastatic-colorectal-or-gastroesophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-vemurafenib-monotherapy-in-patients-with-metastatic-or-unresectable-locally-advanced-malignancies-harboring-braf-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-venetoclax-and-decitabine-in-elderly-patients-with-newly-diagnosed-acute-myeloid-leukemia-eligible-for-allogeneic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-zanubrutinib-in-patients-with-primary-cold-agglutinin-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-evaluation-of-zanubrutinib-tislelizumab-and-sonrotoclax-in-richter-transformation-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-double-blind-randomized-placebo-controlled-trial-evaluating-clopidogrel-for-systemic-sclerosis-prevention-in-patients-with-dysimmunity-and-raynaud-phenomenon2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-multicentric-trial-on-tailored-management-of-locally-advanced-rectal-carcinoma-with-irinotecan-hydrochloride-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-open-label-randomized-trial-of-autologous-cancer-stem-cell-mrna-transfected-dendritic-cells-and-temozolomide-in-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-randomized-study-of-durvalumab-and-tremelimumab-with-or-without-hepatic-arterial-infusion-chemotherapy-in-high-tumor-burden-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-randomized-trial-of-intravitreal-ocul101-versus-aflibercept-in-neovascular-age-related-macular-degeneration-with-without-geographic-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-study-on-the-non-inferiority-of-metronidazole-neomycin-sulfate-nystatin-pessaries-versus-tergynan-in-treating-bacterial-vaginosis-and-vulvovaginal-candidiasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-study-to-assess-the-efficacy-and-safety-of-sublingual-immunotherapy-in-patients-suffering-from-house-dust-mite-allergy-a-prospective-international-randomized-double-blind-placebo-controll2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-iii-trial-of-autologous-dendritic-cell-immunotherapy-in-patients-with-borderline-resectable-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multi-arm-trial-evaluating-io102-io103-and-pembrolizumab-in-metastatic-nsclc-scchn-and-mubc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multi-cohort-trial-of-neoadjuvant-and-post-surgery-io102-io103-and-pembrolizumab-in-patients-with-selected-resectable-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-clinical-trial-mosunetuzumab-for-early-relapse-of-follicular-lymphoma-in-the-nordic-countries-merlin-nlg-fl6-ml438412026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-randomized-controlled-trial-on-high-dose-lamivudine-maraviroc-and-dolutegravir-sodium-for-reducing-hiv-1-latent-reservoir2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-randomized-study-of-roginolisib-ioa-244-versus-investigator-s-choice-in-advanced-metastatic-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-randomized-trial-evaluating-safety-and-durable-response-of-allogeneic-placenta-derived-decidual-stromal-cells-in-steroid-resistant-severe-acute-graft-versus-host-diseas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-asciminib-hydrochloride-in-cml-cp-or-cml-ap-patients-with-t315i-mutation-resistant-intolerant-or-ineligible-to-ponatinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-cabozantinib-for-second-line-treatment-in-unresectable-locally-advanced-or-metastatic-renal-cell-carcinoma-with-clear-cell-component2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-cirtuvivint-as-second-line-therapy-in-advanced-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-datopotamab-deruxtecan-in-non-squamous-nsclc-patients-with-active-brain-metastases-tuxedo-52026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-glofitamab-venetoclax-and-zanubrutinib-in-untreated-or-refractory-high-risk-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-isatuximab-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-high-risk-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-obinutuzumab-monotherapy-in-marginal-zone-lymphoma-patients-refractory-or-ineligible-to-local-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-subcutaneous-anifrolumab-pk-pd-and-safety-in-pediatric-patients-5-18-yr-with-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-study-of-zanubrutinib-and-rituximab-in-igm-mgus-and-anti-mag-polyneuropathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-open-label-trial-evaluating-efficacy-and-safety-of-nal-iri-in-her2-negative-breast-cancer-with-cns-metastases-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-blinded-placebo-controlled-study-evaluating-safety-and-efficacy-of-cd4-cd25-cd127-tregs-and-rituximab-in-pediatric-stage-1-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-double-blind-placebo-controlled-study-of-ipn10200-for-episodic-and-chronic-migraine-prevention-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-double-blind-study-on-phage-therapy-efficacy-and-safety-in-staphylococcus-aureus-induced-prosthetic-joint-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-open-label-study-of-elacestrant-with-without-triptorelin-in-premenopausal-women-with-er-her2-early-luminal-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-open-label-study-of-relatlimab-and-nivolumab-versus-nivolumab-in-locally-advanced-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-open-label-trial-of-denosumab-with-map-regimen-in-metastatic-osteosarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-study-of-avelumab-versus-standard-chemotherapy-in-metastatic-colorectal-cancer-with-microsatellite-instability2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-study-of-regorafenib-in-recurrent-grade-2-and-3-meningioma-post-surgery-and-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-study-on-de-escalation-vs-standard-adjuvant-chemotherapy-in-low-risk-localized-gastroesophageal-adenocarcinoma-with-docetaxel-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-trial-of-neoadjuvant-chemotherapy-and-chemoradiotherapy-regimens-in-resectable-gastric-adenocarcinoma-docetaxel-capecitabine-paclitaxel-oxaliplatin-carboplatin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-trial-of-pipac-and-systemic-chemotherapy-versus-systemic-chemotherapy-alone-in-first-line-treatment-of-malignant-peritoneal-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-trial-of-radiochemotherapy-with-or-without-durvalumab-in-locally-advanced-anal-carcinoma-stage-iib-iiic2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-randomized-trial-of-wt1-mrna-electroporated-dendritic-cell-vaccination-for-relapse-prevention-in-adult-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-single-arm-study-of-durvalumab-with-carboplatin-or-cisplatin-and-etoposide-in-first-line-treatment-of-extensive-stage-extrapulmonary-small-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-evaluating-amivantamab-futibatinib-and-atezolizumab-in-molecularly-selected-advanced-solid-tumor-populations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-evaluating-efficacy-and-safety-of-zongertinib-bi-1810631-in-her2-mutated-or-overexpressed-amplified-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-evaluating-epcoritamab-efficacy-in-relapsed-refractory-large-b-cell-lymphoma-with-tafasitamab-and-lenalidomide-combination-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-177lu-dotatoc-in-sstr-positive-neuroendocrine-tumors-pheochromocytomas-and-paragangliomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-89zr-df-crefmirlimab-pet-imaging-in-metastatic-solid-tumors-with-nivolumab-and-cetrelimab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-acalabrutinib-in-elderly-or-frail-patients-with-treatment-naive-or-relapsed-refractory-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-axitinib-with-or-without-pembrolizumab-in-first-line-treatment-of-locally-advanced-or-metastatic-papillary-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-belantamab-mafodotin-with-vrd-in-newly-diagnosed-transplant-eligible-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-biomarker-guided-post-neoadjuvant-therapy-with-trastuzumab-pertuzumab-and-drug-combinations-in-early-high-risk-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-carfilzomib-lenalidomide-and-dexamethasone-in-high-risk-smoldering-multiple-myeloma-patients-70-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-carfilzomib-lenalidomide-and-dexamethasone-regimens-in-newly-diagnosed-multiple-myeloma-patients-eligible-for-autologous-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-eftilagimod-alpha-and-pembrolizumab-in-unresectable-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-elranatamab-monotherapy-in-relapsed-refractory-multiple-myeloma-post-three-drug-class-exposure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-enasidenib-mesilate-in-idh2-mutated-myelodysplastic-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-iberdomide-and-dexamethasone-alone-or-with-daratumumab-in-transplant-ineligible-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-intraperitoneal-irinotecan-hydrochloride-trihydrate-with-systemic-therapy-in-gastric-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-ivosidenib-in-idh1-mutated-myelodysplastic-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-metronomic-temozolomide-in-clinically-frail-patients-with-advanced-well-differentiated-neuroendocrine-neoplasms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-neoadjuvant-sacituzumab-govitecan-and-zimberelimab-in-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-pembrolizumab-with-neoadjuvant-ec-paclitaxel-in-her2-negative-inflammatory-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-preoperative-chemoradiotherapy-with-capecitabine-and-temozolomide-in-mgmt-silenced-microsatellite-stable-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-rvu120-in-treating-anemia-in-patients-with-lower-risk-myelodysplastic-syndromes-using-sel120-monohydrochloride2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-of-thoracic-radiotherapy-with-cisplatin-carboplatin-etoposide-and-durvalumab-in-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-anastrozole-letrozole-and-exemestane-interruption-vs-maintenance-in-metastatic-low-grade-endometrial-stromal-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-azacitidine-efficacy-and-safety-in-vexas-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-azacitidine-for-minimal-residual-disease-management-post-allogeneic-stem-cell-transplantation-in-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-de-escalation-of-chemoradiotherapy-in-hpv-associated-oropharyngeal-squamous-cell-carcinoma-using-cisplatin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-efficacy-and-safety-of-cetuximab-and-irinotecan-rechallenge-versus-investigator-s-choice-in-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-gilteritinib-with-fludarabine-cytarabine-and-idarubicin-in-newly-diagnosed-flt3-positive-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-imatinib-mesilate-maintenance-vs-interruption-in-advanced-metastatic-gastrointestinal-stromal-tumors-after-10-years-of-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-isatuximab-efficacy-and-safety-in-adult-patients-with-relapsed-refractory-cd38-t-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-laparoscopic-administration-of-allogeneic-adipose-derived-mesenchymal-stem-cells-for-crohn-s-disease-associated-strictures2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-study-on-neoadjuvant-pembrolizumab-and-lenvatinib-in-resectable-mucosal-melanoma-with-maintenance-immunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-evaluating-atezolizumab-with-radiotherapy-in-localized-operable-soft-tissue-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-evaluating-pirtobrutinib-and-rituximab-in-treatment-naive-patients-with-indolent-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-adagrasib-in-krasg12c-mutant-nsclc-patients-aged-70-or-with-ecog-ps-22026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-darolutamide-with-radiotherapy-in-intermediate-unfavorable-risk-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-ibrutinib-and-venetoclax-in-relapsed-refractory-chronic-lymphocytic-leukemia-with-without-tp53-aberrations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-maat033-and-cemiplimab-in-antibiotic-induced-pd-1-pd-l1-blockade-resistance-in-advanced-nsclc-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-maintenance-therapy-with-durvalumab-and-olaparib-post-first-line-treatment-in-hrd-positive-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-neoadjuvant-intraperitoneal-irinotecan-and-systemic-mfolfox4-bevacizumab-in-resectable-colorectal-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-patritumab-deruxtecan-in-her3-expressing-advanced-breast-and-non-small-cell-lung-cancer-with-brain-metastases-and-leptomeningeal-carcinomatosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-of-reduced-intensity-radiochemotherapy-with-carboplatin-etoposide-and-cisplatin-in-stage-iia-b-seminoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicenter-trial-on-mrd-driven-venetoclax-and-rituximab-therapy-in-treatment-naive-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-evaluation-of-olaparib-in-palb2-mutated-advanced-pancreatic-neoplasm2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-evaluation-of-pembrolizumab-efficacy-in-classic-and-endemic-kaposi-s-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-open-label-study-on-mirtazapine-for-social-orofacial-respiratory-and-motor-symptoms-in-rett-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-open-label-trial-of-zolbetuximab-paclitaxel-and-ramucirumab-in-second-line-treatment-for-cldn18-2-positive-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-study-of-hepatocellular-carcinoma-in-cirrhosis-patients-with-child-a-b7-using-hepatic-intra-arterial-idarubicin-and-lipiodol-emulsion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-study-of-pembrolizumab-with-etoposide-cisplatin-chemotherapy-in-first-line-treatment-of-small-cell-ovarian-carcinoma-hypercalcemic-type2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-trial-assessing-efficacy-and-safety-of-glycerol-phenylbutyrate-in-pyruvate-dehydrogenase-deficiency-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-trial-evaluating-ibrutinib-and-rituximab-efficacy-and-safety-in-indolent-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-trial-evaluating-suraparib-efficacy-in-metastatic-homologous-repair-deficient-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicentric-trial-evaluating-volrustomig-in-patients-with-mature-tertiary-lymphoid-structures-in-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multicohort-study-of-trabectedin-and-low-dose-radiation-therapy-in-advanced-metastatic-soft-tissue-and-bone-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multinational-study-on-osimertinib-efficacy-and-safety-in-egfr-mutation-positive-stage-ii-iiib-non-small-cell-lung-cancer-post-resection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multisite-open-label-randomized-trial-of-temozolomide-lomustine-and-perflutren-in-newly-diagnosed-glioblastoma-with-ultrasound-induced-bbb-opening2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-multisite-open-label-trial-of-bnt327-and-docetaxel-in-second-line-stage-iv-or-recurrent-nsclc-post-chemoimmunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-neoadjuvant-evaluation-of-capivasertib-and-fulvestrant-versus-fulvestrant-in-primary-high-risk-lobular-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-neoadjuvant-study-of-pembrolizumab-carboplatin-and-paclitaxel-in-stage-i-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-non-inferiority-trial-comparing-ari-0001-car-t-cells-to-axicabtagene-ciloleucel-in-relapsed-refractory-non-hodgkin-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-evaluation-of-sacituzumab-govitecan-in-patients-with-unresectable-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-multicenter-study-of-durvalumab-in-advanced-or-metastatic-non-small-cell-lung-cancer-post-prior-platinum-based-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-randomized-study-on-sirolimus-efficacy-and-safety-in-drug-resistant-epilepsy-with-mtor-pathway-related-cns-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-single-arm-study-of-pembrolizumab-combined-with-cisplatin-or-carboplatin-and-etoposide-in-treatment-naive-advanced-merkel-cell-carcinoma-mcc-pandora-trial2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-olaparib-and-durvalumab-in-high-grade-epithelial-ovarian-cancer-prior-to-primary-debulking-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-pembrolizumab-and-lenvatinib-in-advanced-hepatocellular-carcinoma-refractory-to-atezolizumab-and-bevacizumab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-pembrolizumab-and-olaparib-in-her2-negative-metastatic-breast-cancer-with-germline-brca1-2-or-homologous-recombination-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-repotrectinib-in-frail-or-elderly-patients-with-ros1-rearranged-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-um171-expanded-cord-blood-transplantation-in-high-and-very-high-risk-acute-leukemia-myelodysplasia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-of-valemetostat-tosylate-monotherapy-in-relapsed-refractory-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-on-lenalidomide-tafasitamab-and-rituximab-in-frontline-diffuse-large-b-cell-lymphoma-in-patients-aged-80-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-on-safety-tolerability-pharmacokinetics-and-efficacy-of-ag13909-in-adults-with-cushing-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-open-label-study-on-sonidegib-compliance-in-locally-advanced-basal-cell-carcinoma-patients-with-complete-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-of-177lu-lu-psma-i-t-radioligand-therapy-in-prostate-carcinoma-with-biochemical-recurrence-post-curative-primary-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-of-digitoxin-combined-with-chemotherapy-in-patients-with-inoperable-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-of-neoadjuvant-177lu-lu-psma-i-t-radioligand-therapy-in-oligometastatic-prostate-carcinoma-diagnosed-via-68ga-ga-psma-11-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-on-alpelisib-efficacy-and-safety-in-dent-2-disease-patients-using-99mtc-dmsa-for-renal-proximal-tubule-reabsorption-assessment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-on-dual-antiretroviral-therapy-with-long-acting-cabotegravir-and-lenacapavir-in-hiv-infected-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pilot-study-on-organ-preservation-in-locally-advanced-rectal-cancer-using-radiochemotherapy-with-calcium-folinate-fluorouracil-and-oxaliplatin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-placebo-controlled-study-of-cannabidiol-in-the-management-of-alcohol-dependence-in-treatment-seeking-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-placebo-controlled-trial-of-cannabidiol-for-the-treatment-of-alcohol-dependence-placoncanalde2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-placebo-controlled-trial-of-cannabidiol-in-adults-with-alcohol-dependence-seeking-abstinence2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-pre-operative-trial-of-nivolumab-ipilimumab-and-relatlimab-in-breast-cancer-for-pathological-complete-response-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-evaluating-abacavir-lamivudine-on-interferon-signature-in-systemic-lupus-erythematosus-patients-with-low-disease-activity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-allogeneic-peripheral-blood-mononuclear-cells-with-mitomycin-c-in-living-donor-kidney-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-autogene-cevumeran-versus-watchful-waiting-in-ctdna-positive-resected-stage-ii-iii-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-intradermal-tilsotolimod-sodium-in-patients-with-pt3-4-cn0m0-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-isatuximab-and-evencaleucel-in-maintenance-therapy-for-multiple-myeloma-post-high-dose-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-nasal-chondrocyte-based-tissue-engineered-cartilage-implantation-for-patellofemoral-osteoarthritis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-tobemstomig-and-platinum-based-chemotherapy-versus-pembrolizumab-and-platinum-based-chemotherapy-in-untreated-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-of-trametinib-vs-vinblastine-in-pediatric-and-aya-patients-with-newly-diagnosed-low-grade-glioma-with-wild-type-braf2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-controlled-trial-on-efficacy-of-fecal-microbiota-transfer-with-colistin-sulfate-and-vancomycin-in-decolonizing-mdr-enterobacteriaceae2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-dose-finding-study-of-montelukast-in-erosive-hand-osteoarthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-placebo-controlled-study-of-intravenous-alteplase-post-andexanet-alfa-reversal-in-acute-ischemic-stroke-on-doac-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-placebo-controlled-study-of-nx210c-in-adult-patients-with-amyotrophic-lateral-sclerosis-als2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-placebo-controlled-trial-of-adenovirus-vector-serotype-5-containing-vegf-d-isoform-in-refractory-angina-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-placebo-controlled-trial-of-ensifentrine-in-non-cystic-fibrosis-bronchiectasis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-placebo-controlled-trial-on-caspofungin-aerosols-for-pneumocystis-pneumonia-treatment-adjunctive-to-systemic-antifungal-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-study-of-atezolizumab-and-tiragolumab-in-recurrent-metastatic-pd-l1-positive-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-study-of-bms-986315-and-nivolumab-with-chemotherapy-in-stage-iv-or-recurrent-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-double-blind-study-of-hlx22-with-trastuzumab-and-xelox-pembrolizumab-in-first-line-treatment-of-advanced-gastroesophageal-junction-and-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-observer-blinded-trial-of-pb-tx-01-vs-polyhexanide-solution-for-safety-and-efficacy-in-chronic-wounds-colonized-by-pseudomonas-aeruginosa2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-open-label-trial-of-dostarlimab-as-maintenance-therapy-in-high-risk-locally-advanced-cervical-cancer-post-chemo-radiation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-placebo-controlled-study-of-azd7798-for-safety-and-mucosal-repair-in-ileal-crohn-s-disease-with-ileostomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-placebo-controlled-study-of-rifamycin-sv-sodium-in-situ-gelling-solution-for-mild-to-moderate-left-sided-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-placebo-controlled-study-on-regorafenib-efficacy-and-safety-in-metastatic-bone-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-placebo-controlled-trial-of-rem0045392-safety-and-efficacy-in-healthy-elderly-and-alzheimer-s-disease-participants2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-comparing-custodiol-n-and-custodiol-cardioplegia-in-pediatric-congenital-heart-malformation-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-comparing-efficacy-of-standard-chemotherapy-versus-letrozole-plus-abemaciclib-in-hr-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-comparing-ponatinib-and-imatinib-with-chemotherapy-in-elderly-patients-with-ph-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-177lu-lu-dotatate-in-recurrent-meningioma-lacking-surgical-or-radiotherapeutic-options2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-3-vs-6-cycles-of-platinum-based-chemotherapy-followed-by-maintenance-avelumab-in-advanced-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-5-fluorouracil-leucovorin-irinotecan-gemcitabine-and-paclitaxel-in-metastatic-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-abemaciclib-with-letrozole-or-fulvestrant-paclitaxel-in-hr-her2-advanced-breast-cancer-with-aggressive-features2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-adjuvant-atezolizumab-and-tiragolumab-in-resectable-solid-tumors-with-high-tumor-mutational-burden-or-microsatellite-instability2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-adjuvant-capecitabine-with-or-without-durvalumab-in-resected-biliary-tract-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-atezolizumab-plus-chemoradiotherapy-versus-chemoradiotherapy-alone-in-limited-disease-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-atezolizumab-with-sbrt-versus-sbrt-alone-in-oligometastatic-soft-tissue-sarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-avelumab-and-cetuximab-rechallenge-in-pre-treated-ras-braf-wild-type-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-bortezomib-with-dexamethasone-mitoxantrone-vincristine-pegaspargase-and-methotrexate-in-high-risk-relapsed-pediatric-all2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-brigatinib-and-carboplatin-pemetrexed-in-advanced-alk-positive-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-cisplatin-and-radiotherapy-versus-durvalumab-and-radiotherapy-in-intermediate-risk-hpv-positive-locoregionally-advanced-oropharyngeal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-dna-damage-repair-agents-with-olaparib-vs-olaparib-monotherapy-in-metastatic-triple-negative-breast-cancer-with-hrr-gene-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-dostarlimab-and-niraparib-versus-niraparib-monotherapy-and-chemotherapy-in-metastatic-or-recurrent-endometrial-or-ovarian-carcinosarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-elacestrant-and-ribociclib-versus-aromatase-inhibitor-combination-in-endocrine-responsive-her2-negative-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-folfox-folfiri-with-fruquintinib-or-bevacizumab-in-second-line-treatment-of-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-folfox6m-bevacizumab-or-anti-egfr-with-hepatic-chemoembolization-in-colorectal-cancer-with-liver-limited-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-gemcitabine-versus-reduced-dose-gemcitabine-and-paclitaxel-albumin-bound-in-frail-patients-with-unresectable-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-intratumoral-int230-6-with-vinblastine-sulfate-and-cisplatin-in-early-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-ipatasertib-atezolizumab-and-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-isatuximab-with-lenalidomide-dexamethasone-vs-lenalidomide-dexamethasone-in-elderly-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-lacutamab-with-gemcitabine-oxaliplatin-vs-gemcitabine-oxaliplatin-in-relapsed-refractory-peripheral-t-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-liposomal-irinotecan-with-s-1-vs-liposomal-irinotecan-with-5-fluorouracil-in-metastatic-pancreatic-cancer-post-gemcitabine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-luxdegalutamide-and-abiraterone-in-metastatic-hormone-sensitive-prostate-cancer-in-adult-males2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-mb-cart2019-1-versus-standard-therapy-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-ineligible-for-high-dose-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-methylprednisolone-hemisuccinate-and-methoxsalen-in-grade-ii-acute-graft-versus-host-disease-post-allogeneic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-neoadjuvant-chemotherapy-and-nivolumab-versus-chemotherapy-alone-in-locally-advanced-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-neoadjuvant-chemotherapy-with-retifanlimab-in-treatment-naive-resectable-retroperitoneal-limb-and-trunk-wall-sarcomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-nivolumab-ipilimumab-and-decitabine-cedazuridine-in-melanoma-and-nsclc-resistant-to-anti-pd-1-pd-l1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-ose2101-and-pembrolizumab-versus-supportive-care-in-platinum-sensitive-recurrent-ovarian-cancer-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-panitumumab-and-regorafenib-sequencing-in-ras-braf-wild-type-chemorefractory-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-pembrolizumab-maintenance-therapy-in-unresectable-stage-iii-non-small-cell-lung-cancer-post-chemo-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-pre-operative-carboplatin-and-olaparib-versus-anthracycline-taxane-chemotherapy-in-hrd-positive-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-ramucirumab-with-or-without-paclitaxel-in-elderly-patients-with-metastatic-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-rilvegostomig-fluoropyrimidine-and-trastuzumab-deruxtecan-vs-trastuzumab-chemotherapy-and-pembrolizumab-in-her2-positive-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-ro7121661-and-ro7247669-versus-nivolumab-in-advanced-or-metastatic-esophageal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-sacituzumab-govitecan-vs-drug-combination-for-efficacy-and-safety-in-patients-with-relapsed-or-refractory-cancer-of-unknown-primary2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-systemic-gemox-chemotherapy-with-or-without-hepatic-arterial-infusion-of-fudr-dexamethasone-in-unresectable-intrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-tebentafusp-versus-investigator-s-choice-in-hla-a-0201-positive-patients-with-advanced-uveal-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-of-trastuzumab-deruxtecan-vs-cdk4-6-inhibitor-based-endocrine-therapy-in-hr-positive-her2-low-ultra-low-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-on-egfr-tki-sequencing-with-dacomitinib-and-osimertinib-in-advanced-egfr-mutant-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-study-on-pharmacokinetics-and-safety-of-high-dose-rifampicin-and-pyrazinamide-in-shortened-treatment-of-drug-sensitive-pulmonary-tuberculosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-cisplatin-5-fluorouracil-and-docetaxel-in-locally-advanced-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-doravirine-and-raltegravir-dual-therapy-for-virological-maintenance-in-hiv-1-patients-with-suppressed-plasma-viremia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-enzalutamide-and-talazoparib-in-metastatic-hormone-naive-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-ivonescimab-versus-folfox-in-second-line-treatment-of-locally-advanced-or-metastatic-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-loratadine-and-sirolimus-in-lymphangioleiomyomatosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-evaluating-sirolimus-safety-and-efficacy-in-pediatric-high-grade-glioma-with-mtor-pathway-activation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-177lu-psma-i-t-and-stereotactic-radiotherapy-versus-radiotherapy-alone-in-oligometastatic-prostate-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-adjuvant-durvalumab-after-neoadjuvant-chemoimmunotherapy-in-patients-with-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-anv419-versus-high-dose-il-2-in-til-therapy-for-advanced-melanoma-nsclc-and-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-atezolizumab-versus-atezolizumab-plus-bevacizumab-in-pd-l1-high-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-atezolizumab-with-chemoradiotherapy-in-locally-advanced-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-bms-986012-with-carboplatin-etoposide-and-nivolumab-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-carboplatin-paclitaxel-bevacizumab-and-rucaparib-in-advanced-ovarian-peritoneal-and-fallopian-tube-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-cemiplimab-and-ose2101-as-maintenance-therapy-in-ctdna-positive-hla-a2-nsclc-patients-post-chemoimmunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-cetuximab-avelumab-cisplatin-and-docetaxel-regimens-in-recurrent-metastatic-head-and-neck-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-chemotherapy-regimens-with-or-without-bevacizumab-in-patients-with-well-differentiated-pancreatic-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-datopotamab-deruxtecan-plus-durvalumab-versus-datopotamab-deruxtecan-in-pd-l1-negative-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-docetaxel-or-cabazitaxel-with-without-darolutamide-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-docetaxel-with-or-without-carboplatin-in-metastatic-castration-resistant-prostate-cancer-post-olaparib-and-androgen-receptor-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-durvalumab-following-stereotactic-body-radiotherapy-in-t1-2n0m0-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-folfirinox-plus-panitumumab-versus-mfolfox6-plus-panitumumab-in-ras-b-raf-wild-type-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-fruquintinib-and-tislelizumab-in-mss-pmmr-metastatic-colorectal-cancer-without-active-hepatic-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-ibrutinib-venetoclax-and-cd20-antibody-therapy-in-untreated-mantle-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-induction-immunochemotherapy-with-durvalumab-cisplatin-paclitaxel-and-vinorelbine-in-resectable-stage-iiia-b-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-intratumoral-as01b-ipilimumab-and-intravenous-nivolumab-autologous-myeloid-dendritic-cells-in-advanced-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-ipilimumab-and-nivolumab-with-concurrent-intracranial-stereotactic-radiotherapy-in-melanoma-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-linzagolix-vs-bilastine-for-mammographic-breast-density-reduction-in-premenopausal-women-at-high-risk-of-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-lutetium-177lu-oxodotreotide-dosing-intervals-in-grade-1-2-advanced-midgut-neuroendocrine-tumors-to-assess-hematological-toxicity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-mirvetuximab-soravtansine-and-carboplatin-in-folate-receptor-alpha-high-recurrent-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-modified-folfirinox-and-folfox-regimens-in-locally-advanced-or-metastatic-small-bowel-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-neo-adjuvant-vs-adjuvant-cisplatin-based-chemotherapy-in-upper-tract-urothelial-carcinoma-with-gemcitabine2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-neoadjuvant-chemotherapy-and-stereotactic-body-radiotherapy-with-durvalumab-and-oleclumab-in-luminal-b-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-neoadjuvant-chemotherapy-with-capecitabine-oxaliplatin-and-drug-combination-in-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-niraparib-versus-best-supportive-care-in-maintenance-therapy-for-locally-advanced-or-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-nivolumab-with-paclitaxel-and-carboplatin-as-neoadjuvant-therapy-in-early-stage-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-precision-therapy-with-decitabine-and-drug-combination-versus-standard-therapy-in-elderly-patients-with-aml-mds-or-cmml-22026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-preoperative-nivolumab-with-or-without-relatlimab-in-stage-ii-iiia-muscle-invasive-urothelial-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-quinacrine-versus-metronidazole-in-pediatric-resistant-intestinal-giardiasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-rsv-vaccines-rsvpref-and-rsvpref3-oa-in-allogeneic-hematopoietic-stem-cell-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-stereotactic-body-radiation-therapy-with-or-without-durvalumab-in-oligometastatic-hormone-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-tarlatamab-maintenance-post-sequential-chemo-radiotherapy-in-limited-stage-small-cell-lung-cancer-patients-ineligible-for-concurrent-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-tedopi-with-docetaxel-or-nivolumab-in-metastatic-nsclc-post-chemoimmunotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-trabectedin-versus-gemcitabine-in-metastatic-or-locally-advanced-leiomyosarcoma-post-anthracycline-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-randomized-trial-of-xelox-plus-dostarlimab-versus-xelox-alone-as-consolidation-treatment-after-standard-chemoradiation-in-pmmr-mss-or-msi-low-locally-advanced-rectal-cancer-larc-patients-immu2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-rct-of-neoadjuvant-pembrolizumab-and-radiotherapy-versus-radiotherapy-alone-in-high-risk-localized-soft-tissue-sarcoma-of-the-extremity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-evaluating-safety-and-efficacy-of-investigational-targeted-radionuclide-therapy-in-patients-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-161tb-labeled-gastrin-analogue-for-precision-therapy-in-patients-with-advanced-medullary-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-68ga-ga-aby-025-pet-for-non-invasive-quantification-of-her2-status-in-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-68ga-nodaga-e-c-rgdyk-2-pet-imaging-for-myocardial-angiogenesis-in-chronic-ischemic-heart-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-99mtc-ntp15-5-imaging-in-adults-with-rheumatoid-arthritis-and-finger-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-acalabrutinib-with-r-chop-in-previously-untreated-mantle-cell-lymphoma-in-spain2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-asciminib-hydrochloride-monotherapy-or-combined-with-nilotinib-in-first-line-treatment-of-bcr-abl1-chronic-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-atezolizumab-as-perioperative-adjuvant-therapy-in-msi-high-mmr-deficient-stage-ii-iii-colorectal-cancer-ineligible-for-oxaliplatin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-autologous-dendritic-cell-vaccine-and-temozolomide-in-post-surgical-glioblastoma-patients-undergoing-standard-radiochemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-autologous-tumor-lysate-loaded-dendritic-cells-and-aldesleukin-in-stage-iv-colorectal-cancer-post-curative-resection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-autologous-tumor-lysate-loaded-mature-dendritic-cell-vaccine-with-standard-radiochemotherapy-in-newly-diagnosed-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-avelumab-and-axitinib-in-unresectable-metastatic-gastrointestinal-stromal-tumor-post-standard-therapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-bi-764532-added-to-platinum-based-chemotherapy-in-adult-patients-with-advanced-large-cell-neuroendocrine-carcinoma-of-the-lung2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-blinatumomab-in-prephase-and-consolidation-therapy-for-adult-precursor-b-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-brentuximab-vedotin-based-combination-therapy-brecadd-in-hiv-positive-patients-with-advanced-stage-classic-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-brentuximab-vedotin-with-cyclophosphamide-doxorubicin-etoposide-and-prednisone-in-untreated-cd30-peripheral-t-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-cabozantinib-alectinib-regorafenib-and-drug-combinations-targeting-molecular-alterations-in-advanced-metastatic-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-cadonilimab-plus-lenvatinib-versus-lenvatinib-alone-in-adults-with-advanced-hepatocellular-carcinoma-after-atezolizumab-bevacizumab-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-carboplatin-paclitaxel-and-tislelizumab-in-biomarker-selected-patients-with-resectable-locally-advanced-oral-cavity-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-carfilzomib-lenalidomide-and-dexamethasone-consolidation-in-pet-positive-multiple-myeloma-post-first-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-cemiplimab-immunotherapy-to-preserve-organs-in-patients-with-locally-advanced-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-circulating-tumor-dna-guided-encorafenib-and-cetuximab-retreatment-in-braf-v600e-mutated-metastatic-colorectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-dabrafenib-imatinib-palbociclib-and-drug-combination-in-metastatic-non-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-daratumumab-carfilzomib-pomalidomide-and-dexamethasone-in-multiple-myeloma-induced-acute-renal-failure2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-daratumumab-lenalidomide-bortezomib-and-dexamethasone-in-primary-plasma-cell-leukemia-with-chemotherapy-and-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-daratumumab-with-bortezomib-cyclophosphamide-dexamethasone-vs-bortezomib-thalidomide-dexamethasone-in-transplant-eligible-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-dostarlimab-based-immunotherapy-in-localized-dmmr-msi-h-esophagogastric-junction-and-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-durvalumab-and-tremelimumab-with-personalized-or-standard-sirt-in-non-resectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-durvalumab-carboplatin-and-etoposide-in-metastatic-pulmonary-large-cell-neuroendocrine-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-durvalumab-following-chemoradiotherapy-in-pdl1-positive-and-negative-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-durvalumab-tremelimumab-and-olaparib-in-solid-tumors-with-homologous-recombination-repair-gene-mutations-post-olaparib-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-early-combination-salvage-therapy-with-venetoclax-and-intensified-decitabine-in-relapsed-refractory-aml2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-eribulin-in-adult-patients-with-advanced-solitary-fibrous-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-exl01-nivolumab-and-folfox-in-first-line-treatment-of-pd-l1-cps-5-metastatic-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-ezabenlimab-and-mdcf-regimen-followed-by-chemoradiotherapy-in-stage-iii-squamous-cell-anal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-fap-2286-pet-ct-for-staging-and-restaging-newly-diagnosed-primary-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-fdg-pet-adapted-brentuximab-vedotin-based-regimens-in-advanced-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-fixed-dose-accelerated-ramp-up-epcoritamab-combined-with-lenalidomide-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma-after-car-t-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-glofitamab-obinutuzumab-and-tocilizumab-in-mantle-cell-lymphoma-patients-with-relapse-or-inadequate-response-after-car-t-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-hyperpolarized-1-13c-pyruvate-mri-in-patients-with-glioblastoma-multiforme2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-imetelstat-sodium-in-high-risk-mds-and-aml-patients-refractory-to-hypomethylating-agent-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-induction-chemotherapy-and-chemoradiotherapy-with-without-durvalumab-in-resectable-stage-iii-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-inotuzumab-ozogamicin-to-prevent-relapse-in-adult-patients-with-high-risk-acute-lymphoblastic-leukaemia-after-allogeneic-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-intraperitoneal-irinotecan-hydrochloride-with-folfox-and-bevacizumab-in-unresectable-colorectal-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-intratumoral-getacatetide-in-patients-with-locally-advanced-or-metastatic-adrenocortical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-intratumoral-hydrogen-peroxide-krc-01-with-radiotherapy-in-patients-with-locally-advanced-stage-iii-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-itacitinib-in-non-severe-hemophagocytic-lymphohistiocytosis-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-jnj-90301900-in-combination-with-concurrent-chemoradiotherapy-in-patients-with-locally-advanced-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-lutetium-177lu-oxodotreotide-and-olaparib-in-pediatric-recurrent-or-relapsed-solid-tumors-expressing-somatostatin-receptors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-lutetium-177lu-vipivotide-tetraxetan-with-androgen-receptor-pathway-inhibitors-in-psma-pet-positive-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-lutetium-177lu-zadavotide-guraxetan-radioligand-therapy-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-ly4337713-in-patients-with-fap-positive-solid-tumors-ovarian-breast-pancreatic-colorectal-esophageal-gastric-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-ly4584180-in-adults-with-relapsed-refractory-diffuse-large-b-cell-and-follicular-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-maintenance-therapy-with-olaparib-durvalumab-tremelimumab-and-nilotinib-in-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-me-401-with-rituximab-bendamustine-for-high-risk-and-rituximab-with-me-401-randomization-for-low-risk-follicular-lymphoma-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-monalizumab-in-acute-myeloid-leukemia-or-myelodysplastic-syndrome-undergoing-haploidentical-transplantation-with-post-transplant-cyclophosphamide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-mp0317-a-fap-dependent-cd40-agonist-with-durvalumab-gemcitabine-and-cisplatin-in-advanced-biliary-tract-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-nemtabrutinib-added-to-venetoclax-obinutuzumab-in-treatment-naive-chronic-lymphocytic-leukemia-small-lymphocytic-leukemia-with-tp53-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neo-adjuvant-pembrolizumab-in-mismatch-repair-deficient-endometrial-uterine-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-and-adjuvant-cemiplimab-in-resectable-high-risk-stage-iii-iv-m0-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-and-adjuvant-dabrafenib-and-trametinib-in-braf-mutated-anaplastic-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-chemotherapy-and-nivolumab-followed-by-adjuvant-therapy-in-resectable-non-small-cell-lung-cancer-pancoast-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-dostarlimab-in-untreated-t3-4n0-2-or-stage-iii-pmmr-mss-resectable-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-durvalumab-and-platinum-based-chemotherapy-in-resectable-stage-iib-iiib-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-pembrolizumab-and-lenvatinib-followed-by-adjuvant-pembrolizumab-in-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-regorafenib-and-nivolumab-with-short-course-radiotherapy-in-intermediate-risk-stage-ii-iii-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-neoadjuvant-ruxotemitide-ltx-315-and-pembrolizumab-in-resectable-stage-iii-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-niraparib-and-dostarlimab-in-advanced-nsclc-or-malignant-pleural-mesothelioma-with-pd-l1-expression-and-hrr-gene-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-nivolumab-and-ipilimumab-in-relapsed-advanced-type-b3-thymoma-and-thymic-carcinoma-post-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-nivolumab-ipilimumab-and-bevacizumab-with-induction-chemotherapy-in-non-squamous-nsclc-with-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-olaparib-in-brca-wild-type-recurrent-high-grade-ovarian-cancer-post-platinum-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-oncolytic-virotherapy-to-enhance-preoperative-immunotherapy-efficacy-in-patients-with-proficient-mismatch-repair-pmmr-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-ose2101-plus-folfiri-versus-folfiri-alone-as-maintenance-therapy-in-hla-a2-positive-patients-with-locally-advanced-or-metastatic-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-pembrolizumab-and-lenvatinib-in-high-risk-locally-advanced-cervical-cancer-following-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-pembrolizumab-and-lenvatinib-in-second-and-third-line-treatment-of-malignant-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-pembrolizumab-in-recurrent-platinum-resistant-cps-1-positive-ovarian-fallopian-tube-and-primary-peritoneal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-pembrolizumab-with-chemotherapy-in-platinum-sensitive-recurrent-low-grade-serous-ovarian-fallopian-tube-and-primary-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-platinum-pemetrexed-and-atezolizumab-bevacizumab-in-stage-iiib-iv-nsclc-with-egfr-alk-or-ros1-alterations-post-targeted-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-preoperative-elacestrant-and-pulsar-adaptive-radiotherapy-in-hr-positive-her2-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-quadruplet-induction-and-consolidation-with-tandem-autologous-stem-cell-transplantation-in-newly-diagnosed-high-risk-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-radiotherapy-followed-by-durvalumab-and-ceralasertib-in-stage-iii-nsclc-patients-with-thoracic-relapse-and-oligometastases-post-pacific-regimen2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-rituximab-lenalidomide-and-tafasitamab-in-high-risk-follicular-lymphoma-and-rituximab-lenalidomide-with-tafasitamab-randomization-in-low-risk-cases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-safety-and-efficacy-of-bay-3771249-in-patients-with-advanced-metastatic-kras-g12d-mutated-colorectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-sasanlimab-and-sacituzumab-govitecan-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-sequential-encorafenib-and-binimetinib-followed-by-nivolumab-and-ipilimumab-versus-immediate-nivolumab-and-ipilimumab-in-braf-v600-mutant-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-sitravatinib-and-tislelizumab-efficacy-in-metastatic-uveal-melanoma-with-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-subcutaneous-tocilizumab-and-intravenous-pulse-steroid-versus-steroid-monotherapy-in-acute-anterior-ischemic-optic-neuropathy-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-tremelimumab-and-durvalumab-in-resectable-msi-high-gastric-and-gastroesophageal-junction-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-vemurafenib-in-patients-with-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-venetoclax-and-acalabrutinib-in-relapsed-chronic-lymphocytic-leukemia-post-venetoclax-and-anti-cd20-mab-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-venetoclax-as-preemptive-therapy-in-ighv-unmutated-high-risk-stage-a-chronic-lymphocytic-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-of-wsd0922-fu-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-harboring-egfr-c797s-mutation-post-osimertinib-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-alpelisib-with-fulvestrant-or-letrozole-in-pik3ca-mutant-hr-her2-advanced-breast-cancer-post-endocrine-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-atezolizumab-and-bevacizumab-with-selective-tace-in-unresectable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-cabozantinib-efficacy-and-safety-in-hepatocellular-carcinoma-patients-post-immune-checkpoint-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-de-escalation-and-treatment-free-remission-in-chronic-myeloid-leukemia-with-nilotinib-and-asciminib-combination-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-durvalumab-etoposide-and-platinum-in-first-line-treatment-of-advanced-large-cell-neuroendocrine-carcinoma-of-the-lung2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-homing-of-autologous-ex-vivo-expanded-cd4-cd25hi-foxp3-regulatory-t-cells-in-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-safety-of-circulating-tumor-dna-guided-second-line-therapy-in-relapsed-dlbcl-hgbcl-using-cytarabine-tafasitamab-and-lenalidomide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-safety-of-enfortumab-vedotin-in-advanced-neuroendocrine-carcinomas-refractory-or-ineligible-to-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-safety-of-sacituzumab-govitecan-in-advanced-differentiated-and-anaplastic-thyroid-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-safety-of-tagraxofusp-and-venetoclax-in-treatment-naive-blastic-plasmacytoid-dendritic-cell-neoplasm-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-efficacy-and-tolerance-of-cemiplimab-carboplatin-and-paclitaxel-in-unresectable-stage-iii-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-hrd-status-and-efficacy-of-olaparib-and-bevacizumab-in-advanced-stage-iii-iv-high-grade-serous-or-endometrioid-ovarian-fallopian-tube-or-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-maintenance-therapy-with-trastuzumab-and-pertuzumab-post-trastuzumab-deruxtecan-in-her2-positive-unresectable-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-nalirifox-optimization-and-5-fu-maintenance-in-metastatic-pancreatic-ductal-adenocarcinoma-with-ciprofloxacin-and-gemcitabine-in-second-line-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-neoadjuvant-chemotherapy-with-liposomal-irinotecan-oxaliplatin-and-5-fluorouracil-folinic-acid-in-hepatic-oligometastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-reinduction-and-cessation-of-ponatinib-in-chronic-myelogenous-leukemia-patients-in-molecular-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-sacituzumab-govitecan-loperamide-and-filgrastim-in-metastatic-triple-negative-and-luminal-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-safety-tolerability-and-efficacy-of-sco-101-with-folfiri-in-metastatic-colorectal-cancer-resistant-to-folfiri2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-and-safety-of-isatuximab-lenalidomide-bortezomib-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-and-safety-of-methyl-aminolevulinate-and-pagetex-device-in-vulvar-extra-mammary-paget-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-and-safety-of-zoledronic-acid-addition-to-standard-therapy-in-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-of-188re-sss-lipiodol-selective-internal-radiation-therapy-in-non-operable-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-of-chemoradiation-with-cisplatin-and-carboplatin-in-early-stage-vulvar-cancer-with-sentinel-lymph-node-macrometastasis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-efficacy-of-pemigatinib-in-recurrent-or-metastatic-solid-tumors-with-fgfr1-fgfr2-or-fgfr3-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-the-safety-and-efficacy-of-venetoclax-atezolizumab-and-obinutuzumab-in-richter-syndrome-of-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-on-topiramate-s-effect-on-hiv-1-reservoir-reactivation-in-patients-on-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-to-evaluate-the-efficacy-and-safety-of-camizestrant-plus-ribociclib-in-patients-with-hormone-receptor-positive-hr-breast-cancer-the-cadillac-study2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-study-to-evaluate-the-safety-and-efficacy-of-ruxolitinib-and-tamoxifen-combination-therapy-in-patients-with-myelofibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-comparing-trifluridine-tipiracil-with-panitumumab-versus-trifluridine-tipiracil-with-bevacizumab-in-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-evaluating-disease-free-survival-with-12-month-neoadjuvant-etoposide-carboplatin-and-cisplatin-in-patients-with-localized-digestive-neuroendocrine-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-amivantamab-lazertinib-and-bevacizumab-in-egfr-mutant-advanced-nsclc-post-third-generation-egfr-tki-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-chemotherapy-and-atezolizumab-in-stage-iiia-iiib-nsclc-with-atezolizumab-adjuvant-and-maintenance-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-durvalumab-olaparib-and-fulvestrant-in-er-positive-her2-negative-metastatic-breast-cancer-with-brca-or-hrr-gene-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-durvalumab-tremelimumab-chemotherapy-and-sbrt-in-synchronous-oligo-metastatic-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-neoadjuvant-endocrine-therapy-with-capivasertib-and-letrozole-in-hormone-receptor-positive-her2-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-pirtobrutinib-and-epcoritamab-in-relapsed-or-refractory-chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-of-trastuzumab-deruxtecan-in-hr-her2-low-metastatic-breast-cancer-with-persistent-ctdna-post-endocrine-and-cdk4-6-inhibitor-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-ii-trial-on-safety-of-expanded-allogeneic-fetal-umbilical-cord-mesenchymal-cells-in-preterm-infants-with-bronchopulmonary-dysplasia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-crossover-study-of-l-citrulline-folic-acid-vericiguat-and-tadalafil-in-treatment-resistant-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-double-blind-randomized-placebo-controlled-study-of-cit-013-on-disease-activity-in-moderately-active-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-evaluation-of-inotuzumab-ozogamicin-efficacy-in-adult-b-cell-acute-lymphoblastic-leukemia-with-minimal-residual-disease-pre-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-evaluation-of-pentoxifylline-retinol-acetate-and-dl-alpha-tocopherol-acetate-in-medication-related-osteonecrosis-of-the-jaw-mronj2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-multicenter-rct-on-ambroxol-efficacy-in-prodromal-and-mild-dementia-with-lewy-bodies2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-multicenter-study-of-isotoxic-radiochemotherapy-with-bevacizumab-in-idh-wild-type-mgmt-unmethylated-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-multicenter-study-on-the-efficacy-and-safety-of-ubiquinol-and-ascorbic-acid-in-mitochondrial-disorders-and-cerebellar-ataxias2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-open-label-dose-finding-study-on-safety-tolerability-and-efficacy-of-etrinabdione-in-peripheral-arterial-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-open-label-study-on-the-efficacy-and-safety-of-allogeneic-fecal-microbiota-transplantation-in-pediatric-autism-spectrum-disorder-with-gastrointestinal-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-randomized-controlled-trial-evaluating-efficacy-safety-and-dosage-of-mbk-01-and-drug-combination-in-recurrent-diverticulitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-randomized-controlled-trial-of-intra-arterial-autologous-cd34-enriched-cell-fraction-in-acute-ischemic-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-randomized-double-blind-placebo-controlled-study-of-acou085-for-prevention-of-cisplatin-induced-sensorineural-hearing-loss-in-testicular-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-randomized-placebo-controlled-trial-evaluating-aptoll-in-st-elevation-myocardial-infarction-patients-undergoing-emergency-angioplasty2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iia-study-of-durvalumab-gemcitabine-cisplatin-and-intraductal-radiofrequency-ablation-in-extrahepatic-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-evaluation-of-ruxolitinib-in-the-treatment-of-inclusion-body-myositis-a-randomized-double-blind-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-evaluation-of-zibotentan-and-dapagliflozin-safety-in-cirrhosis-monotherapy-and-combination-versus-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-iii-randomized-controlled-study-of-lurbinectedin-plus-doxorubicin-versus-doxorubicin-monotherapy-in-metastatic-leiomyosarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-multicenter-double-blind-placebo-controlled-trial-of-allogeneic-adipose-derived-mesenchymal-stem-cells-in-acute-ischemic-stroke-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-multicenter-double-blind-randomized-placebo-controlled-trial-of-intracoronary-autologous-bone-marrow-derived-mononuclear-cells-in-idiopathic-dilated-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-multicenter-open-label-study-on-efficacy-safety-and-pharmacokinetics-of-rilzabrutinib-in-adult-patients-with-warm-autoimmune-hemolytic-anemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-multicentre-randomised-double-blind-study-on-intralesional-allogeneic-adipose-derived-mesenchymal-stem-cells-for-fecal-incontinence-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-open-label-randomized-study-of-nab-paclitaxel-gemcitabine-and-vcn-01-in-metastatic-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-open-label-trial-of-intrathecal-aav9-ap4m1-melpida-in-patients-with-hereditary-spastic-paraplegia-type-50-spg502026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-randomized-placebo-controlled-trial-of-leflunomide-and-hydroxychloroquine-in-primary-sjogren-s-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-randomized-trial-of-carboplatin-cyclophosphamide-vs-paclitaxel-atezolizumab-in-advanced-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-randomized-trial-of-intradiscal-injection-of-autologous-bone-marrow-mesenchymal-stem-cells-for-chronic-low-back-pain-due-to-multilevel-lumbar-intervertebral-disc-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-study-evaluating-the-efficacy-safety-and-tolerability-of-azd8965-in-adults-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-study-on-re-treatment-with-lutetium-177lu-vipivotide-tetraxetan-in-metastatic-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-trial-of-everolimus-and-lutetium-177lu-oxodotreotide-in-refractory-grade-2-and-3-meningioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iib-trial-to-assess-efficacy-and-safety-of-gia632-vs-placebo-in-adults-with-non-segmental-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-clinical-trial-for-cpx-351-in-myeloid-leukemia-in-children-with-down-syndrome-20182026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-cluster-randomized-controlled-trial-of-high-dose-antimicrobials-versus-conventional-therapy-in-critically-ill-patients-with-bacterial-infections2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-comparative-study-of-docetaxel-versus-docetaxel-plus-radium-223-dichloride-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-double-blind-randomized-controlled-trial-evaluating-efficacy-and-safety-of-deupsilocin-besilate-cyb003-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-double-blind-randomized-placebo-controlled-study-of-human-normal-immunoglobulin-for-infection-prophylaxis-in-chronic-lymphocytic-leukemia-with-secondary-immunodeficiency2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-double-blind-randomized-placebo-controlled-study-of-norursodeoxycholic-acid-in-primary-sclerosing-cholangitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-double-blind-randomized-placebo-controlled-trial-of-intravenous-tenecteplase-for-visual-recovery-in-acute-non-arteritic-central-retinal-artery-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-acetylsalicylic-acid-and-atorvastatin-on-overall-survival-in-castration-resistant-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-adjuvant-chemotherapy-with-fluorouracil-capecitabine-and-oxaliplatin-in-resected-stage-i-iii-small-bowel-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-afamelanotide-and-narrow-band-uvb-versus-narrow-band-uvb-monotherapy-in-vitiligo-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-ap063-efficacy-safety-and-immunogenicity-in-her2-positive-metastatic-and-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-atezolizumab-versus-placebo-in-malignant-pleural-mesothelioma-post-pleurectomy-decortication-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-belantamab-mafodotin-bortezomib-and-dexamethasone-versus-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-concurrent-versus-sequential-chemotherapy-and-aromatase-inhibitors-exemestane-letrozole-anastrozole-in-endocrine-responsive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-de-escalated-pembrolizumab-and-pemetrexed-regimen-in-metastatic-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-elotuzumab-with-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-post-autologous-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-etranacogene-dezaparvovec-gene-therapy-in-adults-with-severe-or-moderately-severe-hemophilia-b2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-intensified-peri-operative-chemotherapy-with-doxorubicin-ifosfamide-and-dacarbazine-in-high-risk-resectable-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-isatuximab-carfilzomib-lenalidomide-and-dexamethasone-versus-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-lomustine-and-temozolomide-versus-temozolomide-in-mgmt-promoter-methylated-glioblastoma-with-or-without-tumor-treating-fields2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-n-acetyl-ged-0507-34-levo-gel-5-for-efficacy-and-safety-in-acne-vulgaris-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-onfekafusp-alfa-and-doxorubicin-versus-doxorubicin-monotherapy-in-advanced-or-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-pabinafusp-alfa-and-idursulfase-in-patients-with-mucopolysaccharidosis-type-ii-hunter-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-polatuzumab-vedotin-with-rituximab-gemcitabine-and-oxaliplatin-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-r-codox-m-r-ivac-versus-da-epoch-r-in-newly-diagnosed-high-risk-burkitt-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-reduced-intensity-adjuvant-therapy-with-cisplatin-and-carboplatin-in-hpv-positive-oropharyngeal-cancer-post-transoral-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-sacituzumab-govitecan-versus-physician-s-choice-in-her2-negative-breast-cancer-with-high-relapse-risk-post-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-survodutide-efficacy-and-safety-in-overweight-or-obese-patients-with-presumed-or-confirmed-nonalcoholic-steatohepatitis-nash2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-trabectedin-versus-trabectedin-plus-ttf-ngr-in-metastatic-refractory-soft-tissue-sarcoma-post-anthracycline-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-trastuzumab-deruxtecan-pertuzumab-versus-taxane-trastuzumab-and-pertuzumab-in-her2-positive-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-trastuzumab-deruxtecan-with-rilvegostomig-or-pembrolizumab-versus-chemotherapy-and-pembrolizumab-in-her2-expressing-pmmr-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-evaluation-of-xevinapant-and-radiotherapy-versus-placebo-and-radiotherapy-in-high-risk-resected-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-iv-multicenter-trial-on-escalating-treatment-of-scabies-with-permethrin-5-and-10-cream-and-ivermectin-tablets2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-double-blind-randomized-placebo-controlled-trial-evaluating-subcutaneous-immunotherapy-with-cupressus-arizonica-protein-cup-a-1-in-allergic-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-open-label-randomized-trial-comparing-rituximab-regimens-in-maintenance-therapy-for-relapsing-idiopathic-steroid-sensitive-nephrotic-syndrome-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-open-label-study-comparing-ribociclib-and-palbociclib-in-advanced-hormone-receptor-positive-her2-negative-her2-enriched-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-open-label-trial-evaluating-rituximab-efficacy-in-psychiatric-disorders-with-autoimmunity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-controlled-double-blind-study-of-bevacizumab-versus-placebo-in-corticodependent-or-corticoresistant-brain-radionecrosis-post-radiotherapy-for-brain-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-controlled-trial-evaluating-efficacy-and-safety-of-bilayer-engineered-collagen-hydrogel-based-skin-graft-in-deep-partial-and-full-thickness-burns2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-double-blind-study-on-ketotifen-ophthalmic-solution-0-5-mg-ml-for-seasonal-allergic-conjunctivitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-open-label-trial-of-acalabrutinib-and-obinutuzumab-versus-venetoclax-and-obinutuzumab-in-first-line-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-open-trial-of-allogeneic-vs-autologous-mesenchymal-stem-cells-and-hyaluronic-acid-in-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-study-of-rezvilutamide-plus-androgen-deprivation-therapy-versus-bicalutamide-plus-androgen-deprivation-therapy-in-metastatic-hormone-sensitive-prostate-cancer-with-hig2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-trial-comparing-botensilimab-and-balstilimab-versus-folfox-xelox-plus-nivolumab-in-msi-dmmr-esogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-trial-of-contact-x-ray-brachytherapy-with-capecitabine-folinic-acid-irinotecan-oxaliplatin-and-fluorouracil-in-intermediate-rectal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-trial-of-dose-reduced-chemotherapy-with-fluorouracil-folinic-acid-capecitabine-and-oxaliplatin-in-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-randomized-trial-on-dexrazoxane-for-prevention-of-anthracycline-induced-cardiac-dysfunction-in-diffuse-large-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-study-comparing-entrectinib-and-crizotinib-in-advanced-ros1-positive-non-small-cell-lung-cancer-with-cns-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-study-of-irinotecan-liposome-oxaliplatin-5-fluorouracil-leucovorin-vs-nab-paclitaxel-and-gemcitabine-in-metastatic-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-study-on-safety-pharmacokinetics-and-efficacy-of-crovalimab-vs-eculizumab-in-paroxysmal-nocturnal-hemoglobinuria-patients-on-complement-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-trial-comparing-systematic-versus-serum-tg-and-rai-scintigraphy-guided-radioiodine-therapy-in-intermediate-risk-differentiated-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-trial-evaluating-non-inferiority-of-doravirine-based-regimen-versus-dolutegravir-based-regimen-in-treatment-naive-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-trial-of-allogeneic-cd4-and-cd8-t-lymphocytes-for-chemo-refractory-cmv-ebv-and-adv-infections-post-allogeneic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-trial-of-pipac-with-fluorouracil-docetaxel-and-nivolumab-in-oligometastatic-peritoneal-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicenter-trial-of-rituximab-and-lenalidomide-vs-rituximab-maintenance-post-chemoimmunotherapy-in-relapsed-refractory-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicentre-randomised-double-blind-study-on-emactuzumab-efficacy-and-safety-in-tenosynovial-giant-cell-tumour-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-multicentric-study-on-chemotherapy-efficacy-in-stage-iii-colorectal-cancer-with-positive-ctdna-post-surgery-using-irinotecan-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-non-inferiority-trial-of-lenalidomide-bortezomib-dexamethasone-and-isatuximab-in-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-non-inferiority-trial-of-ribociclib-and-endocrine-therapy-versus-chemotherapy-plus-ribociclib-in-hr-her2-intermediate-risk-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-open-label-study-on-the-efficacy-of-colecalciferol-supplementation-in-young-adults-and-seniors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-open-label-study-on-the-efficacy-of-colecalciferol-supplementation-in-young-adults-and-seniors-a-comparative-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-comparing-thiamazole-and-sodium-iodide-131i-in-graves-disease-with-moderate-to-severe-active-graves-orbitopathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-evaluating-efficacy-and-safety-of-capsaicin-cutaneous-patch-in-post-surgical-neuropathic-pain-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-evaluating-tinengotinib-versus-physician-s-choice-in-fgfr-altered-chemotherapy-and-fgfr-inhibitor-refractory-cholangiocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-abemaciclib-plus-endocrine-therapy-versus-endocrine-therapy-in-hr-her2-early-breast-cancer-with-intermediate-to-high-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-adjuvant-durvalumab-and-tremelimumab-in-resected-high-risk-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-cisplatin-carboplatin-and-durvalumab-in-intermediate-and-high-risk-oropharyngeal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-icef15-in-fecal-incontinence-due-to-external-anal-sphincter-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-jdq443-versus-docetaxel-in-kras-g12c-mutant-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-pembrolizumab-with-platinum-based-chemotherapy-versus-pembrolizumab-monotherapy-in-first-line-treatment-of-nsclc-with-pd-l1-502026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-repeat-local-treatment-with-or-without-neoadjuvant-systemic-therapy-in-recurrent-colorectal-liver-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-of-stereotactic-body-radiation-therapy-with-or-without-androgen-deprivation-therapy-in-acinar-cell-prostatic-carcinoma-using-triptorelin-and-bicalutamide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-controlled-trial-on-efficacy-and-safety-of-vaginal-micronized-progesterone-formulations-in-infertility-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-crossover-study-of-n-acetyl-l-leucine-in-niemann-pick-disease-type-c2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-evaluating-efficacy-and-safety-of-iptacopan-in-patients-with-primary-iga-nephropathy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-durvalumab-with-gemcitabine-and-cisplatin-in-first-line-advanced-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-ianalumab-vay736-in-patients-with-high-symptom-burden-sjogren-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-iptacopan-in-patients-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-iv-trontinemab-in-cognitively-unimpaired-individuals-at-risk-for-symptomatic-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-mocravimod-as-adjunctive-and-maintenance-therapy-in-acute-myeloid-leukemia-undergoing-allo-hct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-neoadjuvant-adjuvant-durvalumab-and-flot-chemotherapy-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-olaparib-and-abiraterone-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-once-daily-oral-asc30-sodium-for-weight-loss-in-adults-with-obesity-overweight-and-type-2-diabetes-mellitus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-pembrolizumab-platinum-based-chemotherapy-and-canakinumab-in-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-remibrutinib-in-generalized-myasthenia-gravis-patients-with-stable-standard-of-care2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-saruparib-azd5305-with-new-hormonal-agents-in-metastatic-castration-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-saruparib-azd5305-with-radiotherapy-and-androgen-deprivation-therapy-in-brcam-high-risk-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-study-of-volrustomig-in-high-risk-locally-advanced-cervical-cancer-post-platinum-based-chemoradiation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-acetylsalicylic-acid-on-recurrence-and-survival-in-non-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-atezolizumab-and-trastuzumab-emtansine-in-high-risk-her2-positive-breast-cancer-post-preoperative-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-lenbelintide-azd6234-as-adjunct-to-incretin-therapy-in-obesity-overweight-with-comorbidities-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-lenbelintide-azd6234-on-body-weight-in-adults-with-t2dm-and-obesity-overweight2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-letrozole-maintenance-therapy-in-epithelial-ovarian-cancer-post-surgery-and-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-once-daily-oral-asc30-sodium-in-adults-with-obesity-or-overweight-and-weight-related-comorbidities2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-placebo-controlled-trial-of-secukinumab-and-glucocorticoid-taper-in-giant-cell-arteritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-comparing-efficacy-and-safety-of-sb27-and-pembrolizumab-in-metastatic-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-alpelisib-and-fulvestrant-in-hr-positive-her2-negative-advanced-breast-cancer-with-pik3ca-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-camizestrant-and-palbociclib-versus-anastrozole-and-palbociclib-in-er-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-capivasertib-and-fulvestrant-versus-placebo-and-fulvestrant-in-hr-her2-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-dexamethasone-and-oseltamivir-versus-placebo-in-patients-with-severe-influenza2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-durvalumab-and-domvanalimab-in-stage-iii-unresectable-nsclc-post-platinum-based-chemoradiation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-durvalumab-with-chemoradiation-in-locally-advanced-unresectable-esophageal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-everolimus-plus-adjuvant-hormone-therapy-in-er-her2-high-risk-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-fixed-dose-laroprovstat-rosuvastatin-vs-monotherapies-and-placebo-on-ldl-c-in-hypercholesterolaemia-subjects-naive-to-llt2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-high-dose-4-versus-standard-2-lidocaine-gel-for-local-anesthesia-in-double-j-ureteral-stent-placement-or-exchange2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-intravenous-glutathione-for-myocardial-injury-prevention-in-pneumonia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-osimertinib-plus-platinum-based-chemotherapy-versus-placebo-in-egfrm-advanced-nsclc-post-first-line-osimertinib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-pembrolizumab-with-neoadjuvant-chemotherapy-and-adjuvant-endocrine-therapy-in-high-risk-er-her2-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-rilvegostomig-plus-chemotherapy-in-adjuvant-treatment-of-resected-biliary-tract-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-of-toripalimab-and-tifcemalimab-as-consolidation-therapy-in-limited-stage-small-cell-lung-cancer-post-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-study-on-efficacy-and-safety-of-10-vs-5-permethrin-cream-in-scabies-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-trial-evaluating-perineural-magnesium-sulfate-and-ropivacaine-hydrochloride-in-total-knee-arthroplasty-analgesia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-trial-of-atezolizumab-with-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-trial-of-pembrolizumab-plus-platinum-doublet-chemotherapy-as-neoadjuvant-adjuvant-therapy-in-resectable-stage-ii-iiib-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-trial-of-polatuzumab-vedotin-rituximab-and-chp-vs-rituximab-and-chop-in-untreated-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-blind-trial-of-tiragolumab-and-atezolizumab-versus-placebo-and-atezolizumab-in-resected-stage-iib-iiib-pd-l1-positive-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-double-masked-placebo-controlled-study-of-atropine-sulfate-0-01-in-pediatric-myopia-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-multicenter-study-of-d2-resection-and-hyperthermic-intraperitoneal-chemotherapy-with-oxaliplatin-fluorouracil-and-calcium-levofolinate-in-advanced-gastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-observer-blind-placebo-controlled-study-of-live-attenuated-rsv-dns2-d1313-i1314l-vaccine-in-infants-and-toddlers-for-rsv-lrtd-prevention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-observer-blind-study-on-safety-and-immunogenicity-of-high-dose-trivalent-influenza-vaccine-in-adults-aged-60-and-above2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-multicenter-trial-of-ruxolitinib-vs-hydroxycarbamide-or-peginterferon-alfa-2a-in-high-risk-polycythemia-vera-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-study-of-pralsetinib-vs-standard-care-in-ret-fusion-positive-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-study-of-regorafenib-and-nivolumab-versus-standard-chemotherapy-in-refractory-advanced-gastro-oesophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-study-of-sacituzumab-govitecan-versus-physician-s-choice-in-metastatic-or-locally-advanced-unresectable-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-trial-of-tisagenlecleucel-versus-standard-of-care-in-adults-with-relapsed-refractory-follicular-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-open-label-trial-of-tisagenlecleucel-versus-standard-of-care-in-relapsed-refractory-aggressive-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-placebo-controlled-study-of-atorvastatin-as-neo-adjuvant-therapy-in-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-placebo-controlled-study-of-venetoclax-with-induction-and-consolidation-chemotherapy-in-newly-diagnosed-aml-or-mds-eb2-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-placebo-controlled-trial-of-trilaciclib-for-myelosuppression-prevention-in-limited-stage-small-cell-lung-cancer-receiving-crt2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-comparing-chemotherapy-versus-endocrine-therapy-with-abemaciclib-in-er-her2-breast-cancer-with-visceral-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-comparing-efficacy-and-safety-of-rosuvastatin-fenofibrate-vs-pravastatin-fenofibrate-in-mixed-dyslipidemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-177lu-psma-617-versus-androgen-receptor-directed-therapy-in-taxane-naive-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-177lu-psma-617-with-standard-of-care-vs-standard-of-care-in-metastatic-hormone-sensitive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-adjuvant-chemotherapy-with-levoleucovorin-capecitabine-folinic-acid-and-fluorouracil-in-resected-stage-iii-colon-adenocarcinoma-in-patients-aged-702026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-adjuvant-datopotamab-deruxtecan-and-rilvegostomig-versus-standard-care-in-stage-i-adenocarcinoma-nsclc-with-ctdna-positive-or-high-risk-features2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-ak112-with-pemetrexed-and-carboplatin-in-egfr-mutant-advanced-non-squamous-nsclc-post-egfr-tki-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-alectinib-versus-crizotinib-in-treatment-naive-alk-positive-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-apalutamide-with-radiotherapy-and-lhrh-agonist-in-high-risk-biochemically-relapsed-prostate-adenocarcinoma-post-prostatectomy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-azd0901-versus-standard-therapy-in-advanced-metastatic-gastric-or-gastroesophageal-junction-adenocarcinoma-expressing-claudin-18-22026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-bortezomib-and-blinatumomab-with-methotrexate-in-pediatric-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-cabazitaxel-and-pelvic-radiotherapy-in-high-risk-localized-prostate-cancer-with-androgen-deprivation-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-camizestrant-and-cdk4-6-inhibitor-versus-aromatase-inhibitor-and-cdk4-6-inhibitor-in-hr-her2-advanced-breast-cancer-with-esr1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-ceralasertib-and-durvalumab-versus-docetaxel-in-advanced-non-small-cell-lung-cancer-post-anti-pd-l-1-and-platinum-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-continuous-vs-fixed-duration-daratumumab-lenalidomide-and-dexamethasone-therapy-in-relapsed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-cpx-351-versus-standard-chemotherapy-in-adults-with-newly-diagnosed-aml-and-intermediate-or-adverse-genetic-risk2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-datopotamab-deruxtecan-and-durvalumab-in-neoadjuvant-and-adjuvant-settings-for-triple-negative-or-hormone-receptor-low-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-datopotamab-deruxtecan-and-rilvegostomig-versus-pembrolizumab-in-advanced-non-squamous-nsclc-with-high-pd-l1-expression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-datopotamab-deruxtecan-durvalumab-and-carboplatin-vs-pembrolizumab-with-platinum-chemotherapy-in-advanced-nsclc-without-genomic-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-datopotamab-deruxtecan-durvalumab-vs-chemotherapy-pembrolizumab-in-pd-l1-positive-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-datopotamab-deruxtecan-rilvegostomig-vs-standard-of-care-in-high-risk-muscle-invasive-urothelial-carcinoma-post-radical-resection2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-durvalumab-and-tremelimumab-versus-sorafenib-in-first-line-treatment-of-unresectable-advanced-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-durvalumab-and-tremelimumab-versus-standard-chemotherapy-in-chemotherapy-naive-unresectable-stage-iv-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-durvalumab-tremelimumab-and-chemotherapy-in-unresectable-locally-advanced-or-metastatic-urothelial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-durvalumab-tremelimumab-and-lenvatinib-with-tace-versus-tace-alone-in-locoregional-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-durvalumab-with-sbrt-and-osimertinib-in-unresected-stage-i-ii-lymph-node-negative-nsclc-with-egfr-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-fuzuloparib-abiraterone-acetate-and-prednisone-in-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-hyperthermic-intraperitoneal-chemotherapy-with-cisplatin-for-recurrent-resectable-ovarian-epithelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-immunotherapy-and-local-ablative-treatments-in-oligometastatic-nsclc-evaluating-carboplatin-ipilimumab-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-induction-chemotherapy-with-modified-dcf-regimen-followed-by-chemoradiotherapy-vs-standard-chemoradiotherapy-in-locally-advanced-anal-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-lomustine-with-or-without-reirradiation-in-first-progression-of-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-lurbinectedin-alone-or-with-irinotecan-versus-topotecan-or-irinotecan-in-relapsed-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-lurbinectedin-and-atezolizumab-versus-atezolizumab-in-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-neoadjuvant-chemotherapy-with-ifosfamide-dacarbazine-and-doxorubicin-hydrochloride-versus-surgery-alone-in-high-risk-retroperitoneal-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-niraparib-monotherapy-versus-niraparib-and-bevacizumab-combination-in-advanced-high-grade-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-olaparib-versus-platinum-based-chemotherapy-post-secondary-cytoreductive-surgery-in-recurrent-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-olorofim-versus-liposomal-amphotericin-b-in-patients-with-invasive-aspergillosis2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-osimertinib-with-or-without-platinum-based-chemotherapy-in-egfr-mutation-positive-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-osimertinib-with-without-datopotamab-deruxtecan-in-egfr-mutation-positive-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-pembrolizumab-and-stereotactic-ablative-radiotherapy-in-oligometastatic-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-rilvegostomig-vs-pembrolizumab-monotherapy-in-pd-l1-high-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-rilvegostomig-vs-pembrolizumab-with-platinum-based-chemotherapy-in-pd-l1-expressing-metastatic-non-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-rilvegostomig-vs-pembrolizumab-with-platinum-based-chemotherapy-in-pd-l1-expressing-metastatic-squamous-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-saruparib-and-camizestrant-versus-cdk4-6-inhibitor-and-endocrine-therapy-in-brca1-2-or-palb2-mutated-hr-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-savolitinib-and-osimertinib-versus-platinum-based-chemotherapy-in-egfr-mutated-met-overexpressed-amplified-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-shortened-vs-standard-chemotherapy-with-rituximab-and-drug-combination-in-high-tumor-burden-follicular-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-trastuzumab-pertuzumab-and-docetaxel-in-her2-positive-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-trifluridine-tipiracil-and-bevacizumab-versus-capecitabine-and-bevacizumab-in-metastatic-colorectal-cancer-unfit-for-intensive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-of-volrustomig-with-carboplatin-and-pemetrexed-versus-standard-care-in-unresectable-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-on-organ-preservation-in-liver-transplantation-custodiol-n-solution-versus-custodiol-solution2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-study-on-the-efficacy-and-safety-of-clobetasol-propionate-mometasone-furoate-and-tacrolimus-in-pediatric-vulvar-lichen-sclerosus2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-comparing-adjuvant-bleomycin-etoposide-and-cisplatin-versus-carboplatin-auc7-in-stage-i-seminomatous-testicular-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-comparing-clofarabine-fludarabine-and-busulfan-vs-busulfan-cyclophosphamide-and-melphalan-in-pediatric-acute-myeloid-leukemia-transplant-conditioning2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-comparing-trifluridine-tipiracil-plus-fruquintinib-versus-trifluridine-tipiracil-in-metastatic-oesogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-evaluating-adjuvant-leuprorelin-acetate-therapy-post-radical-prostatectomy-in-high-risk-prostatic-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-avelumab-in-high-risk-triple-negative-breast-cancer-post-curative-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-cemiplimab-in-resected-stage-ii-iiia-nsclc-with-pd-l1-1-without-prior-adjuvant-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-endocrine-therapy-with-without-chemotherapy-in-hr-positive-her2-negative-breast-cancer-with-rs-252026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-mfolfirinox-versus-capecitabine-or-gemcitabine-in-resected-ampullary-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-nivolumab-with-cisplatin-based-chemoradiotherapy-in-high-risk-resected-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-adjuvant-palbociclib-plus-endocrine-therapy-versus-endocrine-therapy-alone-in-hr-positive-her2-negative-breast-cancer-recurrence2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-atezolizumab-carboplatin-and-paclitaxel-in-elderly-patients-with-advanced-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-atezolizumab-plus-bcg-versus-bcg-alone-in-high-risk-non-muscle-invasive-bladder-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-avelumab-cetuximab-and-radiotherapy-versus-standard-care-in-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-bortezomib-melphalan-prednisone-lenalidomide-dexamethasone-carfilzomib-and-daratumumab-in-elderly-patients-with-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-carfilzomib-lenalidomide-and-dexamethasone-versus-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-patients-ineligible-for-asct2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-de-escalated-matrix-induction-therapy-in-newly-diagnosed-primary-cns-lymphoma-methotrexate-cytarabine-thiotepa-and-rituximab2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-decitabine-venetoclax-and-tretinoin-in-acute-myeloid-leukemia-patients-ineligible-for-induction-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-dostarlimab-versus-chemotherapy-in-mmr-deficient-advanced-metastatic-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-endocrine-therapy-with-or-without-chemotherapy-in-hr-positive-her2-negative-breast-cancer-with-low-recurrence-score2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-enzalutamide-versus-enzalutamide-plus-radium-223-dichloride-in-asymptomatic-or-mildly-symptomatic-bone-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-folfox-with-or-without-anhydrous-docetaxel-in-locally-advanced-or-metastatic-oesophagogastric-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-folfoxiri-plus-bevacizumab-and-atezolizumab-versus-folfoxiri-plus-bevacizumab-in-pmmr-and-immunoscore-ic-high-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-gemtuzumab-ozogamicin-with-induction-chemotherapy-in-pediatric-acute-myeloid-leukemia-high-risk-myelodysplastic-syndrome-and-myeloid-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-high-dose-chemotherapy-with-autologous-stem-cell-transplantation-versus-r-mp-in-elderly-patients-with-primary-cns-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-high-dose-interferon-or-ipilimumab-versus-pembrolizumab-in-patients-with-high-risk-resected-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-hyperthermic-intraperitoneal-chemotherapy-with-cisplatin-and-sodium-thiosulfate-in-epithelial-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-iberdomide-vs-iberdomide-plus-isatuximab-post-autologous-hematopoietic-stem-cell-transplantation-in-newly-diagnosed-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-induction-chemotherapy-with-carboplatin-and-paclitaxel-followed-by-concurrent-chemoradiotherapy-in-cervical-cancer-with-para-aortic-lymph-node-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-intermittent-vs-continuous-androgen-deprivation-therapy-with-ar-pathway-inhibitors-in-metastatic-hormone-naive-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-intraperitoneal-paclitaxel-plus-systemic-therapy-versus-systemic-therapy-alone-in-gastric-cancer-with-peritoneal-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-isatuximab-addition-to-lenalidomide-bortezomib-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-letrozole-versus-carboplatin-and-paclitaxel-in-estrogen-progesterone-receptor-positive-low-grade-serous-ovarian-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-lomustine-versus-lomustine-and-bevacizumab-in-recurrent-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-maintenance-olaparib-versus-observation-post-adjuvant-chemoradiation-in-p53abn-endometrial-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-mfolfirinox-versus-mfolfox-in-adjuvant-treatment-of-high-risk-stage-iii-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-neoadjuvant-capox-or-folfox-chemotherapy-in-obstructive-colon-cancer-post-colostomy-for-curative-therapeutic-sequence-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-neoadjuvant-chemotherapy-and-pelvic-reirradiation-versus-chemotherapy-alone-in-locally-recurrent-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-niraparib-and-dostarlimab-versus-physician-s-choice-chemotherapy-in-recurrent-ovarian-fallopian-tube-or-primary-peritoneal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-paclitaxel-carboplatin-and-letrozole-vs-letrozole-monotherapy-in-stage-ii-iv-low-grade-serous-carcinoma-of-ovary-peritoneum2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-palbociclib-plus-endocrine-therapy-versus-endocrine-therapy-alone-in-hr-her2-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-platinum-based-chemotherapy-with-paclitaxel-bevacizumab-and-atezolizumab-in-metastatic-persistent-or-recurrent-cervical-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-preoperative-chemotherapy-vs-chemotherapy-plus-chemoradiotherapy-in-locally-advanced-resectable-rectal-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-radiotherapy-with-cisplatin-versus-radiotherapy-alone-in-sinus-and-salivary-gland-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-regorafenib-irinotecan-combination-versus-regorafenib-monotherapy-in-metastatic-colorectal-cancer-with-cyclin-d1-a-a-genotype2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-sequential-re-radiochemotherapy-and-pembrolizumab-versus-immunochemotherapy-in-locoregionally-recurrent-pd-l1-positive-hnscc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-short-vs-long-course-preoperative-chemotherapy-with-mfolfirinox-or-paxg-in-stage-i-iii-pancreatic-ductal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-tarlatamab-versus-standard-chemotherapy-in-pre-treated-advanced-pulmonary-or-gastroenteropancreatic-poorly-differentiated-neuroendocrine-carcinomas2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-tip-vs-ti-ce-regimens-in-relapsed-refractory-germ-cell-tumors-paclitaxel-ifosfamide-cisplatin-carboplatin-etoposide2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-trastuzumab-alpelisib-and-fulvestrant-versus-trastuzumab-and-chemotherapy-in-pik3ca-mutated-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-of-zongertinib-vs-standard-of-care-in-her2-mutant-advanced-non-squamous-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-trial-on-biomarker-staging-versus-conventional-staging-in-early-stage-endometrial-cancer-with-paclitaxel-and-carboplatin2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-randomized-triple-blind-placebo-controlled-study-of-vorasidenib-maintenance-therapy-in-idh-mutant-grade-2-or-3-astrocytoma-post-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-comparing-folfox-plus-panitumumab-followed-by-folfiri-plus-bevacizumab-versus-folfox-plus-bevacizumab-followed-by-folfiri-plus-panitumumab-in-wild-type-ras-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-datopotamab-deruxtecan-osimertinib-vs-platinum-based-chemotherapy-in-egfr-mutated-advanced-nsclc-post-osimertinib-progression2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-lisaftoclax-and-acalabrutinib-versus-immunochemotherapy-in-newly-diagnosed-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-lutetium-177lu-vipivotide-tetraxetan-in-psma-positive-oligometastatic-prostate-cancer-in-adult-males2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-mosunetuzumab-and-lenalidomide-versus-anti-cd20-monoclonal-antibody-and-chemotherapy-in-untreated-flipi-2-5-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-mosunetuzumab-plus-lenalidomide-versus-anti-cd20-antibody-and-chemotherapy-in-untreated-flipi-2-5-follicular-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-polatuzumab-vedotin-with-rituximab-ifosfamide-carboplatin-and-etoposide-in-relapsed-refractory-diffuse-large-b-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-savolitinib-plus-durvalumab-versus-sunitinib-and-durvalumab-monotherapy-in-met-driven-unresectable-or-metastatic-papillary-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-of-serenoa-repens-for-reducing-prostate-inflammation-and-need-for-repeat-biopsy-in-men-with-benign-prostatic-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-efficacy-of-neoadjuvant-intratumoral-l19il2-and-l19tnf-in-stage-iii-b-c-melanoma-patients-with-subsequent-surgical-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-immunogenicity-and-safety-of-menacyw-conjugate-vaccine-versus-nimenrix-in-healthy-infants-and-toddlers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-laryngeal-preservation-in-locally-advanced-squamous-cell-carcinomas-of-the-larynx-or-hypopharynx-comparing-induction-chemotherapy-with-cisplatin-5-fluorouracil-and-docetaxel-followe2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-molecular-profiling-and-drug-combination-therapy-in-advanced-unresectable-soft-tissue-sarcoma-using-futibatinib-durvalumab-and-olaparib2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-palbociclib-with-anti-her2-and-endocrine-therapy-in-hr-her2-metastatic-breast-cancer-post-induction-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-safety-and-efficacy-of-brigimadlin-bi-907828-in-treatment-naive-or-pre-treated-advanced-dedifferentiated-liposarcoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-study-on-the-efficacy-and-safety-of-177lu-edotreotide-prrt-versus-everolimus-in-inoperable-progressive-sstr-gep-net-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-superiority-trial-of-human-normal-immunoglobulin-versus-placebo-in-pediatric-acute-onset-neuropsychiatric-syndrome-pans2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-comparing-extended-lenalidomide-bortezomib-dexamethasone-with-early-rescue-vs-isatuximab-lenalidomide-bortezomib-dexamethasone-vs-isatuximab-lenalidomide-iberdomide-dexamethasone-in-ne2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-comparing-folfiri-plus-cetuximab-versus-bevacizumab-in-first-line-treatment-of-mcrc-with-ras-braf-wild-type-tissue-and-mutated-liquid-biopsy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-evaluating-adjuvant-durvalumab-post-neoadjuvant-chemotherapy-and-durvalumab-in-stage-iib-iiib-resectable-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-adjuvant-chemotherapy-versus-nivolumab-based-chemo-immunotherapy-in-stage-ib-iiia-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-bnt324-compared-with-docetaxel-and-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-elecoglipron-to-reduce-kidney-failure-and-death-in-adults-with-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-gemcitabine-and-nab-paclitaxel-switch-maintenance-versus-modified-folfirinox-continuation-in-advanced-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-intensified-alkylating-chemotherapy-with-stem-cell-rescue-and-olaparib-in-stage-iii-her2-negative-hr-deficient-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-intravesical-alpha1h-as-neoadjuvant-therapy-in-low-to-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-perioperative-flot-with-hipec-versus-flot-alone-in-resectable-diffuse-gastric-and-gastroesophageal-junction-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-sacituzumab-govitecan-and-zimberelimab-in-resected-non-small-cell-lung-cancer-lacking-pathological-complete-response2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-short-course-radiotherapy-vs-chemoradiotherapy-with-capecitabine-fluorouracil-and-oxaliplatin-in-intermediate-high-risk-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-of-standard-vs-reduced-dose-intensity-of-checkpoint-inhibitors-in-locally-advanced-or-metastatic-cancer-responders2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-on-disease-free-survival-in-resected-pancreatic-ductal-adenocarcinoma-using-oxaliplatin-or-gemcitabine-based-chemotherapy-allocation-by-transcriptomic-signature2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-on-dose-dense-carboplatin-paclitaxel-regimen-in-poor-prognostic-ovarian-cancer-with-incomplete-debulking-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-on-personalized-vs-non-personalized-177lu-dotatoc-therapy-in-sstr-positive-neuroendocrine-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iii-trial-on-preoperative-chemotherapy-with-irinotecan-oxaliplatin-and-capecitabine-in-resectable-advanced-colon-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-double-blind-placebo-controlled-trial-of-betula-pollen-extract-in-pediatric-birch-pollen-induced-allergic-rhinoconjunctivitis-with-or-without-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-evaluation-of-durvalumab-as-consolidation-therapy-in-limited-stage-small-cell-lung-cancer-post-platinum-based-chemoradiotherapy-in-spain2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-iv-open-label-study-of-lecanemab-in-the-prevention-and-progression-of-dominantly-inherited-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-multicenter-open-label-study-of-asciminib-hydrochloride-in-chronic-myelogenous-leukemia-patients-in-chronic-phase-post-two-or-more-tyrosine-kinase-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-multicenter-open-label-study-on-tezepelumab-for-reducing-maintenance-therapy-in-severe-asthma-patients-aged-12-80-years2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-randomized-double-blind-study-of-high-dose-cholecalciferol-on-bone-metabolism-in-pediatric-cystic-fibrosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-randomized-multicenter-open-label-trial-of-atezolizumab-and-bevacizumab-versus-transarterial-chemoembolization-in-intermediate-stage-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-randomized-study-of-inclisiran-on-atherosclerotic-plaque-progression-in-non-obstructive-coronary-artery-disease-with-statin-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iiib-randomized-trial-of-degarelix-versus-gnrh-agonists-with-flare-protection-in-high-risk-localized-or-locally-advanced-prostate-cancer-with-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iir-trial-of-fianlimab-cemiplimab-and-pemetrexed-platinum-chemotherapy-in-treatment-naive-pleural-mesothelioma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-evaluation-of-faricimab-on-visual-acuity-and-vascular-integrity-in-diabetic-macular-edema-patients-using-adaptive-optics2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-multicenter-immunogenicity-and-safety-study-of-the-seqirus-licensed-zoonotic-influenza-vaccine-h5n8-in-adults-immunized-with-an-h5n1-mf59-influenza-vaccine-approximately-20-years-before-the-t2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-multicentre-trial-evaluating-efficacy-of-hipec-with-mitomycin-c-post-surgical-debulking-in-peritoneal-metastases-of-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-non-inferiority-trial-of-photodynamic-turbt-with-hexaminolevulinate-vs-white-light-turbt-in-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-open-label-clinical-trial-of-the-immunogenicity-and-safety-of-standard-dose-trivalent-inactivated-influenza-vaccine-vaxigrip-in-a-population-of-people-with-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-open-label-multi-center-rollover-study-of-crizanlizumab-in-patients-with-sickle-cell-disease-post-novartis-sponsored-study-completion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-open-label-randomized-clinical-trial-on-the-effect-of-intravenous-iron-on-quality-of-life-in-elderly-patients-with-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-open-label-single-arm-study-on-safety-and-immunogenicity-of-phh-1v111-emulsion-for-injection-against-sars-cov-2-variants-in-covid-19-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-open-label-study-on-immunological-modulation-in-glioblastoma-multiforme-patients-treated-with-bevacizumab-infusion2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-randomized-double-blind-placebo-controlled-study-of-inclisiran-with-lipid-lowering-therapy-in-hypercholesterolemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-randomized-double-blind-placebo-controlled-trial-of-tree-slit-tablet-betula-verrucosa-in-adolescents-with-birch-pollen-induced-ar-arc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-randomized-study-on-disease-progression-in-open-angle-and-pex-glaucoma-brimonidine-pilocarpine-nitrate-and-brinzolamide-combination-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-rollover-study-evaluating-long-term-safety-of-ruxolitinib-alone-or-in-combination-with-panobinostat-siremadlin-or-rineterkib-in-eligible-patients2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-single-center-randomized-crossover-clinical-trial-to-validate-the-use-of-gadopiclenol-versus-gadobutrol-in-the-evaluation-of-magnetic-resonance-imaging-mri-diagnosis-of-perianal-fistula-assoc2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-study-of-abemaciclib-and-endocrine-therapy-in-hormone-receptor-positive-her2-negative-advanced-or-metastatic-breast-cancer-with-digital-side-effect-management2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-study-on-cellular-and-humoral-immunity-post-revaccination-with-measles-mumps-rubella-and-varicella-vaccines-in-pediatric-cancer-survivors2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-study-on-serological-cross-reactivity-in-flavivirus-diagnostics-post-vaccination-with-dengue-tetravalent-vaccine-live-attenuated-in-swedish-travelers2026-10-07 https://dev.clinicalresearch.eu/trial/phase-iv-trial-of-follitropin-delta-drug-combination-for-ovulation-trigger-in-women-with-low-ovarian-reserve-undergoing-ivf2026-10-07 https://dev.clinicalresearch.eu/trial/phase2-double-blind-randomized-placebo-controlled-multicentre-study-to-evaluation-the-safety-efficacy-and-pharmacokinetics-of-tak-242-and-granulocyte-colony-stimulating-factor-g-csf-g-tak-in-subjects-2026-10-07 https://dev.clinicalresearch.eu/trial/phenotype-guided-dose-adjustment-of-fluoropyrimidine-based-chemotherapy-in-dihydropyrimidine-dehydrogenase-deficient-gastrointestinal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/physiologically-based-pharmacokinetic-modeling-of-intravenous-and-intranasal-naloxone-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/physiologically-based-pharmacokinetic-modeling-of-oral-and-intranasal-zolmitriptan-formulations-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pilot-feasibility-study-of-network-pharmacology-guided-personalized-drug-repurposing-in-patients-with-advanced-thyroid-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/pilot-study-on-the-safety-and-efficacy-of-dendritic-cells-loaded-with-frameshift-derived-neopeptides-in-lynch-syndrome-carriers2026-10-07 https://dev.clinicalresearch.eu/trial/pilot-trial-of-methotrexate-tafasitamab-minjuvi-r-lenalidomide-revlimid-r-and-rituximab-in-patients-ineligible-for-hct-asct-with-primary-central-nervous-system-lymphoma-pcnsl-mtr22026-10-07 https://dev.clinicalresearch.eu/trial/pivmecillinam-as-oral-step-down-treatment-for-escherichia-coli-febrile-urinary-tract-infection-versus-standard-of-care-a-randomized-controlled-non-inferiority-multicenter-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pivotal-bioequivalence-study-of-test-statin-formulation-versus-reference-statin-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/pk-pd-of-cefadroxil-in-staphylococcus-aureus-bacteremia-a-preliminary-study2026-10-07 https://dev.clinicalresearch.eu/trial/placebo-controlled-dose-finding-study-of-orka-001-in-adults-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/placental-transfer-of-dapirolizumab-pegol-in-pregnant-women-with-active-systemic-lupus-erythematosus-a-prospective-multicenter-open-label-pk-study2026-10-07 https://dev.clinicalresearch.eu/trial/platelet-function-testing-in-patients-12-to-18-months-after-heart-transplantation-taking-acetylsalicylic-acid2026-10-07 https://dev.clinicalresearch.eu/trial/platform-covid-study-platform-randomised-trial-of-treatments-for-covid-19-in-general-practice2026-10-07 https://dev.clinicalresearch.eu/trial/platform-randomised-trial-of-treatments-for-covid-19-in-general-practice2026-10-07 https://dev.clinicalresearch.eu/trial/pnoc023-open-label-phase-1-and-target-validation-study-of-onc206-in-children-and-young-adults-with-newly-diagnosed-or-recurrent-diffuse-midline-glioma-dmg-and-other-recurrent-primary-malignant-central2026-10-07 https://dev.clinicalresearch.eu/trial/positron-emission-tomography-imaging-of-alpha-7-nicotinic-acetylcholine-receptor-density-in-healthy-volunteers-and-patients-with-mild-cognitive-impairment-and-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/positron-emission-tomography-study-evaluating-novel-radioligand-for-imaging-mutant-huntingtin-in-huntington-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/positron-emission-tomography-study-of-tau-tracer-18f-ro6958948-in-cerebral-commotio-intracerebral-hemorrhage-traumatic-brain-injury-and-subarachnoid-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/post-operative-oxaliplatin-liver-directed-chemotherapy-plus-drug-combination-in-patients-with-resected-colorectal-cancer-liver-metastases-at-high-risk-of-recurrence2026-10-07 https://dev.clinicalresearch.eu/trial/postoperative-recovery-with-the-addition-of-long-acting-nk1-and-5-ht3-receptor-antagonists-as-prophylaxis-for-post-operative-nausea-and-vomiting-a-prospective-double-blind-randomized-trial-in-laparosc2026-10-07 https://dev.clinicalresearch.eu/trial/pramipexole-for-reducing-anhedonia-in-adults-with-bipolar-disorder-during-a-depressive-episode-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/pre-and-post-treatment-evaluation-of-lung-function-with-xenon-gas-enhanced-dual-energy-ct-imaging-in-patients-undergoing-radiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/pre-hospital-sedation-study-of-s-ketamine-versus-propofol-in-patients-with-severe-acute-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/pre-surgical-evaluation-of-azithromycin-dihydrate-doxycycline-hyclate-and-sodium-ascorbate-in-stage-i-iii-early-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/precision-immunosuppressive-drug-monitoring-vs-standard-care-in-liver-transplant-recipients-randomized-trial-of-tacrolimus-and-mycophenolate-mofetil2026-10-07 https://dev.clinicalresearch.eu/trial/prednisone-and-drug-combination-therapy-for-patients-with-surfactant-related-gene-mutation-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/predostar-preventing-second-cancers-with-dostarlimab-a-multicenter-open-label-randomized-phase-ii-study-aiming-to-assess-the-clinical-impact-of-dostarlimab-on-occurrence-of-second-primary-cancer-in-pa2026-10-07 https://dev.clinicalresearch.eu/trial/preeclampsia-intervention-4-a-double-blind-phase-iii-randomised-controlled-trial-assessing-metformin-to-prolong-gestation-in-preterm-preeclampsia2026-10-07 https://dev.clinicalresearch.eu/trial/pregabalin-or-baclofen-in-spastic-motor-behavior-treatment-after-sci-pobsci-prospective-double-blind-randomised-drug-study2026-10-07 https://dev.clinicalresearch.eu/trial/pregnancy-and-infant-preparedness-platform-in-europe-pipeline-rsv-immunisation-adaptive-platform-trial2026-10-07 https://dev.clinicalresearch.eu/trial/prehabilitation-with-botulinum-toxin-type-a-in-patients-with-complex-hernia-an-italian-prospective-study-on-myofascial-release-predictive-scores2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-amivantamab-monotherapy-or-combined-with-carboplatin-pemetrexed-in-resectable-egfr-mutant-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-atezolizumab-and-tiragolumab-immunotherapy-in-colorectal-liver-metastases-a-pathological-tumor-response-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-evaluation-of-giredestrant-gdc-9545-versus-tamoxifen-in-premenopausal-women-with-er-positive-her2-negative-ki67-10-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-ferric-carboxymaltose-infusion-in-gastric-cancer-patients-a-randomized-controlled-trial-evaluating-transfusion-and-complication-risk-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-folfox-versus-postoperative-risk-adapted-chemotherapy-in-locally-advanced-rectal-cancer-a-phase-iii-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-treatment-with-mfolfirinox-or-gem-nab-p-isotoxic-high-dose-stereotactic-body-radiation-therapy-ihd-sbrt-for-borderline-resectable-pancreatic-adenocarcinoma-a-randomised-comparative-multic2026-10-07 https://dev.clinicalresearch.eu/trial/preoperative-use-of-romiplostim-in-thrombocytopenic-patients-undergoing-cardiac-surgery-a-phase-3-multicenter-randomized-double-blinded-controlled-against-placebo-study2026-10-07 https://dev.clinicalresearch.eu/trial/pressurized-intrathoracic-aerosol-chemotherapy-pitac-in-patients-with-malignant-pleural-effusion-a-single-center-phase-ii-trial-pitac-mapepi2026-10-07 https://dev.clinicalresearch.eu/trial/preventing-urinary-tract-infections-in-infants-and-young-children-2-years-with-probiotic-escherichia-coli-nissle-1917-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/prevention-of-acute-kidney-injury-after-cardiac-surgery-in-children-0-12-months-using-carperitide-hanp-injection-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/prevention-of-neuropathic-pain-after-osteoporotic-vertebral-fracture-using-a-5-lidocaine-patch-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/prevention-of-postoperative-endoscopic-recurrence-with-endoscopy-driven-versus-systematic-biological-therapy-a-randomized-multicentre-parallel-group-pragmatic-non-inferiority-trial-in-adult-patients-w2026-10-07 https://dev.clinicalresearch.eu/trial/preventive-analgesia-with-local-anesthetic-injection-prior-to-vaginal-incision-in-hysterectomy-via-vnotes-a-randomized-double-blind-study2026-10-07 https://dev.clinicalresearch.eu/trial/preventive-autologous-dendritic-cell-vaccination-in-individuals-with-lynch-syndrome-a-phase-ii-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/prifetrastat-pf-07248144-and-fulvestrant-in-adults-with-advanced-hr-her2-breast-cancer-after-endocrine-therapy-and-cdk4-6-inhibitor-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/primary-chemoradiation-versus-neoadjuvant-chemotherapy-followed-by-surgery-as-treatment-strategy-for-locally-advanced-vulvar-carcinoma-vulcanize22026-10-07 https://dev.clinicalresearch.eu/trial/prodige-104-neopredict-a-multicenter-phase-ii-trial-using-transcriptomic-signatures-to-personalize-neoadjuvant-chemotherapy-for-patients-with-resectable-borderline-pancreatic-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/prodige-111-domzigast-a-randomized-phase-ii-study-evaluating-folfiri-vs-folfiri-plus-domvanalimab-anti-tigit-and-zimberelimab-anti-pd1-in-patients-with-advanced-gastric-or-gastro-oesophageal-junction-2026-10-07 https://dev.clinicalresearch.eu/trial/prodige-118-pehricca-perioperative-cisgem-plus-rilvegostomig-in-high-risk-resectable-intrahepatic-cholangiocarcinoma-phase-ii-single-arm-study-mutlicenter2026-10-07 https://dev.clinicalresearch.eu/trial/prodige-81-ffcd-2101-triplet-randomized-open-label-phase-ii-iii-study-evaluating-the-benefit-of-adding-ipilimumab-to-the-combination-of-atezolizumab-and-bevacizumab-in-patients-with-hepatocellular-car2026-10-07 https://dev.clinicalresearch.eu/trial/progesterone-as-an-ovulation-trigger-in-women-with-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/progesterone-luteal-phase-support-in-women-with-unexplained-infertility-a-randomized-trial-of-progesterone-vs-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/prognostic-impact-of-early-low-plasma-oseltamivir-carboxylate-concentration-in-critically-ill-adults-with-severe-influenza-in-intensive-care2026-10-07 https://dev.clinicalresearch.eu/trial/prognostic-performance-of-quantitative-myocardial-perfusion-imaging-with-o15-water-pet-adenosine-and-regadenoson-in-adults-with-suspected-or-known-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/prognostic-value-of-psma-t4-spect-ct-imaging-in-patients-with-triple-negative-breast-cancer-undergoing-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/prolonged-versus-single-dose-in-penicillin-oral-challenge-testing-double-blind-parallel-randomized-placebo-controlled-trial-prospector-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/proof-of-concept-study-of-intravesical-hexaminolevulinate-for-rapid-photodynamic-diagnosis-in-patients-with-primary-or-recurrent-papillary-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/proof-of-concept-study-of-sublingual-recombinant-human-insulin-formulation-as-replacement-for-subcutaneous-injection-in-type-1-diabetes-patients-on-pump2026-10-07 https://dev.clinicalresearch.eu/trial/proof-of-concept-study-on-exposure-to-world-anti-doping-agency-prohibited-substances-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/prophylactic-pivmecillinam-to-prevent-enterobacterales-urinary-tract-and-bloodstream-infections-in-kidney-transplant-recipients-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/prophylactic-tinzaparin-sodium-to-prevent-venous-thromboembolism-in-adults-with-cirrhosis-and-hepatocellular-carcinoma-undergoing-locoregional-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/prophylactic-tocilizumab-jnj-79635322-and-human-normal-immunoglobulin-to-prevent-cytokine-release-syndrome-with-ramantamig-in-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-evaluation-of-chikungunya-virus-strain-chikv-lr2006-opy1-live-attenuated-vaccine-efficacy-safety-and-immunogenicity-in-at-risk-populations2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-evaluation-of-linezolid-fusidic-acid-and-rifampicin-in-treating-periprosthetic-joint-infections-using-mbec-and-mic-parameters2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-evaluation-of-model-informed-precision-dosing-of-vancomycin-hydrochloride-in-critically-ill-adults-with-serious-infections2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-evaluation-of-personalized-treatment-efficacy-and-safety-in-young-adults-with-poor-prognosis-non-seminomatous-germ-cell-tumors-using-early-tumor-marker-kinetics2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-multicenter-randomized-open-label-parallel-group-controlled-phase-3-study-of-tacrolimus-minimization-in-kidney-transplant-recipients-selected-according-to-the-agora-algorithm-for-their-low2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-multicenter-study-on-early-discontinuation-of-prednisolone-in-fdg-pet-ct-negative-patients-with-idiopathic-retroperitoneal-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-multicenter-study-on-immune-related-rheumatological-adverse-events-induced-by-checkpoint-inhibitors-in-cancer-patients-using-fludeoxyglucose-18f2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-open-label-single-center-pilot-study-on-the-efficacy-of-daily-tadalafil-in-early-stage-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-pet-imaging-for-early-prediction-of-neoadjuvant-treatment-response-in-patients-with-resectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-phase-ii-study-of-dose-escalated-radiotherapy-and-goserelin-in-high-risk-localized-prostate-cancer-with-ai-driven-personalization2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-pilot-study-of-endoscopic-surveillance-and-biomarker-assessment-in-patients-with-barrett-s-esophagus-esophageal-dysplasia-and-early-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-placebo-controlled-clinical-trial-with-aconite-pain-oil-in-oncological-patients-undergoing-chemotherapy-to-prevent-chemotherapy-induced-polyneuropathy-cipn-grade-ii-to-reduce-symptoms-typi2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-randomized-double-blind-placebo-controlled-single-center-comparative-trial-evaluating-oral-hydroxychloroquine-200-mg-bid-for-reducing-microglial-activation-in-the-brain-of-patients-with-pr2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-randomized-double-blind-study-evaluating-the-superiority-of-vasopressin-versus-noradrenaline-in-the-management-of-the-renal-risk-patient-undergoing-cardiac-surgery-with-extracorporeal-circ2026-10-07 https://dev.clinicalresearch.eu/trial/prospective-study-on-nilotinib-versus-imatinib-with-nilotinib-switch-in-bcr-abl-chronic-myeloid-leukemia-in-chronic-phase2026-10-07 https://dev.clinicalresearch.eu/trial/prostate-medication-metabolism-and-gut-microbiota-promed2026-10-07 https://dev.clinicalresearch.eu/trial/psilocybin-assisted-psychotherapy-for-the-treatment-of-gambling-disorder-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/psilocybin-assisted-psychotherapy-in-the-treatment-of-patients-hospitalized-for-treatment-resistant-depression-an-open-label-feasibility-study-with-an-experiential-and-systemic-focus2026-10-07 https://dev.clinicalresearch.eu/trial/pulmonary-deposition-study-of-nebulized-liposomal-amphotericin-b-and-technetium-99m-in-chronic-pulmonary-aspergillosis2026-10-07 https://dev.clinicalresearch.eu/trial/pumitamig-versus-durvalumab-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-without-progression-after-chemoradiation2026-10-07 https://dev.clinicalresearch.eu/trial/pumitamig-versus-pembrolizumab-in-previously-untreated-advanced-non-small-cell-lung-cancer-with-pd-l1-502026-10-07 https://dev.clinicalresearch.eu/trial/qtx-2101-and-arsenic-trioxide-in-adult-patients-with-newly-diagnosed-low-risk-acute-promyelocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/quantification-of-hsp90-in-neurodegenerative-diseases-using-pet-radioligand-11c-hsp990-in-alzheimer-s-als-and-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/quantification-of-myocardial-manganese-uptake-via-cardiovascular-mri-post-anhydrous-mangafodipir-trisodium-administration-in-hfpef-patients-with-hypertrophic-cardiomyopathy-or-cardiac-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/quantification-of-neuroinflammation-in-multiple-sclerosis-using-18f-dpa-714-pet-imaging-a-multicenter-study-comparing-lesion-activity-in-patients-and-healthy-controls2026-10-07 https://dev.clinicalresearch.eu/trial/quantification-of-synaptic-density-and-tau-pathology-in-alzheimer-s-disease-using-18f-synvest-1-and-18f-flortaucipir-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/quantification-of-whole-body-her3-using-radiolabeled-patritumab-deruxtecan-her3-dxd-pet-ct-in-egfr-mutation-positive-advanced-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-assessment-of-myocardial-blood-flow-in-coronary-artery-disease-using-syn2-adenosine-and-regadenoson-with-dynamic-pet-imaging2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-fluorescence-molecular-endoscopy-for-pd-1-pd-l1-evaluation-in-locally-advanced-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-fluorescence-molecular-imaging-in-patients-with-crohn-s-disease-and-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-hyperpolarized-1-13c-pyruvate-mri-for-metabolic-imaging-in-diabetic-kidney-disease-a-study-on-pyruvic-acid-and-meglumine-gadoterate2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-imaging-of-myocardial-microcalcification-in-transthyretin-amyloid-cardiomyopathy-using-sodium-fluoride-18f-and-iodine-123i-iobenguane2026-10-07 https://dev.clinicalresearch.eu/trial/quantitative-pet-imaging-of-pancreatic-68ga-exendin-tracer-accumulation-in-patients-with-a-history-of-gestational-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/r-mini-chop-versus-r-mini-chp-in-combination-with-polatuzumab-vedotin-as-primary-treatment-for-patients-with-diffuse-large-b-cell-lymphoma-80-years-or-frail-75-years-an-open-label-randomized-nordic-ly2026-10-07 https://dev.clinicalresearch.eu/trial/rabies-infection-prophylaxis-in-healthy-volunteers-rabies-virus-inactivated-strain-flury-lep-booster-vaccination-after-prior-pre-exposure-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/radar-a-randomised-phase-iii-trial-with-a-pet-response-adapted-design-comparing-abvd-isrt-with-a2vd-isrt-in-patients-with-previously-untreated-stage-ia-iia-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/radioactive-labelled-fibrobody-pet-ct-imaging-for-detection-of-fibrotic-tissue-in-patients-with-bmp-r2-mutations-ckd-ipf-masld-pah-and-psc2026-10-07 https://dev.clinicalresearch.eu/trial/radium223-dichloride-223racl-with-drug-combination-for-patients-with-symptomatic-bone-metastases-from-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/ramantamig-jnj-79635322-plus-daratumumab-versus-standard-drug-combination-in-newly-diagnosed-multiple-myeloma-patients-not-eligible-for-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/randomised-crossover-bioequivalence-clinical-trial-of-pregabalin-300-mg-tablets-versus-pregabalin-300-mg-hard-capsules-after-a-single-oral-dose-administration-to-healthy-volunteers-under-fasting-condi2026-10-07 https://dev.clinicalresearch.eu/trial/randomised-crossover-bioequivalence-clinical-trial-of-rosuvastatin-ezetimibe-20-mg-10-mg-film-coated-tablets-versus-rosuvastatin-ezetimibe-20-mg-10-mg-hard-capsules-after-a-single-oral-dose-administra2026-10-07 https://dev.clinicalresearch.eu/trial/randomised-double-blind-placebo-controlled-phase-iib-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-spesolimab-in-patients-with-moderate-to-severe-hidradenitis-suppurativa-lunsayil-12026-10-07 https://dev.clinicalresearch.eu/trial/randomised-study-for-double-blind-placebo-controlled-evaluation-of-bi-765845-on-top-of-standard-of-care-in-patients-with-myocardial-infarction2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-active-controlled-phase-2-3-study-of-gs-1720-and-gs-4182-versus-biktarvy-in-treatment-naive-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-adaptive-bioequivalence-study-of-rifaximin-200-mg-tablets-in-healthy-subjects-under-fed-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-blinded-study-of-neostigmine-glycopyrronium-bromide-vs-sugammadex-for-reversal-of-neuromuscular-blockade-in-patients-aged-75-undergoing-laparoscopic-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-comparing-intranasal-fentanyl-citrate-and-ketamine-to-oral-morphine-sulfate-for-pain-management-in-pediatric-limb-injuries2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-comparing-natural-versus-artificial-cycle-endometrial-preparation-for-frozen-thawed-embryo-transfer-in-subfertility-using-estradiol-valerate-and-micronised-progesterone2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-comparing-post-transplant-cyclophosphamide-versus-anti-t-lymphocyte-immunoglobulin-for-graft-versus-host-disease-prophylaxis-in-unrelated-donor-hematopoietic-cell-transplanta2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-evaluating-safety-and-efficacy-of-maat013-with-ipilimumab-and-nivolumab-in-melanoma-patients-naive-to-ipilimumab-and-anti-pd1-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-on-the-efficacy-of-sugammadex-and-rocuronium-bromide-in-neuromuscular-monitoring-for-pediatric-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-to-assess-the-efficacy-and-safety-of-a-strategy-for-primary-prevention-of-cardiovascular-disease-in-patients-with-inflammatory-rheumatic-diseases-based-on-the-use-of-carotid-2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-clinical-trial-to-evaluate-the-utility-of-cyp2d6-genotyping-to-improve-the-efficacy-and-safety-of-tramadol-in-the-treatment-of-acute-postoperative-pain2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-crossover-study-of-tamsulosin-hydrochloride-in-treating-symptomatic-dysuria-in-female-patients-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-avatrombopag-and-rituximab-in-adult-patients-with-immune-thrombocytopenia-unresponsive-to-corticosteroids2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-benzylpenicillin-sodium-and-cloxacillin-in-patients-with-penicillin-susceptible-staphylococcus-aureus-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-fast-and-slow-tapering-regimens-of-prednisone-in-patients-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-methotrexate-or-leflunomide-with-targeted-therapy-versus-triple-therapy-in-rheumatoid-arthritis-patients-unresponsive-to-methotrexate-or-leflunomide2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-postoperative-topical-nepafenac-and-dexamethasone-versus-dexamethasone-alone-in-fuchs-dystrophy-patients-undergoing-dmec2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-comparing-the-efficacy-and-tolerability-of-polyethylene-glycol-electrolytes-plenvu-versus-sodium-picosulfate-combination-picoprep-for-bowel-cleansing-prior-to-colonoscopy-i2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-evaluating-metformin-versus-standard-care-for-prolonging-type-2-diabetes-remission-post-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-evaluating-mifepristone-for-amelioration-of-treatment-resistant-post-traumatic-stress-disorder-symptoms2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-evaluating-systemic-corticosteroids-versus-placebo-in-acute-severe-erythema-multiforme-prednisone-and-methylprednisolone-acetate-analysis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-adalimumab-versus-placebo-in-needle-fasciotomy-for-dupuytren-disease2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-allogeneic-faecal-microbiota-transplantation-for-postantibiotic-diarrhea-in-critically-ill-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-alteplase-versus-iloprost-in-the-treatment-of-severe-frostbite-injuries-to-extremities2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-autologous-chondrocytes-and-remestemcel-in-symptomatic-articular-cartilage-lesions-of-the-knee2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-azithromycin-dihydrate-in-chronic-obstructive-pulmonary-disease-patients-evaluating-mucus-rheology-and-exacerbation-frequency2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-chemotherapy-regimens-including-gemcitabine-lenvatinib-and-temozolomide-for-recurrent-and-primary-refractory-ewing-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-cladribine-based-induction-regimens-in-acute-myeloid-leukemia-evaluating-efficacy-in-cbf-aml-and-flt3-mutated-subtypes2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-corifollitropin-alfa-and-recombinant-fsh-in-progestin-primed-ovarian-stimulation-for-elective-fertility-preservation-in-infertility2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-dalbavancin-versus-standard-antibiotic-regimen-in-gram-positive-periprosthetic-joint-infections2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-dasatinib-based-combination-therapy-on-bone-resorption-in-patients-with-osteoporosis-or-osteopenia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-esketamine-hydrochloride-infusion-versus-placebo-for-chronic-pelvic-pain-in-endometriosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-ethinylestradiol-levonorgestrel-vs-alpha-tocopherol-in-menstrually-related-and-perimenopausal-migraine-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-gnrh-agonist-luteal-phase-support-versus-hcg-triggering-and-progesterone-in-ivf-icsi-with-embryo-transfer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-high-dose-dexamethasone-disodium-phosphate-for-acute-postoperative-pain-in-high-pain-responder-lung-cancer-patients-undergoing-vats-lobectomy-segmentectomy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-immediate-vs-extended-release-tacrolimus-to-mitigate-calcineurin-inhibitor-toxicity-in-lung-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-indocyanine-green-in-intraoperative-fluorescence-cholangiography-for-acute-cholecystitis-requiring-urgent-cholecystectomy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-induction-chemotherapy-with-irinotecan-folinic-acid-and-oxaliplatin-followed-by-chemoradiotherapy-for-locally-recurrent-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-intra-nodal-gentamicin-injection-versus-placebo-in-suppurative-cat-scratch-disease-lymphadenitis-with-oral-azithromycin2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-intranasal-sufentanil-vs-ketamine-for-severe-acute-trauma-related-pain-in-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-intravenous-paracetamol-for-early-treatment-of-patent-ductus-arteriosus-in-extremely-low-birth-weight-infants2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-mepolizumab-and-functional-endoscopic-sinus-surgery-in-chronic-rhinosinusitis-with-nasal-polyposis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-methylphenidate-hydrochloride-on-neural-mechanisms-in-adults-with-adhd-and-comorbid-mood-disorders-versus-placebo2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-nadofaragene-firadenovec-versus-observation-in-intermediate-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-obinutuzumab-and-mycophenolate-mofetil-versus-corticosteroids-and-mycophenolate-mofetil-in-induction-therapy-for-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-personalized-colecalciferol-supplementation-to-mitigate-fatigue-in-colorectal-cancer-patients-with-suboptimal-vitamin-d-levels2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-phenoxymethylpenicillin-versus-no-antibiotic-in-streptococcus-group-a-negative-acute-tonsillitis-in-primary-care2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-pravastatin-sodium-for-prolonging-pregnancy-in-severe-early-onset-placental-insufficiency-focus-on-preeclampsia-and-intrauterine-growth-restriction2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-prophylactic-versus-selective-less-invasive-surfactant-administration-in-preterm-infants-with-respiratory-distress-syndrome-using-phospholipid-fraction-bovine-lung-and-p2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-rituximab-versus-placebo-in-adults-with-schizophrenia-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-ryz101-versus-standard-of-care-in-advanced-sstr-gastroenteropancreatic-neuroendocrine-tumors-post-177lu-ssa-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-semaglutide-for-weight-reduction-and-metabolic-control-in-obese-liver-transplant-candidates2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-of-tepotinib-versus-standard-therapy-in-advanced-met-exon-14-mutated-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-on-tadalafil-for-sexual-function-recovery-in-post-treatment-rectal-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-on-the-efficacy-of-low-dose-choriogonadotropin-alfa-priming-in-women-with-diminished-ovarian-reserve-undergoing-ivf-icsi2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-on-the-efficacy-of-oxybutynin-in-urodynamic-outcomes-post-posterior-urethral-valve-ablation-in-pediatric-male-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-controlled-trial-on-the-efficacy-of-prednisone-tapering-versus-abrupt-discontinuation-in-patients-with-inflammatory-or-autoimmune-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-crossover-study-of-pg511-pg521-pg531-versus-pg203-in-healthy-volunteers-safety-tolerability-pk-for-schizophrenia-levodopa-induced-dyskinesia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-crossover-trial-of-lisdexamfetamine-dimesylate-vs-methylphenidate-hydrochloride-in-pediatric-adhd-with-type-1-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-active-control-multicenter-phase-3-trial-of-casdatifan-and-cabozantinib-versus-placebo-and-cabozantinib-in-patients-with-advanced-clear-cell-renal-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-and-multicentric-study-to-assess-the-efficiency-security-and-tolerability-of-the-faecal-microbiota-transfer-in-capsule-form-vs-placebo-for-the-treatment-of-patients-with-non-al2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-controlled-trial-evaluating-cholecalciferol-vs-calcifediol-for-severe-vitamin-d-deficiency-correction2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-event-driven-trial-of-posaconazole-vs-fluconazole-for-antifungal-prophylaxis-in-acute-myeloid-leukemia-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-phase-iv-trial-of-safinamide-vs-rasagiline-for-fatigue-in-parkinson-s-disease-patients-on-stable-dopaminergic-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-study-evaluating-inclisiran-versus-placebo-in-pediatric-patients-with-heterozygous-familial-hypercholesterolemia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-study-of-levosimendan-for-weaning-failure-from-invasive-ventilation-in-critically-ill-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-study-on-efficacy-safety-and-immunogenicity-of-abatacept-biosimilar-drl-ab-vs-abatacept-with-methotrexate-in-rheumatoid-arthritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-trial-comparing-prednisolone-and-colchicine-for-acute-gout-attack-management-in-primary-care2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-trial-of-caspofungin-versus-placebo-in-the-treatment-of-yeast-intra-abdominal-infection-in-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-trial-of-oral-fecal-microbiota-transplantation-versus-placebo-in-severe-irritable-bowel-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-multicenter-trial-of-tocilizumab-versus-placebo-in-refractory-chronic-inflammatory-chondrocalcinosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-noninferiority-trial-of-oral-moxifloxacin-versus-placebo-in-the-management-of-uncomplicated-acute-appendicitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-phase-3b-study-of-nivolumab-plus-ipilimumab-versus-nivolumab-monotherapy-in-untreated-advanced-renal-cell-carcinoma-with-intermediate-or-poor-risk2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-phase-ii-study-of-upadacitinib-with-shortened-prednisolone-taper-for-sustained-remission-in-adults-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-phase-iii-trial-of-adjuvant-nivolumab-versus-placebo-in-patients-with-resected-esophageal-or-gastroesophageal-junction-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-12-month-study-of-fasudil-hydrochloride-in-patients-with-early-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-dose-escalation-study-of-grt-001-assessing-safety-tolerability-pk-pd-in-healthy-subjects-for-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-dose-finding-study-of-lu-ag09222-for-migraine-prevention-in-adults-with-episodic-and-chronic-migraine2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-dose-ranging-study-of-nalbuphine-hydrochloride-er-tablets-for-efficacy-and-safety-in-refractory-chronic-cough2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-first-in-human-study-of-pro-203-in-healthy-volunteers-and-patients-with-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-multiple-ascending-dose-study-of-cv-01-evaluating-safety-tolerability-pk-pd-in-drug-resistant-epilepsy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-phase-2-study-of-sodium-bituminosulfonate-in-patients-with-mild-to-moderate-hidradenitis-suppurativa2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-phase-2a-trial-of-methylprednisolone-in-patients-with-cognitive-deficits-post-covid-19-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-phase-ib-ii-trial-of-nivolumab-with-melphalan-based-isolated-limb-perfusion-in-in-transit-melanoma-metastases2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-phase-iii-study-of-olaparib-maintenance-monotherapy-in-brca-mutated-advanced-ovarian-cancer-post-platinum-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-phase-iv-study-of-dupilumab-in-patients-with-type-2-airway-disease-and-chronic-rhinosinusitis-with-nasal-polyps2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-single-and-multiple-ascending-dose-study-of-grt-002-in-healthy-volunteers-and-patients-with-chronic-spontaneous-urticaria2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-assessing-dose-dependent-cardiac-effects-of-verducatib-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-a-nav1-8-1-7-inhibitor-combination-in-adults-with-chronic-neuropathic-pain2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-abatacept-in-patients-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-canakinumab-in-patients-with-pyogenic-sterile-arthritis-pyoderma-gangrenosum-and-acne-papa-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-dapansutrile-for-glycemic-control-in-type-2-diabetes-mellitus-patients-on-standard-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-entr-601-45-in-duchenne-muscular-dystrophy-patients-amenable-to-exon-45-skipping2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-hydrocortisone-in-patients-with-giant-cell-arteritis-polymyalgia-rheumatica-and-adrenal-insufficiency2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-intra-articular-allocetra-ots-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-intravenous-human-alpha1-proteinase-inhibitor-in-hospitalized-patients-with-copd-exacerbations2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-mk-6916-in-healthy-adults-assessing-analgesic-effects-in-acute-and-chronic-pain-models2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-oral-expd-101-40-mg-on-annualized-moderate-severe-copd-exacerbation-rate-in-patients-with-copd2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-oral-metformin-safety-tolerability-and-pro-c3-modulation-in-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-regorafenib-as-maintenance-therapy-in-patients-with-bone-sarcomas-post-first-line-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-simvastatin-in-patients-with-primary-sclerosing-cholangitis-psc2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-spironolactone-in-active-rheumatoid-arthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-tezepelumab-in-adults-with-eosinophilic-granulomatosis-with-polyangiitis-egpa2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-of-vi-0106-extended-release-tacrolimus-on-functional-outcomes-hemodynamics-in-pah-patients-with-persistent-limitation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-study-on-the-efficacy-of-caffeine-in-cognitive-decline-in-early-to-moderate-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-acetylsalicylic-acid-in-colorectal-cancer-with-pik3ca-pik3r1-or-pten-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-adjuvant-cemiplimab-post-surgery-and-radiotherapy-in-high-risk-cutaneous-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-apocynin-and-paeonol-in-knee-osteoarthritis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-clindamycin-hydrochloride-with-standard-decolonization-for-mrsa-throat-carriage2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-colchicine-for-reducing-coronary-artery-inflammation-in-hiv-patients-with-high-cardiovascular-risk2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-diclofenac-sodium-in-patients-with-symptomatic-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-epoetin-alfa-in-mechanically-ventilated-critically-ill-patients-with-traumatic-injury2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-etidronate-disodium-on-ectopic-calcification-in-fahr-s-disease-and-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-galcanezumab-for-preventive-treatment-of-episodic-migraine-in-pediatric-patients-aged-6-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-galcanezumab-in-adolescents-aged-12-17-with-chronic-migraine-rebuild-2-study2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-human-monoclonal-antibody-ng004-in-patients-with-acute-incomplete-cervical-spinal-cord-injury2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-hydroxychloroquine-sulfate-in-women-with-recurrent-pregnancy-loss2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-inhaled-molgramostim-in-adults-with-autoimmune-pulmonary-alveolar-proteinosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-lasmiditan-for-acute-migraine-treatment-in-pediatric-patients-aged-6-to-17-years2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-metronidazole-and-ciprofloxacin-in-reducing-perianal-fistula-formation-post-perianal-abscess-drainage2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-norfloxacin-for-reducing-portal-hypertension-in-patients-with-decompensated-cirrhosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-psilocybin-for-reducing-anhedonia-in-adults-with-major-depressive-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-rituximab-in-psychosis-and-or-obsessive-compulsive-disorder-with-immune-system-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-sc-olive-pollen-extract-immunotherapy-in-patients-with-olive-pollen-induced-allergic-rhinitis-mild-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-subcutaneous-hdm-dermatophagoides-pteronyssinus-d-farinae-and-blomia-tropicalis-extract-in-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-subcutaneous-house-dust-mite-allergoid-immunotherapy-in-patients-with-moderate-severe-allergic-rhinitis-and-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-topical-tuvatexib-vda-1102-ointment-in-patients-with-rapidly-proliferating-actinic-keratosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-of-zinc-acexamate-in-advanced-chronic-liver-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-placebo-controlled-trial-on-tapentadol-hydrochloride-for-prevention-of-chronic-postoperative-pain-in-inguinal-hernia-and-knee-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-safety-and-immunogenicity-trial-of-ruti-added-to-bacillus-calmette-guerin-in-high-risk-non-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-single-and-multiple-ascending-dose-study-of-s072-assessing-safety-and-tolerability-in-healthy-adults-for-treatment-of-pain2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-comparing-mesotherapy-with-piroxicam-and-lidocaine-to-intradermal-dry-needling-in-lateral-epicondylitis-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-of-acetylsalicylic-acid-versus-placebo-in-stage-iii-or-high-risk-stage-ii-resected-colon-adenocarcinoma-with-pi3k-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-of-bacteriophage-therapy-with-pp1493-and-pp1815-in-staphylococcus-aureus-induced-prosthetic-joint-infection2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-of-tenofovir-disoproxil-fumarate-versus-placebo-in-pediatric-patients-with-chronic-hepatitis-b-infection2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-on-clinical-outcomes-tolerability-and-safety-of-oral-pantoprazole-in-pediatric-patients-with-healed-erosive-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-on-efficacy-and-safety-of-methylprednisolone-aceponate-0-1-cream-versus-vehicle-in-mild-to-moderate-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-on-the-efficacy-and-safety-of-5-potassium-hydroxide-solution-versus-placebo-in-treating-mild-to-moderate-actinic-keratosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-on-the-efficacy-and-safety-of-clindamycin-tretinoin-gel-versus-acnatac-gel-and-vehicle-in-papulopustular-acne-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-study-on-the-efficacy-and-safety-of-methylprednisolone-aceponate-0-1-ointment-in-mild-to-moderate-atopic-dermatitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-comparing-fentanyl-continuous-infusion-versus-morphine-bolus-for-refractory-dyspnea-in-acute-heart-failure-hospitalizations2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-intranasal-dexmedetomidine-for-sedation-and-analgesia-in-pediatric-emergency-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-intranasal-oxytocin-as-an-adjunct-to-psychosocial-treatment-in-schizophrenia-spectrum-disorders2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-noradrenaline-tartrate-with-terlipressin-acetate-versus-noradrenaline-tartrate-with-placebo-in-septic-shock-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-onabotulinumtoxina-in-erectile-dysfunction-refractory-to-phosphodiesterase-5-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-sodium-hypochlorite-and-polyhexamethylene-biguanide-for-diabetic-foot-ulcer-healing-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blind-trial-of-subcutaneous-6-grass-pollen-extract-10-000-30-000-tu-ml-in-grass-pollen-induced-allergic-rhinitis-with-or-without-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-blinded-vehicle-controlled-crossover-phase-2-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-intranasal-cenegermin-recombinant-human-nerve-growth-f2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-double-masked-multicenter-trial-comparing-atropine-0-5-vs-0-05-eye-drops-for-myopia-progression-prevention-in-european-pediatric-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-european-trial-of-autologous-transplantation-with-rituximab-ibrutinib-and-ara-c-induction-in-generalized-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-evaluation-of-paclitaxel-carboplatin-with-maintenance-niraparib-versus-paclitaxel-carboplatin-bevacizumab-with-maintenance-niraparib-bevacizumab-in-advanced-ovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-imaging-study-of-jfi447-versus-ffg233-in-metastatic-pdac-nsclc-hr-her2-negative-breast-cancer-tnbc-colorectal-cancer-and-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-interventional-trial-of-spironolactone-and-eplerenone-in-heart-failure-with-preserved-ejection-fraction-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-controlled-trial-of-pancreatic-enzyme-replacement-therapy-in-pancreatic-exocrine-insufficiency-with-unresectable-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-double-blind-trial-of-anakinra-vs-prednisone-for-gout-flare-in-chronic-kidney-disease-stages-3b-5-or-post-transplant-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-open-label-study-comparing-bortezomib-melphalan-prednisone-with-without-daratumumab-vs-lenalidomide-dexamethasone-with-without-daratumumab-in-asct-ineligible-multiple-myeloma-pa2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-study-of-aflibercept-versus-placebo-in-patients-with-macular-telangiectasia-type-12026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-trial-comparing-carboplatin-and-cisplatin-in-intermediate-to-very-high-risk-malignant-extracranial-germ-cell-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-multicenter-trial-of-colchicine-amiodarone-and-posterior-pericardiotomy-for-prevention-of-postoperative-atrial-fibrillation-in-cardiac-surgery-patients-prev-af2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-non-inferiority-trial-of-hypoxia-profile-guided-nimorazole-in-radiotherapy-chemoradiotherapy-for-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-crossover-study-of-salbutamol-in-patients-with-congenital-myopathy-to-evaluate-muscle-strength-and-function-enhancement2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-multicenter-phase-3-study-to-assess-the-efficacy-and-safety-of-givinostat-versus-hydroxyurea-in-jak2v617f-positive-high-risk-polycythemia-vera-patients-the-giv-in-pv-trial2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-multicenter-study-comparing-preservative-free-bimatoprost-ophthalmic-solution-0-1-mg-ml-with-lumigan-in-chronic-open-angle-glaucoma-or-ocular-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-multicenter-study-of-docetaxel-versus-abiraterone-or-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-with-adverse-prognostic-factors2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-multiple-dose-two-period-crossover-pharmacodynamic-study-of-an-investigational-agent-in-healthy-male-and-female-volunteers-under-fasting-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-non-inferiority-study-of-outpatient-oral-antibiotic-therapy-versus-hospitalization-with-intravenous-antibiotics-in-pediatric-acute-osteomyelitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-phase-2-3-study-of-bt8009-monotherapy-and-bt8009-pembrolizumab-vs-chemotherapy-in-locally-advanced-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-phase-3-trial-of-nivolumab-plus-ipilimumab-or-nivolumab-plus-platinum-doublet-chemotherapy-versus-platinum-doublet-chemotherapy-in-early-stage-nsclc2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-study-comparing-bioavailability-of-tacrolimus-formulations-in-adult-kidney-transplant-recipients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-study-of-nipocalimab-versus-human-normal-immunoglobulin-iv-in-pregnancies-at-risk-for-fetal-and-neonatal-alloimmune-thrombocytopenia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-study-of-rituximab-and-ibrutinib-versus-rituximab-and-chemotherapy-in-elderly-patients-with-untreated-mantle-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-study-on-health-related-quality-of-life-in-primary-adrenal-insufficiency-comparison-of-hydrocortisone-plenadren-and-cortisone-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-trial-comparing-standard-care-versus-treat-to-target-with-telemonitoring-in-ulcerative-colitis-patients-initiating-adalimumab2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-open-label-trial-of-trabectedin-with-low-dose-radiotherapy-versus-trabectedin-alone-in-advanced-soft-tissue-osteo-and-ewing-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-2-3-study-of-inbrx-106-and-pembrolizumab-versus-pembrolizumab-in-pd-l1-cps-20-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-2-study-of-dkn-01-plus-folfiri-folfox-and-bevacizumab-versus-folfiri-folfox-and-bevacizumab-as-second-line-treatment-of-advanced-colorectal-cancer-defiance2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-3-study-of-onc-392-versus-docetaxel-in-metastatic-non-small-cell-lung-cancer-post-pd-1-pd-l1-inhibitor-progression2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-3-trial-of-nivolumab-and-ipilimumab-continuation-versus-observation-in-stage-iv-non-small-cell-lung-cancer-post-induction-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-3-trial-on-personalized-tamoxifen-dosing-for-adjuvant-therapy-in-breast-cancer-impact-on-discontinuation-and-efficacy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-i-ii-trial-of-allogeneic-adipose-derived-mesenchymal-stromal-cells-in-severe-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ib-iii-study-of-capivasertib-with-cdk4-6-inhibitors-and-fulvestrant-in-hr-her2-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-study-of-napabucasin-paclitaxel-and-gemcitabine-in-metastatic-pancreatic-adenocarcinoma-post-chemotherapy-failure2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-trial-evaluating-acetylcarnitine-hydrochloride-on-functional-disability-progression-in-amyotrophic-lateral-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-trial-of-cisplatin-gemcitabine-hydrochloride-and-paclitaxel-albumin-bound-as-neoadjuvant-therapy-in-resectable-biliary-tract-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-trial-of-maintenance-pembrolizumab-pemetrexed-versus-observation-pemetrexed-in-stage-iv-non-small-cell-lung-cancer-post-induction-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-trial-of-nivolumab-with-tace-tae-in-intermediate-stage-hepatocellular-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-iii-trial-of-radiation-therapy-with-cisplatin-dosing-schedules-in-locoregionally-advanced-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-study-of-midostaurin-and-decitabine-in-unfit-adults-with-acute-myeloid-leukemia-or-high-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-study-of-stereotactic-body-radiotherapy-with-or-without-bicalutamide-in-unfavorable-intermediate-high-risk-prostate-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-study-on-ctdna-guided-treatment-optimization-in-oligometastatic-colorectal-cancer-using-oxaliplatin-capecitabine-fluorouracil-and-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-trial-for-patients-with-newly-diagnosed-low-risk-multiple-myeloma-to-evaluate-the-benefit-of-6-cycles-of-isatuximab-with-lenalidomide-bortezomib-dexamethasone-i-vrd-followed-by-mai2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-trial-of-multi-peptide-vaccine-combined-with-bispecific-psma-cd3-antibody-in-patients-with-biochemical-relapse-of-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-ii-trial-of-stereotactic-body-radiotherapy-with-or-without-darolutamide-in-oligorecurrent-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-iii-study-of-prednisolone-and-vitamin-d-supplementation-in-elderly-patients-with-diffuse-large-b-cell-lymphoma-dlbcl2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-phase-iii-trial-of-oral-cyclophosphamide-versus-doxorubicin-in-patients-aged-65-and-older-with-advanced-or-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-dose-escalation-study-of-mopevac-las-vaccine-for-safety-immunogenicity-and-optimal-dose-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-double-blind-crossover-study-of-intranasal-oxytocin-on-social-and-repetitive-behaviors-in-youth-with-autism-spectrum-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-double-blind-phase-1b-dose-finding-study-of-trb-001-safety-immunogenicity-and-pharmacodynamics-in-early-idiopathic-parkinson-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-pilot-study-of-intravenous-aptoll-in-acute-ischemic-stroke-patients-using-race-scale-for-prehospital-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-study-of-clemastine-in-children-and-adults-with-pitt-hopkins-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-study-of-imu-838-on-cardiac-repolarization-qt-qtc-in-adults-with-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-trial-assessing-amoxicillin-efficacy-in-chronic-non-specific-low-back-pain-with-modic-type-i-changes2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-trial-evaluating-juniper-berry-oil-100-mg-for-dyspeptic-digestive-complaints-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-trial-of-colchicine-to-slow-disease-progression-in-patients-with-amyotrophic-lateral-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-trial-of-human-normal-immunoglobulin-in-primary-sjogren-s-syndrome-associated-painful-sensory-neuropathies2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-placebo-controlled-trial-of-metformin-hydrochloride-in-patients-with-painful-hand-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-quadruple-blind-placebo-controlled-phase-2b-study-of-batoclimab-in-adults-with-active-chronic-inflammatory-demyelinating-polyneuropathy2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-single-blind-trial-of-high-dose-vs-standard-dose-inactivated-influenza-vaccine-in-adults-with-hematological-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-single-blind-trial-of-phospholipid-fraction-porcine-lung-in-premature-infants-with-respiratory-distress-syndrome-identified-by-lung-ultrasonography2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-single-dose-three-way-crossover-study-of-pharmacokinetics-of-4-mg-nicotine-pouch-vs-4-mg-nicotine-lozenge-in-healthy-adult-smokers2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-a-repurposed-agent-to-decelerate-immune-aging-and-mitigate-chronic-inflammation-in-elderly-individuals2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-early-cryoballoon-pulmonary-vein-isolation-versus-antiarrhythmic-drugs-in-persistent-symptomatic-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-early-versus-delayed-epoetin-alfa-initiation-in-lower-risk-myelodysplastic-syndromes-with-non-transfusion-dependent-anemia-without-del-5q2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-hyperthermic-intrathoracic-chemotherapy-with-cisplatin-and-pleurectomy-vs-standard-care-in-patients-with-malignant-pleural-effusion2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-optimal-subcutaneous-injection-strategy-for-cor-1167-in-chronic-heart-failure2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-tolebrutinib-versus-rituximab-in-patients-with-multiple-sclerosis-evaluating-biomarker-changes2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-trastuzumab-deruxtecan-bevacizumab-vs-platinum-based-chemotherapy-bevacizumab-in-her2-positive-recurrent-ovarian-cancer-after-parp-inhibitor2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-trastuzumab-deruxtecan-versus-standard-of-care-in-her2-positive-or-her2-low-early-breast-cancer-with-molecular-relapse2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-of-zoledronic-acid-monohydrate-in-combination-chemotherapy-for-high-grade-osteosarcoma-in-pediatric-and-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-on-discontinuation-strategies-of-tyrosine-kinase-inhibitors-in-chronic-myeloid-leukemia-impact-on-immune-system-with-dasatinib-imatinib-and-nilotinib2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-on-immunoglobulin-a-g-and-m-infusion-in-sepsis-and-peritonitis-patients-post-infectious-source-control2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-on-the-efficacy-of-activated-charcoal-and-macrogol-based-drug-combination-in-reducing-plasma-toxicant-levels-in-intubated-icu-patients2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-study-to-compare-first-line-treatment-with-either-continuous-or-intermittent-cetuximab-plus-folfiri-in-patients-with-ras-braf-wild-type-metastatic-colorectal-cancer-mcrc-aio-krk-0524-fire-12026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-assessing-isatuximab-efficacy-in-pure-red-cell-aplasia-post-allogeneic-hematopoietic-stem-cell-transplantation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-5-day-versus-7-day-amoxicillin-treatment-in-children-aged-2-17-with-acute-streptococcal-pharyngotonsillitis2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-early-versus-late-withdrawal-of-etanercept-baricitinib-and-tocilizumab-in-juvenile-idiopathic-arthritis-remission-using-imaging-and-multi-omics2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-isglt2-in-patients-with-permanent-atrial-fibrillation-and-heart-failure-with-preserved-ejection-fraction-and-intermediate-nt-probnp2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-mirikizumab-versus-azathioprine-in-newly-diagnosed-patients-with-moderate-to-severe-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-palbociclib-and-fulvestrant-versus-standard-endocrine-therapy-in-er-positive-her2-negative-breast-cancer-with-ctdna-detection2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-revaccination-with-bivalent-recombinant-rsv-vaccine-abrysvo-versus-no-revaccination-to-prevent-rsv-associated-lower-respiratory-tract-disease-in-immunocompromised-adults2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-triple-lipid-lowering-therapy-rosuvastatin-ezetimibe-bempedoic-acid-versus-dual-therapy-in-ascvd-patients-undergoing-elective-revascularisation2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-of-venetoclax-plus-drug-combination-to-improve-response-in-patients-with-relapsed-or-refractory-t-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/randomized-trial-on-spinal-anaesthesia-vs-general-anaesthesia-saga-on-recovery-after-total-hip-total-knee-and-unicompartmental-knee-arthroplasty2026-10-07 https://dev.clinicalresearch.eu/trial/rapid-sequence-emergence-of-general-anaesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/rechallenge-with-pegylated-liposomal-doxorubicin-and-trabectedin-in-recurrent-ovarian-cancer-a-multicenter-prospective-study2026-10-07 https://dev.clinicalresearch.eu/trial/recurrence-free-survival-study-of-cemiplimab-immunotherapy-in-medically-inoperable-stage-i-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/reduced-antithrombotic-strategy-for-high-bleeding-risk-patients-with-myocardial-infarction-treated-with-percutaneous-coronary-intervention-the-dan-dapt-trial2026-10-07 https://dev.clinicalresearch.eu/trial/reduced-dose-versus-full-dose-alteplase-for-patients-with-high-risk-pulmonary-embolism2026-10-07 https://dev.clinicalresearch.eu/trial/reduced-vs-standard-dose-belantamab-mafodotin-with-pomalidomide-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/relapse-prevention-study-of-high-and-low-dose-psilocybin-in-adults-with-severe-alcohol-use-disorder-and-depressive-symptoms-after-detoxification2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-of-neludolat-compared-with-drospirenone-ethinyl-estradiol-in-healthy-female-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-of-pf-08653945-after-subcutaneous-injection-in-the-thigh-upper-arm-or-abdomen-in-adults-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-study-of-fixed-dose-combination-of-ibuprofen-and-paracetamol-versus-free-combination-in-cold-flu-pain-and-fever-patients2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-study-of-four-new-pitolisant-tablet-formulations-versus-reference-pitolisant-in-healthy-male-subjects-with-narcolepsy2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-study-of-leniolisib-phosphate-in-various-dosages-in-healthy-volunteers-with-activated-phosphoinositide-3-kinase-delta-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/relative-bioavailability-study-of-new-pitolisant-hydrochloride-tablet-formulation-versus-marketed-pitolisant-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/remifentanil-for-endotracheal-intubation-in-neonates-a-dose-finding-trial2026-10-07 https://dev.clinicalresearch.eu/trial/renaissance-2-a-double-blind-randomized-placebo-controlled-multicenter-parallel-group-study-to-evaluate-the-efficacy-safety-and-tolerability-of-spn-817-in-adults-with-focal-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/repairing-peri-anal-fistulas-with-regenerative-cell-therapeutics-rep-paf2026-10-07 https://dev.clinicalresearch.eu/trial/repurposing-colchicine-for-reduction-of-residual-inflammatory-risk-in-type-1-diabetes-rec1te-a-randomized-double-blind-placebo-controlled-investigator-initiated-trial2026-10-07 https://dev.clinicalresearch.eu/trial/response-guided-neoadjuvant-therapy-in-her2-positive-breast-cancer-using-docetaxel-pertuzumab-trastuzumab-and-trastuzumab-emtansine2026-10-07 https://dev.clinicalresearch.eu/trial/rifampicin-combination-therapy-versus-targeted-antimicrobial-monotherapy-in-the-oral-antimicrobial-treatment-phase-of-staphylococcal-prosthetic-joint-infection2026-10-07 https://dev.clinicalresearch.eu/trial/rilzabrutinib-sar444671-interaction-study-with-combined-oral-contraceptive-ethinylestradiol-levonorgestrel-in-healthy-women-with-immune-thrombocytopenia-purpura2026-10-07 https://dev.clinicalresearch.eu/trial/rimonabant-improves-functional-recovery-in-subacute-stroke-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/rimonabant-improves-walking-ability-in-chronic-phase-stroke-patients-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/risk-adapted-adjuvant-chemotherapy-with-folfirinox-and-drug-combination-for-resected-pancreatic-adenocarcinoma-following-neoadjuvant-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-based-memory-b-cell-level-guided-therapy-in-pediatric-complicated-steroid-sensitive-nephrotic-syndrome-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-in-patients-with-st-elevation-myocardial-infarction-a-phase-2-placebo-controlled-randomized-clinical-trial-rita-mi-22026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-tapering-strategies-in-rheumatoid-arthritis-interval-prolongation-versus-disease-activity-guided-dose-reduction2026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-versus-azathioprine-for-remission-maintenance-in-patients-with-primary-angiitis-of-the-central-nervous-system2026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-versus-monitoring-with-prednisolone-for-anca-reactivation-in-patients-with-gpa-or-mpa-in-remission2026-10-07 https://dev.clinicalresearch.eu/trial/rituximab-versus-sodium-chloride-for-maintenance-therapy-in-patients-with-stabilized-systemic-sclerosis-associated-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/ro7795068-in-adults-with-obesity-or-overweight-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/role-of-neuroinflammation-and-blood-brain-barrier-breakdown-in-intracerebral-hemorrhage-the-infinite-study2026-10-07 https://dev.clinicalresearch.eu/trial/rollover-study-evaluating-long-term-safety-and-tolerability-of-pemigatinib-in-adults-with-advanced-malignancies-lacking-alternative-access2026-10-07 https://dev.clinicalresearch.eu/trial/rosuvastatin-zinc-in-patients-with-statin-intolerance-comparing-20-mg-dose-continuation-after-a-36-week-self-assessment-n-of-1-trial-vs-standard-statin-titration2026-10-07 https://dev.clinicalresearch.eu/trial/rosy-t-roll-over-study-for-patients-who-have-completed-a-previous-oncology-study-with-osimertinib-tagrisso-and-are-judged-by-the-investigator-to-clinically-benefit-from-continued-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/sacubitril-valsartan-to-prevent-heart-problems-in-women-with-early-breast-cancer-receiving-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/safe-and-effective-postoperative-pain-treatment-with-morphine-hydrochloride-and-oxycodone-hydrochloride-in-patients-with-chronic-opioid-use-undergoing-major-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/safe-study-stopping-antibiotics-after-3-days-for-the-treatment-of-febrile-neutropenia-in-haematology-patients-a-randomized-open-label-non-inferiority-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-antitumor-activity-of-pf-08634404-alone-or-with-enfortumab-vedotin-in-adults-with-locally-advanced-or-metastatic-urothelial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-biological-activity-of-bnt351-in-adults-with-and-without-hiv-1-infection2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-dose-finding-of-trazodone-hydrochloride-and-psilocybin-in-adults-with-treatment-resistant-depression2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-dose-finding-study-of-autologous-t-cell-car-therapy-targeting-cd30-and-cea-in-patients-with-liver-metastases-from-cea-positive-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-dose-finding-study-of-oral-gsk5471713b-in-adult-patients-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-dose-finding-study-of-oral-surzetoclax-and-intravenous-etentamig-in-adults-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-dosing-evaluation-of-kite-363-and-kite-753-in-relapsed-refractory-b-cell-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-car20-nap-t-in-relapsed-refractory-cd20-b-cell-lymphomas-a-phase-i-iia-multicenter-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-hs135-in-adults-with-pulmonary-arterial-hypertension-an-early-phase-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-intravenous-glm101-in-patients-with-pmm2-cdg-a-phase-2-open-label-extension-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-nnc0519-1010-in-patients-with-obesity-and-type-2-diabetes-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-repotrectinib-and-osimertinib-in-advanced-egfr-mutant-metastatic-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-ro7759065-with-atezolizumab-in-patients-with-locally-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-evaluation-of-sot201-in-patients-with-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-act-777991-in-adults-with-non-segmental-vitiligo-a-randomized-placebo-controlled-phase-2a-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-anti-hepatitis-d-virus-antibodies-in-patients-with-chronic-hepatitis-d-infection-the-samba-d-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-autologous-cd34-cells-transduced-with-a-lentiviral-ncf1-gene-vector-in-children-and-adults-with-p47-cgd2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-bemarituzumab-in-combination-with-bevacizumab-in-patients-with-fgfr2b-overexpressing-advanced-or-metastatic-gynecological-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-bemcentinib-with-pembrolizumab-carboplatin-and-pemetrexed-in-advanced-metastatic-non-squamous-nsclc-with-without-stk11-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-biib115-in-infants-with-spinal-muscular-atrophy-previously-treated-with-gene-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-dasatinib-to-reduce-hiv-1-reservoir-chronic-inflammation-and-immune-senescence-in-adults-with-hiv-on-long-term-antiretroviral-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-dgkz-inhibitor-bgb-30813-and-tislelizumab-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-efimosfermin-alfa-in-participants-with-f2-or-f3-stage-metabolic-dysfunction-associated-steatohepatitis-mash-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-escharex-concentrate-of-proteolytic-enzymes-enriched-in-bromelain-versus-placebo-gel-in-adults-with-venous-leg-ulcers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-foxp3-t4-and-aldesleukin-in-patients-with-ipex-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-intra-arterial-tenecteplase-for-non-complete-reperfusion-of-intracranial-occlusion2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-intra-articular-allogeneic-adipose-tissue-derived-mesenchymal-stem-cells-versus-sodium-chloride-in-patients-with-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-locally-administered-apac-heparin-sodium-and-sodium-chloride-in-end-stage-kidney-disease-patients-undergoing-arteriovenous-fistula-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-low-sodium-oxybate-in-adults-with-chronic-nocturnal-cluster-headache2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-maat013-with-vancomycin-in-children-and-adolescents-with-gastrointestinal-acute-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-mk-1045-alone-or-with-tocilizumab-in-adults-with-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-mrt1800-mrt1801-and-mrt1802-mrna-vaccine-in-adults-aged-18-45-with-moderate-to-severe-acne-phase-i-ii2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-obinutuzumab-in-patients-with-newly-diagnosed-or-active-diffuse-systemic-sclerosis-a-phase-ii-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-olanzapine-treatment-in-psychosis-effect-of-genetic-and-epigenetic-factors-covariates-of-treatment-response2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-oral-ghrelin-receptor-agonist-ac01-in-chronic-advanced-hfref-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-pf-08634404-with-drug-combination-in-adults-with-early-stage-resectable-or-locally-advanced-unresectable-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-ponatinib-plus-asciminib-in-chronic-myeloid-leukemia-patients-resistant-to-these-drugs2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-rilvegostomig-with-drug-combination-in-adults-with-unresectable-stage-iii-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-ro7673396-monotherapy-and-combination-therapy-in-patients-with-advanced-ras-mutant-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-sodium-phenylbutyrate-eye-drops-for-paediatric-myopia-in-children2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-stem-cell-therapy-in-patients-with-retinal-degenerative-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-stopping-vs-maintenance-dose-of-filgotinib-tofacitinib-and-upadacitinib-in-adult-ulcerative-colitis-patients-in-remission2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-venetoclax-obinutuzumab-and-daratumumab-in-adult-patients-with-relapsed-chronic-lymphocytic-leukemia-optic2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-efficacy-of-vx-828-deutivacaftor-and-tezacaftor-in-adults-with-cystic-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-feasibility-of-autologous-cord-blood-derived-mononuclear-cells-in-neonatal-hypoxic-ischemic-encephalopathy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-feasibility-of-gradually-extending-dupilumab-dosing-intervals-in-patients-with-severe-asthma-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-feasibility-of-zanidatamab-plus-tislelizumab-with-chemotherapy-in-her2-positive-operable-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immune-response-of-a-mixed-gc-iiv-and-ovx836-vaccine-for-influenza-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immune-response-of-sars-cov-2-variant-lp-8-1-spike-protein-vaccine-bimervax-lp-8-1-in-adults-with-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immunogenicity-evaluation-of-a-therapeutic-hepatitis-b-virus-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immunogenicity-of-dose-ranging-rsv-hmpv-combination-vaccine-and-monovalent-hmpv-vaccine-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immunogenicity-of-experimental-versus-authorized-mrna-sars-cov-2-vaccine-candidates-as-a-booster-dose-in-previously-vaccinated-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-immunogenicity-of-hpv-dc-targeting-vaccine-in-hpv-positive-oropharyngeal-cancer-patients-a-multicentric-randomized-phase-i-iia-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacodynamics-of-cangrelor-tetrasodium-in-children-with-congenital-heart-disease-undergoing-percutaneous-vascular-procedures2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacodynamics-of-rbd4059-and-apixaban-in-patients-with-non-valvular-atrial-fibrillation2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-evaluation-of-nurandociguat-in-combination-with-nitroglycerin-in-patients-with-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-evaluation-of-pti5803-in-patients-with-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-evaluation-of-ro7795081-in-conjunction-with-approved-medications-for-obesity-or-overweight-management-in-type-2-diabetes-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-evaluation-of-single-and-multiple-oral-doses-of-at-587-in-healthy-adults-for-treatment-of-chronic-hepatitis-e-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-interaction-of-ro7795074-and-pitavastatin-in-overweight-or-obese-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetic-study-of-imc-s118ai-in-hla-a-02-01-positive-participants-with-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetics-evaluation-of-blyg8824a-in-patients-with-locally-advanced-or-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetics-of-aic263029-in-patients-with-bkv-associated-nephropathy-a-single-and-multiple-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetics-of-regadenoson-and-gadobutrol-in-pediatric-patients-undergoing-pharmacologic-stress-perfusion-cmr-for-cardiovascular-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetics-of-staphacute-mib2-and-sodium-chloride-in-healthy-volunteers-and-patients-with-staphylococcus-aureus-bacteremia2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacokinetics-of-xmab24306-with-daratumumab-in-relapsed-refractory-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-pharmacological-evaluation-of-gsk2857914-in-adults-with-moderate-to-severe-systemic-lupus-erythematosus2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-preliminary-efficacy-of-azeliragon-with-radiation-and-temozolomide-in-newly-diagnosed-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-preliminary-efficacy-of-ctx112-in-adults-with-relapsed-or-refractory-hematologic-autoimmune-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-preliminary-efficacy-of-transpocart19-car-t-cell-therapy-in-patients-with-refractory-lupus-nephritis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-proof-of-concept-study-of-vonafexor-in-patients-with-alport-syndrome-at-risk-of-progression2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-test-retest-reliability-of-11c-modag-005-pet-imaging-for-pathological-alpha-synuclein-deposition-in-patients-with-parkinson-s-disease-and-multiple-system-atrophy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-a-medicated-chewing-gum-containing-sodium-alginate-calcium-carbonate-and-sodium-bicarbonate-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-bmn-351-in-duchenne-muscular-dystrophy-a-phase-1-2-dose-escalation-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-cmr316-in-healthy-volunteers-and-patients-with-idiopathic-pulmonary-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-dostarlimab-in-adults-with-chronic-hepatitis-b-on-nucleos-t-ide-analogue-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-edoxaban-in-patients-with-porto-sinusoidal-vascular-disorder-a-phase-iia-randomized-double-blind-placebo-controlled-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-intravenous-qeq278-in-patients-with-advanced-non-small-cell-lung-cancer-esophageal-squamous-cell-carcinoma-renal-cell-carcinoma-and-head-and-neck-squamous-cell-ca2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-investigational-agent-the-0504-in-patients-with-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-isaralgagene-civaparvovec-gene-therapy-in-fabry-disease-a-phase-i-ii-multicenter-open-label-dose-ranging-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-odronextamab-and-cemiplimab-in-adult-patients-with-b-cell-non-hodgkin-s-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-odronextamab-in-patients-with-cd20-positive-b-cell-non-hodgkin-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-om-85-in-in-healthy-volunteers-and-patients-with-mild-allergic-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-sdl-m1-nanoparticles-in-septic-cholestasis-a-phase-i-study-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-tev-53408-in-adult-patients-with-celiac-disease-a-phase-1b-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-assessment-of-vrdn-001-an-igf-1r-inhibitor-in-patients-with-thyroid-eye-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-evaluation-of-liv001-in-mild-to-moderate-active-ulcerative-colitis-a-randomized-double-blind-placebo-controlled-phase-1b-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-evaluation-of-pst-611-in-patients-with-dry-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-evaluation-of-qrl-201-in-patients-with-amyotrophic-lateral-sclerosis-a-randomized-double-blind-placebo-controlled-multi-center-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-adjunctive-ov329-in-adults-with-drug-resistant-focal-epilepsy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-agmb-129-in-healthy-adults-a-dose-escalation-study-for-fibrostenotic-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-efimosfermin-alfa-in-adults-with-f2-f3-stage-metabolic-dysfunction-associated-steatohepatitis-mash-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-escalating-multiple-doses-of-nebulised-ss0331-in-healthy-participants-for-the-prevention-of-respiratory-tract-infection2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intraarticular-plx-pad-cell-injection-in-mild-to-moderate-knee-osteoarthritis-a-phase-i-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intranasal-cenegermin-compared-with-vehicle-in-adults-with-moderate-to-severe-subacute-traumatic-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intrathecal-ion337-in-patients-with-dravet-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intrathecal-trcn-1023-in-adults-with-amyotrophic-lateral-sclerosis-als-a-randomized-phase-1-2-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intravenous-and-subcutaneous-azd1163-in-rheumatoid-arthritis-a-placebo-controlled-study-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-intravitreal-spvn20-gene-therapy-in-end-stage-rod-cone-dystrophy-with-dormant-foveal-cone-photoreceptors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-lebrikizumab-in-newly-diagnosed-bullous-pemphigoid-patients-open-label-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-lutetium-177lu-vipivotide-tetraxetan-with-gozetotide-in-women-with-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-oral-sun-627-in-adults-with-non-active-progressive-multiple-sclerosis-spms-ppms-phase-2a-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-pf-07872412-compared-with-a-20-valent-pneumococcal-conjugate-vaccine-for-preventing-pneumococcal-disease-in-healthy-infants2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-probenecid-pti5803-as-add-on-therapy-in-patients-14-years-and-older-with-drug-resistant-seizures-due-to-focal-cortical-dysplasia2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-pst-611-in-patients-with-geographic-atrophy-due-to-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-regn17235-in-adults-with-sf3b1-mutated-clonal-cytopenia-of-undetermined-significance-and-low-risk-myelodysplastic-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-rg6496-in-huntington-s-disease-gene-expansion-carriers-with-the-selected-genetic-variant-point-hd2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-stem-cell-derived-dopamine-neuron-transplantation-in-parkinson-s-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-subcutaneous-pegtibatinase-in-adults-and-children-with-classical-homocystinuria2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-tenofovir-alafenamide-in-healthy-volunteers-with-epstein-barr-virus-infection2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-topical-delgocitinib-in-patients-with-cutaneous-t-cell-lymphoma-mycosis-fungoides2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-vcn-01-with-nab-paclitaxel-and-gemcitabine-in-newly-diagnosed-metastatic-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-and-tolerability-of-xen-d0501-compared-with-placebo-in-adults-with-obesity-a-12-week-randomized-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-assessment-of-argx-121-in-healthy-adult-volunteers-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-assessment-of-continued-gme751-pembrolizumab-biosimilar-in-melanoma-and-non-small-cell-lung-cancer-patients-post-study-participation2026-10-07 https://dev.clinicalresearch.eu/trial/safety-assessment-of-elgn-2112-insulin-human-in-preterm-infants-with-intestinal-malabsorption-a-double-blind-randomized-placebo-controlled-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-assessment-of-endobronchial-administration-of-allogeneic-bone-marrow-derived-mesenchymal-stromal-cells-in-lung-transplant-chronic-rejection2026-10-07 https://dev.clinicalresearch.eu/trial/safety-cns-penetration-and-target-engagement-of-oral-mirivadelgat-in-patients-with-parkinson-s-disease-phase-2a-double-blind-placebo-controlled2026-10-07 https://dev.clinicalresearch.eu/trial/safety-dose-finding-and-pharmacodynamic-study-of-bay-3389934-in-patients-with-sepsis-associated-coagulopathy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-dosing-and-early-efficacy-of-azd6621-in-adult-men-with-metastatic-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-dosing-and-steroid-sparing-efficacy-of-xtmab-16-in-patients-with-pulmonary-sarcoidosis-with-or-without-extrapulmonary-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/safety-efficacy-and-pharmacokinetic-study-of-ide849-ide-161-and-durvalumab-in-patients-with-dll3-positive-tumors-including-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-almagate-in-pregnant-women-with-gastroesophageal-reflux-disease-impact-on-perinatal-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-aminolevulinic-acid-hydrochloride-for-fluorescence-guided-resection-in-pediatric-and-adolescent-intra-axial-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-bay-3283142-in-patients-with-mild-to-moderate-hypertension-and-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-cc-93269-in-patients-with-relapsed-and-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-chf5993-pmdi-formulated-with-hfa-152a-versus-hfa-134a-in-moderate-to-severe-asthma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-es2b-c001-with-or-without-montanide-in-her2-expressing-metastatic-breast-cancer-under-her2-maintenance-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-gskvx000000025896-versus-varicella-virus-oka-merck-strain-in-healthy-children-aged-12-15-months2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-inhaled-isoflurane-sedation-in-patients-with-head-trauma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-int2104-infusions-in-adults-with-refractory-relapsing-b-cell-malignancies2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-intramyocardial-clxr-001-in-ischaemic-cardiomyopathy-patients-undergoing-coronary-artery-bypass-graft-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-lanreotide-and-metformin-in-advanced-progressive-well-differentiated-gastrointestinal-or-lung-carcinoids-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-long-term-finerenone-with-ace-inhibitor-or-angiotensin-receptor-blocker-in-pediatric-chronic-kidney-disease-with-proteinuria2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-long-term-maintenance-therapy-with-a-dihydrotetrabenazine-in-patients-with-moderate-to-severe-tardive-dyskinesia2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-nrg5051-in-healthy-adults-and-patients-with-parkinson-s-disease-or-amyotrophic-lateral-sclerosis-als2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-nurandociguat-in-combination-with-sildenafil-in-male-patients-with-arterial-hypertension-and-chronic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-pancreatic-islet-transplantation-without-immunosuppression-in-adults-with-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-regn17092-in-healthy-adults-for-sars-cov-2-covid-192026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-regn5837-combined-with-odronextamab-in-patients-with-aggressive-b-cell-non-hodgkin-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-sgn-35c-in-adult-patients-with-advanced-diffuse-large-b-cell-lymphoma-hodgkin-disease-peripheral-t-cell-lymphoma-and-anaplastic-large-cell-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-sgn-35t-in-adult-patients-with-advanced-b-cell-and-t-cell-lymphomas2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-sirolimus-in-pediatric-patients-with-familial-adenomatous-polyposis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-sor102-in-healthy-subjects-and-ulcerative-colitis-patients-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-tasimelteon-in-the-management-of-non-24-hour-sleep-wake-disorder-in-totally-blind-individuals-lacking-light-perception2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-tilray-fs-oral-solution-t10-c10-combined-with-temozolomide-and-radiotherapy-in-newly-diagnosed-glioblastoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-tradipitant-in-patients-with-idiopathic-or-diabetic-gastroparesis-a-multicenter-open-label-3-month-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-evaluation-of-xevinapant-cisplatin-and-radiotherapy-in-unresected-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck2026-10-07 https://dev.clinicalresearch.eu/trial/safety-of-benralizumab-in-adults-with-hypereosinophilic-syndrome-hes-eosinophilic-granulomatosis-with-polyangiitis-egpa-or-asthma-who-completed-a-prior-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-of-durvalumab-with-chemotherapy-drug-combination-in-first-line-treatment-of-patients-with-advanced-biliary-tract-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-of-flecainide-acetate-compared-with-amiodarone-hydrochloride-and-sotalol-in-patients-with-atrial-fibrillation-and-stable-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-of-ibuprofen-after-major-orthopaedic-surgeries-the-perisafe-randomized-clinical-multicentre-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-of-nk-cells-with-interleukin-15-and-cd45ra-negative-car-nkg2d-t-cells-injected-into-the-brain-of-children-adolescents-and-young-adults-with-brain-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-anticancer-activity-of-actinium-225-macropa-pelgifatamab-in-advanced-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-efficacy-of-bay-2416964-ahr-inhibitor-and-pembrolizumab-in-adults-with-advanced-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-efficacy-of-ro7567132-alone-and-with-atezolizumab-in-patients-with-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-azd4063-in-pln-r14del-dilated-cardiomyopathy-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-bay2701250-in-healthy-male-subjects-with-pulmonary-hypertension-due-to-left-heart-disease2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-dnl310-in-pediatric-patients-with-hunter-syndrome-mucopolysaccharidosis-type-ii2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-ide397-in-adults-with-advanced-solid-tumors-an-open-label-phase-1-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-jnj-64264681-with-jnj-67856633-in-non-hodgkin-lymphoma-and-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/safety-pharmacokinetics-and-pharmacodynamics-of-mk-4464-monotherapy-and-combination-with-pembrolizumab-in-advanced-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-study-of-nb-4746-and-riluzole-in-participants-with-amyotrophic-lateral-sclerosis-als2026-10-07 https://dev.clinicalresearch.eu/trial/safety-study-of-siplizumab-compared-with-rabbit-anti-human-thymocyte-immunoglobulin-in-kidney-transplant-recipients-receiving-standard-immunosuppression2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-anti-tumor-activity-of-her3-dxd-monotherapy-and-combinations-in-advanced-breast-cancer-post-trastuzumab-deruxtecan-progression2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-antitumor-activity-of-bgb-a3055-alone-and-with-tislelizumab-in-advanced-or-metastatic-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-a-medicinal-nasal-insert-for-chronic-allergic-rhinitis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-intracochlear-sens-601-injections-in-pediatric-patients-with-gjb2-related-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-ly4170156-in-patients-with-advanced-ovarian-endometrial-cervical-nsclc-tnbc-pancreatic-and-colorectal-cancers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-pm14-and-atezolizumab-in-pretreated-patients-with-advanced-solid-tumors-a-phase-ib-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-the-pfspz-larc2-vaccine-against-controlled-human-malaria-infection-in-malaria-naive-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-tolvaptan-in-pediatric-patients-with-autosomal-recessive-polycystic-kidney-disease-a-phase-3b-multicenter-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-efficacy-of-topical-fb-plus-human-fibroblasts-in-adults-with-chronic-refractory-wounds-a-two-part-dose-escalation-and-expansion-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacodynamic-effect-of-rbd4059-injection-in-adults-with-prior-venous-thromboembolism-or-cancer-at-high-risk-of-venous-thromboembolism2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacodynamics-of-azd4144-in-atherosclerotic-cardiovascular-and-chronic-kidney-disease-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacodynamics-of-pbft02-in-adults-with-frontotemporal-dementia-and-grn-or-c9orf72-mutations-a-phase-1b-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-anx1502-in-primary-cold-agglutinin-disease-a-phase-1b-open-label-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-arm210-in-cardiac-arrhythmias-a-randomized-placebo-controlled-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-arv-110-and-abiraterone-in-metastatic-prostate-cancer-patients-a-phase-1b-open-label-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-bp1-7881-in-eosinophilic-esophagitis-a-randomized-double-blind-placebo-controlled-study-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-ent001-in-moderate-to-severe-ulcerative-colitis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-ft751-in-healthy-participants-for-inflammatory-diseases2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-inavolisib-alone-and-in-combination-with-endocrine-and-targeted-therapies-in-advanced-breast-cancer-and-solid-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-mk-3508-in-healthy-participants-with-respiratory-syncytial-virus-infection-a-single-ascending-dose-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-subcutaneous-ocrelizumab-in-children-and-adolescents-with-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-thn391-in-early-alzheimer-s-disease-a-double-blind-randomized-placebo-controlled-phase-1b-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-pharmacokinetics-of-zosurabalpin-via-intravenous-administration-in-healthy-subjects-a-phase-i-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-and-preliminary-efficacy-of-azd4956-alone-and-with-saruparib-in-adults-with-advanced-metastatic-hrr-defective-solid-tumors-phase-i-iia2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-immunogenicity-and-biological-activity-of-trb-001-vaccine-in-parkinson-s-disease-patients-treated-with-synuclein-immunotherapy-single-arm-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azp-3813-in-healthy-subjects-a-study-on-acromegaly-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-bay-3389934-in-sepsis-associated-disseminated-intravascular-coagulation-a-first-in-human-study2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sr-878-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-and-target-engagement-of-nnc6022-0001-in-single-doses-for-cardiometabolic-diseases-in-healthy-adults2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-pharmacodynamics-and-antitumor-activity-of-bg-60366-in-egfr-mutant-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/safety-tolerability-pharmacokinetics-pharmacodynamics-and-efficacy-of-fr104-in-de-novo-renal-transplant-patients-a-phase-i-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/safir-03-a-ctdna-screening-program-in-patients-with-hr-her2-metastatic-breast-cancer-for-detection-of-high-risk-relapse-patients-on-any-cdk4-6-inhibitor-and-a-randomised-phase-ii-study-comparing-alpel2026-10-07 https://dev.clinicalresearch.eu/trial/sara-31-a-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-bio-101-in-elderly-patients-suffering-from-severe-sarcopenia-an-interventional-randomized-double-blind-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/sclerotherapy-of-hydro-and-spermatoceles-with-2ml-aetoxysclerol-30mg-ml-vs-a-combination-of-2ml-aetoxysclerol-30mg-ml-and-25ml-of-ethanol-99-5-with-or-without-local-anesthesia2026-10-07 https://dev.clinicalresearch.eu/trial/screening-and-intervention-for-subclinical-coronary-artery-disease-in-patients-with-type-2-diabetes-the-steno-inten-ct-study2026-10-07 https://dev.clinicalresearch.eu/trial/seer-3-a-phase-3-multi-center-randomized-parallel-double-masked-placebo-controlled-clinical-study-to-assess-the-safety-and-efficacy-of-0-1-rgn-259-ophthalmic-solution-for-the-treatment-of-neurotrophic2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-2-4-mg-weekly-testosterone-undecanoate-1000-mg-q13-weeks-and-combination-on-fat-free-mass-in-obese-men-with-functional-hypogonadism-52-week-double-blind-trial2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-2-4mg-for-low-responders-after-bariatric-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-added-to-sulfonylurea-to-lower-blood-sugar-in-adults-with-hnf1a-mody-or-hnf4a-mody2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-and-granisetron-for-tolerability-in-overweight-adults-without-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-for-prevention-of-post-transplantation-diabetes-mellitus-in-kidney-transplant-recipients-a-proof-of-concept-randomized-study2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-for-the-treatment-of-glucose-intolerance-in-women-with-prior-gestational-diabetes-a-double-blind-rct2026-10-07 https://dev.clinicalresearch.eu/trial/semaglutide-treatment-for-prevention-of-toxicity-in-high-dose-chemotherapy-with-autologous-hematopoietic-stem-cell-transplantation-a-randomized-double-blind-placebo-controlled-investigator-initiated-s2026-10-07 https://dev.clinicalresearch.eu/trial/senolytics-to-improve-osteoporosis-therapy-a-randomised-controlled-clinical-trial-the-senior-trial2026-10-07 https://dev.clinicalresearch.eu/trial/sequential-administration-of-gilteritinib-venetoclax-and-azacitidine-in-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-ineligible-for-intensive-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/sequential-administration-of-radium-223-and-docetaxel-with-prednisone-in-symptomatic-bone-only-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/sequential-immunochemotherapy-with-pembrolizumab-autologous-tumor-lysate-loaded-dendritic-cells-trifluridine-tipiracil-and-bevacizumab-in-refractory-pmmr-mss-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/serorl-effect-of-aspirin-and-folic-acid-for-sudden-sensorineural-hearing-loss2026-10-07 https://dev.clinicalresearch.eu/trial/serum-transthyretin-response-to-tafamidis-vs-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-a-pilot-crossover-study2026-10-07 https://dev.clinicalresearch.eu/trial/sglt2-inhibition-for-cardiovascular-endpoint-reduction-in-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/short-acting-pasireotide-gh-suppression-test-to-predict-long-term-response-to-pasireotide-lar-in-adults-with-acromegaly2026-10-07 https://dev.clinicalresearch.eu/trial/short-course-ciprofloxacin-is-non-inferior-to-14-day-treatment-for-men-with-urinary-tract-infection-with-systemic-involvement2026-10-07 https://dev.clinicalresearch.eu/trial/short-term-dual-antiplatelet-therapy-with-ticagrelor-acetylsalicylic-acid-and-clopidogrel-versus-standard-therapy-in-chronic-coronary-syndrome-patients-undergoing-pci2026-10-07 https://dev.clinicalresearch.eu/trial/short-versus-standard-3-day-versus-7-day-antibiotic-treatment-with-doxycycline-amoxicillin-and-ceftriaxone-in-adults-with-mild-leptospirosis2026-10-07 https://dev.clinicalresearch.eu/trial/shortened-treatment-duration-with-caspofungin-acetate-saline-and-sodium-lactate-in-adult-patients-with-uncomplicated-candidemia2026-10-07 https://dev.clinicalresearch.eu/trial/single-and-multiple-dose-mer511-in-adults-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/single-ascending-dose-evaluation-of-mk-4318-for-acute-and-chronic-pain-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/single-ascending-dose-evaluation-of-mk6916-for-acute-and-chronic-pain-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/single-blind-investigator-initiated-randomized-controlled-trial-to-assess-the-safety-and-efficacy-of-intravenous-corticosteroid-therapy-to-treat-patients-with-acute-myocarditis-with-mildly-reduced-lef2026-10-07 https://dev.clinicalresearch.eu/trial/single-cell-profiling-of-durvalumab-and-tremelimumab-in-mss-msi-colorectal-and-endometrial-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/single-center-phase-i-iia-study-of-infusion-of-autologous-peripheral-blood-t-cells-expanded-and-genetically-modified-by-sleeping-beauty-family-transposons-to-express-a-chimeric-antigen-receptor-with-a2026-10-07 https://dev.clinicalresearch.eu/trial/single-dose-fasting-replicate-crossover-bioequivalence-study-of-modified-release-naproxen-500-mg-esomeprazole-20-mg-tablet-versus-reference-naproxen-500-mg-esomeprazole-20-mg-film-coated-tablet-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/single-dose-open-label-evaluation-of-tx000045-in-patients-with-combined-or-isolated-postcapillary-pulmonary-hypertension-and-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/single-intravenous-benzathine-benzylpenicillin-added-to-oral-phenoxymethylpenicillin-for-symptom-relief-in-adults-with-acute-tonsillitis-peritonsillar-phlegmon-or-abscess2026-10-07 https://dev.clinicalresearch.eu/trial/sirolimus-treatment-in-patients-with-vascular-malformation-undergoing-surgery-and-laser-therapy-long-term-effect-on-port-wine-macrocheilia-volume2026-10-07 https://dev.clinicalresearch.eu/trial/skipp2-cabozantinib-dose-skipping-as-an-alternative-to-dose-reductions2026-10-07 https://dev.clinicalresearch.eu/trial/skyline-tiragolumab-and-atezolizumab-associated-with-chemotherapy-in-triple-negative-breast-cancer-a-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/sodium-selenite-in-patients-with-advanced-carcinoma-a-phase-i-ii-study-with-99-hours-of-continuous-selenite-treatment-followed-by-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/sodium-valproate-plus-lenvatinib-in-patients-with-recurrent-or-metastatic-adenoid-cystic-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/son4pem-study-sonlicromanol-in-post-covid-a-randomized-double-blind-placebo-controlled-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/spraydye-trial-a-phase-i-ii-study-to-assess-the-efficacy-safety-and-tolerability-of-topically-applied-6qc-icg-a-cathepsin-activatable-fluorescent-probe-for-real-time-intraoperative-resection-margin-as2026-10-07 https://dev.clinicalresearch.eu/trial/standard-versus-prolonged-neoadjuvant-conversion-chemotherapy-to-prolong-survival-of-patients-with-borderline-and-locally-advanced-pancreatic-cancer-a-phase-iii-randomized-controlled-trial-advantage2026-10-07 https://dev.clinicalresearch.eu/trial/standardization-of-olea-europaea-pollen-extract-for-patients-with-olive-tree-allergies2026-10-07 https://dev.clinicalresearch.eu/trial/standardized-dermatophagoides-mix-d-pteronyssinus-d-farinae-in-tbu-ml-in-liquid-formulation-for-sublingual-immunotherapy-phase-ii-randomized-dose-determination-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/standardizing-skin-test-extracts-for-dust-mite-allergy-using-dermatophagoides-pteronyssinus-dermatophagoides-farinae-and-histamine-dihydrochloride-in-sensitized-patients2026-10-07 https://dev.clinicalresearch.eu/trial/statins-in-frail-older-patients-with-ischemic-stroke-or-transient-ischemic-attack2026-10-07 https://dev.clinicalresearch.eu/trial/stereotactic-cisternal-lavage-with-urokinase-nimodipine-and-ringer-s-solution-in-aneurysmal-subarachnoid-hemorrhage-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/stop-copd-standard-vs-targeted-oxygen-therapy-prehospital-for-chronic-obstructive-pulmonary-disease2026-10-07 https://dev.clinicalresearch.eu/trial/stop-pkd-sglt2-inhibition-to-improve-prognosis-in-polycystic-kidney-disease2026-10-07 https://dev.clinicalresearch.eu/trial/strateglio-phase-iii-randomised-trial-evaluating-early-treatment-intensification-with-temozolomide-in-adults-with-a-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/stratified-dosing-based-on-augmented-renal-clearance-for-ceftriaxone-in-patients-with-severe-community-acquired-pneumonia-the-strada-cef-trial2026-10-07 https://dev.clinicalresearch.eu/trial/stroke-prophylaxis-with-apixaban-in-chronic-kidney-disease-stage-5-patients-with-atrial-fibrillation-sack2026-10-07 https://dev.clinicalresearch.eu/trial/sts-001-an-explorative-clinical-study-to-assess-the-potential-of-intravenously-administered-sodium-thiosulfate-in-subjects-with-primary-raynaud-s-phenomenon2026-10-07 https://dev.clinicalresearch.eu/trial/study-comparing-7-days-versus-14-days-of-ciprofloxacin-or-ceftriaxone-for-kidney-infection-in-patients-who-have-received-a-kidney-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/study-comparing-linvoseltamab-with-daratumumab-in-adults-with-high-risk-smoldering-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/study-evaluating-methenamine-hippurate-to-prevent-recurrent-urinary-tract-infections-in-women-compared-to-a-drug-combination2026-10-07 https://dev.clinicalresearch.eu/trial/study-evaluating-the-effect-of-levothyroxine-on-kidney-function-and-quality-of-life-in-patients-at-risk-of-hypothyroidism-after-partial-thyroid-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/study-evaluating-the-effectiveness-of-ispaghula-husk-for-managing-low-anterior-resection-syndrome-in-patients-after-rectal-cancer-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/study-evaluating-the-efficacy-and-safety-of-daridorexant-in-patients-with-major-depressive-disorder-and-insomnia2026-10-07 https://dev.clinicalresearch.eu/trial/study-evaluating-the-use-of-levetiracetam-to-improve-recovery-in-patients-with-intracerebral-hemorrhage2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-abbv-706-versus-topotecan-in-adults-with-relapsed-or-refractory-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-acalabrutinib-and-venetoclax-for-patients-with-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-who-have-relapsed-after-initial-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-aflibercept-biosimilar-8-mg-versus-aflibercept-8-mg-in-patients-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-alisertib-plus-paclitaxel-in-patients-with-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-alpelisib-trastuzumab-and-pertuzumab-as-maintenance-therapy-in-patients-with-her2-positive-advanced-breast-cancer-and-pik3ca-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-amivantamab-and-lazertinib-before-surgery-in-patients-with-resectable-egfr-mutated-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-amo959-lutetium-177lu-vipivotide-tetraxetan-and-a-drug-combination-for-adults-with-metastatic-castration-resistant-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-amodiaquine-potassium-canrenoate-and-exenatide-or-glibenclamide-for-patients-with-acute-ischemic-stroke2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-anakinra-and-a-drug-combination-to-prevent-blood-clotting-in-patients-receiving-a-pancreas-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-arsenic-trioxide-tretinoin-and-a-drug-combination-for-children-and-adolescents-with-acute-promyelocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-asciminib-dexamethasone-blinatumomab-and-vincristine-sulfate-in-children-and-young-adults-with-relapsed-or-refractory-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-asp-1929-and-pembrolizumab-for-patients-with-recurrent-squamous-cell-carcinoma-of-the-head-and-neck-without-distant-spread2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-atorvastatin-vs-placebo-for-preventing-episodic-migraine-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-auto1-autologous-car-t-cells-targeting-cd19-and-cd22-in-philadelphia-negative-b-precursor-all-patients-in-first-remission-with-measurable-residual-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-autologous-mature-dendritic-cell-vaccine-plus-atezolizumab-in-patients-with-recurrent-glioblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-azd0120-versus-standard-drug-combination-in-adults-with-newly-diagnosed-multiple-myeloma-ineligible-for-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-azd0901-capecitabine-and-rilvegostomig-in-adults-with-advanced-gastric-gastroesophageal-junction-or-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-belantamab-mafodotin-with-drug-combination-in-adults-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-belumosudil-versus-drug-combination-in-patients-aged-12-years-and-older-with-chronic-graft-versus-host-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bempedoic-acid-drug-combination-on-plaque-reduction-in-coronary-atherosclerosis-patients-without-prior-cardiovascular-events2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bexmarilimab-with-doxorubicin-for-safety-and-efficacy-in-adults-with-metastatic-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bi-1015550-and-nerandomilast-to-assess-safety-dosing-and-efficacy-in-children-and-adolescents-with-fibrosing-interstitial-lung-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-biib080-florbetaben-18f-and-flutemetamol-18f-in-adults-50-80-years-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-or-mild-alzheimer-s-dementia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-biib115-to-assess-safety-and-effectiveness-in-patients-aged-15-60-years-with-spinal-muscular-atrophy-who-are-treatment-naive-or-previously-treated-with-risdiplam2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-blinatumomab-and-a-drug-combination-for-older-adults-with-newly-diagnosed-philadelphia-negative-b-cell-precursor-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bms-986504-with-drug-combination-in-patients-with-advanced-metastatic-solid-tumors-that-have-mtap-deletion2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bms-986523-alone-or-with-a-drug-combination-in-patients-with-advanced-solid-tumors-that-have-kras-alterations2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-bnt327-and-a-drug-combination-for-patients-with-untreated-metastatic-or-locally-recurrent-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-botulinum-toxin-type-a-versus-placebo-to-treat-bowel-movement-issues-in-patients-recovering-from-surgery-for-rectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cabotegravir-and-rilpivirine-ultra-long-acting-vs-long-acting-in-adults-and-adolescents-with-hiv-who-are-virally-suppressed2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-caffeine-citrate-to-manage-primary-apnea-in-preterm-newborns2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cagrilintide-and-semaglutide-for-people-with-type-2-diabetes-that-is-not-well-controlled-with-metformin-and-potentially-an-sglt2-inhibitor2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-camizestrant-and-abemaciclib-switch-based-on-rising-ctdna-in-patients-with-advanced-er-positive-her2-negative-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-camizestrant-plus-ribociclib-as-first-line-treatment-for-patients-with-er-positive-her2-negative-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-canagliflozin-and-18f-canagliflozin-in-patients-with-chronic-kidney-disease-undergoing-dialysis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cd19-targeted-nex-t-car-t-cell-therapy-plus-drug-combination-versus-standard-care-in-adults-with-active-systemic-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cemiplimab-and-cisplatin-for-patients-with-locally-advanced-cervical-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cesnicabtagene-autoleucel-and-a-drug-combination-for-patients-with-relapsed-or-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-cevostamab-drug-combination-versus-standard-of-care-in-patients-with-previously-treated-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-chlorhexidine-metronidazole-and-fb301-to-treat-bacterial-vaginosis-in-women2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-continuous-infusion-of-vancomycin-and-a-drug-combination-for-treating-infectious-diseases-in-children2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-daraxonrasib-alone-or-with-gemcitabine-and-nab-paclitaxel-versus-gemcitabine-and-nab-paclitaxel-as-first-line-therapy-for-metastatic-pancreatic-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-daxdilimab-with-prednisone-in-adults-with-inadequately-controlled-dermatomyositis-or-anti-synthetase-inflammatory-myositis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-denikitug-alone-or-in-drug-combination-for-adult-patients-with-her2-negative-metastatic-gastric-gastroesophageal-junction-and-esophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-denikitug-alone-or-in-drug-combination-in-adults-with-advanced-microsatellite-stable-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-depigmented-polymerized-grass-pollen-extracts-for-patients-with-allergic-rhinitis-and-controlled-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dermatophagoides-farinae-dermatophagoides-pteronyssinus-and-blomia-tropicalis-allergen-extracts-in-patients-with-allergic-rhinitis-rhinoconjunctivitis-with-or-without-mild-to-moderate-asthma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dexamethasone-for-the-treatment-of-brain-contusions-and-swelling-in-patients-with-traumatic-brain-injury2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dexmedetomidine-and-a-drug-combination-for-patients-with-septic-shock-who-are-on-mechanical-ventilation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dexmedetomidine-versus-placebo-to-reduce-opioid-use-in-premature-infants-receiving-invasive-ventilation-for-respiratory-distress2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dexmedetomidine-vs-propofol-sedation-to-reduce-postoperative-delirium-in-patients-over-75-undergoing-femur-fracture-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dienogest-and-drospirenone-tablets-for-preventing-pregnancy-by-inhibiting-ovulation-in-healthy-premenopausal-women2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-different-dosing-methods-for-tocilizumab-in-patients-with-rheumatoid-arthritis-in-remission-or-with-low-disease-activity2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-discontinuing-acetylsalicylic-acid-in-patients-over-65-with-stable-chronic-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-doxycycline-bone-and-joint-penetration-in-non-infected-patients-undergoing-hip-replacement-for-hip-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-drospirenone-lpri-cf113-for-contraception-efficacy-safety-and-tolerability-in-women-of-child-bearing-age2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-dupilumab-dose-de-escalation-vs-standard-dosing-in-adults-with-eosinophilic-esophagitis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-durvalumab-plus-flot-drug-combination-as-total-neoadjuvant-therapy-for-resectable-gastroesophageal-adenocarcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-efficacy-and-safety-of-doravirine-and-islatravir-vs-bictegravir-emtricitabine-and-tenofovir-alafenamide-in-treatment-naive-hiv-1-patients2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-empagliflozin-losartan-and-hydrochlorothiazide-to-prevent-kidney-stones-in-patients-with-paraffin-oil-induced-granulomatous-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-enfortumab-vedotin-plus-pembrolizumab-for-bladder-preservation-in-patients-with-muscle-invasive-bladder-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-enpatoran-in-adults-with-active-cutaneous-lupus-with-or-without-systemic-disease-to-assess-efficacy-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ezetimibe-and-pitavastatin-in-patients-with-high-cholesterol-who-have-an-inadequate-response-to-pitavastatin-4-mg2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-fludarabine-in-patients-with-blood-cancer-receiving-lymphodepletion-before-car-t-cell-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-gadobutrol-to-measure-brain-fluid-clearance-in-children-12-17-years-with-acute-lymphoblastic-leukemia-or-lymphoma-receiving-intrathecal-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-glofitamab-with-drug-combination-in-high-risk-relapsed-refractory-large-b-cell-lymphoma-patients-eligible-for-car-t-therapy-second-line2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-gsk5764227-with-drug-combination-in-adult-patients-with-newly-diagnosed-amyloid-light-chain-amyloidosis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-gvv858-alone-or-with-drug-combination-in-patients-with-advanced-hormone-receptor-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-human-normal-immunoglobulin-remdesivir-and-nirmatrelvir-for-treating-covid-19-in-patients-with-severely-impaired-b-cell-function2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-human-normal-immunoglobulin-to-prevent-serious-infections-in-patients-with-secondary-antibody-deficiency-from-cll-multiple-myeloma-or-nhl2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-hydrogen-inhalation-therapy-to-prevent-the-early-return-of-atrial-fibrillation-in-patients-after-heart-ablation-procedure2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-hyperbaric-oxygen-therapy-and-narrow-band-uvb-phototherapy-for-the-treatment-of-diffuse-vitiligo2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-inavolisib-in-patients-with-advanced-endometrial-cancer-having-pik3ca-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-inavolisib-ribociclib-and-fulvestrant-in-patients-with-advanced-hormone-receptor-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-inavolisib-with-trastuzumab-and-pertuzumab-as-maintenance-therapy-in-patients-with-her2-positive-pik3ca-mutated-locally-advanced-or-metastatic-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-incb123667-versus-drug-combination-in-patients-with-platinum-resistant-ovarian-cancer-and-cyclin-e1-overexpression2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-indocyanine-green-to-help-surgeons-remove-lymph-nodes-in-children-with-kidney-tumors-or-soft-tissue-and-germ-cell-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-intrathecal-mivelsiran-in-adults-with-early-stage-down-syndrome-associated-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-intravitreal-mk-8748-compared-with-aflibercept-in-adults-with-neovascular-age-related-macular-degeneration2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-jnj-79635322-and-teclistamab-in-patients-with-relapsed-or-refractory-multiple-myeloma-after-at-least-3-prior-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-jnj-79635322-versus-teclistamab-in-patients-with-relapsed-or-refractory-multiple-myeloma-after-1-3-prior-therapies2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ketamine-hydrochloride-to-help-recovery-in-adults-in-intensive-care-receiving-unplanned-mechanical-ventilation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-lepidoglyphus-destructor-extract-histamine-dihydrochloride-and-sodium-chloride-in-skin-prick-testing-for-patients-with-lepidoglyphus-destructor-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-levofloxacin-ketorolac-trometamol-and-dexamethasone-eye-drops-for-preventing-inflammation-and-infection-after-cataract-surgery-in-adults2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-levothyroxine-sodium-plus-liothyronine-sodium-versus-levothyroxine-sodium-for-tsh-control-in-patients-with-advanced-thyroid-cancer-on-tyrosine-kinase-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-lidocaine-hydrochloride-to-reduce-side-effects-from-pain-medication-in-patients-undergoing-open-liver-surgery2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-lonapegsomatrin-and-somatropin-in-children-and-adolescents-with-short-stature-or-growth-failure-due-to-turner-syndrome-shox-deficiency-sga-or-idiopathic-short-stature2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-lu-af28996-dh1-in-adults-with-parkinson-s-disease-and-motor-fluctuations2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-lutetium-177lu-oxodotreotide-and-a-drug-combination-for-patients-with-newly-diagnosed-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ly3484356-imlunestrant-with-tamoxifen-and-goserelin-in-premenopausal-women-with-early-er-positive-her2-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mavacamten-effects-on-hemodynamics-and-physiology-in-patients-with-obstructive-hypertrophic-cardiomyopathy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mdma-hydrochloride-for-adolescents-with-treatment-resistant-ptsd2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-melphalan-followed-by-eribulin-vinorelbine-or-capecitabine-versus-those-drugs-alone-in-patients-with-metastatic-breast-cancer-and-liver-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mirikizumab-levels-in-breast-milk-of-breastfeeding-women-with-ulcerative-colitis-or-crohn-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mitapivat-in-children-with-non-transfusion-dependent-alpha-or-beta-thalassemia-to-assess-anemia-improvement2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mitapivat-in-children-with-transfusion-dependent-alpha-or-beta-thalassemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mk-1045-blinatumomab-and-tocilizumab-in-patients-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mk-1084-plus-durvalumab-versus-placebo-plus-durvalumab-in-patients-with-locally-advanced-kras-g12c-mutated-non-small-cell-lung-cancer-after-chemoradiotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-mk-6070-drug-combination-as-first-line-therapy-for-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-momelotinib-combined-with-nivolumab-or-pembrolizumab-in-patients-with-unresectable-stage-iii-or-iv-cutaneous-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-nbi-1065890-versus-placebo-in-adults-with-tardive-dyskinesia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-nemolizumab-safety-efficacy-and-pharmacokinetics-in-infants-6-23-months-with-moderate-to-severe-atopic-dermatitis-not-controlled-by-topical-therapy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-neoadjuvant-intratumoral-ipilimumab-plus-systemic-nivolumab-in-patients-with-locally-advanced-resectable-oral-cavity-squamous-cell-carcinoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-nxt007-and-factor-viii-prophylaxis-in-people-with-hemophilia-a-without-inhibitors2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-obinutuzumab-for-adults-with-idiopathic-nephrotic-syndrome-that-frequently-relapses-after-rituximab-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-onfekafusp-alfa-and-bifikafusp-alfa-in-patients-with-locally-advanced-skin-squamous-cell-carcinoma-who-have-not-responded-well-to-other-treatments2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-oral-contraceptive-effects-in-women-drospirenone-estetrol-versus-drospirenone-ethinylestradiol-versus-drospirenone-alone2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-oral-corticosteroid-prednisone-prednisolone-tapering-with-ravulizumab-in-adults-with-generalized-myasthenia-gravis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-oral-gsk5460025a-in-adult-patients-with-dmmr-msi-h-solid-tumors-including-colorectal-and-endometrial-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-oral-misoprostol-for-labour-induction-in-women-with-an-unprepared-cervix2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-orelabrutinib-vs-placebo-in-patients-with-non-active-secondary-progressive-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-oxaliplatin-plus-drug-combination-as-conversion-therapy-in-patients-with-colorectal-cancer-with-peritoneal-metastases-not-amenable-to-upfront-surgery-and-hipec2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pelabresib-dak539-plus-ruxolitinib-versus-placebo-plus-ruxolitinib-in-adult-patients-with-myelofibrosis-who-are-jak-inhibitor-naive2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pembrolizumab-capecitabine-or-olaparib-in-patients-with-early-stage-triple-negative-breast-cancer-and-residual-disease-after-initial-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pex010-psilocybin-capsules-in-adults-with-depression-comparing-psychotherapy-support-to-basic-support2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pirtobrutinib-and-epcoritamab-in-patients-with-richter-transformation-of-chronic-lymphocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-progesterone-after-letrozole-treatment-for-women-with-infertility-undergoing-intrauterine-insemination2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pumitamig-and-a-drug-combination-versus-bevacizumab-and-chemotherapy-for-patients-with-untreated-unresectable-or-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-pumitamig-and-a-drug-combination-versus-nivolumab-and-a-drug-combination-for-patients-with-untreated-advanced-or-metastatic-stomach-or-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-rec-4881-in-patients-with-familial-adenomatous-polyposis-to-evaluate-safety-and-effectiveness2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-revumenib-and-a-drug-combination-for-patients-with-newly-diagnosed-acute-myeloid-leukemia-with-an-npm1-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-revumenib-cytarabine-and-fludarabine-in-children-with-relapsed-or-refractory-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-rilvegostomig-combined-with-pembrolizumab-in-treatment-naive-patients-with-advanced-gastric-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-rmc-9805-with-chemotherapy-combination-as-first-line-treatment-in-patients-with-metastatic-kras-g12d-mutated-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-rvu120-and-everolimus-in-children-with-recurrent-or-progressive-medulloblastoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-s-241656-alone-or-with-posaconazole-in-adults-with-acute-myeloid-leukemia-mds-aml-or-chronic-myelomonocytic-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-s-241656-and-a-drug-combination-in-patients-with-cancers-having-kras-braf-or-other-specific-ras-mapk-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-safety-and-pharmacodynamic-effects-of-rbd1119-injection-in-participants-with-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-selinexor-plus-gemcitabine-in-patients-with-advanced-soft-tissue-sarcoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-semaglutide-acetylsalicylic-acid-and-clopidogrel-on-blood-clotting-in-patients-with-diabetes-or-overweight-obesity-and-cardiovascular-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-semaglutide-and-counselling-to-reduce-cravings-and-use-of-drugs-related-to-chemsex-in-patients-with-drug-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-sil204-combined-with-chemotherapy-in-patients-with-non-resectable-locally-advanced-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-sotorasib-and-carboplatin-pemetrexed-versus-pembrolizumab-and-carboplatin-pemetrexed-for-advanced-non-small-cell-lung-cancer-with-kras-g12c-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-sotorasib-panitumumab-and-a-drug-combination-for-patients-with-untreated-metastatic-colorectal-cancer-with-a-kras-mutation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-spironolactone-dapagliflozin-and-al-18f-f-fapi-74-to-improve-circulation-in-adults-with-fontan-circulation2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-stopping-acetylsalicylic-acid-at-24-26-weeks-vs-continuing-to-36-weeks-to-prevent-preterm-preeclampsia-in-pregnant-women2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-stopping-antibiotic-treatment-with-a-drug-combination-for-children-with-cancer-and-fever-and-low-white-blood-cell-counts2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-tarlatamab-and-durvalumab-compared-to-durvalumab-alone-for-patients-with-extensive-stage-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-teclistamab-with-drug-combination-to-improve-outcomes-in-newly-diagnosed-transplant-eligible-multiple-myeloma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-telisotuzumab-adizutecan-versus-drug-combinations-in-adults-with-advanced-or-metastatic-egfr-mutated-non-small-cell-lung-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-tezepelumab-on-tslp-protein-response-in-adults-with-severe-asthma-with-and-without-chronic-rhinosinusitis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-distribution-of-cefazolin-in-the-chest-area-of-children-following-heart-surgery-to-prevent-infection2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-drug-tasadenoturev-for-the-treatment-of-recurrent-or-resistant-high-grade-brain-tumors-in-children-and-young-adults2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-duration-of-remission-after-stopping-elranatamab-and-teclistamab-in-patients-with-multiple-myeloma-who-have-a-strong-response-to-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effect-of-empagliflozin-on-protein-levels-in-the-urine-for-patients-with-type-2-diabetes-and-kidney-impairment2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effect-of-recombinant-varicella-zoster-virus-glycoprotein-e-on-heart-problems-and-dementia-in-adults-aged-65-years-or-older-with-shingles2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effect-of-recombinant-varicella-zoster-virus-glycoprotein-e-on-the-risk-of-dementia-in-adults-aged-76-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effect-of-valproic-acid-for-the-treatment-of-adenomyosis-in-women-of-reproductive-age2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effectiveness-and-safety-of-inclisiran-and-a-drug-combination-in-patients-with-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effectiveness-and-safety-of-ladarixin-and-rabbit-anti-human-thymocyte-immunoglobulin-in-adolescents-and-adults-with-new-onset-type-1-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-aging-and-parkinson-s-disease-on-brain-receptors-using-11c-orm-130702026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-hyperbaric-oxygen-therapy-on-the-bacteria-in-the-wounds-of-patients-with-chronic-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-ipilimumab-and-nivolumab-on-the-immune-system-in-patients-with-unresectable-stage-iii-or-iv-melanoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-metyrapone-in-patients-with-mild-cushing-syndrome-caused-by-primary-bilateral-macronodular-adrenal-hyperplasia2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-pitolisant-on-migraine-without-aura-in-women2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-effects-of-sodium-oxybate-on-sleep-quality-in-critically-ill-adult-patients-in-intensive-care-units2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-efficacy-and-safety-of-zasocitinib-in-children-and-adolescents-with-moderate-to-severe-plaque-psoriasis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-efficacy-of-semaglutide-in-children-aged-12-to-17-years-with-obesity-caused-by-craniopharyngioma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-the-safety-of-injecting-bupivacaine-and-dexamethasone-into-the-parotid-gland-for-patients-undergoing-surgery-for-a-benign-parotid-tumor2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ticagrelor-acetylsalicylic-acid-and-prasugrel-for-antiplatelet-management-in-patients-after-acute-coronary-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-tirabrutinib-rituximab-and-temozolomide-in-patients-with-relapsed-refractory-primary-central-nervous-system-lymphoma2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-tovorafenib-for-the-treatment-of-newly-diagnosed-or-recurrent-craniopharyngioma-in-children-and-young-adults2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ubamatamab-with-drug-combination-in-patients-with-ovarian-cancer-who-have-poor-response-to-first-line-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-venetoclax-plus-rituximab-in-adult-patients-with-relapsed-chronic-lymphocytic-leukemia-in-poland2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-volrustomig-or-volrustomig-and-a-drug-combination-for-patients-with-advanced-solid-tumors-including-pleural-mesothelioma-and-esophageal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-whether-omitting-exemestane-letrozole-anastrozole-or-tamoxifen-is-safe-for-postmenopausal-women-with-low-risk-early-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zanidatamab-tucatinib-and-drug-combination-for-patients-with-her2-positive-advanced-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zenagamtide-to-treat-weight-loss-and-pain-in-patients-with-overweight-or-obesity-and-knee-osteoarthritis2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zenagamtide-versus-insulin-glargine-in-adults-with-type-2-diabetes-and-high-cardiovascular-risk-not-controlled-by-oral-medications2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zenagamtide-versus-placebo-in-adults-with-heart-failure-with-preserved-or-mildly-reduced-ejection-fraction-and-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-ziftomenib-with-venetoclax-azacitidine-or-a-drug-combination-for-adults-with-newly-diagnosed-acute-myeloid-leukemia-with-npm1-or-kmt2a-genetic-changes2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zongertinib-fulvestrant-and-goserelin-in-patients-with-hormone-receptor-positive-her2-negative-advanced-breast-cancer-with-her2-mutations2026-10-07 https://dev.clinicalresearch.eu/trial/study-of-zongertinib-in-patients-with-cancer-to-assess-anti-tumor-activity-and-safety2026-10-07 https://dev.clinicalresearch.eu/trial/study-on-the-effect-of-semaglutide-on-the-healing-of-diabetic-foot-ulcers-in-patients-with-diabetic-foot-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/study-on-the-effectiveness-of-oral-vancomycin-for-children-with-inflammatory-bowel-disease-including-ulcerative-colitis2026-10-07 https://dev.clinicalresearch.eu/trial/study-on-the-effects-of-support-and-music-during-psilocybin-therapy-for-people-with-depression2026-10-07 https://dev.clinicalresearch.eu/trial/study-on-the-influence-of-flumazenil-regarding-the-incidence-of-pediatric-emergence-delirium-ed-in-children-undergoing-ent-surgery-fluma-study2026-10-07 https://dev.clinicalresearch.eu/trial/study-pacific-fixed-duration-treatment-with-combined-pirtobrutinib-and-short-course-immuno-chemotherapy-in-fit-patients-with-previously-untreated-symptomatic-chronic-lymphocytic-leukemia-cll-a-phase-i2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-if-dexamethasone-prolongs-the-effects-of-chloroprocaine-during-spinal-anesthesia-for-patients-undergoing-knee-arthroscopy2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effect-of-colchicine-on-inflammation-in-patients-with-chronic-coronary-artery-disease2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effect-of-colecalciferol-on-the-survival-of-critically-ill-adults-with-severe-vitamin-d-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effect-of-dapagliflozin-on-the-development-of-post-transplant-diabetes-in-patients-who-have-received-a-kidney-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effectiveness-and-safety-of-deucrictibant-for-preventing-and-treating-angioedema-attacks-in-adults-with-acquired-angioedema-due-to-c1-inhibitor-deficiency2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effectiveness-of-upadacitinib-and-pirfenidone-in-improving-symptoms-for-patients-with-long-covid2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-effects-of-baxdrostat-and-dapagliflozin-on-protein-in-the-urine-for-patients-with-chronic-kidney-disease-and-high-blood-pressure2026-10-07 https://dev.clinicalresearch.eu/trial/study-to-evaluate-the-use-of-fapi-46-68ga-imaging-for-detecting-cancer-spread-in-the-abdomen-for-patients-with-colorectal-gastric-ovarian-or-pancreatic-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/subcutaneous-administration-of-jnj-80202135-nipocalimab-via-prefilled-syringe-autoinjector-and-standard-syringe-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/subcutaneous-administration-of-mannan-conjugated-birch-pollen-allergoids-in-adolescents-and-adults-with-birch-pollen-induced-allergic-rhinitis-or-rhinoconjunctivitis2026-10-07 https://dev.clinicalresearch.eu/trial/subcutaneous-fentanyl-titration-for-rapid-adequate-exposure-in-cancer-related-pain-management-the-ferrari-study2026-10-07 https://dev.clinicalresearch.eu/trial/subcutaneous-immunotherapy-with-investigational-agent-for-cervical-cancer-a-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/subcutaneous-vedolizumab-dose-de-escalation-in-patients-with-inflammatory-bowel-disease-a-multicenter-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/sublingual-immunotherapy-with-betula-verrucosa-and-lactobacillus-rhamnosus-gg-in-patients-with-birch-pollen-related-food-allergy2026-10-07 https://dev.clinicalresearch.eu/trial/sufentanil-versus-fentanyl-for-pain-relief-after-urgent-laparoscopic-cholecystectomy-in-adult-patients2026-10-07 https://dev.clinicalresearch.eu/trial/summit-a-multi-part-randomized-double-blind-placebo-controlled-phase-2-clinical-study-of-the-safety-and-efficacy-of-cgt9486-in-subjects-with-nonadvanced-systemic-mastocytosis2026-10-07 https://dev.clinicalresearch.eu/trial/supplementary-oxygen-therapy-in-patients-with-fracture-related-infection-after-limb-debridement-and-reconstruction-surgery-pilot-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/surgery-versus-polidocanol-sclerotherapy-for-superficial-labial-venous-malformations-in-children-and-adults-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/surgery-with-or-without-darolutamide-in-high-risk-and-or-locally-advanced-prostate-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/survodutide-for-patients-with-compensated-nash-mash-cirrhosis-a-phase-iii-trial-of-liver-outcomes2026-10-07 https://dev.clinicalresearch.eu/trial/switch-maintenance-with-paclitaxel-ramucirumab-and-tislelizumab-versus-continued-chemotherapy-for-her2-negative-pd-l1-positive-gastroesophageal-adenocarcinoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/switching-to-long-acting-lenacapavir-drug-combination-versus-cabotegravir-and-rilpivirine-in-virologically-suppressed-adults-with-hiv-12026-10-07 https://dev.clinicalresearch.eu/trial/symbol-clinical-treatment-of-severe-ocular-chemical-burns-by-subconjunctival-injection-of-allogeneic-mesenchymal-stem-cells-a-multicentre-single-arm-open-label-phase-ii-trial2026-10-07 https://dev.clinicalresearch.eu/trial/symptoms-control-and-adherence-assessment-during-treatment-with-mepolizumab-new-prefilled-devices-secure2026-10-07 https://dev.clinicalresearch.eu/trial/synergistic-effects-of-parp-inhibition-with-cisplatin-and-hyperthermia-in-cytoreductive-surgery-and-hipec-for-ovarian-fallopian-tube-and-extraovarian-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/systemic-analgesic-effect-of-lidocaine-hydrochloride-and-ropivacaine-versus-placebo-in-healthy-volunteers-aged-18-64-years-with-acute-pain-undergoing-tap-block2026-10-07 https://dev.clinicalresearch.eu/trial/systemic-bioavailability-and-bioequivalence-of-topical-diclofenac-23-2-mg-g-gel-compared-with-diclofenac-diethylamine-2-32-gel-in-patients-with-musculoskeletal-pain2026-10-07 https://dev.clinicalresearch.eu/trial/systemic-bioavailability-study-of-diclofenac-sodium-gel-vs-diclofenac-diethylamine-gel-in-healthy-volunteers-for-musculoskeletal-conditions2026-10-07 https://dev.clinicalresearch.eu/trial/tacrolimus-to-prevent-post-ercp-pancreatitis-in-moderate-to-high-risk-patients-undergoing-ercp2026-10-07 https://dev.clinicalresearch.eu/trial/tailored-antiplatelet-secondary-prevention-in-non-cardioembolic-ischemic-stroke-a-phase-iv-gender-stratified-randomized-controlled-trial-tailor-trial2026-10-07 https://dev.clinicalresearch.eu/trial/tailored-ibrutinib-and-venetoclax-regimens-in-untreated-chronic-lymphocytic-leukemia-a-multicohort-efficacy-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/tambiciclib-venetoclax-and-azacitidine-for-newly-diagnosed-acute-myeloid-leukemia-not-responding-to-initial-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/targeted-vs-standard-peri-operative-prophylaxis-with-eravacycline-based-drug-combination-in-cpe-colonized-liver-transplant-patients2026-10-07 https://dev.clinicalresearch.eu/trial/targeting-inflammation-to-reduce-90-day-and-1-year-postoperative-severe-morbidity-in-patients-with-unfavorable-inflammatory-profile-undergoing-oncologic-surgery-post-care-trial2026-10-07 https://dev.clinicalresearch.eu/trial/teclistamab-drug-combination-versus-standard-therapy-to-achieve-mrd-negative-status-in-multiple-myeloma-patients-after-stem-cell-transplant2026-10-07 https://dev.clinicalresearch.eu/trial/teclistamab-with-autologous-lymphocyte-infusion-for-patients-with-relapsed-refractory-multiple-myeloma2026-10-07 https://dev.clinicalresearch.eu/trial/telisotuzumab-adizutecan-drug-combination-versus-standard-therapy-in-adult-patients-with-refractory-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/telisotuzumab-adizutecan-for-locally-advanced-or-metastatic-solid-tumors-with-met-amplification-in-patients-12-years-and-older2026-10-07 https://dev.clinicalresearch.eu/trial/temocillin-compared-with-ceftriaxone-for-gonorrhea-in-adults-with-neisseria-gonorrhoeae-infection2026-10-07 https://dev.clinicalresearch.eu/trial/temporal-analysis-of-endothelial-extracellular-vesicles-in-car-t-cell-therapy-and-icans-using-lisocabtagene-maraleucel-and-drug-combinations-in-hematology2026-10-07 https://dev.clinicalresearch.eu/trial/tenecteplase-in-acute-ischemic-stroke-patients-planned-for-transfer-to-thrombectomy-within-4-5-24-hours-after-symptom-onset-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/tertio-evaluation-of-the-interest-to-combine-a-cd4-th1-inducer-cancer-vaccine-derived-from-telomerase-and-atezolizumab-plus-bevacizumab-in-unresectable-hepatocellular-carcinoma-a-proof-of-concept-rand2026-10-07 https://dev.clinicalresearch.eu/trial/test-retest-evaluation-of-18f-f-arag-in-lung-tumors-treat2026-10-07 https://dev.clinicalresearch.eu/trial/the-3tr-molecular-pathobiology-driven-precision-therapy-in-ra-3tr-precis-the-ra-study2026-10-07 https://dev.clinicalresearch.eu/trial/the-colchicine-and-atrial-fibrillation-trial2026-10-07 https://dev.clinicalresearch.eu/trial/the-dexa-psych-study-dexamethasone-repurposing-for-moderate-to-severe-depression-a-double-blind-randomized-parallel-group-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-cabergoline-in-infertile-women-on-peritoneal-endometriosis-related-dysmenorrhea-chronic-pelvic-pain-and-fertility2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-cbd-on-sleep-quality-following-late-evening-exercise2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-colchicine-on-insulin-sensitivity-in-individuals-with-type-1-diabetes-and-systemic-low-grade-inflammation-ins1ght2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-early-landiolol-in-patients-with-st-elevation-acute-coronary-syndrome-undergoing-primary-percutaneous-coronary-intervention-a-prospective-randomized-double-blinded-placebo-controlled-pha2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-empagliflozin-on-peripheral-microvascular-dysfunction-in-heart-failure-with-preserved-ejection-fraction2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-oral-folinic-acid-rescue-therapy-on-pemetrexed-induced-neutropenia-and-other-toxicity-a-randomized-open-label-trial2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-ropinirole-on-functional-connectivity-and-metacognition-in-healthy-subjects2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-of-transdermal-17-b-estradiol-progesterone-supplementation-on-glucose-regulation-in-peri-and-postmenopausal-women-with-type-1-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/the-effect-op-corticosteroids-on-quality-of-life-following-total-hip-arthroplasty-hipster-study2026-10-07 https://dev.clinicalresearch.eu/trial/the-efficacy-of-pipamperone-and-aripiprazole-on-behaviors-that-challenge-in-people-with-intellectual-disabilities-a-series-of-n-of-1-cross-over-trials2026-10-07 https://dev.clinicalresearch.eu/trial/the-enact-trial-a-randomized-double-blind-placebo-controlled-adjunctive-treatment-trial-to-evaluate-the-efficacy-and-safety-of-enx-101-in-patients-with-focal-partial-onset-seizures2026-10-07 https://dev.clinicalresearch.eu/trial/the-expression-of-fibroblast-activation-protein-in-patients-with-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/the-growth-hormone-deficiency-reversal-trial-effect-on-final-height-of-discontinuation-vs-continuation-of-growth-hormone-treatment-in-pubertal-children-with-isolated-growth-hormone-deficiency-a-non-in2026-10-07 https://dev.clinicalresearch.eu/trial/the-imagine-study-a-phase-3b-open-label-single-arm-study-to-assess-the-effect-of-depemokimab-on-airway-structure-and-function-in-asthma-with-type-2-inflammation-characterized-by-an-eosinophilic-phenot2026-10-07 https://dev.clinicalresearch.eu/trial/the-influence-of-tramadol-on-opioid-induced-bowel-dysfunction2026-10-07 https://dev.clinicalresearch.eu/trial/the-intertransverse-process-block-for-minor-breast-cancer-surgery-single-or-multiple-injection-a-randomised-procedure-related-blinded-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/the-intertransverse-process-block-single-or-multiple-injection-a-randomised-procedure-related-blinded-crossover-trial-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/the-neotrack-trial-neoadjuvant-tiragolumab-atezolizumab-and-chemotherapy-dissection-of-io-efficacy-in-nsclc-by-longitudinal-tracking-a-non-randomized-open-label-single-arm-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/the-node-202-study-multi-center-multi-national-open-label-efficacy-and-safety-study-of-etripamil-nasal-spray-in-pediatric-patients-with-paroxysmal-supraventricular-tachycardia2026-10-07 https://dev.clinicalresearch.eu/trial/the-pancreatic-enzymes-after-gastrectomy-trial2026-10-07 https://dev.clinicalresearch.eu/trial/the-safety-and-efficacy-of-acute-subcutaneous-administration-of-semaglutide-in-non-diabetic-patients-with-acute-ischemic-stroke-a-multicentre-phase-2-prospective-randomized-open-label-blinded-endpoint2026-10-07 https://dev.clinicalresearch.eu/trial/the-surf-trial-optimizing-surgical-excision-using-real-time-fluorescence-imaging-with-indocyanine-green2026-10-07 https://dev.clinicalresearch.eu/trial/the-use-of-intranasal-dexmedetomidine-for-pediatric-sedation-in-non-invasive-radiological-procedures-ctms-004321-assessing-the-efficacy-and-safety-profile-of-intranasal-dexmedetomidine-for-procedural-2026-10-07 https://dev.clinicalresearch.eu/trial/theophylline-effects-in-the-fontan-circulation2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-de-escalation-strategy-evaluation-using-therapeutic-drug-monitoring-in-chronic-noninfectious-uveitis-treated-with-adalimumab2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-dose-monitoring-of-epirubicin-cyclophosphamide-docetaxel-paclitaxel-and-doxorubicin-in-female-breast-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-drug-monitoring-guided-de-escalation-of-subcutaneous-vedolizumab-in-inflammatory-bowel-disease-remission-a-randomized-controlled-pilot-study2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-drug-monitoring-guided-versus-standard-dosing-of-alectinib-in-alk-positive-non-small-cell-lung-cancer-patients2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-equivalence-study-of-clindamycin-and-tretinoin-gel-in-acne-vulgaris-a-randomized-double-blind-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/therapeutic-monitoring-of-ocrelizumab-serum-concentrations-in-relapsing-remitting-and-primary-progressive-multiple-sclerosis-patients2026-10-07 https://dev.clinicalresearch.eu/trial/thiamine-against-chronic-rheumatoid-arthritis-fatigue2026-10-07 https://dev.clinicalresearch.eu/trial/thiamine-hydroxocobalamin-acetate-thiamine-hydrochloride-pyridoxine-hydrochloride-supplementation-to-reduce-brain-injury-in-outpatients-with-alcohol-use-disorder2026-10-07 https://dev.clinicalresearch.eu/trial/think-intensification-of-blood-pressure-lowering-therapeutics-based-on-diuretics-versus-usual-management-for-uncontrolled-hypertension-in-patients-with-moderate-to-severe-chronic-kidney-disease-an-ope2026-10-07 https://dev.clinicalresearch.eu/trial/thorough-qt-qtc-study-of-glpg3667-in-healthy-volunteers2026-10-07 https://dev.clinicalresearch.eu/trial/thrombolysis-with-tenecteplase-for-acute-ischemic-stroke-in-patients-taking-direct-oral-anticoagulants-a-multicentre-randomised-placebo-controlled-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/thromboprophylaxis-in-good-and-intermediate-prognosis-advanced-germ-cell-tumors-gig-t2026-10-07 https://dev.clinicalresearch.eu/trial/ticagrelor-versus-placebo-for-preventing-cerebral-ischemia-in-patients-with-low-grade-aneurysmal-subarachnoid-hemorrhage-wfns-1-3-within-72-hours2026-10-07 https://dev.clinicalresearch.eu/trial/ticagrelor-with-or-without-acetylsalicylic-acid-in-medically-managed-myocardial-infarction-patients-a-safety-and-efficacy-trial2026-10-07 https://dev.clinicalresearch.eu/trial/tirzepatide-versus-cpap-and-lifestyle-modification-for-obstructive-sleep-apnea-in-adults-65-years-with-overweight-or-obesity2026-10-07 https://dev.clinicalresearch.eu/trial/topology-a-phase-ii-study-to-evaluate-the-efficacy-and-toxicities-of-plx038-in-patients-with-locally-advanced-or-metastatic-triple-negative-breast-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/total-body-pet-imaging-with-flutemetamol-18f-to-locate-amyloid-containing-microclots-in-adults-with-post-covid-syndrome2026-10-07 https://dev.clinicalresearch.eu/trial/tramornot-tramadol-versus-morphine-in-postoperative-analgesia-after-laparoscopic-abdominal-surgery-a-randomized-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/tranexamic-acid-for-hyperacute-spontaneous-intracerebral-haemorrhage-tich-32026-10-07 https://dev.clinicalresearch.eu/trial/transcript-an-open-label-controlled-randomized-multicentric-international-study-evaluating-the-benefit-of-autologous-stem-cell-transplantation-after-complete-response-in-frontline-setting-patients-wit2026-10-07 https://dev.clinicalresearch.eu/trial/transdermal-testosterone-pretreatment-in-poor-responders-with-androgen-receptor-polymorphism-undergoing-icsi-a-randomized-clinical-investigation2026-10-07 https://dev.clinicalresearch.eu/trial/transfer-of-metformin-into-human-breast-milk-and-the-plasma-of-breastfeeding-children-a-low-intervention-trial-with-biobanking-of-breast-milk-and-plasma-in-vastra-gotalandsregionen-and-region-orebro2026-10-07 https://dev.clinicalresearch.eu/trial/treatment-of-high-risk-prostate-cancer-guided-by-novel-diagnostic-radio-and-molecular-tracers-thunder-a-two-part-phase-2-3-trial2026-10-07 https://dev.clinicalresearch.eu/trial/treatment-of-keratolyttreatment-of-keratolytic-winter-erythema-with-systemic-nitroxoline-a-phase-2a-randomized-placebo-controlled-crossover-study-of-male-and-female-adults-from-three-norwegian-familie2026-10-07 https://dev.clinicalresearch.eu/trial/treatment-of-rhinosinusitis-with-nasal-polyposis-with-dupilumab-and-mepolizumab-a-randomized-multi-centre-head-to-head-comparison-in-real-world-danish-patients2026-10-07 https://dev.clinicalresearch.eu/trial/treatment-with-zoledronate-subsequent-to-denosumab-in-osteoporosis-22026-10-07 https://dev.clinicalresearch.eu/trial/trio-a-prospective-randomized-trial-of-non-inferiority-comparing-rituximab-versus-ocrelizumab-in-relapsing-remitting-multiple-sclerosis2026-10-07 https://dev.clinicalresearch.eu/trial/triple-oral-lipid-lowering-therapy-including-bempedoic-acid-versus-usual-care-in-early-management-of-acute-coronary-syndrome-patients2026-10-07 https://dev.clinicalresearch.eu/trial/triton-cm-a-phase-3-global-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-nucresiran-in-patients-with-transthyretin-mediated-amyloidosis-with-cardiomyopathy-at2026-10-07 https://dev.clinicalresearch.eu/trial/tuc-toc-tucatinib-in-combination-with-oral-etoposide-vp16-trastuzumab-in-patients-with-metastatic-her2-breast-cancer-after-progression-under-tucatinib-capecitabine-trastuzumab-or-toxicity-related-to-c2026-10-07 https://dev.clinicalresearch.eu/trial/tulmistar-01-a-two-part-phase-i-dose-escalation-and-expansion-followed-by-a-randomized-open-label-multicenter-phase-ii-study-to-assess-the-safety-and-efficacy-of-the-combination-of-tulmimetostat-dzr122026-10-07 https://dev.clinicalresearch.eu/trial/tulmistar-02-a-two-part-phase-i-dose-escalation-study-of-tulmimetostat-dzr123-in-combination-with-darolutamide-or-abiraterone-followed-by-open-label-randomized-phase-ii-dose-expansion-study-to-assess-2026-10-07 https://dev.clinicalresearch.eu/trial/ublituximab-in-pediatric-participants-with-relapsing-forms-of-multiple-sclerosis-rms2026-10-07 https://dev.clinicalresearch.eu/trial/ultrasound-guided-inter-sphincteric-botulinum-toxin-type-a-injections-for-chronic-anal-fissure-efficacy-and-safety-evaluation2026-10-07 https://dev.clinicalresearch.eu/trial/use-of-fludeoxyglucose-18f-in-pet-ct-scans-to-diagnose-and-monitor-cardiovascular-device-infections2026-10-07 https://dev.clinicalresearch.eu/trial/using-18f-ded-brain-imaging-to-study-early-changes-in-patients-with-dementia-and-alzheimer-s-disease2026-10-07 https://dev.clinicalresearch.eu/trial/using-18f-fapi-74-pet-imaging-to-improve-the-diagnosis-and-follow-up-of-patients-with-giant-cell-arteritis2026-10-07 https://dev.clinicalresearch.eu/trial/using-68ga-fapi-46-imaging-to-detect-scarring-in-patients-with-inflammatory-diseases-such-as-crohn-s-disease-ulcerative-colitis-systemic-sclerosis-and-lung-fibrosis2026-10-07 https://dev.clinicalresearch.eu/trial/using-68ga-fapi-46-pet-ct-for-initial-staging-in-patients-with-gastric-cancer-eligible-for-curative-treatment2026-10-07 https://dev.clinicalresearch.eu/trial/using-atorvastatin-to-prevent-graves-ophthalmopathy-in-patients-newly-diagnosed-with-graves-disease2026-10-07 https://dev.clinicalresearch.eu/trial/using-canagliflozin-dapagliflozin-and-empagliflozin-to-stabilize-artery-buildup-in-patients-with-diabetes-after-a-heart-attack2026-10-07 https://dev.clinicalresearch.eu/trial/using-capecitabine-oxaliplatin-fluorouracil-irinotecan-and-folinic-acid-to-personalize-chemotherapy-for-patients-with-stage-iii-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/using-ceftazidime-and-avibactam-with-rapid-testing-for-patients-with-bloodstream-infections-hospital-acquired-pneumonia-or-ventilator-associated-pneumonia2026-10-07 https://dev.clinicalresearch.eu/trial/using-ceftriaxone-clotrimazole-metronidazole-azithromycin-and-doxycycline-to-treat-vaginal-flora-abnormalities-in-pregnant-women-at-high-risk-of-preterm-birth2026-10-07 https://dev.clinicalresearch.eu/trial/using-focused-ultrasound-to-improve-temozolomide-delivery-in-patients-with-diffuse-midline-glioma2026-10-07 https://dev.clinicalresearch.eu/trial/using-technetium-99mtc-galactosyl-serum-albumin-to-predict-complications-in-patients-undergoing-surgery-for-liver-tumors2026-10-07 https://dev.clinicalresearch.eu/trial/ustekinumab-to-reduce-toxicity-of-dual-pd-1-and-ctla-4-checkpoint-inhibitors-in-patients-with-pleural-mesothelioma2026-10-07 https://dev.clinicalresearch.eu/trial/vaccination-against-human-papillomavirus-hpv-after-allogeneic-stem-cell-transplantation-a-randomized-study-between-early-and-late-vaccination2026-10-07 https://dev.clinicalresearch.eu/trial/validation-and-evaluation-of-non-radioactive-methods-for-measuring-glomerular-filtration-rate-in-chronic-kidney-disease-using-iohexol-sodium-iotalamate-125i-and-iotalamate-meglumine2026-10-07 https://dev.clinicalresearch.eu/trial/validation-of-sentinel-lymph-node-technique-in-early-stage-ovarian-cancer-using-pertechnetate-99mtc-sodium-human-serum-albumin-and-indocyanine-green2026-10-07 https://dev.clinicalresearch.eu/trial/vasodilatation-or-loop-diuretics-for-initial-treatment-of-pulmonary-congestion-due-to-acute-heart-failure-a-randomized-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/vasopressin-and-steroids-in-addition-to-adrenaline-in-cardiac-arrest-a-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/vasopressin-versus-norepinephrine-after-pulmonary-endarterectomy-in-patients-with-chronic-thromboembolic-pulmonary-hypertension2026-10-07 https://dev.clinicalresearch.eu/trial/vats-versus-intrapleural-alteplase-and-dornase-alfa-for-adults-with-pleural-empyema2026-10-07 https://dev.clinicalresearch.eu/trial/vegf-targeted-optical-fluorescent-imaging-for-detection-of-peritoneal-metastases-of-colorectal-origin-during-diagnostic-laparoscopy2026-10-07 https://dev.clinicalresearch.eu/trial/venetoclax-added-to-standard-fludarabine-cytarabine-and-gemtuzumab-ozogamicin-drug-combination-for-children-with-relapsed-acute-myeloid-leukemia2026-10-07 https://dev.clinicalresearch.eu/trial/venetoclax-added-to-standard-induction-chemotherapy-in-patients-with-flt3-mutated-acute-myeloid-leukemia-eligible-for-intensive-chemotherapy2026-10-07 https://dev.clinicalresearch.eu/trial/venetoclax-in-combination-with-the-btk-inhibitor-ibrutinib-and-rituximab-or-conventional-chemotherapy-bendamustine-and-ibrutinib-and-rituximab-in-patients-with-treatment-naive-mantle-cell-lymphoma-not2026-10-07 https://dev.clinicalresearch.eu/trial/verteporfin-for-scar-prevention-after-surgery-in-patients-with-surgical-wounds2026-10-07 https://dev.clinicalresearch.eu/trial/vigabatrin-prophylaxis-for-prevention-of-infantile-spasms-in-high-risk-infants-with-tuberous-sclerosis-or-large-vascular-cortical-injury2026-10-07 https://dev.clinicalresearch.eu/trial/viral-clearance-in-immunocompromised-patients-with-persistent-covid-19-using-nirmatrelvir-and-remdesivir-an-open-label-randomized-trial2026-10-07 https://dev.clinicalresearch.eu/trial/virological-and-immunological-evaluation-of-dolutegravir-lamivudine-versus-bictegravir-emtricitabine-tenofovir-alafenamide-in-hiv-1-positive-patients2026-10-07 https://dev.clinicalresearch.eu/trial/vitamin-k-antagonist-and-direct-thrombin-inhibitor-dabigatran-for-thrombus-resolution-in-left-ventricular-thrombus-after-acute-stemi-an-open-label-randomized-controlled-multicenter-phase-ii-study2026-10-07 https://dev.clinicalresearch.eu/trial/vmx-c001-for-patients-taking-a-factor-xa-inhibitor-who-need-urgent-surgery-or-an-invasive-procedure-with-high-bleeding-risk2026-10-07 https://dev.clinicalresearch.eu/trial/waiting-on-atrial-fibrillation-intervention-therapy-wait-study2026-10-07 https://dev.clinicalresearch.eu/trial/walkals-a-pilot-phase-ii-study-to-evaluate-the-effect-of-salbutamol-on-walking-capacity-in-ambulatory-als-patients2026-10-07 https://dev.clinicalresearch.eu/trial/weekly-iv-human-alpha1-proteinase-inhibitor-at-multiple-doses-for-safety-and-effectiveness-in-adults-with-alpha1-antitrypsin-deficiency-related-emphysema2026-10-07 https://dev.clinicalresearch.eu/trial/weekly-somatrogon-versus-daily-somatropin-in-children-with-small-for-gestational-age-or-idiopathic-short-stature2026-10-07 https://dev.clinicalresearch.eu/trial/what-is-the-optimal-antithrombotic-strategy-in-patients-with-atrial-fibrillation-having-acute-coronary-syndrome-or-undergoing-percutaneous-coronary-intervention2026-10-07 https://dev.clinicalresearch.eu/trial/window-of-opportunity-umbrella-platform-trial-of-short-course-pre-operative-or-neoadjuvant-targeted-treatment-in-patients-with-molecularly-selected-and-resectable-primary-colorectal-cancer-the-unicorn2026-10-07 https://dev.clinicalresearch.eu/trial/women-more-prospective-phase-iii-multi-center-open-label-study-of-the-efficacy-safety-and-acceptability-of-mifepristone-50-mg-once-weekly-as-a-contraceptive2026-10-07 https://dev.clinicalresearch.eu/trial/xerostomia-in-patients-with-a-life-limiting-condition-or-frailty-a-double-blind-placebo-controlled-randomized-clinical-trial2026-10-07 https://dev.clinicalresearch.eu/trial/z0011001-a-phase-1-2-open-label-multi-center-study-of-zn-c3-administered-in-combination-with-encorafenib-and-cetuximab-in-adults-with-metastatic-colorectal-cancer2026-10-07 https://dev.clinicalresearch.eu/trial/zangea-phase-ii-study-of-zanidatamab-in-combination-with-pembrolizumab-and-chemotherapy-in-her2-and-pd-l1-positive-metastatic-gastroesophageal-adenocarcinoma-gea-patients2026-10-07 https://dev.clinicalresearch.eu/trial/zanubrutinib-a-second-generation-btk-inhibitor-in-anti-mag-antibody-neuropathy-a-phase-ii-italian-multicenter-clinical-trial-mazinga2026-10-07 https://dev.clinicalresearch.eu/trial/zenagamtide-compared-with-semaglutide-for-weight-loss-in-adults-with-overweight-or-obesity-and-type-2-diabetes2026-10-07 https://dev.clinicalresearch.eu/trial/zenith-a-phase-3-global-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-zilebesiran-in-addition-to-standard-of-care-in-reducing-major-adverse-cardiovascular-eve2026-10-07 https://dev.clinicalresearch.eu/trial/zirconium-89-crefmirlimab-berdoxam-pet-imaging-of-cd8-t-cells-in-kidney-transplant-recipients-with-allograft-rejection2026-10-07 https://dev.clinicalresearch.eu/trial/zoledronic-acid-to-prevent-glucocorticoid-induced-osteoporosis-in-lymphoma-patients2026-10-07 https://dev.clinicalresearch.eu/trial/zoledronic-acid-versus-placebo-for-pain-relief-in-children-with-nsaid-resistant-chronic-recurrent-multifocal-osteomyelitis2026-10-07 https://dev.clinicalresearch.eu/trial/zoledronic-acid-versus-placebo-in-pre-parathyroidectomy-management-of-primary-hyperparathyroidism-a-randomized-blinded-placebo-controlled-trial2026-10-07 https://dev.clinicalresearch.eu/trial/zongertinib-with-carboplatin-or-cisplatin-and-pemetrexed-with-or-without-pembrolizumab-in-patients-with-advanced-her2-mutated-non-small-cell-lung-cancer2026-10-07